,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC004496-41,"October 01, 2017 -  September 30, 2018",Chromosomal Proteins and Chromosomal Functions,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",Ravikanth  Nanduri; PhD|Shaofei  Zhang,"Vasily  Studitsky (Department of Pharmacology, University of Medicine and Dentistry of New Jersey)|Jefferey  Hayes (University of Rochester medical Center)","Takashi  Furusawa (Laboratory of Metabolism)|Yuri  Postnikov; MD, PhD (Laboratory of Metabolism)|Joost J Oppenheim; MD (Cancer Inflammation Program)",David  Landsman; PhD (NLM),"1. Deng T, Postnikov Y, Zhang S, Garrett L, Becker L, Rácz I, Hölter SM, Wurst W, Fuchs H, Gailus-Durner V, de Angelis MH, Bustin M (2017). Interplay between H1 and HMGN epigenetically regulates OLIG1&2 expression and oligodendrocyte differentiation. Nucleic Acids Res  45, 3031-3045.   https://doi.org/10.1093/nar/gkw1222|2. Kugler J, Postnikov YV, Furusawa T, Kimura S, Bustin M (2017). Elevated HMGN4 expression potentiates thyroid tumorigenesis. Carcinogenesis  38, 391-401.   https://doi.org/10.1093/carcin/bgx015|3. Murphy KJ, Cutter AR, Fang H, Postnikov YV, Bustin M, Hayes JJ (2017). HMGN1 and 2 remodel core and linker histone tail domains within chromatin. Nucleic Acids Res  45, 9917-9930.   https://doi.org/10.1093/nar/gkx579",https://intramural.nih.gov/search/searchview.taf?ipid=103587
1,BC004504-46,"October 01, 2017 -  September 30, 2018",Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Christophe  Cataisson|Serena Yeliz Korkmaz|Luowei  Li|Amalia Rose Sweet|Kenneth  Wong|Wendy  Weinberg,NULL,Giorgio  Trinchieri (Cancer Inflammation Program),Maria Irene Morasso; PhD (NIAMS),"1. Palazzo E, Kellett MD, Cataisson C, Bible PW, Bhattacharya S, Sun HW, Gormley AC, Yuspa SH, Morasso MI (2017). A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation. Cell Death Differ  24, 717-730.   https://doi.org/10.1038/cdd.2017.5",https://intramural.nih.gov/search/searchview.taf?ipid=103588
2,BC004517-42,"October 01, 2017 -  September 30, 2018",DNA Repair in Human Cancer-Prone Genetic Diseases,Kenneth H Kraemer; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Laila Abdulkareem Al-Eryani|Eric Bryan Bowman|John  Digiovanna|Sikandar  Khan|Melissa Ann Levoska|Nathaniel Anup Patel|Show all 11,"Steffen  Emmert|Vera  Price (Univ of California, SF)|Hanoch  Slor (Tel Aviv Univ Med School)|Alain  Sarasin|Allen  Lehmann (Genome Damage and Stability Centre, Univ of Sussex)|N G  Jaspers (Genetics, Erasmus Univ)|Show all 14",Margaret Anne Tucker (Human Genetics Program)|Alisa  Goldstein; PhD (Clinical Genetics Branch)|Michael  Bustin; PhD (Protein Section)|Mark  Raffeld; MD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology),"Nicholas  Patronas; MD (CC) |Vilhelm A Bohr; MD, PhD (NIA) |Brian Patrick Brooks; MD, PhD (NEI) |Melissa A Merideth (NHGRI) |Carmen Crowell Brewer; PhD (NIDCD) |Andrew J Griffith; MD, PhD (NIDCD)","1. Kraemer K, Sarasin A (2017) Xeroderma Pigmentosum, in WHO Classification of Skin Tumours (4th edition), in press.|2. Tamura D, Kraemer K, DiGiovanna J (2017) Xeroderma Pigmentosum, in Treatment of skin diseases (5th edition), in press.|3. Tamura D, Ono R, DiGiovanna J, Kraemer K (2017) Management of xeroderma pigmentosum, in DNA Repair Disorders, in press.|4. Hirai Y, Noda A, Kodama Y, Cordodva K, Cullings H, Yonehara S, Fujihara M, Moriwaki S, Nishigori C, Mabuchi K, Kraemer K, Nakamura N (2018) Increased skin cancer risk in Japanese XPA heterozygotes. Journal of Human Genetics, in press.|5. Randall G, Kraemer K, Pugh J, Tamura D, DiGiovanna J, Khan S, Oetjen K (2018) Mortality associated Immunologic abnormalities in trichothiodystrophy: Correlation of reduced levels of immunoglobulin and neutrophils with poor patient survival. British Journal of Haematology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103589
3,BC005093-40,"October 01, 2017 -  September 30, 2018",Growth-Differentiation Factors in Organogenesis,Alan O Perantoni; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",Michael David Hall|Nirmala D Sharma|Heather Marie Wojcik|Susan  Mackem; MD,Harold  Lovvorn (Vanderbilt University)|Mark  de Caestecker (Vanderbilt University),Mark B Lewandoski (Genetics of Vertebrate Development Section)|James  Lautenberger; PhD (Office of the Director)|George  Nelson (Office of the Director)|Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Hall MD, Murray CA, Valdez MJ, Perantoni AO (2017). Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes. PLoS Genet  13, e1006610.   https://doi.org/10.1371/journal.pgen.1006610|2. Yun K, Perantoni AO (2017). Hydronephrosis in the Wnt5a-ablated kidney is caused by an abnormal ureter-bladder connection. Differentiation  94, 1-7.   https://doi.org/10.1016/j.diff.2016.11.006",https://intramural.nih.gov/search/searchview.taf?ipid=103590
4,BC005177-38,"October 01, 2017 -  September 30, 2018",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,Daniel  Martineau (University of Montreal at St. Hyacinthe)|John  Wise,Qing  Lan (Occupational and Environmental Epidemiology Branch)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Daniel C Edelman (Cancer Genetics Branch),Esther Jo Asaki (CIT),"1. Anholt H, Haulena M, Poirier M, Divi K, Raverty S (2018). Endometrial Adenocarcinoma and Carcinomatosis in an Adult Display Beluga. Aquatic Mammals  44, 499-507.|2. Poirier MC, Lair S, Michaud R, Hernández-Ramon EE, Divi KV, Dwyer JE, Ester CD, Si NN, Ali M, Loseto LL, Raverty SA, St Leger JA, Van Bonn WG, Colegrove K, Burek-Huntington KA, Suydam R, Stimmelmayr R, Wise JP, Wise SS, Beauchamp G, Martineau D (2019). Intestinal polycyclic aromatic hydrocarbon-DNA adducts in a population of beluga whales with high levels of gastrointestinal cancers. Environ Mol Mutagen  60, 29-41.   https://doi.org/10.1002/em.22251",https://intramural.nih.gov/search/searchview.taf?ipid=103591
5,BC005268-31,"October 01, 2017 -  September 30, 2018",Mechanism of Meiotic Recombination,Michael Joseph Lichten; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Matan  Cohen|Krishnaprasad Gurukripa Nandanan; PhD|Jasvinder  Singh; PhD|Anura Gokul Shodhan; PhD|Martin  Xaver; PhD,Alastair  Goldman (University of Sheffield)|Akira  Shinohara (Osaka University)|Soni  Lacefield (Indiana University),NULL,NULL,"1. Lichten M (2017). Proteasomes on the chromosome. Cell Res  27, 602-603.   https://doi.org/10.1038/cr.2017.28",https://intramural.nih.gov/search/searchview.taf?ipid=103592
6,BC005270-37,"October 01, 2017 -  September 30, 2018",Molecular Mechanism of Action of Phorbol Ester,Peter  Blumberg; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Adelle  Abramovitz|Agnes  Czikora|Amelework Deneke Habtemichael|Gary Alexander Mitchell|Xiaoling  Zhou|Stuart H Yuspa; MD,"Gary  Keck (Dept. of Chemistry, University of Utah)|Marie  Comin (National Institute of Industrial Technology)|Jeewoo  Lee (Seoul National Univeristy)|Derek C Braun|Sun J Choi|Joydip  Das (University of Houston)|Show all 13",Noemi  Kedei (Office of the Director)|Megan L Peach (Chemical Biology Laboratory),Kenton J Swartz; PhD (NINDS) |Heather R Kalish; PhD (NIBIB),"1. Cooke M, Zhou X, Casado-Medrano V, Lopez-Haber C, Baker MJ, Garg R, Ann J, Lee J, Blumberg PM, Kazanietz MG (2018). Characterization of AJH-836, a diacylglycerol-lactone with selectivity for novel PKC isozymes. J Biol Chem  293, 8330-8341.   https://doi.org/10.1074/jbc.RA117.000235|2. Czikora A, Kedei N, Kalish H, Blumberg PM (2017). Importance of the REM (Ras exchange) domain for membrane interactions by RasGRP3. Biochim Biophys Acta Biomembr  1859, 2350-2360.   https://doi.org/10.1016/j.bbamem.2017.09.010|3. Czikora A, Pany S, You Y, Saini AS, Lewin NE, Mitchell GA, Abramovitz A, Kedei N, Blumberg PM, Das J (2018). Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta. Biochim Biophys Acta Biomembr  1860, 1046-1056.   https://doi.org/10.1016/j.bbamem.2018.01.007|4. Das J, Kedei N, Kelsey JS, You Y, Pany S, Mitchell GA, Lewin NE, Blumberg PM (2018). Critical Role of Trp-588 of Presynaptic Munc13-1 for Ligand Binding and Membrane Translocation. Biochemistry  57, 732-741.   https://doi.org/10.1021/acs.biochem.7b00764|5. Elhalem E, Donadío LG, Zhou X, Lewin NE, Garcia LC, Lai CC, Kelley JA, Peach ML, Blumberg PM, Comin MJ (2017). Exploring the influence of indololactone structure on selectivity for binding to the C1 domains of PKCα, PKCε, and RasGRP. Bioorg Med Chem  25, 2971-2980.   https://doi.org/10.1016/j.bmc.2017.03.022|6. Kelsey JS, Géczy T, Kaler CJ, Blumberg PM (2017). The C1 domain of Vav3, a novel potential therapeutic target. Cell Signal  40, 133-142.   https://doi.org/10.1016/j.cellsig.2017.09.008|7. Lee S, Kang DW, Ryu H, Kim C, Ann J, Lee H, Kim E, Hong S, Choi S, Blumberg PM, Frank-Foltyn R, Bahrenberg G, Stockhausen H, Christoph T, Lee J (2017). t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists. Bioorg Med Chem  25, 2451-2462.   https://doi.org/10.1016/j.bmc.2017.03.004|8. Ohashi N, Kobayashi R, Nomura W, Kobayakawa T, Czikora A, Herold BK, Lewin NE, Blumberg PM, Tamamura H (2017). Synthesis and Evaluation of Dimeric Derivatives of Diacylglycerol-Lactones as Protein Kinase C Ligands. Bioconjug Chem  28, 2135-2144.   https://doi.org/10.1021/acs.bioconjchem.7b00299|9. Pearce LV, Ann J, Jung A, Thorat SA, Herold BKA, Habtemichael AD, Blumberg PM, Lee J (2017). Novel Radiolabeled Vanilloid with Enhanced Specificity for Human Transient Receptor Potential Vanilloid 1 (TRPV1). J Med Chem  60, 8246-8252.   https://doi.org/10.1021/acs.jmedchem.7b00859",https://intramural.nih.gov/search/searchview.taf?ipid=103593
7,BC005271-27,"October 01, 2017 -  September 30, 2018",Gene Regulation and Function: The B-ZIP Proteins,Charles  Vinson; PhD|IRP Faculty Profile,NULL,"Nucleic Acids Section, NCI",Nima Michael Assad|Sreejana  Ray|Desiree Christine Tillo|Aniekanabasi Ime Ufot,Tim  Hughes (University of Toronto)|Matthew T Weirauch (University of Toronto)|John  Stamatoyannopoulos (University of Washington)|Andrew  Smith (University of Southern California)|Jussi  Taipale (Karolinska Institute),Shioko  Kimura; PhD (Endocrinology Section)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Michael  Bustin; PhD (Protein Section)|Peter C Fitzgerald (Office of the Director)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism),Ann  Dean; PhD (NIDDK) |Kai  Ge; PhD (NIDDK),"1. Jain P, Shah K, Sharma N, Kaur R, Singh J, Vinson C, Rishi V (2017). A-ZIP53, a dominant negative reveals the molecular mechanism of heterodimerization between bZIP53, bZIP10 and bZIP25 involved in Arabidopsis seed maturation. Sci Rep  7, 14343.   https://doi.org/10.1038/s41598-017-14167-5|2. Ray S, Tillo D, Assad N, Ufot A, Deppmann C, Durell SR, Porollo A, Vinson C (2018). Replacing C189 in the bZIP domain of Zta with S, T, V, or A changes DNA binding specificity to four types of double-stranded DNA. Biochem Biophys Res Commun  501, 905-912.   https://doi.org/10.1016/j.bbrc.2018.05.080|3. Sarda S, Das A, Vinson C, Hannenhalli S (2017). Distal CpG islands can serve as alternative promoters to transcribe genes with silenced proximal promoters. Genome Res  27, 553-566.   https://doi.org/10.1101/gr.212050.116|4. Tillo D, Ray S, Syed KS, Gaylor MR, He X, Wang J, Assad N, Durell SR, Porollo A, Weirauch MT, Vinson C (2017). The Epstein-Barr Virus B-ZIP Protein Zta Recognizes Specific DNA Sequences Containing 5-Methylcytosine and 5-Hydroxymethylcytosine. Biochemistry  56, 6200-6210.   https://doi.org/10.1021/acs.biochem.7b00741",https://intramural.nih.gov/search/searchview.taf?ipid=103594
8,BC005445-34,"October 01, 2017 -  September 30, 2018",Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer,Stuart H Yuspa; MD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Ji  Luo|Kent W Hunter; PhD,NULL,Christina M Annunziata (Womens Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103595
9,BC005450-35,"October 01, 2017 -  September 30, 2018",Chromatin Structure and Gene Expression,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Miroslav  Dundr|Saori  Fujiwara|Ido  Goldstein; PhD|Thomas A Johnson|Sohyoung  Kim|Show all 13,Susanne  Mandrup (University of Southern Denmark)|Dan  Theodorescu (University of Colorado)|Lars  Grontved|Miroslav  Dundr|Jeremy  Gunawardena (Harvard Medical School)|Richard  Treisman (The Francis Crick Institute),Michael L Nickerson (Laboratory Translational Genomics)|Peter L Choyke; MD (Molecular Imaging Program)|Vassiliki  Saloura; MD (Thoracic & Oncologic Surgery Branch)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling)|Carol J Thiele (Pediatric Oncology Branch),"Jay H Chung; MD, PhD (NHLBI) |David Johannes Clark; PhD (NICHD) |Iain  Fraser (NIAID) |Myong-Hee  Sung (NIA)","1. Goldstein I, Paakinaho V, Baek S, Sung MH, Hager GL (2017). Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading. Nat Commun  8, 1849.   https://doi.org/10.1038/s41467-017-02055-5|2. Paakinaho V, Presman DM, Ball DA, Johnson TA, Schiltz RL, Levitt P, Mazza D, Morisaki T, Karpova TS, Hager GL (2017). Single-molecule analysis of steroid receptor and cofactor action in living cells. Nat Commun  8, 15896.   https://doi.org/10.1038/ncomms15896|3. Palangat M, Anastasakis DG, Fei DL, Lindblad KE, Bradley R, Hourigan CS, Hafner M, Larson DR (2019). The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation. Genes Dev  33, 482-497.   https://doi.org/10.1101/gad.319590.118|4. Rodriguez J, Ren G, Day CR, Zhao K, Chow CC, Larson DR (2019). Intrinsic Dynamics of a Human Gene Reveal the Basis of Expression Heterogeneity. Cell  176, 213-226.e18.   https://doi.org/10.1016/j.cell.2018.11.026",https://intramural.nih.gov/search/searchview.taf?ipid=103596
10,BC005522-31,"October 01, 2017 -  September 30, 2018",Stem-Progenitor Cells and Carcinogenesis of Thyroid,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Henrique Bregolin Dias|Yo-Taro  Shirai|Yongtao  Wang|Shigetoshi  Yokoyama,NULL,NULL,NULL,"1. Iwadate M, Takizawa Y, Shirai Y, Kimura S (2018). An in vivo model for thyroid regeneration and folliculogenesis. Lab Invest  98, In Press.|2. Murata T, Iwadate M, Takizawa Y, Miyakoshi M, Hayase S, Yang W, Cai Y, Yokoyama S, Nagashima K, Wakabayashi Y, Zhu J, Kimura S (2017). An Adult Mouse Thyroid Side Population Cell Line that Exhibits Enriched Epithelial-Mesenchymal Transition. Thyroid  27, 460-474.   https://doi.org/10.1089/thy.2016.0130|3. Ostrin EJ, Little DR, Gerner-Mauro KN, Sumner EA, Ríos-Corzo R, Ambrosio E, Holt SE, Forcioli-Conti N, Akiyama H, Hanash SM, Kimura S, Huang SXL, Chen J (2018). β-Catenin maintains lung epithelial progenitors after lung specification. Development  145.   https://doi.org/10.1242/dev.160788|4. Zou M, Baitei EY, BinEssa HA, Al-Mohanna FA, Parhar RS, St-Arnaud R, Kimura S, Pritchard C, Alzahrani AS, Assiri AM, Meyer BF, Shi Y (2017). Cyp24a1 Attenuation Limits Progression of BrafV600E -Induced Papillary Thyroid Cancer Cells and Sensitizes Them to BRAFV600E Inhibitor PLX4720. Cancer Res  77, 2161-2172.   https://doi.org/10.1158/0008-5472.CAN-16-2066",https://intramural.nih.gov/search/searchview.taf?ipid=103597
11,BC005562-31,"October 01, 2017 -  September 30, 2018",Xenobiotic receptors,Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Chad Nicholas Brocker|Kristopher W Krausz,Jeffrey  Peters (NCI)|Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Yatrik  Shah|Changtao  Jiang|Moshe  Levi (University of Colorado School of Medicine)|Show all 8,Linda G Byrd (Nucleic Acids Section)|Donghwan  Kim (Nucleic Acids Section)|Yuhong  Luo (Nucleic Acids Section)|Qiong  Wang (Nucleic Acids Section)|Cen  Xie (Nucleic Acids Section)|Tomoki  Yagai (Nucleic Acids Section),Oksana  Gavrilova; PhD (NIDDK),"1. Battistelli C, Cicchini C, Santangelo L, Tramontano A, Grassi L, Gonzalez FJ, de Nonno V, Grassi G, Amicone L, Tripodi M (2017). The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition. Oncogene  36, 942-955.   https://doi.org/10.1038/onc.2016.260|2. Borland MG, Yao PL, Kehres EM, Lee C, Pritzlaff AM, Ola E, Wagner AL, Shannon BE, Albrecht PP, Zhu B, Kang BH, Robertson GP, Gonzalez FJ, Peters JM (2017). Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis. Toxicol Sci  159, 436-448.   https://doi.org/10.1093/toxsci/kfx147|3. Brocker CN, Yue J, Kim D, Qu A, Bonzo JA, Gonzalez FJ (2017). Hepatocyte-specific PPARA expression exclusively promotes agonist-induced cell proliferation without influence from nonparenchymal cells. Am J Physiol Gastrointest Liver Physiol  312, G283-G299.   https://doi.org/10.1152/ajpgi.00205.2016|4. Chen Y, Wang Y, Huang Y, Zeng H, Hu B, Guan L, Zhang H, Yu AM, Johnson CH, Gonzalez FJ, Huang M, Bi H (2017). PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C. Carcinogenesis  38, 474-483.   https://doi.org/10.1093/carcin/bgx023|5. Dai M, Hua H, Lin H, Xu G, Hu X, Li F, Gonzalez FJ, Liu A, Yang J (2018). Targeted Metabolomics Reveals a Protective Role for Basal PPARα in Cholestasis Induced by α-Naphthylisothiocyanate. J Proteome Res  17, 1500-1508.   https://doi.org/10.1021/acs.jproteome.7b00838|6. Dai M, Yang J, Xie M, Lin J, Luo M, Hua H, Xu G, Lin H, Song D, Cheng Y, Guo B, Zhao J, Gonzalez FJ, Liu A (2017). Inhibition of JNK signalling mediates PPARα-dependent protection against intrahepatic cholestasis by fenofibrate. Br J Pharmacol  174, 3000-3017.   https://doi.org/10.1111/bph.13928|7. Dant TA, Lin KL, Bruce DW, Montgomery SA, Kolupaev OV, Bommiasamy H, Bixby LM, Woosley JT, McKinnon KP, Gonzalez FJ, Blazar BR, Vincent BG, Coghill JM, Serody JS (2017). T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD. Blood  130, 348-359.   https://doi.org/10.1182/blood-2016-08-734244|8. Fang ZZ, Tanaka N, Lu D, Jiang CT, Zhang WH, Zhang C, Du Z, Fu ZW, Gao P, Cao YF, Sun HZ, Zhu ZT, Cai Y, Krausz KW, Yao Z, Gonzalez FJ (2017). Role of the lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury. Arch Toxicol  91, 2235-2244.   https://doi.org/10.1007/s00204-016-1877-6|9. González-Barbosa E, Mejía-García A, Bautista E, Gonzalez FJ, Segovia J, Elizondo G (2017). TCDD induces UbcH7 expression and synphilin-1 protein degradation in the mouse ventral midbrain. J Biochem Mol Toxicol  31.   https://doi.org/10.1002/jbt.21947|10. Gonzalez FJ, Jiang C (2017). A Western diet-induced mouse model reveals a possible mechanism by which metformin decreases obesity. Eur J Clin Pharmacol  73, 1337-1339.   https://doi.org/10.1007/s00228-017-2322-3|11. Gonzalez FJ, Jiang C, Xie C, Patterson AD (2017). Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease. Dig Dis  35, 178-184.   https://doi.org/10.1159/000450908|12. Hao H, Cao L, Jiang C, Che Y, Zhang S, Takahashi S, Wang G, Gonzalez FJ (2017). Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. Cell Metab  25, 856-867.e5.   https://doi.org/10.1016/j.cmet.2017.03.007|13. Hu X, Tanaka N, Guo R, Lu Y, Nakajima T, Gonzalez FJ, Aoyama T (2017). PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis. J Nutr Biochem  39, 77-85.   https://doi.org/10.1016/j.jnutbio.2016.09.015|14. Idris-Khodja N, Ouerd S, Trindade M, Gornitsky J, Rehman A, Barhoumi T, Offermanns S, Gonzalez FJ, Neves MF, Paradis P, Schiffrin EL (2017). Vascular smooth muscle cell peroxisome proliferator-activated receptor γ protects against endothelin-1-induced oxidative stress and inflammation. J Hypertens  35, 1390-1401.   https://doi.org/10.1097/HJH.0000000000001324|15. Kim T, Wahyudi LD, Gonzalez FJ, Kim JH (2017). Nuclear Receptor PPARα Agonist Wy-14,643 Ameliorates Hepatic Cell Death in Hepatic IKKβ-Deficient Mice. Biomol Ther (Seoul)  25, 504-510.   https://doi.org/10.4062/biomolther.2016.218|16. Li G, Xie C, Lu S, Nichols RG, Tian Y, Li L, Patel D, Ma Y, Brocker CN, Yan T, Krausz KW, Xiang R, Gavrilova O, Patterson AD, Gonzalez FJ (2017). Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota. Cell Metab  26, 672-685.e4.   https://doi.org/10.1016/j.cmet.2017.08.019|17. Li G, Xie C, Lu S, Nichols RG, Tian Y, Li L, Patel D, Ma Y, Brocker CN, Yan T, Krausz KW, Xiang R, Gavrilova O, Patterson AD, Gonzalez FJ (2017). Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota. Cell Metab  26, 801.   https://doi.org/10.1016/j.cmet.2017.10.007|18. Luo M, Tan Z, Dai M, Song D, Lin J, Xie M, Yang J, Sun L, Wei D, Zhao J, Gonzalez FJ, Liu A (2017). Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity. Arch Toxicol  91, 897-907.   https://doi.org/10.1007/s00204-016-1779-7|19. Morimoto A, Kannari M, Tsuchida Y, Sasaki S, Saito C, Matsuta T, Maeda T, Akiyama M, Nakamura T, Sakaguchi M, Nameki N, Gonzalez FJ, Inoue Y (2017). An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function. J Biol Chem  292, 10574-10585.   https://doi.org/10.1074/jbc.M117.785592|20. Nair SG, Patel DP, Gonzalez FJ, Patel BM, Singhal P, Chaudhary DV (2018). Simultaneous determination of etonogestrel and ethinyl estradiol in human plasma by UPLC-MS/MS and its pharmacokinetic study. Biomed Chromatogr  32, e4165.   https://doi.org/10.1002/bmc.4165|21. Qin Z, Li S, Yao Z, Hong X, Xu J, Lin P, Zhao G, Gonzalez FJ, Yao X (2018). Metabolic profiling of corylin in vivo and in vitro. J Pharm Biomed Anal  155, 157-168.   https://doi.org/10.1016/j.jpba.2018.03.047|22. Scott CH, Cha KM, Ngai J, Jiang C, Cheng K, Stokes RA, Ho KWK, George J, Gonzalez FJ, Gunton JE (2017). Hepatic Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) regulates metabolism in mice. PLoS One  12, e0186543.   https://doi.org/10.1371/journal.pone.0186543|23. Sheng L, Jena PK, Liu HX, Kalanetra KM, Gonzalez FJ, French SW, Krishnan VV, Mills DA, Wan YY (2017). Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation. Sci Rep  7, 1748.   https://doi.org/10.1038/s41598-017-01576-9|24. Shi C, Min L, Yang J, Dai M, Song D, Hua H, Xu G, Gonzalez FJ, Liu A (2017). Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil. Basic Clin Pharmacol Toxicol  121, 169-174.   https://doi.org/10.1111/bcpt.12794|25. Song D, Luo M, Dai M, Bu S, Wang W, Zhang B, Gonzalez FJ, Liu A (2017). PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate. Can J Physiol Pharmacol  95, 199-205.   https://doi.org/10.1139/cjpp-2016-0140|26. Takahashi S, Tanaka N, Golla S, Fukami T, Krausz KW, Polunas MA, Weig BC, Masuo Y, Xie C, Jiang C, Gonzalez FJ (2017). Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway. Toxicol Sci  158, 334-346.   https://doi.org/10.1093/toxsci/kfx094|27. Tanaka N, Takahashi S, Hu X, Lu Y, Fujimori N, Golla S, Fang ZZ, Aoyama T, Krausz KW, Gonzalez FJ (2017). Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet. Biochim Biophys Acta Mol Basis Dis  1863, 3170-3182.   https://doi.org/10.1016/j.bbadis.2017.08.017|28. Wang L, Hong X, Yao Z, Dai Y, Zhao G, Qin Z, Wu B, Gonzalez FJ, Yao X (2018). Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes. Xenobiotica  48, 357-367.   https://doi.org/10.1080/00498254.2017.1323139|29. Wang W, Xu MJ, Cai Y, Zhou Z, Cao H, Mukhopadhyay P, Pacher P, Zheng S, Gonzalez FJ, Gao B (2017). Inflammation is independent of steatosis in a murine model of steatohepatitis. Hepatology  66, 108-123.   https://doi.org/10.1002/hep.29129|30. Xie C, Gao X, Sun D, Zhang Y, Krausz KW, Qin X, Gonzalez FJ (2018). Metabolic Profiling of the Novel Hypoxia-Inducible Factor 2α Inhibitor PT2385 In Vivo and In Vitro. Drug Metab Dispos  46, 336-345.   https://doi.org/10.1124/dmd.117.079723|31. Xie C, Jiang C, Shi J, Gao X, Sun D, Sun L, Wang T, Takahashi S, Anitha M, Krausz KW, Patterson AD, Gonzalez FJ (2017). An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice. Diabetes  66, 613-626.   https://doi.org/10.2337/db16-0663|32. Xie C, Yagai T, Luo Y, Liang X, Chen T, Wang Q, Sun D, Zhao J, Ramakrishnan SK, Sun L, Jiang C, Xue X, Tian Y, Krausz KW, Patterson AD, Shah YM, Wu Y, Jiang C, Gonzalez FJ (2017). Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. Nat Med  23, 1298-1308.   https://doi.org/10.1038/nm.4412|33. Yao PL, Chen L, Dobrzański TP, Zhu B, Kang BH, Müller R, Gonzalez FJ, Peters JM (2017). Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation. Mol Carcinog  56, 1472-1483.   https://doi.org/10.1002/mc.22607|34. Yao PL, Morales JL, Gonzalez FJ, Peters JM (2017). Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype. Immunology  150, 456-467.   https://doi.org/10.1111/imm.12699|35. Zhao Q, Li XM, Liu HN, Gonzalez FJ, Li F (2018). Metabolic map of osthole and its effect on lipids. Xenobiotica  48, 285-299.   https://doi.org/10.1080/00498254.2017.1306660",https://intramural.nih.gov/search/searchview.taf?ipid=103598
12,BC005598-29,"October 01, 2017 -  September 30, 2018",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Sachi  Horibata|Lyn Ann J Mickley|Robert W Robey|Kandice Danielle Tanner; PhD|Pedro Jorge De Oliveira Rodrigues Batista; PhD,"JeanPierre  Gillet (University of Namur)|Bates  Susan (Columbia University)|Antonio  Fojo; MD, PhD (NCI)",Fatima Ghazanfar Ali-Rahmani (Multidrug Resistence Section)|Crystal Chari Cole Lipsey (Multidrug Resistence Section)|James Patrick Madigan (Thoracic & Oncologic Surgery Branch)|Rajalakshm L Padmanabhan (Multidrug Resistence Section)|Ruchi Pramod Patel (Office Of Training & Education)|Andrea Nicole Robinson (Multidrug Resistence Section),Matthew David Hall (NCATS) |Raman  Sood; PhD (NHGRI) |Christopher Simon Hourigan (NHLBI) |Kevin G Chen; MD (NINDS),"1. Chen K, Mallon B, Park K, Robey P, McKay R, Gottesman M, Zheng W (2018) Pluripotent and Multipotent Stem-Cell Platforms: Major Contributing Variables and Mechanisms Underlying  Drug Discovery and Repurposing. Trends Mol Med, in press.|2. Esser L, Zhou F, Pluchino KM, Shiloach J, Ma J, Tang WK, Gutierrez C, Zhang A, Shukla S, Madigan JP, Zhou T, Kwong PD, Ambudkar SV, Gottesman MM, Xia D (2017). Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity. J Biol Chem  292, 446-461.   https://doi.org/10.1074/jbc.M116.755884",https://intramural.nih.gov/search/searchview.taf?ipid=103600
13,BC005599-28,"October 01, 2017 -  September 30, 2018","Tumor Suppressor Protein, p53",Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Aamir  Akbarali|Subrata  Debnath; PhD|Sharlyn  Mazur; PhD|Daniel James Schilling|Harichandra Dnyaneshwar Tagad; PhD,NULL,Stewart  Durell (Laboratory of Cell Biology)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Robert Taylor Ripley; MD (Thoracic & Oncologic Surgery Branch),NULL,"1. Cooks T, Pateras IS, Jenkins LM, Patel KM, Robles AI, Morris J, Forshew T, Appella E, Gorgoulis VG, Harris CC (2018). Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nat Commun  9, 771.   https://doi.org/10.1038/s41467-018-03224-w",https://intramural.nih.gov/search/searchview.taf?ipid=103601
14,BC005645-29,"October 01, 2017 -  September 30, 2018",T-cell Transformation by Oncoviruses,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Veronica  Galli|Corrado  Gurgo|Ramona  Moles|Robyn M Washington Parks|Maria  Omsland|Sarkis  Sarkis; PhD,"Vincenzo  Ciminale (Department of Oncology and Surgical Sciences, University of Padova)|Christophe  Nicot (-, University of Kansas Medical Center)|Anthony  Cunningham|Lloyd  Einsiedel (Baker Heart And Diabetes Institute)|Dinny  Graham (University Of Sydney School Of Medicine)|John  Kaldor (University Of New South Wales)|Show all 11",Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Cynthia  Masison (Office of the Director),Steven J Jacobson; PhD (NINDS),"1. Omsland M, PiseMasison C, Fujikawa D, Galli V, Fenizia C, WashingtonParks R, Gjertsen B, Franchini G, Andresen V (2018) Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine. Scientific Reports, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103602
15,BC005708-27,"October 01, 2017 -  September 30, 2018","Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers",Frank Jess Gonzalez; PhD|IRP Faculty Profile,NULL,"Laboratory of Metabolism, NCI",Kristopher W Krausz,"Jeffrey  Peters (NCI)|Toshifumi  Aoyama (Department of Metabolic Regulation, Shinshu University, Institute on Aging and Adaptation)|Jeffrey  Idle (University of Bern)|Andrew  Patterson (Pennsylvania State University)|Huichang  Bi (Sun Yat-sen University)|Zhong-Ze  Fang",Linda G Byrd (Nucleic Acids Section)|Dasheng  Lu (Nucleic Acids Section)|Thomas John Velenosi (Nucleic Acids Section)|Cen  Xie (Nucleic Acids Section)|Jie  Zhao (Nucleic Acids Section)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis),Oksana  Gavrilova; PhD (NIDDK),"1. Cai J, Zhang J, Tian Y, Zhang L, Hatzakis E, Krausz KW, Smith PB, Gonzalez FJ, Patterson AD (2017). Orthogonal Comparison of GC-MS and 1H NMR Spectroscopy for Short Chain Fatty Acid Quantitation. Anal Chem  89, 7900-7906.   https://doi.org/10.1021/acs.analchem.7b00848|2. Cao YF, Du Z, Zhu ZT, Sun HZ, Fu ZW, Yang K, Liu YZ, Hu CM, Dong PP, Gonzalez FJ, Fang ZZ (2017). Inhibitory effects of fifteen phthalate esters in human cDNA-expressed UDP-glucuronosyltransferase supersomes. Chemosphere  185, 983-990.   https://doi.org/10.1016/j.chemosphere.2017.07.105|3. Golla S, Golla JP, Krausz KW, Manna SK, Simillion C, Beyoğlu D, Idle JR, Gonzalez FJ (2017). Metabolomic Analysis of Mice Exposed to Gamma Radiation Reveals a Systemic Understanding of Total-Body Exposure. Radiat Res  187, 612-629.   https://doi.org/10.1667/RR14592.1|4. Hong X, Zheng Y, Qin Z, Wu B, Dai Y, Gao H, Yao Z, Gonzalez FJ, Yao X (2017). In Vitro Glucuronidation of Wushanicaritin by Liver Microsomes, Intestine Microsomes and Expressed Human UDP-Glucuronosyltransferase Enzymes. Int J Mol Sci  18.   https://doi.org/10.3390/ijms18091983|5. Li F, Zhu W, Gonzalez FJ (2017). Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol Ther  178, 18-30.   https://doi.org/10.1016/j.pharmthera.2017.03.007|6. Patel CN, Georrge JJ, Modi KM, Narechania MB, Patel DP, Gonzalez FJ, Pandya HA (2018). Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease. J Biomol Struct Dyn  36, 3938-3957.   https://doi.org/10.1080/07391102.2017.1404931|7. Patel DP, Krausz KW, Xie C, Beyoğlu D, Gonzalez FJ, Idle JR (2017). Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice. PLoS One  12, e0177953.   https://doi.org/10.1371/journal.pone.0177953|8. Pingili AK, Davidge KN, Thirunavukkarasu S, Khan NS, Katsurada A, Majid DSA, Gonzalez FJ, Navar LG, Malik KU (2017). 2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice. Hypertension  69, 1104-1112.   https://doi.org/10.1161/HYPERTENSIONAHA.117.09175|9. Wang H, Fang ZZ, Meng R, Cao YF, Tanaka N, Krausz KW, Gonzalez FJ (2017). Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption. Toxicology  386, 133-142.   https://doi.org/10.1016/j.tox.2017.05.012|10. Yao ZH, Qin ZF, He LL, Wang XL, Dai Y, Qin L, Gonzalez FJ, Ye WC, Yao XS (2017). Identification, bioactivity evaluation and pharmacokinetics of multiple components in rat serum after oral administration of Xian-Ling-Gu-Bao capsule by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci  1041-1042, 104-112.   https://doi.org/10.1016/j.jchromb.2016.12.026|11. Zhao J, Sun T, Wu JJ, Cao YF, Fang ZZ, Sun HZ, Zhu ZT, Yang K, Liu YZ, Gonzalez FJ, Yin J (2017). Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis. Fitoterapia  119, 26-31.   https://doi.org/10.1016/j.fitote.2017.03.010",https://intramural.nih.gov/search/searchview.taf?ipid=103603
16,BC005785-24,"October 01, 2017 -  September 30, 2018",TGF-betas in breast cancer progression,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Nellie  Moshkovich; BS|Binwu  Tang|Steven David Cappell|Jing  Huang|Maxwell P Lee; PhD|Howard H Yang,John  Condeelis (Albert Einstein College of Medicine)|Maja  Oktay (Albert Einstein College of Medicine),Dominic  Esposito; PhD (Office Of The Director)|Jinqiu  Chen (Office of the Director)|Noemi  Kedei (Office of the Director)|Patricia  Steeg; PhD (Womens Malignancies Branch)|Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling),NULL,"1. Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C, Kim J, Tang B, Glogowska MJ, Morton JJ, Padilla-Just N, Gomez K, Warnock E, Reisinger J, Arcaroli JJ, Messersmith WA, Wakefield LM, Gao D, Tan AC, Serracino H, Vasiliou V, Roop DR, Wang XJ, Jimeno A (2017). Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djw189",https://intramural.nih.gov/search/searchview.taf?ipid=103604
17,BC005793-24,"October 01, 2017 -  September 30, 2018",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu,NULL,Marshonna J Forgues (Laboratory of Human Carcinogenesis)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103605
18,BC006150-37,"October 01, 2017 -  September 30, 2018","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs",Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Shar-Yin Naomi Huang|Ukhyun  Jo|Evgeny Anatolyevich Kiselev; PhD|Junko  Murai|Ann  Orr|Show all 12,"Mark  Cushman (Medicinal Chemistry, Purdue University)|William  Gmeiner (PHARMACOLOGY, WAKE FOREST UNIVERSITY)|William  Jorgensen (CHEMISTRY, Yale University)|Christopher  Self (Provide Pharma)|Gary  Olson (Provid Pharma)|Yuk  Sham (University of Minnesota)|Show all 17","Robert  Shoemaker (Chemopreventive Agent Development Research Group)|David S Waugh; PhD (Protein Engineering Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)|George T Lountos (Protein Engineering Section)|Terrence R Burke; PhD (Chemical Biology Laboratory)","Weidong  Wang; PhD (NIA) |Christopher P Austin; AB, MD (NCATS)","1. Al Abo M, Sasanuma H, Liu X, Rajapakse VN, Huang SY, Kiselev E, Takeda S, Plunkett W, Pommier Y (2017). TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors. Mol Cancer Ther  16, 2543-2551.   https://doi.org/10.1158/1535-7163.MCT-17-0110|2. Ballestrero A, Bedognetti D, Ferraioli D, Franceschelli P, Labidi-Galy SI, Leo E, Murai J, Pommier Y, Tsantoulis P, Vellone VG, Zoppoli G (2017). Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer. J Transl Med  15, 199.   https://doi.org/10.1186/s12967-017-1296-3|3. Bruno PM, Liu Y, Park GY, Murai J, Koch CE, Eisen TJ, Pritchard JR, Pommier Y, Lippard SJ, Hemann MT (2017). A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress. Nat Med  23, 461-471.   https://doi.org/10.1038/nm.4291|4. Jdey W, Thierry S, Russo C, Devun F, Al Abo M, Noguiez-Hellin P, Sun JS, Barillot E, Zinovyev A, Kuperstein I, Pommier Y, Dutreix M (2017). Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors. Clin Cancer Res  23, 1001-1011.   https://doi.org/10.1158/1078-0432.CCR-16-1193|5. Murai J, Tang SW, Leo E, Baechler SA, Redon CE, Zhang H, Al Abo M, Rajapakse VN, Nakamura E, Jenkins LMM, Aladjem MI, Pommier Y (2018). SLFN11 Blocks Stressed Replication Forks Independently of ATR. Mol Cell  69, 371-384.e6.   https://doi.org/10.1016/j.molcel.2018.01.012|6. Reinhold WC, Thomas A, Pommier Y (2017). DNA-Targeted Precision Medicine; Have we Been Caught Sleeping? Trends Cancer  3, 2-6.   https://doi.org/10.1016/j.trecan.2016.11.002|7. Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A (2017). HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia. Sci Rep  7, 12849.   https://doi.org/10.1038/s41598-017-12924-0|8. Tang SW, Thomas A, Murai J, Trepel JB, Bates SE, Rajapakse VN, Pommier Y (2018). Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11) Expression with Class I Histone Deacetylase Inhibitors. Clin Cancer Res  24, 1944-1953.   https://doi.org/10.1158/1078-0432.CCR-17-0443|9. Thomas A, Murai J, Pommier Y (2018). The evolving landscape of predictive biomarkers of response to PARP inhibitors. J Clin Invest  128, 1727-1730.   https://doi.org/10.1172/JCI120388|10. Tsuda M, Cho K, Ooka M, Shimizu N, Watanabe R, Yasui A, Nakazawa Y, Ogi T, Harada H, Agama K, Nakamura J, Asada R, Fujiike H, Sakuma T, Yamamoto T, Murai J, Hiraoka M, Koike K, Pommier Y, Takeda S, Hirota K (2017). ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair. PLoS One  12, e0188320.   https://doi.org/10.1371/journal.pone.0188320|11. Tsuda M, Terada K, Ooka M, Kobayashi K, Sasanuma H, Fujisawa R, Tsurimoto T, Yamamoto J, Iwai S, Kadoda K, Akagawa R, Huang SN, Pommier Y, Sale JE, Takeda S, Hirota K (2017). The dominant role of proofreading exonuclease activity of replicative polymerase ε in cellular tolerance to cytarabine (Ara-C). Oncotarget  8, 33457-33474.   https://doi.org/10.18632/oncotarget.16508",https://intramural.nih.gov/search/searchview.taf?ipid=103606
19,BC006161-35,"October 01, 2017 -  September 30, 2018",DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Keli  Agama|Andrea Simone Baechler|Valentina  Factor|Shar-Yin Naomi Huang|Evgeny Anatolyevich Kiselev; PhD|Laetitia  Marzi|Show all 11,"Mark  Cushman (Medicinal Chemistry, Purdue University)|Takehiro  Yasukawa (University College of London)",Melinda  Hollingshead (Biological Testing Branch),"Keir Cajal Neuman; BA, PhD (NHLBI)","1. Dalla Rosa I, Zhang H, Khiati S, Wu X, Pommier Y (2017). Transcription profiling suggests that mitochondrial topoisomerase IB acts as a topological barrier and regulator of mitochondrial DNA transcription. J Biol Chem  292, 20162-20172.   https://doi.org/10.1074/jbc.M117.815241|2. Huang SN, Williams JS, Arana ME, Kunkel TA, Pommier Y (2017). Topoisomerase I-mediated cleavage at unrepaired ribonucleotides generates DNA double-strand breaks. EMBO J  36, 361-373.   https://doi.org/10.15252/embj.201592426|3. Sloan R, Huang SN, Pommier Y, Jinks-Robertson S (2017). Effects of camptothecin or TOP1 overexpression on genetic stability in Saccharomyces cerevisiae. DNA Repair (Amst)  59, 69-75.   https://doi.org/10.1016/j.dnarep.2017.09.004|4. Yu LM, Hu Z, Chen Y, Ravji A, Lopez S, Plescia CB, Yu Q, Yang H, Abdelmalak M, Saha S, Agama K, Kiselev E, Marchand C, Pommier Y, An LK (2018). Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2). Eur J Med Chem  151, 777-796.   https://doi.org/10.1016/j.ejmech.2018.04.024|5. Zhang H, Seol Y, Agama K, Neuman KC, Pommier Y (2017). Distribution bias and biochemical characterization of TOP1MT single nucleotide variants. Sci Rep  7, 8614.   https://doi.org/10.1038/s41598-017-09258-2",https://intramural.nih.gov/search/searchview.taf?ipid=103607
20,BC006198-29,"October 01, 2017 -  September 30, 2018",Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Dominique Lucia Kunciw|Kohei  Tsuji|Xue Zhi  Zhao|James A Kelley; PhD,"Michael  Yaffe (Massachusetts Institute of Technology)|Christoph  Rader; PhD|Robert  Ulrich (Molecular Immunology, USAMRIID)",Kyung  Lee; PhD (Chemistry Section)|Kylie Janice Walters (Structural Biophysics Laboratory)|David S Waugh; PhD (Protein Engineering Section),NULL,"1. Hymel D, Burke TR (2017). Corrigendum: Phosphatase-Stable Phosphoamino Acid Mimetics That Enhance Binding Affinities with the Polo-Box Domain of Polo-like Kinase 1. ChemMedChem  12, 278.   https://doi.org/10.1002/cmdc.201700019|2. Hymel D, Burke TR (2017). Phosphatase-Stable Phosphoamino Acid Mimetics That Enhance Binding Affinities with the Polo-Box Domain of Polo-like Kinase 1. ChemMedChem  12, 202-206.   https://doi.org/10.1002/cmdc.201600574|3. Li X, Nelson CG, Nair RR, Hazlehurst L, Moroni T, Martinez-Acedo P, Nanna AR, Hymel D, Burke TR, Rader C (2017). Stable and Potent Selenomab-Drug Conjugates. Cell Chem Biol  24, 433-442.e6.   https://doi.org/10.1016/j.chembiol.2017.02.012|4. Nanna AR, Li X, Walseng E, Pedzisa L, Goydel RS, Hymel D, Burke TR, Roush WR, Rader C (2017). Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates. Nat Commun  8, 1112.   https://doi.org/10.1038/s41467-017-01257-1|5. Zhao XZ, Hymel D, Burke TR (2017). Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides. Bioorg Med Chem  25, 5041-5049.   https://doi.org/10.1016/j.bmc.2017.02.063",https://intramural.nih.gov/search/searchview.taf?ipid=103608
21,BC007333-27,"October 01, 2017 -  September 30, 2018",Pharmacology of HIV Viral DNA  Retroviral Integrases,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Evgeny Anatolyevich Kiselev; PhD|Azhar A Ravji,"Roberto  Di Santo (Univerty of Roma ""La Sapienza"")|Yuk  Sham (University of Minnesota)|ZhengQuiang  Wang (University of Minnesota)|A. Jun  Komano (AIDS Research Center)|Peter  Cherepanov (Imperial College London)|Seth A Cohen",Terrence R Burke; PhD (Chemical Biology Laboratory)|Xue Zhi  Zhao (Chemical Biology Laboratory)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103609
22,BC007363-24,"October 01, 2017 -  September 30, 2018",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,Terrence R Burke; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Xue Zhi  Zhao,"Peter  Cherepanov (Imperial College London)|Arnold  Edward (Rutgers University)|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)",Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Zhao X, Metifiot M, Kiselev E, Kessl J, Maddali K, Marchand C, Kvaratskhelia M, Pommier Y, Burke T (2018). HIV-1 integrase-targeted short peptides derived from a viral protein R sequence. Molecules  23, 1858.|2. Zhao X, Smith S, Maskell D, Metifiot M, Pye V, Fesen K, Marchand C, Pommier Y, Cherepanov P, Hughes S, Burke T (2017) Structure-guided optimization of HIV integrase strand transfer inhibitors. Journal of Medicinal Chemistry, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103610
23,BC007365-24,"October 01, 2017 -  September 30, 2018",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI","Anjelika  Gasilina|Sofia Alexandra Girald Berlingeri|Xiaoying  Jian; PhD|Ruibai  Luo|Neeladri Sekhar Roy; PhD|Roberto  Weigert; MSc Chemistry, PhD",Elizabeth  Sztul (University of Alabama)|Robert  Kalb|Thomas  Abrams (University of Maryland School of Medicine),"Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Marielle Elizabeth Yohe (Pediatric Oncology Branch)|Di S Xia; PhD, MS, BS (Crystallography Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|John Frederick Shern (Pediatric Oncology Branch)",James  Gruschus; PhD (NHLBI) |James Robert Sellers; PhD (NHLBI),"1. Luo R, Chen PW, Kuo JC, Jenkins L, Jian X, Waterman CM, Randazzo PA (2018). ARAP2 inhibits Akt independently of its effects on focal adhesions. Biol Cell  110, 257-270.   https://doi.org/10.1111/boc.201800044|2. Luo R, Reed CE, Sload JA, Wordeman L, Randazzo PA, Chen PW (2019). Arf GAPs and molecular motors. Small GTPases  10, 196-209.   https://doi.org/10.1080/21541248.2017.1308850|3. Vitali T, Girald-Berlingeri S, Randazzo PA, Chen PW (2019). Arf GAPs: A family of proteins with disparate functions that converge on a common structure, the integrin adhesion complex. Small GTPases  10, 280-288.   https://doi.org/10.1080/21541248.2017.1299271",https://intramural.nih.gov/search/searchview.taf?ipid=103611
24,BC008382-35,"October 01, 2017 -  September 30, 2018",Computational Approaches for RNA StructureFunction Determination,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Eckart  Bindewald|Kazimierz Wojcieck Kasprzak|Anu  Puri; PhD|Brigit  Shields|Tae Jin  Kim|Manav  Mathur|Show all 8,"Anne  Simon (Cell Biology and Molecular Genetics, University of Maryland)|Hanan  Samet (University of Maryland)",Gisela Esta Sterneck; PhD (Laboratory of Cell and Developmental Signaling)|Yun Xing M Wang (Structural Biophysics Laboratory)|Stuart F J Le Grice; PhD (Basic Research Laboratory),NULL,"1. Le MT, Kasprzak WK, Kim T, Gao F, Young MY, Yuan X, Shapiro BA, Seog J, Simon AE (2017). Folding behavior of a T-shaped, ribosome-binding translation enhancer implicated in a wide-spread conformational switch. Elife  6.   https://doi.org/10.7554/eLife.22883|2. Le MT, Kasprzak WK, Shapiro BA, Simon AE (2017). Combined single molecule experimental and computational approaches for understanding the unfolding pathway of a viral translation enhancer that participates in a conformational switch. RNA Biol  14, 1466-1472.   https://doi.org/10.1080/15476286.2017.1325069|3. Sajja S, Chandler M, Fedorov D, Kasprzak WK, Lushnikov A, Viard M, Shah A, Dang D, Dahl J, Worku B, Dobrovolskaia MA, Krasnoslobodtsev A, Shapiro BA, Afonin KA (2018). Dynamic Behavior of RNA Nanoparticles Analyzed by AFM on a Mica/Air Interface. Langmuir  34, 15099-15108.   https://doi.org/10.1021/acs.langmuir.8b00105",https://intramural.nih.gov/search/searchview.taf?ipid=103612
25,BC008710-41,"October 01, 2017 -  September 30, 2018",Molecular Chaperones and DNA Replication,Sue H Wickner; PhD|IRP Faculty Profile,NULL,"DNA Molecular Biology Section, NCI",Anuradha  Balasubramanian|Audrey Lynne Heffner|Joel R Hoskins|Andrea Nicole Kravats,George  Stan (University of Cincinnati)|Alexandra Monica Deaconescu (BIOCHEMISTRY & BIOPHYSICS CENTER)|Jill  Johnson (University Of Idaho),Shannon M Doyle (Laboratory of Molecular Biology)|Srilakshmi A Garikapati (Laboratory of Molecular Biology)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Susan  Gottesman; PhD (Biochemical Genetics Section),Daniel C Masison; PhD (NIDDK),"1. Wickner S, Camberg J, Doyle S (2017) Molecular Chaperones, in Brenner's Encyclopedia of Genetics, 2nd Edition, update, in press.|2. Johnston DM, Miot M, Hoskins JR, Wickner S, Doyle SM (2017). Substrate Discrimination by ClpB and Hsp104. Front Mol Biosci  4, 36.   https://doi.org/10.3389/fmolb.2017.00036|3. Kravats AN, Doyle SM, Hoskins JR, Genest O, Doody E, Wickner S (2017). Interaction of E. coli Hsp90 with DnaK Involves the DnaJ Binding Region of DnaK. J Mol Biol  429, 858-872.   https://doi.org/10.1016/j.jmb.2016.12.014",https://intramural.nih.gov/search/searchview.taf?ipid=103583
26,BC008714-41,"October 01, 2017 -  September 30, 2018",Bacterial Functions Involved in Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Jiandong  Chen|Francois  De Mets|Kumari  Kavita|Nadim  Majdalani|Leann  To|Song  Tong|Show all 7,NULL,NULL,"Erin Ashley Wall (NIGMS) |Gisela  Storz; PhD (NICHD) |Stephen H Leppla; PhD (NIAID) |Susan K Buchanan (NIDDK) |Karen Moore Frank; MD, PhD (CC) |Yasmine  Belkaid; PhD (NIAID)","1. Frohlich K, Gottesman S (2018) Small Regulatory RNAs in the Enterobacterial REsponse to Envelope Damage and Oxidative Stress, in Regulating with RNA, in press.|2. Chen J, Gottesman S (2017). Hfq links translation repression to stress-induced mutagenesis in E. coli. Genes Dev  31, 1382-1395.   https://doi.org/10.1101/gad.302547.117|3. Keefer AB, Asare EK, Pomerantsev AP, Moayeri M, Martens C, Porcella SF, Gottesman S, Leppla SH, Vrentas CE (2017). In vivo characterization of an Hfq protein encoded by the Bacillus anthracis virulence plasmid pXO1. BMC Microbiol  17, 63.   https://doi.org/10.1186/s12866-017-0973-y|4. Parker A, Cureoglu S, De Lay N, Majdalani N, Gottesman S (2017). Alternative pathways for Escherichia coli biofilm formation revealed by sRNA overproduction. Mol Microbiol  105, 309-325.   https://doi.org/10.1111/mmi.13702",https://intramural.nih.gov/search/searchview.taf?ipid=103613
27,BC008751-38,"October 01, 2017 -  September 30, 2018",Regulation of Gene Transcription,Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",Dale  Lewis; PhD,Szabolcs  Semsey|Michal  Hammel (Lawrence Berkeley National Laboratory),Sangmi  Lee (Laboratory of Molecular Biology)|Victor  Zhurkin; PhD (Laboratory of Cell Biology)|David  Levens; PhD (Laboratory of Pathology),Zhong  Qian (OD),"1. Qian Z, Adhya S (2017). DNA repeat sequences: diversity and versatility of functions. Curr Genet  63, 411-416.   https://doi.org/10.1007/s00294-016-0654-7",https://intramural.nih.gov/search/searchview.taf?ipid=103614
28,BC008752-38,"October 01, 2017 -  September 30, 2018",Thyroid Hormone Nuclear Receptors in Health and Disease,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Cho Rong  Han|Sunmi  Park|Li  Zhao|Xuguang  Zhu,"G.R.  Williams (Imperial College London, Imperial College London)|Paul M Yen; MD (NIDDK)|Gregory  Brent (VA Greater Los Angeles Healthcare System)","Erik Kristian Holmsen (Biochemical Genetics Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Yun-Bo  Shi; PhD (NICHD),"1. Flamant F, Cheng SY, Hollenberg AN, Moeller LC, Samarut J, Wondisford FE, Yen PM, Refetoff S (2017). Thyroid Hormone Signaling Pathways: Time for a More Precise Nomenclature. Endocrinology  158, 2052-2057.   https://doi.org/10.1210/en.2017-00250|2. Han CR, Park S, Cheng SY (2017). NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1. Sci Rep  7, 18080.   https://doi.org/10.1038/s41598-017-18409-4|3. Hine C, Kim HJ, Zhu Y, Harputlugil E, Longchamp A, Matos MS, Ramadoss P, Bauerle K, Brace L, Asara JM, Ozaki CK, Cheng SY, Singha S, Ahn KH, Kimmelman A, Fisher FM, Pissios P, Withers DJ, Selman C, Wang R, Yen K, Longo VD, Cohen P, Bartke A, Kopchick JJ, et al. [3 more authors] (2017). Hypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production. Cell Metab  25, 1320-1333.e5.   https://doi.org/10.1016/j.cmet.2017.05.003|4. Jang JY, Choi SY, Park I, Park DY, Choe K, Kim P, Kim YK, Lee BJ, Hirashima M, Kubota Y, Park JW, Cheng SY, Nagy A, Park YJ, Alitalo K, Shong M, Koh GY (2017). VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis. EMBO Mol Med  9, 750-769.   https://doi.org/10.15252/emmm.201607341|5. Milanesi A, Lee JW, Yang A, Liu YY, Sedrakyan S, Cheng SY, Perin L, Brent GA (2017). Thyroid Hormone Receptor Alpha is Essential to Maintain the Satellite Cell Niche During Skeletal Muscle Injury and Sarcopenia of Aging. Thyroid  27, 1316-1322.   https://doi.org/10.1089/thy.2017.0021|6. Park S, Han CR, Park JW, Zhao L, Zhu X, Willingham M, Bodine DM, Cheng SY (2017). Defective erythropoiesis caused by mutations of the thyroid hormone receptor α gene. PLoS Genet  13, e1006991.   https://doi.org/10.1371/journal.pgen.1006991",https://intramural.nih.gov/search/searchview.taf?ipid=103615
29,BC008753-36,"October 01, 2017 -  September 30, 2018",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Richard A Beers|Tapan K Bera|Alexander  Chan|Noah Lejiang Chen|Steven Willis Cummings|Jasmin  Leshem|Show all 12,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Satoshi  Nagata (Sanford Research/USD)|Ulrich  Brinkmann (NCI)|Taiji  Matsusaka (Tokyo Medical & Dental University)|Itai  Benhar (Tel Aviv University)|Show all 10","Adam Charles Cerise; MD (Laboratory of Molecular Biology)|Dominique N Daly (Laboratory of Molecular Biology)|Xiu Fen Liu (Laboratory of Molecular Biology)|Chin-Hsien  Tai (Laboratory of Molecular Biology)|Dawn A Walker (Laboratory of Molecular Biology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",NULL,"1. Leshem Y, O'Brien J, Liu X, Bera TK, Terabe M, Berzofsky JA, Bossenmaier B, Niederfellner G, Tai CH, Reiter Y, Pastan I (2017). Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity. Cancer Immunol Res  5, 685-694.   https://doi.org/10.1158/2326-6066.CIR-16-0330|2. Liu XF, Zhou Q, Hassan R, Pastan I (2017). Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway. Oncotarget  8, 87307-87316.   https://doi.org/10.18632/oncotarget.20263|3. Müller F, Cunningham T, Stookey S, Tai CH, Burkett S, Jailwala P, Stetler Stevenson M, Cam MC, Wayne AS, Pastan I (2018). 5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox. Proc Natl Acad Sci U S A  115, E1867-E1875.   https://doi.org/10.1073/pnas.1714512115|4. Müller F, Stookey S, Cunningham T, Pastan I (2017). Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies. Oncotarget  8, 30644-30655.   https://doi.org/10.18632/oncotarget.16141|5. Mazor R, Crown D, Addissie S, Jang Y, Kaplan G, Pastan I (2017). Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo. Cell Mol Immunol  14, 432-442.   https://doi.org/10.1038/cmi.2015.91|6. Mazor R, Kaplan G, Park D, Jang Y, Lee F, Kreitman R, Pastan I (2017). Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38. Cell Immunol  313, 59-66.   https://doi.org/10.1016/j.cellimm.2017.01.003|7. Wang C, Gao W, Feng M, Pastan I, Ho M (2017). Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy. Oncotarget  8, 32450-32460.   https://doi.org/10.18632/oncotarget.10592",https://intramural.nih.gov/search/searchview.taf?ipid=103616
30,BC008756-31,"October 01, 2017 -  September 30, 2018",Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Kerrie Leanne Marie|Helen Thompson Michael|Antonella  Sassano|Yanlin  Yu,"Edward  De Fabo (GWU)|Hitoshi  Takagi (First Dept of Internal Medicien, Gunma University School of Medicine)|Thomas  Tuting (Dermatology, University of Bonn)|Dot  Bennett (St. George's Hospital Medical School)|Ron  DePinho (Dana Farber, Harvard)|Chris  Counter (Duke University)|Show all 9","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)|Margaret Anne Tucker (Human Genetics Program)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Curtis  Henrich (Molecular Targets Laboratory)|Norman Edward Sharpless; MD (Office Of The Director)",Heinz  Arnheiter; MD (NINDS) |William James Pavan; PhD (NHGRI),"1. Leachman SA, Merlino G (2017). Medicine: The final frontier in cancer diagnosis. Nature  542, 36-38.   https://doi.org/10.1038/nature21492|2. Michael HT, Merlino G (2017). A Topical Solution to the Sunless Tanning Problem. Trends Mol Med  23, 771-773.   https://doi.org/10.1016/j.molmed.2017.07.010",https://intramural.nih.gov/search/searchview.taf?ipid=103617
31,BC008757-31,"October 01, 2017 -  September 30, 2018",Bio-Therapies for the Treatment of Cancer,David J Fitzgerald; PhD|IRP Faculty Profile,NULL,"Biotherapy Section, NCI","Antonella  Antignani; BS, PhD|Robert J Sarnovsky|Nathan C Simon",NULL,"Peter C Fitzgerald (Office of the Director)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Mitchell  Ho (Laboratory of Molecular Biology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Christine Campo Alewine (Laboratory of Molecular Biology)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)",Massimo Giulio Gadina; PhD (NIAMS) |Michael J Iadarola; PhD (CC) |Craig Joseph Thomas (NCATS),"1. Iadarola MJ, Sapio MR, Wang X, Carrero H, Virata-Theimer ML, Sarnovsky R, Mannes AJ, FitzGerald DJ (2017). Analgesia by Deletion of Spinal Neurokinin 1 Receptor Expressing Neurons Using a Bioengineered Substance P-Pseudomonas Exotoxin Conjugate. Mol Pain  13, 1744806917727657.   https://doi.org/10.1177/1744806917727657",https://intramural.nih.gov/search/searchview.taf?ipid=103618
32,BC008905-37,"October 01, 2017 -  September 30, 2018",Tumor gene expression in vitro and in vivo,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Marian E Durkin|Richard P Koller|Alexander G Papageorge|Xiaolan  Qian; MD, PhD|Beatriz  Sanchez-Solana|Brajendra  Tripathi; MS, PhD|Show all 7",Steven J Carr|Igor  Barsukov (University of Liverpool),NULL,NULL,"1. Tripathi BK, Lowy DR (2017). DLC1: a tumor suppressor that regulates Rho signaling. Oncotarget  8, 27674-27675.   https://doi.org/10.18632/oncotarget.16805",https://intramural.nih.gov/search/searchview.taf?ipid=103619
33,BC009052-29,"October 01, 2017 -  September 30, 2018",Papillomavirus Virion Proteins and Vaccines,John  Schiller; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Carla Vanessa Correia Cerqueira|Nicolas  Cuburu; PhD|Patricia  Day; PhD|Rhonda C Kines|Yuk Ying S Pang|Cynthia D Thompson,Denise  Nardelli-Haefliger (Centre Hospitalier Universitaire Vaudois)|Richard  Roden (Johns Hopkins University)|Bryce  Chackerian (University of New Mexico)|Elisabet  de los Pinos (Aura Biosciences Inc.)|Ali  Salanti (University of Copenhagen)|Gert  Scheper (Crucell/Johnson&Johnson),Tara Ariela Berman; MD (Office Of The Clinical Director)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Aimee Rebecca Kreimer (Infection & Immunoepidemiology Branch)|Peter L Choyke; MD (Molecular Imaging Program),"Barney S Graham; MD, PhD (NIAID) |Jeffrey  Cohen; MD (NIAID) |Alan T Remaley; MD, PhD (NHLBI)","1. Berman TA, Schiller JT (2017). Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer  123, 2219-2229.   https://doi.org/10.1002/cncr.30588|2. Cerqueira C, Schiller JT (2017). Papillomavirus assembly: An overview and perspectives. Virus Res  231, 103-107.   https://doi.org/10.1016/j.virusres.2016.11.010",https://intramural.nih.gov/search/searchview.taf?ipid=103620
34,BC009265-36,"October 01, 2017 -  September 30, 2018",Analysis of the T Cell Repertoire,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Farrah Ali Alkhaleel (Immune Regulation Section)|Joseph Byung Hoon An (Immune Regulation Section)|Yungping  Chiang (Immune Regulation Section)|Karen  Hathcock (Immune Regulation Section)|Ying  Lu (Immune Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103621
35,BC009273-31,"October 01, 2017 -  September 30, 2018",T Cell Differentiation and Repertoire Selection,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD|Dinah  Singer; PhD|Show all 7,"Naomi  Taylor|Batu M Erman|Deitmar  Kappes (Immunology, Fox Chase Cancer Center)|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)|Ed  Palmer (University of Basel)|Show all 7",Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Tejas Bharat Kadakia (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section),"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103622
36,BC009279-33,"October 01, 2017 -  September 30, 2018",Regulation of Expression of MHC Class I Genes,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Susan  Sharrow,NULL,Oliver James Hendy (Immune Regulation Section)|Jocelyn D Weissman (Molecular Regulation Section)|Daniel Robert Larson; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103623
37,BC009281-32,"October 01, 2017 -  September 30, 2018",Receptor Mediated T and B Cell Activation,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Yungping  Chiang (Immune Regulation Section)|Karen  Hathcock (Immune Regulation Section)|Ying  Lu (Immune Regulation Section),"Ronald N Germain; MD, PhD (NIAID) |Keji  Zhao; PhD (NHLBI)","1. Watanabe M, Fujihara C, Radtke AJ, Chiang YJ, Bhatia S, Germain RN, Hodes RJ (2017). Co-stimulatory function in primary germinal center responses: CD40 and B7 are required on distinct antigen-presenting cells. J Exp Med  214, 2795-2810.   https://doi.org/10.1084/jem.20161955",https://intramural.nih.gov/search/searchview.taf?ipid=103624
38,BC009283-34,"October 01, 2017 -  September 30, 2018",Consequences of chronic Interferon-gamma expression on the host,Howard A Young; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Ashley V Bushey|Elizabeth Mariya Engle|Rebecca Ann Erwin-Cohen|John Maxwell Fenimore|Megan Marie Hess|Michael E Sanford|Show all 11,Monika  Wolkers (Sanquin)|M  Gershwin (University of Califernia at Davis)|Zia  Rahman (Penn State Univ. College of Medicine),Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program),Miles  Herkenham; PhD (NIMH) |Michael N Sack; MD (NHLBI) |Ethan M Shevach; MD (NIAID) |Danielle A Springer; VMD (NHLBI),"1. Green DS, Young HA, Valencia JC (2017). Current prospects of type II interferon γ signaling and autoimmunity. J Biol Chem  292, 13925-13933.   https://doi.org/10.1074/jbc.R116.774745|2. Salerno F, Engels S, van den Biggelaar M, P J van Alphen F, Guislain A, Zhao W, L Hodge D, E Bell S, Paul Medema J, von Lindern M, Turner M, Young H, C Wolkers M (2018) Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells. Nature Immunology, in press.|3. Sallin MA, Sakai S, Kauffman KD, Young HA, Zhu J, Barber DL (2017). Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis. Cell Rep  18, 3091-3104.   https://doi.org/10.1016/j.celrep.2017.03.007|4. Tanakaa A, Leung PS, Young HA, Gershwin ME (2017). Toward solving the etiological mystery of primary biliary cholangitis. Hepatol Commun  1, 275-287.   https://doi.org/10.1002/hep4.1044",https://intramural.nih.gov/search/searchview.taf?ipid=103625
39,BC009287-34,"October 01, 2017 -  September 30, 2018",Cytokines and T Cell Development,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Caroline Elizabeth Salter|Julie  Hixon|Wenqing  Li|Emilee Rose Senkevitch,Joao  Barata (U.Lisbon)|Richard  Hotchkiss (Wash U)|Scott  Walsh (University of Maryland),Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Peter D Aplan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103627
40,BC009369-28,"October 01, 2017 -  September 30, 2018",Studies of Receptor Interactions and Effects of Alarmins,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Md Masud Alam|Zhen  Han; PhD|Anna Lee  Trivett|De  Yang|Nadya I Tarasova; PhD|David Anderson Wink,Feng  Wei|Oystein  Rekdal (Lytix Biopharma)|Richard  Jewell (University of Maryland)|W  Wu (University of Maryland)|Xin  Chen (University Of Macao)|Yingjie No Nie (LABORATORY MOLECULAR IMMUNOREGULATION)|Show all 7,Michael  Bustin; PhD (Protein Section)|Poonam  Tewary (Office Of The Director)|Joseph John Barchi (Chemical Biology Laboratory)|Bruce Allen Shapiro; PhD (Rna Biology Laboratory),NULL,"1. Oppenheim J (2017) Cytokines, their receptors and signals, in The Autoimmune Disease, in press.|2. Oppenheim J (2017) The future of cytokine discipline, in Cytokine, in press.|3. Nie Y, Yang, Trivett A, Han Z, Xin H, Chen X, Oppenheim JJ (2017). Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Large Established Tumors. Sci Rep  7, 14186.   https://doi.org/10.1038/s41598-017-14655-8|4. Stolzenberg E, Berry D, Yang, Lee EY, Kroemer A, Kaufman S, Wong GCL, Oppenheim JJ, Sen S, Fishbein T, Bax A, Harris B, Barbut D, Zasloff MA (2017). A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity. J Innate Immun  9, 456-463.   https://doi.org/10.1159/000477990|5. Yang, Han Z, Oppenheim JJ (2017). Alarmins and immunity. Immunol Rev  280, 41-56.   https://doi.org/10.1111/imr.12577",https://intramural.nih.gov/search/searchview.taf?ipid=103628
41,BC009392-26,"October 01, 2017 -  September 30, 2018",Determining the Fate of Transmembrane Proteins,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Martha Iveth Garcia; PhD|Meredith Boyle Metzger; PhD|Christopher Edward Smith|Yien-Che  Tsai|Mei  Yang; MD|Federico  Bernal,Joseph  Roitelman|Mickael  Cohen (IBPC)|Jeffrey  Brodsky (University of Pittsburgh),Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,"1. Briggs JW, Ren L, Chakrabarti KR, Tsai YC, Weissman AM, Hansen RJ, Gustafson DL, Khan YA, Dinman JD, Khanna C (2017). Activation of the unfolded protein response in sarcoma cells treated with rapamycin or temsirolimus. PLoS One  12, e0185089.   https://doi.org/10.1371/journal.pone.0185089|2. Cavellini L, Meurisse J, Findinier J, Erpapazoglou Z, Belgareh-Touzé N, Weissman AM, Cohen MM (2017). An ubiquitin-dependent balance between mitofusin turnover and fatty acids desaturation regulates mitochondrial fusion. Nat Commun  8, 15832.   https://doi.org/10.1038/ncomms15832",https://intramural.nih.gov/search/searchview.taf?ipid=103577
42,BC009404-24,"October 01, 2017 -  September 30, 2018",Regulation of MHC Class II Trafficking in Antigen Presenting Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Joanna Marta Bandola-Simon; PhD|Kyung Jin  Cho|Karis  Faust|Sunil  Kaul|Hei Jung  Kim|Even  Walseng,"Lisa  Denzin (Immunology Program, Sloan-Kettering Institute)|Satoshi  Ishido (Riken Center for Allergy and Immunology)|Laura  Santambrogio (Memorial Sloan Kettering)|James  Drake (NCI)|Laurence  Eisenlohr (University of Pennsylvania)|J  Blander (Icahn School of Medicine at Mount Sinai)|Show all 7",NULL,Lei  Lei (NIAID),"1. Bandola-Simon J, Roche PA (2019). Dysfunction of antigen processing and presentation by dendritic cells in cancer. Mol Immunol  113, 31-37.   https://doi.org/10.1016/j.molimm.2018.03.025",https://intramural.nih.gov/search/searchview.taf?ipid=103629
43,BC009405-24,"October 01, 2017 -  September 30, 2018",Regulation of Lymphocyte Proliferation and Replicative Capacity,Richard J Hodes; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Joseph Byung Hoon An (Immune Regulation Section)|Yungping  Chiang (Immune Regulation Section)|Karen  Hathcock (Immune Regulation Section)|Ying  Lu (Immune Regulation Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"1. Lustig A, Liu HB, Metter EJ, An Y, Swaby MA, Elango P, Ferrucci L, Hodes RJ, Weng NP (2017). Telomere Shortening, Inflammatory Cytokines, and Anti-Cytomegalovirus Antibody Follow Distinct Age-Associated Trajectories in Humans. Front Immunol  8, 1027.   https://doi.org/10.3389/fimmu.2017.01027",https://intramural.nih.gov/search/searchview.taf?ipid=103630
44,BC010001-23,"October 01, 2017 -  September 30, 2018",Molecular-Cellular Regulation of Hematopoietic Stem Cells,Jonathan  Keller; PhD,NULL,"Mouse Cancer Genetics Program, NCI",Brad Lamar Jakubison; PhD|Tanmoy  Sarkar; PhD|Shweta  Singh; PhD|Kathrin  Muegge; MD,NULL,"Laura  Schmidt (Urologic Oncology Branch)|Pengnian Charles Lin; PhD (Cancer Inflammation Program)|Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",NULL,"1. Nickerson ML, Das S, Im KM, Turan S, Berndt SI, Li H, Lou H, Brodie SA, Billaud JN, Zhang T, Bouk AJ, Butcher D, Wang Z, Sun L, Misner K, Tan W, Esnakula A, Esposito D, Huang WY, Hoover RN, Tucker MA, Keller JR, Boland J, Brown K, Anderson SK, et al. [6 more authors] (2017). TET2 binds the androgen receptor and loss is associated with prostate cancer. Oncogene  36, 2172-2183.   https://doi.org/10.1038/onc.2016.376|2. Song Y, Sullivan T, Klarmann K, Gilbert D, O'Sullivan TN, Lu L, Wang S, Haines DC, Van Dyke T, Keller JR (2017). RB inactivation in keratin 18 positive thymic epithelial cells promotes non-cell autonomous T cell hyperproliferation in genetically engineered mice. PLoS One  12, e0171510.   https://doi.org/10.1371/journal.pone.0171510",https://intramural.nih.gov/search/searchview.taf?ipid=103631
45,BC010006-23,"October 01, 2017 -  September 30, 2018",Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways,Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Moonsup  Lee|Jian  Sun; PhD|Jaeho  Yoon; PhD|Nariaki Sean Nakamura,Sally  Moody (George Washington University Medical Center)|Hee Jun  Cho; PhD,NULL,NULL,"1. Cho HJ, Hwang YS, Yoon J, Lee M, Lee HG, Daar IO (2018). EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1. Oncogene  37, 861-872.   https://doi.org/10.1038/onc.2017.386",https://intramural.nih.gov/search/searchview.taf?ipid=103632
46,BC010008-23,"October 01, 2017 -  September 30, 2018",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Daniel George Connors|Kathleen Connolly Jevtich|Patricia Ann Wiley|Shuling  Zhang; MD, PhD|Robert Mark Simpson; DVM, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103633
47,BC010012-23,"October 01, 2017 -  September 30, 2018",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,NULL,"Cancer Inflammation Program, NCI",Alan  Brooks,NULL,Poonam  Tewary (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103634
48,BC010013-23,"October 01, 2017 -  September 30, 2018",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,NULL,"Cancer Inflammation Program, NCI","Frederick Joseph Goodson-Gregg|Hong-Chuan  Li|Donnell Dee White|Paul  Wright|Mary  Carrington; MS, PhD|Daniel  McVicar; PhD",Jeffrey  Miller (University of Minnesota Cancer Center)|Taku  Kambayashi (University of Pennsylvania)|Martin  Ivarsson (Karolinska),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103635
49,BC010014-23,"October 01, 2017 -  September 30, 2018",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,NULL,"Mouse Cancer Genetics Program, NCI",Yafeng  He|Kai  Ni; PhD|Andrew James Schwader|Xiaoping  Xu,NULL,Carl E Mcintosh (Office of the Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103636
50,BC010015-23,"October 01, 2017 -  September 30, 2018",The Role of Cellular Receptors Involved in Inflammation and Tumor Progression,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Zhiyao  Bao|Keqiang  Chen|Wang Hua  Gong|Stacey Ann Krepel|Weiwei  Liang|Meihua  Zhang,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,NULL,"1. Yoshimura T, McLean MH, Dzutsev AK, Yao X, Chen K, Huang J, Gong W, Zhou J, Xiang Y, H Badger J, O'hUigin C, Thovarai V, Tessarollo L, Durum SK, Trinchieri G, Bian XW, Wang JM (2018). The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance. J Immunol  200, 2174-2185.   https://doi.org/10.4049/jimmunol.1602073",https://intramural.nih.gov/search/searchview.taf?ipid=103637
51,BC010017-23,"October 01, 2017 -  September 30, 2018","Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases",Sankar  Adhya; PhD|IRP Faculty Profile,NULL,"Developmental Genetics Section, NCI",NULL,NULL,NULL,NULL,"1. Keen EC, Bliskovsky VV, Malagon F, Baker JD, Prince JS, Klaus JS, Adhya SL (2017). Novel ""Superspreader"" Bacteriophages Promote Horizontal Gene Transfer by Transformation. MBio  8.   https://doi.org/10.1128/mBio.02115-16",https://intramural.nih.gov/search/searchview.taf?ipid=103638
52,BC010020-23,"October 01, 2017 -  September 30, 2018",Clinical Trials with Immunotoxins,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",NULL,"DARELL  BIGNER (Duke University Medical Center, Dept. of Pathology)|JOHN  SAMPSON (Div of Neurosurgery, Duke University Medical Center, Div. of Neurosurgery)|Alan S Wayne; MD","Barbara  Debrah (Clinical Immunotherapy Section)|Sonya C Duke (Clinical Immunotherapy Section)|Christine Campo Alewine (Laboratory of Molecular Biology)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)",NULL,"1. Chandramohan V, Pegram CN, Piao H, Szafranski SE, Kuan CT, Pastan IH, Bigner DD (2017). Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial. Appl Microbiol Biotechnol  101, 2747-2766.   https://doi.org/10.1007/s00253-016-8063-x",https://intramural.nih.gov/search/searchview.taf?ipid=103639
53,BC010021-23,"October 01, 2017 -  September 30, 2018",Biology of Mammary Gland Development and Tumorigenesis,Gilbert  Smith; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Corinne A Boulanger-Espeut|Jabril Rahim Johnson|Lauren Elizabeth Ragle,"Cathrin  Brisken (ISREC/EPFL)|John P. Lydon; PhD (Department of Molecular and Cellular Biology, Baylor College of Medicine)|Nelson  Horseman (Univ. Cinn.)|Robert D Bruno|Pepper  Schedin (University of Colorado)|Brian  Booth",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103640
54,BC010022-23,"October 01, 2017 -  September 30, 2018",Genetics of Complex Diseases and Health Disparities,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI","Elizabeth  Binns-Roemer|Sungkweon  Cho; MD, PhD|Victor A David|Brean Elysse Derrett|Semone  Thakoordeen",Rajendra  Bhimma (University of KwaZulu-Natal)|Michael  Lipkowitz (Georgetown University)|Rakhi  Naik (Johns Hopkins University)|Saraladevi  Naicker (University of the Witwatersrand)|Frederick  Kaskel (Albert Einstein College of Medicine)|Carmen  Peralta (University of California at San Francisco),George  Nelson (Office of the Director)|Stephen J Lockett; PhD (Office Of The Director)|Randall C Johnson (Office Of The Director),Jeffrey Burnett Kopp; MD (NIDDK),"1. Chen TK, Appel LJ, Grams ME, Tin A, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM (2017). APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension). Arterioscler Thromb Vasc Biol  37, 1765-1769.   https://doi.org/10.1161/ATVBAHA.117.309384|2. Chen TK, Estrella MM, Vittinghoff E, Lin F, Gutierrez OM, Kramer H, Lewis CE, Kopp JB, Allen NB, Winkler CA, Bibbins-Domingo KB, Peralta CA (2017). APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults. Kidney Int  92, 964-971.   https://doi.org/10.1016/j.kint.2017.03.028|3. Chen TK, Tin A, Peralta CA, Appel LJ, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM (2017). APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD. Clin J Am Soc Nephrol  12, 1771-1777.   https://doi.org/10.2215/CJN.01180117|4. Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, et al. [6 more authors] (2017). A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease. Nat Med  23, 945-953.   https://doi.org/10.1038/nm.4362|5. Hoy WE, Kopp JB, Mott SA, Winkler CA (2017). Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease. Kidney Int  91, 990.   https://doi.org/10.1016/j.kint.2016.11.031|6. Naik RP, Irvin MR, Judd S, Gutiérrez OM, Zakai NA, Derebail VK, Peralta C, Lewis MR, Zhi D, Arnett D, McClellan W, Wilson JG, Reiner AP, Kopp JB, Winkler CA, Cushman M (2017). Sickle Cell Trait and the Risk of ESRD in Blacks. J Am Soc Nephrol  28, 2180-2187.   https://doi.org/10.1681/ASN.2016101086|7. Parsa A, Kanetsky PA, Xiao R, Gupta J, Mitra N, Limou S, Xie D, Xu H, Anderson AH, Ojo A, Kusek JW, Lora CM, Hamm LL, He J, Sandholm N, Jeff J, Raj DE, Böger CA, Bottinger E, Salimi S, Parekh RS, Adler SG, Langefeld CD, Bowden DW, FIND Consortium, Groop PH, and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators, et al. [6 more authors] (2017). Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study. J Am Soc Nephrol  28, 923-934.   https://doi.org/10.1681/ASN.2015101152",https://intramural.nih.gov/search/searchview.taf?ipid=103641
55,BC010027-24,"October 01, 2017 -  September 30, 2018",Function of Steroid Receptors in Subcellular Compartments,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Thomas A Johnson|Rodney Louis Schiltz; PhD|Diana  Stavreva|Lyuba  Varticovski,NULL,Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology),NULL,"1. Oh KS, Patel H, Gottschalk RA, Lee WS, Baek S, Fraser IDC, Hager GL, Sung MH (2017). Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action. Immunity  47, 298-309.e5.   https://doi.org/10.1016/j.immuni.2017.07.012",https://intramural.nih.gov/search/searchview.taf?ipid=103642
56,BC010030-23,"October 01, 2017 -  September 30, 2018",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,Suresh V Ambudkar; PhD|IRP Faculty Profile,NULL,"Transport Biochemistry Section, NCI",Biebele  Abel|John E Golin|Sabrina  Lusvarghi|Megumi  Murakami|Khurts  Shilagardi,"Zhe-Sheng  Chen (Pharmaceutical Sciences, St. John's University)|Tanaji  Tallele (St. Johns University)|Michael  Mayer (University of Michigan)|Chung-Pu  Wu (Chang Gung University)","Andaleeb  Sajid (Laboratory of Cell Biology)|Sriram  Subramaniam; PhD (Office Of The Director)|Stewart  Durell (Laboratory of Cell Biology)|Di S Xia; PhD, MS, BS (Crystallography Section)","Shahrooz  Vahedi (NIA) |Kenneth A Jacobson; BA, MS, PhD (NIDDK) |Michael Marc Gottesman; MD (OD)","1. Murakami M, Ohnuma S, Fukuda M, Chufan EE, Kudoh K, Kanehara K, Sugisawa N, Ishida M, Naitoh T, Shibata H, Iwabuchi Y, Ambudkar SV, Unno M (2017). Synthetic Analogs of Curcumin Modulate the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCG2. Drug Metab Dispos  45, 1166-1177.   https://doi.org/10.1124/dmd.117.076000|2. Shukla S, Abel B, Chufan EE, Ambudkar SV (2017). Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions. J Biol Chem  292, 7066-7076.   https://doi.org/10.1074/jbc.M116.771634|3. Vahedi S, Chufan EE, Ambudkar SV (2017). Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency. Biochem Pharmacol  143, 53-64.   https://doi.org/10.1016/j.bcp.2017.07.014|4. Wang YJ, Patel BA, Anreddy N, Zhang YK, Zhang GN, Alqahtani S, Singh S, Shukla S, Kaddoumi A, Ambudkar SV, Talele TT, Chen ZS (2017). Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1. Sci Rep  7, 42106.   https://doi.org/10.1038/srep42106|5. Wang YJ, Zhang YK, Zhang GN, Al Rihani SB, Wei MN, Gupta P, Zhang XY, Shukla S, Ambudkar SV, Kaddoumi A, Shi Z, Chen ZS (2017). Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study. Cancer Lett  396, 145-154.   https://doi.org/10.1016/j.canlet.2017.03.011|6. Wu CP, Hsiao SH, Murakami M, Lu MJ, Li YQ, Hsieh CH, Ambudkar SV, Wu YS (2017). Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines. Cancer Lett  409, 56-65.   https://doi.org/10.1016/j.canlet.2017.08.035",https://intramural.nih.gov/search/searchview.taf?ipid=103643
57,BC010277-21,"October 01, 2017 -  September 30, 2018",Mechanisms of Chromosome Maintenance in Bacteria,Dhruba K Chattoraj; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Soniya  Chatterjee|Peter Nicholas Ciaccia|Roopa  Kothapalli|Revathy  Ramachandran; PhD|Yawen  Bai; PhD,NULL,Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Lisa Marie Jenkins (Pigment Cell Biology Section),Aravind L Iyer; PhD (NLM) |Rodolfo  Ghirlando; PhD (NIDDK),"1. Jha J, Li M, Ghirlando R, Miller Jenkins L, Wlodawer A, Chattoraj D (2017). The DnaK chaperone uses different mechanisms to promote and inhibit replication of Vibrio cholerae chromosome 2. mBio  8, e00427-17.|2. Ramachandran R, Jha J, Paulsson J, Chattoraj D (2017). Random versus cell cycle regulated replication initiation in bacteria: Insights from studying Vibrio cholerae chromosome 2. Microbiology and Molecular Biology Reviews  81, e00033-16.",https://intramural.nih.gov/search/searchview.taf?ipid=103644
58,BC010278-21,"October 01, 2017 -  September 30, 2018",Imaging cellular assemblies with three-dimensional electron microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Brian James Caffrey|Andrei Radu Florescu|Lisa M. Hartnell,Chris  Szakal (NIST)|Primal  de Lanerolle (University of Illinois at Chicago),Jeffrey D Lifson; MD (Office Of The Director)|Kumaran S Ramamurthi (Laboratory of Molecular Biology),Donald F Bliss (NLM) |Luigi  Ferrucci; MD (NIA),"1. Glancy B, Hartnell LM, Combs CA, Femnou A, Sun J, Murphy E, Subramaniam S, Balaban RS (2017). Power Grid Protection of the Muscle Mitochondrial Reticulum. Cell Rep  19, 487-496.   https://doi.org/10.1016/j.celrep.2017.03.063",https://intramural.nih.gov/search/searchview.taf?ipid=103645
59,BC010283-21,"October 01, 2017 -  September 30, 2018",DNA repair,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Maria Elsa  Callen Moreu|Yaakov  Maman|Jacob J Paiano|Andres  Canela Rodriguez|Nicholas Franklin Sciascia; BS|Kenta  Shinoda|Show all 13,Eraz Lieberman  Aiden (Baylor College of Medicine)|Chuna  Choudhary (University Of Copenhagen)|Olivier  Hyrien (Cnrs)|Massimo  Lopes (University Of Zurich)|Manuela  Pellegrini|Arnab  Ray Chaudhuri (LABORATORY OF GENOME INTEGRITY)|Show all 8,Yves  Pommier; PhD (Developmental Therapeutics Branch)|David  Levens; PhD (Laboratory of Pathology),Clare M Waterman (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS),"1. Tubbs A, Sridharan S, vanWietmarschen N, Maman Y, Callen E, Stanlie A, Wu X, Day A, Wong N, Wu W, Yin M, Canela A, Redon C, Dahl J, Kunkel T, Aladjem M, Aplan P, Hyrien O, Nussenzweig A (2018) Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103646
60,BC010292-21,"October 01, 2017 -  September 30, 2018",Enzymes and Substrates of the Ubiquitin Conjugating System,Allan M Weissman; MD|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Martha Iveth Garcia; PhD|Jennifer B Mariano|Christopher Edward Smith|Yien-Che  Tsai|Mei  Yang; MD|Federico  Bernal,"Karen H Vousden|David  Fushman (Biochemistry, University of Maryland)|George  Oyler (JHU)|Sina  Bavari (-, USAMRIID)|Danny  Huang (Beatson Institute)|Charles B Shoemaker; PhD (Veterinary Medicine, Tufts University)",Robert Andrew Byrd (Structural Biophysics Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,"1. Metzger MB, Scales JL, Dunklebarger MF, Weissman AM (2017). The Ubiquitin Ligase (E3) Psh1p Is Required for Proper Segregation of both Centromeric and Two-Micron Plasmids in Saccharomyces cerevisiae. G3 (Bethesda)  7, 3731-3743.   https://doi.org/10.1534/g3.117.300227",https://intramural.nih.gov/search/searchview.taf?ipid=103578
61,BC010297-21,"October 01, 2017 -  September 30, 2018",Identification of Genetic Factors Associated with Infectious Diseases,Cheryl Ann Winkler,NULL,"Basic Research Laboratory, NCI",Ping  An; PhD|Elizabeth  Binns-Roemer|Victor A David|Brean Elysse Derrett,Gregory D Kirk|William  Wester (Vanderbilt University School of Medicine)|Rajendra  Bhimma (University of KwaZulu-Natal)|Saraladevi  Naicker (University of the Witwatersrand)|Frederick  Kaskel (Albert Einstein College of Medicine)|Sophie Mh Limou|Show all 7,Charles  Rabkin (Infection & Immunoepidemiology Branch),Jeffrey Burnett Kopp; MD (NIDDK),"1. Heymann J, Winkler CA, Hoek M, Susztak K, Kopp JB (2017). Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte. Nephrol Dial Transplant  32, i65-i70.   https://doi.org/10.1093/ndt/gfw402|2. Kopp JB, Heymann J, Winkler CA (2017). APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy. Semin Nephrol  37, 514-519.   https://doi.org/10.1016/j.semnephrol.2017.07.004|3. Miller HK, Santo L, Camargo MC, Winkler CA, Goedert JJ, Kersh GJ, Rabkin CS (2017). Coxiella burnetii antibody seropositivity is not a risk factor for AIDS-related non-Hodgkin lymphoma. Blood  129, 3262-3264.   https://doi.org/10.1182/blood-2016-12-756569|4. Sartorius K, Sartorius B, Kramvis A, Singh E, Turchinovich A, Burwinkel B, Madiba T, Winkler CA (2017). Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology. BMC Cancer  17, 894.   https://doi.org/10.1186/s12885-017-3915-z|5. Su H, Zhu G, Djaja P KI, Lin Y, Gong Y, Liu X, Li J, Liu Z, Qin X, Li L, Liu T, Lu Z, Wei M, Yan L, Winkler CA, O'Brien SJ, Li J, Xiao K, Peng T (2017). Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse. Oncotarget  8, 54402-54415.   https://doi.org/10.18632/oncotarget.17660",https://intramural.nih.gov/search/searchview.taf?ipid=103647
62,BC010298-21,"October 01, 2017 -  September 30, 2018",Growth Regulation Section,Ira H Pastan; MD|IRP Faculty Profile,NULL,"Molecular Biology Section, NCI",Tapan K Bera,Ulrich  Brinkmann (NCI)|Iekuni  Ichikawa (Vanderbilt University School of Medicine)|Namiko  Kobayashi (University of Tsukaba)|Taiji  Matsusaka (Tokyo Medical & Dental University)|John  Weldon (Towson University),"Christine Campo Alewine (Laboratory of Molecular Biology)|Di S Xia; PhD, MS, BS (Crystallography Section)",NULL,"1. Lim BJ, Yang JW, Zou J, Zhong J, Matsusaka T, Pastan I, Zhang MZ, Harris RC, Yang HC, Fogo AB (2017). Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury. Kidney Int  92, 1395-1403.   https://doi.org/10.1016/j.kint.2017.04.010|2. Marconi C, Canobbio I, Bozzi V, Pippucci T, Simonetti G, Melazzini F, Angori S, Martinelli G, Saglio G, Torti M, Pastan I, Seri M, Pecci A (2017). 5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia. J Hematol Oncol  10, 18.   https://doi.org/10.1186/s13045-016-0382-y|3. Raciti GA, Spinelli R, Desiderio A, Longo M, Parrillo L, Nigro C, D'Esposito V, Mirra P, Fiory F, Pilone V, Forestieri P, Formisano P, Pastan I, Miele C, Beguinot F (2017). Specific CpG hyper-methylation leads to Ankrd26 gene down-regulation in white adipose tissue of a mouse model of diet-induced obesity. Sci Rep  7, 43526.   https://doi.org/10.1038/srep43526",https://intramural.nih.gov/search/searchview.taf?ipid=103648
63,BC010300-21,"October 01, 2017 -  September 30, 2018",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Luke Cynlais Davies; BSC|Marieli  Gonzalez-Cotto|Erika Mariana Palmieri; PhD|Christopher Michael Rice; PhD|Jeffrey J Subleski|Jessica Frances Walls|Show all 7,"Valance  Washington (Anatomy and Cell biology, Universidad Central del Caribe)|James  Finke (Cleveland Clinic)|Philip  Taylor (Cardiff University)|Selinda Jane Orr|Andrew  Lane (U. of Louisville)|Teresa  Fan (University of Louisville)|Show all 7",William Marston Linehan; MD (Urologic Oncology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch),"Suk See De Ravin; MD, PhD (NIAID) |Doug B Kuhns; PhD (NIAID) |Leslie Glenn Biesecker; MD (NHGRI)","1. Davies LC, Rice CM, Palmieri EM, Taylor PR, Kuhns DB, McVicar DW (2017). Peritoneal tissue-resident macrophages are metabolically poised to engage microbes using tissue-niche fuels. Nat Commun  8, 2074.   https://doi.org/10.1038/s41467-017-02092-0|2. Palmieri EM, Menga A, Martín-Pérez R, Quinto A, Riera-Domingo C, De Tullio G, Hooper DC, Lamers WH, Ghesquière B, McVicar DW, Guarini A, Mazzone M, Castegna A (2017). Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis. Cell Rep  20, 1654-1666.   https://doi.org/10.1016/j.celrep.2017.07.054",https://intramural.nih.gov/search/searchview.taf?ipid=103649
64,BC010301-21,"October 01, 2017 -  September 30, 2018",Development of Recombinant Toxins to Treat Hematologic Malignancies,"Robert J Kreitman; MD, PhD|IRP Faculty Profile",NULL,"Clinical Immunotherapy Section, NCI",Lacey Renee James|Mark  Sokolsky|Hong  Zhou,Arthur  Frankel (Texas A&M)|Francesco  Forconi (Policlinico le Scotte)|Tadeusz  Robak (University of Lodz)|Martin  Tallman (Memorial Sloan Kettering Cancer Center)|Farhad  Ravandi (MD Anderson)|Michael  Grever (Ohio State Universithy)|Show all 8,"Evgeny  Arons (Laboratory of Molecular Biology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Constance M Yuan (Laboratory of Pathology)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)|Ira H Pastan; MD (Molecular Biology Section)",Nicholas  Patronas; MD (CC),"1. Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, et al. [16 more authors] (2017). Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood  129, 553-560.   https://doi.org/10.1182/blood-2016-01-689422|2. Wayne AS, Shah NN, Bhojwani D, Silverman LB, Whitlock JA, Stetler-Stevenson M, Sun W, Liang M, Yang J, Kreitman RJ, Lanasa MC, Pastan I (2017). Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia. Blood  130, 1620-1627.   https://doi.org/10.1182/blood-2017-02-749101",https://intramural.nih.gov/search/searchview.taf?ipid=103650
65,BC010304-20,"October 01, 2017 -  September 30, 2018",Biochemical Basis of T Cell Activation,Lawrence Elliot Samelson; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Lakshmi  Balagopalan|Grace Alice Bugos|Ana Maria Dios Esponera|Wenmei  Li; PhD|Asit Kumar Manna; PhD|Junya  Wada|Show all 9,NULL,Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Ettore  Appella; MD (Chemical Immunology Section),Peter W Schuck; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103651
66,BC010307-19,"October 01, 2017 -  September 30, 2018",Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells,Gisela Esta Sterneck; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Balamurugan  Kuppusamy|Dipak Kumar Poria|Shikha  Sharan|Namratha  Sheshadri,"Naoto  Ueno (National Institute for Basic Biology)|Wendy  Woodward (The University of Texas MD Anderson Cancer Center)|Savitri  Krishnamurthy (The University of Texas MD Anderson Cancer Center)|Michael  Lewis (Lester and Sue Smith Breast Center, Baylor College of Medicine)",Philip Jeffrey Tofilon (Radiation Oncology Branch)|Bruce Allen Shapiro; PhD (Rna Biology Laboratory)|Ruth  Nussinov; PhD (Cancer Inflammation Program)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,"1. Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, El-Zein R, Rahal OM, Alexander A, Reuben JM, Krishnamurthy S, Lucci A, Ueno NT (2017). Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference. J Cancer  8, 3607-3614.   https://doi.org/10.7150/jca.21200",https://intramural.nih.gov/search/searchview.taf?ipid=103585
67,BC010308-20,"October 01, 2017 -  September 30, 2018",In vivo Imaging Analysis of Steroid-Nuclear Receptor Function,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",David Alejandro Garcia Grisales|Diego Martin Presman; PhD|Razi  Raziuddin|Rodney Louis Schiltz; PhD|Diana  Stavreva|Lyuba  Varticovski,Luke  Iwanowicz (USGS-BRD)|Adali  Pecci (Ciudad Universitaria)|Michael  Collins (Center for Natural Capital)|Patricia  Bright (U.S. Geological Survey)|Arpita  Upadhyaya (University of Maryland/Maryland Nanocenter),"Mary Helen Ward; MS, PhD (Occupational and Environmental Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103654
68,BC010309-20,"October 01, 2017 -  September 30, 2018",Nuclear Architecture and Disease,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Carmen  Adriaens|Hesam  Babahosseini; PhD|Elizabeth  Finn|Leonard Pieter Kubben|Karen J Meaburn|Madaiah  Puttaraju|Show all 13,Job  Dekker; PhD (University of Massachusetts)|Dan  Levy (University of Wyoming),Stephen A Mabon (Hormone Action and Oncogenesis Section)|Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. DeBoy E, Puttaraju M, Jailwala P, Kasoji M, Cam M, Misteli T (2017). Identification of novel RNA isoforms of LMNA. Nucleus  8, 573-582.   https://doi.org/10.1080/19491034.2017.1348449|2. Finn EH, Misteli T (2017). Genome Architecture from a Different Angle. Dev Cell  41, 3-4.   https://doi.org/10.1016/j.devcel.2017.03.017|3. Finn EH, Pegoraro G, Shachar S, Misteli T (2017). Comparative analysis of 2D and 3D distance measurements to study spatial genome organization. Methods  123, 47-55.   https://doi.org/10.1016/j.ymeth.2017.01.007|4. Gudla PR, Nakayama K, Pegoraro G, Misteli T (2017). SpotLearn: Convolutional Neural Network for Detection of Fluorescence In Situ Hybridization (FISH) Signals in High-Throughput Imaging Approaches. Cold Spring Harb Symp Quant Biol  82, 57-70.   https://doi.org/10.1101/sqb.2017.82.033761|5. Kubben N, Misteli T (2017). Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases. Nat Rev Mol Cell Biol  18, 595-609.   https://doi.org/10.1038/nrm.2017.68|6. Larson DR, Misteli T (2017). The genome-seeing it clearly now. Science  357, 354-355.   https://doi.org/10.1126/science.aao1893|7. Pegoraro G, Misteli T (2017). High-Throughput Imaging for the Discovery of Cellular Mechanisms of Disease. Trends Genet  33, 604-615.   https://doi.org/10.1016/j.tig.2017.06.005|8. Shachar S, Misteli T (2017). Causes and consequences of nuclear gene positioning. J Cell Sci  130, 1501-1508.   https://doi.org/10.1242/jcs.199786|9. Zane L, Chapus F, Pegoraro G, Misteli T (2017). HiHiMap: single-cell quantitation of histones and histone posttranslational modifications across the cell cycle by high-throughput imaging. Mol Biol Cell  28, 2290-2302.   https://doi.org/10.1091/mbc.E16-12-0870",https://intramural.nih.gov/search/searchview.taf?ipid=103655
69,BC010313-20,"October 01, 2017 -  September 30, 2018",Molecular signatures for liver cancer diagnosis and treatment stratification,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI","Anuradha Samantha Budhu|Hien Thi-Thu Dang|Man Hsin  Hung; MD, PhD|Jinping  Liu|Lichun  Ma|Ravinder Singh Parhar|Show all 7","Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Christoffer  Loffredo (Georgetown University)|Mathuros  Ruchirawat (Chulabhorn Research Institute)|Dean  Felsher (Division of Oncology, Stanford University School of Medicine)|Show all 15",Marshonna J Forgues (Laboratory of Human Carcinogenesis)|Maria Luisa Hernandez (Laboratory of Human Carcinogenesis)|Sean  Martin (Thoracic & Oncologic Surgery Branch)|Valerie Fako Miller (Laboratory of Human Carcinogenesis)|Haiyang  Wang (Laboratory of Human Carcinogenesis)|Na  Zhao; PhD (Laboratory of Human Carcinogenesis),NULL,"1. Dang H, Takai A, Forgues M, Pomyen Y, Mou H, Xue W, Ray D, Ha KCH, Morris QD, Hughes TR, Wang XW (2017). Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma. Cancer Cell  32, 101-114.e8.   https://doi.org/10.1016/j.ccell.2017.06.002|2. Fako V, Wang XW (2017). The status of transarterial chemoembolization treatment in the era of precision oncology. Hepat Oncol  4, 55-63.   https://doi.org/10.2217/hep-2017-0009|3. Nepal C, O'Rourke CJ, Oliveira DVNP, Taranta A, Shema S, Gautam P, Calderaro J, Barbour A, Raggi C, Wennerberg K, Wang XW, Lautem A, Roberts LR, Andersen JB (2018). Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma. Hepatology  68, 949-963.   https://doi.org/10.1002/hep.29764|4. Xue R, Li J, Bai F, Wang X, Ji J, Lu Y (2017). A race to uncover a panoramic view of primary liver cancer. Cancer Biol Med  14, 335-340.   https://doi.org/10.20892/j.issn.2095-3941.2017.0112|5. Zheng H, Pomyen Y, Hernandez MO, Li C, Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y, Mehta M, Levin Y, Shetty J, Tran B, Budhu A, Wang XW (2018). Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology  68, 127-140.   https://doi.org/10.1002/hep.29778",https://intramural.nih.gov/search/searchview.taf?ipid=103657
70,BC010319-20,"October 01, 2017 -  September 30, 2018",Structural Basis of Biological Membrane Protein Functions and Drug Resistance,"Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Xiaoyun  Bai|Lothar  Esser|Fei  Zhou|Wai-Kwan  Tang,Min  Chen (University Of Massachusetts Amherst)|Zhaohai  Qin (Chinese Agriculture University),Christopher  Simion (Laboratory of Cell Biology)|Suresh V Ambudkar; PhD (Transport Biochemistry Section),Mario J Borgnia; PhD (NIEHS) |Joseph  Shiloach; PhD (NIDDK) |Michael Marc Gottesman; MD (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103658
71,BC010326-19,"October 01, 2017 -  September 30, 2018","Biomolecular Structure and Mechanism, Structure-Based Drug Design",Xinhua  Ji; PhD|IRP Faculty Profile,NULL,"Biomolecular Structure Section, NCI",Lan  Jin|Joshua Steven Rose; PhD|Gary X Shaw|Genbin  Shi|He  Song|Chao  Wang,Honggao  Yan|Sherif  Abou Elela (University of Sherbrooke)|Allen  Nicholson (Temple University)|Shivendra  Singh (University of Pittsburgh),David S Waugh; PhD (Protein Engineering Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory)|Yun Xing M Wang (Structural Biophysics Laboratory)|Shuo  Gu (Rna Biology Laboratory),NULL,"1. Singh K, Ji X, Singh S (2018) Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer. Mol Cancer Ther, in press.|2. Song H, Fang X, Jin L, Shaw GX, Wang YX, Ji X (2017). The Functional Cycle of Rnt1p: Five Consecutive Steps of Double-Stranded RNA Processing by a Eukaryotic RNase III. Structure  25, 353-363.   https://doi.org/10.1016/j.str.2016.12.013|3. Yu F, Song H, Wu Y, Chang SY, Wang L, Li W, Hong B, Xia S, Wang C, Khurana S, Feng Y, Wang Y, Sun Z, He B, Hou D, Manischewitz J, King LR, Song Y, Min JY, Golding H, Ji X, Lu L, Jiang S, Dimitrov DS, Ying T (2017). A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin. Cell Host Microbe  22, 471-483.e5.   https://doi.org/10.1016/j.chom.2017.08.011",https://intramural.nih.gov/search/searchview.taf?ipid=103659
72,BC010328-19,"October 01, 2017 -  September 30, 2018",Role of CEBP transcription factors in cell growth and tumorigenesis,Peter F Johnson; PhD|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Srikanta  Basu; PhD|Linshan  Hu|Nancy C Martin|Jacqueline  Salotti; PhD|Jonathan  Keller; PhD,NULL,Karen Lynn Saylor (Office Of The Director)|Maria  Miller (Protein Structure Section)|Deborah K Morrison (Laboratory of Cell and Developmental Signaling)|Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling),Myriam  Gorospe; PhD (NIA),"1. Basu SK, Lee S, Salotti J, Basu S, Sakchaisri K, Xiao Z, Walia V, Westlake CJ, Morrison DK, Johnson PF (2018). Oncogenic RAS-Induced Perinuclear Signaling Complexes Requiring KSR1 Regulate Signal Transmission to Downstream Targets. Cancer Res  78, 891-908.   https://doi.org/10.1158/0008-5472.CAN-17-2353|2. Kim KM, Noh JH, Bodogai M, Martindale JL, Yang X, Indig FE, Basu SK, Ohnuma K, Morimoto C, Johnson PF, Biragyn A, Abdelmohsen K, Gorospe M (2017). Identification of senescent cell surface targetable protein DPP4. Genes Dev  31, 1529-1534.   https://doi.org/10.1101/gad.302570.117",https://intramural.nih.gov/search/searchview.taf?ipid=103660
73,BC010329-19,"October 01, 2017 -  September 30, 2018",Regulation of Ras-Dependent Signal Transduction Pathways,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",David Ellis Durrant|Daniel A Ritt|Russell Spencer Smith|Elizabeth Mclean Terrell,"Channing J Der (Department of Pharmacology, University of North Carolina at Chapel Hill)|Adrienne  Cox (University of North Carolina School of Medicine)|Craig  Ceol (University Of Massachusetts Medical School)|Arvin  Dar (Ichan School Of Medicine At Mount Sinai)|John  Porco (Boston University)",Matthew T Holderfield (Office Of The Director)|Andrew G Stephen (Office Of The Director)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory)|Ping  Zhang (Structural Biophysics Laboratory),NULL,"1. Neiswender JV, Kortum RL, Bourque C, Kasheta M, Zon LI, Morrison DK, Ceol CJ (2017). KIT Suppresses BRAFV600E-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling. Cancer Res  77, 5820-5830.   https://doi.org/10.1158/0008-5472.CAN-17-0473",https://intramural.nih.gov/search/searchview.taf?ipid=103661
74,BC010331-19,"October 01, 2017 -  September 30, 2018",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",Shika Naidu Inala|Kenneth Min Kim|Kunduri  Govind; PhD,"Pedro  Labarca (Arturo Prat 514, Centro de Estudios Cientificos)|Usha  Acharya (University of Mass. Medical School)|joost  holthuis (University of Utrecht)|Vivek  Jayaraman (HHMI Janelia Farms Research Campus)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103662
75,BC010334-19,"October 01, 2017 -  September 30, 2018",Conserved Element DNA Vaccine,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Jenifer L Bear|Xintao  Hu|Zhongyan  Lu|George N Pavlakis; MD, PhD","Deborah  Fuller (University of Washington)|Sylvie  Le Gall (Massachusetts General Hospital)|Harriett L Robinson|James  Mullins; PhD (Microbiology, University of Washington)|Nicole  Frahm (Fred Hutchinson Cancer Research Center)|Kate  Broderick (Inovio Pharmaceuticals, Inc.)|Show all 16",Bethany Anne Nagy (Office Of The Director)|Stuart F J Le Grice; PhD (Basic Research Laboratory),"Lucio  Gama; PhD (NIAID) |Richard A Koup; MD (NIAID) |John R Mascola; MD (NIAID) |Bernard  Moss; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103663
76,BC010336-19,"October 01, 2017 -  September 30, 2018",Lambda Genetic Networks and Lambda Red-Mediated Recombination,Donald L Court; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Nina C Costantino|Carolyn B McGill|Xintian  Li|Lynn C Thomason|Gokhan  Tolun; PhD|Mikhail V Kashlev,"Max  Gottesman (Institute of Cancer Research, Columbia University)|William  Margolin (Microbiology and Molecular Genetics, University of Texas Medical School)|Joel  Stavans (Physics of Complex Systems, Weizmann Institute of Science)",Sankar  Adhya; PhD (Developmental Genetics Section)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103664
77,BC010338-19,"October 01, 2017 -  September 30, 2018",The Role of Fgf Signaling in Vertebrate Development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Michael Graham Stanley Boylan|Cynthia M Elder,"Trevor  Williams (University of Colarado)|David M Ornitz; MD (Department of Developmental Biology, Washington University, School of Medicine)|Anna-katerina  Hadjantonakis (Memorial Sloan Kettering Cancer Center)|Ryoichiro  Kageyama (Institute for Virus Research, Kyoto University)|Ernestina  Schipani (University Of Michigan)",Mccauley Grace Brown (Cancer and Developmental Biology Laboratory)|Thilinie Dilrukshi Kuruppu (Cancer and Developmental Biology Laboratory)|Salvia  Misaghian (Cancer and Developmental Biology Laboratory)|Sumi  Mondal (Cancer and Developmental Biology Laboratory)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section),NULL,"1. Ulmer B, Tingler M, Kurz S, Maerker M, Andre P, Mönch D, Campione M, Deißler K, Lewandoski M, Thumberger T, Schweickert A, Fainsod A, Steinbeißer H, Blum M (2017). A novel role of the organizer gene Goosecoid as an inhibitor of Wnt/PCP-mediated convergent extension in Xenopus and mouse. Sci Rep  7, 43010.   https://doi.org/10.1038/srep43010",https://intramural.nih.gov/search/searchview.taf?ipid=103665
78,BC010341-19,"October 01, 2017 -  September 30, 2018",Protein Expression and Purification in the Fast Lane,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",Sreedevi  Nallamsetty|Danielle  Needle,NULL,Rajesh  Gumpena (Macromolecular Crystallography Laboratory),NULL,"1. Gumpena R, Lountos G, Waugh D (2018) MBP-binding DARPins facilitate crystallization of an MBP fusion protein. Acta Crystallographica Section F, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103666
79,BC010345-19,"October 01, 2017 -  September 30, 2018",The Role of Wnt Genes in Vertebrate Development and Cancer,Terence P Yamaguchi; PhD|IRP Faculty Profile,NULL,"Cell Signaling in Vertebrate Development Section, NCI",Ravindra Babu  Chalamalasetty|Akhil  Kapoor|Matthew John Koury|Nikolaos Panagiotis Mandalos|Sara E Parkin,NULL,Aysegul  Dogan; PhD (Cancer and Developmental Biology Laboratory)|Mark B Lewandoski (Genetics of Vertebrate Development Section),NULL,"1. Gao B, Ajima R, Yang W, Li C, Song H, Anderson MJ, Liu RR, Lewandoski MB, Yamaguchi TP, Yang Y (2018). Coordinated directional outgrowth and pattern formation by integration of Wnt5a and Fgf signaling in planar cell polarity. Development  145.   https://doi.org/10.1242/dev.163824|2. Muley A, Odaka Y, Lewkowich IP, Vemaraju S, Yamaguchi TP, Shawber C, Dickie BH, Lang RA (2017). Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature. PLoS One  12, e0181549.   https://doi.org/10.1371/journal.pone.0181549",https://intramural.nih.gov/search/searchview.taf?ipid=103667
80,BC010348-19,"October 01, 2017 -  September 30, 2018",Protein Structure,Alexander  Wlodawer; PhD|IRP Faculty Profile,NULL,"Macromolecular Crystallography Laboratory, NCI",NULL,NULL,Alla E Gustchina (Protein Structure Section)|Maria  Miller (Protein Structure Section)|Pawel  Strzelczyk (Protein Structure Section)|Di  Zhang (Protein Structure Section)|Zbigniew  Dauter (Synchrotron Radiation Research Section)|Barry R O'Keefe (Molecular Targets Laboratory),NULL,"1. Iwaï H, Mikula KM, Oeemig JS, Zhou D, Li M, Wlodawer A (2017). Structural Basis for the Persistence of Homing Endonucleases in Transcription Factor IIB Inteins. J Mol Biol  429, 3942-3956.   https://doi.org/10.1016/j.jmb.2017.10.016|2. Jha JK, Li M, Ghirlando R, Miller Jenkins LM, Wlodawer A, Chattoraj D (2017). The DnaK Chaperone Uses Different Mechanisms To Promote and Inhibit Replication of Vibrio cholerae Chromosome 2. MBio  8.   https://doi.org/10.1128/mBio.00427-17|3. Ottaiano TF, Andrade SS, de Oliveira C, Silva MCC, Buri MV, Juliano MA, Girão MJBC, Sampaio MU, Schmaier AH, Wlodawer A, Maffei FHA, Oliva MLV (2017). Plasma kallikrein enhances platelet aggregation response by subthreshold doses of ADP. Biochimie  135, 72-81.   https://doi.org/10.1016/j.biochi.2017.01.010|4. Wlodawer A (2017). Online tools for enhancing presentation, understanding, and retention of 3D structural data. FEBS J  284, 3974-3976.   https://doi.org/10.1111/febs.14316|5. Wlodawer A (2017). Stereochemistry and Validation of Macromolecular Structures. Methods Mol Biol  1607, 595-610.   https://doi.org/10.1007/978-1-4939-7000-1_24",https://intramural.nih.gov/search/searchview.taf?ipid=103668
81,BC010350-19,"October 01, 2017 -  September 30, 2018",Prevention of AIDS,Barbara K Felber|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Jenifer L Bear|Zhongyan  Lu|Santhi  Devasundaram|George N Pavlakis; MD, PhD|Marjorie  Robert-Guroff; PhD|Jay Arthur Berzofsky; MD, PhD|Show all 7","Bart  Haynes (Duke Human Vaccine Institute)|Robert  Gallo; MD (Institute of Human Virology, Maryland University)|David C Montefiori; PhD (Department of Surgery, NIAID)|Mangala  Rao (USMHRP at the Walter Reed Army Institute of Research)|Steven  Reed; MD (Infectious Disease Research Institute)|Niranjan  Sardesai (Inovio Pharmaceuticals, Inc.)|Show all 33",Bethany Anne Nagy (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Brandon Frank Keele (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section)|Oleg Y Chertov (Office Of The Director)|Elena  Chertova (Office Of The Director),Malcolm A Martin; MD (NIAID) |Konstantinos  Petrovas (NIAID) |Vanessa  Hirsch (NIAID) |Mario  Roederer; PhD (NIAID) |Merlin L Robb (NIAID),"1. Jayanthi S, Koppolu BP, Nguyen KG, Smith SG, Felber BK, Zaharoff DA (2017). Modulation of Interleukin-12 activity in the presence of heparin. Sci Rep  7, 5360.   https://doi.org/10.1038/s41598-017-05382-1",https://intramural.nih.gov/search/searchview.taf?ipid=103669
82,BC010378-19,"October 01, 2017 -  September 30, 2018",Macromolecular Crystallography Research with Synchrotron Radiation,Zbigniew  Dauter|IRP Faculty Profile,NULL,"Synchrotron Radiation Research Section, NCI",Sergei V Pletnev|Milosz Jacek Ruszkowski; PhD|Bartosz  Sekula,"Andrzej  Joachimiak (Biosciences, Argonne Natl. Lab.)|Wladek  Minor|Zbyszek  Otwinowski (Biomedical Sciences, Southwestern Medical School)|Mariusz  Jaskolski (University of  Poznan)|Gerold  Rosenbaum (SER-CAT, Univeresity of Georgia)|Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)",Miroslawa  Dauter (Macromolecular Crystallography Laboratory)|Zhipu  Luo (Macromolecular Crystallography Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Dauter M, Dauter Z (2017). Many Ways to Derivatize Macromolecules and Their Crystals for Phasing. Methods Mol Biol  1607, 349-356.   https://doi.org/10.1007/978-1-4939-7000-1_14|2. Dauter Z (2017). Collection of X-Ray Diffraction Data from Macromolecular Crystals. Methods Mol Biol  1607, 165-184.   https://doi.org/10.1007/978-1-4939-7000-1_7|3. Luo Z, Dauter Z (2017). Embarras de richesses - It is not good to be too anomalous: Accurate structure of selenourea, a chiral crystal of planar molecules. PLoS One  12, e0171740.   https://doi.org/10.1371/journal.pone.0171740|4. Luo Z, Dauter Z, Gilski M (2017). Four highly pseudosymmetric and/or twinned structures of d(CGCGCG)2 extend the repertoire of crystal structures of Z-DNA. Acta Crystallogr D Struct Biol  73, 940-951.   https://doi.org/10.1107/S2059798317014954|5. Pyra A, Brzozowska E, Pawlik K, Gamian A, Dauter M, Dauter Z (2017). Tail tubular protein A: a dual-function tail protein of Klebsiella pneumoniae bacteriophage KP32. Sci Rep  7, 2223.   https://doi.org/10.1038/s41598-017-02451-3|6. Ruszkowski M, Dauter Z (2017). Structures of Medicago truncatula L-Histidinol Dehydrogenase Show Rearrangements Required for NAD+ Binding and the Cofactor Positioned to Accept a Hydride. Sci Rep  7, 10476.   https://doi.org/10.1038/s41598-017-10859-0|7. Wlodawer A, Dauter Z (2017). `Atomic resolution': a badly abused term in structural biology. Acta Crystallogr D Struct Biol  73, 379-380.   https://doi.org/10.1107/S205979831700225X|8. Wlodawer A, Li M, Dauter Z (2017). High-Resolution Cryo-EM Maps and Models: A Crystallographer's Perspective. Structure  25, 1589-1597.e1.   https://doi.org/10.1016/j.str.2017.07.012",https://intramural.nih.gov/search/searchview.taf?ipid=103670
83,BC010379-19,"October 01, 2017 -  September 30, 2018",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Yuba Raj Bhandari; PhD|Angel  Cantero-Camacho|Jienyu  Ding|Junfeng  Ma; PhD|Negin  Orfanian Azimzadeh Khosravi|Chelsie Elea Smith|Show all 8,John  Spence (Arizona State University)|Henry  Chapman (CFEL/DESY/University of Hamburg),Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,"1. Stagno JR, Bhandari YR, Conrad CE, Liu Y, Wang YX (2017). Real-time crystallographic studies of the adenine riboswitch using an X-ray free-electron laser. FEBS J  284, 3374-3380.   https://doi.org/10.1111/febs.14110",https://intramural.nih.gov/search/searchview.taf?ipid=103671
84,BC010387-19,"October 01, 2017 -  September 30, 2018",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",Jonathan  Keller; PhD (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103672
85,BC010390-19,"October 01, 2017 -  September 30, 2018",Role of Neurotrophins in the Development of the Mammalian Nervous System,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Gianluca  Fulgenzi,"Italo  Mocchetti (Pharmacology, Georgetown University)|Juan Carlos  Arevalo (University of Salamanca)|Barbara  Hempstead (Cornell University)|Ted  Dawson (Johns Hopkins University)|Valina  Dawson (Johns Hopkins University)",Colleen A Barrick (Office Of The Director)|Zhenyi  Hong; PhD (Neural Development Section)|Mary Ellen  Palko (Neural Development Section)|Francesco  Tomassoni Ardori; PhD (Neural Development Section)|Sudhirkumar U Yanpallewar (Neural Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103673
86,BC010391-19,"October 01, 2017 -  September 30, 2018",Role of Trk Receptors in the Development and Function of Non-neuronal Structures,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Gianluca  Fulgenzi,NULL,Colleen A Barrick (Office Of The Director)|Zhenyi  Hong; PhD (Neural Development Section)|Mary Ellen  Palko (Neural Development Section)|Francesco  Tomassoni Ardori; PhD (Neural Development Section)|Sudhirkumar U Yanpallewar (Neural Development Section),NULL,"1. Ma Q, Yang J, Milner TA, Vonsattel JG, Palko ME, Tessarollo L, Hempstead BL (2017). SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington's disease. JCI Insight  2.   https://doi.org/10.1172/jci.insight.88995",https://intramural.nih.gov/search/searchview.taf?ipid=103674
87,BC010411-19,"October 01, 2017 -  September 30, 2018",Initiation of DNA Replication in Mammalian Cells,Mirit I Aladjem; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Adrian M Baris|Haiqing  Fu|Sangmin  Jang|Christophe  Redon|Bhushan L Thakur|Yves  Pommier; PhD|Show all 7,"Eric  Bouhassira (hematology, Albert Einstein College of Medicine)|Jean-Marc  Lemaitre (Institute of Functional Genomics)|lizhao  wu (Rutgers New Jersey Medical School Cancer Center)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Patricia  Steeg; PhD (Womens Malignancies Branch)",Karen P Usdin; PhD (NIDDK),"1. Aladjem MI, Redon CE (2017). Order from clutter: selective interactions at mammalian replication origins. Nat Rev Genet  18, 101-116.   https://doi.org/10.1038/nrg.2016.141|2. Marks AB, Fu H, Aladjem MI (2017). Regulation of Replication Origins. Adv Exp Med Biol  1042, 43-59.   https://doi.org/10.1007/978-981-10-6955-0_2|3. Utani K, Fu H, Jang SM, Marks AB, Smith OK, Zhang Y, Redon CE, Shimizu N, Aladjem MI (2017). Phosphorylated SIRT1 associates with replication origins to prevent excess replication initiation and preserve genomic stability. Nucleic Acids Res  45, 7807-7824.   https://doi.org/10.1093/nar/gkx468|4. Wang Y, Khan A, Marks AB, Smith OK, Giri S, Lin YC, Creager R, MacAlpine DM, Prasanth KV, Aladjem MI, Prasanth SG (2017). Temporal association of ORCA/LRWD1 to late-firing origins during G1 dictates heterochromatin replication and organization. Nucleic Acids Res  45, 2490-2502.   https://doi.org/10.1093/nar/gkw1211",https://intramural.nih.gov/search/searchview.taf?ipid=103675
88,BC010412-19,"October 01, 2017 -  September 30, 2018",Structural Analysis of Macromolecular Complexes by Electron Microscopy,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Alan Anthony Merk,NULL,Sriram  Subramaniam; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103676
89,BC010413-18,"October 01, 2017 -  September 30, 2018",Human Artificial Chromosomes for Cancer Research and Functional Genomics,"Vladimir L Larionov; PhD, DSc|IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",Jung-Hyun  Kim|Hee-Sheung  Lee|Mikhail A Liskovykh|Vladimir  Noskov; PhD|Nikolai S Petrov|Yves  Pommier; PhD,"Mitsuo  Oshimura (Tottori University)|William  Earnshaw (Laboratory of Cell Biology, Wellcome Trust Centre for Cell Biology)|Hiroshi  Masumoto (NCI)|Phil  Hieter (University of British Columbia)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Adam Michael Phillippy (NHGRI) |Danny L Sackett; PhD (NICHD) |David  Schlessinger; PhD (NIA),"1. Lee NCO, Kim JH, Petrov NS, Lee HS, Masumoto H, Earnshaw WC, Larionov V, Kouprina N (2018). Method to Assemble Genomic DNA Fragments or Genes on Human Artificial Chromosome with Regulated Kinetochore Using a Multi-Integrase System. ACS Synth Biol  7, 63-74.   https://doi.org/10.1021/acssynbio.7b00209|2. Molina O, Kouprina N, Masumoto H, Larionov V, Earnshaw WC (2017). Using human artificial chromosomes to study centromere assembly and function. Chromosoma  126, 559-575.   https://doi.org/10.1007/s00412-017-0633-x|3. Partolina M, Thoms HC, MacLeod KG, Rodriguez-Blanco G, Clarke MN, Venkatasubramani AV, Beesoo R, Larionov V, Neergheen-Bhujun VS, Serrels B, Kimura H, Carragher NO, Kagansky A (2017). Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array. Cell Death Discov  3, 16077.   https://doi.org/10.1038/cddiscovery.2016.77|4. Pesenti E, Kouprina N, Liskovykh M, Aurich-Costa J, Larionov V, Masumoto H, Earnshaw WC, Molina O (2018). Generation of a Synthetic Human Chromosome with Two Centromeric Domains for Advanced Epigenetic Engineering Studies. ACS Synth Biol  7, 1116-1130.   https://doi.org/10.1021/acssynbio.8b00018",https://intramural.nih.gov/search/searchview.taf?ipid=103586
90,BC010419-19,"October 01, 2017 -  September 30, 2018",Molecular Mechanisms of TGF-beta Signaling Pathway,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI","Jee-Hye  Shin; PhD|Christina  Stuelten|Liuya  Tang|Roberto  Weigert; MSc Chemistry, PhD","Jun  Liu (Johns Hopkins University School of Medicine)|Steven  Cheng (Nanjing Medical University)|Hans  Clevers (Hubrecht Laboratory and Centre for Biomedical Genetics, Netherlands Institute for Developmental Biology)",Jing  Huang (Laboratory of Cancer Biology and Genetics)|Lisa Marie Jenkins (Pigment Cell Biology Section)|James  Gao (Thoracic & Oncologic Surgery Branch),Veenu  Tripathi; PhD (NIA),"1. Tang LY, Heller M, Meng Z, Yu LR, Tang Y, Zhou M, Zhang YE (2017). Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway. J Biol Chem  292, 4302-4312.   https://doi.org/10.1074/jbc.M116.773085|2. Tripathi V, Zhang YE (2017). Redirecting RNA splicing by SMAD3 turns TGF-β into a tumor promoter. Mol Cell Oncol  4, e1265699.   https://doi.org/10.1080/23723556.2016.1265699|3. Zhang YE (2017). Non-Smad Signaling Pathways of the TGF-β Family. Cold Spring Harb Perspect Biol  9.   https://doi.org/10.1101/cshperspect.a022129",https://intramural.nih.gov/search/searchview.taf?ipid=103678
91,BC010425-19,"October 01, 2017 -  September 30, 2018",Strategies for Cancer Immunotherapy Clinical Trials,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Martine  Policard|Angela Mae Schwab|Caroline Mikaela Maria Jochems; PhD|Morgan Lee Gargulak|Samuel Troy Pellom; PhD|Show all 9,"Paul  Chaplin (Bavarian Nordic, Inc.)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Hege KM, Bergsland EK, Fisher GA, Nemunaitis JJ, Warren RS, McArthur JG, Lin AA, Schlom J, June CH, Sherwin SA (2017). Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer. J Immunother Cancer  5, 22.   https://doi.org/10.1186/s40425-017-0222-9",https://intramural.nih.gov/search/searchview.taf?ipid=103679
92,BC010440-17,"October 01, 2017 -  September 30, 2018","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Hyunbum  Jang|Tsung-Jen  Liao|Buyong  Ma|Chung  Tsai|Mingzhen  Zhang; PhD|Giorgio  Trinchieri|Show all 8,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Ratnesh  Lal (Medical School, University of Chicago)|Bruce  Kagan (UCLA)|Show all 18",Terrence R Burke; PhD (Chemical Biology Laboratory)|Kyung  Lee; PhD (Chemistry Section),"David Barry Sacks (CC) |Carter  Van Waes; MD, PhD (NIDCD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103652
93,BC010441-17,"October 01, 2017 -  September 30, 2018",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Emine  Guven-Maiorov; PhD|Hyunbum  Jang|Tsung-Jen  Liao|Buyong  Ma|Chung  Tsai|Mingzhen  Zhang; PhD|Show all 9,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Peter  Csermely (Semmelweis University)|Jie  Zheng (University of Akron)|Show all 18",Terrence R Burke; PhD (Chemical Biology Laboratory)|Kyung  Lee; PhD (Chemistry Section),"David Barry Sacks (CC) |Carter  Van Waes; MD, PhD (NIDCD)","1. Nussinov R, Tsai CJ, Jang H (2018). Oncogenic Ras Isoforms Signaling Specificity at the Membrane. Cancer Res  78, 593-602.   https://doi.org/10.1158/0008-5472.CAN-17-2727",https://intramural.nih.gov/search/searchview.taf?ipid=103653
94,BC010442-17,"October 01, 2017 -  September 30, 2018",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,NULL,"Cancer Inflammation Program, NCI",Emine  Guven-Maiorov; PhD|Hyunbum  Jang|Tsung-Jen  Liao|Buyong  Ma|Chung  Tsai|Mingzhen  Zhang; PhD|Show all 9,"Turkan  Haliloglu|Ozlem  Keskin (Koc University)|Attila  Gursoy (Computer Science Dept., Koc University)|Haim  Wolfson (Tel Aviv Univ)|Jie  Zheng (University of Akron)|Yoshitaka  Ishii|Show all 18",Terrence R Burke; PhD (Chemical Biology Laboratory)|Kyung  Lee; PhD (Chemistry Section),"David Barry Sacks (CC) |Carter  Van Waes; MD, PhD (NIDCD)","1. Andrabi M, Hutchins AP, Miranda-Saavedra D, Kono H, Nussinov R, Mizuguchi K, Ahmad S (2017). Predicting conformational ensembles and genome-wide transcription factor binding sites from DNA sequences. Sci Rep  7, 4071.   https://doi.org/10.1038/s41598-017-03199-6|2. Cheng F, Nussinov R (2018). KRAS Activating Signaling Triggers Arteriovenous Malformations. Trends Biochem Sci  43, 481-483.   https://doi.org/10.1016/j.tibs.2018.04.007|3. Dong X, Sun Y, Wei G, Nussinov R, Ma B (2017). Binding of protofibrillar Aβ trimers to lipid bilayer surface enhances Aβ structural stability and causes membrane thinning. Phys Chem Chem Phys  19, 27556-27569.   https://doi.org/10.1039/c7cp05959k|4. Gan W, Schneidman D, Zhang N, Ma B, Nussinov R (2017). Probing Oligomerized Conformations of Defensin in the Membrane. Methods Mol Biol  1529, 353-362.   https://doi.org/10.1007/978-1-4939-6637-0_18|5. Gong Y, Zhu Y, Zou Y, Ma B, Nussinov R, Zhang Q (2017). Human Neuronal Calcium Sensor-1 Protein Avoids Histidine Residues To Decrease pH Sensitivity. J Phys Chem B  121, 508-517.   https://doi.org/10.1021/acs.jpcb.6b11094|6. Guven-Maiorov E, Tsai CJ, Nussinov R (2017). Structural host-microbiota interaction networks. PLoS Comput Biol  13, e1005579.   https://doi.org/10.1371/journal.pcbi.1005579|7. Ideker T, Nussinov R (2017). Network approaches and applications in biology. PLoS Comput Biol  13, e1005771.   https://doi.org/10.1371/journal.pcbi.1005771|8. Jang H, Banerjee A, Chavan T, Gaponenko V, Nussinov R (2017). Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction. J Biol Chem  292, 12544-12559.   https://doi.org/10.1074/jbc.M117.785063|9. Kuzu G, Keskin O, Nussinov R, Gursoy A (2018). PRISM-EM: template interface-based modelling of multi-protein complexes guided by cryo-electron microscopy density maps. Corrigendum. Acta Crystallogr D Struct Biol  74, 65-66.   https://doi.org/10.1107/S2059798317017739|10. Lee J, Kim YH, T Arce F, Gillman AL, Jang H, Kagan BL, Nussinov R, Yang J, Lal R (2017). Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts. ACS Chem Neurosci  8, 1348-1357.   https://doi.org/10.1021/acschemneuro.7b00006|11. Li X, Dong X, Wei G, Margittai M, Nussinov R, Ma B (2018). The distinct structural preferences of tau protein repeat domains. Chem Commun (Camb)  54, 5700-5703.   https://doi.org/10.1039/c8cc01263f|12. Liao TJ, Jang H, Tsai CJ, Fushman D, Nussinov R (2017). The dynamic mechanism of RASSF5 and MST kinase activation by Ras. Phys Chem Chem Phys  19, 6470-6480.   https://doi.org/10.1039/c6cp08596b|13. Libardo MDJ, Bahar AA, Ma B, Fu R, McCormick LE, Zhao J, McCallum SA, Nussinov R, Ren D, Angeles-Boza AM, Cotten ML (2017). Nuclease activity gives an edge to host-defense peptide piscidin 3 over piscidin 1, rendering it more effective against persisters and biofilms. FEBS J  284, 3662-3683.   https://doi.org/10.1111/febs.14263|14. Liu J, Nussinov R (2017). Energetic redistribution in allostery to execute protein function. Proc Natl Acad Sci U S A  114, 7480-7482.   https://doi.org/10.1073/pnas.1709071114|15. Nussinov R, Jang H, Tsai CJ, Liao TJ, Li S, Fushman D, Zhang J (2017). Intrinsic protein disorder in oncogenic KRAS signaling. Cell Mol Life Sci  74, 3245-3261.   https://doi.org/10.1007/s00018-017-2564-3|16. Nussinov R, Papin JA (2017). How can computation advance microbiome research? PLoS Comput Biol  13, e1005547.   https://doi.org/10.1371/journal.pcbi.1005547|17. Nussinov R, Papin JA, Vakser I (2017). Computing the Dynamic Supramolecular Structural Proteome. PLoS Comput Biol  13, e1005290.   https://doi.org/10.1371/journal.pcbi.1005290|18. Nussinov R, Tsai CJ, Jang H (2017). A New View of Pathway-Driven Drug Resistance in Tumor Proliferation. Trends Pharmacol Sci  38, 427-437.   https://doi.org/10.1016/j.tips.2017.02.001|19. Nussinov R, Tsai CJ, Jang H (2018). Oncogenic Ras Isoforms Signaling Specificity at the Membrane. Cancer Res  78, 593-602.   https://doi.org/10.1158/0008-5472.CAN-17-2727|20. Nussinov R, Tsai CJ, Jang H (2019). Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant? Semin Cancer Biol  54, 114-120.   https://doi.org/10.1016/j.semcancer.2018.01.002|21. Nussinov R, Tsai CJ, Jang H (2019). Oncogenic KRas mobility in the membrane and signaling response. Semin Cancer Biol  54, 109-113.   https://doi.org/10.1016/j.semcancer.2018.02.009|22. Nussinov R, Wang G, Tsai CJ, Jang H, Lu S, Banerjee A, Zhang J, Gaponenko V (2017). Calmodulin and PI3K Signaling in KRAS Cancers. Trends Cancer  3, 214-224.   https://doi.org/10.1016/j.trecan.2017.01.007|23. Nussinov R, Zhang M, Tsai CJ, Jang H (2018). Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers. Biochim Biophys Acta Mol Basis Dis  1864, 2304-2314.   https://doi.org/10.1016/j.bbadis.2017.10.032|24. Ozdemir ES, Jang H, Gursoy A, Keskin O, Li Z, Sacks DB, Nussinov R (2018). Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2. J Biol Chem  293, 3685-3699.   https://doi.org/10.1074/jbc.RA117.001596|25. Qi R, Wei G, Ma B, Nussinov R (2018). Replica Exchange Molecular Dynamics: A Practical Application Protocol with Solutions to Common Problems and a Peptide Aggregation and Self-Assembly Example. Methods Mol Biol  1777, 101-119.   https://doi.org/10.1007/978-1-4939-7811-3_5|26. Qian Z, Zou Y, Zhang Q, Chen P, Ma B, Wei G, Nussinov R (2018) Atomistic-level study of the interactions between hIAPP protofibrils and membranes: Influence of pH and lipid composition. Biochim Biophys Acta Biomembr, in press (e-pub ahead of print)  https://doi.org/10.1016/j.bbamem.2018.02.005|27. Ren B, Hu R, Zhang M, Liu Y, Xu L, Jiang B, Ma J, Ma B, Nussinov R, Zheng J (2018). Experimental and Computational Protocols for Studies of Cross-Seeding Amyloid Assemblies. Methods Mol Biol  1777, 429-447.   https://doi.org/10.1007/978-1-4939-7811-3_27|28. Tsai CJ, Nussinov R (2017). Allostery modulates the beat rate of a cardiac pacemaker. J Biol Chem  292, 6429-6430.   https://doi.org/10.1074/jbc.H116.773697|29. Wang G, Zhang M, Jang H, Lu S, Lin S, Chen G, Nussinov R, Zhang J, Gaponenko V (2018). Interaction of Calmodulin with the cSH2 Domain of the p85 Regulatory Subunit. Biochemistry  57, 1917-1928.   https://doi.org/10.1021/acs.biochem.7b01130|30. Wang M, Zhu D, Zhu J, Nussinov R, Ma B (2018). Local and global anatomy of antibody-protein antigen recognition. J Mol Recognit  31, e2693.   https://doi.org/10.1002/jmr.2693|31. Wu D, Wang W, Chen W, Lian F, Lang L, Huang Y, Xu Y, Zhang N, Chen Y, Liu M, Nussinov R, Cheng F, Lu W, Huang J (2018). Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells. Haematologica  103, 1472-1483.   https://doi.org/10.3324/haematol.2018.188185|32. Yang YA, Lee S, Zhao J, Thompson AJ, McBride R, Tsogtbaatar B, Paulson JC, Nussinov R, Deng L, Song J (2018). In vivo tropism of Salmonella Typhi toxin to cells expressing a multiantennal glycan receptor. Nat Microbiol  3, 155-163.   https://doi.org/10.1038/s41564-017-0076-4|33. Zhang M, Jang H, Gaponenko V, Nussinov R (2017). Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH2 Domains. Biophys J  113, 1956-1967.   https://doi.org/10.1016/j.bpj.2017.09.008|34. Zhang M, Zheng J, Nussinov R, Ma B (2017). Release of Cytochrome C from Bax Pores at the Mitochondrial Membrane. Sci Rep  7, 2635.   https://doi.org/10.1038/s41598-017-02825-7|35. Zhao J, Nussinov R, Ma B (2017). Allosteric control of antibody-prion recognition through oxidation of a disulfide bond between the CH and CL chains. Protein Eng Des Sel  30, 67-76.   https://doi.org/10.1093/protein/gzw065|36. Zhao J, Nussinov R, Ma B (2017). Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies. J Biol Chem  292, 18325-18343.   https://doi.org/10.1074/jbc.M117.801514|37. Zhao J, Zhang B, Zhu J, Nussinov R, Ma B (2018). Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients. Biochim Biophys Acta Mol Basis Dis  1864, 2294-2303.   https://doi.org/10.1016/j.bbadis.2017.12.009",https://intramural.nih.gov/search/searchview.taf?ipid=103656
95,BC010449-17,"October 01, 2017 -  September 30, 2018",Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung,Shioko  Kimura; PhD|IRP Faculty Profile,NULL,"Endocrinology Section, NCI",Henrique Bregolin Dias|Yongtao  Wang|Shigetoshi  Yokoyama,NULL,Xu  Naizhen (Laboratory of Pathology),NULL,"1. Kim JH, Yamaori S, Tanabe T, Takagi M, Matsubara T, Okamoto M, Kimura S, Gonzalez FJ (2017). Lack of epithelial PPARγ causes cystic adenomatoid malformations in mouse fetal lung. Biochem Biophys Res Commun  491, 271-276.   https://doi.org/10.1016/j.bbrc.2017.07.113|2. Kurotani R, Kimura S (2017). Secretoglobin 3A2: potential for treatment of respiratory diseases. The Allergy in Practice  37, 48-53.|3. Tanaka N, Aoyama T, Kimura S, Gonzalez FJ (2017). Targeting nuclear receptors for the treatment of fatty liver disease. Pharmacol Ther  179, 142-157.   https://doi.org/10.1016/j.pharmthera.2017.05.011",https://intramural.nih.gov/search/searchview.taf?ipid=103680
96,BC010451-17,"October 01, 2017 -  September 30, 2018",Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Kevin Roland Trabbic; PhD|Jeffrey  Gildersleeve,"Philip  Deshong (University of Maryland, College Park)|David  Cheresh (University of California San Diego)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103732
97,BC010453-17,"October 01, 2017 -  September 30, 2018",Genetics  Molecular Mechanisms of Prostate Cancer,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Cindy Huong-Bich Chau|Emily Mae Harris|Suzana  Markolovic|Edel Marie McCrea|Douglas K Price,"Ian Abban Thompson; MD|Robin  Leach (UT Health Science Center San Antonio)|Phyllis  Goodman (Fred Hutchinson Cancer Research Center)|Ashraful  Hoque (MD Anderson Cancer Center)|Elizabeth  Platz; PhD (School of Public Health, Johns Hopkins University)|Catherine  Tangen (Fred Hutchinson Cancer Research Center)|Show all 11",Phoebe Ao-Xue Huang (Office Of The Clinical Director)|Howard  Parnes (Prostate and Urologic Cancer Research Group),NULL,"1. Price D, Chau C, Figg W (2017). Mapping a Path for Cancer Precision Medicine. Lancet Oncology  18, 1444.|2. Tuerff D, Sissung T, Figg WD (2017). Cellular identity crisis: Antiandrogen resistance by lineage plasticity. Cancer Biol Ther  18, 841-842.   https://doi.org/10.1080/15384047.2017.1323599",https://intramural.nih.gov/search/searchview.taf?ipid=103681
98,BC010476-16,"October 01, 2017 -  September 30, 2018",Time Domian Electron Paramagnetic Resonance Imaging,Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Jeffrey Robert Brender|Nallathamby  Devasahayam|Shun Kishimoto Kishimoto|Yu  Saida|Tomohiro  Seki; PhD|Kazutoshi  Yamamoto; PhD|Show all 7,Robert  Gillies (Moffitt Cancer Center)|Charles  Hart (Threshold Pharmaceuticals),NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS) |Thomas J Pohida; MS (CIT),"1. Chou CC, Chandramouli GV, Shin T, Devasahayam N, McMillan A, Babadi B, Gullapalli R, Krishna MC, Zhuo J (2017). Accelerated electron paramagnetic resonance imaging using partial Fourier compressed sensing reconstruction. Magn Reson Imaging  37, 90-99.   https://doi.org/10.1016/j.mri.2016.10.029",https://intramural.nih.gov/search/searchview.taf?ipid=103691
99,BC010477-16,"October 01, 2017 -  September 30, 2018",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Murali  Krishna; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Jeffrey Robert Brender|Nallathamby  Devasahayam|Shun Kishimoto Kishimoto|Yu  Saida|Tomohiro  Seki; PhD|Kazutoshi  Yamamoto; PhD|Show all 7,NULL,NULL,Alan Paul Koretsky; PhD (NINDS) |Jeeva P Munasinghe (NINDS),"1. Kishimoto S, Oshima N, Yamamoto K, Munasinghe J, Ardenkjaer-Larsen JH, Mitchell JB, Choyke PL, Krishna MC (2018). Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes. Free Radic Biol Med  116, 1-10.   https://doi.org/10.1016/j.freeradbiomed.2017.12.034|2. Matsumoto KI, Mitchell JB, Krishna MC (2018). Comparative studies with EPR and MRI on the in vivo tissue redox status estimation using redox-sensitive nitroxyl probes: influence of the choice of the region of interest. Free Radic Res  52, 248-255.   https://doi.org/10.1080/10715762.2018.1427235",https://intramural.nih.gov/search/searchview.taf?ipid=103690
100,BC010481-16,"October 01, 2017 -  September 30, 2018",HIV-1 Reverse Transcriptase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Paul L Boyer|Patrick K Clark|Linda L Dunn|Andrea L Ferris|Steven J Smith,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)",Terrence R Burke; PhD (Chemical Biology Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Gary T Pauly (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103687
101,BC010484-16,"October 01, 2017 -  September 30, 2018",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",James Michael Dunleavey; PhD|Yang  Feng|Steven  Seaman,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries)|Dimiter Stanchev Dimitrov; PhD (NCI),Nancy J Emenaker (Nutritional Science Research Group),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103696
102,BC010487-16,"October 01, 2017 -  September 30, 2018",The role of CPSF6 in HIV-1 infection,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Szu-Wei  Huang; PhD|Ya-Chuan  Huang|Kyeongeun  Lee|Sekou-Tidiane T Yoda|Hyun Jae  Yu,"Alan  Engelman; PhD (Dana-Farber, Harvard University)|Thomas  Hope (Northwestern University)|Richard  Sutton|Mamuka  Kvaratskhelia; PhD (College of Pharmacy, Ohio State University)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Xiaolin  Wu; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103688
103,BC010488-16,"October 01, 2017 -  September 30, 2018",HIV-1 passage through the nuclear pore complex,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Guangai  Xue; PhD|Sekou-Tidiane T Yoda|Hyun Jae  Yu,"Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Jeremy  Luban (Columbia University)|Filipe  Diaz-griffero (Albert Einstein College Of Medicine)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103689
104,BC010493-16,"October 01, 2017 -  September 30, 2018",Nucleic Acid Footprinting and development of small molecule antagonists,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Fardokht Assadi Abulwerdi|Samantha Beatrice Gacasan|Stefano  Ginocchio|Regan Michael Leblanc|Jennifer T Miller|Julie Marie Nyman|Show all 9,"David  Rekosh (Myles Thayler AIDS Institute, University of Virginia)|Marie-Louise  Hammarskjold (University of Virginia)|John  Tavis (Saint Louis University)|Theodore  Dayie (University of Maryland)|Peter  Stockley (University of Leeds)",Barry R O'Keefe (Molecular Targets Laboratory)|John Stephen Schneekloth (Chemical Biology Laboratory)|Denise  Whitby (Office Of The Director),NULL,"1. Le Grice SF, Sztuba-Solinska J, Maccioni E, Purzycka KJ, Parolin C, Tramontano E (2017). Meeting report: Third Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS). Antiviral Res  139, 13-17.   https://doi.org/10.1016/j.antiviral.2016.12.004|2. Rausch JW, Miller JT, Le Grice SF (2017). Reverse Transcription in the Saccharomyces cerevisiae Long-Terminal Repeat Retrotransposon Ty3. Viruses  9.   https://doi.org/10.3390/v9030044|3. Sztuba-Solinska J, Rausch JW, Smith R, Miller JT, Whitby D, Le Grice SFJ (2017). Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA: a structural scaffold for nuclear, cytoplasmic and viral proteins. Nucleic Acids Res  45, 6805-6821.   https://doi.org/10.1093/nar/gkx241",https://intramural.nih.gov/search/searchview.taf?ipid=103693
105,BC010494-16,"October 01, 2017 -  September 30, 2018",Small molecule targeting viral nucleotidyltransferases,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Fardokht Assadi Abulwerdi|Samantha Beatrice Gacasan|Stefano  Ginocchio|Regan Michael Leblanc|Jennifer T Miller|Julie Marie Nyman|Show all 9,"Graziella  Tocco (University of Cagliari)|John  Tavis (Saint Louis University)|Ryan  Murelli (Brooklyn College)|Lynda  Morrison (St. Louis University)|Blossom  Damania (University of North Carolina, Chapel Hill, NC)",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|John A Beutler (Molecular Targets Laboratory),NULL,"1. Grady LM, Szczepaniak R, Murelli RP, Masaoka T, Le Grice SFJ, Wright DL, Weller SK (2017). The Exonuclease Activity of Herpes Simplex Virus 1 UL12 Is Required for Production of Viral DNA That Can Be Packaged To Produce Infectious Virus. J Virol  91.   https://doi.org/10.1128/JVI.01380-17|2. Hirsch DR, Schiavone DV, Berkowitz AJ, Morrison LA, Masaoka T, Wilson JA, Lomonosova E, Zhao H, Patel BS, Datla SH, Hoft SG, Majidi SJ, Pal RK, Gallicchio E, Tang L, Tavis JE, Le Grice SFJ, Beutler JA, Murelli RP (2017). Synthesis and biological assessment of 3,7-dihydroxytropolones. Org Biomol Chem  16, 62-69.   https://doi.org/10.1039/c7ob02453c|3. Miller J, Zhao H, Masaoka T, Varnado B, CornejoCastro E, Marshall V, Kaivon Kouhestani K, Lynn A, Aron K, Beutler J, Hirsch D, Tang L, Whitby D, Murelli R, Le Grice S (2018) Sensitivity of the C-terminal nuclease domain of Kaposis sarcoma-associated herpesvirus ORF29 to two classes of active site ligands. Antimicrobial Agents and Chemotherapy, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103692
106,BC010499-16,"October 01, 2017 -  September 30, 2018",Maryland Prostate Cancer Case-Control Study,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Margaret Saira Pichardo,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Rick  Kittles (University of Illinois at Chicago)|Carlos  Casiano (Loma Linda University School of Medicine)",Tsion Zewdu Minas (Molecular Genetics and Carcinogenesis Section)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Karunasinghe N, Ambs S, Wang A, Tang W, Zhu S, Dorsey TH, Goudie M, Masters JG, Ferguson LR (2018). Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts. PLoS One  13, e0199122.   https://doi.org/10.1371/journal.pone.0199122|2. Pichardo MS, Smith CJ, Dorsey TH, Loffredo CA, Ambs S (2018). Association of Anthropometric Measures with Prostate Cancer among African American Men in the NCI-Maryland Prostate Cancer Case-Control Study. Cancer Epidemiol Biomarkers Prev  27, 936-944.   https://doi.org/10.1158/1055-9965.EPI-18-0242|3. Tang W, Wallace TA, Yi M, Magi-Galluzzi C, Dorsey TH, Onabajo OO, Obajemu A, Jordan SV, Loffredo CA, Stephens RM, Silverman RH, Stark GR, Klein EA, Prokunina-Olsson L, Ambs S (2018). IFNL4-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer. Clin Cancer Res  24, 5471-5481.   https://doi.org/10.1158/1078-0432.CCR-18-1060",https://intramural.nih.gov/search/searchview.taf?ipid=103682
107,BC010504-16,"October 01, 2017 -  September 30, 2018","Understanding Retroviral Reverse Transcription, Recombination, and Replication",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Alice Ann Duchon; PhD|Yang  Liu; PhD|Olga A Nikolaitchik|Jonathan Mark Olivares Rawson|Xayathed  Somoulay|Chijioke Nkemjika Umunnakwe|Show all 7,NULL,Brandon Frank Keele (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103686
108,BC010506-16,"October 01, 2017 -  September 30, 2018","Defining Mechanisms of HIV-1 RNA Trafficking, Virus Assembly,  Virion Structure",Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Alice Ann Duchon; PhD|Yang  Liu; PhD|Olga A Nikolaitchik|Jonathan Mark Olivares Rawson|Xayathed  Somoulay|Show all 10,David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|John  Briggs (European Molecular Biology Laboratory)|Kelvin  Li (University of Pittsburgh School of Medicine),Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Christopher John Westlake; PhD (Laboratory of Cell and Developmental Signaling)|Eric O Freed; PhD (HIV Drug Resistance Program),NULL,"1. Burdick RC, Delviks-Frankenberry KA, Chen J, Janaka SK, Sastri J, Hu WS, Pathak VK (2017). Dynamics and regulation of nuclear import and nuclear movements of HIV-1 complexes. PLoS Pathog  13, e1006570.   https://doi.org/10.1371/journal.ppat.1006570|2. Comas-Garcia M, Kroupa T, Datta SA, Harvin DP, Hu WS, Rein A (2018). Efficient support of virus-like particle assembly by the HIV-1 packaging signal. Elife  7.   https://doi.org/10.7554/eLife.38438|3. Dilley KA, Nikolaitchik OA, Galli A, Burdick RC, Levine L, Li K, Rein A, Pathak VK, Hu WS (2017). Interactions between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly. J Virol  91.   https://doi.org/10.1128/JVI.02319-16",https://intramural.nih.gov/search/searchview.taf?ipid=103685
109,BC010511-16,"October 01, 2017 -  September 30, 2018",Retrovirus Assembly and Maturation,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Tomas  Kroupa; PhD|Diborah Mengistu Yimer|Wei-Shau  Hu; PhD,"Mark  Yeager|Bogdan  Dragnea (University of Indiana)|Adam  Zlotnick; PhD (Biochemistry and Molecular Biology, University of Oklahoma)|Volker  Vogt (Cornell University)|John  Briggs (European Molecular Biology Laboratory)|Hans-Georg  Krausslich (Heidelberg University)|Show all 11",Yun Xing M Wang (Structural Biophysics Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Kunio  Nagashima (Office of the Director)|Thorkell  Andresson (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Xinhua  Ji; PhD (Biomolecular Structure Section),Peter W Schuck; PhD (NIBIB),"1. Comas-Garcia M, Datta SA, Baker L, Varma R, Gudla PR, Rein A (2017). Dissection of specific binding of HIV-1 Gag to the 'packaging signal' in viral RNA. Elife  6.   https://doi.org/10.7554/eLife.27055",https://intramural.nih.gov/search/searchview.taf?ipid=103694
110,BC010512-16,"October 01, 2017 -  September 30, 2018",Interactions of Retroviral Proteins with Nucleic Acids,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Siddhartha  Datta; PhD|Demetria P Harvin|Tomas  Kroupa; PhD|Diborah Mengistu Yimer|Wei-Shau  Hu; PhD,Kevin  Weeks (University of North Carolina)|Karin  Musier-Forsyth (Ohio State University)|Rajat  Varma; PhD,"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)|Stephen J Lockett; PhD (Office Of The Director)|Prabhakar R Gudla; PhD (Laboratory of Receptor Biology and Gene Expression)",Peter W Schuck; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103695
111,BC010516-16,"October 01, 2017 -  September 30, 2018",Gated Optical Detectors-Dose Guided Radiotherapy,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Peter  Guion|Mary Kathleen Hawes|Holly  Ning|Ying  Zhuge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103699
112,BC010518-16,"October 01, 2017 -  September 30, 2018",Role of BMP and FGF signaling during limb development,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder,Trevor  Williams (University of Colarado)|Miguel Humberto Torres|Yingzi  Yang; PhD,Thilinie Dilrukshi Kuruppu (Cancer and Developmental Biology Laboratory)|Salvia  Misaghian (Cancer and Developmental Biology Laboratory)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103702
113,BC010523-16,"October 01, 2017 -  September 30, 2018",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Vanivilasini  Balachandran|Jothy  Dhakshnamoorthy|Hernan Diego Folco|Sahana  Holla|Madeline Michelle Larkin|Lixia  Pan|Show all 10,NULL,Peter C Fitzgerald (Office of the Director),Tommy Van Vo (NIGMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103579
114,BC010524-16,"October 01, 2017 -  September 30, 2018",HIV Integrase Modeling and Computer-Aided Inhibitor and Microbicide Development,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach,"Vladimir  Poroikov (Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)|Karen  Buckheit (ImQuest Biosciences)|Chenzhong  Liao",Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103700
115,BC010525-16,"October 01, 2017 -  September 30, 2018",Immune Reconstitution,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Catherine Virginia Bare|Don Eugene Farthing|Francis  Flomerfelt; PhD|Hye Kyung  Kim|Philip J Lucas; PhD|Ruifeng  Teng|Show all 7,NULL,Jung-Hyun  Park (Experimental Immunology Branch),NULL,"1. Curtis LM, Pirsl F, Steinberg SM, Mitchell SA, Baird K, Cowen EW, Mays J, Buxbaum NP, Pichard DC, Im A, Avila D, Taylor T, Fowler DH, Gress RE, Pavletic SZ (2017). Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients. Biol Blood Marrow Transplant  23, 1980-1988.   https://doi.org/10.1016/j.bbmt.2017.08.005|2. Farthing DE, Buxbaum NP, Lucas PJ, Maglakelidze N, Oliver B, Wang J, Hu K, Castro E, Bare CV, Gress RE (2017). Comparing DNA enrichment of proliferating cells following administration of different stable isotopes of heavy water. Sci Rep  7, 4043.   https://doi.org/10.1038/s41598-017-04404-2|3. Williams KM, Moore AR, Lucas PJ, Wang J, Bare CV, Gress RE (2017). FLT3 ligand regulates thymic precursor cells and hematopoietic stem cells through interactions with CXCR4 and the marrow niche. Exp Hematol  52, 40-49.   https://doi.org/10.1016/j.exphem.2017.05.005",https://intramural.nih.gov/search/searchview.taf?ipid=103684
116,BC010538-16,"October 01, 2017 -  September 30, 2018",Molecular Analysis of Breast Cancer Metastasis to the Brain,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Hardik Hastibhai Amin|Brunilde M Gril|Anurag Narasimha Paranjape|Debbie  Wei|Stanley  Lipkowitz; MD, PhD|Alexandra Dos Santos Zimmer","Quentin  Smith; PhD (Dept. of Pharmacy, Texas Technical University)|Jacek  Jassem (Medical University of Gdansk)|Renata  Duchnowska (Military Institute of Medicine,)|Priscilla  Brastianos (MGH)|Scott  Carter (Dana-Farber Cancer Center)|David  Lyden (Weill Cornell Medical School)|Show all 8",Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Terri Sue Armstrong; PhD (Neuro-Oncology Branch)|Simone  Difilippantonio (Office Of The Director)|William Douglas Figg Ii (Genitourinary Malignancies Branch),Rolf Eric Swenson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103697
117,BC010547-16,"October 01, 2017 -  September 30, 2018",Drug Development for Prostate Cancer and other Metastatic Processes,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Suzana  Markolovic|Edel Marie McCrea|Douglas K Price|James L Gulley; MD, PhD|William Laurence Dahut; MD|Show all 9","Brent R Copp; PhD (Chemistry, University of Auckland)|Wooin  Lee (Seoul National University)|Walter  Jager (University of Vienna)|Donald  McDonnel (Duke University School of Medicine)|Michael  Gutschow (University of Bonn)|Christopher  Schofield (University of Oxford)|Show all 7",Munjid  Al Harthy; MD (Office Of The Clinical Director)|Gang  Chen (Office Of The Clinical Director)|Phoebe Ao-Xue Huang (Office Of The Clinical Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Jane Beth Trepel (Developmental Therapeutics Branch),"Lisa Marie Cordes; PHARMD, BCACP (CC) |Nigel H Greig; PhD (NIA)","1. Chau C, Figg W, Chabner B (2018) Antimitotic Drugs, in Cancer Chemotherapy, Immunotherapy, and Biotherapy; Principles and Practices 6th Edition, in press.|2. Chau CH, Figg WD (2018). Revisiting 5α-reductase inhibitors and the risk of prostate cancer. Nat Rev Urol  15, 400-401.   https://doi.org/10.1038/s41585-018-0018-9|3. Feinman HE, Price DK, Figg WD (2017). Piecing the puzzle together: Docetaxel cycles and current considerations in the treatment of metastatic castration-resistant prostate cancer. Cancer Biol Ther  18, 203-204.   https://doi.org/10.1080/15384047.2017.1295192|4. Lee DK, Figg WD (2017). A new predictive tool for postoperative radiotherapy in prostate cancer. Cancer Biol Ther  18, 277-278.   https://doi.org/10.1080/15384047.2017.1310347|5. Norris JD, Ellison SJ, Baker JG, Stagg DB, Wardell SE, Park S, Alley HM, Baldi RM, Yllanes A, Andreano KJ, Stice JP, Lawrence SA, Eisner JR, Price DK, Moore WR, Figg WD, McDonnell DP (2017). Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer. J Clin Invest  127, 2326-2338.   https://doi.org/10.1172/JCI87328|6. Price D, Chau C, Figg W (2017). Mapping a Path for Cancer Precision Medicine. Lancet Oncology  18, 1444.",https://intramural.nih.gov/search/searchview.taf?ipid=103683
118,BC010549-16,"October 01, 2017 -  September 30, 2018",Zebrafish Models of Cancer,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103580
119,BC010578-15,"October 01, 2017 -  September 30, 2018",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",James Michael Dunleavey; PhD|Yang  Feng|Steven  Seaman|Kuo-Hui  Su,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries)|Dimiter Stanchev Dimitrov; PhD (NCI),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103582
120,BC010579-15,"October 01, 2017 -  September 30, 2018",Papillomavirus Virion Proteins and Vaccines,Douglas  Lowy; MD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI","Marian E Durkin|Richard P Koller|Alexander G Papageorge|Xiaolan  Qian; MD, PhD|Beatriz  Sanchez-Solana|Brajendra  Tripathi; MS, PhD|Show all 9",NULL,Lauren V Wood; MD (Vaccine Branch)|Ligia  Pinto (Infection & Immunoepidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch),NULL,"1. Cerqueira C, Thompson CD, Day PM, Pang YS, Lowy DR, Schiller JT (2017). Efficient Production of Papillomavirus Gene Delivery Vectors in Defined In Vitro Reactions. Mol Ther Methods Clin Dev  5, 165-179.   https://doi.org/10.1016/j.omtm.2017.04.005|2. Day PM, Thompson CD, Lowy DR, Schiller JT (2017). Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism. J Virol  91.   https://doi.org/10.1128/JVI.00168-17|3. Lowy DR, Schiller JT (2017). Preventing Cancer and Other Diseases Caused by Human Papillomavirus Infection: 2017 Lasker-DeBakey Clinical Research Award. JAMA  318, 901-902.   https://doi.org/10.1001/jama.2017.11706|4. Lowy DR, Singer DS (2017). Implementing the Cancer Moonshot and beyond. Lancet Oncol  18, e622-e623.   https://doi.org/10.1016/S1470-2045(17)30797-0",https://intramural.nih.gov/search/searchview.taf?ipid=103710
121,BC010580-15,"October 01, 2017 -  September 30, 2018",Phase II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103703
122,BC010595-15,"October 01, 2017 -  September 30, 2018",Structure and Function of Vif and APOBEC3 (A3) Proteins,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Michal Mateusz Bonar; PhD|John Y Chen|Krista A Delviks-Frankenberry|Belete Ayele Desimmie|Wei-Shau  Hu; PhD,Yong  Xiong (Yale University)|Hiroshi  Matsuo; PhD (STRUCTURAL BIOPHYSICS LABORATORY)|Eric  Barklis (University of Oregon),Mary  Kearney (Host Virus Interaction Branch)|Frank  Maldarelli (Host Virus Interaction Branch),NULL,"1. Desimmie BA, Smith JL, Matsuo H, Hu WS, Pathak VK (2017). Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function. Retrovirology  14, 19.   https://doi.org/10.1186/s12977-017-0346-5|2. Maiti A, Myint W, Kanai T, Delviks-Frankenberry K, Sierra Rodriguez C, Pathak VK, Schiffer CA, Matsuo H (2018). Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA. Nat Commun  9, 2460.   https://doi.org/10.1038/s41467-018-04872-8",https://intramural.nih.gov/search/searchview.taf?ipid=103712
123,BC010598-15,"October 01, 2017 -  September 30, 2018",Human Immune Responses to Tumor Antigens for Cancer Immunotherapy,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Renee Nicole Donahue|Morgan Lee Gargulak|Caroline Mikaela Maria Jochems; PhD|Samuel Troy Pellom; PhD|Martine  Policard|Claire Alison Smalley|Show all 9,"Paul  Chaplin (Bavarian Nordic, Inc.)|Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Donahue RN, Lepone LM, Grenga I, Jochems C, Fantini M, Madan RA, Heery CR, Gulley JL, Schlom J (2017). Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody. J Immunother Cancer  5, 20.   https://doi.org/10.1186/s40425-017-0220-y|2. Griffith P, Sun D, Tritsch S, Jochems C, Gulley J, Schlom J, Wu X (2017). Droplet-digital PCR provides a rapid, accurate and cost-effective method for identification of biomarker Fc?RIIIa-F158V genotypes. Gene Technol  6, 2.|3. Heery CR, O'Sullivan-Coyne G, Madan RA, Cordes L, Rajan A, Rauckhorst M, Lamping E, Oyelakin I, Marté JL, Lepone LM, Donahue RN, Grenga I, Cuillerot JM, Neuteboom B, Heydebreck AV, Chin K, Schlom J, Gulley JL (2017). Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial. Lancet Oncol  18, 587-598.   https://doi.org/10.1016/S1470-2045(17)30239-5",https://intramural.nih.gov/search/searchview.taf?ipid=103581
124,BC010600-15,"October 01, 2017 -  September 30, 2018","AAA Proteins, Their Functions and Related Diseases","Di S Xia; PhD, MS, BS|IRP Faculty Profile",NULL,"Crystallography Section, NCI",Wai-Kwan  Tang,NULL,NULL,Yihong  Ye (NIDDK),"1. Tang WK, Zhang T, Ye Y, Xia D (2017). Structural basis for nucleotide-modulated p97 association with the ER membrane. Cell Discov  3, 17045.   https://doi.org/10.1038/celldisc.2017.45|2. Ye Y, Tang WK, Zhang T, Xia D (2017). A Mighty ""Protein Extractor"" of the Cell: Structure and Function of the p97/CDC48 ATPase. Front Mol Biosci  4, 39.   https://doi.org/10.3389/fmolb.2017.00039",https://intramural.nih.gov/search/searchview.taf?ipid=103704
125,BC010607-15,"October 01, 2017 -  September 30, 2018",Ras-mediated signals in human epithelial cell transformation and metastasis,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin|Juanjuan  Yin,NULL,Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103708
126,BC010624-15,"October 01, 2017 -  September 30, 2018",The Molecular Profile of Prostate Tumors in African-American Men,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Wei  Tang; PhD,"Chris  Loffredo (Cancer Genetics and Epidemiology Program, Georgetown University)|Arun  Sreekumar (Baylor College of Medicine)|Rick  Kittles (University of Illinois at Chicago)|Nagireddy  Putluri (Baylor College of Medicine)|Clayton  Yates (Tuskegee University)",Tsion Zewdu Minas (Molecular Genetics and Carcinogenesis Section)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),NULL,"1. Smith CJ, Dorsey TH, Tang W, Jordan SV, Loffredo CA, Ambs S (2017). Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men. Cancer Epidemiol Biomarkers Prev  26, 845-853.   https://doi.org/10.1158/1055-9965.EPI-16-1027",https://intramural.nih.gov/search/searchview.taf?ipid=103715
127,BC010627-15,"October 01, 2017 -  September 30, 2018",Clinical Pharmacogenetics,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Sheryl A Gere|Phoebe Ao-Xue Huang|Cody John Peer|Keith Thomas Schmidt|Tristan  Sissung|Jonathan Dale Strope,C  Landgren (Memorial Sloan Kettering Cancer Center)|Susan  Bates; MD (NCI)|Richard  Horenstein (University of Maryland),Emily Mae Harris (Genitourinary Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|David J Venzon; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Richard Lawrence Piekarz (Investigational Drug Branch),Heidi H Kong (NIAMS),"1. Sissung T, Figg W (2018) UGT1A1 Polymorphisms and Mutations Affect Anticancer Drug Therapy, in Handbook of Therapeutic Biomarkers in Cancer, in press.|2. Alyamani M, Emamekhoo H, Park S, Taylor J, Almassi N, Upadhyay S, Tyler A, Berk MP, Hu B, Hwang TH, Figg WD, Peer CJ, Chien C, Koshkin VS, Mendiratta P, Grivas P, Rini B, Garcia J, Auchus RJ, Sharifi N (2018). HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancer. J Clin Invest  128, 3333-3340.   https://doi.org/10.1172/JCI98319|3. Backman JD, O'Connell JR, Tanner K, Peer CJ, Figg WD, Spencer SD, Mitchell BD, Shuldiner AR, Yerges-Armstrong LM, Horenstein RB, Lewis JP (2017). Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response. Pharmacogenet Genomics  27, 159-163.   https://doi.org/10.1097/FPC.0000000000000272|4. Green DJ, Duong SQ, Burckart GJ, Sissung T, Price DK, Figg WD, Brooks MM, Chinnock R, Canter C, Addonizio L, Bernstein D, Naftel DC, Zeevi A, Kirklin JK, Webber SA, Feingold B (2018). Association Between Thiopurine S-Methyltransferase (TPMT) Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis. J Pediatr Pharmacol Ther  23, 106-110.   https://doi.org/10.5863/1551-6776-23.2.106|5. Hauke RJ, Sissung TM, Figg WD (2017). Discussing the predictive, prognostic, and therapeutic value of germline DNA-repair gene mutations in metastatic prostate cancer patients. Cancer Biol Ther  18, 545-546.   https://doi.org/10.1080/15384047.2017.1345398|6. McCrea EM, Lee DK, Sissung TM, Figg WD (2018). Precision medicine applications in prostate cancer. Ther Adv Med Oncol  10, 1758835918776920.   https://doi.org/10.1177/1758835918776920|7. Sissung TM, McKeeby JW, Patel J, Lertora JJ, Kumar P, Flegel WA, Adams SD, Eckes EJ, Mickey F, Plona TM, Mellot SD, Baugher RN, Wu X, Soppet DR, Barcus ME, Datta V, Pike KM, DiPatrizio G, Figg WD, Goldspiel BR (2017). Pharmacogenomics Implementation at the National Institutes of Health Clinical Center. J Clin Pharmacol  57 Suppl 10, S67-S77.   https://doi.org/10.1002/jcph.993|8. Sissung TM, Peer CJ, Korde N, Mailankody S, Kazandjian D, Venzon DJ, Landgren O, Figg WD (2017). Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms. Cancer Chemother Pharmacol  80, 217-221.   https://doi.org/10.1007/s00280-017-3323-8",https://intramural.nih.gov/search/searchview.taf?ipid=103705
128,BC010632-15,"October 01, 2017 -  September 30, 2018",Transcription Regulation in E. coli and H. pylori,Ding Jun Jin,NULL,"Rna Biology Laboratory, NCI",Yixiong  Chen; PhD|Carmen  Mata Martin; PhD|Zhe  Sun|Yan Ning H Zhou|Mikhail V Kashlev|Thomas Dana Schneider; PhD|Show all 7,NULL,Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103707
129,BC010646-15,"October 01, 2017 -  September 30, 2018",Chromatin Remodeling Proteins,Gordon Lee Hager; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Songjoon  Baek|Diego Martin Presman; PhD|Rodney Louis Schiltz; PhD,NULL,NULL,NULL,"1. Johnson TA, Chereji RV, Stavreva DA, Morris SA, Hager GL, Clark DJ (2018). Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo. Nucleic Acids Res  46, 203-214.   https://doi.org/10.1093/nar/gkx1044",https://intramural.nih.gov/search/searchview.taf?ipid=103706
130,BC010654-14,"October 01, 2017 -  September 30, 2018",Lymphatic Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,Peter A Pinto; MD (Urologic Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103717
131,BC010655-14,"October 01, 2017 -  September 30, 2018",Prostate Cancer Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Ethan Schuyler Bergvall; MD|Marcin Boguslaw Czarniecki|Dagane  Daar|Philip Charles Eclarinal|Alicia Nicole Forest|Show all 16,Anwar  Padhani (Mt Vernon Hospital)|Jeff  Weinreb (Yale New Haven Hospital)|Francois  Cornud (Hopital Neckers)|Art  Rastinehed (Long Island Jewish Hospital)|Martin G Pomper|Jelle  Barentsz (Nijmegen University)|Show all 10,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch)|Deborah E Citrin (Radiation Oncology Branch),"Ronald M Summers; MD, PhD (CC) |Rolf Eric Swenson; PhD (NHLBI)","1. Bednarova S, Lindenberg ML, Vinsensia M, Zuiani C, Choyke PL, Turkbey B (2017). Positron emission tomography (PET) in primary prostate cancer staging and risk assessment. Transl Androl Urol  6, 413-423.   https://doi.org/10.21037/tau.2017.03.53|2. Buyyounouski MK, Choyke PL, McKenney JK, Sartor O, Sandler HM, Amin MB, Kattan MW, Lin DW (2017). Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin  67, 245-253.   https://doi.org/10.3322/caac.21391|3. Choyke PL, Loeb S (2017). Active Surveillance of Prostate Cancer. Oncology (Williston Park)  31, 67-70.|4. Greer MD, Choyke PL, Turkbey B (2017). PI-RADSv2: How we do it. J Magn Reson Imaging  46, 11-23.   https://doi.org/10.1002/jmri.25645|5. Harmon SA, Perk T, Lin C, Eickhoff J, Choyke PL, Dahut WL, Apolo AB, Humm JL, Larson SM, Morris MJ, Liu G, Jeraj R (2017). Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone. J Clin Oncol  35, 2829-2837.   https://doi.org/10.1200/JCO.2017.72.2348|6. Lindenberg ML, Turkbey B, Mena E, Choyke PL (2017). Imaging Locally Advanced, Recurrent, and Metastatic Prostate Cancer: A Review. JAMA Oncol  3, 1415-1422.   https://doi.org/10.1001/jamaoncol.2016.5840|7. Thoeny HC, Barbieri S, Froehlich JM, Turkbey B, Choyke PL (2017). Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges. Radiology  285, 728-743.   https://doi.org/10.1148/radiol.2017161517|8. Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB (2017). The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology  285, 343-356.   https://doi.org/10.1148/radiol.2017161684|9. Verma S, Rosenkrantz AB, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS (2017). Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsy. Abdom Radiol (NY)  42, 346-349.   https://doi.org/10.1007/s00261-016-0920-7",https://intramural.nih.gov/search/searchview.taf?ipid=103718
132,BC010656-14,"October 01, 2017 -  September 30, 2018",Growth Factor Imaging and Photoimmunotherapy,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Kingsley O Asiedu|Noriko  Sato; PhD|Karen J Wong,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)|Peter A Pinto; MD (Urologic Oncology Branch),Gadi Victor Cohen (CC) |Joshua  Farber; MD (NIAID),"1. Kishimoto S, Oshima N, Yamamoto K, Munasinghe J, Ardenkjaer-Larsen JH, Mitchell JB, Choyke PL, Krishna MC (2018). Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes. Free Radic Biol Med  116, 1-10.   https://doi.org/10.1016/j.freeradbiomed.2017.12.034|2. Maruoka Y, Nagaya T, Nakamura Y, Sato K, Ogata F, Okuyama S, Choyke PL, Kobayashi H (2017). Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging. Mol Pharm  14, 4628-4635.   https://doi.org/10.1021/acs.molpharmaceut.7b00731|3. Mochida A, Ogata F, Nagaya T, Choyke PL, Kobayashi H (2018). Activatable fluorescent probes in fluorescence-guided surgery: Practical considerations. Bioorg Med Chem  26, 925-930.   https://doi.org/10.1016/j.bmc.2017.12.002|4. Nagaya T, Gorka AP, Nani RR, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Schnermann MJ, Kobayashi H (2018). Molecularly Targeted Cancer Combination Therapy with Near-Infrared Photoimmunotherapy and Near-Infrared Photorelease with Duocarmycin-Antibody Conjugate. Mol Cancer Ther  17, 661-670.   https://doi.org/10.1158/1535-7163.MCT-17-0851|5. Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Allen C, Kobayashi H (2017). Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT. Mol Cancer Res  15, 1667-1677.   https://doi.org/10.1158/1541-7786.MCR-17-0333|6. Nagaya T, Nakamura Y, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H (2017). Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody. Mol Cancer Res  15, 1153-1162.   https://doi.org/10.1158/1541-7786.MCR-17-0164|7. Nagaya T, Nakamura YA, Choyke PL, Kobayashi H (2017). Fluorescence-Guided Surgery. Front Oncol  7, 314.   https://doi.org/10.3389/fonc.2017.00314|8. Nagaya T, Okuyama S, Ogata F, Maruoka Y, Choyke PL, Kobayashi H (2018). Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer. Cancer Sci  109, 1902-1908.   https://doi.org/10.1111/cas.13621|9. Nagaya T, Okuyama S, Ogata F, Maruoka Y, Knapp DW, Karagiannis SN, Fazekas-Singer J, Choyke PL, LeBlanc AK, Jensen-Jarolim E, Kobayashi H (2018). Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody. Oncotarget  9, 19026-19038.   https://doi.org/10.18632/oncotarget.24876|10. Nakamura Y, Mochida A, Nagaya T, Okuyama S, Ogata F, Choyke PL, Kobayashi H (2017). A topically-sprayable, activatable fluorescent and retaining probe, SPiDER-βGal for detecting cancer: Advantages of anchoring to cellular proteins after activation. Oncotarget  8, 39512-39521.   https://doi.org/10.18632/oncotarget.17080|11. Nakamura Y, Nagaya T, Sato K, Okuyama S, Ogata F, Wong K, Adler S, Choyke PL, Kobayashi H (2017). Cerenkov Radiation-Induced Photoimmunotherapy with 18F-FDG. J Nucl Med  58, 1395-1400.   https://doi.org/10.2967/jnumed.116.188789|12. Nakamura Y, Ohler ZW, Householder D, Nagaya T, Sato K, Okuyama S, Ogata F, Daar D, Hoa T, Choyke PL, Kobayashi H (2017). Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer. Mol Cancer Ther  16, 408-414.   https://doi.org/10.1158/1535-7163.MCT-16-0663|13. Nakamura Y, Shen Z, Harada T, Nagaya T, Sato K, Okuyama S, Ogata F, Choyke PL, McCarley RL, Kobayashi H (2017). Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD(P)H: quinone oxidoreductase isozyme 1 (hNQO1). Oncotarget  8, 61181-61192.   https://doi.org/10.18632/oncotarget.18044|14. Ogata F, Nagaya T, Nakamura Y, Sato K, Okuyama S, Maruoka Y, Choyke PL, Kobayashi H (2017). Near-infrared photoimmunotherapy: a comparison of light dosing schedules. Oncotarget  8, 35069-35075.   https://doi.org/10.18632/oncotarget.17047|15. Ogata F, Nagaya T, Okuyama S, Maruoka Y, Choyke PL, Yamauchi T, Kobayashi H (2017). Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy. Oncotarget  8, 104295-104302.   https://doi.org/10.18632/oncotarget.22223|16. Okuyama S, Nagaya T, Ogata F, Maruoka Y, Sato K, Nakamura Y, Choyke PL, Kobayashi H (2017). Avoiding thermal injury during near-infrared photoimmunotherapy (NIR-PIT): the importance of NIR light power density. Oncotarget  8, 113194-113201.   https://doi.org/10.18632/oncotarget.20179|17. Okuyama S, Nagaya T, Sato K, Ogata F, Maruoka Y, Choyke PL, Kobayashi H (2018). Interstitial near-infrared photoimmunotherapy: effective treatment areas and light doses needed for use with fiber optic diffusers. Oncotarget  9, 11159-11169.   https://doi.org/10.18632/oncotarget.24329|18. Railkar R, Krane LS, Li QQ, Sanford T, Siddiqui MR, Haines D, Vourganti S, Brancato SJ, Choyke PL, Kobayashi H, Agarwal PK (2017). Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Mol Cancer Ther  16, 2201-2214.   https://doi.org/10.1158/1535-7163.MCT-16-0924",https://intramural.nih.gov/search/searchview.taf?ipid=103719
133,BC010657-14,"October 01, 2017 -  September 30, 2018",Cellular In vivo Imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI","Stephen Scott Adler|Philip Charles Eclarinal|Alicia Nicole Forest|Michael  Green|Gary Leonard Griffiths; BSc, PhD|Elaine Marie Jagoda; MS|Show all 12",NULL,Christian S Hinrichs (Experimental Transplantation and Immunology Branch),Joshua  Farber; MD (NIAID) |Richard  Childs; MD (NHLBI),"1. Adler S, Seidel J, Choyke P, Knopp MV, Binzel K, Zhang J, Barker C, Conant S, Maass-Moreno R (2017). Minimum lesion detectability as a measure of PET system performance. EJNMMI Phys  4, 13.   https://doi.org/10.1186/s40658-017-0179-2|2. Basuli F, Zhang X, Jagoda EM, Choyke PL, Swenson RE (2018). Rapid synthesis of maleimide functionalized fluorine-18 labeled prosthetic group using ""radio-fluorination on the Sep-Pak"" method. J Labelled Comp Radiopharm  61, 599-605.   https://doi.org/10.1002/jlcr.3623|3. Basuli F, Zhang X, Williams MR, Seidel J, Green MV, Choyke PL, Swenson RE, Jagoda EM (2018). One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging. Nucl Med Biol  62-63, 63-70.   https://doi.org/10.1016/j.nucmedbio.2018.05.004|4. Basuli F, Zhang X, Woodroofe CC, Jagoda EM, Choyke PL, Swenson RE (2017). Fast indirect fluorine-18 labeling of protein/peptide using the useful 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl prosthetic group: A method comparable to direct fluorination. J Labelled Comp Radiopharm  60, 168-175.   https://doi.org/10.1002/jlcr.3487|5. Green MV, Seidel J, Choyke PL, Jagoda EM (2017). A simple device to convert a small-animal PET scanner into a multi-sample tissue and injection syringe counter. Nucl Med Biol  53, 9-13.   https://doi.org/10.1016/j.nucmedbio.2017.05.012|6. Green MV, Seidel J, Williams MR, Wong KJ, Ton A, Basuli F, Choyke PL, Jagoda EM (2017). Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model. Nucl Med Biol  53, 29-36.   https://doi.org/10.1016/j.nucmedbio.2017.06.004|7. Lindenberg L, Adler S, Turkbey IB, Mertan F, Ton A, Do K, Kummar S, Gonzalez EM, Bhattacharyya S, Jacobs PM, Choyke P (2017). Dosimetry and first human experience with 89Zr-panitumumab. Am J Nucl Med Mol Imaging  7, 195-203.|8. Weiss ID, Huff LM, Evbuomwan MO, Xu X, Dang HD, Velez DS, Singh SP, Zhang HH, Gardina PJ, Lee JH, Lindenberg L, Myers TG, Paik CH, Schrump DS, Pittaluga S, Choyke PL, Fojo T, Farber JM (2017). Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET. Oncotarget  8, 73387-73406.   https://doi.org/10.18632/oncotarget.19945",https://intramural.nih.gov/search/searchview.taf?ipid=103720
134,BC010661-14,"October 01, 2017 -  September 30, 2018",Vaccine and Drug Combination Therapy for Human Cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Kellsye Paula Fabian|Sofia Ribeiro Gameiro|Kristen  Solocinski|Marion G Taylor|Benjamin Robert Wolfson|Jeffrey  Schlom; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103731
135,BC010666-14,"October 01, 2017 -  September 30, 2018",Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Jennifer L Marte|Ravi  Madan|William Laurence Dahut; MD,"John  Marshall|Douglas  McNeel (University of Wisconsin)|Paul  Chaplin (Bavarian Nordic, Inc.)","William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Jennifer Clare Jones; MD, PhD (Vaccine Branch)",Andrew Lee Mammen (NIAMS),"1. Apolo AB, Infante JR, Balmanoukian A, Patel MR, Wang D, Kelly K, Mega AE, Britten CD, Ravaud A, Mita AC, Safran H, Stinchcombe TE, Srdanov M, Gelb AB, Schlichting M, Chin K, Gulley JL (2017). Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study. J Clin Oncol  35, 2117-2124.   https://doi.org/10.1200/JCO.2016.71.6795|2. Bilusic M, Madan R, Gulley J (2017). Immunotherapy of prostate cancer: facts and hopes. Clin Cancer Res  23, 6764-6770.|3. David J, Dominguez C, McCampbell K, Gulley J, Schlom J, Palena C (2017). A novel bifunctional anti-PD-L1TGF- Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. OncoImmunology  6, e1349589.|4. Gulley JL, Madan RA, Pachynski R, Mulders P, Sheikh NA, Trager J, Drake CG (2017). Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djw261|5. Gulley JL, Rajan A, Spigel DR, Iannotti N, Chandler J, Wong DJL, Leach J, Edenfield WJ, Wang D, Grote HJ, Heydebreck AV, Chin K, Cuillerot JM, Kelly K (2017). Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial. Lancet Oncol  18, 599-610.   https://doi.org/10.1016/S1470-2045(17)30240-1|6. Kantoff PW, Gulley JL, Pico-Navarro C (2017). Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol  35, 124-125.   https://doi.org/10.1200/JCO.2016.69.7748|7. Madan R, Gulley J (2017) Personalized peptide vaccine in prostate cancer: capitalizing on existing immunity. Transl Cancer Res, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103730
136,BC010668-14,"October 01, 2017 -  September 30, 2018",Instrumentation for microSPECT and microPET imaging,Peter L Choyke; MD|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Stephen Scott Adler|Alicia Nicole Forest|Michael  Green|Jurgen  Seidel; PhD,NULL,NULL,Thomas J Pohida; MS (CIT),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103716
137,BC010670-14,"October 01, 2017 -  September 30, 2018",Radiation-induced molecular targets,Norman Norman Coleman; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Molykutty J Aryankalayil|Sunita  Chopra; PhD|Iris Regina Eke; MD|Adeola Yetunde Makinde|Deborah E Citrin,Emanuel  Petricoin (George Mason University)|Lance  Liotta (George Mason University)|Sylvia  Formenti (NYU)|Sandra  Demaria (Weill Cornell Medical School)|Rocco  Cassagrande (Gryphon Scientific),James B Mitchell; PhD (Radiation Biology Branch)|Mansoor Mukhtar Ahmed; PhD (Radiotherapy Development Branch)|Murali  Krishna; PhD (Radiation Biology Branch),NULL,"1. Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, et al. [2 more authors] (2018). Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint. Cancer Res  78, 2166-2170.   https://doi.org/10.1158/0008-5472.CAN-17-3760|2. Eke I, Makinde AY, Aryankalayil MJ, Sandfort V, Palayoor ST, Rath BH, Liotta L, Pierobon M, Petricoin EF, Brown MF, Stommel JM, Ahmed MM, Coleman CN (2018). Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example. Mol Cancer Ther  17, 355-367.   https://doi.org/10.1158/1535-7163.MCT-17-0262|3. Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S (2017). DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat Commun  8, 15618.   https://doi.org/10.1038/ncomms15618",https://intramural.nih.gov/search/searchview.taf?ipid=103714
138,BC010671-14,"October 01, 2017 -  September 30, 2018",Genetic Analysis of T-cell Differentiation,"Remy J Bosselut; MD, PhD|IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Mariah Sarahjane Balmaceno-Criss|Laura Beth Chopp|Thomas  Ciucci|Yayi  Gao|Assaf Yosef Magen|Jia  Nie|Show all 8,"Marc  Jenkins|Wilfried  Ellmeier (Immunology, University of Vienna)|Georg  Hollander (University of Oxford)|Hai-Hui  Xue; MD, PhD (University of Iowa)|Yi  Zhang (Temple University)|Jonathan  Kaye (Cedars Sinai Medical Center)|Show all 7","Charles  Vinson; PhD (Nucleic Acids Section)|Avinash  Bhandoola; MD, PhD (Laboratory Of Genome Integrity)|Richard J Hodes; MD (Experimental Immunology Branch)|Michael Christopher Kelly; PhD (Office of the Director)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Bao D Quoe  Tran (Office of the Director)","Paul E Love; MD, PhD (NICHD) |Dorian  McGavern (NINDS) |Yasmine  Belkaid; PhD (NIAID)","1. Ciucci T, Vacchio MS, Bosselut R (2017). A STAT3-dependent transcriptional circuitry inhibits cytotoxic gene expression in T cells. Proc Natl Acad Sci U S A  114, 13236-13241.   https://doi.org/10.1073/pnas.1711160114",https://intramural.nih.gov/search/searchview.taf?ipid=103713
139,BC010675-14,"October 01, 2017 -  September 30, 2018",Development of a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",David W Farnsworth|Joel Sebastian Temme; BS|Joseph John Barchi,NULL,Benjamin Andres Garcia (Office Of Workforce Planning & Development),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103722
140,BC010677-14,"October 01, 2017 -  September 30, 2018",NADPH Oxidases as Novel Targets for Cancer Therapy,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI","Guojian  Jiang; MD|Agnes  Juhasz|Jiamo  Lu; MD, MPH, MHS|Jennifer Lynn Meitzler|Yongzhong  Wu",NULL,NULL,NULL,"1. Chu FF, Esworthy RS, Doroshow JH, Grasberger H, Donko A, Leto TL, Gao Q, Shen B (2017). Deficiency in Duox2 activity alleviates ileitis in GPx1- and GPx2-knockout mice without affecting apoptosis incidence in the crypt epithelium. Redox Biol  11, 144-156.   https://doi.org/10.1016/j.redox.2016.11.001|2. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, Wu X, Antony S, Wu Y, Melillo G, Meitzler JL, Haines DC, Butcher D, Roy K, Doroshow JH (2017). NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem  292, 7866-7887.   https://doi.org/10.1074/jbc.M116.768283|3. Liu H, Antony S, Roy K, Juhasz A, Wu Y, Lu J, Meitzler JL, Jiang G, Polley E, Doroshow JH (2017). Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells. Oncotarget  8, 38113-38135.   https://doi.org/10.18632/oncotarget.17494|4. Lu J, Risbood P, Kane CT, Hossain MT, Anderson L, Hill K, Monks A, Wu Y, Antony S, Juhasz A, Liu H, Jiang G, Harris E, Roy K, Meitzler JL, Konaté M, Doroshow JH (2017). Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases. Biochem Pharmacol  143, 25-38.   https://doi.org/10.1016/j.bcp.2017.07.007|5. Meitzler JL, Makhlouf HR, Antony S, Wu Y, Butcher D, Jiang G, Juhasz A, Lu J, Dahan I, Jansen-Dürr P, Pircher H, Shah AM, Roy K, Doroshow JH (2017). Decoding NADPH oxidase 4 expression in human tumors. Redox Biol  13, 182-195.   https://doi.org/10.1016/j.redox.2017.05.016",https://intramural.nih.gov/search/searchview.taf?ipid=103721
141,BC010681-14,"October 01, 2017 -  September 30, 2018",Development of inhibitors targeting Plk1 polo-box domain,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Seongjin  Choe|Jung Eun  Park|Celeste Natalie Alverez|Yaozong  Chen,Michael  Yaffe (Massachusetts Institute of Technology)|Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,Terrence R Burke; PhD (Chemical Biology Laboratory),"Kenneth A Jacobson; BA, MS, PhD (NIDDK)","1. Park JE, Hymel D, Burke TR, Lee KS (2017). Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents. F1000Res  6, 1024.   https://doi.org/10.12688/f1000research.11398.1",https://intramural.nih.gov/search/searchview.taf?ipid=103727
142,BC010683-14,"October 01, 2017 -  September 30, 2018",Role of FH loss in development of HLRCC heriditary kidney cancer,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Joseph Andrew Baiocco|Kristin  Eckfeld|Ryo  Ishida|Nobu  Oshima|William Marston Linehan; MD|Piyush Kumar Agarwal; MD|Show all 8,Sunil  Sudarshan|Victor  Darley-Usmar (University of Alabama-Birmingham)|Didier  Picard (University of Geneva)|Richard  Wooster (Wellcome Trust Sanger Inst),Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert Taylor Ripley; MD (Thoracic & Oncologic Surgery Branch),NULL,"1. Rai G, Brimacombe KR, Mott BT, Urban DJ, Hu X, Yang SM, Lee TD, Cheff DM, Kouznetsova J, Benavides GA, Pohida K, Kuenstner EJ, Luci DK, Lukacs CM, Davies DR, Dranow DM, Zhu H, Sulikowski G, Moore WJ, Stott GM, Flint AJ, Hall MD, Darley-Usmar VM, Neckers LM, Dang CV, et al. [4 more authors] (2017). Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH). J Med Chem  60, 9184-9204.   https://doi.org/10.1021/acs.jmedchem.7b00941",https://intramural.nih.gov/search/searchview.taf?ipid=103729
143,BC010696-14,"October 01, 2017 -  September 30, 2018",Study of Hereditary Renal and Other Familial Syndromes,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Xu  Naizhen|David D Roberts; PhD,NULL,"Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Mark Wayne Ball (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Sidana A, Kadakia M, Friend JC, Krane LS, Su D, Merino MJ, Srinivasan R (2017). Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer. Urol Oncol  35, 114.e9-114.e14.   https://doi.org/10.1016/j.urolonc.2016.10.023",https://intramural.nih.gov/search/searchview.taf?ipid=103728
144,BC010707-13,"October 01, 2017 -  September 30, 2018",Role of T Regulatory Cell Suppression in Autoimmunity and Cancer,Joost J Oppenheim; MD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Xin  Chen|Tianzhen  He|Anna Lee  Trivett|De  Yang,Xin  Chen (University of Macao)|Dimiter Stanchev Dimitrov; PhD (NCI)|Yingjie No Nie (LABORATORY MOLECULAR IMMUNOREGULATION),NULL,Rachel R Caspi; PhD (NEI),"1. Oppenheim J (2017) Cytokines, their receptors and signals, in The Autoimmune Disease, in press.|2. Chen X, Oppenheim JJ (2017). Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer. Sci Signal  10.   https://doi.org/10.1126/scisignal.aal2328",https://intramural.nih.gov/search/searchview.taf?ipid=103735
145,BC010709-13,"October 01, 2017 -  September 30, 2018",Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103745
146,BC010717-13,"October 01, 2017 -  September 30, 2018",Phase I study of bortezomib and DA-EPOCH-R with microarray in DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Lydia L Yee|Christopher Joseph Melani|Saleema  Osman|Mark Jason Roschewski|Joseph Lee Roswarski,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Louis  Staudt; MD (Center for Cancer Genomics),NULL,"1. Dimitriades VR, Devlin V, Pittaluga S, Su HC, Holland SM, Wilson W, Dunleavy K, Shah NN, Freeman AF (2017). DOCK 8 Deficiency, EBV+ Lymphomatoid Granulomatosis, and Intrafamilial Variation in Presentation. Front Pediatr  5, 38.   https://doi.org/10.3389/fped.2017.00038|2. Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Karlin L, Robak T, Gladstone DE, le Coutre P, Dietrich S, Gotic M, Larratt L, Offner F, Schiller G, Swords R, Bacon L, Bocchia M, Bouabdallah K, Breems DA, Cortelezzi A, Dinner S, Doubek M, Gjertsen BT, Gobbi M, Hellmann A, Lepretre S, et al. [18 more authors] (2018). Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia. Leukemia  32, 1768-1777.   https://doi.org/10.1038/s41375-018-0210-1|3. Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, FitzGerald DJ, Santiago L, Gao G, Lanasa MC, Pastan I (2018). Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up. Blood  131, 2331-2334.   https://doi.org/10.1182/blood-2017-09-803072|4. Mailankody S, Kazandjian D, Korde N, Roschewski M, Manasanch E, Bhutani M, Tageja N, Kwok M, Zhang Y, Zingone A, Lamy L, Costello R, Morrison C, Hultcrantz M, Christofferson A, Washington M, Boateng M, Steinberg SM, Stetler-Stevenson M, Figg WD, Papaemmanuil E, Wilson WH, Keats JJ, Landgren O (2017). Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma. Blood Adv  1, 1911-1918.   https://doi.org/10.1182/bloodadvances.2017005934|5. Melani C, Advani R, Roschewski M, Walters KM, Chen CC, Baratto L, Ahlman MA, Miljkovic MD, Steinberg SM, Lam J, Shovlin M, Dunleavy K, Pittaluga S, Jaffe ES, Wilson WH (2018). End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making. Haematologica  103, 1337-1344.   https://doi.org/10.3324/haematol.2018.192492|6. Melani C, Major A, Schowinsky J, Roschewski M, Pittaluga S, Jaffe ES, Pack SD, Abdullaev Z, Ahlman MA, Kwak JJ, Morgan R, Rabinovitch R, Pan Z, Haverkos BM, Gutman JA, Pollyea DA, Smith CA, Wilson WH, Kamdar M (2017). PD-1 Blockade in Mediastinal Gray-Zone Lymphoma. N Engl J Med  377, 89-91.   https://doi.org/10.1056/NEJMc1704767|7. Melani C, Roschewski M, Wilson WH (2018). End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al. Haematologica  103, e382.   https://doi.org/10.3324/haematol.2018.199547|8. Melani C, Wilson WH, Roschewski M (2019). What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R? Br J Haematol  184, 836-838.   https://doi.org/10.1111/bjh.15185|9. Navarro A, Clot G, Martínez-Trillos A, Pinyol M, Jares P, González-Farré B, Martínez D, Trim N, Fernández V, Villamor N, Colomer D, Costa D, Salaverria I, Martín-Garcia D, Erber W, López C, Jayne S, Siebert R, Dyer MJS, Wiestner A, Wilson WH, Aymerich M, López-Guillermo A, Sánchez À, Campo E, et al. [2 more authors] (2017). Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier. Haematologica  102, e360-e363.   https://doi.org/10.3324/haematol.2016.160374|10. Younes A, Ansell S, Fowler N, Wilson W, de Vos S, Seymour J, Advani R, Forero A, Morschhauser F, Kersten MJ, Tobinai K, Zinzani PL, Zucca E, Abramson J, Vose J (2017). The landscape of new drugs in lymphoma. Nat Rev Clin Oncol  14, 335-346.   https://doi.org/10.1038/nrclinonc.2016.205|11. Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Seymour JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, et al. [25 more authors] (2017). International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol  28, 1436-1447.   https://doi.org/10.1093/annonc/mdx097",https://intramural.nih.gov/search/searchview.taf?ipid=103746
147,BC010719-13,"October 01, 2017 -  September 30, 2018",Randomized Phase II study of borteozmib-EPOCH-R in Mantle cell lymphoma,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Lydia L Yee|Christopher Joseph Melani|Saleema  Osman|Mark Jason Roschewski|Joseph Lee Roswarski,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),"Adrian U Wiestner; MD, PhD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103747
148,BC010725-13,"October 01, 2017 -  September 30, 2018",Role of Formylpeptide Receptors in Host Defense,"Ji Ming  Wang; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Keqiang  Chen|Wang Hua  Gong|Jiaqiang  Huang|Stacey Ann Krepel|Weiwei  Liang|Meihua  Zhang,"Xiuwu  Bian (Southwest Hospital, Institute of Pathology)|Gert  Schmid-Schonbein (Whitaker Institute, UC San Diego)|Chunfu  Wu (Medicinal Chemistry, Shenyang Pharmaceutical University)|Yingying  Le (Immunology, Institute for Nutritional Sciences)",NULL,"Ronald N Germain; MD, PhD (NIAID) |Yasmine  Belkaid; PhD (NIAID)","1. Chen K, Bao Z, Gong W, Tang P, Yoshimura T, Wang JM (2017). Regulation of inflammation by members of the formyl-peptide receptor family. J Autoimmun  85, 64-77.   https://doi.org/10.1016/j.jaut.2017.06.012|2. Chen K, Bao Z, Gong W, Yoshimura T, Wang J (2017) Regulation of inflammation by members of the FPR family. Journal of Autoimmunity, in press.|3. Chen K, Bao Z, Tang P, Gong W, Yoshimura T, Wang JM (2018). Chemokines in homeostasis and diseases. Cell Mol Immunol  15, 324-334.   https://doi.org/10.1038/cmi.2017.134|4. Shi Y, Lai X, Ye L, Chen K, Cao Z, Gong W, Jin L, Wang C, Liu M, Liao Y, Wang JM, Zhou N (2017). Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization. Sci Rep  7, 42279.   https://doi.org/10.1038/srep42279|5. Tang P, Wang JM (2018). Chemokines: the past, the present and the future. Cell Mol Immunol  15, 295-298.   https://doi.org/10.1038/cmi.2018.9|6. Yu Y, Bao Z, Wang X, Gong W, Chen H, Guan H, Le Y, Su S, Chen K, Wang JM (2017). The G-Protein-Coupled Chemoattractant Receptor Fpr2 Exacerbates High Glucose-Mediated Proinflammatory Responses of Müller Glial Cells. Front Immunol  8, 1852.   https://doi.org/10.3389/fimmu.2017.01852",https://intramural.nih.gov/search/searchview.taf?ipid=103738
149,BC010728-13,"October 01, 2017 -  September 30, 2018",Phase III Study of R-CHOP v DA-EPOCH-R with microarray,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Lydia L Yee|Christopher Joseph Melani|Saleema  Osman|Mark Jason Roschewski|Joseph Lee Roswarski,"Myron  Czuczman (Oncology, Roswell Park Cancer Institute)|Bruce Allan Chabner|Andrew  Zelenetz (Medicine, MSKCC)|Bruce  Cheson (NCI)",Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Louis  Staudt; MD (Center for Cancer Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103748
150,BC010736-13,"October 01, 2017 -  September 30, 2018",Unraveling the function of CD276,Bradley D St Croix,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Yang  Feng|Steven  Seaman,Saurabh  Saha (BioMed Valley Discoveries)|Michelle  Zhang (BioMed Valley Discoveries)|Gary  DeCrescenzo (BioMed Valley Discoveries)|Dean  Welsch (BioMed Valley Discoveries)|Dimiter Stanchev Dimitrov; PhD (NCI),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103744
151,BC010738-13,"October 01, 2017 -  September 30, 2018","Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging",Steven X Hou|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Poonam  Aggarwal|Cristopher Eduardo Aguilar Ortiz|Hyunhee  Shin|Shree Ram  Singh|Guohao  Wang|Weiqin  Yin,NULL,Lino  Tessarollo (Mouse Cancer Genetics Program),Wanjun  Chen; PhD (NIDCR),"1. Hou SX, Singh SR (2017). Stem-Cell-Based Tumorigenesis in Adult Drosophila. Curr Top Dev Biol  121, 311-337.   https://doi.org/10.1016/bs.ctdb.2016.07.013|2. Kapil S, Sharma BK, Patil M, Elattar S, Yuan J, Hou SX, Kolhe R, Satyanarayana A (2017). The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget  8, 26515-26531.   https://doi.org/10.18632/oncotarget.15713",https://intramural.nih.gov/search/searchview.taf?ipid=103741
152,BC010740-13,"October 01, 2017 -  September 30, 2018",Carbohydrate Microarray Profiling of Glycan-Binding Antibodies and Lectins,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Dorothy Leeann Ackerman|Rayleen  Hu|Aislinn Katherine McMillan|Joel Sebastian Temme; BS|Li  Xia|Marc C Nicklaus|Show all 7,"Lara  Mahal (Chemistry, University of Texas at Austin)|Mai  Xu; PhD|Lynn  Morris (National Institute for Communicable Diseases)|James  Fleckenstein (Washington University School of Medicine, St. Louis)|Hanping  Feng (University of Maryland)|Paul  Lampe (Fred Hutchinson Cancer Research Center)",Jacek Tadeusz Lubkowski (Macromolecular Crystallography Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,"1. Lubkowski J, Durbin SV, Silva MC, Farnsworth D, Gildersleeve JC, Oliva ML, Wlodawer A (2017). Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth. FEBS J  284, 429-450.   https://doi.org/10.1111/febs.13989|2. Sterner E, Peach ML, Nicklaus MC, Gildersleeve JC (2017). Therapeutic Antibodies to Ganglioside GD2 Evolved from Highly Selective Germline Antibodies. Cell Rep  20, 1681-1691.   https://doi.org/10.1016/j.celrep.2017.07.050",https://intramural.nih.gov/search/searchview.taf?ipid=103740
153,BC010747-13,"October 01, 2017 -  September 30, 2018",Characterization of the Expression and Ligands of KIR3DS1,Daniel  McVicar; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Geraldine Martina O'Connor,"Andrew  Brooks (University of Melbourne)|Jamie  Rossjohn (Dept. of Biochemistry & Molecular Biology, Monash University)|David  Price (Cardiff University)|Alain  Rook (University of Pennsylvania)",NULL,"Suk See De Ravin; MD, PhD (NIAID)","1. Benoit BM, Jariwala N, O'Connor G, Oetjen LK, Whelan TM, Werth A, Troxel AB, Sicard H, Zhu L, Miller C, Takeshita J, McVicar DW, Kim BS, Rook AH, Wysocka M (2017). CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214. Arch Dermatol Res  309, 11-19.   https://doi.org/10.1007/s00403-016-1698-8",https://intramural.nih.gov/search/searchview.taf?ipid=103734
154,BC010749-13,"October 01, 2017 -  September 30, 2018",Immunotherapeutic Approaches for AIDS,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI","Bhabadeb S Chowdhury; PhD|Margherita  Rosati|Antonio L Valentin|Marjorie  Robert-Guroff; PhD|Barbara K Felber|Jay Arthur Berzofsky; MD, PhD|Show all 7","David C Montefiori; PhD (Department of Surgery, NIAID)|James  Mullins; PhD (Microbiology, University of Washington)|Sylvie  Le Gall (Massachusetts General Hospital)|John  Eldridge (Wyeth Lederle Vaccines)|Drew  Hannaman (Ichor Medical Systems, Inc.)|Bart  Haynes (Duke Human Vaccine Institute)|Show all 26",Bethany Anne Nagy (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Brandon Frank Keele (Office Of The Director)|David J Venzon; PhD (Biostatistics and Data Management Section),"Lucio  Gama; PhD (NIAID) |Vanessa  Hirsch (NIAID) |Richard A Koup; MD (NIAID) |John R Mascola; MD (NIAID) |Bernard  Moss; MD, PhD (NIAID)","1. Hu X, Lu Z, Valentin A, Rosati M, Broderick KE, Sardesai NY, Marx PA, Mullins JI, Pavlakis GN, Felber BK (2018). Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques. Hum Vaccin Immunother  14, 2163-2177.   https://doi.org/10.1080/21645515.2018.1489949|2. Hu X, Valentin A, Cai Y, Dayton F, Rosati M, Ramírez-Salazar EG, Kulkarni V, Broderick KE, Sardesai NY, Wyatt LS, Earl PL, Moss B, Mullins JI, Pavlakis GN, Felber BK (2018). DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination. Hum Gene Ther  29, 1029-1043.   https://doi.org/10.1089/hum.2018.065|3. Hu X, Valentin A, Rosati M, Manocheewa S, Alicea C, Chowdhury B, Bear J, Broderick KE, Sardesai NY, Gall SL, Mullins JI, Pavlakis GN, Felber BK (2017). HIV Env conserved element DNA vaccine alters immunodominance in macaques. Hum Vaccin Immunother  13, 2859-2871.   https://doi.org/10.1080/21645515.2017.1339852|4. Munson P, Liu Y, Bratt D, Fuller JT, Hu X, Pavlakis GN, Felber BK, Mullins JI, Fuller DH (2018). Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection. Hum Vaccin Immunother  14, 1820-1831.   https://doi.org/10.1080/21645515.2018.1448328|5. Singh S, Ramírez-Salazar EG, Doueiri R, Valentin A, Rosati M, Hu X, Keele BF, Shen X, Tomaras GD, Ferrari G, LaBranche C, Montefiori DC, Das J, Alter G, Trinh HV, Hamlin C, Rao M, Dayton F, Bear J, Chowdhury B, Alicea C, Lifson JD, Broderick KE, Sardesai NY, Sivananthan SJ, et al. [6 more authors] (2018). Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques. J Virol  92.   https://doi.org/10.1128/JVI.00281-18",https://intramural.nih.gov/search/searchview.taf?ipid=103736
155,BC010750-13,"October 01, 2017 -  September 30, 2018",Heterodimeric IL-15 in Cancer Immunotherapy,"George N Pavlakis; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Bhabadeb S Chowdhury; PhD|Konstantinos  Dimas; MD|Sevasti  Karaliota|Dimitrios  Stellas|Vasiliki  Stravokefalou|Antonio L Valentin|Show all 9,"Karen  Gaensler (University of California)|Rafick-Pierre  Sekaly (Centre de Recherche du Centre Hospitalier de l'Universite de Montreal)|Morten  Thaysen-Andersen (Macquarie University)|Bernard  Fox (Oregon Cancer Center)|Francois  Villinger (New Iberia Research Center, University of Louisiana at Lafayette)|Dimiter Stanchev Dimitrov; PhD (NCI)|Show all 11","Bethany Anne Nagy (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Elena  Chertova (Office Of The Director)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Kevin Charles Conlon (Lymphoid Malignancies Branch)|Jacob D Estes (Office Of The Director)",Konstantinos  Petrovas (NIAID) |Mario  Roederer; PhD (NIAID) |Xiaoyuan  Chen; PhD (NIBIB) |Thomas Arthur Fleisher; MD (CC),"1. Bergamaschi C, Watson DC, Valentin A, Bear J, Peer CJ, Figg WD, Felber BK, Pavlakis GN (2018). Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques. Cytokine  108, 213-224.   https://doi.org/10.1016/j.cyto.2018.01.011|2. Ng SSM, Nagy BA, Jensen SM, Hu X, Alicea C, Fox BA, Felber BK, Bergamaschi C, Pavlakis GN (2017). Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion. Clin Cancer Res  23, 2817-2830.   https://doi.org/10.1158/1078-0432.CCR-16-1808|3. Watson DC, Moysi E, Valentin A, Bergamaschi C, Devasundaram S, Fortis SP, Bear J, Chertova E, Bess J, Sowder R, Venzon DJ, Deleage C, Estes JD, Lifson JD, Petrovas C, Felber BK, Pavlakis GN (2018). Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes. PLoS Pathog  14, e1006902.   https://doi.org/10.1371/journal.ppat.1006902|4. Watson DC, Yung BC, Bergamaschi C, Chowdhury B, Bear J, Stellas D, Morales-Kastresana A, Jones JC, Felber BK, Chen X, Pavlakis GN (2018). Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes. J Extracell Vesicles  7, 1442088.   https://doi.org/10.1080/20013078.2018.1442088",https://intramural.nih.gov/search/searchview.taf?ipid=103737
156,BC010759-13,"October 01, 2017 -  September 30, 2018",Functional Genomics of Sarcoma,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sarah Faith Clatterbuck Soper; PhD|Sean Richard Davis; MD, PhD|Yuan  Jiang; MD|John E Lueders|Sanjit  Mukherjee|Shuhei  Osaki|Show all 13","Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|Ashok  Venkitaraman (University of Cambridge)|Lee Jay Helman; MD (NCI)",Sharon Ann Savage (Clinical Genetics Branch)|Lisa  Mirabello (Clinical Genetics Branch),NULL,"1. Morrow JJ, Bayles I, Funnell APW, Miller TE, Saiakhova A, Lizardo MM, Bartels CF, Kapteijn MY, Hung S, Mendoza A, Dhillon G, Chee DR, Myers JT, Allen F, Gambarotti M, Righi A, DiFeo A, Rubin BP, Huang AY, Meltzer PS, Helman LJ, Picci P, Versteeg HH, Stamatoyannopoulos JA, Khanna C, et al. [1 more author] (2018). Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat Med  24, 176-185.   https://doi.org/10.1038/nm.4475",https://intramural.nih.gov/search/searchview.taf?ipid=103742
157,BC010763-13,"October 01, 2017 -  September 30, 2018",Building on the success of the adoptive immunotherapy of cancer,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Surgery Branch, NCI",Arash D Eidizadeh|Devikala  Gurusamy|Amanda Nicole Henning|S M Rafiqul  Islam; PhD|Rigel Joseph Kishton|Ping-Hsien  Lee; PhD|Show all 16,Paul  Antony (Univeristy of Maryland)|Vincenzo  Bronte,Giorgio  Trinchieri (Cancer Inflammation Program),NULL,"1. Afzali B, Grönholm J, Vandrovcova J, O'Brien C, Sun HW, Vanderleyden I, Davis FP, Khoder A, Zhang Y, Hegazy AN, Villarino AV, Palmer IW, Kaufman J, Watts NR, Kazemian M, Kamenyeva O, Keith J, Sayed A, Kasperaviciute D, Mueller M, Hughes JD, Fuss IJ, Sadiyah MF, Montgomery-Recht K, McElwee J, et al. [12 more authors] (2017). BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency. Nat Immunol  18, 813-823.   https://doi.org/10.1038/ni.3753|2. Gurusamy D, Clever D, Eil R, Restifo NP (2017). Novel ""Elements"" of Immune Suppression within the Tumor Microenvironment. Cancer Immunol Res  5, 426-433.   https://doi.org/10.1158/2326-6066.CIR-17-0117|3. Kishton RJ, Sukumar M, Restifo NP (2017). Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy. Cell Metab  26, 94-109.   https://doi.org/10.1016/j.cmet.2017.06.016|4. Slaney CY, von Scheidt B, Davenport AJ, Beavis PA, Westwood JA, Mardiana S, Tscharke DC, Ellis S, Prince HM, Trapani JA, Johnstone RW, Smyth MJ, Teng MW, Ali A, Yu Z, Rosenberg SA, Restifo NP, Neeson P, Darcy PK, Kershaw MH (2017). Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. Clin Cancer Res  23, 2478-2490.   https://doi.org/10.1158/1078-0432.CCR-16-1860|5. Sukumar M, Kishton RJ, Restifo NP (2017). Metabolic reprograming of anti-tumor immunity. Curr Opin Immunol  46, 14-22.   https://doi.org/10.1016/j.coi.2017.03.011",https://intramural.nih.gov/search/searchview.taf?ipid=103743
158,BC010770-12,"October 01, 2017 -  September 30, 2018",Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs,Miriam Christine Poirier; PhD,NULL,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,NULL,William Chenery Copeland; PhD (NIEHS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103790
159,BC010773-12,"October 01, 2017 -  September 30, 2018",Interactions of APOBEC3 Proteins with Murine Leukemia Viruses,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Demetria P Harvin|Diborah Mengistu Yimer|Kin Kui  Lai,John  Coffin (Tufts University)|Mark  Williams (Northeastern University),Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103789
160,BC010774-12,"October 01, 2017 -  September 30, 2018",T Cell Alternative p38 Activation Pathway,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Muhammad Shamsul Alam|Bei  Dong,Al  Fornace (Georgetown University)|Matthias Martin Gaida,Ettore  Appella; MD (Chemical Immunology Section),"David Harvey Margulies; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103749
161,BC010778-12,"October 01, 2017 -  September 30, 2018",HIV-1 Maturation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",NULL,Tatyana  Polenova; PhD (University of Delaware)|Feng  Li; PhD|Ritu  Gaur|Carl  Wild (Panacos Pharmaceuticals)|-  Hetero Drugs (Hetero Research Foundation)|Owen  Pornillos (University of Virginia)|Show all 7,Sherimay  Ablan (Retroviral Replication Laboratory)|Hannah Mary Carter (Retroviral Replication Laboratory)|Phuong Nhat Pham (Retroviral Replication Laboratory)|Alan  Rein; PhD (Retroviral Replication Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Alasdair C Steven; PhD (NIAMS),"1. Wang M, Quinn CM, Perilla JR, Zhang H, Shirra R, Hou G, Byeon IJ, Suiter CL, Ablan S, Urano E, Nitz TJ, Aiken C, Freed EO, Zhang P, Schulten K, Gronenborn AM, Polenova T (2017). Quenching protein dynamics interferes with HIV capsid maturation. Nat Commun  8, 1779.   https://doi.org/10.1038/s41467-017-01856-y",https://intramural.nih.gov/search/searchview.taf?ipid=103755
162,BC010782-12,"October 01, 2017 -  September 30, 2018",Study of the Roles of SDF1 and CXCR4 in Hematopoiesis,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Michael Joseph Diprima|Jing-Xin  Feng|Hidetaka  Ohnuki|Douglas  Lowy; MD,Frederick  Wang (Harvard Univ)|Maria  Cid (Univ. of Barcelona Medical School)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),"Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David  Levens; PhD (Laboratory of Pathology)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory)|Roberto  Weigert; MSc Chemistry, PhD (Laboratory of Cellular and Molecular Biology)",Yosuke  Mukoyama; PhD (NHLBI),"1. Ohnuki H, Tosato G (2017). Characterization of Semaphorin 6A-Mediated Effects on Angiogenesis Through Regulation of VEGF Signaling. Methods Mol Biol  1493, 345-361.   https://doi.org/10.1007/978-1-4939-6448-2_25|2. Tosato G (2017). Ephrin ligands and Eph receptors contribution to hematopoiesis. Cell Mol Life Sci  74, 3377-3394.   https://doi.org/10.1007/s00018-017-2566-1",https://intramural.nih.gov/search/searchview.taf?ipid=103759
163,BC010783-12,"October 01, 2017 -  September 30, 2018","Inflammation, Macrophage Differentiation, and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Jin Young  Baik|Swati Suresh Choksi|Chamila Charthuranga Kadigamuwa|Hyung Joon  Kwon; PhD,"Xuemin  Zhang|Brian  Rowan (School of Medicine, Tulane University)|Jennifer  Yu (Cleveland Clinic)",Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),Chengyu  Liu; PhD (NHLBI),"1. Man J, Yu X, Huang H, Zhou W, Xiang C, Huang H, Miele L, Liu Z, Bebek G, Bao S, Yu JS (2018). Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells. Cell Stem Cell  22, 104-118.e6.   https://doi.org/10.1016/j.stem.2017.10.005",https://intramural.nih.gov/search/searchview.taf?ipid=103760
164,BC010788-12,"October 01, 2017 -  September 30, 2018",Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sukriti  Bagchi|Deblina  Banerjee|Fatima  Barragan|Zhihui  Liu|Sydney Margaret Loria|Ming  Sun|Show all 11,"Jinhua  Zhang (Hematology, 2nd China Medical School)|John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Chesler  Louis (The Royal Marsden NHS Foundation Trust)|Cheryl  Arrowsmith (University of Toronto)|Jian  Jin (Icahn School of Medicine at Mt. Sinai)|Kimberly  Stegmaier (Dana-Farber Cancer Institute)",Javed  Khan; MD (Cancer Genetics Branch)|Lino  Tessarollo (Mouse Cancer Genetics Program)|Ettore  Appella; MD (Chemical Immunology Section)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Chunhua  Yan (Cancer Informatics Branch),NULL,"1. Hua Z, Zhan Y, Zhang S, Dong Y, Jiang M, Tan F, Liu Z, Thiele CJ, Li Z (2018). P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB). Apoptosis  23, 408-419.   https://doi.org/10.1007/s10495-018-1467-6|2. Liu Z, Thiele CJ (2017). When LMO1 Meets MYCN, Neuroblastoma Is Metastatic. Cancer Cell  32, 273-275.   https://doi.org/10.1016/j.ccell.2017.08.014|3. Veschi V, Thiele CJ (2017). High-SETD8 inactivates p53 in neuroblastoma. Oncoscience  4, 21-22.   https://doi.org/10.18632/oncoscience.344",https://intramural.nih.gov/search/searchview.taf?ipid=103761
165,BC010789-12,"October 01, 2017 -  September 30, 2018",Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma,Carol J Thiele|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Sukriti  Bagchi|Ming  Sun|Veronica  Veschi|Zhihui  Liu,"David  Kaplan (Hospital for Sick Kids)|Jinhua  Zhang (Hematology, 2nd China Medical School)|Zhijie  Li (China Medical University)|Richard  Woessner (AstraZeneca Pharmaceuticals)",Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David J Liewehr (Biostatistics and Data Management Section),NULL,"1. Gu X, Hua Z, Dong Y, Zhan Y, Zhang X, Tian W, Liu Z, Thiele CJ, Li Z (2017). Proteome and Acetylome Analysis Identifies Novel Pathways and Targets Regulated by Perifosine in Neuroblastoma. Sci Rep  7, 42062.   https://doi.org/10.1038/srep42062|2. Odate S, Veschi V, Yan S, Lam N, Woessner R, Thiele CJ (2017). Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity. Clin Cancer Res  23, 1771-1784.   https://doi.org/10.1158/1078-0432.CCR-16-1317",https://intramural.nih.gov/search/searchview.taf?ipid=103762
166,BC010791-12,"October 01, 2017 -  September 30, 2018","Effects of genetic polymorphism in MHC, KIR, and related loci on human disease","Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI","Marjan  Akdag|Arman A Bashirova|Xiaojiang  Gao|Amir  Horowitz|Maureen P Martin|Vivek  Naranbhai; MD, PhD, DPHIL|Show all 9","Chloe  Thio (University Medicine, Johns Hopkins University)|David  Thomas (Johns Hopkins University)|Michael  Knowles (Cystic Fibrosis Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill)|Bruce  Walker (Harvard Medical School)|Marcus  Altfeld (Infectious Disease Unit, Partners AIDS Research Center)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Show all 25","James Jerome Goedert; MD (Epidemiology and Biostatistics Program)|Denise  Whitby (Office Of The Director)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)",Daniel C Douek; MD (NIAID),"1. Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, et al. [15 more authors] (2018). Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection. J Virol  92.   https://doi.org/10.1128/JVI.01685-17|2. Körner C, Simoneau CR, Schommers P, Granoff M, Ziegler M, Hölzemer A, Lunemann S, Chukwukelu J, Corleis B, Naranbhai V, Kwon DS, Scully EP, Jost S, Kirchhoff F, Carrington M, Altfeld M (2017). HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells. Cell Host Microbe  22, 111-119.e4.   https://doi.org/10.1016/j.chom.2017.06.008|3. Laher F, Ranasinghe S, Porichis F, Mewalal N, Pretorius K, Ismail N, Buus S, Stryhn A, Carrington M, Walker BD, Ndung'u T, Ndhlovu ZM (2017). HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer+ Gag-Specific CD4+ T Cells in Chronic Clade C HIV-1 Infection. J Virol  91.   https://doi.org/10.1128/JVI.02477-16|4. Manolio TA, Hutter CM, Avigan M, Cibotti R, Davis RL, Denny JC, Grenade L, Wheatley LM, Carrington MN, Chantratita W, Chung WH, Dalton AD, Hung SI, Lee MTM, Leeder JS, Lertora JJL, Mahasirimongkol S, McLeod HL, Mockenhaupt M, Pacanowski M, Phillips EJ, Pinheiro S, Pirmohamed M, Sung C, Suwankesawong W, et al. [5 more authors] (2018). Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis. Clin Pharmacol Ther  103, 390-394.   https://doi.org/10.1002/cpt.890|5. Naranbhai V, Carrington M (2017). Host genetic variation and HIV disease: from mapping to mechanism. Immunogenetics  69, 489-498.   https://doi.org/10.1007/s00251-017-1000-z|6. Park YJ, Etemad B, Ahmed H, Naranbhai V, Aga E, Bosch RJ, Mellors JW, Kuritzkes DR, Para M, Gandhi RT, Carrington M, Li JZ (2017). Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption. Pathog Immun  2, 431-445.   https://doi.org/10.20411/pai.v2i3.222|7. Pavlos R, McKinnon EJ, Ostrov DA, Peters B, Buus S, Koelle D, Chopra A, Schutte R, Rive C, Redwood A, Restrepo S, Bracey A, Kaever T, Myers P, Speers E, Malaker SA, Shabanowitz J, Jing Y, Gaudieri S, Hunt DF, Carrington M, Haas DW, Mallal S, Phillips EJ (2017). Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Sci Rep  7, 8653.   https://doi.org/10.1038/s41598-017-08876-0|8. Strickland N, Müller TL, Berkowitz N, Goliath R, Carrington MN, Wilkinson RJ, Burgers WA, Riou C (2017) Characterization of Mycobacterium tuberculosis-Specific Cells Using MHC Class II Tetramers Reveals Phenotypic Differences Related to HIV Infection and Tuberculosis Disease. J Immunol, in press (e-pub ahead of print)  https://doi.org/10.4049/jimmunol.1700849|9. Walker-Sperling VE, Pohlmeyer CW, Veenhuis RT, May M, Luna KA, Kirkpatrick AR, Laeyendecker O, Cox AL, Carrington M, Bailey JR, Arduino RC, Blankson JN (2017). Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller. EBioMedicine  16, 141-149.   https://doi.org/10.1016/j.ebiom.2017.01.034|10. Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Smedby KE, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, et al. [58 more authors] (2018). HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res  78, 4086-4096.   https://doi.org/10.1158/0008-5472.CAN-17-2900",https://intramural.nih.gov/search/searchview.taf?ipid=103753
167,BC010792-12,"October 01, 2017 -  September 30, 2018",Molecular genetics and population studies of the KIR and HLA gene complexes,"Mary  Carrington; MS, PhD",NULL,"Cancer Inflammation Program, NCI",Marjan  Akdag|Arman A Bashirova|Xiaojiang  Gao|Maureen P Martin|Victoria Elizabeth Keery Walker-Sperling|Yuko  Yuki|Show all 7,John  Trowsdale (University of Cambridge)|Richard  Single (University of Vermont)|Kenneth  Kidd (Yale University)|Bruce  Walker (Harvard Medical School)|Judith  Kidd (Yale University)|Daniel  Geraghty (Fred Hutchinson Cancer Research Center)|Show all 11,NULL,NULL,"1. Kaur G, Gras S, Mobbs JI, Vivian JP, Cortes A, Barber T, Kuttikkatte SB, Jensen LT, Attfield KE, Dendrou CA, Carrington M, McVean G, Purcell AW, Rossjohn J, Fugger L (2017). Structural and regulatory diversity shape HLA-C protein expression levels. Nat Commun  8, 15924.   https://doi.org/10.1038/ncomms15924",https://intramural.nih.gov/search/searchview.taf?ipid=103752
168,BC010793-12,"October 01, 2017 -  September 30, 2018","Role of inflammation, innate resistance, and immunity in carcinogenesis",Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sharon A Bargo|Ren Ming  Dai|Amiran  Dzutsev; PhD|John Anthony McCulloch; PhD|Soumen  Roy; PhD|Rosalba  Salcedo|Show all 12,"Uzma  Hasan (Infections and Cancer Biology, International Agency for Research on Cancer (IARC-WHO))|Sergei A. Nedospasov; PhD, DSc|Sergey  Grivennikov (Fox Chase Cancer Center)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Yasmine  Belkaid; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103763
169,BC010795-12,"October 01, 2017 -  September 30, 2018",Mechanisms of transcription fidelity in prokaryotes and eukaryotes,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Maria L Kireeva|Lucyna E Lubkowska,Carlos  Bustamante (University of California - Berkeley)|Michelle  Wang (Cornell University)|Michael  Poirier (Ohio State University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103764
170,BC010801-12,"October 01, 2017 -  September 30, 2018",Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Andrea Maria Baldwin|Eva  Dombi|Ira Lignugaris Kraft|Joni Yvette Mills|Pamela  Wolters|Stacia Martin Peron; PhD|Show all 7,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|Bruce  Korf (University of Alabama)|Victor  Mautner (Genetics, Hamburg University)|Nancy  Ratner (Division of Experimental Hematology, Children's Hospital Medical Center)|Ludwine  Messiaen; PhD (Dept of Genetics, University of Alabama)|Jaishri  Blakeley (Johns Hopkins)|Show all 13","Kara Suzanne Heisey (Office Of The Clinical Director)|Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Abby  Sandler (Office Of The Director)|Alice Pinting Chen (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)","Constantine Argyrios Stratakis; MD, DSc (NICHD) |Scott Mitchell Paul; MD (CC) |Edmond Joseph Fitzgibbon; MD (NEI) |James C Reynolds; MD (CC) |Leslie Glenn Biesecker; MD (NHGRI) |Prashant  Chittiboina; MD (NINDS)","1. Allen TM, Struemph KL, Toledo-Tamula MA, Wolters PL, Baldwin A, Widemann B, Martin S (2018). The Relationship Between Heart Rate Variability, Psychological Flexibility, and Pain in Neurofibromatosis Type 1. Pain Pract  18, 969-978.   https://doi.org/10.1111/papr.12695|2. Avery RA, Katowitz JA, Fisher MJ, Heidary G, Dombi E, Packer RJ, Widemann BC, OPPN Working Group (2017). Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care. Ophthalmology  124, 123-132.   https://doi.org/10.1016/j.ophtha.2016.09.020|3. Cai W, Steinberg SM, Bredella MA, Basinsky G, Somarouthu B, Plotkin SR, Solomon J, Widemann BC, Harris GJ, Dombi E (2018). Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two Methods. Acad Radiol  25, 144-152.   https://doi.org/10.1016/j.acra.2017.09.004|4. Fisher MJ, Belzberg AJ, de Blank P, De Raedt T, Elefteriou F, Ferner RE, Giovannini M, Harris GJ, Kalamarides M, Karajannis MA, Kim A, Lázaro C, Le LQ, Li W, Listernick R, Martin S, Morrison H, Pasmant E, Ratner N, Schorry E, Ullrich NJ, Viskochil D, Weiss B, Widemann BC, Zhu Y, et al. [2 more authors] (2018). 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Am J Med Genet A  176, 1258-1269.   https://doi.org/10.1002/ajmg.a.38675|5. Gross A, Bishop R, Widemann BC (2017). Selumetinib in Plexiform Neurofibromas. N Engl J Med  376, 1195.   https://doi.org/10.1056/NEJMc1701029|6. Gross AM, Singh G, Akshintala S, Baldwin A, Dombi E, Ukwuani S, Goodwin A, Liewehr DJ, Steinberg SM, Widemann BC (2018). Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1. Neuro Oncol  20, 1643-1651.   https://doi.org/10.1093/neuonc/noy067|7. Higham CS, Dombi E, Rogiers A, Bhaumik S, Pans S, Connor SEJ, Miettinen M, Sciot R, Tirabosco R, Brems H, Baldwin A, Legius E, Widemann BC, Ferner RE (2018). The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors. Neuro Oncol  20, 818-825.   https://doi.org/10.1093/neuonc/noy013|8. Higham CS, Steinberg SM, Dombi E, Perry A, Helman LJ, Schuetze SM, Ludwig JA, Staddon A, Milhem MM, Rushing D, Jones RL, Livingston M, Goldman S, Moertel C, Wagner L, Janhofer D, Annunziata CM, Reinke D, Long L, Viskochil D, Baker L, Widemann BC (2017). SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors. Sarcoma  2017, 8685638.   https://doi.org/10.1155/2017/8685638|9. Jakacki RI, Dombi E, Steinberg SM, Goldman S, Kieran MW, Ullrich NJ, Pollack IF, Goodwin A, Manley PE, Fangusaro J, Allen R, Widemann BC (2017). Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. Neuro Oncol  19, 289-297.   https://doi.org/10.1093/neuonc/now158|10. Pemov A, Li H, Patidar R, Hansen NF, Sindiri S, Hartley SW, Wei JS, Elkahloun A, Chandrasekharappa SC, NISC Comparative Sequencing Program, Boland JF, Bass S, NCI DCEG Cancer Genomics Research Laboratory, Mullikin JC, Khan J, Widemann BC, Wallace MR, Stewart DR (2017). The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas. Oncogene  36, 3168-3177.   https://doi.org/10.1038/onc.2016.464|11. Reilly K, Kim A, Blakeley J, Ferner R, Gutmann D, Legius E, Miettinen M, Randall L, Ratner N, Jumbe S, Bakker A, Viskochil D, Widemann B, Stewart D (2017) Neurofibromatosis Type-1 associated MPNST State of the Science: Outlining a Research Agenda for the Future. JNCI, in press.|12. Wiener L, Battles H, Bedoya SZ, Baldwin A, Widemann BC, Pao M (2018). Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1). J Genet Couns  27, 115-123.   https://doi.org/10.1007/s10897-017-0128-1",https://intramural.nih.gov/search/searchview.taf?ipid=103765
171,BC010802-12,"October 01, 2017 -  September 30, 2018",Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Supreet  Agarwal,NULL,NULL,NULL,"1. Patnaik A, Swanson KD, Csizmadia E, Solanki A, Landon-Brace N, Gehring MP, Helenius K, Olson BM, Pyzer AR, Wang LC, Elemento O, Novak J, Thornley TB, Asara JM, Montaser L, Timmons JJ, Morgan TM, Wang Y, Levantini E, Clohessy JG, Kelly K, Pandolfi PP, Rosenblatt JM, Avigan DE, Ye H, et al. [4 more authors] (2017). Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity. Cancer Discov  7, 750-765.   https://doi.org/10.1158/2159-8290.CD-16-0778",https://intramural.nih.gov/search/searchview.taf?ipid=103766
172,BC010806-12,"October 01, 2017 -  September 30, 2018",Developing Novel Therapies for Neuroblastoma and Rhabdomyosarcoma,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Berkley Eric Gryder|Jeetendra  Kumar|Nityashree  Shivaprasad|Young K Song|Jun S Wei,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|David  Azorsa (NHGRI)|Lee Jay Helman; MD (NCI)",Carol J Thiele (Pediatric Oncology Branch),Craig Joseph Thomas (NCATS),"1. Veschi V, Liu Z, Voss TC, Ozbun L, Gryder B, Yan C, Hu Y, Ma A, Jin J, Mazur SJ, Lam N, Souza BK, Giannini G, Hager GL, Arrowsmith CH, Khan J, Appella E, Thiele CJ (2017). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell  31, 50-63.   https://doi.org/10.1016/j.ccell.2016.12.002",https://intramural.nih.gov/search/searchview.taf?ipid=103767
173,BC010808-12,"October 01, 2017 -  September 30, 2018",Chromatin structure and dynamics,Yawen  Bai; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Hanqiao  Feng|Bingquan  Gao; PhD|Ruifang  Guan; PhD|Bing-Rui  Zhou,NULL,Ping  Zhang (Structural Biophysics Laboratory)|Sriram  Subramaniam; PhD (Office Of The Director)|Victor  Zhurkin; PhD (Laboratory of Cell Biology),Rodolfo  Ghirlando; PhD (NIDDK) |Jiansheng  Jiang; PhD (NIAID),"1. Chittori S, Hong J, Saunders H, Feng H, Ghirlando R, Kelly AE, Bai Y, Subramaniam S (2018). Structural mechanisms of centromeric nucleosome recognition by the kinetochore protein CENP-N. Science  359, 339-343.   https://doi.org/10.1126/science.aar2781|2. Liu C, Wang T, Bai Y, Wang J (2017). Electrostatic forces govern the binding mechanism of intrinsically disordered histone chaperones. PLoS One  12, e0178405.   https://doi.org/10.1371/journal.pone.0178405",https://intramural.nih.gov/search/searchview.taf?ipid=103750
174,BC010814-12,"October 01, 2017 -  September 30, 2018",Elucidating the Regulation of HIV RNA Functions and Genome Packaging,Wei-Shau  Hu; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Jianbo  Chen|Alice Ann Duchon; PhD|Yang  Liu; PhD|Olga A Nikolaitchik|Jonathan Mark Olivares Rawson|Xayathed  Somoulay|Show all 11,"David  Grnwald (Technical University of Delft)|Dmitriy  Mazurov (Institute of Immunology)|Jeffrey  Chao (Friedrich Miescher Institute for Biomedical Research)|Kevin  Weeks (University of North Carolina, Chapel Hill)",Robert  Gorelick (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Brandon Frank Keele (Office Of The Director),Madhu A Lal (NCATS),"1. Liu Y, Chen J, Nikolaitchik OA, Desimmie BA, Busan S, Pathak VK, Weeks KM, Hu WS (2018). The roles of five conserved lentiviral RNA structures in HIV-1 replication. Virology  514, 1-8.   https://doi.org/10.1016/j.virol.2017.10.020|2. Liu Y, Nikolaitchik OA, Rahman SA, Chen J, Pathak VK, Hu WS (2017). HIV-1 Sequence Necessary and Sufficient to Package Non-viral RNAs into HIV-1 Particles. J Mol Biol  429, 2542-2555.   https://doi.org/10.1016/j.jmb.2017.06.018",https://intramural.nih.gov/search/searchview.taf?ipid=103768
175,BC010816-12,"October 01, 2017 -  September 30, 2018","Immunotherapy for  Malignant Mesothelioma, Lung Cancer and Thymic Malignancies",Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Romi  Biswas|James  Gao|Qun  Jiang|Firouzeh  Korangy|Betsy J Morrow|Jingli  Zhang,NULL,Mana Kamana Kamana Khanal (Thoracic and GI Malignancies Branch)|Daniel Kim Rathkey (Thoracic and GI Malignancies Branch)|Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,"1. Khanna S, Graef S, Mussai F, Thomas A, Wali N, Yenidunya BG, Yuan C, Morrow B, Zhang J, Korangy F, Greten TF, Steinberg SM, Stetler-Stevenson M, Middleton G, De Santo C, Hassan R (2018). Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients. Clin Cancer Res  24, 2859-2872.   https://doi.org/10.1158/1078-0432.CCR-17-3757",https://intramural.nih.gov/search/searchview.taf?ipid=103769
176,BC010819-12,"October 01, 2017 -  September 30, 2018",HIV-1 Genetic Variation in Infected Individuals,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Elizabeth M Anderson|Jennifer Marie Bell|Zehava  Grossman; PhD|Pamela Jo Harris|Shawn A Hill|Kristi  Huik; PhD|Show all 9,John W Mellors|Zandrea  Ambrose (University of Pittsburgh)|Michael  Jordan (Tufts University)|John  Coffin (Tufts University),Paul L Boyer (Retroviral Replication Laboratory)|Wei-Shau  Hu; PhD (Retroviral Replication Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Eric O Freed; PhD (HIV Drug Resistance Program)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Cheryl Ann Winkler (Basic Research Laboratory),"Henry  Masur; MD (CC) |Shyamasundaran  Kottilil; MD, PhD (NIAID) |Caryn G Morse; MD (CC) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Joseph A Kovacs; MD (CC)","1. Paredes R, Tzou PL, van Zyl G, Barrow G, Camacho R, Carmona S, Grant PM, Gupta RK, Hamers RL, Harrigan PR, Jordan MR, Kantor R, Katzenstein DA, Kuritzkes DR, Maldarelli F, Otelea D, Wallis CL, Schapiro JM, Shafer RW (2017). Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation. PLoS One  12, e0181357.   https://doi.org/10.1371/journal.pone.0181357",https://intramural.nih.gov/search/searchview.taf?ipid=103770
177,BC010822-12,"October 01, 2017 -  September 30, 2018",Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation,Munira A Basrai; PhD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Wei-Chun  Au|Jessica Rose Eisenstatt|Prashant  Mishra|Kentaro  Ohkuni|Austin Reed Rossi|Roshan Lal Shrestha|Show all 12,"Grant  Hartzog (MCD Biology, Univ. of California, Santa Cruz)|Richard  Baker (Univ. of Massachusetts, Amherst)|Charles  Boone (NCI)|Dan  Foltz (Univ. of VA)|Kerry  Bloom (University of North Carolina (UNC) @ Chapel HIll)|Brenda  Andrews; PhD (University of Toronto)|Show all 10",Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression)|Gianluca  Pegoraro (Laboratory of Receptor Biology and Gene Expression)|Thorkell  Andresson (Office Of The Director),David  Landsman; PhD (NLM) |David Johannes Clark; PhD (NICHD),"1. Shrestha RL, Ahn GS, Staples MI, Sathyan KM, Karpova TS, Foltz DR, Basrai MA (2017). Mislocalization of centromeric histone H3 variant CENP-A contributes to chromosomal instability (CIN) in human cells. Oncotarget  8, 46781-46800.   https://doi.org/10.18632/oncotarget.18108",https://intramural.nih.gov/search/searchview.taf?ipid=103751
178,BC010824-12,"October 01, 2017 -  September 30, 2018",Molecular structures of membrane protein assemblies,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Sagar  Chittori|Reinhard Karl Grisshammer; PhD|Jana  Ognjenovic,Frank  McCormick (UCSF School of Medicine)|Eduardo  Perozo (University of Chicago)|John  Kuriyan (UC Berkeley),Suresh V Ambudkar; PhD (Transport Biochemistry Section),"Bernard R Brooks; PhD (NHLBI) |Mark Lee Mayer; BSc, PhD (NINDS) |Kenton J Swartz; PhD (NINDS) |Sanjay Arvind Desai; MD, PhD (NIAID)","1. Earl LA, Falconieri V, Milne JL, Subramaniam S (2017). Cryo-EM: beyond the microscope. Curr Opin Struct Biol  46, 71-78.   https://doi.org/10.1016/j.sbi.2017.06.002|2. Earl LA, Falconieri V, Subramaniam S (2018). Microbiology catches the cryo-EM bug. Curr Opin Microbiol  43, 199-207.   https://doi.org/10.1016/j.mib.2018.02.012|3. Kang Y, Kuybeda O, de Waal PW, Mukherjee S, Van Eps N, Dutka P, Zhou XE, Bartesaghi A, Erramilli S, Morizumi T, Gu X, Yin Y, Liu P, Jiang Y, Meng X, Zhao G, Melcher K, Ernst OP, Kossiakoff AA, Subramaniam S, Xu HE (2018). Publisher Correction: Cryo-EM structure of human rhodopsin bound to an inhibitory G protein. Nature  561, E44.   https://doi.org/10.1038/s41586-018-0302-0|4. Wohlbold TJ, Podolsky KA, Chromikova V, Kirkpatrick E, Falconieri V, Meade P, Amanat F, Tan J, tenOever BR, Tan GS, Subramaniam S, Palese P, Krammer F (2017). Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. Nat Microbiol  2, 1415-1424.   https://doi.org/10.1038/s41564-017-0011-8",https://intramural.nih.gov/search/searchview.taf?ipid=103771
179,BC010825-12,"October 01, 2017 -  September 30, 2018",HIV neutralization and mechanisms of cellular entry,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Alberto  Bartesaghi|Joseph Edgar Darling|Erin E Tran|Andrew Ryan Wilbur|Xing  Zhu; PhD,"Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Michael  Rossman (Purdue University)|Peter  Palese (Mount Sinai School of Medicine)|Judith  White (University of Virginia)|Florian  Krammer (Mt. Sinai School of Medicine)|Raghavan  Varadarajan (Indian Institute of Science)",Jeffrey D Lifson; MD (Office Of The Director),Donald F Bliss (NLM),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103772
180,BC010826-12,"October 01, 2017 -  September 30, 2018",Technology Development for 3D Electron Microscopy,Sriram  Subramaniam; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI","Alberto  Bartesaghi|Joseph Edgar Darling|Jean-Philippe  Demers|Joseph Emmanuel Finney|Martin  Kessel; BSc, PhD|Jana  Ognjenovic","Guillermo  Sapiro (Electrical Engineering, Uinversity of Minnesota)|Frank  McCormick (UCSF School of Medicine)|Michael  Rossman (Purdue University)|Miljan  Simonovic (University of Illinois at Chicago)",Suresh V Ambudkar; PhD (Transport Biochemistry Section)|Kumaran S Ramamurthi (Laboratory of Molecular Biology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Bernard R Brooks; PhD (NHLBI) |Xiongwu  Wu; PhD (NHLBI),"1. Bartesaghi A, Aguerrebere C, Falconieri V, Banerjee S, Earl LA, Zhu X, Grigorieff N, Milne JLS, Sapiro G, Wu X, Subramaniam S (2018). Atomic Resolution Cryo-EM Structure of β-Galactosidase. Structure  26, 848-856.e3.   https://doi.org/10.1016/j.str.2018.04.004|2. Guo TW, Bartesaghi A, Yang H, Falconieri V, Rao P, Merk A, Eng ET, Raczkowski AM, Fox T, Earl LA, Patel DJ, Subramaniam S (2017). Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex. Cell  171, 414-426.e12.   https://doi.org/10.1016/j.cell.2017.09.006|3. Patwardhan A, Brandt R, Butcher SJ, Collinson L, Gault D, Grünewald K, Hecksel C, Huiskonen JT, Iudin A, Jones ML, Korir PK, Koster AJ, Lagerstedt I, Lawson CL, Mastronarde D, McCormick M, Parkinson H, Rosenthal PB, Saalfeld S, Saibil HR, Sarntivijai S, Solanes Valero I, Subramaniam S, Swedlow JR, Tudose I, et al. [2 more authors] (2017). Building bridges between cellular and molecular structural biology. Elife  6.   https://doi.org/10.7554/eLife.25835",https://intramural.nih.gov/search/searchview.taf?ipid=103773
181,BC010827-12,"October 01, 2017 -  September 30, 2018",Structural Studies of Metabolic Enzymes and Their Regulation,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Alan Anthony Merk,NULL,Sriram  Subramaniam; PhD (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103774
182,BC010830-12,"October 01, 2017 -  September 30, 2018",Mechanisms of non-classical multidrug resistance in cancer,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Sachi  Horibata|Lyn Ann J Mickley|Radhakrishnan  Padmanabhan|Robert W Robey|Pedro Jorge De Oliveira Rodrigues Batista; PhD|Kandice Danielle Tanner; PhD,"Doron  Levy (University of Maryland)|Bates  Susan (Columbia University)|Ram  Ganapathi (Univ of North Carolina, Charlotte)|Nathan  Sheffield (Univ of Virginia)",Fatima Ghazanfar Ali-Rahmani (Multidrug Resistence Section)|Crystal Chari Cole Lipsey (Multidrug Resistence Section)|James Patrick Madigan (Thoracic & Oncologic Surgery Branch)|Rajalakshm L Padmanabhan (Multidrug Resistence Section)|Ruchi Pramod Patel (Office Of Training & Education)|Andrea Nicole Robinson (Multidrug Resistence Section),"Thomas J Pohida; MS (CIT) |Matthew David Hall (NCATS) |Nicole Yen-I Morgan; PhD (NIBIB) |Kevin G Chen; MD (NINDS) |Christopher Simon Hourigan (NHLBI) |Antonina I Roll-Mecak; BE, PhD (NINDS)","1. Kannan P, Schain M, Kretzschmar WW, Weidner L, Mitsios N, Gulyás B, Blom H, Gottesman MM, Innis RB, Hall MD, Mulder J (2017). An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter. J Cereb Blood Flow Metab  37, 2062-2075.   https://doi.org/10.1177/0271678X16660984|2. Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM (2018). Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer  18, 452-464.   https://doi.org/10.1038/s41568-018-0005-8",https://intramural.nih.gov/search/searchview.taf?ipid=103775
183,BC010832-12,"October 01, 2017 -  September 30, 2018",Fundamentals of Ligand-Protein Interactions,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ulf  Ryde (Lund University)|Alberto  Podjarny (IGBMC),Raul Eduardo Cachau (Office Of The Director)|Igor  Topol (Office Of The Director),NULL,"1. Peach ML, Cachau RE, Nicklaus MC (2017). Conformational energy range of ligands in protein crystal structures: The difficult quest for accurate understanding. J Mol Recognit  30.   https://doi.org/10.1002/jmr.2618",https://intramural.nih.gov/search/searchview.taf?ipid=103776
184,BC010833-12,"October 01, 2017 -  September 30, 2018",Global consequences of aneuploidy on gene expression and nuclear architecture,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Markus Alexander Brown|Bernard N Chen|Wei-Dong  Chen|Reinhard  Ebner|Oyku  Gonul Geyik|Yue  Hu|Show all 9,"Michael  Ghadimi (Surgery, U. of Goettingen)|Daniel Paul Rosenberg|Jens  Habermann|Indika  Rajapakse (University of Michigan)|Stephen  Smale (University Of California, Berkeley)",Thomas A Misteli; PhD (Office of the Director),Keji  Zhao; PhD (NHLBI),"1. Chen H, Seaman L, Liu S, Ried T, Rajapakse I (2017). Chromosome conformation and gene expression patterns differ profoundly in human fibroblasts grown in spheroids versus monolayers. Nucleus  8, 383-391.   https://doi.org/10.1080/19491034.2017.1280209",https://intramural.nih.gov/search/searchview.taf?ipid=103777
185,BC010834-12,"October 01, 2017 -  September 30, 2018",Intratumor heterogeneity and tumor evolution,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Bernard N Chen|Reinhard  Ebner|Kerstin  Heselmeyer|Yue  Hu|Juliane Christine Irene Kamlah|Tim Eric Thoerner|Show all 11,Gert  Auer|Timo  Gaiser|Philipp  Stroebel (Georg August University GÃ¶ttingen)|Jens  Habermann|Daniel  Rosenberg (University Of Connecticut)|Russell  Schwartz|(Department of Biological Sciences),NULL,Alejandro Alberto Schaffer; PhD (NLM),"1. Hu Y, Gaedcke J, Emons G, Beissbarth T, Grade M, Jo P, Yeager M, Chanock SJ, Wolff H, Camps J, Ghadimi BM, Ried T (2018). Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery. Genes Chromosomes Cancer  57, 140-149.   https://doi.org/10.1002/gcc.22512|2. Oltmann J, Heselmeyer-Haddad K, Hernandez LS, Meyer R, Torres I, Hu Y, Doberstein N, Killian JK, Petersen D, Zhu YJ, Edelman DC, Meltzer PS, Schwartz R, Gertz EM, Schäffer AA, Auer G, Habermann JK, Ried T (2018). Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients. Genes Chromosomes Cancer  57, 165-175.   https://doi.org/10.1002/gcc.22515|3. Rausch V, Krieg A, Camps J, Behrens B, Beier M, Wangsa D, Heselmeyer-Haddad K, Baldus SE, Knoefel WT, Ried T, Stoecklein NH (2017). Array comparative genomic hybridization of 18 pancreatic ductal adenocarcinomas and their autologous metastases. BMC Res Notes  10, 560.   https://doi.org/10.1186/s13104-017-2886-0",https://intramural.nih.gov/search/searchview.taf?ipid=103778
186,BC010837-12,"October 01, 2017 -  September 30, 2018",Disease prognostication and treatment response in rectal cancer patients,Karl Thomas Ried; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Noam  Auslander|Markus Alexander Brown|Bernard N Chen|Reinhard  Ebner|Yue  Hu|Damrong M Wangsa|Show all 7,"Michael  Ghadimi (Surgery, U. of Goettingen)|Gert  Auer|Timo  Gaiser|Daniel  Rosenberg (University Of Connecticut)",NULL,Danny L Sackett; PhD (NICHD),"1. Emons G, Spitzner M, Reineke S, Möller J, Auslander N, Kramer F, Hu Y, Beissbarth T, Wolff HA, Rave-Fränk M, Heßmann E, Gaedcke J, Ghadimi BM, Johnsen SA, Ried T, Grade M (2017). Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling. Mol Cancer Res  15, 1481-1490.   https://doi.org/10.1158/1541-7786.MCR-17-0205",https://intramural.nih.gov/search/searchview.taf?ipid=103780
187,BC010844-12,"October 01, 2017 -  September 30, 2018",DNA Folding in Chromatin and Interaction with Transcription Factors,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Seyed Davood  Norouzi; PhD|Tatiana Vladimirovna Nikitina,"Wilma  Olson (Wright-Rieman Laboratories, Rutgers University)|Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui (Rochester Institute of Technology)",Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology)|Sankar  Adhya; PhD (Developmental Genetics Section),David Johannes Clark; PhD (NICHD),"1. Bao F, LoVerso PR, Fisk JN, Zhurkin VB, Cui F (2017). p53 binding sites in normal and cancer cells are characterized by distinct chromatin context. Cell Cycle  16, 2073-2085.   https://doi.org/10.1080/15384101.2017.1361064|2. Buckwalter JM, Norouzi D, Harutyunyan A, Zhurkin VB, Grigoryev SA (2017). Regulation of chromatin folding by conformational variations of nucleosome linker DNA. Nucleic Acids Res  45, 9372-9387.   https://doi.org/10.1093/nar/gkx562|3. Nikitina T, Norouzi D, Grigoryev SA, Zhurkin VB (2017). DNA topology in chromatin is defined by nucleosome spacing. Sci Adv  3, e1700957.   https://doi.org/10.1126/sciadv.1700957|4. Norouzi D, Zhurkin V (2018) Conformational Dynamics of Chromatin Fibers. Comparison of Monte Carlo Simulations with Force Spectroscopy. Biophys J, in press.|5. Qian Z, Zhurkin VB, Adhya S (2017). DNA-RNA interactions are critical for chromosome condensation in Escherichia coli. Proc Natl Acad Sci U S A  114, 12225-12230.   https://doi.org/10.1073/pnas.1711285114",https://intramural.nih.gov/search/searchview.taf?ipid=103781
188,BC010845-12,"October 01, 2017 -  September 30, 2018",p53-induced Regulation of Transcription in the Chromatin Context,Victor  Zhurkin; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Seyed Davood  Norouzi; PhD|Tatiana Vladimirovna Nikitina,Sergei  Grigoryev (Pennsylvania State University College of Medicine)|Feng  Cui,NULL,NULL,"1. Norouzi D, Zhurkin V (2018) Conformational Dynamics of Chromatin Fibers. Comparison of Monte Carlo Simulations with Force Spectroscopy. Biophys J, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103758
189,BC010850-12,"October 01, 2017 -  September 30, 2018",Mechanisms of Normal Tissue Toxicity From Irradiation,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Seok Joo  Kwon; PhD|Bradley T Scroggins|Ayla Oksuz White|Hong G Zhang; PhD,NULL,James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, et al. [2 more authors] (2018). Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint. Cancer Res  78, 2166-2170.   https://doi.org/10.1158/0008-5472.CAN-17-3760|2. Citrin DE (2017). Introduction. Semin Radiat Oncol  27, 299.   https://doi.org/10.1016/j.semradonc.2017.05.001|3. Citrin DE (2017). Recent Developments in Radiotherapy. N Engl J Med  377, 1065-1075.   https://doi.org/10.1056/NEJMra1608986|4. Citrin DE (2017). Recent Developments in Radiotherapy. N Engl J Med  377, 2200-2201.   https://doi.org/10.1056/NEJMc1713349|5. Citrin DE, Mitchell JB (2017). Mechanisms of Normal Tissue Injury From Irradiation. Semin Radiat Oncol  27, 316-324.   https://doi.org/10.1016/j.semradonc.2017.04.001|6. Citrin DE, Prasanna PGS, Walker AJ, Freeman ML, Eke I, Barcellos-Hoff MH, Arankalayil MJ, Cohen EP, Wilkins RC, Ahmed MM, Anscher MS, Movsas B, Buchsbaum JC, Mendonca MS, Wynn TA, Coleman CN (2017). Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. Radiat Res  188, 1-20.   https://doi.org/10.1667/RR14784.1|7. Pan J, Li D, Xu Y, Zhang J, Wang Y, Chen M, Lin S, Huang L, Chung EJ, Citrin DE, Wang Y, Hauer-Jensen M, Zhou D, Meng A (2017). Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice. Int J Radiat Oncol Biol Phys  99, 353-361.   https://doi.org/10.1016/j.ijrobp.2017.02.216",https://intramural.nih.gov/search/searchview.taf?ipid=103782
190,BC010852-12,"October 01, 2017 -  September 30, 2018",Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Emilie  Goguet; PhD|Begum Han Horuluoglu; MSC|Neslihan  Turan|Debra  Tross|Giorgio  Trinchieri|Nadya I Tarasova; PhD|Show all 8,Ihsan  Gursel|Jay  Hooper (USAMRIID)|Sven  Klaschik|Masuhiro  Takahashi (Niigata University)|John  Vasilakos (3M Corporation)|Christian Hans Bode; MD|Show all 9,"Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)",Igal  Gery; PhD (NEI),"1. Kayraklioglu N, Scheiermann J, Alvord WG, Klinman DM (2017). Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides. Mol Ther Nucleic Acids  8, 243-249.   https://doi.org/10.1016/j.omtn.2017.06.015|2. Shirota H, Klinman DM, Ito SE, Ito H, Kubo M, Ishioka C (2017). IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity. Cancer Immunol Res  5, 61-71.   https://doi.org/10.1158/2326-6066.CIR-16-0113|3. Tan C, Wandu WS, Lee RS, Hinshaw SH, Klinman DM, Wawrousek E, Gery I (2017). Shedding New Light on the Process of ""Licensing"" for Pathogenicity by Th Lymphocytes. J Immunol  198, 681-690.   https://doi.org/10.4049/jimmunol.1502108|4. Zampeli E, Klinman DM, Gershwin ME, Moutsopoulos HM (2017). A comprehensive evaluation for the treatment of lupus nephritis. J Autoimmun  78, 1-10.   https://doi.org/10.1016/j.jaut.2016.12.011",https://intramural.nih.gov/search/searchview.taf?ipid=103786
191,BC010853-12,"October 01, 2017 -  September 30, 2018",Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"Dennis M Klinman; MD, PhD|IRP Faculty Profile",NULL,"Cancer Inflammation Program, NCI",Neslihan  Turan|Debra  Tross|Giorgio  Trinchieri|Joost J Oppenheim; MD,Sven  Klaschik|Takashi  Sato,NULL,Igal  Gery; PhD (NEI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103787
192,BC010870-11,"October 01, 2017 -  September 30, 2018",Hematopoietic Stem Cell Transplant for GATA2 Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Lisa J Embree|Julia  Scheiermann|Laura M Tuschong|Robert R West,NULL,NULL,Steven M Holland; MD (NIAID),"1. Brooks KM, Jarosinski P, Hughes T, Kang E, Shah NN, Gall JBL, Hickstein DD, De Ravin SS, George JM, Kumar P (2018). Test Dose Pharmacokinetics in Pediatric Patients Receiving Once-Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach? J Clin Pharmacol  58, 332-339.   https://doi.org/10.1002/jcph.1049|2. Hickstein DD, Notarangelo L (2017). Transplant for NEMO: this and much, much more. Blood  130, 1391-1393.   https://doi.org/10.1182/blood-2017-07-795930|3. Nguyen J, Alexander T, Jiang H, Hill N, Abdullaev Z, Pack SD, Hsu AP, Holland SM, Hickstein DD, Engels EA, Brownell I (2018). Melanoma in patients with GATA2 deficiency. Pigment Cell Melanoma Res  31, 337-340.   https://doi.org/10.1111/pcmr.12671|4. Parta M, Cuellar-Rodriguez J, Freeman AF, Gea-Banacloche J, Holland SM, Hickstein DD (2017). Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation. J Clin Immunol  37, 61-66.   https://doi.org/10.1007/s10875-016-0360-8",https://intramural.nih.gov/search/searchview.taf?ipid=103821
193,BC010876-11,"October 01, 2017 -  September 30, 2018",The role of cancer stem cells in liver cancer heterogeneity and subtypes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Ching Wen  Chang,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Takahiro  Uenishi (Osaka City University)|Hui-Chuan  Sun (Liver Cancer Institute)|Lola  Reid (University of North Carolina)|Show all 8,"Marshonna J Forgues (Laboratory of Human Carcinogenesis)|Valerie Fako Miller (Laboratory of Human Carcinogenesis)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mitchell  Ho (Laboratory of Molecular Biology)|Javed  Khan; MD (Cancer Genetics Branch)|Snorri S. Thorgeirsson; MD, PhD (Laboratory of Human Carcinogenesis)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103861
194,BC010877-11,"October 01, 2017 -  September 30, 2018",The identification of human hepatocellular carcinoma metastasis genes,Xin Wei Wang; PhD|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Anuradha Samantha Budhu|Ching Wen  Chang,Zhao-You  Tang (Liver Cancer Institute)|Lun-Xiu  Qin (Liver Cancer Institute)|Qinghai  Ye (Liver Cancer Insitute)|Hui-Chuan  Sun (Liver Cancer Institute),Marshonna J Forgues (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103860
195,BC010881-11,"October 01, 2017 -  September 30, 2018",Development of TGF-beta antagonists for cancer therapy,Lalage  Wakefield; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yu-an  Yang|Kent W Hunter; PhD|Maxwell P Lee; PhD|Howard H Yang,Amer  Mirza (XOMA (US) LLC)|Caroline  Hill (Francis Crick Institute)|Maureen  O'Connor-McCourt (Formation Biologics Inc),Patricia  Steeg; PhD (Womens Malignancies Branch),"Sushil Gopal Rane; MS, PhD (NIDDK) |Ashok Balkrishna Kulkarni; PhD (NIDCR)","1. Brooks D, Zimmer A, Wakefield L, Lyle LT, Difilippantonio S, Tucci FC, Illiano S, Annunziata CM, Steeg PS (2018). Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target. Oncotarget  9, 23462-23481.   https://doi.org/10.18632/oncotarget.25231|2. Hunter KW, Amin R, Deasy S, Ha NH, Wakefield L (2018). Genetic insights into the morass of metastatic heterogeneity. Nat Rev Cancer  18, 211-223.   https://doi.org/10.1038/nrc.2017.126|3. Yang Y, Yang HH, Hu Y, Watson PH, Liu H, Geiger TR, Anver MR, Haines DC, Martin P, Green JE, Lee MP, Hunter KW, Wakefield LM (2017). Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis. Oncotarget  8, 30621-30643.   https://doi.org/10.18632/oncotarget.15695",https://intramural.nih.gov/search/searchview.taf?ipid=103858
196,BC010885-11,"October 01, 2017 -  September 30, 2018",Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Hong Seok  Choi|David A Davis; MD|Prabha  Shrestha; PhD|Alexandra Joyce Stream|Victoria Y Wang|Yi-Quan  Wu|Show all 8,"Rolf  Renne (Case Western Reserave University, Cleveland, OH)|Robert  Newton (University Of York)","Denise  Whitby (Office Of The Director)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)|Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",Paul T Wingfield; PhD (NIAMS),"1. Davis DA, Mishra S, Anagho HA, Aisabor AI, Shrestha P, Wang V, Takamatsu Y, Maeda K, Mitsuya H, Zeldis JB, Yarchoan R (2017). Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide. Oncotarget  8, 50342-50358.   https://doi.org/10.18632/oncotarget.17960|2. Goncalves PH, Ziegelbauer J, Uldrick TS, Yarchoan R (2017). Kaposi sarcoma herpesvirus-associated cancers and related diseases. Curr Opin HIV AIDS  12, 47-56.   https://doi.org/10.1097/COH.0000000000000330|3. Nalwoga A, Cose S, Nash S, Miley W, Asiki G, Kusemererwa S, Yarchoan R, Labo N, Whitby D, Newton R (2018). Relationship Between Anemia, Malaria Coinfection, and Kaposi Sarcoma-Associated Herpesvirus Seropositivity in a Population-Based Study in Rural Uganda. J Infect Dis  218, 1061-1065.   https://doi.org/10.1093/infdis/jiy274|4. Shrestha P, Davis DA, Veeranna RP, Carey RF, Viollet C, Yarchoan R (2017). Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. PLoS Pathog  13, e1006628.   https://doi.org/10.1371/journal.ppat.1006628|5. Viollet C, Davis DA, Tekeste SS, Reczko M, Ziegelbauer JM, Pezzella F, Ragoussis J, Yarchoan R (2017). RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. PLoS Pathog  13, e1006143.   https://doi.org/10.1371/journal.ppat.1006143|6. Wang V, Davis DA, Yarchoan R (2017). Identification of functional hypoxia inducible factor response elements in the human lysyl oxidase gene promoter. Biochem Biophys Res Commun  490, 480-485.   https://doi.org/10.1016/j.bbrc.2017.06.066|7. Yarchoan R, Uldrick TS (2018). HIV-Associated Cancers and Related Diseases. N Engl J Med  378, 1029-1041.   https://doi.org/10.1056/NEJMra1615896|8. Yarchoan R, Uldrick TS (2018). HIV-Associated Cancers and Related Diseases. N Engl J Med  378, 2145.   https://doi.org/10.1056/NEJMc1804812",https://intramural.nih.gov/search/searchview.taf?ipid=103867
197,BC010886-11,"October 01, 2017 -  September 30, 2018",Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,NULL,Daniel K Lee (Office Of The Clinical Director)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics),Obadi Mohammed Obadi (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103791
198,BC010887-11,"October 01, 2017 -  September 30, 2018",Novel Markers for Disease Outcome in Breast Cancer,Stefan  Ambs|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Tiffany Marie Howe|Wei  Tang; PhD,Arun  Sreekumar (Baylor College of Medicine)|Olufunmilayo  Olopade (University of Chicago)|Nagireddy  Putluri (Baylor College of Medicine)|Clayton  Yates (Tuskegee University),Prachi  Mishra (Molecular Genetics and Carcinogenesis Section)|Gatikrushna  Panigrahi; PhD (Molecular Genetics and Carcinogenesis Section)|Ashish Kumar Lal (Cancer Genetics Branch)|David Anderson Wink (Cancer Inflammation Program),Obadi Mohammed Obadi (OD),"1. Basudhar D, Glynn SA, Greer M, Somasundaram V, No JH, Scheiblin DA, Garrido P, Heinz WF, Ryan AE, Weiss JM, Cheng RYS, Ridnour LA, Lockett SJ, McVicar DW, Ambs S, Wink DA (2017). Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer. Proc Natl Acad Sci U S A  114, 13030-13035.   https://doi.org/10.1073/pnas.1709119114|2. Basudhar D, Somasundaram V, de Oliveira GA, Kesarwala A, Heinecke JL, Cheng RY, Glynn SA, Ambs S, Wink DA, Ridnour LA (2017). Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression. Antioxid Redox Signal  26, 1044-1058.   https://doi.org/10.1089/ars.2016.6813|3. Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, Deming SL, Rodriguez-Gil JL, Zheng Y, Yao S, Han YJ, Ogundiran TO, Rebbeck TR, Adebamowo C, Ojengbede O, Falusi AG, et al. [20 more authors] (2017). Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiol Biomarkers Prev  26, 1016-1026.   https://doi.org/10.1158/1055-9965.EPI-16-0567|4. Murphy ME, Liu S, Yao S, Huo D, Liu Q, Dolfi SC, Hirshfield KM, Hong CC, Hu Q, Olshan AF, Ogundiran TO, Adebamowo C, Domchek SM, Nathanson KL, Nemesure B, Ambs S, Blot WJ, Feng Y, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Ingles SA, et al. [8 more authors] (2017). A functionally significant SNP in TP53 and breast cancer risk in African-American women. NPJ Breast Cancer  3, 5.   https://doi.org/10.1038/s41523-017-0007-9|5. Ng MCY, Graff M, Lu Y, Justice AE, Mudgal P, Liu CT, Young K, Yanek LR, Feitosa MF, Wojczynski MK, Rand K, Brody JA, Cade BE, Dimitrov L, Duan Q, Guo X, Lange LA, Nalls MA, Okut H, Tajuddin SM, Tayo BO, Vedantam S, Bradfield JP, Chen G, Chen WM, Bone Mineral Density in Childhood Study (BMDCS) Group, et al. [87 more authors] (2017). Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. PLoS Genet  13, e1006719.   https://doi.org/10.1371/journal.pgen.1006719|6. Noonepalle SK, Gu F, Lee EJ, Choi JH, Han Q, Kim J, Ouzounova M, Shull AY, Pei L, Hsu PY, Kolhe R, Shi F, Choi J, Chiou K, Huang TH, Korkaya H, Deng L, Xin HB, Huang S, Thangaraju M, Sreekumar A, Ambs S, Tang SC, Munn DH, Shi H (2017). Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers. Cancer Immunol Res  5, 330-344.   https://doi.org/10.1158/2326-6066.CIR-16-0182|7. Smith CJ, Minas TZ, Ambs S (2018). Analysis of Tumor Biology to Advance Cancer Health Disparity Research. Am J Pathol  188, 304-316.   https://doi.org/10.1016/j.ajpath.2017.06.019|8. Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y (2017). Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium. Carcinogenesis  38, 789-796.   https://doi.org/10.1093/carcin/bgx055",https://intramural.nih.gov/search/searchview.taf?ipid=103792
199,BC010888-11,"October 01, 2017 -  September 30, 2018",Clinical Trials of Patients with AIDS-Related Malignancies,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Ramya Meenakshi Ramaswami|Joseph M Ziegelbauer,NULL,"Kathryn Anne Lurain; MD, MPH (Office Of The Clinical Director)|Denise  Whitby (Office Of The Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Stefania  Pittaluga (Laboratory of Pathology)|Christopher  Buck (Laboratory of Cellular Oncology)|Giovanna  Tosato; PhD (Laboratory of Cellular Oncology)",Amir Hossein Gandjbakhche; PhD (NICHD) |Irina  Maric; MD (CC) |Irini  Sereti; MD (NIAID) |Corina M Millo; MD (CC) |Joseph A Kovacs; MD (CC),"1. Gonçalves PH, Uldrick TS, Yarchoan R (2017). HIV-associated Kaposi sarcoma and related diseases. AIDS  31, 1903-1916.   https://doi.org/10.1097/QAD.0000000000001567|2. Polizzotto MN, Uldrick TS, Hu D, Yarchoan R (2017). Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome. Front Microbiol  8, 1572.   https://doi.org/10.3389/fmicb.2017.01572|3. Roshan R, Labo N, Trivett M, Miley W, Marshall V, Coren L, Cornejo Castro EM, Perez H, Holdridge B, Davis E, Matus-Nicodemos R, Ayala VI, Sowder R, Wyvill KM, Aleman K, Fennessey C, Lifson J, Polizzotto MN, Douek D, Keele B, Uldrick TS, Yarchoan R, Ohlen C, Ott D, Whitby D (2017). T-cell responses to KSHV infection: a systematic approach. Oncotarget  8, 109402-109416.   https://doi.org/10.18632/oncotarget.22683|4. Sanchez-Martin D, Uldrick TS, Kwak H, Ohnuki H, Polizzotto MN, Annunziata CM, Raffeld M, Wyvill KM, Aleman K, Wang V, Marshall VA, Whitby D, Yarchoan R, Tosato G (2017). Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx016|5. Uldrick TS, Gonçalves PH, Wyvill KM, Peer CJ, Bernstein W, Aleman K, Polizzotto MN, Venzon D, Steinberg SM, Marshall V, Whitby D, Little RF, Wright JJ, Rudek MA, Figg WD, Yarchoan R (2017). A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma. Oncologist  22, 505-e49.   https://doi.org/10.1634/theoncologist.2016-0486|6. Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, Uldrick TS, Yarchoan R, Medeiros LJ, Li Y, Fajgenbaum DC, Young KH (2017). Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood  129, 1658-1668.   https://doi.org/10.1182/blood-2016-11-748855",https://intramural.nih.gov/search/searchview.taf?ipid=103866
200,BC010891-11,"October 01, 2017 -  September 30, 2018",Development of new antibody-based cancer therapies,Mitchell  Ho|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Hejiao  Bian|Holly E Holden|Ying  Fu|Jessica Diana Hong|Nan  Li,NULL,"Ira H Pastan; MD (Molecular Biology Section)|Javed  Khan; MD (Cancer Genetics Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,"1. Li N, Fu H, Hewitt SM, Dimitrov DS, Ho M (2017). Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma. Proc Natl Acad Sci U S A  114, E6623-E6631.   https://doi.org/10.1073/pnas.1706055114|2. Zhang YF, Ho M (2017). Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples. MAbs  9, 419-429.   https://doi.org/10.1080/19420862.2017.1289302",https://intramural.nih.gov/search/searchview.taf?ipid=103822
201,BC010898-11,"October 01, 2017 -  September 30, 2018",Redox Mechanism Process of Angiogenesis and Wound Healing,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Debashree  Basudhar|Gaurav  Bharadwaj|Yuk Sing Robert Cheng|Mayumi  Fujita; PhD|Luiz Gonzaga De Franca Lopes|Jae Hong  No; PhD|Show all 11,NULL,Joseph  Saavedra (Office Of The Director)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Murali  Krishna; PhD (Radiation Biology Branch)|Stefan  Ambs (Laboratory of Human Carcinogenesis)|David D Roberts; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103863
202,BC010899-11,"October 01, 2017 -  September 30, 2018",Inflammation and cancer treatment,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Debashree  Basudhar|Gaurav  Bharadwaj|Yuk Sing Robert Cheng|Mayumi  Fujita; PhD|Luiz Gonzaga De Franca Lopes|Jae Hong  No; PhD|Show all 11,"Bruce  King (Department of Chemistry, Wake Forest University)|Micheal  Vitek (Neurology, Duke Uniuversity Medical School)",Joseph  Saavedra (Office Of The Director)|Murali  Krishna; PhD (Radiation Biology Branch)|David D Roberts; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103864
203,BC010914-11,"October 01, 2017 -  September 30, 2018",Gene Expression Profiling and Clinical Characterization of Phototoxicity,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,Christophe  Cataisson (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103875
204,BC010938-11,"October 01, 2017 -  September 30, 2018",Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,Eric  Simpson (Oregon Health and Sciences University)|Alan  Irvine (Trinity College)|Carsten  Flohr (St. John's College)|Lora  Hooper (UT Southwestern)|Lloyd  Miller (Johns Hopkins),NULL,Iryna Leonidivna Chub (NIAMS) |Jay Hyun  Jo; PhD (NIAMS) |Valentina Shobhana Pillai; CRNP (NIAMS) |Nicole Helen Schwardt (NIAMS) |Julia A Segre; PhD (NHGRI) |Alexandra  Freeman (NIAID),"1. Byrd AL, Deming C, Cassidy SKB, Harrison OJ, Ng WI, Conlan S, NISC Comparative Sequencing Program, Belkaid Y, Segre JA, Kong HH (2017). Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci Transl Med  9.   https://doi.org/10.1126/scitranslmed.aal4651|2. Kennedy EA, Connolly J, Hourihane JO, Fallon PG, McLean WHI, Murray D, Jo JH, Segre JA, Kong HH, Irvine AD (2017). Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol  139, 166-172.   https://doi.org/10.1016/j.jaci.2016.07.029|3. Kobayashi T, Voisin B, Kim DY, Kennedy EA, Jo JH, Shih HY, Truong A, Doebel T, Sakamoto K, Cui CY, Schlessinger D, Moro K, Nakae S, Horiuchi K, Zhu J, Leonard WJ, Kong HH, Nagao K (2019). Homeostatic Control of Sebaceous Glands by Innate Lymphoid Cells Regulates Commensal Bacteria Equilibrium. Cell  176, 982-997.e16.   https://doi.org/10.1016/j.cell.2018.12.031|4. Kong HH, Andersson B, Clavel T, Common JE, Jackson SA, Olson ND, Segre JA, Traidl-Hoffmann C (2017). Performing Skin Microbiome Research: A Method to the Madness. J Invest Dermatol  137, 561-568.   https://doi.org/10.1016/j.jid.2016.10.033|5. Kong HH, Morris A (2017). The emerging importance and challenges of the human mycobiome. Virulence  8, 310-312.   https://doi.org/10.1080/21505594.2017.1279780|6. Shah NN, Freeman AF, Su H, Cole K, Parta M, Moutsopoulos NM, Baris S, Karakoc-Aydiner E, Hughes TE, Kong HH, Holland SM, Hickstein DD (2017). Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide. Biol Blood Marrow Transplant  23, 980-990.   https://doi.org/10.1016/j.bbmt.2017.03.016",https://intramural.nih.gov/search/searchview.taf?ipid=103876
205,BC010940-11,"October 01, 2017 -  September 30, 2018",Cutaneous Adverse Drug Reactions,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,"Alice Pinting Chen (Office of the Director)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)",Valentina Shobhana Pillai; CRNP (NIAMS) |Monica Elizabeth Taylor (NIAMS) |Edward W Cowen (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103874
206,BC010944-11,"October 01, 2017 -  September 30, 2018",Strategies for Cancer Immunotherapy Development:  Preclinical Studies,Jeffrey  Schlom; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Lajuan  Chase|Garland M Davis|Bertina L Gibbs|John  Greiner; PhD|Duane Howard Hamilton|Karin Le-Shi Lee|Show all 15,"Mario  Roselli (Oncology, Tor Vergata)|Fiorella  Guadagni (Pathology, Regina Elena Cancer Institute)|Paul  Chaplin (Bavarian Nordic, Inc.)|Frank E Jones; PhD (Tulane School of Medicine)|Shahrooz  Rabizadeh (Nantbioscience/nantomics)",NULL,NULL,"1. Fallon JK, Vandeveer AJ, Schlom J, Greiner JW (2017). Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody. Oncotarget  8, 20558-20571.   https://doi.org/10.18632/oncotarget.16137|2. Friedman J, Morisada M, Sun L, Moore EC, Padget M, Hodge JW, Schlom J, Gameiro SR, Allen CT (2018). Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies. J Immunother Cancer  6, 59.   https://doi.org/10.1186/s40425-018-0374-2|3. Fujii R, Jochems C, Tritsch SR, Wong HC, Schlom J, Hodge JW (2018). An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression. Cancer Immunol Immunother  67, 675-689.   https://doi.org/10.1007/s00262-018-2121-4|4. Fujii R, Schlom J, Hodge JW (2018). A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab. J Neurosurg  128, 1419-1427.   https://doi.org/10.3171/2017.1.JNS162610|5. Grenga I, Donahue RN, Gargulak ML, Lepone LM, Roselli M, Bilusic M, Schlom J (2018). Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis. Urol Oncol  36, 93.e1-93.e11.   https://doi.org/10.1016/j.urolonc.2017.09.027|6. Hicks K, Fantini M, Donahue R, Knudson K, Tritsch S, Jochems C, Clavijo P, Allen C, Hodge J, Tsang K, Schlom J, Gameiro S (2018) Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types. OncoImmunology, in press.|7. Jochems C, Hodge JW, Fantini M, Tsang KY, Vandeveer AJ, Gulley JL, Schlom J (2017). ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody. Int J Cancer  141, 583-593.   https://doi.org/10.1002/ijc.30767|8. Jochems C, Tritsch SR, Pellom ST, Su Z, Soon-Shiong P, Wong HC, Gulley JL, Schlom J (2017). Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824). Oncotarget  8, 75217-75231.   https://doi.org/10.18632/oncotarget.20680|9. Knudson KM, Hicks KC, Luo X, Chen JQ, Schlom J, Gameiro SR (2018). M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine. Oncoimmunology  7, e1426519.   https://doi.org/10.1080/2162402X.2018.1426519|10. Malamas AS, Hammond SA, Schlom J, Hodge JW (2017). Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer. Oncotarget  8, 90825-90841.   https://doi.org/10.18632/oncotarget.19967|11. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy WJ, Kelly K, Monjazeb AM (2018). Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys  101, 1259-1270.   https://doi.org/10.1016/j.ijrobp.2018.04.038|12. Morillon YM, Hammond SA, Durham NM, Schlom J, Greiner JW (2017). Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion protein. Oncotarget  8, 73469-73482.   https://doi.org/10.18632/oncotarget.20703",https://intramural.nih.gov/search/searchview.taf?ipid=103832
207,BC010945-11,"October 01, 2017 -  September 30, 2018",Clinical trials employing cancer vaccine combination therapies,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Genitourinary Malignancies Branch, NCI",Fatima Hafiz Karzai; MD|William Laurence Dahut; MD,"Douglas  McNeel (University of Wisconsin)|Paul  Chaplin (Bavarian Nordic, Inc.)",Ariel Elan Marciscano; MD (Office Of The Clinical Director)|William Marston Linehan; MD (Urologic Oncology Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,"1. Bilsuc M, Gulley J (2017). Local immunotherapy: converting tumors from cold to hot. J Natl Cancer Inst  109, djx132.|2. Bilusic M, Madan R, Gulley J (2017). Immunotherapy of prostate cancer: facts and hopes. Clin Cancer Res  23, 6764-6770.|3. David J, Dominguez C, McCampbell K, Gulley J, Schlom J, Palena C (2017). A novel bifunctional anti-PD-L1TGF- Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. OncoImmunology  6, e1349589.|4. Gulley J, Repasky E, Wood L, Butterfield L (2017). Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016. J Immunother Cancer  5, 55.|5. Gulley JL, Berzofsky JA, Butler MO, Cesano A, Fox BA, Gnjatic S, Janetzki S, Kalavar S, Karanikas V, Khleif SN, Kirsch I, Lee PP, Maccalli C, Maecker H, Schlom J, Seliger B, Siebert J, Stroncek DF, Thurin M, Yuan J, Butterfield LH (2017). Immunotherapy biomarkers 2016: overcoming the barriers. J Immunother Cancer  5, 29.   https://doi.org/10.1186/s40425-017-0225-6|6. Madan RA, Gulley JL (2017). Prostate cancer immunotherapy: the path forward. Curr Opin Support Palliat Care  11, 225-230.   https://doi.org/10.1097/SPC.0000000000000278|7. Madan RA, Gulley JL (2017). Prostate cancer: Better VISTAs ahead? Potential and pitfalls of immunotherapy. Nat Rev Urol  14, 455-456.   https://doi.org/10.1038/nrurol.2017.75",https://intramural.nih.gov/search/searchview.taf?ipid=103818
208,BC010946-11,"October 01, 2017 -  September 30, 2018",Protection against Radiation-Induced Carcinogenesis,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|Sangeeta  Gohain|Sarwat  Naz; PhD|Anastasia L Sowers|Murali  Krishna; PhD,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,"1. Ueno M, Matsumoto S, Matsumoto A, Manda S, Nakanishi I, Matsumoto KI, Mitchell JB, Krishna MC, Anzai K (2017). Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. J Clin Biochem Nutr  60, 151-155.   https://doi.org/10.3164/jcbn.15-130",https://intramural.nih.gov/search/searchview.taf?ipid=103893
209,BC010958-11,"October 01, 2017 -  September 30, 2018","Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion",Ira  Daar; PhD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Yoo-Seok  Hwang|Moonsup  Lee|Jaeho  Yoon; PhD|Nariaki Sean Nakamura,NULL,NULL,NULL,"1. Yoon J, Hwang Y, Lee M, Sun J, Cho H, Knapik L, Daar I (2018) TBC1d24-ephrinB2 interaction regulates contact inhibition of locomotion in neural crest cell migration. Nature Communications, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103805
210,BC010959-11,"October 01, 2017 -  September 30, 2018",Relationship between DNA damage detection and signaling,Andre A Nussenzweig; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",Maria Elsa  Callen Moreu|Yaakov  Maman|Jacob J Paiano|Andres  Canela Rodriguez|Nicholas Franklin Sciascia; BS|Kenta  Shinoda|Show all 13,Eraz Lieberman  Aiden (Baylor College of Medicine)|Chuna  Choudhary (University Of Copenhagen)|Olivier  Hyrien (Cnrs)|Massimo  Lopes (University Of Zurich)|Manuela  Pellegrini|Arnab  Ray Chaudhuri (LABORATORY OF GENOME INTEGRITY)|Show all 8,Yves  Pommier; PhD (Developmental Therapeutics Branch)|David  Levens; PhD (Laboratory of Pathology),Clare M Waterman (NHLBI) |Rafael Cristian Casellas; PhD (NIAMS),"1. Canela A, Maman Y, Jung S, Wong N, Callen E, Day A, Kieffer-Kwon KR, Pekowska A, Zhang H, Rao SSP, Huang SC, Mckinnon PJ, Aplan PD, Pommier Y, Aiden EL, Casellas R, Nussenzweig A (2017). Genome Organization Drives Chromosome Fragility. Cell  170, 507-521.e18.   https://doi.org/10.1016/j.cell.2017.06.034|2. Greer YE, Gao B, Yang Y, Nussenzweig A, Rubin JS (2017). Lack of Casein Kinase 1 Delta Promotes Genomic Instability - The Accumulation of DNA Damage and Down-Regulation of Checkpoint Kinase 1. PLoS One  12, e0170903.   https://doi.org/10.1371/journal.pone.0170903|3. Mijic S, Zellweger R, Chappidi N, Berti M, Jacobs K, Mutreja K, Ursich S, Ray Chaudhuri A, Nussenzweig A, Janscak P, Lopes M (2017). Replication fork reversal triggers fork degradation in BRCA2-defective cells. Nat Commun  8, 859.   https://doi.org/10.1038/s41467-017-01164-5|4. Ray Chaudhuri A, Nussenzweig A (2017). The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol  18, 610-621.   https://doi.org/10.1038/nrm.2017.53|5. Ray Chaudhuri A, Nussenzweig A (2017). Thwarting endogenous stress: BRCA protects against aldehyde toxicity. EMBO Mol Med  9, 1331-1333.   https://doi.org/10.15252/emmm.201708194|6. Skau CT, Fischer RS, Gurel P, Thiam HR, Tubbs A, Baird MA, Davidson MW, Piel M, Alushin GM, Nussenzweig A, Steeg PS, Waterman CM (2018). Retraction Notice to: FMN2 Makes Perinuclear Actin to Protect Nuclei during Confined Migration and Promote Metastasis. Cell  173, 529.   https://doi.org/10.1016/j.cell.2018.03.058|7. Tubbs A, Nussenzweig A (2017). Endogenous DNA Damage as a Source of Genomic Instability in Cancer. Cell  168, 644-656.   https://doi.org/10.1016/j.cell.2017.01.002|8. Tubbs A, Sridharan S, vanWietmarschen N, Maman Y, Callen E, Stanlie A, Wu X, Day A, Wong N, Wu W, Yin M, Canela A, Redon C, Dahl J, Kunkel T, Aladjem M, Aplan P, Hyrien O, Nussenzweig A (2018) Dual Roles of Poly(dA:dT) Tracts in Replication Initiation and Fork Collapse. Cell, in press.|9. Vian L, Pękowska A, Rao SSP, Kieffer-Kwon KR, Jung S, Baranello L, Huang SC, El Khattabi L, Dose M, Pruett N, Sanborn AL, Canela A, Maman Y, Oksanen A, Resch W, Li X, Lee B, Kovalchuk AL, Tang Z, Nelson S, Di Pierro M, Cheng RR, Machol I, St Hilaire BG, Durand NC, et al. [8 more authors] (2018). The Energetics and Physiological Impact of Cohesin Extrusion. Cell  173, 1165-1178.e20.   https://doi.org/10.1016/j.cell.2018.03.072|10. Weyemi U, Paul BD, Snowman AM, Jailwala P, Nussenzweig A, Bonner WM, Snyder SH (2018). Histone H2AX deficiency causes neurobehavioral deficits and impaired redox homeostasis. Nat Commun  9, 1526.   https://doi.org/10.1038/s41467-018-03948-9|11. Yazinski SA, Comaills V, Buisson R, Genois MM, Nguyen HD, Ho CK, Todorova Kwan T, Morris R, Lauffer S, Nussenzweig A, Ramaswamy S, Benes CH, Haber DA, Maheswaran S, Birrer MJ, Zou L (2017). ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells. Genes Dev  31, 318-332.   https://doi.org/10.1101/gad.290957.116",https://intramural.nih.gov/search/searchview.taf?ipid=103900
211,BC010960-11,"October 01, 2017 -  September 30, 2018",ETIB Clinical Trials,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Daniele N Avila|Judy Liliana Baruffaldi|Megan Irene Kenyon|Jennifer Amy Mann|Lauren R Skeffington|Jennifer Sproul Wilder|Show all 7,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103817
212,BC010975-11,"October 01, 2017 -  September 30, 2018",Vaccine and radiation for the therapy of human cancers,James W Hodge; PhD|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Kellsye Paula Fabian|Sofia Ribeiro Gameiro|Kristen  Solocinski|Marion G Taylor|Benjamin Robert Wolfson|Jeffrey  Schlom; PhD,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch),NULL,"1. Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S (2017). Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer  123, 1259-1271.   https://doi.org/10.1002/cncr.30449|2. Morisada M, Moore EC, Hodge R, Friedman J, Cash HA, Hodge JW, Mitchell JB, Allen CT (2017). Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer. Oral Oncol  71, 87-94.   https://doi.org/10.1016/j.oraloncology.2017.06.005|3. Nagaya T, Nakamura Y, Sato K, Harada T, Choyke PL, Hodge JW, Schlom J, Kobayashi H (2017). Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody. Oncotarget  8, 8807-8817.   https://doi.org/10.18632/oncotarget.12410",https://intramural.nih.gov/search/searchview.taf?ipid=103868
213,BC010977-11,"October 01, 2017 -  September 30, 2018",Cbl Proteins as Regulators of Tyrosine Kinase Signaling,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Silvano Rakeem Daniels|Mariya Sergeyevna Liyasova; PhD|Donna M Voeller,Steven  Jay (University Of Maryland)|Rachel  Klevit (University Of Washington),Anand S Merchant (Cancer Diagnosis Program)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Barry R O'Keefe (Molecular Targets Laboratory),Richard  Childs; MD (NHLBI) |Richard J Hodes; MD (NIA),"1. Schardt JS, Oubaid JM, Williams SC, Howard JL, Aloimonos CM, Bookstaver ML, Lamichhane TN, Sokic S, Liyasova MS, O'Neill M, Andresson T, Hussain A, Lipkowitz S, Jay SM (2017). Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells. Mol Pharm  14, 1047-1056.   https://doi.org/10.1021/acs.molpharmaceut.6b00919",https://intramural.nih.gov/search/searchview.taf?ipid=103885
214,BC010982-11,"October 01, 2017 -  September 30, 2018",Collaborative Pathways that Lead to Leukemia,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI","Subhadip  Kundu|Toshihiro  Matsukawa|Vijay  Negi|Mianmian  Yin|Paul S Meltzer; MD, PhD",Trang  Hoang (U. Montreal)|Donald  Small (Johns Hopkins University School of Medicine)|Steven  Pruitt (Rpci),Scott K Durum; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103794
215,BC010983-11,"October 01, 2017 -  September 30, 2018",Pre-clinical Studies of Therapy for Myelodysplastic Syndrome,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Sara  Hazaveh; BA|Ghanwa Naveed Khawaja,JP  Issa (MD Anderson)|Chris  Slape (Monash University)|Laura  Schuettpelz (Washington University)|Donald  Small (Johns Hopkins University School of Medicine)|Amit  Verma (Alberrt Einstein),NULL,NULL,"1. Bhagat TD, Chen S, Bartenstein M, Barlowe AT, Von Ahrens D, Choudhary GS, Tivnan P, Amin E, Marcondes AM, Sanders MA, Hoogenboezem RM, Kambhampati S, Ramachandra N, Mantzaris I, Sukrithan V, Laurence R, Lopez R, Bhagat P, Giricz O, Sohal D, Wickrema A, Yeung C, Gritsman K, Aplan P, Hochedlinger K, et al. [13 more authors] (2017). Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation. Cancer Res  77, 4846-4857.   https://doi.org/10.1158/0008-5472.CAN-17-0282|2. Chung Y, Wolcott K, Khawaja G, Aplan P (2018) Use of hematopoietic stem cell transplantation to assess the origin of myelodysplastic syndrome. J Vis Exp, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103795
216,BC010984-11,"October 01, 2017 -  September 30, 2018",Adoptive Cell Transfer Immunotherapy of Cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Drew Caldwell Deniger; PhD|Jared Joseph Gartner|Stephanie  Goff|Frank Joseph Lowery; PhD|Richard  Sherry; MD|Gal  Cafri|Show all 12,NULL,Vid  Leko (Office Of The Clinical Director),NULL,"1. Deniger DC, Pasetto A, Robbins PF, Gartner JJ, Prickett TD, Paria BC, Malekzadeh P, Jia L, Yossef R, Langhan MM, Wunderlich JR, Danforth DN, Somerville RPT, Rosenberg SA (2018). T-cell Responses to TP53 ""Hotspot"" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers. Clin Cancer Res  24, 5562-5573.   https://doi.org/10.1158/1078-0432.CCR-18-0573|2. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu YC, Zheng Z, Pasetto A, Langhan M, Shelton T, Prickett T, Gartner J, Jia L, Trebska-McGowan K, Somerville RP, Robbins PF, Rosenberg SA, Goff SL, Feldman SA (2018). Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med  24, 724-730.   https://doi.org/10.1038/s41591-018-0040-8",https://intramural.nih.gov/search/searchview.taf?ipid=103830
217,BC010985-11,"October 01, 2017 -  September 30, 2018",Gene therapy of cancer,"Steven Aaron Rosenberg; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI","Drew Caldwell Deniger; PhD|Almin Iqbalali Lalani|Yong-Chen  Lu; PhD|Todd  Prickett|Richard  Sherry; MD|James Chung-Yin Yang; MD, PhD|Show all 10",NULL,Vid  Leko (Office Of The Clinical Director),NULL,"1. Jin BY, Campbell TE, Draper LM, Stevanović S, Weissbrich B, Yu Z, Restifo NP, Rosenberg SA, Trimble CL, Hinrichs CS (2018). Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model. JCI Insight  3.   https://doi.org/10.1172/jci.insight.99488|2. Kochenderfer JN, Somerville RPT, Lu T, Yang JC, Sherry RM, Feldman SA, McIntyre L, Bot A, Rossi J, Lam N, Rosenberg SA (2017). Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy. Mol Ther  25, 2245-2253.   https://doi.org/10.1016/j.ymthe.2017.07.004|3. Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV (2017). LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases. Cancer Res  77, 1880-1891.   https://doi.org/10.1158/0008-5472.CAN-16-1655|4. Qutob N, Masuho I, Alon M, Emmanuel R, Cohen I, Di Pizio A, Madore J, Elkahloun A, Ziv T, Levy R, Gartner JJ, Hill VK, Lin JC, Hevroni Y, Greenberg P, Brodezki A, Rosenberg SA, Kosloff M, Hayward NK, Admon A, Niv MY, Scolyer RA, Martemyanov KA, Samuels Y (2018). RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells. Sci Rep  8, 653.   https://doi.org/10.1038/s41598-017-18851-4|5. Rossi J, Paczkowski P, Shen YW, Morse K, Flynn B, Kaiser A, Ng C, Gallatin K, Cain T, Fan R, Mackay S, Heath JR, Rosenberg SA, Kochenderfer JN, Zhou J, Bot A (2018). Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL. Blood  132, 804-814.   https://doi.org/10.1182/blood-2018-01-828343",https://intramural.nih.gov/search/searchview.taf?ipid=103829
218,BC010998-11,"October 01, 2017 -  September 30, 2018",Identification of Novel Mutations In Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Berkley Eric Gryder|Jeetendra  Kumar|Nityashree  Shivaprasad|Young K Song|Jun S Wei|Show all 7,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|David  Azorsa (NHGRI)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Show all 7",Carol J Thiele (Pediatric Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch),NULL,"1. Tricoli JV, Boardman LA, Patidar R, Sindiri S, Jang JS, Walsh WD, McGregor PM, Camalier CE, Mehaffey MG, Furman WL, Bahrami A, Williams PM, Lih CJ, Conley BA, Khan J (2018). A mutational comparison of adult and adolescent and young adult (AYA) colon cancer. Cancer  124, 1070-1082.   https://doi.org/10.1002/cncr.31136",https://intramural.nih.gov/search/searchview.taf?ipid=103872
219,BC010999-11,"October 01, 2017 -  September 30, 2018","Targeting FGFR4,  RAS, and  PAX3-FOXO1 gene in Rhabdomyosarcoma",Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Berkley Eric Gryder|Jeetendra  Kumar|Nityashree  Shivaprasad|Young K Song|Jun S Wei,Daniel  Catchpoole (The Children's Hospital at Westmead)|Terry J Fry (NCI)|Crystal L. Mackall; MD (NCI),Brigitte  Widemann; MD (Pediatric Oncology Branch)|Mitchell  Ho (Laboratory of Molecular Biology)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch),NULL,"1. Orentas RJ, Sindiri S, Duris C, Wen X, He J, Wei JS, Jarzembowski J, Khan J (2017). Paired Expression Analysis of Tumor Cell Surface Antigens. Front Oncol  7, 173.   https://doi.org/10.3389/fonc.2017.00173",https://intramural.nih.gov/search/searchview.taf?ipid=103873
220,BC011002-11,"October 01, 2017 -  September 30, 2018",Bioinformatics: Systems Biology of Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Berkley Eric Gryder|Jeetendra  Kumar|Nityashree  Shivaprasad|Young K Song|Jun S Wei|Show all 11,NULL,NULL,NULL,"1. Bosse KR, Raman P, Zhu Z, Lane M, Martinez D, Heitzeneder S, Rathi KS, Kendsersky NM, Randall M, Donovan L, Morrissy S, Sussman RT, Zhelev DV, Feng Y, Wang Y, Hwang J, Lopez G, Harenza JL, Wei JS, Pawel B, Bhatti T, Santi M, Ganguly A, Khan J, Marra MA, et al. [4 more authors] (2017). Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma. Cancer Cell  32, 295-309.e12.   https://doi.org/10.1016/j.ccell.2017.08.003",https://intramural.nih.gov/search/searchview.taf?ipid=103871
221,BC011006-11,"October 01, 2017 -  September 30, 2018",Molecular diagnosis and outcome prediction in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Da Wei  Huang|Roland  Schmitz|Weihong  Xu|Wyndham H Wilson; MD, PhD|Mark Jason Roschewski",John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Bouska A, Bi C, Lone W, Zhang W, Kedwaii A, Heavican T, Lachel CM, Yu J, Ferro R, Eldorghamy N, Greiner TC, Vose J, Weisenburger DD, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, Siebert R, Miles RR, Dave S, Reddy A, Delabie J, et al. [7 more authors] (2017). Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. Blood  130, 1819-1831.   https://doi.org/10.1182/blood-2017-02-767335|2. Jais JP, Molina TJ, Ruminy P, Gentien D, Reyes C, Scott DW, Rimsza LM, Wright G, Gascoyne RD, Staudt LM, Haioun C, Tilly H, Gaulard P, Salles GA, Jardin F, Leroy K (2017). Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay. Haematologica  102, e404-e406.   https://doi.org/10.3324/haematol.2017.166827|3. Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, et al. [15 more authors] (2018). Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med  378, 1396-1407.   https://doi.org/10.1056/NEJMoa1801445|4. Scott DW, Abrisqueta P, Wright GW, Slack GW, Mottok A, Villa D, Jares P, Rauert-Wunderlich H, Royo C, Clot G, Pinyol M, Boyle M, Chan FC, Braziel RM, Chan WC, Weisenburger DD, Cook JR, Greiner TC, Fu K, Ott G, Delabie J, Smeland EB, Holte H, Jaffe ES, Steidl C, Lymphoma/Leukemia Molecular Profiling Project, et al. [6 more authors] (2017). New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies. J Clin Oncol  35, 1668-1677.   https://doi.org/10.1200/JCO.2016.70.7901",https://intramural.nih.gov/search/searchview.taf?ipid=103846
222,BC011007-11,"October 01, 2017 -  September 30, 2018",RNA interference-based screens for molecular targets in cancer,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Da Wei  Huang|James Daniel Phelan|Zhuo  Wang|Yandan  Yang; PhD|Hong  Zhao,NULL,George W Wright (Computational & Systems Biology Branch),NULL,"1. Phelan JD, Young RM, Webster DE, Roulland S, Wright GW, Kasbekar M, Shaffer AL, Ceribelli M, Wang JQ, Schmitz R, Nakagawa M, Bachy E, Huang DW, Ji Y, Chen L, Yang Y, Zhao H, Yu X, Xu W, Palisoc MM, Valadez RR, Davies-Hill T, Wilson WH, Chan WC, Jaffe ES, et al. [15 more authors] (2018). A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature  560, 387-391.   https://doi.org/10.1038/s41586-018-0290-0",https://intramural.nih.gov/search/searchview.taf?ipid=103847
223,BC011008-11,"October 01, 2017 -  September 30, 2018",Oncogenic mechanisms and molecular targets in lymphoma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Da Wei  Huang|Arthur L Shaffer|James Q Wang|Ryan Matthew Young|Xin H Yu|Hong  Zhao|Show all 8,John  Chan (Univ. of Nebraska Medical Center)|Elias  Campo (University of Barcelona)|Randy  Gascoyne (British Columbia Cancer Center)|Erlend  Smeland (Norwegian Radium Hospital)|Lisa  Rimsza (University of Arizona Cancer Center)|Joseph  Connors (British Columbia Cancer Agency)|Show all 8,Elaine S Jaffe; MD (Laboratory of Pathology)|George W Wright (Computational & Systems Biology Branch)|Stefania  Pittaluga (Laboratory of Pathology),NULL,"1. Phelan JD, Young RM, Webster DE, Roulland S, Wright GW, Kasbekar M, Shaffer AL, Ceribelli M, Wang JQ, Schmitz R, Nakagawa M, Bachy E, Huang DW, Ji Y, Chen L, Yang Y, Zhao H, Yu X, Xu W, Palisoc MM, Valadez RR, Davies-Hill T, Wilson WH, Chan WC, Jaffe ES, et al. [15 more authors] (2018). A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature  560, 387-391.   https://doi.org/10.1038/s41586-018-0290-0|2. Pongas GN, Annunziata CM, Staudt LM (2017). PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma. Oncotarget  8, 81794-81802.   https://doi.org/10.18632/oncotarget.20864",https://intramural.nih.gov/search/searchview.taf?ipid=103844
224,BC011010-11,"October 01, 2017 -  September 30, 2018",Oncogenic mechanisms and molecular targets in myeloma,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Ryan Matthew Young|Yandan  Yang; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103845
225,BC011011-11,"October 01, 2017 -  September 30, 2018",The genome-wide function of supercoiling and alternative DNA conformations,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Lipeng  Wu,NULL,NULL,Keji  Zhao; PhD (NHLBI) |Teresa M Przytycka (NLM) |Rafael Cristian Casellas; PhD (NIAMS),"1. Kouzine F, Wojtowicz D, Baranello L, Yamane A, Nelson S, Resch W, Kieffer-Kwon KR, Benham CJ, Casellas R, Przytycka TM, Levens D (2017). Permanganate/S1 Nuclease Footprinting Reveals Non-B DNA Structures with Regulatory Potential across a Mammalian Genome. Cell Syst  4, 344-356.e7.   https://doi.org/10.1016/j.cels.2017.01.013",https://intramural.nih.gov/search/searchview.taf?ipid=103879
226,BC011028-11,"October 01, 2017 -  September 30, 2018",Clinical Studies of the Molecular Genetic Basis of Kidney Cancer,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mark Wayne Ball|Daniel  Crooks|Martin  Lang; PhD|Lindsay A. Middelton|Christopher James Ricketts; PhD|Laura  Schmidt|Show all 11,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)","1. Greer YE, Porat-Shliom N, Nagashima K, Stuelten C, Crooks D, Koparde VN, Gilbert SF, Islam C, Ubaldini A, Ji Y, Gattinoni L, Soheilian F, Wang X, Hafner M, Shetty J, Tran B, Jailwala P, Cam M, Lang M, Voeller D, Reinhold WC, Rajapakse V, Pommier Y, Weigert R, Linehan WM, et al. [1 more author] (2018). ONC201 kills breast cancer cells in vitro by targeting mitochondria. Oncotarget  9, 18454-18479.   https://doi.org/10.18632/oncotarget.24862|2. McGowan A, An JY, Tanakchi S, Maruf M, Muthigi A, George A, Su D, Merino MJ, Linehan WM, Boyle SL, Metwalli AR (2017). Multiple Recurrent Paraganglioma in a Pediatric Patient with Germline SDH-B Mutation. Urol Case Rep  13, 107-109.   https://doi.org/10.1016/j.eucr.2017.03.017|3. Schmidt LS, Linehan WM (2018). FLCN: The causative gene for Birt-Hogg-Dubé syndrome. Gene  640, 28-42.   https://doi.org/10.1016/j.gene.2017.09.044|4. Scroggins BT, Burkeen J, White AO, Chung EJ, Wei D, Chung SI, Valle LF, Patil SS, McKay-Corkum G, Hudak KE, Linehan WM, Citrin DE (2018). Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage. Int J Radiat Oncol Biol Phys  100, 344-352.   https://doi.org/10.1016/j.ijrobp.2017.09.049",https://intramural.nih.gov/search/searchview.taf?ipid=103883
227,BC011032-11,"October 01, 2017 -  September 30, 2018",Post-translational modifications of Hsp90,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Kristin  Eckfeld|Paolo  Pergami-Peries|Marianne  Poruchynsky|Genesis Mayliz Rivera-Marquez|Megan Leighann Tigue|Wanping  Xu,"Brian  Blagg (Chemistry, University of Kansas)|Laurence  Pearl (University of Sussex)|Matthias  Mayer (University of Heidelberg)|Marc  Cox (University of Texas at El Paso)|Gabriela X Chiosis|Timothy  Haystead (Duke University)|Show all 11",NULL,Daniel C Masison; PhD (NIDDK),"1. Li QQ, Hao JJ, Zhang Z, Krane LS, Hammerich KH, Sanford T, Trepel JB, Neckers L, Agarwal PK (2017). Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics. Sci Rep  7, 201.   https://doi.org/10.1038/s41598-017-00143-6|2. Zuehlke AD, Reidy M, Lin C, LaPointe P, Alsomairy S, Lee DJ, Rivera-Marquez GM, Beebe K, Prince T, Lee S, Trepel JB, Xu W, Johnson J, Masison D, Neckers L (2017). An Hsp90 co-chaperone protein in yeast is functionally replaced by site-specific posttranslational modification in humans. Nat Commun  8, 15328.   https://doi.org/10.1038/ncomms15328",https://intramural.nih.gov/search/searchview.taf?ipid=103899
228,BC011033-11,"October 01, 2017 -  September 30, 2018",Mechanisms of MHC Class II Association with Plasma Membrane Microdomains,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul,Satoshi  Ishido (Riken Center for Allergy and Immunology)|James  Drake (NCI),NULL,NULL,"1. Bandola-Simon J, Roche PA (2019). Dysfunction of antigen processing and presentation by dendritic cells in cancer. Mol Immunol  113, 31-37.   https://doi.org/10.1016/j.molimm.2018.03.025|2. Cresswell P, Roche PA (2017). Editorial Overview: Antigen Processing and Presentation; many fingers in many pies. Curr Opin Immunol  46, v-vii.   https://doi.org/10.1016/j.coi.2017.07.002|3. Da Q, Shaw T, Pradhan S, Roche PA, Cruz MA, Vijayan KV (2017). Disruption of protein complexes containing protein phosphatase 2B and Munc18c reduces the secretion of von Willebrand factor from endothelial cells. J Thromb Haemost  15, 1032-1039.   https://doi.org/10.1111/jth.13671|4. Kaul S, Mittal SK, Roche PA (2018). A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene. J Biol Chem  293, 4478-4485.   https://doi.org/10.1074/jbc.RA118.001775|5. Klein O, Roded A, Zur N, Azouz NP, Pasternak O, Hirschberg K, Hammel I, Roche PA, Yatsu A, Fukuda M, Galli SJ, Sagi-Eisenberg R (2017). Rab5 is critical for SNAP23 regulated granule-granule fusion during compound exocytosis. Sci Rep  7, 15315.   https://doi.org/10.1038/s41598-017-15047-8|6. Lei L, Bandola-Simon J, Roche PA (2018). Ubiquitin-conjugating enzyme E2 D1 (Ube2D1) mediates lysine-independent ubiquitination of the E3 ubiquitin ligase March-I. J Biol Chem  293, 3904-3912.   https://doi.org/10.1074/jbc.RA117.001322",https://intramural.nih.gov/search/searchview.taf?ipid=103828
229,BC011035-11,"October 01, 2017 -  September 30, 2018",Regulation of Exocytosis from Immune Cells,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Karis  Faust|Sunil  Kaul,Burton  Dickey (University of Texas MD Anderson Cancer Center)|Vinod  Vijayan (Baylor College of Medicine),Lino  Tessarollo (Mouse Cancer Genetics Program),Katherine Walton Roche; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103827
230,BC011038-11,"October 01, 2017 -  September 30, 2018",Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mark Wayne Ball|Daniel  Crooks|Martin  Lang; PhD|Cristiane  Leite|Lindsay A. Middelton|Christopher James Ricketts; PhD|Show all 11,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)","1. Kulkarni RA, Worth AJ, Zengeya TT, Shrimp JH, Garlick JM, Roberts AM, Montgomery DC, Sourbier C, Gibbs BK, Mesaros C, Tsai YC, Das S, Chan KC, Zhou M, Andresson T, Weissman AM, Linehan WM, Blair IA, Snyder NW, Meier JL (2017). Discovering Targets of Non-enzymatic Acylation by Thioester Reactivity Profiling. Cell Chem Biol  24, 231-242.   https://doi.org/10.1016/j.chembiol.2017.01.002|2. Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, Yeung AT, Clapper ML, Uzzo RG, Henske EP, Ricketts CJ, Vocke CD, Linehan WM, Testa JR, Bellacosa A, Kopelovich L, et al. [1 more author] (2017). Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. Oncotarget  8, 17628-17642.   https://doi.org/10.18632/oncotarget.12192",https://intramural.nih.gov/search/searchview.taf?ipid=103884
231,BC011043-11,"October 01, 2017 -  September 30, 2018",Molecular Therapeutics of Kidney Cancer:  MET Gene and BHD Gene,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mark Wayne Ball|Daniel  Crooks|Martin  Lang; PhD|Lindsay A. Middelton|Christopher James Ricketts; PhD|Laura  Schmidt|Show all 10,NULL,Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),NULL,"1. Schmidt LS, Linehan WM (2018). FLCN: The causative gene for Birt-Hogg-Dubé syndrome. Gene  640, 28-42.   https://doi.org/10.1016/j.gene.2017.09.044",https://intramural.nih.gov/search/searchview.taf?ipid=103880
232,BC011053-11,"October 01, 2017 -  September 30, 2018",TMPRSS2-ERG chromosomal translocations and prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin|Juanjuan  Yin,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103870
233,BC011054-11,"October 01, 2017 -  September 30, 2018",Nuclear Factor-kappaB in Ovarian Cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",David Michael Anderson|Lidia F Hernandez|Carrie D House|Michelle K Ozaki,NULL,George W Wright (Computational & Systems Biology Branch)|Margaret  Cam; PhD (Office of the Director),"Craig Joseph Thomas (NCATS) |Madhu A Lal (NCATS) |Carter  Van Waes; MD, PhD (NIDCD)","1. House CD, Jordan E, Hernandez L, Ozaki M, James JM, Kim M, Kruhlak MJ, Batchelor E, Elloumi F, Cam MC, Annunziata CM (2017). NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells. Cancer Res  77, 6927-6940.   https://doi.org/10.1158/0008-5472.CAN-17-0366|2. Pongas G, Kim MK, Min DJ, House CD, Jordan E, Caplen N, Chakka S, Ohiri J, Kruhlak MJ, Annunziata CM (2017). BRD4 facilitates DNA damage response and represses CBX5/Heterochromatin protein 1 (HP1). Oncotarget  8, 51402-51415.   https://doi.org/10.18632/oncotarget.17572",https://intramural.nih.gov/search/searchview.taf?ipid=103793
234,BC011055-11,"October 01, 2017 -  September 30, 2018",Serum Antibody Profiling with a Carbohydrate Microarray,Jeffrey  Gildersleeve|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Dorothy Leeann Ackerman|Li  Xia,Xuefei  Huang (Michigan State University)|Lynn  Morris (National Institute for Communicable Diseases)|Julie  Lucas (MRI Global),"Lisa  Mcshane (Biostatistics Branch)|James W Hodge; PhD (Laboratory of Tumor Immunology and Biology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Howard A Young; PhD (Cancer Inflammation Program)",NULL,"1. Lucas JL, Tacheny EA, Ferris A, Galusha M, Srivastava AK, Ganguly A, Williams PM, Sachs MC, Thurin M, Tricoli JV, Ricker W, Gildersleeve JC (2017). Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy. PLoS One  12, e0182739.   https://doi.org/10.1371/journal.pone.0182739|2. Scheepers C, Chowdhury S, Wright WS, Campbell CT, Garrett NJ, Abdool Karim Q, Abdool Karim SS, Moore PL, Gildersleeve JC, Morris L (2017). Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses. AIDS  31, 2199-2209.   https://doi.org/10.1097/QAD.0000000000001643",https://intramural.nih.gov/search/searchview.taf?ipid=103815
235,BC011056-11,"October 01, 2017 -  September 30, 2018",Promoting tumor cell apoptosis by death ligands,Thomas Joseph Sayers; PhD,NULL,"Cancer Inflammation Program, NCI",Alan  Brooks,William  Murphy (University of Nevada)|Robert  Rees (John van Geest Cancer Centre)|Neil  Cross (Sheffield Hallam University)|AA Leslie  Gunatilaka (University of Arizona),Poonam  Tewary (Office Of The Director)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Curtis  Henrich (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103831
236,BC011058-11,"October 01, 2017 -  September 30, 2018",Development of a Vaccine for HIV-AIDS: Humoral Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Gospel Menakam Enyindah-Asonye|Sabrina  Helmold Hait|Tanya N Hoang|Christopher James Hogge|Zuena  Mushtaq|Mohammad Arif  Rahman; PhD|Show all 10,"David C Montefiori; PhD (Department of Surgery, NIAID)|Susan  Zolla-Pazner (NYU Med School)|miroslaw  gorny; PhD (NYU Medical School)|Galit  Alter; PhD (Division of Medical Sciences, Harvard Medical School)|Margaret  Ackerman (Dartmouth University)|Mark  Cameron (Case Western Reserve University)|Show all 7",David J Venzon; PhD (Biostatistics and Data Management Section)|Ettore  Appella; MD (Chemical Immunology Section)|Colm  Ohuigin (Cancer Inflammation Program),Daniel  Appella; PhD (NIDDK),"1. MillerNovak L, Das J, Musich T, Demberg T, Weiner J, Venzon D, Mohanram V, VargasInchaustegui D, Tuero I, Ackerman M, Alter G, Robert-Guroff M (2018) Analysis of complement-mediated lysis of SIV and SIV-infected cells reveals sex differences in vaccine-induced immune responses in Rhesus macaques. J Virol, in press.|2. Musich T, Li L, Liu L, Zolla-Pazner S, Robert-Guroff M, Gorny MK (2017). Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner. J Virol  91.   https://doi.org/10.1128/JVI.02325-16|3. Plank-Bazinet JL, Sampson A, Kornstein SG, Germino GG, Robert-Guroff M, Gilman SE, Wetherington CL, Cook N, Cornelison TL, Begg L, Clayton JA (2018). A Report of the 24th Annual Congress on Women's Health-Workshop on Transforming Women's Health: From Research to Practice. J Womens Health (Larchmt)  27, 115-120.   https://doi.org/10.1089/jwh.2017.29016.orwh|4. Shaw JM, Miller-Novak LK, Mohanram V, McKinnon K, Demberg T, Vargas-Inchaustegui DA, Venzon D, Robert-Guroff M (2017). Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia. J Virol  91.   https://doi.org/10.1128/JVI.01727-16",https://intramural.nih.gov/search/searchview.taf?ipid=103825
237,BC011061-11,"October 01, 2017 -  September 30, 2018",Computational and Experimental RNA Nanobiology,Bruce Allen Shapiro; PhD|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Eckart  Bindewald|Arabella Franziska Chen|Eric Alexander Fields|Sarah  Jeong|Kazimierz Wojcieck Kasprzak|Tae Jin  Kim|Show all 13,Hanan  Samet (University of Maryland)|Eliahu  Heldman|Amit Shridhar Joshi (LIPID TRAFCING & ORGNLE BIOGN SEC)|Kirill Andreevich Afonin|Kshitij  Gupta|Christopher  Jewell (University of Maryland)|Show all 7,Mathias  Viard (Cancer Inflammation Program)|Marina A Dobrovolskaia (Cancer Imaging Program)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Stephen J Lockett; PhD (Office Of The Director)|Robert  Blumenthal; PhD (Chemical Biology Laboratory)|Joost J Oppenheim; MD (Cancer Inflammation Program),NULL,"1. Puri A, Viard M, Zakrevsky P, Parlea L, Singh K, Shapiro B (2018) Alliance of Lipids with siRNA, in Molecular Medicines for Cancer: Concepts and Applications of Nanotechnology, in press.|2. Gupta K, Puri A, Shapiro B (2017). Functionalized non-viral cationic vectors for effective siRNA induced cancer therapy. DNA and RNA Nanotechnology  4, 1-20.|3. Halman JR, Satterwhite E, Roark B, Chandler M, Viard M, Ivanina A, Bindewald E, Kasprzak WK, Panigaj M, Bui MN, Lu JS, Miller J, Khisamutdinov EF, Shapiro BA, Dobrovolskaia MA, Afonin KA (2017). Functionally-interdependent shape-switching nanoparticles with controllable properties. Nucleic Acids Res  45, 2210-2220.   https://doi.org/10.1093/nar/gkx008|4. Viard M, Reichard H, Shapiro B, Durranic F, Marko A, Watson R, Pandey R, Puri A (2018) Design and Biological Activity of Novel Stealth Polymeric Lipid Nanoparticles for Enhanced Delivery of Hydrophobic Photodynamic Therapy Drugs. Nanomedicine: Nanotechnology, Biology, and Medicine, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103834
238,BC011062-11,"October 01, 2017 -  September 30, 2018",Development of a Vaccine for HIV-AIDS: Cellular Immunity,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI","Ruth Mesfin  Hunegnaw; PhD|Eunju  Ko; PhD|Mohammad Arif  Rahman; PhD|Tanya N Hoang|Jay Arthur Berzofsky; MD, PhD|Jennifer Clare Jones; MD, PhD",NULL,David J Venzon; PhD (Biostatistics and Data Management Section)|Tatiana  Karpova (Laboratory of Receptor Biology and Gene Expression)|David Allan Ball (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Morales-Kastresana A, Telford B, Musich TA, McKinnon K, Clayborne C, Braig Z, Rosner A, Demberg T, Watson DC, Karpova TS, Freeman GJ, DeKruyff RH, Pavlakis GN, Terabe M, Robert-Guroff M, Berzofsky JA, Jones JC (2017). Labeling Extracellular Vesicles for Nanoscale Flow Cytometry. Sci Rep  7, 1878.   https://doi.org/10.1038/s41598-017-01731-2|2. Rahman MA, McKinnon KM, Karpova TS, Ball DA, Venzon DJ, Fan W, Kang G, Li Q, Robert-Guroff M (2018). Associations of Simian Immunodeficiency Virus (SIV)-Specific Follicular CD8+ T Cells with Other Follicular T Cells Suggest Complex Contributions to SIV Viremia Control. J Immunol  200, 2714-2726.   https://doi.org/10.4049/jimmunol.1701403|3. Vargas-Inchaustegui DA, Helmold Hait S, Chung HK, Narola J, Hoang T, Robert-Guroff M (2017). Phenotypic and Functional Characterization of Circulatory, Splenic, and Hepatic NK Cells in Simian Immunodeficiency Virus-Controlling Macaques. J Immunol  199, 3202-3211.   https://doi.org/10.4049/jimmunol.1700586",https://intramural.nih.gov/search/searchview.taf?ipid=103826
239,BC011063-11,"October 01, 2017 -  September 30, 2018",Development of a Vaccine for HIV-AIDS: Translation to the Clinic,Marjorie  Robert-Guroff; PhD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Gospel Menakam Enyindah-Asonye|Sabrina  Helmold Hait|Tanya N Hoang|Christopher James Hogge|Ruth Mesfin  Hunegnaw; PhD|Eunju  Ko; PhD|Show all 10,NULL,Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Brandon Frank Keele (Office Of The Director)|Ettore  Appella; MD (Chemical Immunology Section)|Thomas S Uldrick (HIV and AIDS Malignancy Branch),Mark  Connors; MD (NIAID) |Daniel  Appella; PhD (NIDDK),"1. Musich T, Jones JC, Keele BF, Jenkins LMM, Demberg T, Uldrick TS, Yarchoan R, Robert-Guroff M (2017). Flow virometric sorting and analysis of HIV quasispecies from plasma. JCI Insight  2, e90626.   https://doi.org/10.1172/jci.insight.90626",https://intramural.nih.gov/search/searchview.taf?ipid=103824
240,BC011064-11,"October 01, 2017 -  September 30, 2018",A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1,Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI","Ke  Zhang|Shuling  Zhang; MD, PhD",NULL,"Sandra Lynn Wolin; MD, PhD (Rna Biology Laboratory)",NULL,"1. Calabrese D, Chen X, Leon E, Gaikwad S, Phyo Z, Hewitt W, He F, Michalowski A, Simmons J, Saunders L, Zhang S, Connors D, Walters K, Mock B, Schneekloth Jr J (2018) Chemical and Structural Studies Provide a Mechanistic Basis for Recognition of the MYC G-Quadraplex. Nature Communications, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103896
241,BC011065-11,"October 01, 2017 -  September 30, 2018","Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)",Beverly  Mock; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Daniel George Connors|Snehal Mahendra Gaikwad|Nana Abena Gyabaah-Kessie|Vincent Keith Hughitt|Tyler John Peat|Ke  Zhang|Show all 9,"Leif  Bergsagel (Division of Hematology, Cornell Medical School)|Ola Anders Landgren|Vinod  Ravi (Md Anderson Cancer Center)|Jing  Zhang (U Of Wisconsin)",John Stephen Schneekloth (Chemical Biology Laboratory)|Haobin  Chen (Thoracic & Oncologic Surgery Branch)|Kyung  Lee; PhD (Chemistry Section)|Anish  Thomas; MD (Developmental Therapeutics Branch),NULL,"1. Calabrese D, Chen X, Leon E, Gaikwad S, Phyo Z, Hewitt W, He F, Michalowski A, Simmons J, Saunders L, Zhang S, Connors D, Walters K, Mock B, Schneekloth Jr J (2018) Chemical and Structural Studies Provide a Mechanistic Basis for Recognition of the MYC G-Quadraplex. Nature Communications, in press.|2. Calabrese DR, Zlotkowski K, Alden S, Hewitt WM, Connelly CM, Wilson RM, Gaikwad S, Chen L, Guha R, Thomas CJ, Mock BA, Schneekloth JS (2018). Characterization of clinically used oral antiseptics as quadruplex-binding ligands. Nucleic Acids Res  46, 2722-2732.   https://doi.org/10.1093/nar/gky084|3. He Y, Zhu W, Shin MH, Gary J, Liu C, Dubois W, Hoover SB, Jiang S, Marrogi E, Mock B, Simpson RM, Huang J (2017). cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma. Stem Cell Reports  8, 1630-1644.   https://doi.org/10.1016/j.stemcr.2017.04.029|4. Simmons JK, Michalowski AM, Gamache BJ, DuBois W, Patel J, Zhang K, Gary J, Zhang S, Gaikwad S, Connors D, Watson N, Leon E, Chen JQ, Kuehl WM, Lee MP, Zingone A, Landgren O, Ordentlich P, Huang J, Mock BA (2017). Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. Mol Cancer Ther  16, 2008-2021.   https://doi.org/10.1158/1535-7163.MCT-17-0171",https://intramural.nih.gov/search/searchview.taf?ipid=103897
242,BC011070-11,"October 01, 2017 -  September 30, 2018",Hematopathology Diagnosis,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Jayalakshmi Panicker Balakrishna|Theresa M Davies Hill|Nancy Ellen Diener|Princess Yah Dorley|Pallavi Kanwar  Galera|Gaurav Kumar Gupta; MD, PhD|Show all 11",NULL,NULL,Jeffrey  Cohen; MD (NIAID),"1. Bhavsar T, Lee JC, Perner Y, Raffeld M, Xi L, Pittaluga S, Jaffe ES (2017). KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: New Findings and Review of the Literature. Am J Surg Pathol  41, 795-800.   https://doi.org/10.1097/PAS.0000000000000823|2. Brett FM, Flavin R, Chen D, Loftus T, Looby S, McCarthy A, de Gascun C, Jaffe ES, Nor N, Javadpour M, McCabe D (2017). EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline. Hum Pathol (N Y)  10, 64-68.   https://doi.org/10.1016/j.ehpc.2017.06.007|3. Chadburn A, Said J, Gratzinger D, Chan JK, de Jong D, Jaffe ES, Natkunam Y, Goodlad JR (2017). HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3. Am J Clin Pathol  147, 171-187.   https://doi.org/10.1093/ajcp/aqw218|4. Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA (2017). Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proc Natl Acad Sci U S A  114, 3975-3980.   https://doi.org/10.1073/pnas.1700682114|5. de Jong D, Roemer MG, Chan JK, Goodlad J, Gratzinger D, Chadburn A, Jaffe ES, Said J, Natkunam Y (2017). B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2. Am J Clin Pathol  147, 153-170.   https://doi.org/10.1093/ajcp/aqw216|6. Estrada-Veras JI, O'Brien KJ, Boyd LC, Dave RH, Durham B, Xi L, Malayeri AA, Chen MY, Gardner PJ, Alvarado-Enriquez JR, Shah N, Abdel-Wahab O, Gochuico BR, Raffeld M, Jaffe ES, Gahl WA (2017). The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv  1, 357-366.   https://doi.org/10.1182/bloodadvances.2016001784|7. Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, et al. [13 more authors] (2017). International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood  129, 1646-1657.   https://doi.org/10.1182/blood-2016-10-746933|8. Gratzinger D, de Jong D, Jaffe ES, Chadburn A, Chan JK, Goodlad JR, Said J, Natkunam Y (2017). T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4. Am J Clin Pathol  147, 188-203.   https://doi.org/10.1093/ajcp/aqw213|9. Gratzinger D, Jaffe ES, Chadburn A, Chan JK, de Jong D, Goodlad JR, Said J, Natkunam Y (2017). Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5. Am J Clin Pathol  147, 204-216.   https://doi.org/10.1093/ajcp/aqw215|10. Gru AA, Jaffe ES (2017). Cutaneous EBV-related lymphoproliferative disorders. Semin Diagn Pathol  34, 60-75.   https://doi.org/10.1053/j.semdp.2016.11.003|11. Gru AA, Jaffe ES (2017). The Landscape of Cutaneous Lymphomas in 2016, An Introduction. Semin Diagn Pathol  34, 1-2.   https://doi.org/10.1053/j.semdp.2016.11.010|12. Jaffe ES, Barr PM, Smith SM (2017). Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice. Am Soc Clin Oncol Educ Book  37, 535-546.   https://doi.org/10.1200/EDBK_175437|13. Lionakis MS, Dunleavy K, Roschewski M, Widemann BC, Butman JA, Schmitz R, Yang Y, Cole DE, Melani C, Higham CS, Desai JV, Ceribelli M, Chen L, Thomas CJ, Little RF, Gea-Banacloche J, Bhaumik S, Stetler-Stevenson M, Pittaluga S, Jaffe ES, Heiss J, Lucas N, Steinberg SM, Staudt LM, Wilson WH (2017). Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. Cancer Cell  31, 833-843.e5.   https://doi.org/10.1016/j.ccell.2017.04.012|14. Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, Said J, Jaffe ES (2017). EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1. Am J Clin Pathol  147, 129-152.   https://doi.org/10.1093/ajcp/aqw214|15. Sharma K, Janik JE, O'Mahony D, Stewart D, Pittaluga S, Stetler-Stevenson M, Jaffe ES, Raffeld M, Fleisher TA, Lee CC, Steinberg SM, Waldmann TA, Morris JC (2017). Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma. Clin Cancer Res  23, 35-42.   https://doi.org/10.1158/1078-0432.CCR-16-1022|16. Xie Y, Pittaluga S, Price S, Raffeld M, Hahn J, Jaffe ES, Rao VK, Maric I (2017). Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation. Haematologica  102, 364-372.   https://doi.org/10.3324/haematol.2015.138081",https://intramural.nih.gov/search/searchview.taf?ipid=103869
243,BC011078-11,"October 01, 2017 -  September 30, 2018",Phase 0-1 Clinical Trials,James Halpern Doroshow|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Agnes  Juhasz|Yves  Pommier; PhD|Anish  Thomas; MD,Edward  Newman (City of Hope Comprehensive Cancer Center)|Shivaani  Kummar (Stanford University School of Medicine),"Ralph  Parchment (Office of the Director)|Peter L Choyke; MD (Molecular Imaging Program)|Amy Kathleen Leblanc; DVM (Molecular Imaging Program)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)",NULL,"1. Balasubramanian P, Kinders RJ, Kummar S, Gupta V, Hasegawa D, Menachery A, Lawrence SM, Wang L, Ferry-Galow K, Davis D, Parchment RE, Tomaszewski JE, Doroshow JH (2017). Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® system. PLoS One  12, e0175414.   https://doi.org/10.1371/journal.pone.0175414|2. Cristofaro JV, Ansher SS, Zwiebel JA, Ivy P, Conley B, Abrams JS, Doroshow JH (2017). National Cancer Institute Formulary: A Public-Private Partnership Providing Investigators Access to Investigational Anticancer Agents. Clin Pharmacol Ther  101, 616-618.   https://doi.org/10.1002/cpt.585|3. Holbeck SL, Camalier R, Crowell JA, Govindharajulu JP, Hollingshead M, Anderson LW, Polley E, Rubinstein L, Srivastava A, Wilsker D, Collins JM, Doroshow JH (2017). The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity. Cancer Res  77, 3564-3576.   https://doi.org/10.1158/0008-5472.CAN-17-0489|4. Ji J, Zhang Y, Redon CE, Reinhold WC, Chen AP, Fogli LK, Holbeck SL, Parchment RE, Hollingshead M, Tomaszewski JE, Dudon Q, Pommier Y, Doroshow JH, Bonner WM (2017). Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay. PLoS One  12, e0171582.   https://doi.org/10.1371/journal.pone.0171582|5. Kummar S, O'Sullivan Coyne G, Do KT, Turkbey B, Meltzer PS, Polley E, Choyke PL, Meehan R, Vilimas R, Horneffer Y, Juwara L, Lih A, Choudhary A, Mitchell SA, Helman LJ, Doroshow JH, Chen AP (2017). Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). J Clin Oncol  35, 1561-1569.   https://doi.org/10.1200/JCO.2016.71.1994|6. Lih CJ, Harrington RD, Sims DJ, Harper KN, Bouk CH, Datta V, Yau J, Singh RR, Routbort MJ, Luthra R, Patel KP, Mantha GS, Krishnamurthy S, Ronski K, Walther Z, Finberg KE, Canosa S, Robinson H, Raymond A, Le LP, McShane LM, Polley EC, Conley BA, Doroshow JH, Iafrate AJ, et al. [3 more authors] (2017). Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial. J Mol Diagn  19, 313-327.   https://doi.org/10.1016/j.jmoldx.2016.10.007|7. O'Sullivan Coyne G, Chen AP, Meehan R, Doroshow JH (2017). PARP Inhibitors in Reproductive System Cancers: Current Use and Developments. Drugs  77, 113-130.   https://doi.org/10.1007/s40265-016-0688-7",https://intramural.nih.gov/search/searchview.taf?ipid=103806
244,BC011081-11,"October 01, 2017 -  September 30, 2018",Prostate Section,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",John Michael  Dibianco|Samuel Alexander Gold|Graham Robert Hale|Charlotte Sophronia Payne|Stephanie Daniela Knights Purnell|Nana  Yaqub-Ogun|Show all 9,Arul Moli Chinnaiyan|Mohummad Minhaj Siddiqui,Nida T Hussain (Office Of The Clinical Director)|Sherif  Mehralivand (Molecular Imaging Program)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology),Sheng  Xu (CC),"1. Cheng R, Roth HR, Lay N, Lu L, Turkbey B, Gandler W, McCreedy ES, Pohida T, Pinto PA, Choyke P, McAuliffe MJ, Summers RM (2017). Automatic magnetic resonance prostate segmentation by deep learning with holistically nested networks. J Med Imaging (Bellingham)  4, 041302.   https://doi.org/10.1117/1.JMI.4.4.041302|2. Sugano D, Sidana A, Calio B, Cobb K, Turkbey B, Pinto PA (2017). MRI-targeted biopsy: is systematic biopsy obsolete? Can J Urol  24, 8876-8882.",https://intramural.nih.gov/search/searchview.taf?ipid=103904
245,BC011090-11,"October 01, 2017 -  September 30, 2018",Molecular biology of human polyomaviruses,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Alberto  Peretti; PhD|Gabriel James Starrett; PhD|Michael Joseph Tisza|Nicole Lynne Welch,John  Doorbar (National Institute for Medical Research)|Thilo  Stehle (International Max Planck Research School)|Jianxin  You (U Penn)|Paola  Cinque (San Raffaele Milan)|Ellen  Cahir-McFarland (Biogen),NULL,Alison Anne McBride; PhD (NIAID) |Pawel J Muranski (NHLBI),"1. Cantalupo PG, Buck CB, Pipas JM (2017). Complete Genome Sequence of a Polyomavirus Recovered from a Pomona Leaf-Nosed Bat (Hipposideros pomona) Metagenome Data Set. Genome Announc  5.   https://doi.org/10.1128/genomeA.01053-16|2. Geoghegan EM, Pastrana DV, Schowalter RM, Ray U, Gao W, Ho M, Pauly GT, Sigano DM, Kaynor C, Cahir-McFarland E, Combaluzier B, Grimm J, Buck CB (2017). Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses. Cell Rep  21, 1169-1179.   https://doi.org/10.1016/j.celrep.2017.10.027|3. Geoghegan EM, Welch NL, Yabsley MJ, Church ME, Pesavento PA, Buck CB (2017). Identification of a Second Raccoon-Associated Polyomavirus. Genome Announc  5.   https://doi.org/10.1128/genomeA.00548-17|4. Gupta G, Kuppachi S, Kalil RS, Buck CB, Lynch CF, Engels EA (2018). Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States. Am J Transplant  18, 245-252.   https://doi.org/10.1111/ajt.14530|5. Nguyen KD, Lee EE, Yue Y, Stork J, Pock L, North JP, Vandergriff T, Cockerell C, Hosler GA, Pastrana DV, Buck CB, Wang RC (2017). Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses. J Am Acad Dermatol  76, 932-940.e3.   https://doi.org/10.1016/j.jaad.2016.11.035|6. Peretti A, Geoghegan EM, Pastrana DV, Smola S, Feld P, Sauter M, Lohse S, Ramesh M, Lim ES, Wang D, Borgogna C, FitzGerald PC, Bliskovsky V, Starrett GJ, Law EK, Harris RS, Killian JK, Zhu J, Pineda M, Meltzer PS, Boldorini R, Gariglio M, Buck CB (2018). Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution. Cell Host Microbe  23, 628-635.e7.   https://doi.org/10.1016/j.chom.2018.04.005",https://intramural.nih.gov/search/searchview.taf?ipid=103799
246,BC011091-11,"October 01, 2017 -  September 30, 2018",Cancer Genomics Technology Development,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","Sean Richard Davis; MD, PhD|John E Lueders|Marbin A Pineda|Robert L Walker; BS|Fan  Yang|Yuelin  Zhu|Show all 11",Albert  Fornace Jr (Georgetown University)|Jerry  Shay (UT Southwestern),"Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Sharon Ann Savage (Clinical Genetics Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|James Halpern Doroshow (Developmental Therapeutics Branch)|Sheueyann  Cheng; PhD (Gene Regulation Section)|Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)",Leslie Glenn Biesecker; MD (NHGRI),"1. Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, TIGER-LC Consortium, et al. [12 more authors] (2017). Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell  32, 57-70.e3.   https://doi.org/10.1016/j.ccell.2017.05.009|2. Goldberg L, Gough SM, Lee F, Dang C, Walker RL, Zhu YJ, Bilke S, Pineda M, Onozawa M, Jo Chung Y, Meltzer PS, Aplan PD (2017). Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance. Genes Chromosomes Cancer  56, 472-483.   https://doi.org/10.1002/gcc.22451|3. Kraft IL, Akshintala S, Zhu Y, Lei H, Derse-Anthony C, Dombi E, Steinberg SM, Lodish M, Waguespack SG, Kapustina O, Fox E, Balis FM, Merino MJ, Meltzer PS, Glod JW, Shern JF, Widemann BC (2018). Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib. Clin Cancer Res  24, 753-765.   https://doi.org/10.1158/1078-0432.CCR-17-2101|4. Oltmann J, Heselmeyer-Haddad K, Hernandez LS, Meyer R, Torres I, Hu Y, Doberstein N, Killian JK, Petersen D, Zhu YJ, Edelman DC, Meltzer PS, Schwartz R, Gertz EM, Schäffer AA, Auer G, Habermann JK, Ried T (2018). Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients. Genes Chromosomes Cancer  57, 165-175.   https://doi.org/10.1002/gcc.22515|5. Rozenblum E, Sotelo-Silveira JR, Kim GY, Zhu JY, Lau CC, McNeil N, Korolevich S, Liao H, Cherry JM, Munroe DJ, Ried T, Meltzer PS, Kuehl WM, Roschke AV (2017). Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor. PLoS One  12, e0182610.   https://doi.org/10.1371/journal.pone.0182610|6. Shukla V, Rao M, Zhang H, Beers J, Wangsa D, Wangsa D, Buishand FO, Wang Y, Yu Z, Stevenson H, Reardon E, McLoughlin KC, Kaufman A, Payabyab E, Hong JA, Zhang M, Davis SR, Edelman DC, Chen G, Miettinen M, Restifo N, Ried T, Meltzer PS, Schrump DS (2018). Identification of Novel Targets for Lung Cancer Therapy Using an Induced Pluripotent Stem Cell Model. Ann Am Thorac Soc  15, S127-S128.   https://doi.org/10.1513/AnnalsATS.201707-610MG|7. Shukla V, Rao M, Zhang H, Beers J, Wangsa D, Wangsa D, Buishand FO, Wang Y, Yu Z, Stevenson HS, Reardon ES, McLoughlin KC, Kaufman AS, Payabyab EC, Hong JA, Zhang M, Davis S, Edelman D, Chen G, Miettinen MM, Restifo NP, Ried T, Meltzer PA, Schrump DS (2017). ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer. Cancer Res  77, 6267-6281.   https://doi.org/10.1158/0008-5472.CAN-17-0570|8. Sourbier C, Liao PJ, Ricketts CJ, Wei D, Yang Y, Baranes SM, Gibbs BK, Ohanjanian L, Spencer Krane L, Scroggins BT, Keith Killian J, Wei MH, Kijima T, Meltzer PS, Citrin DE, Neckers L, Vocke CD, Marston Linehan W (2018). Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers. Oncotarget  9, 10723-10733.   https://doi.org/10.18632/oncotarget.24112",https://intramural.nih.gov/search/searchview.taf?ipid=103891
247,BC011095-11,"October 01, 2017 -  September 30, 2018",Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Molly Marie Lee|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD","Brian M Shuch|Jean-Baptiste  Lattouf|Paul  Dent (Virginia Commonwealth University)|Ching-Shih  Chen (The Ohio State University)|Irmgard  Irminger (Clinical Development, University Hospitals Geneva HUG)","Tawnya Carlene McKee; BA, PhD (Diagnostic Biomarkers and Technology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103797
248,BC011106-11,"October 01, 2017 -  September 30, 2018",Specification of T cell function during development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD,"Batu M Erman|Wilfried  Ellmeier (Immunology, University of Vienna)|Sophia D Sarafova (NCI)",Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Tejas Bharat Kadakia (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section),"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103842
249,BC011107-11,"October 01, 2017 -  September 30, 2018",Role of Protein Scaffolds in RTK-Ras-dependent Signal Transduction,Deborah K Morrison|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Daniel A Ritt|Elizabeth Mclean Terrell|Christopher John Westlake; PhD,NULL,Konstadinos  Moissoglu (Laboratory of Cellular and Molecular Biology)|Peter F Johnson; PhD (Mouse Cancer Genetics Program),NULL,"1. Sandí MJ, Marshall CB, Balan M, Coyaud É, Zhou M, Monson DM, Ishiyama N, Chandrakumar AA, La Rose J, Couzens AL, Gingras AC, Raught B, Xu W, Ikura M, Morrison DK, Rottapel R (2017). MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity. Sci Signal  10.   https://doi.org/10.1126/scisignal.aan3286",https://intramural.nih.gov/search/searchview.taf?ipid=103898
250,BC011109-11,"October 01, 2017 -  September 30, 2018",Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Debananda  Das; PhD,Arun  Ghosh|Kenji  Maeda (National Center For Global Health And Medicine),NULL,NULL,"1. Ghosh AK, Sarkar A, Mitsuya H (2017). HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment. Med Res Arch  5.",https://intramural.nih.gov/search/searchview.taf?ipid=103895
251,BC011111-11,"October 01, 2017 -  September 30, 2018",Cytokine signaling in developing thymocytes and T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD|Jung-Hyun  Park,NULL,Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Tejas Bharat Kadakia (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section),NULL,"1. Etzensperger R, Kadakia T, Tai X, Alag A, Guinter TI, Egawa T, Erman B, Singer A (2017). Identification of lineage-specifying cytokines that signal all CD8+-cytotoxic-lineage-fate 'decisions' in the thymus. Nat Immunol  18, 1218-1227.   https://doi.org/10.1038/ni.3847|2. Gegonne A, Chen QR, Dey A, Etzensperger R, Tai X, Singer A, Meerzaman D, Ozato K, Singer DS (2018). Immature CD8 Single-Positive Thymocytes Are a Molecularly Distinct Subpopulation, Selectively Dependent on BRD4 for Their Differentiation. Cell Rep  24, 117-129.   https://doi.org/10.1016/j.celrep.2018.06.007|3. Madi A, Poran A, Shifrut E, Reich-Zeliger S, Greenstein E, Zaretsky I, Arnon T, Laethem FV, Singer A, Lu J, Sun PD, Cohen IR, Friedman N (2017). T cell receptor repertoires of mice and humans are clustered in similarity networks around conserved public CDR3 sequences. Elife  6.   https://doi.org/10.7554/eLife.22057",https://intramural.nih.gov/search/searchview.taf?ipid=103843
252,BC011112-11,"October 01, 2017 -  September 30, 2018",Development and function of regulatory T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD|Dinah  Singer; PhD,NULL,Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Tejas Bharat Kadakia (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103839
253,BC011113-11,"October 01, 2017 -  September 30, 2018",T cell survival,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD|Jung-Hyun  Park,NULL,Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section)|Xuguang C Tai (Lymphocyte Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103840
254,BC011114-11,"October 01, 2017 -  September 30, 2018",Role of microRNAs in T cell development,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD,NULL,Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Tejas Bharat Kadakia (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section),"Paul E Love; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103841
255,BC011115-11,"October 01, 2017 -  September 30, 2018",Epigenetic Mechanisms of Gene Expression in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Vivek  Shukla; BSc, MSc|Sichuan  Xi|Mary R Zhang","Xinmin  Li (Functional Genomics, University of Chicago)|Raphael  Bueno (Brigham and Women's Hosp)|David  Beer (Thoracic Surgery, University of Michigan)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)",NULL,"1. Song NY, Zhu F, Wang Z, Willette-Brown J, Xi S, Sun Z, Su L, Wu X, Ma B, Nussinov R, Xia X, Schrump DS, Johnson PF, Karin M, Hu Y (2018). IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways. Proc Natl Acad Sci U S A  115, E812-E821.   https://doi.org/10.1073/pnas.1717520115|2. Taylor Ripley R, Surman DR, Diggs LP, Trepel JB, Lee MJ, Ryan J, Davis JL, Steinberg SM, Hernandez JM, Hoang C, Kenney CM, Bond CD, Kunst TF, Letai A, Schrump DS (2018). Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy. BMC Gastroenterol  18, 94.   https://doi.org/10.1186/s12876-018-0823-x|3. Xu Y, Feingold PL, Surman DR, Brown K, Xi S, Davis JL, Hernandez J, Schrump DS, Ripley RT (2017). Bile acid and cigarette smoke enhance the aggressive phenotype of esophageal adenocarcinoma cells by downregulation of the mitochondrial uncoupling protein-2. Oncotarget  8, 101057-101071.   https://doi.org/10.18632/oncotarget.22380",https://intramural.nih.gov/search/searchview.taf?ipid=103833
256,BC011116-11,"October 01, 2017 -  September 30, 2018",MHC-independent T cells,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD|Jung-Hyun  Park,Batu M Erman|Gunter  Bernhardt (Hannover Medical School),Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Tejas Bharat Kadakia (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103837
257,BC011117-11,"October 01, 2017 -  September 30, 2018",T cell receptor regulation of cytokine signaling,Alfred  Singer; MD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Abhisek  Bhattacharya; PhD|Alyssa Christina Indart|Marco Filipe  Marques Craveiro; PhD|Francois  Van Laethem|Zhongmei  Zhang; PhD,NULL,Amala Shenai Alag (Lymphocyte Development Section)|Mohamedelsherif G Gadelhaq Badr (Lymphocyte Development Section)|Ruth  Etzensperger; PhD (Lymphocyte Development Section)|Terry I Guinter (Lymphocyte Development Section)|Tejas Bharat Kadakia (Lymphocyte Development Section)|Miho  Shinzawa (Lymphocyte Development Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103838
258,BC011118-11,"October 01, 2017 -  September 30, 2018",Role of Shh in developmental patterning and growth of digit skeleton,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Anna Marie Trofka|Jianjian  Zhu,"Steve  Vokes (U. Texas, Austin)|Brian  Harfe; PhD (Molecular Genetics and Microbiology, University of Florida)",Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Mackem S (2018). From fin to limb and back again:  New insights on the evolution of limb development in the age of functional genomics. Genesis  56, 1-2.|2. Zhu J, Mackem S (2017). John Saunders' ZPA, Sonic hedgehog and digit identity - How does it really all work? Dev Biol  429, 391-400.   https://doi.org/10.1016/j.ydbio.2017.02.001",https://intramural.nih.gov/search/searchview.taf?ipid=103888
259,BC011119-11,"October 01, 2017 -  September 30, 2018",Hoxd and Gli3-Hoxd interaction roles in Hedgehog regulated digit morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka|Jianjian  Zhu,"John  Rasweiler (SUNY Downstate)|Makoto  Taketo (Orthopedics, Kyoto University)|Steve  Vokes (U. Texas, Austin)|Maurizio  Pacifici (Univ. Pennsylvania School of Medicine)|Marian  Ros; PhD (Universidad de Cantabria)|H  Stadler (Shriner's Hospital For Children, Oregon Health & Science University)","Mark B Lewandoski (Genetics of Vertebrate Development Section)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","Richa  Agarwala; BTech, MS, PhD (NLM)","1. Mackem S (2018). From fin to limb and back again:  New insights on the evolution of limb development in the age of functional genomics. Genesis  56, 1-2.",https://intramural.nih.gov/search/searchview.taf?ipid=103889
260,BC011120-11,"October 01, 2017 -  September 30, 2018",Genome-wide target analysis of Shh-activated transcription network in limb bud,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang|Anna Marie Trofka|Jianjian  Zhu,"Steve  Vokes (U. Texas, Austin)|John  Rasweiler (SUNY Downstate)|Marian  Ros; PhD (Universidad de Cantabria)|H  Stadler (Shriner's Hospital For Children, Oregon Health & Science University)","Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","Richa  Agarwala; BTech, MS, PhD (NLM)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103886
261,BC011121-11,"October 01, 2017 -  September 30, 2018",Role of Brachyury in regulating notochord development and neoplasia,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Jianjian  Zhu,NULL,Terence P Yamaguchi; PhD (Cell Signaling in Vertebrate Development Section)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103887
262,BC011124-11,"October 01, 2017 -  September 30, 2018",Oncogenic Met Signaling in Urologic Malignancies,Donald P Bottaro; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI","Dinuka Mihirani de Silva; PhD|Molly Marie Lee|Arpita Avijit Roy; PhD|Cathy  Vocke; PhD|Ramaprasad  Srinivasan; MD, PhD|Leonard  Neckers; PhD|Show all 8","Angela  Coxon (Amgen)|Regina  Day (NCI)|Irmgard  Irminger (Clinical Development, University Hospitals Geneva HUG)|Anne-Marie  Martin (GlaxoSmithKline)|Freidmann  Muller (Curacyte AG)|Andreas  van de Locht (Department of Pathology, Curacyte AG)|Show all 15","Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Melinda  Hollingshead (Biological Testing Branch)|Gary Leonard Griffiths; BSc, PhD (Molecular Imaging Program)|Ralph  Parchment (Office of the Director)",Rolf Eric Swenson; PhD (NHLBI),"1. De Silva D, Roy A, Kato T, Bottaro D (2018) Met Signaling in Carcinogenesis, in Predictive Biomarkers in Oncology: Applications in Precision Medicine, in press.|2. De Silva DM, Roy A, Kato T, Cecchi F, Lee YH, Matsumoto K, Bottaro DP (2017). Targeting the hepatocyte growth factor/Met pathway in cancer. Biochem Soc Trans  45, 855-870.   https://doi.org/10.1042/BST20160132|3. Matsumoto K, Umitsu M, De Silva DM, Roy A, Bottaro DP (2017). Hepatocyte growth factor/MET in cancer progression and biomarker discovery. Cancer Sci  108, 296-307.   https://doi.org/10.1111/cas.13156|4. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwiatkowski DJ, Lui W, Merino MJ, Mills GB, Cancer Genome Atlas Research Network, et al. [20 more authors] (2018). The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep  23, 313-326.e5.   https://doi.org/10.1016/j.celrep.2018.03.075|5. Srivastava AK, Navas T, Herrick WG, Hollingshead MG, Bottaro DP, Doroshow JH, Parchment RE (2017). Effective implementation of novel MET pharmacodynamic assays in translational studies. Ann Transl Med  5, 3.   https://doi.org/10.21037/atm.2016.12.78|6. Yau TCC, Lencioni R, Sukeepaisarnjaroen W, Chao Y, Yen CJ, Lausoontornsiri W, Chen PJ, Sanpajit T, Camp A, Cox DS, Gagnon RC, Liu Y, Raffensperger KE, Kulkarni DA, Kallender H, Ottesen LH, Poon RTP, Bottaro DP (2017). A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. Clin Cancer Res  23, 2405-2413.   https://doi.org/10.1158/1078-0432.CCR-16-1789",https://intramural.nih.gov/search/searchview.taf?ipid=103798
263,BC011126-11,"October 01, 2017 -  September 30, 2018",Preventive Vaccines for HIV,Genoveffa  Franchini; MD|IRP Faculty Profile,NULL,"Vaccine Branch, NCI",Massimiliano  Bissa; MBA|Melvin Nelson Doster|Veronica  Galli|Ramona  Moles|Luca  Schifanella|Isabela  Silva De Castro|Show all 9,"Donald  Forthal (School of Medicine, Univ of CA)|Chris  Miller; MS|Christophe  Nicot (-, University of Kansas Medical Center)|Guido  Ferrari (Duke University)|Rafick  Sekaly; PhD (Vaccine & Gene Therapy Institute)|Elias  Haddad (VGTI-Florida)|Show all 18",Brandon Frank Keele (Office Of The Director),James D Stamos (OD) |Nancy R Miller (NIAID) |Steven J Jacobson; PhD (NINDS) |Mario  Roederer; PhD (NIAID) |Richard A Koup; MD (NIAID) |James  Arthos; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103814
264,BC011131-11,"October 01, 2017 -  September 30, 2018",Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Domarin  Khago|Jess R Li|Olivier Francois Andre  Soubias; PhD,NULL,Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling),NULL,"1. Chakrabarti KS, Li J, Das R, Byrd RA (2017). Conformational Dynamics and Allostery in E2:E3 Interactions Drive Ubiquitination: gp78 and Ube2g2. Structure  25, 794-805.e5.   https://doi.org/10.1016/j.str.2017.03.016",https://intramural.nih.gov/search/searchview.taf?ipid=103801
265,BC011132-11,"October 01, 2017 -  September 30, 2018",Methods Development,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Fa-An  Chao|Jess R Li|Olivier Francois Andre  Soubias; PhD|Yue  Zhang,NULL,NULL,Nico  Tjandra; PhD (NHLBI),"1. Byrd R, Chao F (2018). Protein dynamics revealed by NMR relaxation methods. Emerging Topics in Life Sciences  2, 93-105.|2. Chao FA, Byrd RA (2017). Application of geometric approximation to the CPMG experiment: Two- and three-site exchange. J Magn Reson  277, 8-14.   https://doi.org/10.1016/j.jmr.2017.01.022",https://intramural.nih.gov/search/searchview.taf?ipid=103800
266,BC011150-10,"October 01, 2017 -  September 30, 2018",Chronic Inflammation and Carcinogenesis,Scott K Durum; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Caroline Elizabeth Salter|Julie  Hixon|Wenqing  Li|Emilee Rose Senkevitch|Howard A Young; PhD,NULL,NULL,Sandip  Datta (NIAID),"1. Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmelé T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS (2018). Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight  3.   https://doi.org/10.1172/jci.insight.98960|2. McLean MH, Andrews C, Hanson ML, Baseler WA, Anver MR, Senkevitch E, Staniszewska AK, Smith C, Davies LC, Hixon J, Li W, Shen W, Steidler L, Durum SK (2017). Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses. Inflamm Bowel Dis  23, 1983-1995.   https://doi.org/10.1097/MIB.0000000000001274|3. Plank MW, Kaiko GE, Maltby S, Weaver J, Tay HL, Shen W, Wilson MS, Durum SK, Foster PS (2017). Th22 Cells Form a Distinct Th Lineage from Th17 Cells In Vitro with Unique Transcriptional Properties and Tbet-Dependent Th1 Plasticity. J Immunol  198, 2182-2190.   https://doi.org/10.4049/jimmunol.1601480|4. Senkevitch E, Li W, Hixon JA, Andrews C, Cramer SD, Pauly GT, Back T, Czarra K, Durum SK (2018). Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations. Oncotarget  9, 22605-22617.   https://doi.org/10.18632/oncotarget.25194|5. Shen W, Li W, Hixon JA, Andrews C, Durum SK (2017). Visualization of IL-22-expressing Lymphocytes Using Reporter Mice. J Vis Exp  .  https://doi.org/10.3791/54710|6. Yoshimura T, McLean MH, Dzutsev AK, Yao X, Chen K, Huang J, Gong W, Zhou J, Xiang Y, H Badger J, O'hUigin C, Thovarai V, Tessarollo L, Durum SK, Trinchieri G, Bian XW, Wang JM (2018). The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance. J Immunol  200, 2174-2185.   https://doi.org/10.4049/jimmunol.1602073",https://intramural.nih.gov/search/searchview.taf?ipid=103918
267,BC011152-10,"October 01, 2017 -  September 30, 2018",Regulation of human dendritic cell activation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sharon A Bargo|Amiran  Dzutsev; PhD|Carolyne Kelly Smith|Rodrigo  Xavier Das Neves,NULL,NULL,NULL,"1. Dutzan N, Abusleme L, Bridgeman H, Greenwell-Wild T, Zangerle-Murray T, Fife ME, Bouladoux N, Linley H, Brenchley L, Wemyss K, Calderon G, Hong BY, Break TJ, Bowdish DME, Lionakis MS, Jones SA, Trinchieri G, Diaz PI, Belkaid Y, Konkel JE, Moutsopoulos NM (2017). On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier. Immunity  46, 133-147.   https://doi.org/10.1016/j.immuni.2016.12.010|2. Namasivayam S, Maiga M, Yuan W, Thovarai V, Costa DL, Mittereder LR, Wipperman MF, Glickman MS, Dzutsev A, Trinchieri G, Sher A (2017). Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome  5, 71.   https://doi.org/10.1186/s40168-017-0286-2",https://intramural.nih.gov/search/searchview.taf?ipid=103942
268,BC011153-10,"October 01, 2017 -  September 30, 2018",Role of mouse microbiome in cancer and inflammation,Giorgio  Trinchieri|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sharon A Bargo|Ren Ming  Dai|Amiran  Dzutsev; PhD|John Anthony McCulloch; PhD|Soumen  Roy; PhD|Rosalba  Salcedo|Show all 9,"Sergei A. Nedospasov; PhD, DSc|Marilia  Seelaender (University of Sao Paulo)|Sergey  Grivennikov (Fox Chase Cancer Center)",Li  Yang; PhD (Laboratory of Cancer Biology and Genetics)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis),"Stephanie Mullis Prescott; MSN, NNP-BC, RN, NRP (NINR) |Yasmine  Belkaid; PhD (NIAID) |Karen Moore Frank; MD, PhD (CC) |Heidi H Kong (NIAMS)","1. Linehan JL, Harrison OJ, Han SJ, Byrd AL, Vujkovic-Cvijin I, Villarino AV, Sen SK, Shaik J, Smelkinson M, Tamoutounour S, Collins N, Bouladoux N, Dzutsev A, Rosshart SP, Arbuckle JH, Wang CR, Kristie TM, Rehermann B, Trinchieri G, Brenchley JM, O'Shea JJ, Belkaid Y (2018). Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell  172, 784-796.e18.   https://doi.org/10.1016/j.cell.2017.12.033|2. Rosshart SP, Vassallo BG, Angeletti D, Hutchinson DS, Morgan AP, Takeda K, Hickman HD, McCulloch JA, Badger JH, Ajami NJ, Trinchieri G, Pardo-Manuel de Villena F, Yewdell JW, Rehermann B (2017). Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance. Cell  171, 1015-1028.e13.   https://doi.org/10.1016/j.cell.2017.09.016|3. Roy S, Trinchieri G (2017). Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer  17, 271-285.   https://doi.org/10.1038/nrc.2017.13|4. Sui Y, Dzutsev A, Venzon D, Frey B, Thovarai V, Trinchieri G, Berzofsky JA (2018). Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques. Mucosal Immunol  11, 1219-1229.   https://doi.org/10.1038/s41385-018-0029-0",https://intramural.nih.gov/search/searchview.taf?ipid=103941
269,BC011154-10,"October 01, 2017 -  September 30, 2018",Biological Functions of Chromosomal Proteins,Michael  Bustin; PhD|IRP Faculty Profile,NULL,"Protein Section, NCI",Ravikanth  Nanduri; PhD|Shaofei  Zhang,NULL,"Takashi  Furusawa (Laboratory of Metabolism)|Yuri  Postnikov; MD, PhD (Laboratory of Metabolism)|Joost J Oppenheim; MD (Cancer Inflammation Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103911
270,BC011158-10,"October 01, 2017 -  September 30, 2018",The roles of p53 in embryonic stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shunlin  Jiang|Hualong  Yan|Navdeep  Malik,NULL,NULL,Chengyu  Liu; PhD (NHLBI),"1. Yan H, Shi YB, Huang J (2017). iPSCs are safe! Cell Biosci  7, 30.   https://doi.org/10.1186/s13578-017-0157-3",https://intramural.nih.gov/search/searchview.taf?ipid=103925
271,BC011162-10,"October 01, 2017 -  September 30, 2018",Integrative Molecular Profiling of Human Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Limin  Wang; PhD|Shouhui  Yang; PhD,"Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Frank  Bergmann (University of Heidelberg)|Katsuhiko  Yanaga (Jikei University School of Medicine)|Michael  Ghadimi (Surgery, U. of Goettingen)|H Richard  Alexander (University of Maryland Medical System)|Show all 7",Peijun  He (Laboratory of Human Carcinogenesis)|David Anderson Wink (Cancer Inflammation Program)|Karl Thomas Ried; MD (Cancer Genetics Branch),NULL,"1. Wang J, Hussain SP (2017). NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential. Antioxid Redox Signal  26, 1000-1008.   https://doi.org/10.1089/ars.2016.6809",https://intramural.nih.gov/search/searchview.taf?ipid=103926
272,BC011163-10,"October 01, 2017 -  September 30, 2018",Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Mary  Hollander|Hiroki  Ishii|Alisa  Malyavko|Zhiguang  Xiao,NULL,Giorgio  Trinchieri (Cancer Inflammation Program)|Pengnian Charles Lin; PhD (Cancer Inflammation Program)|Ashish Kumar Lal (Cancer Genetics Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch),Lawrence L Latour; PhD (NINDS) |Manfred  Boehm; MD (NHLBI),"1. Hollander C, Latour L, Yang D, Ishii H, Xiao Z, Min Y, RayChoudhury A, Munasinghe J, Merchant A, Lin P, Hallenbeck J, Boehm M, Yang L (2017). Attenuation of myeloid TGF signaling induces inflammatory cerebrovascular disease and stroke. Circulation Research  121, 1360.|2. Ishii H, Vodnala S, Achyut B, Hollander C, Lal A, Yang L (2018) MicroRNA 130a and 145 mediated reprogramming of Gr1+ CD11b+ myeloid cells in cancer metastasis. Nature Communications, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103944
273,BC011165-10,"October 01, 2017 -  September 30, 2018",Role of inflammation in epigenetic alterations of metastatic cancer cells,Li  Yang; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Woo Yong  Park|Jae Young  So|Xiang  Wang|Sara  Zahraeifard|Maxwell P Lee; PhD,NULL,NULL,Keji  Zhao; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103945
274,BC011167-10,"October 01, 2017 -  September 30, 2018",Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response,Glenn  Merlino; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chi-Ping  Day|Helen Thompson Michael|Eva Eugenia Perez Guijarro|Antonella  Sassano,"Thomas  Tuting (Dermatology, University of Bonn)|Marcus  Bosenberg (Yale University)|Keith  Flaherty (Harvard Medical School)|Jennifer A Wargo|Jedd  Wolchok (Memorial Sloan Kettering)",Melinda  Hollingshead (Biological Testing Branch)|Dominic  Esposito; PhD (Office Of The Director)|Nicholas Phillip Restifo; MD (Surgery Branch)|Norman Edward Sharpless; MD (Office Of The Director),NULL,"1. Day CP, Marchalik R, Merlino G, Michael H (2017). Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance. Lab Invest  97, 698-705.   https://doi.org/10.1038/labinvest.2016.155|2. Hernandez B, Adissu HA, Wei BR, Michael HT, Merlino G, Simpson RM (2018). Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas. Int J Mol Sci  19.   https://doi.org/10.3390/ijms19020394|3. Pérez-Guijarro E, Day CP, Merlino G, Zaidi MR (2017). Genetically engineered mouse models of melanoma. Cancer  123, 2089-2103.   https://doi.org/10.1002/cncr.30684|4. Pérez-Guijarro E, Merlino G (2017). Lymphangiogenesis: From passive disseminator to dynamic metastatic enabler. Pigment Cell Melanoma Res  30, 509-510.   https://doi.org/10.1111/pcmr.12621|5. Patel SJ, Sanjana NE, Kishton RJ, Eidizadeh A, Vodnala SK, Cam M, Gartner JJ, Jia L, Steinberg SM, Yamamoto TN, Merchant AS, Mehta GU, Chichura A, Shalem O, Tran E, Eil R, Sukumar M, Guijarro EP, Day CP, Robbins P, Feldman S, Merlino G, Zhang F, Restifo NP (2017). Identification of essential genes for cancer immunotherapy. Nature  548, 537-542.   https://doi.org/10.1038/nature23477|6. Tarasen A, Carlson JA, Leonard MK, Merlino G, Kaetzel D, Slominski AT (2017). Pigmented Epithelioid Melanocytoma (PEM)/Animal Type Melanoma (ATM): Quest for an Origin. Report of One Unusual Case Indicating Follicular Origin and Another Arising in an Intradermal Nevus. Int J Mol Sci  18.   https://doi.org/10.3390/ijms18081769",https://intramural.nih.gov/search/searchview.taf?ipid=103930
275,BC011168-10,"October 01, 2017 -  September 30, 2018",Physiological and pathological functions of E3 ubiquitin ligases Smurfs,Ying  Zhang|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Christina  Stuelten|Yi  Tang|Xuan  Xu,NULL,Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Lisa Marie Jenkins (Pigment Cell Biology Section)|Kunio  Nagashima (Office of the Director)|Ming  Zhou (Nucleic Acids Section),Chengyu  Liu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103946
276,BC011176-10,"October 01, 2017 -  September 30, 2018",Functions of KSHV microRNAs,Joseph M Ziegelbauer|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",Insun  Kook|Anna  Serquina|Tagawa  Takanobu|Thomas S Uldrick,NULL,"Sean Richard Davis; MD, PhD (Cancer Genetics Branch)","John Lawrence Spouge; MD, PhD (NLM)","1. Liu X, Happel C, Ziegelbauer JM (2017). Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis. J Virol  91.   https://doi.org/10.1128/JVI.02045-16|2. Ramalingam D, Ziegelbauer JM (2017). Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses. Sci Rep  7, 40813.   https://doi.org/10.1038/srep40813|3. Serquiña AKP, Kambach DM, Sarker O, Ziegelbauer JM (2017). Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. MBio  8.   https://doi.org/10.1128/mBio.00576-17",https://intramural.nih.gov/search/searchview.taf?ipid=103947
277,BC011181-10,"October 01, 2017 -  September 30, 2018",Functional Analysis of Human Breast Cancer Susceptibility Gene Variants,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)|Edwin  Iversen (Duke University)|Stefan  Meyer (Manchester Academic Health Science Centre, University Of Manchester)",NULL,NULL,"1. Meyer S, Stevens A, Paredes R, Schneider M, Walker MJ, Williamson AJK, Gonzalez-Sanchez MB, Smetsers S, Dalal V, Teng HY, White DJ, Taylor S, Muter J, Pierce A, de Leonibus C, Rockx DAP, Rooimans MA, Spooncer E, Stauffer S, Biswas K, Godthelp B, Dorsman J, Clayton PE, Sharan SK, Whetton AD (2017). Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption. Cell Death Dis  8, e2875.   https://doi.org/10.1038/cddis.2017.264",https://intramural.nih.gov/search/searchview.taf?ipid=103937
278,BC011185-10,"October 01, 2017 -  September 30, 2018",Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer,Syed Perwez  Hussain|IRP Faculty Profile,NULL,"Molecular Genetics and Carcinogenesis Section, NCI",Limin  Wang; PhD|Shouhui  Yang; PhD,Jochen  Gaedcke|Carlo  Croce (Ohio State University Cancer Center)|Richard  Bucala (Yale University)|Fleming  Jason (MD Anderson Cancer Center)|Diane  Simeone (University of Michigan),Peijun  He (Laboratory of Human Carcinogenesis)|David Anderson Wink (Cancer Inflammation Program)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Christine Campo Alewine (Laboratory of Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103927
279,BC011187-10,"October 01, 2017 -  September 30, 2018",Sphingolipid Signaling in Mammals,"Jairaj K Acharya; MBBS, PhD|IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",Varna  Kishore|Sagar Singh Matharu|Dru Gabriel Myerscough|Mekhala Shankar Rao|Nisarg Nirmal Shah|Parthibane  Velayoudame,NULL,Sarangan  Ravichandran (Office Of The Director)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Lino  Tessarollo (Mouse Cancer Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103908
280,BC011190-10,"October 01, 2017 -  September 30, 2018",Chemical Biology of Nitroxyl (HNO),David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Debashree  Basudhar|Gaurav  Bharadwaj|Yuk Sing Robert Cheng|Mayumi  Fujita; PhD|Luiz Gonzaga De Franca Lopes|Jae Hong  No; PhD|Show all 9,"Bruce  King (Department of Chemistry, Wake Forest University)|Jon  Fukuto (UCLA)|Nazerano  Paolocci (Department of Cardiology, Johns Hopkins University Medical School)",Joseph  Saavedra (Office Of The Director)|Murali  Krishna; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103943
281,BC011191-10,"October 01, 2017 -  September 30, 2018",Preclinical Mouse Models of Thyroid Cancer,Sheueyann  Cheng; PhD|IRP Faculty Profile,NULL,"Gene Regulation Section, NCI",Keisuke  Enomoto|Sunmi  Park|Li  Zhao|Xuguang  Zhu,John  Copland (Mayo Clinic College of Medicine)|Jun  Qi (Harvard Medical School),"Erik Kristian Holmsen (Biochemical Genetics Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",Minkyung  Kang (NEI),"1. Enomoto K, Zhu X, Park S, Zhao L, Zhu YJ, Willingham MC, Qi J, Copland JA, Meltzer P, Cheng SY (2017). Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer. J Clin Endocrinol Metab  102, 2268-2280.   https://doi.org/10.1210/jc.2016-3771|2. Park JW, Zhao L, Willingham MC, Cheng SY (2017). Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model. Am J Cancer Res  7, 727-739.|3. Zhu X, Cheng SY (2017). Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer. Endocrinol Metab (Seoul)  32, 326-331.   https://doi.org/10.3803/EnM.2017.32.3.326|4. Zhu X, Enomoto K, Zhao L, Zhu YJ, Willingham MC, Meltzer P, Qi J, Cheng SY (2017). Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model. Clin Cancer Res  23, 430-440.   https://doi.org/10.1158/1078-0432.CCR-16-0914",https://intramural.nih.gov/search/searchview.taf?ipid=103912
282,BC011197-10,"October 01, 2017 -  September 30, 2018",Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,Ettore  Appella; MD|IRP Faculty Profile,NULL,"Chemical Immunology Section, NCI",Aamir  Akbarali|Subrata  Debnath; PhD|Sharlyn  Mazur; PhD|Harichandra Dnyaneshwar Tagad; PhD,Oleg  Demidov|Barbara  Stecca (Istituto Toscano Tumori Azienda),Stewart  Durell (Laboratory of Cell Biology)|Lisa Marie Jenkins (Pigment Cell Biology Section),Daniel  Appella; PhD (NIDDK) |Frederick P Dyda; PhD (NIDDK),"1. Alam MS, Gaida MM, Debnath S, Tagad HD, Miller Jenkins LM, Appella E, Rahman MJ, Ashwell JD (2018). Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation. PLoS Biol  16, e2004111.   https://doi.org/10.1371/journal.pbio.2004111|2. Debnath S, Kosek D, Tagad HD, Durell SR, Appella DH, Acevedo R, Grishaev A, Dyda F, Appella E, Mazur SJ (2018). A trapped human PPM1A-phosphopeptide complex reveals structural features critical for regulation of PPM protein phosphatase activity. J Biol Chem  293, 7993-8008.   https://doi.org/10.1074/jbc.RA117.001213|3. Giardino Torchia ML, Dutta D, Mittelstadt PR, Guha J, Gaida MM, Fish K, Barr VA, Akpan IO, Samelson LE, Tagad HD, Debnath S, Miller Jenkins LM, Appella E, Ashwell JD (2018). Intensity and duration of TCR signaling is limited by p38 phosphorylation of ZAP-70T293 and destabilization of the signalosome. Proc Natl Acad Sci U S A  115, 2174-2179.   https://doi.org/10.1073/pnas.1713301115",https://intramural.nih.gov/search/searchview.taf?ipid=103909
283,BC011202-10,"October 01, 2017 -  September 30, 2018",Mechanism of transcription-coupled DNA repair and transcription mutagenesis,Mikhail V Kashlev|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI",Lucyna E Lubkowska,Michelle  Wang (Cornell University)|Paul  Doetsch (Emory University),Yun Xing M Wang (Structural Biophysics Laboratory),NULL,"1. Bubunenko MG, Court CB, Rattray AJ, Gotte DR, Kireeva ML, Irizarry-Caro JA, Li X, Jin DJ, Court DL, Strathern JN, Kashlev M (2017). A Cre Transcription Fidelity Reporter Identifies GreA as a Major RNA Proofreading Factor in Escherichia coli. Genetics  206, 179-187.   https://doi.org/10.1534/genetics.116.198960|2. Herrera-Asmat O, Lubkowska L, Kashlev M, Bustamante CJ, Guerra DG, Kireeva ML (2017). Production and characterization of a highly pure RNA polymerase holoenzyme from Mycobacterium tuberculosis. Protein Expr Purif  134, 1-10.   https://doi.org/10.1016/j.pep.2017.03.013|3. KIreeva M, Trang C, Matevosyan G, Turek-Herman J, Chasov V, Lubkowska L, Kashlev M (2018). RNA-DNA and DNA-DNA base-pairing at the upstream edge of the transcription bubble regulate translocation of RNA polymerase and transcription rate. Nucleic Acids Res  46, 5764-5775.   https://doi.org/10.1093/nar/gky393",https://intramural.nih.gov/search/searchview.taf?ipid=103929
284,BC011203-10,"October 01, 2017 -  September 30, 2018",Proteolysis and Regulation of Bacterial Cell Growth Control,Susan  Gottesman; PhD|IRP Faculty Profile,NULL,"Biochemical Genetics Section, NCI",Issam Nihad Hamdallah|Nadim  Majdalani|Song  Tong|Arti  Tripathi,Alexandra Monica Deaconescu (BIOCHEMISTRY & BIOPHYSICS CENTER)|Aurelia  Battesti,Sue H Wickner; PhD (DNA Molecular Biology Section)|Yan Ning H Zhou (Rna Biology Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,"1. Gottesman S (2017). Stress Reduction, Bacterial Style. J Bacteriol  199.   https://doi.org/10.1128/JB.00433-17",https://intramural.nih.gov/search/searchview.taf?ipid=103921
285,BC011204-10,"October 01, 2017 -  September 30, 2018",Development of TIMP-2 derivatives or strategies as biologic therapies for cancer,"William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Ananda  Chowdhury; PhD|Sarvesh  Kumar|David  Peeney; PhD|Beiyang  Wei|Sandra  Jensen-Taubman,John  Caterina; PhD (NIDR)|Robert G Brinson; PhD,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)",Rolf Eric Swenson; PhD (NHLBI) |Olga  Vasalatiy; PhD (NHLBI),"1. Chowdhury A, Brinson R, Wei B, Stetler-Stevenson WG (2017). Tissue Inhibitor of Metalloprotease-2 (TIMP-2): Bioprocess Development, Physicochemical, Biochemical, and Biological Characterization of Highly Expressed Recombinant Protein. Biochemistry  56, 6423-6433.   https://doi.org/10.1021/acs.biochem.7b00700",https://intramural.nih.gov/search/searchview.taf?ipid=103940
286,BC011206-10,"October 01, 2017 -  September 30, 2018",Genome wide profiling of histone variants in tumors,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Arun Kumar  Ganesan; PhD|Mary Elizabeth Pitman|David  Sturgill,NULL,NULL,Jonathan Douglas Nye (NIAID) |Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Nuccio AG, Bui M, Dalal Y, Nita-Lazar A (2017). Mass Spectrometry-Based Methodology for Identification of Native Histone Variant Modifications From Mammalian Tissues and Solid Tumors. Methods Enzymol  586, 275-290.   https://doi.org/10.1016/bs.mie.2016.09.035|2. Nye J, Melters DP, Dalal Y (2018). The Art of War: harnessing the epigenome against cancer. F1000Res  7, 141.   https://doi.org/10.12688/f1000research.12833.1",https://intramural.nih.gov/search/searchview.taf?ipid=103913
287,BC011207-10,"October 01, 2017 -  September 30, 2018",Analysis of centromere identity and structure in human cells,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|Daniel Patrick Melters|Mary Elizabeth Pitman|Tatini  Rakshit|David  Sturgill,"Jennifer  Otteson (Ohio State University)|Garegin  Papaoin (University of Maryland)|Cees  Dekker (Delft University of Technology)|Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)",NULL,Emilios K Dimitriadis; PhD (NIBIB) |Aleksandra Urszula Nita-Lazar; PhD (NIAID),"1. Bui M, Pitman M, Nuccio A, Roque S, Donlin-Asp PG, Nita-Lazar A, Papoian GA, Dalal Y (2017). Internal modifications in the CENP-A nucleosome modulate centromeric dynamics. Epigenetics Chromatin  10, 17.   https://doi.org/10.1186/s13072-017-0124-6",https://intramural.nih.gov/search/searchview.taf?ipid=103914
288,BC011208-10,"October 01, 2017 -  September 30, 2018",Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome,Shivinder Singh Grewal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Vanivilasini  Balachandran|Amber Rae Cutter|Jothy  Dhakshnamoorthy|Sahana  Holla|Madeline Michelle Larkin|Yi  Wei|Show all 8,NULL,Peter C Fitzgerald (Office of the Director),Tommy Van Vo (NIGMS) |Henry L Levin; PhD (NICHD),"1. Folco HD, Chalamcharla VR, Sugiyama T, Thillainadesan G, Zofall M, Balachandran V, Dhakshnamoorthy J, Mizuguchi T, Grewal SI (2017). Untimely expression of gametogenic genes in vegetative cells causes uniparental disomy. Nature  543, 126-130.   https://doi.org/10.1038/nature21372|2. Mizuguchi T, Taneja N, Matsuda E, Belton JM, FitzGerald P, Dekker J, Grewal SIS (2017). Shelterin components mediate genome reorganization in response to replication stress. Proc Natl Acad Sci U S A  114, 5479-5484.   https://doi.org/10.1073/pnas.1705527114|3. Taneja N, Zofall M, Balachandran V, Thillainadesan G, Sugiyama T, Wheeler D, Zhou M, Grewal SI (2017). SNF2 Family Protein Fft3 Suppresses Nucleosome Turnover to Promote Epigenetic Inheritance and Proper Replication. Mol Cell  66, 50-62.e6.   https://doi.org/10.1016/j.molcel.2017.02.006",https://intramural.nih.gov/search/searchview.taf?ipid=103922
289,BC011209-10,"October 01, 2017 -  September 30, 2018",Formation of Centromeres in vivo,Yamini Praful Dalal|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Minh  Bui|David  Sturgill,"Garegin  Papaoin (University of Maryland)|Yuri  Lyubchenko; PhD (Pharmaceutical Sciences, Univ. of Nebraska Medical Center)",Karl Thomas Ried; MD (Cancer Genetics Branch),Aleksandra Urszula Nita-Lazar; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103915
290,BC011211-10,"October 01, 2017 -  September 30, 2018",Subcellular protein localization in B. subtilis,Kumaran S Ramamurthi|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Brandon Ramal Anjuwon-Foster|Carissa M Chan|Thomas  Delerue|Haoyuan  Jing|Minsuk  Kong|Emily Ann Peluso|Show all 7,"Fang  Tian (Penn State University, College of Medicine)|Kerwyn  Huang (Stanford University)",Sriram  Subramaniam; PhD (Office Of The Director),Hari  Shroff; PhD (NIBIB) |Aravind L Iyer; PhD (NLM),"1. Decker AR, Ramamurthi KS (2017). Cell Death Pathway That Monitors Spore Morphogenesis. Trends Microbiol  25, 637-647.   https://doi.org/10.1016/j.tim.2017.03.005|2. Eswara PJ, Ramamurthi KS (2017). Bacterial Cell Division: Nonmodels Poised to Take the Spotlight. Annu Rev Microbiol  71, 393-411.   https://doi.org/10.1146/annurev-micro-102215-095657|3. Kim EY, Tyndall ER, Huang KC, Tian F, Ramamurthi KS (2017). Dash-and-Recruit Mechanism Drives Membrane Curvature Recognition by the Small Bacterial Protein SpoVM. Cell Syst  5, 518-526.e3.   https://doi.org/10.1016/j.cels.2017.10.004|4. Updegrove TB, Ramamurthi KS (2017). Geometric protein localization cues in bacterial cells. Curr Opin Microbiol  36, 7-13.   https://doi.org/10.1016/j.mib.2016.12.001",https://intramural.nih.gov/search/searchview.taf?ipid=103936
291,BC011212-10,"October 01, 2017 -  September 30, 2018",Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Na-Young  Song; PhD|Jami D Willette brown|Feng  Zhu; PhD|Giorgio  Trinchieri,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103924
292,BC011214-10,"October 01, 2017 -  September 30, 2018",Post-Transcriptional Regulation of Interleukin-7 Receptor Expression,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Devon Thomas Dipalma|Juliet  Fink|Juntae  Kwon; PhD|April Rose Masters|Joo Young  Park|Show all 7,Batu M Erman|Youngnim  Choi (Seoul National University),NULL,Bibiana  Bielekova; MD (NIAID),"1. Le Saout C, Luckey MA, Villarino AV, Smith M, Hasley RB, Myers TG, Imamichi H, Park JH, O'Shea JJ, Lane HC, Catalfamo M (2017). IL-7-dependent STAT1 activation limits homeostatic CD4+ T cell expansion. JCI Insight  2.   https://doi.org/10.1172/jci.insight.96228|2. Waickman AT, Ligons DL, Hwang S, Park JY, Lazarevic V, Sato N, Hong C, Park JH (2017). CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans. Cytokine  99, 266-274.   https://doi.org/10.1016/j.cyto.2017.08.004",https://intramural.nih.gov/search/searchview.taf?ipid=103934
293,BC011215-10,"October 01, 2017 -  September 30, 2018",Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules,Jung-Hyun  Park|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Megan A Luckey|Devon Thomas Dipalma|Juliet  Fink|Juntae  Kwon; PhD|Joo Young  Park|Alfred  Singer; MD,NULL,NULL,NULL,"1. Park JY, Chung H, Choi Y, Park JH (2017). Phenotype and Tissue Residency of Lymphocytes in the Murine Oral Mucosa. Front Immunol  8, 250.   https://doi.org/10.3389/fimmu.2017.00250",https://intramural.nih.gov/search/searchview.taf?ipid=103935
294,BC011222-10,"October 01, 2017 -  September 30, 2018",CNS sirtuins in radiation-induced vascular permeability and neurodegeneration,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alexandra  Lin|Nihar Jaydeep Mehta,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103939
295,BC011232-10,"October 01, 2017 -  September 30, 2018",A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead,Joseph John Barchi|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan Ruth Hauptman,NULL,NULL,NULL,"1. Siddiqui MA, Ambre S, Keay SK, Rhyne JM, Zhang CO, Barchi JJ (2017). Glycoamino Acid Analogues of the Thomsen-Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides. ACS Omega  2, 5618-5632.   https://doi.org/10.1021/acsomega.7b01018",https://intramural.nih.gov/search/searchview.taf?ipid=103910
296,BC011255-09,"October 01, 2017 -  September 30, 2018",Genetic Modifiers of Initiation and Progression of Mammary Cancer,Kent W Hunter; PhD|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Md Ruhul Amin|Randall Andrew Dass|Sarah Kimberly Deasy|Ngoc-Han  Ha|Somayeh  Hooshmand|Devin Eugene Jackson|Show all 14,"Yijun  Ruan; PhD (Department of Genetic and Development Biology, Jackson Laboratory for Genomic Medicine)|Michael  Lewis (Baylor University)|Sophia  Lunt (Michigan State University)|Eran  Andrecheck (Michigan State University)",NULL,Robert Joseph Crouch; PhD (NICHD),"1. Ross C, Hunter K (2018) Metastasis signatures  The tell-tale signs of metastasis, in Encyclopedia of Cancer, in press.|2. Teoh S, Ogrodzinski M, Ross C, Hunter K, Lung S (2018) Sialic acid metabolism: a key player in breast cancer metastasis revealed by metabolomics. Frontiers in Oncology, in press.|3. Vera-Ramirez L, Hunter KW (2017). Tumor cell dormancy as an adaptive cell stress response mechanism. F1000Res  6, 2134.   https://doi.org/10.12688/f1000research.12174.1",https://intramural.nih.gov/search/searchview.taf?ipid=103949
297,BC011264-09,"October 01, 2017 -  September 30, 2018",Glucocorticoids and T cell development and function,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Paul  Mittelstadt; PhD|Matthew Donald Taves,NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103950
298,BC011267-09,"October 01, 2017 -  September 30, 2018",Preclinical drug development in pancreatic cancer,Udo  Rudloff|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI","Yansong  Bian; MD, PhD|Zachary Daniel Knotts|Dandan  Li|Victoria Thanh Nguyen|Rushikesh Vilas Sable; PhD",Duncan  Jodrell (CRUK Cambridge Research Institute)|Jesse  Jaynes (Tuskegee University)|Sui  Huang (Northwestern University)|Clayton  Yates (Tuskegee University)|Michael  Baltezor (University of Kansas)|Chan-young  Ock (Seoul National University Hospital),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Thorkell  Andresson (Office Of The Director)|Serguei V Kozlov (Office of the Director)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Sarangan  Ravichandran (Office Of The Director)|Natalia  De Val Alda; PhD (Office of the Director)",Juan  Marugan (NCATS) |Xin  Xu (NCATS) |Marc  Ferrer-Alegre (NCATS) |Xin  Hu; PhD (NCATS) |Craig Joseph Thomas (NCATS),"1. Chen I, Mathews-Greiner L, Li D, Abisoye-Ogunniyan A, Ray S, Bian Y, Shukla V, Zhang X, Guha R, Thomas C, Gryder B, Zacharia A, Beane JD, Ravichandran S, Ferrer M, Rudloff U (2017). Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. J Transl Med  15, 92.   https://doi.org/10.1186/s12967-017-1197-5|2. Feingold PL, Kwong ML, Davis JL, Rudloff U (2017). Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review. J Surg Oncol  115, 192-201.   https://doi.org/10.1002/jso.24476|3. Frankowski KJ, Wang C, Patnaik S, Schoenen FJ, Southall N, Li D, Teper Y, Sun W, Kandela I, Hu D, Dextras C, Knotts Z, Bian Y, Norton J, Titus S, Lewandowska MA, Wen Y, Farley KI, Griner LM, Sultan J, Meng Z, Zhou M, Vilimas T, Powers AS, Kozlov S, et al. [23 more authors] (2018). Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis. Sci Transl Med  10.   https://doi.org/10.1126/scitranslmed.aap8307|4. Li D, Mullinax J, Aiken T, Xin H, Wiegand G, Anderson A, Thorgeirsson S, Avital I, Rudloff U (2018) Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells. BMC Cancer, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103952
299,BC011275-09,"October 01, 2017 -  September 30, 2018",Genomic and genetic studies of endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Myriem  Boufraqech; PhD,NULL,Sudheer Kumar Gara (Thoracic & Oncologic Surgery Branch),NULL,"1. Angelousi A, Szarek E, Shram V, Kebebew E, Quezado M, Stratakis CA (2017). Lipofuscin Accumulation in Cortisol-Producing Adenomas With and Without PRKACA Mutations. Horm Metab Res  49, 786-792.   https://doi.org/10.1055/s-0043-116385|2. Guan B, Welch JM, Vemulapalli M, Li Y, Ling H, Kebebew E, Simonds WF, Marx SJ, Agarwal SK (2017). Ethnicity of Patients With Germline GCM2-Activating Variants and Primary Hyperparathyroidism. J Endocr Soc  1, 488-499.   https://doi.org/10.1210/js.2017-00043|3. Keutgen XM, Kumar S, Gara SK, Boufraqech M, Agarwal S, Hruban RH, Nilubol N, Quezado M, Finney R, Cam M, Kebebew E (2018). Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype. Cancer  124, 636-647.   https://doi.org/10.1002/cncr.31057|4. Kotian S, Zhang L, Boufraqech M, Gaskins K, Gara SK, Quezado M, Nilubol N, Kebebew E (2017). Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases. Clin Cancer Res  23, 5044-5054.   https://doi.org/10.1158/1078-0432.CCR-17-1043|5. Liu-Chittenden Y, Jain M, Gaskins K, Wang S, Merino MJ, Kotian S, Kumar Gara S, Davis S, Zhang L, Kebebew E (2017). RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma. Oncogene  36, 3541-3552.   https://doi.org/10.1038/onc.2016.497|6. Parekh VI, Modali SD, Welch J, Simonds WF, Weinstein LS, Kebebew E, Agarwal SK (2018). Frequency and consequence of the recurrent YY1 p.T372R mutation in sporadic insulinomas. Endocr Relat Cancer  25, L31-L35.   https://doi.org/10.1530/ERC-17-0311|7. Patel D, Thompson MD, Manna SK, Krausz KW, Zhang L, Nilubol N, Gonzalez FJ, Kebebew E (2017). Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms. Clin Cancer Res  23, 5302-5310.   https://doi.org/10.1158/1078-0432.CCR-16-3156|8. Thakur S, Daley B, Gaskins K, Vasko VV, Boufraqech M, Patel D, Sourbier C, Reece J, Cheng SY, Kebebew E, Agarwal S, Klubo-Gwiezdzinska J (2018). Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo. Clin Cancer Res  24, 4030-4043.   https://doi.org/10.1158/1078-0432.CCR-17-3167",https://intramural.nih.gov/search/searchview.taf?ipid=103953
300,BC011283-09,"October 01, 2017 -  September 30, 2018","Investigating the link between DNA damage, chromatin and nuclear dysfunction",Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Jeongkyu  Kim; PhD|Robin  Sebastian|David  Sturgill|Andy Dong-Anh Tran; PhD,"David  Sinclair (Harvard Medical School)|karolin  Luger (Biochemsitry, Univ. of Colorado)|Matthew  Gamble (Albert Einstein College Of Medicine)|Richard  Gibbons; MD (Clinical Laboratory of Sciences, University of Oxford)",Mirit I Aladjem; PhD (Developmental Therapeutics Branch),Yie  Liu; PhD (NIA),"1. Kim J, Oberdoerffer P, Khurana S (2018). The histone variant macroH2A1 is a splicing-modulated caretaker of genome integrity and tumor growth. Molecular and Cellular Oncology  5, Issue 3.|2. Kim J, Sturgill D, Sebastian R, Khurana S, Tran AD, Edwards GB, Kruswick A, Burkett S, Hosogane EK, Hannon WW, Weyemi U, Bonner WM, Luger K, Oberdoerffer P (2018). Replication Stress Shapes a Protective Chromatin Environment across Fragile Genomic Regions. Mol Cell  69, 36-47.e7.   https://doi.org/10.1016/j.molcel.2017.11.021",https://intramural.nih.gov/search/searchview.taf?ipid=103955
301,BC011286-09,"October 01, 2017 -  September 30, 2018",Therapeutic targets and novel anticancer agents for endocrine cancers,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Myriem  Boufraqech; PhD|Mustapha Ahmed el Lakis|Patience Chantel Green|Douglas Shane Wiseman; MD,NULL,Sudheer Kumar Gara (Thoracic & Oncologic Surgery Branch),NULL,"1. Kebebew E (2018). Thyroid Cancer: Is It All in the Genes? J Natl Cancer Inst  110, 327-328.   https://doi.org/10.1093/jnci/djx210|2. Luo H, Tobey A, Auh S, Cochran C, Zemskova M, Reynolds J, Lima C, Burman K, Wartofsky L, Skarulis M, Kebebew E, Klubo-Gwiezdzinska J (2018). The effect of lithium on the progression-free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy. Clin Endocrinol (Oxf)  89, 481-488.   https://doi.org/10.1111/cen.13806|3. Shell J, Patel D, Powers A, Quezado M, Killian K, Meltzer P, Zhu J, Gaitanidis A, Karzai F, Neychev V, Green P, Kebebew E (2017). Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report. J Endocr Soc  1, 1124-1134.   https://doi.org/10.1210/js.2017-00156|4. Tirosh A, El Lakis M, Green P, Nockel P, Patel D, Nilubol N, Gara SK, Keutgen XM, Linehan WM, Kebebew E (2018). In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease. J Clin Endocrinol Metab  103, 1631-1638.   https://doi.org/10.1210/jc.2017-02434|5. Zhang L, Lu L, Summers RM, Kebebew E, Yao J (2018). Convolutional Invasion and Expansion Networks for Tumor Growth Prediction. IEEE Trans Med Imaging  37, 638-648.   https://doi.org/10.1109/TMI.2017.2774044",https://intramural.nih.gov/search/searchview.taf?ipid=103957
302,BC011287-09,"October 01, 2017 -  September 30, 2018",Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC),Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Mustapha Ahmed el Lakis|Patience Chantel Green|Douglas Shane Wiseman; MD,NULL,Sudheer Kumar Gara (Thoracic & Oncologic Surgery Branch),NULL,"1. Klubo-Gwiezdzinska J, Yang L, Merkel R, Patel D, Nilubol N, Merino MJ, Skarulis M, Sadowski SM, Kebebew E (2017). Results of Screening in Familial Non-Medullary Thyroid Cancer. Thyroid  27, 1017-1024.   https://doi.org/10.1089/thy.2016.0668",https://intramural.nih.gov/search/searchview.taf?ipid=103958
303,BC011293-09,"October 01, 2017 -  September 30, 2018",Cytidine modifications in mRNA processing and function,Shalini  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Daniel Alejandro Arango Tamayo|Masaki  Hosogane|Mariana D Mandler|Kyster Krsna Nanan|Maria Fernanda Prigge,NULL,Jordan Leslie Meier; PhD (Chemical Biology Laboratory),NULL,"1. Nanan KK, Ocheltree C, Sturgill D, Mandler MD, Prigge M, Varma G, Oberdoerffer S (2017). Independence between pre-mRNA splicing and DNA methylation in an isogenic minigene resource. Nucleic Acids Res  45, 12780-12797.   https://doi.org/10.1093/nar/gkx900",https://intramural.nih.gov/search/searchview.taf?ipid=103960
304,BC011295-09,"October 01, 2017 -  September 30, 2018",ALL immunobiology and the bone marrow niche,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD|Mark Eric Kohler|Haiying  Qin|Sneha  Ramakrishna|Zachary Hudson Walsh|Lila  Yang|Show all 8,NULL,Kazusa  Ishii (Experimental Transplantation and Immunology Branch)|Peter D Aplan; MD (Cancer Genetics Branch),NULL,"1. Allen ES, Stroncek DF, Ren J, Eder AF, West KA, Fry TJ, Lee DW, Mackall CL, Conry-Cantilena C (2017). Autologous lymphapheresis for the production of chimeric antigen receptor T cells. Transfusion  57, 1133-1141.   https://doi.org/10.1111/trf.14003|2. Chung YJ, Fry TJ, Aplan PD (2017). Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome. PLoS One  12, e0185219.   https://doi.org/10.1371/journal.pone.0185219|3. Fry TJ, Shah NN, Orentas RJ, Stetler-Stevenson M, Yuan CM, Ramakrishna S, Wolters P, Martin S, Delbrook C, Yates B, Shalabi H, Fountaine TJ, Shern JF, Majzner RG, Stroncek DF, Sabatino M, Feng Y, Dimitrov DS, Zhang L, Nguyen S, Qin H, Dropulic B, Lee DW, Mackall CL (2018). CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med  24, 20-28.   https://doi.org/10.1038/nm.4441|4. Gough SM, Goldberg L, Pineda M, Walker RL, Zhu YJ, Bilke S, Chung YJ, Dufraine J, Kundu S, Jacoby E, Fry TJ, Fischer S, Panzer-Grümayer R, Meltzer PS, Aplan PD (2017). Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways. Blood Adv  1, 1749-1759.   https://doi.org/10.1182/bloodadvances.2017009837|5. Jacobsohn DA, Loken MR, Fei M, Adams A, Brodersen LE, Logan BR, Ahn KW, Shaw BE, Kletzel M, Olszewski M, Khan S, Meshinchi S, Keating A, Harris A, Teira P, Duerst RE, Margossian SP, Martin PL, Petrovic A, Dvorak CC, Nemecek ER, Boyer MW, Chen AR, Davis JH, Shenoy S, et al. [24 more authors] (2018). Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression. Biol Blood Marrow Transplant  24, 2040-2046.   https://doi.org/10.1016/j.bbmt.2018.06.010|6. Shah NN, Fry TJ (2017). Anti-CD19 resistance can ""stem"" from progenitors. Blood  130, 1961-1963.   https://doi.org/10.1182/blood-2017-09-804070|7. Shalabi H, Kraft IL, Wang HW, Yuan CM, Yates B, Delbrook C, Zimbelman JD, Giller R, Stetler-Stevenson M, Jaffe ES, Lee DW, Shern JF, Fry TJ, Shah NN (2018). Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma. Haematologica  103, e215-e218.   https://doi.org/10.3324/haematol.2017.183459|8. Shalabi H, Wolters PL, Martin S, Toledo-Tamula MA, Roderick MC, Struemph K, Kane E, Yates B, Delbrook C, Mackall CL, Lee DW, Fry TJ, Shah NN (2018). Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy. J Immunother  41, 350-358.   https://doi.org/10.1097/CJI.0000000000000241|9. Stroncek DF, Lee DW, Ren J, Sabatino M, Highfill S, Khuu H, Shah NN, Kaplan RN, Fry TJ, Mackall CL (2017). Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells. J Transl Med  15, 59.   https://doi.org/10.1186/s12967-017-1160-5|10. Walker AJ, Majzner RG, Zhang L, Wanhainen K, Long AH, Nguyen SM, Lopomo P, Vigny M, Fry TJ, Orentas RJ, Mackall CL (2017). Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase. Mol Ther  25, 2189-2201.   https://doi.org/10.1016/j.ymthe.2017.06.008|11. Yang Y, Kohler ME, Chien CD, Sauter CT, Jacoby E, Yan C, Hu Y, Wanhainen K, Qin H, Fry TJ (2017). TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance. Sci Transl Med  9.   https://doi.org/10.1126/scitranslmed.aag1209",https://intramural.nih.gov/search/searchview.taf?ipid=103961
305,BC011298-09,"October 01, 2017 -  September 30, 2018",Phase I Trial of Radiation and Lenalidomide in Pediatric Malignant Glioma,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Sean Joseph Hipp|Mark  Atlas (Cohen Children's Medical Center)|Jason  Fangusaro (Lurie Children's Hospital)|Adam  Levy",Kevin A Camphausen; MD (Radiation Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch),NULL,"1. Cooney T, Lane A, Bartels U, Bouffet E, Goldman S, Leary SES, Foreman NK, Packer RJ, Broniscer A, Minturn JE, Shih CS, Chintagumpala M, Hassall T, Gottardo NG, Dholaria H, Hoffman L, Chaney B, Baugh J, Doughman R, Leach JL, Jones BV, Fouladi M, Warren KE, Monje M (2017). Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study. Neuro Oncol  19, 1279-1280.   https://doi.org/10.1093/neuonc/nox107|2. Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, et al. [48 more authors] (2018). Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol  36, 1963-1972.   https://doi.org/10.1200/JCO.2017.75.9308",https://intramural.nih.gov/search/searchview.taf?ipid=103962
306,BC011299-09,"October 01, 2017 -  September 30, 2018",Noninvasive Evaluation of Pediatric CNS TumorsRAPNO,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Roger  Packer (CNMC)|Darren  Hargrave (Great ormond Street Hospital for Children)|Gilbert  Vezina (Children's National Medical Center)|Tina  Young Poussaint (Children's Hospital)|Mark  Kieran (Children's Hospital)|Sean Joseph Hipp|Show all 10,NULL,"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |Peter  Herscovitch; MD (CC)","1. Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY (2018). Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro Oncol  20, 897-906.   https://doi.org/10.1093/neuonc/noy056|2. Dang Do AN, Baker EH, Warren KE, Bianconi SE, Porter FD (2018). Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome. Am J Med Genet A  176, 386-390.   https://doi.org/10.1002/ajmg.a.38563|3. Jones D, Kieran M, Bouffet E, Alexandrescu S, Bandopdhayay P, Bornhorst M, Ellison D, Fangusaro J, Fisher M, Foreman N, Hargrave D, Hawkins C, Hecker E, Jabado N, Jenkinson D, Massimino M, Mueller S, Perilongo G, Schouten N, Tabori U, Warren K, Waanders A, Walker D, Weiss W, Witt O, et al. [5 more authors] (2017) Ellison. Neuro-Oncology, in press.|4. Packer RJ, Pfister S, Bouffet E, Avery R, Bandopadhayay P, Bornhorst M, Bowers DC, Ellison D, Fangusaro J, Foreman N, Fouladi M, Gajjar A, Haas-Kogan D, Hawkins C, Ho CY, Hwang E, Jabado N, Kilburn LB, Lassaletta A, Ligon KL, Massimino M, Meeteren SV, Mueller S, Nicolaides T, Perilongo G, et al. [7 more authors] (2017). Pediatric low-grade gliomas: implications of the biologic era. Neuro Oncol  19, 750-761.   https://doi.org/10.1093/neuonc/now209|5. Ranjan S, Warren KE (2017). Gliomatosis Cerebri: Current Understanding and Controversies. Front Oncol  7, 165.   https://doi.org/10.3389/fonc.2017.00165|6. Warren KE, Vezina G, Poussaint TY, Warmuth-Metz M, Chamberlain MC, Packer RJ, Brandes AA, Reiss M, Goldman S, Fisher MJ, Pollack IF, Prados MD, Wen PY, Chang SM, Dufour C, Zurakowski D, Kortmann RD, Kieran MW (2018). Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol  20, 13-23.   https://doi.org/10.1093/neuonc/nox087|7. Warren KE, Vezina G, Poussaint TY, Warmuth-Metz M, Packer RJ, Kieran MW (2018). Response to Harreld re: ""Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee"". Neuro Oncol  20, 144-145.   https://doi.org/10.1093/neuonc/nox219",https://intramural.nih.gov/search/searchview.taf?ipid=103963
307,BC011303-09,"October 01, 2017 -  September 30, 2018",Role of the protein SUMOylation pathway in Ras-driven oncogenesis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Haibo  Zhang; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103964
308,BC011304-09,"October 01, 2017 -  September 30, 2018",Methods for mammalian genetic analysis,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Fehad Jamil Khan|Chih-Shia  Lee,NULL,James  Gao (Thoracic & Oncologic Surgery Branch)|Eric  Batchelor; PhD (Laboratory of Pathology),NULL,"1. Brown ZJ, Fu Q, Ma C, Kruhlak M, Zhang H, Luo J, Heinrich B, Yu SJ, Zhang Q, Wilson A, Shi ZD, Swenson R, Greten TF (2018). Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development. Cell Death Dis  9, 620.   https://doi.org/10.1038/s41419-018-0687-6|2. Porter JR, Fisher BE, Baranello L, Liu JC, Kambach DM, Nie Z, Koh WS, Luo J, Stommel JM, Levens D, Batchelor E (2017). Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response. Mol Cell  67, 1013-1025.e9.   https://doi.org/10.1016/j.molcel.2017.07.028|3. Read A, Gao S, Batchelor E, Luo J (2017). Flexible CRISPR library construction using parallel oligonucleotide retrieval. Nucleic Acids Res  45, e101.   https://doi.org/10.1093/nar/gkx181|4. Sissung TM, Ley AM, Strope JD, McCrea EM, Beedie S, Peer CJ, Shukla S, van Velkinburgh J, Reece K, Troutman S, Campbell T, Fernandez E, Huang P, Smith J, Thakkar N, Venzon DJ, Brenner S, Lee W, Merino M, Luo J, Jager W, Price DK, Chau CH, Figg WD (2017). Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx. Mol Cancer Res  15, 1096-1105.   https://doi.org/10.1158/1541-7786.MCR-16-0477|5. Yuen G, Khan FJ, Gao S, Stommel JM, Batchelor E, Wu X, Luo J (2017). CRISPR/Cas9-mediated gene knockout is insensitive to target copy number but is dependent on guide RNA potency and Cas9/sgRNA threshold expression level. Nucleic Acids Res  45, 12039-12053.   https://doi.org/10.1093/nar/gkx843",https://intramural.nih.gov/search/searchview.taf?ipid=103965
309,BC011306-09,"October 01, 2017 -  September 30, 2018",Inhibitors of protein-protein interactions,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Pedro Felipe Andrade Bonilla|Lyuba Aleksandrovna Khavrutskii|Victor  Nelson; PhD|Bangalore K Sathyanarayana|Karen Marie Stefanisko|Wei  Zhang; PhD|Show all 9,Joseph R Kates|Vadim  Gaponenko|Alla  Ivanova|Olga  Timofeeva (Georgetown University)|Mercedes  Gonzalez-Juarrero (Colorado State University)|Philip  Kim (University of Toronto)|Show all 7,Michael  Dean; PhD (Laboratory Translational Genomics)|Alan O Perantoni; PhD (Cancer and Developmental Biology Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory)|Marc C Nicklaus (Chemical Biology Laboratory)|Kylie Janice Walters (Structural Biophysics Laboratory),NULL,"1. Lu X, Nowicka U, Sridharan V, Liu F, Randles L, Hymel D, Dyba M, Tarasov SG, Tarasova NI, Zhao XZ, Hamazaki J, Murata S, Burke TR, Walters KJ (2017). Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets. Nat Commun  8, 15540.   https://doi.org/10.1038/ncomms15540",https://intramural.nih.gov/search/searchview.taf?ipid=103966
310,BC011307-09,"October 01, 2017 -  September 30, 2018",Self-assembling protoviral nanoparticles,Nadya I Tarasova; PhD,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Joshua Hoyoung Yu|Joost J Oppenheim; MD,Joseph R Kates|Vadim  Gaponenko|Mattheas  Majestachak (Loyola University Chicago)|Steven  Ackerman; PhD (University of Illinois at Chicago),Sriram  Subramaniam; PhD (Office Of The Director)|Sergey G Tarasov (Structural Biophysics Laboratory)|Raul Eduardo Cachau (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103967
311,BC011311-09,"October 01, 2017 -  September 30, 2018",Identification of genetic interactors of Brca2,Shyam K Sharan|IRP Faculty Profile,NULL,"Genetics of Cancer Susceptibility Section, NCI",NULL,"Debananda  Pati (Texas Children's Cancer Center, Baylor College of Medicine)|William  Foulkes (McGill University)",NULL,NULL,"1. Ding X, Philip S, Martin BK, Pang Y, Burkett S, Swing DA, Pamala C, Ritt DA, Zhou M, Morrison DK, Ji X, Sharan SK (2017). Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2. Genetics  207, 1335-1345.   https://doi.org/10.1534/genetics.117.300357|2. Dungrawala H, Bhat KP, Le Meur R, Chazin WJ, Ding X, Sharan SK, Wessel SR, Sathe AA, Zhao R, Cortez D (2017). RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks. Mol Cell  67, 374-386.e5.   https://doi.org/10.1016/j.molcel.2017.06.023|3. Singh S, Narayanan SP, Biswas K, Gupta A, Ahuja N, Yadav S, Panday RK, Samaiya A, Sharan SK, Shukla S (2017). Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect. Proc Natl Acad Sci U S A  114, 11440-11445.   https://doi.org/10.1073/pnas.1708447114",https://intramural.nih.gov/search/searchview.taf?ipid=103970
312,BC011313-09,"October 01, 2017 -  September 30, 2018",Design and Utility of Novel Proteinaceous Biomaterials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Poulami  Majumder|Stephen Edward Miller; PhD|Allix Marie Settemia Sanders|Junfeng  Shi|Scott Thomas Walsh|Yuji  Yamada; PhD,Darrin  Pochan (University of Delaware)|Gerald  Brandacher (Johns Hopkins University)|Eric  Furst (University of Delaware),"William G Stetler-Stevenson; MD, PhD (Radiation Oncology Branch)|Scott K Durum; PhD (Cancer Inflammation Program)",Robert  Tycko; PhD (NIDDK),"1. Medina SH, Michie MS, Miller SE, Schnermann MJ, Schneider JP (2017). Fluorous Phase-Directed Peptide Assembly Affords Nano-Peptisomes Capable of Ultrasound-Triggered Cellular Delivery. Angew Chem Int Ed Engl  56, 11404-11408.   https://doi.org/10.1002/anie.201704649|2. Nagy-Smith K, Beltramo PJ, Moore E, Tycko R, Furst EM, Schneider JP (2017). Molecular, Local, and Network-Level Basis for the Enhanced Stiffness of Hydrogel Networks Formed from Coassembled Racemic Peptides: Predictions from Pauling and Corey. ACS Cent Sci  3, 586-597.   https://doi.org/10.1021/acscentsci.7b00115|3. Shi J, Fichman G, Schneider JP (2018). Enzymatic Control of the Conformational Landscape of Self-Assembling Peptides. Angew Chem Int Ed Engl  57, 11188-11192.   https://doi.org/10.1002/anie.201803983|4. Sinthuvanich C, Nagy K, Walsh S, Schneider J (2017). Triggered Formation of Anionic Hydrogels from Self-Assembling Acidic Peptide Amphiphiles. Macromolecules  50, 5643.",https://intramural.nih.gov/search/searchview.taf?ipid=103971
313,BC011314-09,"October 01, 2017 -  September 30, 2018",Development of antibacterial agents and materials,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Galit  Fichman|Ken  Ishikawa|Stephen Edward Miller; PhD|Junfeng  Shi|Scott Thomas Walsh|Martin John Schnermann; PhD,Darrin  Pochan (University of Delaware)|Gerald  Brandacher (Johns Hopkins University)|Brian  Bush (NIST),Cem  Sonmez (Macromolecular Crystallography Laboratory),NULL,"1. Ishikawa K, Medina SH, Schneider JP, Klar AJS (2017). Glycan Alteration Imparts Cellular Resistance to a Membrane-Lytic Anticancer Peptide. Cell Chem Biol  24, 149-158.   https://doi.org/10.1016/j.chembiol.2016.12.009",https://intramural.nih.gov/search/searchview.taf?ipid=103972
314,BC011319-09,"October 01, 2017 -  September 30, 2018",Role of FIR in limb morphogenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao|Bau Lin Huang,NULL,David  Levens; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103974
315,BC011321-09,"October 01, 2017 -  September 30, 2018",Identification and characterization of FGF target genes,Mark B Lewandoski|IRP Faculty Profile,NULL,"Genetics of Vertebrate Development Section, NCI",Matthew J Anderson|Cynthia M Elder,NULL,Salvia  Misaghian (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103975
316,BC011324-09,"October 01, 2017 -  September 30, 2018",Polo-like kinase 1 (Plk1)-dependent centrosome maturation and spindle bipolarity,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jong Il  Ahn,Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103976
317,BC011325-09,"October 01, 2017 -  September 30, 2018",Retrovirus Biology,Alan  Rein; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Yadvinder Singh Ahi|Demetria P Harvin|Tomas  Kroupa; PhD|Diborah Mengistu Yimer|Kin Kui  Lai|Alex  Compton,Stephen P Goff|Heinrich  Gottlinger (University of Massachusetts Medical School)|Sara  Sukumar (Johns Hopkins Oncology Center)|Delphine  Muriaux (Centre d'Ã‰tudes d'Agents PathogÃ¨nes et Biotechnologies pour la SantÃ©)|Rahm  Gummuluru (Boston University)|Ina  O'Carroll|Show all 7,Yun Xing M Wang (Structural Biophysics Laboratory)|Kunio  Nagashima (Office of the Director)|Thorkell  Andresson (Office Of The Director)|Stephen J Lockett; PhD (Office Of The Director)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Ulrich  Baxa; PhD (Office Of The Director),NULL,"1. Merino VF, Cho S, Liang X, Park S, Jin K, Chen Q, Pan D, Zahnow CA, Rein AR, Sukumar S (2017). Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors. Mol Oncol  11, 552-566.   https://doi.org/10.1002/1878-0261.12053|2. O'Carroll IP, Thappeta Y, Fan L, Ramirez-Valdez EA, Smith S, Wang YX, Rein A (2017). Contributions of Individual Domains to Function of the HIV-1 Rev Response Element. J Virol  91.   https://doi.org/10.1128/JVI.00746-17",https://intramural.nih.gov/search/searchview.taf?ipid=103977
318,BC011328-09,"October 01, 2017 -  September 30, 2018",Characterization of the Osteosarcoma Genome,"Paul S Meltzer; MD, PhD|IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI","James Leland Thomas Dalgleish|Sean Richard Davis; MD, PhD|Arthur A Glatfelter; MS|John E Lueders|Marbin A Pineda|Robert L Walker; BS|Show all 7","Ching  Lau (Ped Heme/Onc, Texas Children's Hospital)|Richard  Gorlick (Laboratory of Cellular Carcinogenesis and Tumor Promotion, Albert Einstein College of Medicine)|John  Healey (Memorial Sloan Kettering Cancer Center)|Lee Jay Helman; MD (NCI)",Sharon Ann Savage (Clinical Genetics Branch)|Lisa  Mirabello (Clinical Genetics Branch)|Amy Kathleen Leblanc; DVM (Molecular Imaging Program),NULL,"1. Nakka M, Allen-Rhoades W, Li Y, Kelly AJ, Shen J, Taylor AM, Barkauskas DA, Yustein JT, Andrulis IL, Wunder JS, Gorlick R, Meltzer PS, Lau CC, Man TK, TARGET osteosarcoma consortium (2017). Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma. Oncotarget  8, 96738-96752.   https://doi.org/10.18632/oncotarget.18236",https://intramural.nih.gov/search/searchview.taf?ipid=103978
319,BC011332-09,"October 01, 2017 -  September 30, 2018",Tumor Microenvironment in Cancer Progression,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Daniel Wirth Beury|Wei  Ju|Sabina Anna Kaczanowska|Meera  Murgai|Shil  Patel|Carol J Thiele,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|David  Lyden (Weill Cornell Medical Center)|Shahin  Rafii (Weill Cornell Medical Center)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Show all 8",Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Murgai M, Ju W, Eason M, Kline J, Beury DW, Kaczanowska S, Miettinen MM, Kruhlak M, Lei H, Shern JF, Cherepanova OA, Owens GK, Kaplan RN (2017). KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis. Nat Med  23, 1176-1190.   https://doi.org/10.1038/nm.4400|2. Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, Bissell MJ, Cox TR, Giaccia AJ, Erler JT, Hiratsuka S, Ghajar CM, Lyden D (2017). Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer  17, 302-317.   https://doi.org/10.1038/nrc.2017.6",https://intramural.nih.gov/search/searchview.taf?ipid=103981
320,BC011333-09,"October 01, 2017 -  September 30, 2018",Neuropsychological outcome measures in patients receiving whole brain radiation,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,"1. Smart D (2017). Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction. Semin Radiat Oncol  27, 332-339.   https://doi.org/10.1016/j.semradonc.2017.04.006",https://intramural.nih.gov/search/searchview.taf?ipid=103982
321,BC011334-09,"October 01, 2017 -  September 30, 2018",Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,Rosandra N Kaplan|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Daniel Wirth Beury|Wei  Ju|Sabina Anna Kaczanowska|Meera  Murgai|Shil  Patel|Lauren Myrbeck Hittson|Show all 8,"Leonard  Wexler (Memorial Sloan Kettering Cancer Center)|Tanya  Trippett (Pediatrics, Memorial Sloan Kettering)|Jackie  Bromberg (Memorial Sloan Kettering Cancer Center)|Shakeel  Modak (Memorial Sloan Kettering Cancer Center)|Paul  Meyers (Memorial Sloan Kettering Cancer Center)|Peter  Steinherz (Memorial Sloan Kettering Cancer Center)|Show all 8",Sharon Ann Savage (Clinical Genetics Branch)|Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Goyal N, Apolo AB, Berman ED, Bagheri MH, Levine JE, Glod JW, Kaplan RN, Machado LB, Folio LR (2017). ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases. J Digit Imaging  30, 275-286.   https://doi.org/10.1007/s10278-016-9938-1",https://intramural.nih.gov/search/searchview.taf?ipid=103983
322,BC011336-09,"October 01, 2017 -  September 30, 2018",Tools for Prediction of ADMETox Properties,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Victorien Cedric Delannee,"Ann  Richard (EPA)|Antony  Williams|Huixiao  Hong (NCI)|Kamel  Mansouri (EPA)|Barry  Bunin (Collaborative Drug Discovery (CDD), Inc.)|Alex  Clark (Molecular Materials Informatics, Inc.)",NULL,"Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103984
323,BC011337-09,"October 01, 2017 -  September 30, 2018",Generation of T-cell receptors recognizing antigens on non-melanoma tumors,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Kenichi  Hanada|Amanda Jayne Lyon; PhD,NULL,NULL,NULL,"1. Wang QJ, Yu Z, Hanada KI, Patel K, Kleiner D, Restifo NP, Yang JC (2017). Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers. Clin Cancer Res  23, 2267-2276.   https://doi.org/10.1158/1078-0432.CCR-16-1421",https://intramural.nih.gov/search/searchview.taf?ipid=103985
324,BC011340-09,"October 01, 2017 -  September 30, 2018",Preclinical evaluation of novel therapeutics for CNS tumor therapy,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Cynthia M Lester mccully|Arman Bayazit Odabas|Kanwalpreet Kaur Walia|Robert F Murphy|Srivandana  Akshintala|Andrea Michelle Gross; MD,"Paul  Hergenrother (Chemistry, University of Illinois)|Gary  Kohanbash (Children's Hospital Of Pittsburgh)|Javad  Nazarian (Children's National Medical Center)|Ian  Pollack (Children's Hospital, Pittsburgh)|Eric H Raabe|Jeffrey Aaron Rubens (PEDIATRIC ONCOLOGY BRANCH)|Show all 9",Rafael  Cruz Garcia (Office Of The Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Cody John Peer (Office Of The Clinical Director)|Simone  Difilippantonio (Office Of The Director),Craig Joseph Thomas (NCATS),"1. Miyahara H, Yadavilli S, Natsumeda M, Rubens JA, Rodgers L, Kambhampati M, Taylor IC, Kaur H, Asnaghi L, Eberhart CG, Warren KE, Nazarian J, Raabe EH (2017). The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma. Cancer Lett  400, 110-116.   https://doi.org/10.1016/j.canlet.2017.04.019|2. Nellan A, McCully CML, Cruz Garcia R, Jayaprakash N, Widemann BC, Lee DW, Warren KE (2018). Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques. Blood  132, 662-666.   https://doi.org/10.1182/blood-2018-05-846428|3. Nellan A, Rota C, Majzner R, Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK, Warren KE, Lee DW (2018). Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells. J Immunother Cancer  6, 30.   https://doi.org/10.1186/s40425-018-0340-z",https://intramural.nih.gov/search/searchview.taf?ipid=103986
325,BC011343-09,"October 01, 2017 -  September 30, 2018",Clinical protocols for the treatment of gastrointestinal cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Donna  Mabry|Haleluya Gedlu Yimamu,NULL,"Bradford J Wood; MD (Office of the Director)|Douglas K Price (Genitourinary Malignancies Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)",Theo  Heller; MD (NIDDK) |Venkatesh P Krishnasamy (CC) |Elliot Brian Levy (CC),"1. Brown ZJ, Heinrich B, Greten TF (2018). Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nat Rev Gastroenterol Hepatol  15, 536-554.   https://doi.org/10.1038/s41575-018-0033-6|2. Brown ZJ, Heinrich B, Steinberg SM, Yu SJ, Greten TF (2017). Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer. J Immunother Cancer  5, 93.   https://doi.org/10.1186/s40425-017-0298-2|3. Brown ZJ, Yu SJ, Heinrich B, Ma C, Fu Q, Sandhu M, Agdashian D, Zhang Q, Korangy F, Greten TF (2018). Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma. Cancer Immunol Immunother  67, 1305-1315.   https://doi.org/10.1007/s00262-018-2190-4|4. Duffy AG, Ma C, Ulahannan SV, Rahma OE, Makarova-Rusher O, Cao L, Yu Y, Kleiner DE, Trepel J, Lee MJ, Tomita Y, Steinberg SM, Heller T, Turkbey B, Choyke PL, Peer CJ, Figg WD, Wood BJ, Greten TF (2017). Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma. Clin Cancer Res  23, 4633-4641.   https://doi.org/10.1158/1078-0432.CCR-16-3171|5. Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, Davis JL, Hughes MS, Heller T, ElGindi M, Uppala A, Korangy F, Kleiner DE, Figg WD, Venzon D, Steinberg SM, Venkatesan AM, Krishnasamy V, Abi-Jaoudeh N, Levy E, Wood BJ, Greten TF (2017). Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol  66, 545-551.   https://doi.org/10.1016/j.jhep.2016.10.029|6. Eggert T, Greten TF (2017). Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma. Digestion  96, 1-4.   https://doi.org/10.1159/000464282|7. Eggert T, Greten TF (2017). Tumor regulation of the tissue environment in the liver. Pharmacol Ther  173, 47-57.   https://doi.org/10.1016/j.pharmthera.2017.02.005|8. Greten TF (2017). Does CSF1R Blockade Turn into Friendly Fire? Cancer Cell  32, 546-547.   https://doi.org/10.1016/j.ccell.2017.10.012|9. Greten TF (2018). The ABC of adaptive immunity in liver cancer. Hepatology  68, 777-779.   https://doi.org/10.1002/hep.29839|10. Greten TF, Eggert T (2017). Cellular senescence associated immune responses in liver cancer. Hepat Oncol  4, 123-127.   https://doi.org/10.2217/hep-2017-0011|11. Greten TF, Korangy F (2017). Shall we blame CD4 T cells for everything? Gut  66, 763-764.   https://doi.org/10.1136/gutjnl-2016-312900|12. Greten TF, Korangy F (2018). CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC. Gut  67, 783-784.   https://doi.org/10.1136/gutjnl-2017-315091|13. Greten TF, Sangro B (2017) Targets for immunotherapy of liver cancer. J Hepatol, in press (e-pub ahead of print)  https://doi.org/10.1016/j.jhep.2017.09.007|14. Hou J, Greten TF, Xia Q (2017). Immunosuppressive cell death in cancer. Nat Rev Immunol  17, 401.   https://doi.org/10.1038/nri.2017.46|15. Khanna S, Graef S, Mussai F, Thomas A, Wali N, Yenidunya BG, Yuan C, Morrow B, Zhang J, Korangy F, Greten TF, Steinberg SM, Stetler-Stevenson M, Middleton G, De Santo C, Hassan R (2018). Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients. Clin Cancer Res  24, 2859-2872.   https://doi.org/10.1158/1078-0432.CCR-17-3757|16. Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, et al. [21 more authors] (2017). Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science  357, 409-413.   https://doi.org/10.1126/science.aan6733|17. Ma C, Greten TF (2017). Commensal bacteria (ab)use CD8+ T cells to induce insulin resistance. Sci Immunol  2.   https://doi.org/10.1126/sciimmunol.aan1473|18. Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, Agdashian D, Terabe M, Berzofsky JA, Fako V, Ritz T, Longerich T, Theriot CM, McCulloch JA, Roy S, Yuan W, Thovarai V, Sen SK, Ruchirawat M, Korangy F, Wang XW, Trinchieri G, Greten TF (2018). Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science  360.   https://doi.org/10.1126/science.aan5931|19. Ma C, Zhang Q, Greten TF (2018). Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes. FEBS J  285, 752-762.   https://doi.org/10.1111/febs.14209|20. Stroncek DF, Butterfield LH, Cannarile MA, Dhodapkar MV, Greten TF, Grivel JC, Kaufman DR, Kong HH, Korangy F, Lee PP, Marincola F, Rutella S, Siebert JC, Trinchieri G, Seliger B (2017). Systematic evaluation of immune regulation and modulation. J Immunother Cancer  5, 21.   https://doi.org/10.1186/s40425-017-0223-8|21. Ziegler PK, Bollrath J, Pallangyo CK, Matsutani T, Canli Ö, De Oliveira T, Diamanti MA, Müller N, Gamrekelashvili J, Putoczki T, Horst D, Mankan AK, Öner MG, Müller S, Müller-Höcker J, Kirchner T, Slotta-Huspenina J, Taketo MM, Reinheckel T, Dröse S, Larner AC, Wels WS, Ernst M, Greten TF, Arkan MC, et al. [3 more authors] (2018). Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis. Cell  174, 88-101.e16.   https://doi.org/10.1016/j.cell.2018.05.028",https://intramural.nih.gov/search/searchview.taf?ipid=103987
326,BC011344-09,"October 01, 2017 -  September 30, 2018",Immune suppressor mechanisms in patients with GI cancer,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Chunhui  Wang,NULL,Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103988
327,BC011345-09,"October 01, 2017 -  September 30, 2018",Analysis of cancer-related immune suppressor mechanisms in mice,Tim Friedrich Greten|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Zachary John Brown; DO|Qiong  Fu|Chi  Ma,NULL,"Bernd  Heinrich (Thoracic and GI Malignancies Branch)|Qianfei  Zhang (Thoracic and GI Malignancies Branch)|Bradford J Wood; MD (Office of the Director)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Masaki  Terabe (Vaccine Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103989
328,BC011351-09,"October 01, 2017 -  September 30, 2018",Bladder Cancer Program,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Rene A Costello; MT|Nikhil  Goyal|Yang-Min  Ning|James L Gulley; MD, PhD",Dean  Bajorin (MSKCC)|Matthew  Galsky (Mount Sinai)|Dan  Theodorescu (University of Colorado)|Jean  Hoffman-Censits (Jefferson University Hospital)|Sumanta  Pal (City of Hope)|Arthur  DeCillis (Exelixis),Maria  Merino; PhD (Laboratory of Pathology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program),Les Roger Folio (CC) |Ashkan A Malayeri (CC),"1. Apolo AB, Karzai FH, Trepel JB, Alarcon S, Lee S, Lee MJ, Tomita Y, Cao L, Yu Y, Merino MJ, Madan RA, Parnes HL, Steinberg SM, Rodriguez BW, Seon BK, Gulley JL, Arlen PM, Dawson NA, Figg WD, Dahut WL (2017). A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma. Clin Genitourin Cancer  15, 77-85.   https://doi.org/10.1016/j.clgc.2016.05.010|2. Bagheri MH, Ahlman MA, Lindenberg L, Turkbey B, Lin J, Cahid Civelek A, Malayeri AA, Agarwal PK, Choyke PL, Folio LR, Apolo AB (2017). Advances in medical imaging for the diagnosis and management of common genitourinary cancers. Urol Oncol  35, 473-491.   https://doi.org/10.1016/j.urolonc.2017.04.014|3. Machado LB, Apolo AB, Steinberg SM, Folio LR (2017). Radiology Reports With Hyperlinks Improve Target Lesion Selection and Measurement Concordance in Cancer Trials. AJR Am J Roentgenol  208, W31-W37.   https://doi.org/10.2214/AJR.16.16845|4. Pham MN, Apolo AB, De Santis M, Galsky MD, Leibovich BC, Pisters LL, Siefker-Radtke AO, Sonpavde G, Steinberg GD, Sternberg CN, Tagawa ST, Weizer AZ, Woods ME, Milowsky MI (2017). Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. World J Urol  35, 367-378.   https://doi.org/10.1007/s00345-016-1885-4",https://intramural.nih.gov/search/searchview.taf?ipid=103990
329,BC011354-09,"October 01, 2017 -  September 30, 2018",BCR Signaling in ABC DLBCL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Christopher Joseph Melani|Saleema  Osman|Mark Jason Roschewski|Joseph Lee Roswarski,NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Louis  Staudt; MD (Center for Cancer Genomics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103991
330,BC011372-08,"October 01, 2017 -  September 30, 2018",Microenvironmental regulation of glioblastoma radiosensitivity,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Stacey Lynne Lehman|Joseph Hiram McAbee|Barbara Helen Rath|Cindy Rishma Timme|Theresa Faith Wechsler|Kevin A Camphausen; MD|Show all 7,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103992
331,BC011373-08,"October 01, 2017 -  September 30, 2018",Radiation-induced translational control of gene expression,Philip Jeffrey Tofilon|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Stacey Lynne Lehman|Joseph Hiram McAbee|Barbara Helen Rath|Cindy Rishma Timme|Theresa Faith Wechsler|Kevin A Camphausen; MD|Show all 7,NULL,NULL,NULL,"1. Wahba A, Lehman SL, Tofilon PJ (2017). Radiation-induced translational control of gene expression. Translation (Austin)  5, e1265703.   https://doi.org/10.1080/21690731.2016.1265703",https://intramural.nih.gov/search/searchview.taf?ipid=103993
332,BC011374-08,"October 01, 2017 -  September 30, 2018",Allotransplant for DOCK8 deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,"Steven M Holland; MD (NIAID) |Helen C Su; MD, PhD (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103994
333,BC011378-08,"October 01, 2017 -  September 30, 2018",Studies of amplification in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Bishwanath  Chatterjee; PhD|Thanh Hung Nguyen|Prasantha Lakshmi Vemu|Rahul  Agrawal; PhD|Wenyue  Sun|Stephen M Hewitt; MD, PhD|Show all 7",NULL,John Frederick Shern (Pediatric Oncology Branch)|Javed  Khan; MD (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103995
334,BC011379-08,"October 01, 2017 -  September 30, 2018",Inhibitor Development Against the Wip1 Phosphatase,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK) |Frederick P Dyda; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103996
335,BC011381-08,"October 01, 2017 -  September 30, 2018",Brd4 is an atypical kinase that regulates transcription,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Devaiah Nanjappa Ballachanda (Molecular Regulation Section)|Benjamin Ross Akman (Immune Regulation Section)|Chanelle Monet Case Borden (Center For Cancer Training)|Jie  Mu (Molecular Regulation Section)|Jocelyn D Weissman (Molecular Regulation Section)|David  Levens; PhD (Laboratory of Pathology),S Stoney  Simons; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103998
336,BC011382-08,"October 01, 2017 -  September 30, 2018",Systems-level analysis of the regulation and function of p53 dynamics,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Ryan Lee Hanson; PhD|Marie Deborah Gaynelle Harton; PhD|Woo Seuk  Koh|Mark  Raffeld; MD,NULL,William G Telford (Experimental Transplantation and Immunology Branch),NULL,"1. Batchelor E, Loewer A (2017). Recent progress and open challenges in modeling p53 dynamics in single cells. Curr Opin Syst Biol  3, 54-59.   https://doi.org/10.1016/j.coisb.2017.04.007",https://intramural.nih.gov/search/searchview.taf?ipid=103999
337,BC011383-08,"October 01, 2017 -  September 30, 2018",Transcription and Splicing Dynamics in Single Cells,Daniel Robert Larson; PhD|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Ulrike  Boehm; PhD|Gloria Rene Garcia|Murali  Palangat; PhD|Simona Saiprasad Patange|Yihan  Wan; PhD,Eric  Drier (Mad City Labs)|David  Auble (Univ. Virginia)|Siddhartha  Mukherjee (Columbia University Medical Center)|Michael  Poirier (Ohio State University)|Carole A Parent; PhD (NCI)|Harold  Varmus; MD (OD),David  Levens; PhD (Laboratory of Pathology)|Dinah  Singer; PhD (Experimental Immunology Branch)|Jordan Leslie Meier; PhD (Chemical Biology Laboratory)|Eytan  Ruppin (Cancer Data Science Laboratory),"Joseph  Rodriguez (NIEHS) |Carson C Chow; BASc, PhD (NIDDK) |Markus  Hafner (NIAMS)","1. Das S, Parker JM, Guven C, Wang W, Kriebel PW, Losert W, Larson DR, Parent CA (2017). Adenylyl cyclase mRNA localizes to the posterior of polarized DICTYOSTELIUM cells during chemotaxis. BMC Cell Biol  18, 23.   https://doi.org/10.1186/s12860-017-0139-7|2. Hendy O, Campbell J, Weissman JD, Larson DR, Singer DS (2017). Differential context-specific impact of individual core promoter elements on transcriptional dynamics. Mol Biol Cell  28, 3360-3370.   https://doi.org/10.1091/mbc.E17-06-0408|3. Ren G, Jin W, Cui K, Rodrigez J, Hu G, Zhang Z, Larson DR, Zhao K (2017). CTCF-Mediated Enhancer-Promoter Interaction Is a Critical Regulator of Cell-to-Cell Variation of Gene Expression. Mol Cell  67, 1049-1058.e6.   https://doi.org/10.1016/j.molcel.2017.08.026",https://intramural.nih.gov/search/searchview.taf?ipid=104000
338,BC011387-08,"October 01, 2017 -  September 30, 2018",Studies of gene fusions in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Salah  Boudjadi|Bishwanath  Chatterjee; PhD|Thanh Hung Nguyen|Wenyue  Sun|Prasantha Lakshmi Vemu|Markku Martti Miettinen|Show all 7,"Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Stephen  Skapek (The University of Chicago)|Lisa  Teot (Children's Hospital)|Erin  Rudzinski (Oregon Health and Science University)|Julie  Gastier-Foster (Nationwide Children's Hospital)|Michael  Arnold (Nationwide Childrenâ€™s Hospital)|Show all 9",Javed  Khan; MD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch),NULL,"1. Rudzinski ER, Anderson JR, Chi YY, Gastier-Foster JM, Astbury C, Barr FG, Skapek SX, Hawkins DS, Weigel BJ, Pappo A, Meyer WH, Arnold MA, Teot LA, Parham DM (2017). Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer  64.   https://doi.org/10.1002/pbc.26645",https://intramural.nih.gov/search/searchview.taf?ipid=104002
339,BC011390-08,"October 01, 2017 -  September 30, 2018",Vascular Biology Section,Pengnian Charles Lin; PhD|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jae Woo Hong|Wooram  Jung|Jingyi  Liu|Yongfen  Min|Peng  Qu|Howard A Young; PhD,"Michelle A. Petri; MD (Internal Medicine, Johns Hopkins University)|Dan  Berkowitz; MD (Johns Hopkins School of Medicine)|S  Wang (Adimmune Corporation)|Peter  Zhou (UNiversity of Kentuky)|Chuanshu  Huang (Nelson Institute of Environmental Medicine, New York University)",Lois  McKennett (Office Of The Director)|Shyam K Sharan (Genetics of Cancer Susceptibility Section)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics),Ilias  Alevizos; DMD (NIDCR),"1. Stone OA, Carter JG, Lin PC, Paleolog E, Machado MJ, Bates DO (2017). Differential regulation of blood flow-induced neovascularization and mural cell recruitment by vascular endothelial growth factor and angiopoietin signalling. J Physiol  595, 1575-1591.   https://doi.org/10.1113/JP273430",https://intramural.nih.gov/search/searchview.taf?ipid=104003
340,BC011391-08,"October 01, 2017 -  September 30, 2018",Role of IKK alpha in lung cancer development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Sayantan  Banerjee|Gongping  Shi|Na-Young  Song; PhD|Jami D Willette brown|Giorgio  Trinchieri,Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Nancy  Jenkins (Houston Methodist Research Institute),Curtis  Harris; MD (Laboratory of Human Carcinogenesis),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104004
341,BC011393-08,"October 01, 2017 -  September 30, 2018",Development and regulation of stem cell lineages in skin,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,Sunny  Wong (University of Michigan)|Radhika  Atit (Case Western Reserve University),NULL,Keisuke  Nagao (NIAMS) |Matthew William Kelley; PhD (NIDCD),"1. Barkdull S, Brownell I (2017). PD-L1 blockade with avelumab: A new paradigm for treating Merkel cell carcinoma. Cancer Biol Ther  18, 937-939.   https://doi.org/10.1080/15384047.2017.1394552|2. Carroll TM, Williams JS, Daily K, Rogers T, Gelb T, Coxon A, Wang SQ, Crago AM, Busam KJ, Brownell I (2017). Hedgehog Signaling Inhibitors Fail to Reduce Merkel Cell Carcinoma Viability. J Invest Dermatol  137, 1187-1190.   https://doi.org/10.1016/j.jid.2017.01.008|3. Dasgeb B, Kornreich D, McGuinn K, Okon L, Brownell I, Sackett DL (2018). Colchicine: an ancient drug with novel applications. Br J Dermatol  178, 350-356.   https://doi.org/10.1111/bjd.15896|4. Eid M, Nguyen J, Brownell I (2017). Seeking Standards for the Detection of Merkel Cell Polyomavirus and its Clinical Significance. J Invest Dermatol  137, 797-799.   https://doi.org/10.1016/j.jid.2016.12.024|5. Gaiser MR, Bongiorno M, Brownell I (2018). PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma. Expert Rev Clin Pharmacol  11, 345-359.   https://doi.org/10.1080/17512433.2018.1445966|6. Gaiser MR, Weis CA, Gaiser T, Jiang H, Buder-Bakhaya K, Herpel E, Warth A, Xiao Y, Miao L, Brownell I (2018). Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells. Oncoimmunology  7, e1426517.   https://doi.org/10.1080/2162402X.2018.1426517|7. Kaufman HL, Russell JS, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Milella M, Brownell I, Lewis KD, Lorch JH, von Heydebreck A, Hennessy M, Nghiem P (2018). Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial. J Immunother Cancer  6, 7.   https://doi.org/10.1186/s40425-017-0310-x",https://intramural.nih.gov/search/searchview.taf?ipid=104005
342,BC011394-08,"October 01, 2017 -  September 30, 2018",Molecular pathogenesis and therapy innovation for Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,"Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Emily Yu-Kuang Chu; MD, PhD|Clayton  Green (Marshfield Clinic)|Bahar  Dasgeb (Memorial Sloan Ketting Cancer Center)|Show all 9","Christopher  Buck (Laboratory of Cellular Oncology)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Chyi-Chia Richard Lee (Laboratory of Pathology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)",Jay Robert Knutson; PhD (NHLBI) |Amir Hossein Gandjbakhche; PhD (NICHD) |Matthew David Hall (NCATS) |Madhu A Lal (NCATS),"1. Harms PW, Harms KL, Moore PS, DeCaprio JA, Nghiem P, Wong MKK, Brownell I, International Workshop on Merkel Cell Carcinoma Research (IWMCC) Working Group (2018). The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. Nat Rev Clin Oncol  15, 763-776.   https://doi.org/10.1038/s41571-018-0103-2",https://intramural.nih.gov/search/searchview.taf?ipid=104006
343,BC011398-08,"October 01, 2017 -  September 30, 2018",Regulation of Ciliogenesis and Ciliary-related signaling,Christopher John Westlake; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI","Adrian Alejandro Cuenca; MHS, PhD|Christine Antoinette Kettenhofen; PhD|Quanlong  Lu; PhD|Mihindukulasuriya Weliweriyage Sumeth Perera; DPHIL|Huijie  Zhao|Deborah K Morrison",Andrew  Peden (University of Sheffield)|Esben  Lorentzen (Max Plank Institute for  Biochemistry)|Jeffery  Axelrod (Standford)|Steve H Caplan; PhD (NICHD)|Chad  Pearson (University Of Colorado)|Lotte  Pedersen (University Of Copenhagen)|Show all 7,Kedar  Narayan (Office of the Director)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Peter F Johnson; PhD (Mouse Cancer Genetics Program),Anand  Swaroop; PhD (NEI) |Kapil  Bharti; PhD (NEI) |Richard D Leapman; PhD (NIBIB),"1. Shimada H, Lu Q, Insinna-Kettenhofen C, Nagashima K, English MA, Semler EM, Mahgerefteh J, Cideciyan AV, Li T, Brooks BP, Gunay-Aygun M, Jacobson SG, Cogliati T, Westlake CJ, Swaroop A (2017). In Vitro Modeling Using Ciliopathy-Patient-Derived Cells Reveals Distinct Cilia Dysfunctions Caused by CEP290 Mutations. Cell Rep  20, 384-396.   https://doi.org/10.1016/j.celrep.2017.06.045",https://intramural.nih.gov/search/searchview.taf?ipid=104007
344,BC011405-08,"October 01, 2017 -  September 30, 2018",microRNA Profiling in the Spectrum of Kidney Tumors,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Xu  Naizhen|Mark  Raffeld; MD,NULL,"William Marston Linehan; MD (Urologic Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Mark Wayne Ball (Urologic Oncology Branch)|Jennifer Clare Jones; MD, PhD (Vaccine Branch)|Vladmir Alexander Valera Romero; MD, PhD (Urologic Oncology Branch)","Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104008
345,BC011406-08,"October 01, 2017 -  September 30, 2018",miRNA profiling  of prostate cancer in young and older male patients,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Xu  Naizhen|David D Roberts; PhD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|William Laurence Dahut; MD (Office Of The Clinical Director)|Jennifer Clare Jones; MD, PhD (Vaccine Branch)|Vladmir Alexander Valera Romero; MD, PhD (Urologic Oncology Branch)",NULL,"1. Navaei AH, Walter BA, Moreno V, Pack SD, Pinto P, Merino MJ (2017). Correlation between ERG Fusion Protein and Androgen Receptor Expression by Immunohistochemistry in Prostate, Possible Role in Diagnosis and Therapy. J Cancer  8, 2604-2613.   https://doi.org/10.7150/jca.16751",https://intramural.nih.gov/search/searchview.taf?ipid=104009
346,BC011407-08,"October 01, 2017 -  September 30, 2018",The International DIPG Registry,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,Maryam  Fouladi (Cincinnati Children's Hospital Center)|Dannis  van Vuurden (VU University medical Center)|Darren  Hargrave (Great ormond Street Hospital for Children)|Chris  Jones (Institute of Cancer Research)|Ute  Bartels (Hospital for Sick Children),NULL,NULL,"1. Baugh J, Bartels U, Leach J, Jones B, Chaney B, Warren KE, Kirkendall J, Doughman R, Hawkins C, Miles L, Fuller C, Hassall T, Bouffet E, Lane A, Hargrave D, Grill J, Hoffman LM, Jones C, Towbin A, Savage SA, Monje M, Li XN, Ziegler DS, Veldhuijzen van Zanten S, Kramm CM, et al. [2 more authors] (2017). The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease. J Neurooncol  132, 323-331.   https://doi.org/10.1007/s11060-017-2372-5",https://intramural.nih.gov/search/searchview.taf?ipid=104010
347,BC011408-08,"October 01, 2017 -  September 30, 2018",Comparison of substrate specificities of wild type and mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104011
348,BC011410-08,"October 01, 2017 -  September 30, 2018",Protein phosphorylation downstream of mutant EGFR kinases,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Shivangi  Awasthi|Tapan Kumar Maity|Xu  Zhang,"Andrea  Califano; PhD|Cathy  Wu (Protein Information Resource, Georgetown University)|Teresa  Fan (University of Louisville)",NULL,NULL,"1. Zhang X, Maity T, Kashyap MK, Bansal M, Venugopalan A, Singh S, Awasthi S, Marimuthu A, Charles Jacob HK, Belkina N, Pitts S, Cultraro CM, Gao S, Kirkali G, Biswas R, Chaerkady R, Califano A, Pandey A, Guha U (2017). Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response. Mol Cell Proteomics  16, 891-910.   https://doi.org/10.1074/mcp.M117.067439",https://intramural.nih.gov/search/searchview.taf?ipid=104012
349,BC011412-08,"October 01, 2017 -  September 30, 2018",Role of MIG6 in mutant EGFR-driven lung tumorigenesis,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Constance M Cultraro|Abhilash  Venugopalan,NULL,NULL,Xiaoyuan  Chen; PhD (NIBIB),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104013
350,BC011414-08,"October 01, 2017 -  September 30, 2018",Identification of potentially active tyrosine kinases in lung cancer,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Tapan Kumar Maity,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104014
351,BC011415-08,"October 01, 2017 -  September 30, 2018",Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Jennifer  Brudno|Judith Lorraine Lawrence; RN|Danielle Anne Vanasse|Ronald E Gress; MD|Luca  Gattinoni,NULL,"Lekha  Mikkilineni; MD (Office Of The Clinical Director)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104015
352,BC011417-08,"October 01, 2017 -  September 30, 2018",Improved Chimeric Antigen Receptor Therapies B-cell Malignancies,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Christina  Amatya|Jennifer  Brudno|Norris Lio Lam|Danielle Anne Vanasse|Shicheng  Yang,"Adrian  Bot (Kite Pharma, Inc.)|Scott  Rodig (Brigham And Women's Hospital)","Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Mitchell  Ho (Laboratory of Molecular Biology)",David F Stroncek; MD (CC),"1. Alabanza L, Pegues M, Geldres C, Shi V, Wiltzius JJW, Sievers SA, Yang S, Kochenderfer JN (2017). Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains. Mol Ther  25, 2452-2465.   https://doi.org/10.1016/j.ymthe.2017.07.013",https://intramural.nih.gov/search/searchview.taf?ipid=104016
353,BC011418-08,"October 01, 2017 -  September 30, 2018",Modulating Cancer Stem Cell Signaling in Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI","Julie A Hong|Vivek  Shukla; BSc, MSc|Sichuan  Xi|Mary R Zhang",NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104017
354,BC011419-08,"October 01, 2017 -  September 30, 2018",Structural Biology of GTPase Activating Proteins,Robert Andrew Byrd|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Jess R Li|Yifei  Li|Olivier Francois Andre  Soubias; PhD|Yue  Zhang,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Di S Xia; PhD, MS, BS (Crystallography Section)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104018
355,BC011422-07,"October 01, 2017 -  September 30, 2018",Role of IKK alpha in lymphoid organ development,Yinling  Hu|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Jami D Willette brown|Feng  Zhu; PhD|Giorgio  Trinchieri,Michael W Karin|Xiaoxia  Li (Lerner Research Institute)|Florian  Greten (The International Max Planck Research School for Molecular and Cellular Life Sciences),NULL,NULL,"1. Diamanti MA, Gupta J, Bennecke M, De Oliveira T, Ramakrishnan M, Braczynski AK, Richter B, Beli P, Hu Y, Saleh M, Mittelbronn M, Dikic I, Greten FR (2017). IKKα controls ATG16L1 degradation to prevent ER stress during inflammation. J Exp Med  214, 423-437.   https://doi.org/10.1084/jem.20161867",https://intramural.nih.gov/search/searchview.taf?ipid=104036
356,BC011423-07,"October 01, 2017 -  September 30, 2018",Epigenetic studies in rhabdomyosarcoma,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Bishwanath  Chatterjee; PhD|Radhika Sanjeev Gholap|Wenyue  Sun|Stephen M Hewitt; MD, PhD",Corinne  Linardic (Duke University)|Peter  Houghton (Greehey Children's Cancer Research Institute)|Bruce  Pawel (Children's Hospital of Philadelphia),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|John Frederick Shern (Pediatric Oncology Branch)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,"1. Arnold MA, Barr FG (2017). Molecular diagnostics in the management of rhabdomyosarcoma. Expert Rev Mol Diagn  17, 189-194.   https://doi.org/10.1080/14737159.2017.1275965|2. Boudjadi S, Chatterjee B, Sun W, Vemu P, Barr FG (2018). The expression and function of PAX3 in development and disease. Gene  666, 145-157.   https://doi.org/10.1016/j.gene.2018.04.087",https://intramural.nih.gov/search/searchview.taf?ipid=104042
357,BC011426-07,"October 01, 2017 -  September 30, 2018",HIV-1 Integrase,Stephen H Hughes; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Dimiter  Demirov; PhD|Andrea L Ferris|Shuang  Guo; PhD|Katharine Kim Hewlett|Steven J Smith|David  Wells,"Eddy  Arnold; PhD (Chemistry and Chemical Biology, CABM and Rutgers University)|Zandrea  Ambrose (University of Pittsburgh)|Alan  Engelman; PhD (Dana-Farber, Harvard University)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Peter  Cherepanov (Imperial College London)|Eric  Poeschla (University of Colorado)|Show all 10",Frank  Maldarelli (Host Virus Interaction Branch)|Xiaolin  Wu; PhD (Office Of The Director)|Jeffrey D Lifson; MD (Office Of The Director)|Mary  Kearney (Host Virus Interaction Branch)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Joel Patrick Schneider; PhD (Chemical Biology Laboratory),Henry L Levin; PhD (NICHD) |Daniel C Douek; MD (NIAID),"1. Bui JK, Sobolewski MD, Keele BF, Spindler J, Musick A, Wiegand A, Luke BT, Shao W, Hughes SH, Coffin JM, Kearney MF, Mellors JW (2017). Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir. PLoS Pathog  13, e1006283.   https://doi.org/10.1371/journal.ppat.1006283|2. Zhao XZ, Smith SJ, Maskell DP, Métifiot M, Pye VE, Fesen K, Marchand C, Pommier Y, Cherepanov P, Hughes SH, Burke TR (2017). Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors. J Med Chem  60, 7315-7332.   https://doi.org/10.1021/acs.jmedchem.7b00596",https://intramural.nih.gov/search/searchview.taf?ipid=104019
358,BC011427-07,"October 01, 2017 -  September 30, 2018",Immunohistochemical analysis of tumors,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104043
359,BC011431-07,"October 01, 2017 -  September 30, 2018",Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yukun  Guan; PhD,NULL,NULL,Dorian  McGavern (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104046
360,BC011433-07,"October 01, 2017 -  September 30, 2018",The role of coherent angular motion in adult tissue remodeling,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Hannah Alison Burr|Jack Rory Staunton; PhD,NULL,NULL,NULL,"1. Staunton JR, Blehm B, Devine A, Tanner K (2017). In situ calibration of position detection in an optical trap for active microrheology in viscous materials. Opt Express  25, 1746-1761.   https://doi.org/10.1364/OE.25.001746",https://intramural.nih.gov/search/searchview.taf?ipid=104049
361,BC011436-07,"October 01, 2017 -  September 30, 2018",Retroviral Replication and Interactions with Host Factors,Vinay K Pathak; PhD|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Michal Mateusz Bonar; PhD|Ryan C Burdick|Krista A Delviks-Frankenberry|Chenglei  Li; PhD|Mohamed Husen Mohamedhabib Munshi; PhD|Wei-Shau  Hu; PhD,NULL,Robert  Gorelick (Office Of The Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104022
362,BC011437-07,"October 01, 2017 -  September 30, 2018",Combinatorial genetic analysis using validated siRNA libraries,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Chih-Shia  Lee,Frank  McCormick (UCSF School of Medicine)|Scott  Lowe (Cold Spring Harbor Laboratory),Natasha  Caplen (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104038
363,BC011438-07,"October 01, 2017 -  September 30, 2018",Genetic screens for target discovery in cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Haibo  Zhang; PhD|Glenn  Merlino; PhD|Li  Yang; PhD|Stuart H Yuspa; MD,NULL,Yves  Pommier; PhD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104039
364,BC011439-07,"October 01, 2017 -  September 30, 2018",Development of Chimeric Antigen Receptors Targeting Multiple Myeloma,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Christina  Amatya|Jennifer  Brudno|Norris Lio Lam|Judith Lorraine Lawrence; RN|Danielle Anne Vanasse,NULL,"Lekha  Mikkilineni; MD (Office Of The Clinical Director)|Steven A Feldman (Surgery Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Philippe Bijin Youkharibache; PhD (Cancer Data Science Laboratory)",David F Stroncek; MD (CC) |Irina  Maric; MD (CC),"1. Mikkilineni L, Kochenderfer JN (2017). Chimeric antigen receptor T-cell therapies for multiple myeloma. Blood  130, 2594-2602.   https://doi.org/10.1182/blood-2017-06-793869",https://intramural.nih.gov/search/searchview.taf?ipid=104035
365,BC011441-07,"October 01, 2017 -  September 30, 2018",Cell density effects on therapeutic sensitivity,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alan Surya Halim|Deven Shankarbhai Patel|Qian  Sun|Kevin A Camphausen; MD,NULL,Fahim  Ahmad; PhD (Molecular Imaging Program)|Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Eric  Batchelor; PhD (Laboratory of Pathology)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104040
366,BC011443-07,"October 01, 2017 -  September 30, 2018",Single-Molecule Spectroscopy of HIV-1 Replication Complexes,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Fardokht Assadi Abulwerdi|Samantha Beatrice Gacasan|Stefano  Ginocchio|Regan Michael Leblanc|Jennifer T Miller|Julie Marie Nyman|Show all 9,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104021
367,BC011447-07,"October 01, 2017 -  September 30, 2018",Early Clinical Trials for Children with CNS Tumors,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Pamela  Wolters|John Walter Glod,"Roger  Packer (CNMC)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Maryam  Fouladi (Cincinnati Children's Hospital Center)|Mark  Kieran (Children's Hospital)|Michelle  Monje-Deisseroth (Stanford)|Sean Joseph Hipp|Show all 8",William D Figg; PharmD (Genitourinary Malignancies Branch),"Nicholas  Patronas; MD (CC) |Eva Halle Baker; MD, PhD (CC) |John D Heiss; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104033
368,BC011449-07,"October 01, 2017 -  September 30, 2018",Identification of Inhibitors of Protein Sumoylation,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Robert Edward Boer|David Raymond Calabrese; PhD|Colleen Marie Connelly|William Merton Hewitt|Thomas Aaron Hilimire|Sara Nicole Journey|Show all 8,NULL,David S Waugh; PhD (Protein Engineering Section)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory),NULL,"1. Schneekloth JS (2017). Drug discovery: Controlling protein SUMOylation. Nat Chem Biol  13, 1141-1142.   https://doi.org/10.1038/nchembio.2496",https://intramural.nih.gov/search/searchview.taf?ipid=104044
369,BC011450-07,"October 01, 2017 -  September 30, 2018",Clinical treatment of advanced Merkel cell carcinoma,"Isaac Franklin Brownell; MD, PhD|IRP Faculty Profile",NULL,"Dermatology Branch, NCI",NULL,Klaus  Busam (Memorial Sloan-Kettering)|Daniel  Coit (Memorial Sloan-Kettering)|Jedd  Wolchok (Memorial Sloan-Kettering)|Sandra  D'Angelo (Memorial Sloan-Kettering Cancer Center)|Sacha  Gnjatic (Icahn School of Medicine Mount Sinai),"Christopher  Buck (Laboratory of Cellular Oncology)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",Heidi H Kong (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104041
370,BC011458-07,"October 01, 2017 -  September 30, 2018",Molecular Targeted Photoimmunotherapy for Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar|Mohammad Rashid Siddiqui,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Peter L Choyke; MD (Molecular Imaging Program)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Anu  Puri; PhD (Rna Biology Laboratory)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104048
371,BC011459-07,"October 01, 2017 -  September 30, 2018",Control of centrosome biogenesis,Jadranka  Loncarek|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Dong  Kong; PhD|Kimberly Racine Lukasik|Natalie Ashenka Sahabandu|Catherine Elaine Sullenberger|Alejandra  Vasquez Limeta; PhD|Allan M Weissman; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104045
372,BC011460-07,"October 01, 2017 -  September 30, 2018",BKV and JCV vaccine development,Christopher  Buck|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Diana  Pastrana|Alberto  Peretti; PhD|Gabriel James Starrett; PhD|Michael Joseph Tisza|Nicole Lynne Welch,Paola  Cinque (San Raffaele Milan)|Patrick  McTamney,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104025
373,BC011461-07,"October 01, 2017 -  September 30, 2018",HIV-1 evasion of cytosolic factors,Vineet Narain KewalRamani; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Szu-Wei  Huang; PhD|Kyeongeun  Lee|Sekou-Tidiane T Yoda,Jeremy  Luban (Columbia University)|Irene  Pedersen (University of California - Irvine),Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104020
374,BC011464-07,"October 01, 2017 -  September 30, 2018",Clinical Interventional Studies of HIV Reservoirs,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Jennifer Marie Bell|Monica Ann Gouzoulis|Pamela Jo Harris|Shawn A Hill|James Quinn Virga|Mary  Kearney,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|Erin  Reid (University of California San Diego)|John  Coffin (Tufts University)|John A Zaia|Show all 10,"Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Bradford J Wood; MD (Office of the Director)|Robert  Gorelick (Office Of The Director)",Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID) |Irini  Sereti; MD (NIAID) |Michael  Proschan; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104026
375,BC011465-07,"October 01, 2017 -  September 30, 2018",c-Myc Function,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Fedor Edmundovich Kouzine|Brian  Lewis|Zuqin  Nie; PhD|Ying  Zheng,NULL,Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Keji  Zhao; PhD (NHLBI) |Craig Joseph Thomas (NCATS) |Rafael Cristian Casellas; PhD (NIAMS),"1. Zheng Y, Levens D (2017). Enhancers not required. Elife  6.   https://doi.org/10.7554/eLife.28339",https://intramural.nih.gov/search/searchview.taf?ipid=104024
376,BC011466-07,"October 01, 2017 -  September 30, 2018",HIV Persistence During Suppressive Antiretroviral Therapy,Frank  Maldarelli|IRP Faculty Profile,NULL,"Host Virus Interaction Branch, NCI",Elizabeth M Anderson|Jennifer Marie Bell|Monica Ann Gouzoulis|Pamela Jo Harris|Shawn A Hill|Kristi  Huik; PhD|Show all 10,Anuradha  Ganesan (Henry M. Jackson Foundation)|John W Mellors|Deborah  McMahon (University of Pittsburgh)|Jantenat  Ananworanich (HIV Netherlands Australia Thailand Research Collaboration (HIV/NAT))|John  Coffin (Tufts University),Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory),Henry  Masur; MD (CC) |Richard T Davey; MD (NIAID) |Michael  Polis; MD (NIAID) |Mark  Connors; MD (NIAID) |H. Clifford  Lane; MD (NIAID) |Joann  Mican; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104027
377,BC011469-07,"October 01, 2017 -  September 30, 2018",Building Libraries with Chemical Diversity for Screening,John A Beutler,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Ekaterina  Goncharo|Cheryl L Thomas,John  Porco (Boston University)|Peter  Wipf (University of Pittsburgh)|Young Ho  Kim|Michael  Goetz (Baruch Blumberg Institute)|Laila  Espindola (University of Brasilia)|Pedro  Rosalen (University of Campinas),NULL,NULL,"1. Cho N, Ransom TT, Sigmund J, Tran T, Cichewicz RH, Goetz M, Beutler JA (2017). Growth Inhibition of Colon Cancer and Melanoma Cells by Versiol Derivatives from a Paraconiothyrium Species. J Nat Prod  80, 2037-2044.   https://doi.org/10.1021/acs.jnatprod.7b00170",https://intramural.nih.gov/search/searchview.taf?ipid=104029
378,BC011470-07,"October 01, 2017 -  September 30, 2018",Development of Natural Product Leads as Anticancer Therapeutics,John A Beutler,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Marshall Steven Darby|Esra  Eroglu Ozkan|Ekaterina  Goncharo|Dongdong  Wang,"William  Chain (University of Hawaii)|Kathlyn  Parker (Stony Brook University)|Antonio  Echavarren (Institute of Chemical Research of Catalonia)|Ryan  Murelli (Brooklyn College)|David  Wiemer (organic synthesis/molecular target identification, University of Iowa)|David  Beech (University of Leeds School of Medicine)","William Marston Linehan; MD (Urologic Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Karlyne M Reilly; BS, PhD (Pediatric Oncology Branch)",NULL,"1. Elliott DC, Beutler JA, Parker KA (2017). Importance of a 4-Alkyl Substituent for Activity in the Englerin Series. ACS Med Chem Lett  8, 746-750.   https://doi.org/10.1021/acsmedchemlett.7b00161|2. Stockdale DP, Beutler JA, Wiemer DF (2017). Synthesis of amide isosteres of schweinfurthin-based stilbenes. Bioorg Med Chem  25, 5483-5489.   https://doi.org/10.1016/j.bmc.2017.08.016|3. Wu Z, Zhao S, Fash DM, Li Z, Chain WJ, Beutler JA (2017). Englerins: A Comprehensive Review. J Nat Prod  80, 771-781.   https://doi.org/10.1021/acs.jnatprod.6b01167",https://intramural.nih.gov/search/searchview.taf?ipid=104030
379,BC011471-07,"October 01, 2017 -  September 30, 2018",Cell-free assay technologies for the identification of active compounds,Barry R O'Keefe,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Tadeusz P Guszczynski|Lauren R Haugh Krumpe|Shilpa R Kurian|Joe Sumagang Matarlo; PhD|Brice Alexander Pitt Wilson|Kirk R Gustafson; PhD,NULL,"Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Kylie Janice Walters (Structural Biophysics Laboratory)|Ping  Zhang (Structural Biophysics Laboratory)",NULL,"1. Aimaiti S, Suzuki A, Saito Y, Fukuyoshi S, Goto M, Miyake K, Newman DJ, O'Keefe BR, Lee KH, Nakagawa-Goto K (2018). Corymbulosins I-W, Cytotoxic Clerodane Diterpenes from the Bark of Laetia corymbulosa. J Org Chem  83, 951-963.   https://doi.org/10.1021/acs.joc.7b02951|2. Mitchell CA, Ramessar K, O'Keefe BR (2017). Antiviral lectins: Selective inhibitors of viral entry. Antiviral Res  142, 37-54.   https://doi.org/10.1016/j.antiviral.2017.03.007|3. Suzuki A, Saito Y, Fukuyoshi S, Goto M, Miyake K, Newman DJ, O'Keefe BR, Lee KH, Nakagawa-Goto K (2017). Corymbulosins D-H, 2-Hydroxy- and 2-Oxo-clerodane Diterpenes from the Bark of Laetia corymbulosa. J Nat Prod  80, 1065-1072.   https://doi.org/10.1021/acs.jnatprod.6b01151|4. Suzuki Y, Saito Y, Goto M, Newman DJ, O'Keefe BR, Lee KH, Nakagawa-Goto K (2017). (-)-Neocaryachine, an Antiproliferative Pavine Alkaloid from Cryptocarya laevigata, Induces DNA Double-Strand Breaks. J Nat Prod  80, 220-224.   https://doi.org/10.1021/acs.jnatprod.6b01153|5. Tsurumi F, Miura Y, Saito Y, Miyake K, Fujie T, Newman DJ, O'Keefe BR, Lee KH, Nakagawa-Goto K (2018). Secondary Metabolites, Monoterpene-Polyketides Containing a Spiro[3.5]nonane from Cryptocarya laevigata. Org Lett  20, 2282-2286.   https://doi.org/10.1021/acs.orglett.8b00624",https://intramural.nih.gov/search/searchview.taf?ipid=104031
380,BC011472-07,"October 01, 2017 -  September 30, 2018",Isolation of bioactive proteins from natural product extracts,Barry R O'Keefe,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",Lauren R Haugh Krumpe|Carter Alexander Mitchell; PhD|Brice Alexander Pitt Wilson,"Kenneth E. Palmer; PhD (Department of Pharmacology and Toxicology, University of Louisville)|Elibio  Rech (Embrapa, Brasil)|Paul  Christou (Universitat de Lleida)|Robert Walter Buckheit (RETROVIRAL REPLICATION LABORATORY)|Romero  Jose (The Population Council)|John  Samuelson (Boston University)|Show all 8",Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104032
381,BC011476-06,"October 01, 2017 -  September 30, 2018",Studies of the fate of environmental contaminants in humans and animals,Linda Silber Birnbaum; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Marian  Pavuk (CDC)|Arnold  Schecter (NIEHS)|Hoang  Quynh (University of Hanoi)|Steven T Szabo|Michael  Hughes (U.S. Environmental Protection Agency),Sherry Jones Coulter; BS (Basic Research Laboratory)|Gabriel Arther Knudsen (Basic Research Laboratory)|Alicia Carolyn Richards (Basic Research Laboratory)|Andrew William Trexler (Basic Research Laboratory),"Gaylia Jean Harry; PhD (NIEHS) |Stavros  Garantziotis; MD (NIEHS) |Suzanne Elizabeth Fenton; MS, PhD (NIEHS) |Shepherd H Schurman; MD (NIEHS) |Douglas  Bell; PhD (NIEHS)","1. Callahan CL, Pavuk M, Birnbaum LS, Ren X, Olson JR, Bonner MR (2017). Serum polychlorinated biphenyls and leukocyte telomere length in a highly-exposed population: The Anniston Community Health Survey. Environ Int  108, 212-220.   https://doi.org/10.1016/j.envint.2017.08.018|2. Knudsen GA, Sanders JM, Hughes MF, Hull EP, Birnbaum LS (2017). The biological fate of decabromodiphenyl ethane following oral, dermal or intravenous administration. Xenobiotica  47, 894-902.   https://doi.org/10.1080/00498254.2016.1250180",https://intramural.nih.gov/search/searchview.taf?ipid=104088
382,BC011479-06,"October 01, 2017 -  September 30, 2018",T-cell receptor gene therapy for cancer,Christian S Hinrichs|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",John Stephen Davies; BS|Lindsey Meredith Draper|Benjamin Yongzhu Jin|Bridget Clare Marcinkowski|Nisha Bharat Nagarsheth|Carylinda  Serna|Show all 8,NULL,Christina M Annunziata (Womens Malignancies Branch),David F Stroncek; MD (CC) |Clint Tanner Allen (NIDCD) |Nicole Cherie Schmitt (NIDCD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104073
383,BC011480-06,"October 01, 2017 -  September 30, 2018",Programming T Cell Fates for Therapeutic Use,Luca  Gattinoni|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Jessica  Fioravanti; PhD|Sanjivan  Gautam|Jinhui  Hu|Yun  Ji|Neal Edward Lacey|John Brian Le Gall|Show all 8,"Pedro  Romero; MD (Ludwig Center for Cancer Research, University of Lausanne)|Yi  Zhang (Temple University)|Timothy  Bender (University of Virginia)",Nicholas Phillip Restifo; MD (Surgery Branch),David F Stroncek; MD (CC) |Mario  Roederer; PhD (NIAID) |Stefan Adi Muljo; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104058
384,BC011486-06,"October 01, 2017 -  September 30, 2018",Development of Novel Agents Active against Hepatitis B Virus,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Hiromi  Aoki|Manabu  Aoki; PhD|Debananda  Das; PhD|Yuki  Takamatsu; MD,"Masayuki  Amano (Kumamoto University School of Medicine)|Eiichi  Kodama (Kyoto University)|Nobuyo  Kuwata (National Center for Global Health & Medicine)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Satoru  Kohgo (National Center for Global Health & Medicine)|Yasuhito  Tanaka (na)|Show all 10",David J Venzon; PhD (Biostatistics and Data Management Section),NULL,"1. Huber AD, Michailidis E, Tang J, Puray-Chavez MN, Boftsi M, Wolf JJ, Boschert KN, Sheridan MA, Leslie MD, Kirby KA, Singh K, Mitsuya H, Parniak MA, Wang Z, Sarafianos SG (2017). 3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H. Antimicrob Agents Chemother  61.   https://doi.org/10.1128/AAC.00245-17",https://intramural.nih.gov/search/searchview.taf?ipid=104052
385,BC011487-06,"October 01, 2017 -  September 30, 2018",Systems-level analysis of the regulation and function of MYC,Eric  Batchelor; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Woo Seuk  Koh|David  Levens; PhD,NULL,Jayne M Stommel (Radiation Oncology Branch)|Ji  Luo (Laboratory of Cancer Biology and Genetics),NULL,"1. Harton MD, Batchelor E (2017). Determining the Limitations and Benefits of Noise in Gene Regulation and Signal Transduction through Single Cell, Microscopy-Based Analysis. J Mol Biol  429, 1143-1154.   https://doi.org/10.1016/j.jmb.2017.03.007",https://intramural.nih.gov/search/searchview.taf?ipid=104075
386,BC011488-06,"October 01, 2017 -  September 30, 2018",Defining and Manipulating Epigenomic Regulators in Endogenous Systems,Jordan Leslie Meier; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Sarah Elizabeth Bergholtz|Chloe Ann Briney|Rhushikesh Arun Kulkarni; PhD|Jonathan Harold Shrimp|Jeffrey Eduardo Lopez|Kellie D'Nee Nance|Show all 8,NULL,Abigail Lane Thorpe (Office Of The Director)|Shalini  Oberdoerffer (Laboratory of Receptor Biology and Gene Expression)|Carol J Thiele (Pediatric Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch),Anton  Simeonov (NCATS) |Ajit  Jadhav (NCATS),"1. Carrer A, Parris JL, Trefely S, Henry RA, Montgomery DC, Torres A, Viola JM, Kuo YM, Blair IA, Meier JL, Andrews AJ, Snyder NW, Wellen KE (2017). Impact of a High-fat Diet on Tissue Acyl-CoA and Histone Acetylation Levels. J Biol Chem  292, 3312-3322.   https://doi.org/10.1074/jbc.M116.750620|2. Cha J, Nani RR, Luciano MP, Kline G, Broch A, Kim K, Namgoong JM, Kulkarni RA, Meier JL, Kim P, Schnermann MJ (2018). A chemically stable fluorescent marker of the ureter. Bioorg Med Chem Lett  28, 2741-2745.   https://doi.org/10.1016/j.bmcl.2018.02.040|3. Dahlin JL, Nelson KM, Strasser JM, Barsyte-Lovejoy D, Szewczyk MM, Organ S, Cuellar M, Singh G, Shrimp JH, Nguyen N, Meier JL, Arrowsmith CH, Brown PJ, Baell JB, Walters MA (2017). Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors. Nat Commun  8, 1527.   https://doi.org/10.1038/s41467-017-01657-3",https://intramural.nih.gov/search/searchview.taf?ipid=104084
387,BC011490-06,"October 01, 2017 -  September 30, 2018",Ubiquitin signaling for protein degradation,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Brandon Jarrod Wright; PhD|Xiang  Chen|Danielle  Ebelle|Evan Douglas Hooper|Olumide R Kayode|Xiuxiu  Lu|Show all 8,Daniel  Finley (Harvard Medical School)|Richard  Roden (The Johns Hopkins University)|Lan  Huang,Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104085
388,BC011491-06,"October 01, 2017 -  September 30, 2018",Role of kinetochore proteins in chromosome segregation,Alexander Ernest Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Mary Kate  Bonner; PhD|Julian Bernd Haase|Hayden Samuel Saunders|Biyun  Li|Yawen  Bai; PhD,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),"Nasser M Rusan; PhD (NHLBI) |Antonina I Roll-Mecak; BE, PhD (NINDS)","1. Haase J, Bonner MK, Halas H, Kelly AE (2017). Distinct Roles of the Chromosomal Passenger Complex in the Detection of and Response to Errors in Kinetochore-Microtubule Attachment. Dev Cell  42, 640-654.e5.   https://doi.org/10.1016/j.devcel.2017.08.022",https://intramural.nih.gov/search/searchview.taf?ipid=104083
389,BC011492-06,"October 01, 2017 -  September 30, 2018","Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Ana  Robles,"Ping  Yang; MD, PhD (Mayo Clinic)|Wataru  Yasui (Hiroshima University)",Kanke  Yasuyuki; MD (Molecular Genetics and Carcinogenesis Section)|Mohammed A. Khan; PhD (Molecular Genetics and Carcinogenesis Section)|Amelia Louise Parker (Molecular Genetics and Carcinogenesis Section)|Elisa A Spillare (Molecular Genetics and Carcinogenesis Section)|Judith A Welsh (Molecular Genetics and Carcinogenesis Section)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,"1. Balatti V, Nigita G, Veneziano D, Drusco A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu CG, Palamarchuk A, Hart JR, Bell C, Carosi M, Pescarmona E, Perracchio L, Diodoro M, Russo A, Antenucci A, Visca P, Ciardi A, Harris CC, Vogt PK, Pekarsky Y, Croce CM (2017). tsRNA signatures in cancer. Proc Natl Acad Sci U S A  114, 8071-8076.   https://doi.org/10.1073/pnas.1706908114|2. Ben Khedher S, Neri M, Papadopoulos A, Christiani DC, Diao N, Harris CC, Olivo-Marston S, Schwartz AG, Cote M, Koushik A, Siemiatycki J, Landi MT, Hung RJ, McLaughlin J, Duell EJ, Andrew AS, Orlow I, Park BJ, Brenner H, Saum KU, Pesatori AC, Stücker I (2017). Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium. Int J Cancer  141, 309-323.   https://doi.org/10.1002/ijc.30750|3. George J, Saito M, Tsuta K, Iwakawa R, Shiraishi K, Scheel AH, Uchida S, Watanabe SI, Nishikawa R, Noguchi M, Peifer M, Jang SJ, Petersen I, Büttner R, Harris CC, Yokota J, Thomas RK, Kohno T (2017). Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer. Clin Cancer Res  23, 1220-1226.   https://doi.org/10.1158/1078-0432.CCR-16-1069|4. Li XL, Subramanian M, Jones MF, Chaudhary R, Singh DK, Zong X, Gryder B, Sindri S, Mo M, Schetter A, Wen X, Parvathaneni S, Kazandjian D, Jenkins LM, Tang W, Elloumi F, Martindale JL, Huarte M, Zhu Y, Robles AI, Frier SM, Rigo F, Cam M, Ambs S, Sharma S, et al. [4 more authors] (2017). Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer. Cell Rep  20, 2408-2423.   https://doi.org/10.1016/j.celrep.2017.08.041|5. Noro R, Ishigame T, Walsh N, Shiraishi K, Robles AI, Ryan BM, Schetter AJ, Bowman ED, Welsh JA, Seike M, Gemma A, Skaug V, Mollerup S, Haugen A, Yokota J, Kohno T, Harris CC (2017). A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts. J Thorac Oncol  12, 65-76.   https://doi.org/10.1016/j.jtho.2016.08.141|6. Robles AI, Harris CC (2017). Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djw328",https://intramural.nih.gov/search/searchview.taf?ipid=104053
390,BC011495-06,"October 01, 2017 -  September 30, 2018",Integrative Molecular Epidemiology of Human Cancer,Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Elise Dawn Bowman|Akihiko  Miyanaga; MD|Ana  Robles,NULL,Mohammed A. Khan; PhD (Molecular Genetics and Carcinogenesis Section)|Elisa A Spillare (Molecular Genetics and Carcinogenesis Section)|Judith A Welsh (Molecular Genetics and Carcinogenesis Section),NULL,"1. Fehringer G, Brenner DR, Zhang ZF, Lee YA, Matsuo K, Ito H, Lan Q, Vineis P, Johansson M, Overvad K, Riboli E, Trichopoulou A, Sacerdote C, Stucker I, Boffetta P, Brennan P, Christiani DC, Hong YC, Landi MT, Morgenstern H, Schwartz AG, Wenzlaff AS, Rennert G, McLaughlin JR, Harris CC, et al. [31 more authors] (2017). Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study. Int J Cancer  140, 1976-1984.   https://doi.org/10.1002/ijc.30618|2. Gardner LD, Loffredo PhD CA, Langenberg P, George DMS, Deepak J, Harris CC, Amr S (2018). Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race. Ann Epidemiol  28, 543-548.   https://doi.org/10.1016/j.annepidem.2018.04.012|3. Harris CC (2018). Tobacco smoking, E-cigarettes, and nicotine harm. Proc Natl Acad Sci U S A  115, 1406-1407.   https://doi.org/10.1073/pnas.1722636115|4. Haznadar M, Krausz KW, Margono E, Diehl CM, Bowman ED, Manna SK, Robles AI, Ryan BM, Gonzalez FJ, Harris CC (2018). Inverse association of vitamin D3 levels with lung cancer mediated by genetic variation. Cancer Med  7, 2764-2775.   https://doi.org/10.1002/cam4.1444",https://intramural.nih.gov/search/searchview.taf?ipid=104054
391,BC011496-06,"October 01, 2017 -  September 30, 2018","p53, Aging, and Cancer",Curtis  Harris; MD|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Jessica Ann Beck|Izumi  Horikawa|Kazunobu  Isogaya|Akriti  Trehan|Natalia  von Muhlinen; PhD,NULL,"Tomer  Cooks (Molecular Genetics and Carcinogenesis Section)|Delphine  Lissa; PHARMD, PhD (Molecular Genetics and Carcinogenesis Section)|Abdul Matin Mondal (Molecular Genetics and Carcinogenesis Section)|Elisa A Spillare (Molecular Genetics and Carcinogenesis Section)|Ettore  Appella; MD (Chemical Immunology Section)",NULL,"1. Horikawa I, Harris CC (2017). Δ133p53: A p53 isoform enriched in human pluripotent stem cells. Cell Cycle  16, 1631-1632.   https://doi.org/10.1080/15384101.2017.1345228|2. Horikawa I, Park KY, Isogaya K, Hiyoshi Y, Li H, Anami K, Robles AI, Mondal AM, Fujita K, Serrano M, Harris CC (2017). Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells. Cell Death Differ  24, 1017-1028.   https://doi.org/10.1038/cdd.2017.48|3. Ohkouchi C, Kumamoto K, Saito M, Ishigame T, Suzuki SI, Takenoshita S, Harris CC (2017). ING2, a tumor associated gene, enhances PAI‑1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C‑terminal. Mol Med Rep  16, 7367-7374.   https://doi.org/10.3892/mmr.2017.7553",https://intramural.nih.gov/search/searchview.taf?ipid=104055
392,BC011501-06,"October 01, 2017 -  September 30, 2018",Regulation and functional effects of localized RNAs,Stavroula  Mili|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",George Constantine Chrisafis|Konstadinos  Moissoglu|Michael Scott Stueland|Tianhong  Wang,Helim  Aranda-Espinoza (University of Maryland)|James  Shorter (MIT)|Kimberly  Stroka (University Of Maryland),Stephen J Lockett; PhD (Office Of The Director),NULL,"1. Yasuda K, Clatterbuck-Soper SF, Jackrel ME, Shorter J, Mili S (2017). FUS inclusions disrupt RNA localization by sequestering kinesin-1 and inhibiting microtubule detyrosination. J Cell Biol  216, 1015-1034.   https://doi.org/10.1083/jcb.201608022",https://intramural.nih.gov/search/searchview.taf?ipid=104080
393,BC011502-06,"October 01, 2017 -  September 30, 2018",Characterization of Biological Nanoparticle Subsets,"Jennifer Clare Jones; MD, PhD","Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI","Joshua Aden Welsh|Marjorie  Robert-Guroff; PhD|Masaki  Terabe|George N Pavlakis; MD, PhD|Katherine M McKinnon",Marty  Bigos (Stanford)|David  Park (Stanford)|Gordon  Freeman (Harvard)|Susan  Knox (Stanford)|Vasilis  Toxavidis (Beth Israel Deaconess Medical Center)|Tigges  John (BIDMC)|Show all 8,"William G Telford (Experimental Transplantation and Immunology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Anu  Puri; PhD (Rna Biology Laboratory)|Aparna Hemant Kesarwala (Radiation Oncology Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Peter L Choyke; MD (Molecular Imaging Program)",Julia Ann Kepley (OD) |Marc  Ferrer-Alegre (NCATS),"1. Datta A, Kim H, Lal M, McGee L, Johnson A, Moustafa AA, Jones JC, Mondal D, Ferrer M, Abdel-Mageed AB (2017). Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells. Cancer Lett  408, 73-81.   https://doi.org/10.1016/j.canlet.2017.08.020|2. Kato S, Berzofsky JA, Terabe M (2018). Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity. Front Immunol  9, 314.   https://doi.org/10.3389/fimmu.2018.00314|3. Maeng H, Terabe M, Berzofsky JA (2018). Cancer vaccines: translation from mice to human clinical trials. Curr Opin Immunol  51, 111-122.   https://doi.org/10.1016/j.coi.2018.03.001|4. Nolan JP, Jones JC (2017). Detection of platelet vesicles by flow cytometry. Platelets  28, 256-262.   https://doi.org/10.1080/09537104.2017.1280602|5. Terabe M, Robertson FC, Clark K, De Ravin E, Bloom A, Venzon DJ, Kato S, Mirza A, Berzofsky JA (2017). Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy. Oncoimmunology  6, e1308616.   https://doi.org/10.1080/2162402X.2017.1308616",https://intramural.nih.gov/search/searchview.taf?ipid=104081
394,BC011503-06,"October 01, 2017 -  September 30, 2018",Novel Combinations of Radiation and Immunotherapy,"Jennifer Clare Jones; MD, PhD","Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI","George N Pavlakis; MD, PhD",Gordon  Freeman (Harvard)|Rosemarie  DeKruyff (Children's Hospital Boston)|Susan  Knox (Stanford),"Kevin A Camphausen; MD (Radiation Oncology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)|Kevin Charles Conlon (Lymphoid Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104082
395,BC011504-06,"October 01, 2017 -  September 30, 2018",Study the roles of p53 and p53 mutants in mesenchymal stem cells,Jing  Huang|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Yan  Fang|Shunlin  Jiang|Jian  Xu|Waseem  Alzamzami|Beverly  Mock; PhD,NULL,Rosandra N Kaplan (Pediatric Oncology Branch),Chengyu  Liu; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104066
396,BC011506-06,"October 01, 2017 -  September 30, 2018",New Synthetic Approaches to Small Molecules for Imaging,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Gabrielle Renee Hammersley|Michael Philip Luciano; PhD|Saghar  Nourian,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling)|Kirk R Gustafson; PhD (Molecular Targets Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104079
397,BC011511-06,"October 01, 2017 -  September 30, 2018",Chemical Targeting of Multi-Protein Complexes,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Francisco Antonio Aguilar Alonso; PhD|Merissa Lynnea Baxter|Ye Joon  Kim,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104071
398,BC011512-06,"October 01, 2017 -  September 30, 2018",Activatable molecular cancer imaging probe,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Yasuhiro  Maruoka|Fusa Ogata Motoki|Tadanobu  Nagaya|Yuko  Nakamura,Yasuteru  Urano|Marcin  Ptaszek (UMBC)|Yu  Chen (Univ of Maryland)|Neil  Bander (Cornell Univ),Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104064
399,BC011513-06,"October 01, 2017 -  September 30, 2018",Cancer-cell specific therapy: photo-immunotherapy,Hisataka  Kobayashi|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI","Daiki  Fujimura|Fuyuki  Inagaki; PhD, MD|Yasuhiro  Maruoka|Fusa Ogata Motoki|Tadanobu  Nagaya|Yuko  Nakamura|Show all 8",Mikako  Ogawa|Yu  Chen (Univ of Maryland)|Peter  Marinkovich (Stnford Univ)|Zaver  Bhujwalla (Johns Hopkins)|Toshiyoshi  Fujiwara (Okayama Univ),Mitchell  Ho (Laboratory of Molecular Biology)|Ira H Pastan; MD (Molecular Biology Section)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory),NULL,"1. Nani RR, Gorka AP, Nagaya T, Yamamoto T, Ivanic J, Kobayashi H, Schnermann MJ (2017). In Vivo Activation of Duocarmycin-Antibody Conjugates by Near-Infrared Light. ACS Cent Sci  3, 329-337.   https://doi.org/10.1021/acscentsci.7b00026|2. Tang Q, Nagaya T, Liu Y, Lin J, Sato K, Kobayashi H, Chen Y (2017). Real-time monitoring of microdistribution of antibody-photon absorber conjugates during photoimmunotherapy in vivo. J Control Release  260, 154-163.   https://doi.org/10.1016/j.jconrel.2017.06.004",https://intramural.nih.gov/search/searchview.taf?ipid=104065
400,BC011514-06,"October 01, 2017 -  September 30, 2018",Investigating Pediatric CNS tumor biology,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",NULL,"Charles  Eberhart (Pathology, Johns Hopkins University School of Medicine)|Eric H Raabe|Javad  Nazarian (Children's National Medical Center)|Michelle  Monje-Deisseroth (Stanford)|Nada  Jabado (McGill University)",Martha Maria Nicacio Quezado; MD (Laboratory of Pathology),NULL,"1. Morales La Madrid A, Ranjan S, Warren KE (2018). Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA. J Neurooncol  140, 1-4.   https://doi.org/10.1007/s11060-018-2938-x",https://intramural.nih.gov/search/searchview.taf?ipid=104063
401,BC011518-06,"October 01, 2017 -  September 30, 2018",Molecular basis of centriole duplication,Kyung  Lee; PhD|IRP Faculty Profile,NULL,"Chemistry Section, NCI",Jong Il  Ahn|Yang  Chen|Seongjin  Choe|Jung Eun  Park|Liang  Zhang; PhD,Bo  Kim (Korea Research Institute of Bioscience and Biotechnology)|Jeong Kyu Bang,Jadranka  Loncarek (Laboratory of Protein Dynamics and Signaling)|Yun Xing M Wang (Structural Biophysics Laboratory),Rodolfo  Ghirlando; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104056
402,BC011519-06,"October 01, 2017 -  September 30, 2018",Telomere Biology,Julia Promisel Cooper|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",Manasi Sadanand Apte; PhD|Adenrele Madeline Gleason; PhD|Haitong  Hou|Hirohisa  Masuda; PhD|Rishi Kumar  Nageshan; PhD|Rahul Rajan Thadani; PhD,"Nevan  Krogan (Univ of California, San Francisco)|Geeta  Narlikar (UC San Francisco)",NULL,NULL,"1. Apte MS, Cooper JP (2017). Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet. Crit Rev Biochem Mol Biol  52, 57-73.   https://doi.org/10.1080/10409238.2016.1260090|2. Fernández-Álvarez A, Cooper JP (2017). Chromosomes Orchestrate Their Own Liberation: Nuclear Envelope Disassembly. Trends Cell Biol  27, 255-265.   https://doi.org/10.1016/j.tcb.2016.11.005|3. Fernández-Álvarez A, Cooper JP (2017). The functionally elusive RabI chromosome configuration directly regulates nuclear membrane remodeling at mitotic onset. Cell Cycle  16, 1392-1396.   https://doi.org/10.1080/15384101.2017.1338986",https://intramural.nih.gov/search/searchview.taf?ipid=104086
403,BC011524-06,"October 01, 2017 -  September 30, 2018",Mechanical regulation of the microenvironmental niche in skin tumorigenesis,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Kathryn Marcella Daly|Anna  Tesei|Michele  Zanoni,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104078
404,BC011525-06,"October 01, 2017 -  September 30, 2018",Leveraging DNA damage repair pathways as therapeutic targets in womens cancers,Jung-Min  Lee|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Brittany Michelle Haynes|Tzu-Ting  Huang|Jayakumar Ramachandran Nair|Erin Kathleen Manricks|Daniel  An,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch),Erika Joelle Lampert (CC) |Craig Joseph Thomas (NCATS) |Michael Marc Gottesman; MD (OD),"1. Brill E, Yokoyama T, Nair J, Yu M, Ahn YR, Lee JM (2017). Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer. Oncotarget  8, 111026-111040.   https://doi.org/10.18632/oncotarget.22195|2. Kohn EC, Lee JM, Ivy SP (2017). The HRD Decision-Which PARP Inhibitor to Use for Whom and When. Clin Cancer Res  23, 7155-7157.   https://doi.org/10.1158/1078-0432.CCR-17-2186|3. Lee JM, Gulley JL (2017). Checkpoint and PARP inhibitors, for whom and when. Oncotarget  8, 95036-95037.   https://doi.org/10.18632/oncotarget.20852|4. Liu J, Lee J, Strock E, Phillips R, Mari K, Killiam B, Bonam M, Milenkova T, Kohn E, Ivy P (2018) Technology Applications: Use of Digital Health Technology to Enable Drug Development. Journal of Clinical Oncology Clinical Cancer Informatics, in press.|5. Yokoyama T, Kohn EC, Brill E, Lee JM (2017) Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol, in press (e-pub ahead of print)  https://doi.org/10.3892/ijo.2017.3914",https://intramural.nih.gov/search/searchview.taf?ipid=104069
405,BC011528-06,"October 01, 2017 -  September 30, 2018","A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillus",Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Rebecca Christine Dolan|Yvonne  Wall,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)",NULL,"1. Rayn KN, Hale GR, Grave GP, Agarwal PK (2018). New therapies in nonmuscle invasive bladder cancer treatment. Indian J Urol  34, 11-19.   https://doi.org/10.4103/iju.IJU_296_17|2. Siddiqui M, Grant C, Sanford T, Agarwal P (2017) Current clinical trials in nonmuscle invasive bladder cancer. Urologic Oncology, in press.|3. Siddiqui MR, Grant C, Sanford T, Agarwal PK (2017). Current clinical trials in non-muscle invasive bladder cancer. Urol Oncol  35, 516-527.   https://doi.org/10.1016/j.urolonc.2017.06.043",https://intramural.nih.gov/search/searchview.taf?ipid=104076
406,BC011529-06,"October 01, 2017 -  September 30, 2018",In-patient hospice and rapid autopsy to interrogate tumor heterogeneity,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Constance M Cultraro|Tapan Kumar Maity|Abhilash  Venugopalan,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104074
407,BC011547-05,"October 01, 2017 -  September 30, 2018",Cancer Immunotherapy Clinical Trials,Julius Yehuda Strauss; MD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",Andrea Danielle Burmeister|Bonnie L Casey|Margaret Elena Gatti-Mays|Cynthia Ann Moye|Camilo  Pacheco|James W Hodge; PhD|Show all 7,"Christopher Ryan Heery; MD (Genitourinary Malignancies Branch)|Paul  Chaplin (Bavarian Nordic, Inc.)","William Laurence Dahut; MD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)","Isaac Franklin Brownell; MD, PhD (NIAMS) |Lisa Marie Cordes; PHARMD, BCACP (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104114
408,BC011549-05,"October 01, 2017 -  September 30, 2018",Chronic graft-versus-host disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,"Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)",Dominique C Pichard (NIAMS),"1. Goklemez S, Pirsl F, Curtis LM, Steinberg SM, Cowen EW, Mays JW, Kenyon M, Baruffaldi J, Hakim FT, Pavletic SZ (2017). Clinical significance of IgE in a large cohort of patients with moderate or severe chronic graft-versus-host disease. Am J Hematol  92, E162-E164.   https://doi.org/10.1002/ajh.24768",https://intramural.nih.gov/search/searchview.taf?ipid=104111
409,BC011550-05,"October 01, 2017 -  September 30, 2018",Anakinra for neutrophilic pustular skin disease,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,"Nehal N Mehta (NHLBI) |Raphaela  Goldbach-Mansky; MD, MHS (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104112
410,BC011551-05,"October 01, 2017 -  September 30, 2018",Structural studies of molecular targets for drug development,David S Waugh; PhD|IRP Faculty Profile,NULL,"Protein Engineering Section, NCI",George T Lountos|Anna Maria Mielech|Danielle  Needle,"Robert  Ulrich (Molecular Immunology, USAMRIID)|Kamal  Saikh (USAMRIID)",Rajesh  Gumpena (Macromolecular Crystallography Laboratory)|Wonchull  Kang (Macromolecular Crystallography Laboratory)|John Stephen Schneekloth (Chemical Biology Laboratory)|Terrence R Burke; PhD (Chemical Biology Laboratory)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Joseph Edward Tropea (Macromolecular Crystallography Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104113
411,BC011552-05,"October 01, 2017 -  September 30, 2018",Targeting mechanisms of radiation resistance,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Shilpa Shantinath Patil; PhD|Jessica Leigh Reedy|Bradley T Scroggins|Ayla Oksuz White|Hong G Zhang; PhD,NULL,James B Mitchell; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Bradford J Wood; MD (Office of the Director)|Murali  Krishna; PhD (Radiation Biology Branch)|Adam G Sowalsky (Laboratory Of Genitourinary Cancer Pathogenesis),NULL,"1. Liu Q, Gheorghiu L, Drumm M, Clayman R, Eidelman A, Wszolek MF, Olumi A, Feldman A, Wang M, Marcar L, Citrin DE, Wu CL, Benes CH, Efstathiou JA, Willers H (2018). PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene  37, 2793-2805.   https://doi.org/10.1038/s41388-018-0130-6",https://intramural.nih.gov/search/searchview.taf?ipid=104110
412,BC011554-05,"October 01, 2017 -  September 30, 2018",Lung Cancer Health Disparities,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Adriana  Zingone; MD|Curtis  Harris; MD,Pine  Sharon (Rutgers Cancer Institute of New Jersey)|Rick  Kittles (University of Arizona Cancer Center)|Keisha  Houston (Centers for Disease Control and Prevention)|Isidore  Rigoutsos (Thomas Jefferson University)|Ann  Schwartz (Karmanos Cancer Center),"Claire Laurie Anne Meaney (Cancer Prevention Fellowship Program)|Sanju  Sinha (Molecular Genetics and Carcinogenesis Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Daniel C Edelman (Cancer Genetics Branch)|Bin  Zhu (Biostatistics Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)",Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS) |Julian Marcelo Candia (NIAID),"1. Mitchell K, Zingone A, Toulabi L, Boeckelman J, Ryan B (2017) Comparative Transcriptome Profiling Reveals Coding and Non-Coding RNA Differences in Lung Cancer from African and European Americans. Clinical Cancer Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=104108
413,BC011555-05,"October 01, 2017 -  September 30, 2018",Gene-Environment Interactions in Lung Cancer,Brid Mairead Ryan|IRP Faculty Profile,NULL,"Laboratory of Human Carcinogenesis, NCI",Adriana  Zingone; MD,NULL,Christopher Edward Grant (Molecular Genetics and Carcinogenesis Section)|Leila Bahadori Toulabi; PhD (Molecular Genetics and Carcinogenesis Section)|Rachael Zoe Solomon (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Zingone A, Brown D, Bowman E, Vidal O, Sage J, Neal J, Ryan B (2017). Relationship between anti-depressant use and lung cancer survival. Cancer Research and Treatment Communications  10, 33-39.",https://intramural.nih.gov/search/searchview.taf?ipid=104109
414,BC011558-05,"October 01, 2017 -  September 30, 2018",Effects of systemic and topical perturbations on human microbes,Heidi H Kong|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,Eric  Simpson (Oregon Health and Sciences University)|Alan  Irvine (Trinity College)|Carsten  Flohr (St. John's College)|Lora  Hooper (UT Southwestern)|Lloyd  Miller (Johns Hopkins),"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Giorgio  Trinchieri (Cancer Inflammation Program)",Iryna Leonidivna Chub (NIAMS) |Jay Hyun  Jo; PhD (NIAMS) |Valentina Shobhana Pillai; CRNP (NIAMS) |Nicole Helen Schwardt (NIAMS) |Monica Elizabeth Taylor (NIAMS) |Julia A Segre; PhD (NHGRI),"1. Harris TA, Gattu S, Propheter DC, Kuang Z, Bel S, Ruhn KA, Chara AL, Edwards M, Zhang C, Jo JH, Raj P, Zouboulis CC, Kong HH, Segre JA, Hooper LV (2019). Resistin-like Molecule α Provides Vitamin-A-Dependent Antimicrobial Protection in the Skin. Cell Host Microbe  25, 777-788.e8.   https://doi.org/10.1016/j.chom.2019.04.004|2. Kong HH, Segre JA (2017). The Molecular Revolution in Cutaneous Biology: Investigating the Skin Microbiome. J Invest Dermatol  137, e119-e122.   https://doi.org/10.1016/j.jid.2016.07.045",https://intramural.nih.gov/search/searchview.taf?ipid=104107
415,BC011559-05,"October 01, 2017 -  September 30, 2018",The role of the tumor biofilm in determining tissue tropism,Kandice Danielle Tanner; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Kathryn Marcella Daly|Colin Dowlin Paul; PhD|Jack Rory Staunton; PhD|Hannah Alison Burr,NULL,David J Fitzgerald; PhD (Biotherapy Section)|Zhenggang  Liu; PhD (Laboratory of Immune Cell Biology)|Kumaran S Ramamurthi (Laboratory of Molecular Biology),Michael Marc Gottesman; MD (OD),"1. Paul C, Bishop K, Devine A, Paine E, Staunton J, Thomas S, Jenkins L, Morgan N, Sood R, Tanner K (2018) Tissue architectural cues drive organ targeting of human tumor cells in zebrafish. bioRxiv, in press.|2. Paul C, Devine A, Bishop K, Xu Q, Wulftange W, Burr H, Daly K, Lewis C, Green D, Staunton J, Choksi S, Liu Z, Sood R, Tanner K (2018) Human macrophages survive and adopt activated genotypes in living zebrafish. bioRxiv, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=104106
416,BC011561-05,"October 01, 2017 -  September 30, 2018",Exploring mechanisms that govern immune homeostasis in skin,Keisuke  Nagao|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,Daniel M Kaplan|Masayuki  Amagai (Keio University School of Medicine)|Moro  Kazuyo (Riken Institute),Stefania  Pittaluga (Laboratory of Pathology)|Bao D Quoe  Tran (Office of the Director)|Michael Christopher Kelly; PhD (Office of the Director)|Chunhua  Yan (Cancer Informatics Branch),Thomas  Doebel (NIAMS) |Tetsuro  Kobayashi (NIAMS) |Benjamin  Voisin (NIAMS) |Julia A Segre; PhD (NHGRI) |Warren J Leonard; MD (NHLBI) |Alexandra  Freeman (NIAID),"1. Doebel T, Voisin B, Nagao K (2017). Langerhans Cells - The Macrophage in Dendritic Cell Clothing. Trends Immunol  38, 817-828.   https://doi.org/10.1016/j.it.2017.06.008",https://intramural.nih.gov/search/searchview.taf?ipid=104104
417,BC011564-05,"October 01, 2017 -  September 30, 2018",Near-IR Photorelease Chemistry: Discovery and Applications,Martin John Schnermann; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Erin Danielle Anderson; PhD|Michael Philip Luciano; PhD|Saghar  Nourian|Tsuyoshi  Yamamoto; PhD,NULL,Hisataka  Kobayashi (Molecular Imaging Program)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104105
418,BC011565-05,"October 01, 2017 -  September 30, 2018",Adoptive T cell Therapy for Pediatric Leukemia,Terry J Fry|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Christopher Daniel Chien; PhD|Mark Eric Kohler|Haiying  Qin|Sneha  Ramakrishna|Zachary Hudson Walsh|Lila  Yang|Show all 8,"Boro  Dropulic|Stephen  Grupp (University of Pennsylvania Cancer Center,)|Sarah  Tasian (Children's Hospital of Philadelphia)|Mark  Gilbert (Juno Therapeutics)|David  Hilbert (HGSI, Inc.)|Crystal L. Mackall; MD (NCI)",Kazusa  Ishii (Experimental Transplantation and Immunology Branch),NULL,"1. Fry TJ, Shah NN, Orentas RJ, Stetler-Stevenson M, Yuan CM, Ramakrishna S, Wolters P, Martin S, Delbrook C, Yates B, Shalabi H, Fountaine TJ, Shern JF, Majzner RG, Stroncek DF, Sabatino M, Feng Y, Dimitrov DS, Zhang L, Nguyen S, Qin H, Dropulic B, Lee DW, Mackall CL (2018). CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med  24, 20-28.   https://doi.org/10.1038/nm.4441|2. Shah NN, Fry TJ (2019). Mechanisms of resistance to CAR T cell therapy. Nat Rev Clin Oncol  16, 372-385.   https://doi.org/10.1038/s41571-019-0184-6|3. Shalabi H, Wolters PL, Martin S, Toledo-Tamula MA, Roderick MC, Struemph K, Kane E, Yates B, Delbrook C, Mackall CL, Lee DW, Fry TJ, Shah NN (2018). Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy. J Immunother  41, 350-358.   https://doi.org/10.1097/CJI.0000000000000241",https://intramural.nih.gov/search/searchview.taf?ipid=104103
419,BC011566-05,"October 01, 2017 -  September 30, 2018","Mechanism, Regulation and Application of miRNA pathway in cancer",Shuo  Gu|IRP Faculty Profile,NULL,"Rna Biology Laboratory, NCI","Francesc Xavier  Bofill De Ros|Lisheng  Dai|Minjie  Jiang|Acong  Yang|Zhi Ming  Zheng; MD, PhD|Bruce Allen Shapiro; PhD",NULL,Xinhua  Ji; PhD (Biomolecular Structure Section)|Yun Xing M Wang (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104100
420,BC011568-05,"October 01, 2017 -  September 30, 2018",Natural Products Discovery and Characterization Through Network Collaborations,Kirk R Gustafson; PhD|IRP Faculty Profile,NULL,"Molecular Targets Laboratory, NCI",Heidi  Bokesch|Richard W Fuller|Unwoo  Kang|Chang-Kwon  Kim; PhD|Xiangrong  Tian; PhD|Laura  Cartner,NULL,Thomas Joseph Sayers; PhD (Cancer Inflammation Program)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Martin John Schnermann; PhD (Chemical Biology Laboratory)|David  Covell (Screening Technologies Branch)|Megan L Peach (Chemical Biology Laboratory),NULL,"1. Irie R, Takada K, Ise Y, Ohtsuka S, Okada S, Gustafson KR, Matsunaga S (2017). Structure Revision of Poecillastrin C and the Absolute Configuration of the β-Hydroxyaspartic Acid Residue. Org Lett  19, 5395-5397.   https://doi.org/10.1021/acs.orglett.7b02835",https://intramural.nih.gov/search/searchview.taf?ipid=104102
421,BC011575-05,"October 01, 2017 -  September 30, 2018",Modulation of Radiation Response and Metabolism,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Jenna Elizabeth Bingham,NULL,"James B Mitchell; PhD (Radiation Biology Branch)|David Anderson Wink (Cancer Inflammation Program)|Jennifer Clare Jones; MD, PhD (Vaccine Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)",NULL,"1. Kambach DM, Halim AS, Cauer AG, Sun Q, Tristan CA, Celiku O, Kesarwala AH, Shankavaram U, Batchelor E, Stommel JM (2017). Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma. Oncotarget  8, 14860-14875.   https://doi.org/10.18632/oncotarget.14740",https://intramural.nih.gov/search/searchview.taf?ipid=104096
422,BC011577-05,"October 01, 2017 -  September 30, 2018",Novel Imaging Approaches to Solid Tumors,Aparna Hemant Kesarwala|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Jenna Elizabeth Bingham,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch),NULL,"1. Kesarwala AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, Cengel KA, Evans TL, Aggarwal C, Cohen RB, Langer CJ, Rengan R, Simone CB (2018). The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer. Clin Lung Cancer  19, e205-e209.   https://doi.org/10.1016/j.cllc.2017.10.001|2. Kim C, Hoang CD, Kesarwala AH, Schrump DS, Guha U, Rajan A (2017). Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer. J Thorac Oncol  12, 179-193.   https://doi.org/10.1016/j.jtho.2016.10.012",https://intramural.nih.gov/search/searchview.taf?ipid=104097
423,BC011584-05,"October 01, 2017 -  September 30, 2018",Clinical trials in womens cancers,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Daniel Saul Green|Michelle K Ozaki|Stanley  Lipkowitz; MD, PhD|Jung-Min  Lee",NULL,Jinqiu  Chen (Office of the Director),"Kathryn C Zoon; PhD (NIAID) |Carter  Van Waes; MD, PhD (NIDCD)","1. Dull AB, Wilsker D, Hollingshead M, Mazcko C, Annunziata CM, LeBlanc AK, Doroshow JH, Kinders RJ, Parchment RE (2018). Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug-induced DNA double strand breaks from DNA double strand breaks associated with apoptosis. Oncotarget  9, 17104-17116.   https://doi.org/10.18632/oncotarget.24936|2. Wang PY, Li J, Walcott FL, Kang JG, Starost MF, Talagala SL, Zhuang J, Park JH, Huffstutler RD, Bryla CM, Mai PL, Pollak M, Annunziata CM, Savage SA, Fojo AT, Hwang PM (2017). Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome. J Clin Invest  127, 132-136.   https://doi.org/10.1172/JCI88668",https://intramural.nih.gov/search/searchview.taf?ipid=104093
424,BC011585-05,"October 01, 2017 -  September 30, 2018",Identification of Nucleic Acid Binding Small Molecules,John Stephen Schneekloth|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Robert Edward Boer|David Raymond Calabrese; PhD|Colleen Marie Connelly|William Merton Hewitt|Thomas Aaron Hilimire|Sara Nicole Journey|Show all 8,NULL,Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Thomas A Misteli; PhD (Office of the Director)|Natasha  Caplen (Cancer Genetics Branch)|Kylie Janice Walters (Structural Biophysics Laboratory)|Barry R O'Keefe (Molecular Targets Laboratory),NULL,"1. Connelly CM, Abulwerdi FA, Schneekloth JS (2017). Discovery of RNA Binding Small Molecules Using Small Molecule Microarrays. Methods Mol Biol  1518, 157-175.   https://doi.org/10.1007/978-1-4939-6584-7_11|2. Connelly CM, Boer RE, Moon MH, Gareiss P, Schneekloth JS (2017). Discovery of Inhibitors of MicroRNA-21 Processing Using Small Molecule Microarrays. ACS Chem Biol  12, 435-443.   https://doi.org/10.1021/acschembio.6b00945",https://intramural.nih.gov/search/searchview.taf?ipid=104094
425,BC011593-05,"October 01, 2017 -  September 30, 2018",Investigation of Epigenetic Modifiers in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Qingdi Q Li|Leonard  Neckers; PhD,NULL,Jane Beth Trepel (Developmental Therapeutics Branch),Marc  Ferrer-Alegre (NCATS) |Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104092
426,BC011594-05,"October 01, 2017 -  September 30, 2018",Targeting the MET pathway in urothelial carcinoma,Andrea Borghese Apolo|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Rene A Costello; MT|Nikhil  Goyal|Yang-Min  Ning,NULL,Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Donald P Bottaro; PhD (Urologic Oncology Branch)|Mark  Raffeld; MD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104090
427,BC011627-04,"October 01, 2017 -  September 30, 2018",Myosin VI: a new ubiquitin receptor,Kylie Janice Walters|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Gwen Rebecca Buel,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104133
428,BC011630-04,"October 01, 2017 -  September 30, 2018",Metabolomic Profiling of Esophageal Cancers,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Deborah Rae Surman|Yuan  Xu; PhD|David  Schrump; MD|Udayan  Guha,NULL,Leonard  Neckers; PhD (Urologic Oncology Branch),NULL,"1. Brown ZJ, Hernandez JM, Ripley RT, Davis JL (2017). Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now. J Gastrointest Oncol  8, 1109-1113.   https://doi.org/10.21037/jgo.2017.09.01|2. Davis JL, Ripley RT (2017). Postgastrectomy Syndromes and Nutritional Considerations Following Gastric Surgery. Surg Clin North Am  97, 277-293.   https://doi.org/10.1016/j.suc.2016.11.005|3. Diggs LP, Ripley RT (2018). Da Vinci's ascent: Continually broadening the scope of robotic thoracic surgery. J Thorac Cardiovasc Surg  156, e133-e134.   https://doi.org/10.1016/j.jtcvs.2018.02.028|4. Diggs LP, Ripley RT (2018). The good, the bad, and the uncertain: Can matrix metalloproteinase 12 simultaneously be protumorigenic and antitumorigenic? J Thorac Cardiovasc Surg  155, 2162-2163.   https://doi.org/10.1016/j.jtcvs.2018.01.002|5. Lo WM, Ripley RT (2017). EGFR mutational status in lung adenocarcinoma: Staging implications or continuous evolution? J Thorac Cardiovasc Surg  154, 1766-1767.   https://doi.org/10.1016/j.jtcvs.2017.07.053|6. McLoughlin KC, Goldin JW, Ripley RT (2017). Biology is king and continues to rule. J Thorac Cardiovasc Surg  154, 1448-1449.   https://doi.org/10.1016/j.jtcvs.2017.07.047|7. McLoughlin KC, Ripley RT (2017). Clinical nomograms: Is a picture worth a thousand words? J Thorac Cardiovasc Surg  153, 470-471.   https://doi.org/10.1016/j.jtcvs.2016.11.002|8. McLoughlin KC, Ripley RT (2017). Looks aren't everything, but neither is microRNA profiling. J Thorac Cardiovasc Surg  154, 728-729.   https://doi.org/10.1016/j.jtcvs.2017.03.092|9. McLoughlin KC, Ripley RT (2018). Finding a needle in a haystack of needles: The difficulty of defining a consistently meaningful cytokine signature. J Thorac Cardiovasc Surg  155, 2646-2647.   https://doi.org/10.1016/j.jtcvs.2018.02.081|10. Ripley RT, Ayabe RI (2018). Immunotherapy: The power of perseverance. J Thorac Cardiovasc Surg  155, 1775-1776.   https://doi.org/10.1016/j.jtcvs.2017.12.002|11. van Beek EJAH, Hernandez JM, Goldman DA, Davis JL, McLaughlin K, Ripley RT, Kim TS, Tang LH, Hechtman JF, Zheng J, Capanu M, Schultz N, Hyman DM, Ladanyi M, Berger MF, Solit DB, Janjigian YY, Strong VE (2018). Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer. Ann Surg Oncol  25, 2027-2033.   https://doi.org/10.1245/s10434-018-6502-x",https://intramural.nih.gov/search/searchview.taf?ipid=104134
429,BC011631-04,"October 01, 2017 -  September 30, 2018",Synergy of Bile Acid and Cigarette Smoke on Esophageal Cancer Progression,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Yuan  Xu; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104135
430,BC011632-04,"October 01, 2017 -  September 30, 2018",Metabolic and p53 Targets of Cellular Respiration of Esophageal Cancer,Robert Taylor Ripley; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Kate Elizabeth Brown|David  Schrump; MD,NULL,Ettore  Appella; MD (Chemical Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104130
431,BC011633-04,"October 01, 2017 -  September 30, 2018",T cell Development and Regeneration,"Avinash  Bhandoola; MD, PhD|IRP Faculty Profile",NULL,"Laboratory Of Genome Integrity, NCI",Jennifer Elizabeth Cowan|Arundhoti  Das|Christelle Mathilde Charlotte Harly|Devin James Kenney|Brian Matthew Larsen|Yongge  Zhao|Show all 7,David  Allman (University of Pennsylvania)|Golnaz  Vahedi|Nancy  Manley (University Of Georgia)|Anjana  Rao (La Jolla Institute For Allergy And Immunology),"Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)",Xiao  Lu; PhD (NCATS) |John Allan Hanover; PhD (NIDDK) |Luigi Daniele Notarangelo (NIAID) |Keji  Zhao; PhD (NHLBI),"1. Larsen BM, Bhandoola A (2017). A novel role for p53 in self-tolerance. Blood  130, 388-389.   https://doi.org/10.1182/blood-2017-06-789115|2. Nish SA, Zens KD, Kratchmarov R, Lin WW, Adams WC, Chen YH, Yen B, Rothman NJ, Bhandoola A, Xue HH, Farber DL, Reiner SL (2017). CD4+ T cell effector commitment coupled to self-renewal by asymmetric cell divisions. J Exp Med  214, 39-47.   https://doi.org/10.1084/jem.20161046|3. Smith MJ, Reichenbach DK, Parker SL, Riddle MJ, Mitchell J, Osum KC, Mohtashami M, Stefanski HE, Fife BT, Bhandoola A, Hogquist KA, Holländer GA, Zúñiga-Pflücker JC, Tolar J, Blazar BR (2017). T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction. JCI Insight  2.   https://doi.org/10.1172/jci.insight.92056|4. Zhang K, Xu X, Pasha MA, Siebel CW, Costello A, Haczku A, MacNamara K, Liang T, Zhu J, Bhandoola A, Maillard I, Yang Q (2017). Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells. J Immunol  198, 1798-1803.   https://doi.org/10.4049/jimmunol.1601421",https://intramural.nih.gov/search/searchview.taf?ipid=104129
432,BC011637-04,"October 01, 2017 -  September 30, 2018",BRD4 is a HAT,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Devaiah Nanjappa Ballachanda (Molecular Regulation Section)|Jie  Mu (Molecular Regulation Section)|Chanelle Monet Case Borden (Center For Cancer Training)|Daoud M Meerzaman (Cancer Informatics Branch)|Qingrong  Chen (Cancer Informatics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104131
433,BC011640-04,"October 01, 2017 -  September 30, 2018",Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Jinkyu  Jung|Aiguo  Li|Virginia W Rodriguez|Hua  Song|Wei  Zhang,NULL,NULL,NULL,"1. Colwell N, Larion M, Giles AJ, Seldomridge AN, Sizdahkhani S, Gilbert MR, Park DM (2017). Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol  19, 887-896.   https://doi.org/10.1093/neuonc/now258|2. Lee DH, Cheul Oh S, Giles AJ, Jung J, Gilbert MR, Park DM (2017). Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells. Oncotarget  8, 40233-40245.   https://doi.org/10.18632/oncotarget.16714|3. Soeda A, Lathia J, Williams BJ, Wu Q, Gallagher J, Androutsellis-Theotokis A, Giles AJ, Yang C, Zhuang Z, Gilbert MR, Rich JN, Park DM (2017). The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking. Oncotarget  8, 33316-33328.   https://doi.org/10.18632/oncotarget.16741",https://intramural.nih.gov/search/searchview.taf?ipid=104140
434,BC011643-04,"October 01, 2017 -  September 30, 2018",Rare Central Nervous System Cancers Initiative,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orwa  Aboud|Susie  Ahn|Ramya  Parthasarathy|Lisa Marie Boris|Christine Alexis Cordova|Nancy B Garren|Show all 18,NULL,Kevin A Camphausen; MD (Radiation Oncology Branch)|Martha Maria Nicacio Quezado; MD (Laboratory of Pathology)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Rosandra N Kaplan (Pediatric Oncology Branch)|Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Phuong L Mai (Clinical Genetics Branch),"John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Prashant  Chittiboina; MD (NINDS) |Elizabeth A Erickson (NHGRI) |Abhik  Ray-Chaudhury; MD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104139
435,BC011646-04,"October 01, 2017 -  September 30, 2018",Role of long non-coding RNAs in p53 signaling,Ashish Kumar Lal|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Emily Ann Dangelmaier|Sarah Bayla Lazar|Xiao Ling  Li|Xing  Lu|Bruna Rodrigues Muys,NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stefan  Ambs (Laboratory of Human Carcinogenesis),NULL,"1. Chaudhary R, Lal A (2017). Long noncoding RNAs in the p53 network. Wiley Interdiscip Rev RNA  8.   https://doi.org/10.1002/wrna.1410|2. Parvathaneni S, Lu X, Chaudhary R, Lal A, Madhusudan S, Sharma S (2017). RECQ1 expression is upregulated in response to DNA damage and in a p53-dependent manner. Oncotarget  8, 75924-75942.   https://doi.org/10.18632/oncotarget.18237",https://intramural.nih.gov/search/searchview.taf?ipid=104150
436,BC011647-04,"October 01, 2017 -  September 30, 2018",Identifying New Glioma-Associated Tumor Suppressors  Oncogenes,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Susie  Ahn|Orieta  Celiku|Jinkyu  Jung|Aiguo  Li|Funita Pindria Phan; PhD|Virginia W Rodriguez|Show all 12,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104149
437,BC011648-04,"October 01, 2017 -  September 30, 2018",Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC,"Ramaprasad  Srinivasan; MD, PhD|IRP Faculty Profile",NULL,"Urologic Oncology Branch, NCI",Julia C Friend; PA|Janet  Gichonge|Roma  Pahwa|William Marston Linehan; MD|Donald P Bottaro; PhD|Leonard  Neckers; PhD|Show all 7,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|John Walter Glod (Pediatric Oncology Branch)|Joanna H Shih (Biostatistics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)","Karel  Pacak; MD, PhD (NICHD) |Heidi H Kong (NIAMS) |Edward W Cowen (NIAMS) |Pamela  Stratton; MD (NINDS) |Wadih Michel Zein; MD (NEI) |Ashkan A Malayeri (CC)","1. Ball MW, Singer EA, Srinivasan R (2017) Renal cell carcinoma: molecular characterization and evolving treatment paradigms. Curr Opin Oncol, in press (e-pub ahead of print)  https://doi.org/10.1097/CCO.0000000000000364",https://intramural.nih.gov/search/searchview.taf?ipid=104148
438,BC011649-04,"October 01, 2017 -  September 30, 2018",The Hippo Pathway in Human Gliomas,Jayne M Stommel|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Alan Surya Halim|Deven Shankarbhai Patel|Qian  Sun|Kevin A Camphausen; MD,NULL,Fahim  Ahmad; PhD (Molecular Imaging Program)|Natasha  Caplen (Cancer Genetics Branch)|Ettore  Appella; MD (Chemical Immunology Section)|Eric  Batchelor; PhD (Laboratory of Pathology)|Ji  Luo (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104147
439,BC011650-04,"October 01, 2017 -  September 30, 2018",Genomic characterization of breast cancer in high risk subsets of breast cancer,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Patricia  Steeg; PhD|Alexandra Dos Santos Zimmer,Hai  Hu (Windber Research Institute)|Kangmin  Zhu|Jeremy  Perkins|Craig David Shriver (Office Of The Clinical Director),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Zimmer AS, Zhu K, Steeg PS, Wu A, Gatti-Mays ME, Soltani S, Perkins JG, Shao S, Brown D, Georg M, Hu H, Shriver CD, Lipkowitz S (2018). Analysis of breast cancer in young women in the Department of Defense (DOD) database. Breast Cancer Res Treat  168, 501-511.   https://doi.org/10.1007/s10549-017-4615-8",https://intramural.nih.gov/search/searchview.taf?ipid=104145
440,BC011651-04,"October 01, 2017 -  September 30, 2018",Laboratory and Clinical studies on T-cells recognizing NSCLC,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Kenichi  Hanada|Chihao  Zhao,NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104146
441,BC011652-04,"October 01, 2017 -  September 30, 2018",Mesothelin-targeted immunotoxins in Pancreatic Cancer,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",Leela Rani  Avula|Salma E El-Behaedi|Xianyu  Zhang; MS,NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Ira H Pastan; MD (Molecular Biology Section)|Serguei V Kozlov (Office of the Director)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Masanori  Onda (Molecular Biology Section)|Seth M Steinberg; PhD (Biostatistics and Data Management Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104144
442,BC011654-04,"October 01, 2017 -  September 30, 2018",TEDDI-R in PCNSL,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Lydia L Yee|Christopher Joseph Melani|Saleema  Osman|Mark Jason Roschewski|Joseph Lee Roswarski,NULL,"Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Louis  Staudt; MD (Center for Cancer Genomics)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104143
443,BC011655-04,"October 01, 2017 -  September 30, 2018",Targeting protein-DNA interactions in prokaryotic systems,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Merissa Lynnea Baxter|Ye Joon  Kim,NULL,NULL,NULL,"1. Payne SR, Pau DI, Whiting AL, Kim YJ, Pharoah BM, Moi C, Boddy CN, Bernal F (2018). Inhibition of Bacterial Gene Transcription with an RpoN-Based Stapled Peptide. Cell Chem Biol  25, 1059-1066.e4.   https://doi.org/10.1016/j.chembiol.2018.05.007",https://intramural.nih.gov/search/searchview.taf?ipid=104126
444,BC011657-04,"October 01, 2017 -  September 30, 2018",microRNA regulatory networks in thoracic cancers,Chuong Dinh Hoang|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Nathanael David Pruett; PhD|Anand  Singh; PhD|David  Schrump; MD,NULL,"Joel Patrick Schneider; PhD (Chemical Biology Laboratory)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Eytan  Ruppin (Cancer Data Science Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104128
445,BC011659-04,"October 01, 2017 -  September 30, 2018",Deciphering the efficacy of posttransplant cyclophosphamide in haplo transplant,Christopher George Kanakry|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Michael Tyrone Patterson|Lucas Paul Wachsmuth,NULL,David J Venzon; PhD (Biostatistics and Data Management Section),Michael  Eckhaus; DVM (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104124
446,BC011660-04,"October 01, 2017 -  September 30, 2018",Development of fully-human anti-CD30 chimeric antigen receptors,James N Kochenderfer|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Steven Dustin Hartman|Ronald E Gress; MD,NULL,NULL,David F Stroncek; MD (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104125
447,BC011666-04,"October 01, 2017 -  September 30, 2018",Synthetically Accessible Virtual Inventory (SAVI),Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",NULL,"Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Peter  Ertl (Novartis)|Martin  Ott (Lhasa Limited)|Philip  Judson (Lhasa Limited)|Alex  Sukharevsky (LHASA, LLC)|Alan  Long (LHASA, LLC)|Show all 11",Nadya I Tarasova; PhD (Cancer Inflammation Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104123
448,BC011669-04,"October 01, 2017 -  September 30, 2018",NCI X-ray free electron laser (XFEL) initiative,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",NULL,John  Spence (Arizona State University)|Henry  Chapman (CFEL/DESY/University of Hamburg),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104122
449,BC011670-04,"October 01, 2017 -  September 30, 2018",Role of the microbiota in regulating the mononuclear phagocyte system,Silvana Romina Goldszmid|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Romina Elizabeth Araya|Quanyi  Chen|Khiem Chi Lam|Luisa Mourao Dias Magalhaes; PhD|Nicole Alexis Mihelson|Gregoire Yves Altan-Bonnet,NULL,NULL,Mariana Julieta Kaplan (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104121
450,BC011672-03,"October 01, 2017 -  September 30, 2018",Clinical Protocols in the Cancer Signaling Networks Section,Udayan  Guha|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Constance M Cultraro|Tapan Kumar Maity|Abhilash  Venugopalan|Xu  Zhang|David  Schrump; MD,NULL,"Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Javed  Khan; MD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104152
451,BC011679-03,"October 01, 2017 -  September 30, 2018",Molecular alterations driving the development of primary prostate cancers,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Nicole Vincele Carrabba|Sean Thomas Hennigan|Shana Y Trostel|Nichelle Chantil Whitlock; PhD|Scott Christopher Wilkinson|Huihui  Ye|Show all 9,Steven  Balk (Beth Israel Deaconess Medical Center)|Huihui  Ye (Laboratory Of Genitourinary Cancer Pathogenesis),William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Hisataka  Kobayashi (Molecular Imaging Program)|Fatima Hafiz Karzai; MD (Genitourinary Malignancies Branch)|Ismail Baris Turkbey (Molecular Imaging Program),NULL,"1. Sowalsky AG, Kissick HT, Gerrin SJ, Schaefer RJ, Xia Z, Russo JW, Arredouani MS, Bubley GJ, Sanda MG, Li W, Ye H, Balk SP (2017). Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4. Clin Cancer Res  23, 3823-3833.   https://doi.org/10.1158/1078-0432.CCR-16-2414",https://intramural.nih.gov/search/searchview.taf?ipid=104153
452,BC011680-03,"October 01, 2017 -  September 30, 2018",Detection of prostate cancer using circulating tumor DNA,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Sean Thomas Hennigan,Steven  Balk (Beth Israel Deaconess Medical Center)|Glenn  Bubley (Beth Israel Deaconess Medical Center)|Huihui  Ye (Laboratory Of Genitourinary Cancer Pathogenesis),Peter A Pinto; MD (Urologic Oncology Branch),NULL,"1. Ye H, Sowalsky A (2018) Molecular correlates of intermediate- and high-risk localized prostate cancer. Urologic Oncology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=104154
453,BC011681-03,"October 01, 2017 -  September 30, 2018",Dynamics and Genetics of HIV Proviruses before and during Antiretroviral Therapy,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Michael Javier Bale|Valerie F Boltz|Cristina  Ceriani|Jenna Mohammad Hasson|William Richard McManus|Andrew Timothy Rajendra Musick|Show all 11,"John  Coffin (Tufts University)|Mark  Cotton (Stellenbosch University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Jonathan  Li (Harvard University)|John W Mellors|Gert  van Zyl (Stellenbosch University)",Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Jeffrey D Lifson; MD (Office Of The Director),NULL,"1. Kearney M, Wiegand A, Shao W, McManus W, Bale M, Luke B, Maldarelli F, Mellors J, Coffin J (2017). Perspectives: Ongoing HIV replication during ART reconsidered. Open Forum Infect Dis  4, 1-5.|2. Van Zyl GU, Katusiime MG, Wiegand A, McManus WR, Bale MJ, Halvas EK, Luke B, Boltz VF, Spindler J, Laughton B, Engelbrecht S, Coffin JM, Cotton MF, Shao W, Mellors JW, Kearney MF (2017). No evidence of HIV replication in children on antiretroviral therapy. J Clin Invest  127, 3827-3834.   https://doi.org/10.1172/JCI94582|3. Wiegand A, Spindler J, Hong FF, Shao W, Cyktor JC, Cillo AR, Halvas EK, Coffin JM, Mellors JW, Kearney MF (2017). Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART. Proc Natl Acad Sci U S A  114, E3659-E3668.   https://doi.org/10.1073/pnas.1617961114",https://intramural.nih.gov/search/searchview.taf?ipid=104155
454,BC011682-03,"October 01, 2017 -  September 30, 2018",Molecular mechanisms of membrane remodeling,"Roberto  Weigert; MSc Chemistry, PhD|IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",Desu  Chen|Seham  Ebrahim; PhD|Lenka Nicole Malec|Ian Haywood Mather|Yeap Shen Ng|Weiye  Wang|Show all 10,Marino  Zerial (Max Planck Institute)|Peter  Gunning (University of New South Wales)|Douglas  Brooks (University of South Australia)|Alexander  Sorkin (Univeristy of Pittsburgh),NULL,"Kelly G Ten Hagen; BS, PhD (NIDCR) |Irwin Monroe Arias; BS, MD (CC)","1. Amornphimoltham P, Thompson J, Melis N, Weigert R (2017). Non-invasive intravital imaging of head and neck squamous cell carcinomas in live mice. Methods  128, 3-11.   https://doi.org/10.1016/j.ymeth.2017.07.026|2. Ebrahim S, Milberg O, Weigert R (2017). Isoform-specific roles of NMII drive membrane remodeling in vivo. Cell Cycle  16, 1851-1852.   https://doi.org/10.1080/15384101.2017.1372545|3. Gonzalez JM, Ko MK, Hong YK, Weigert R, Tan JCH (2017). Deep tissue analysis of distal aqueous drainage structures and contractile features. Sci Rep  7, 17071.   https://doi.org/10.1038/s41598-017-16897-y|4. Madsen DH, Jürgensen HJ, Siersbæk MS, Kuczek DE, Grey Cloud L, Liu S, Behrendt N, Grøntved L, Weigert R, Bugge TH (2017). Tumor-Associated Macrophages Derived from Circulating Inflammatory Monocytes Degrade Collagen through Cellular Uptake. Cell Rep  21, 3662-3671.   https://doi.org/10.1016/j.celrep.2017.12.011|5. Masedunskas A, Chen Y, Stussman R, Weigert R, Mather IH (2017). Kinetics of milk lipid droplet transport, growth, and secretion revealed by intravital imaging: lipid droplet release is intermittently stimulated by oxytocin. Mol Biol Cell  28, 935-946.   https://doi.org/10.1091/mbc.E16-11-0776|6. Milberg O, Shitara A, Ebrahim S, Masedunskas A, Tora M, Tran DT, Chen Y, Conti MA, Adelstein RS, Ten Hagen KG, Weigert R (2017). Concerted actions of distinct nonmuscle myosin II isoforms drive intracellular membrane remodeling in live animals. J Cell Biol  216, 1925-1936.   https://doi.org/10.1083/jcb.201612126",https://intramural.nih.gov/search/searchview.taf?ipid=104207
455,BC011684-03,"October 01, 2017 -  September 30, 2018",Investigation on the biology of IDH mutant glioma,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Yang  Liu|Di  Yu|Yiqiang  Zhou; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104157
456,BC011685-03,"October 01, 2017 -  September 30, 2018",Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson,Sadhana  Jackson|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Mark Richard Gilbert; MD,"Stuart  Grossman (Neuro-Oncology, Johns Hopkins Oncology Center)|Michelle A Rudek",Christine M Bryla (Office Of The Clinical Director)|William D Figg; PharmD (Genitourinary Malignancies Branch),Edjah K Nduom (NINDS),"1. Jackson S, George RT, Lodge MA, Piotrowski A, Wahl RL, Gujar SK, Grossman SA (2017). The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study. J Neurooncol  132, 513-519.   https://doi.org/10.1007/s11060-017-2404-1",https://intramural.nih.gov/search/searchview.taf?ipid=104158
457,BC011686-03,"October 01, 2017 -  September 30, 2018",Modulating BBB Permeability in Malignant Glioma,Sadhana  Jackson|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Amelie  Vezina,NULL,Caitlin Bryanna Meeks (Office Of Training & Education)|Kunio  Nagashima (Office of the Director),"Kenneth A Jacobson; BA, MS, PhD (NIDDK) |Dorian  McGavern (NINDS) |Christina Margaret Van Itallie; PhD (NHLBI) |Marsha J Merrill; PhD (NINDS) |Patricia M Zerfas (OD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104159
458,BC011687-03,"October 01, 2017 -  September 30, 2018",Dysregulation of Antigen Presenting Cell Function in Cancer,Paul A Roche; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Joanna Marta Bandola-Simon; PhD|Even  Walseng,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104160
459,BC011688-03,"October 01, 2017 -  September 30, 2018",In vivo function of BRD4,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Alfred  Singer; MD,NULL,Devaiah Nanjappa Ballachanda (Molecular Regulation Section)|Anne G M Gegonne Bosselut (Molecular Regulation Section)|Jie  Mu (Molecular Regulation Section)|Daoud M Meerzaman (Cancer Informatics Branch)|Qingrong  Chen (Cancer Informatics Branch)|Xuguang C Tai (Lymphocyte Development Section),Sheetal  Uppal (NEI) |Keiko  Ozato; PhD (NICHD) |Jinfang  Zhu; PhD (NIAID) |Anup  Dey; PhD (NICHD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104162
460,BC011690-03,"October 01, 2017 -  September 30, 2018",Novel Tumor Suppressing Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Anusha Parthav Jailwala|Christina  Walker,Alexandra  Newton (University of California at San Diego)|Tony C Hunter|Crispin  Miller (CRUK Manchester Institute),NULL,NULL,"1. Newton AC, Brognard J (2017). Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor. Trends Pharmacol Sci  38, 438-447.   https://doi.org/10.1016/j.tips.2017.02.002",https://intramural.nih.gov/search/searchview.taf?ipid=104164
461,BC011691-03,"October 01, 2017 -  September 30, 2018",Oncogenic Kinases in Cancer,John Fickes Brognard; MS|IRP Faculty Profile,NULL,"Laboratory of Cell and Developmental Signaling, NCI",Elvira  An|Van Tuyet Hoang|Amy Lynn Funk|Katherine M Nyswaner|Pedro  Torres-Ayuso|Deborah K Morrison,Richard  Marais (CRUK Manchester Institute)|Crispin  Miller (CRUK Manchester Institute)|Caroline  Dive (CRUK Manchester Institute),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104165
462,BC011692-03,"October 01, 2017 -  September 30, 2018",Comparative Oncology Program Laboratory,Amy Kathleen Leblanc; DVM,Peter L Choyke; MD,"Pediatric Oncology Branch, NCI",Christina  Mazcko|Ling  Ren|Hisataka  Kobayashi|Elaine Marie Jagoda; MS,"Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Louis  Stancato (NCI)|Cheryl  London (Center for Comparative Medicine, University Of California)|Doug  Thamm (Colorado State University)|John  Rossmeisl (Virginia Polytechnical University)|Shruthi  Naik (Mayo Clinic - Rochester)|Show all 8","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Rosandra N Kaplan (Pediatric Oncology Branch)|Lawrence R Sternberg (Office Of The Director)|Jiuping  Ji (Office of the Director)",Gregory James Tawa (NCATS) |Matthew David Hall (NCATS) |Rolf Eric Swenson; PhD (NHLBI) |Xiang  Zhang; PhD (NHLBI),"1. Koehler JW, Miller AD, Miller CR, Porter B, Aldape K, Beck J, Brat D, Cornax I, Corps K, Frank C, Giannini C, Horbinski C, Huse JT, O'Sullivan MG, Rissi DR, Mark Simpson R, Woolard K, Shih JH, Mazcko C, Gilbert MR, LeBlanc AK (2018). A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma. J Neuropathol Exp Neurol  77, 1039-1054.   https://doi.org/10.1093/jnen/nly085|2. Naik S, Galyon GD, Jenks NJ, Steele MB, Miller AC, Allstadt SD, Suksanpaisan L, Peng KW, Federspiel MJ, Russell SJ, LeBlanc AK (2018). Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer. Mol Cancer Ther  17, 316-326.   https://doi.org/10.1158/1535-7163.MCT-17-0432|3. Ren L, Hong ES, Mendoza A, Issaq S, Tran Hoang C, Lizardo M, LeBlanc A, Khanna C (2017). Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis. Oncotarget  8, 38541-38553.   https://doi.org/10.18632/oncotarget.15872|4. Yu P, Gardner H, Roberts R, Cam H, Hariharan S, Ren L, Leblanc A, Xiao H, Lin J, Guttridge D, Mo X, Bennett C, Coss C, Ling Y, Phelps M, Houghton P (2017). Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PLoS One  12, e0181885.",https://intramural.nih.gov/search/searchview.taf?ipid=104163
463,BC011696-03,"October 01, 2017 -  September 30, 2018",Comparative Brain Tumor Consortium,Amy Kathleen Leblanc; DVM,Peter L Choyke; MD,"Pediatric Oncology Branch, NCI",NULL,"Matthew  Breen; PhD (Veterinary Medicine, North Carolina State University)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Michael  Kent (UC Davis)|William  Kisseberth (Veterinary Medicine, Ohio State University)|John  Rossmeisl (Virginia Polytechnical University)|Drew  Miller (Cornell University College of Veterinary Medicine)|Show all 17","Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Robert Mark Simpson; DVM, PhD (Laboratory of Cancer Biology and Genetics)|Kara Nichole Corps (Laboratory of Cancer Biology and Genetics)",Gregory James Tawa (NCATS) |Matthew David Hall (NCATS) |Rolf Eric Swenson; PhD (NHLBI),"1. Leblanc A, Packer R, Kent M, Rossmeisl J, Griffin J, Mazcko C (2018). Consensus recommendations for harmonized imaging standards for multicenter canine brain tumor clinical trials. Veterinary Radiology and Ultrasound  59, 261-271.|2. Nagaya T, Okuyama S, Ogata F, Maruoka Y, Knapp DW, Karagiannis SN, Fazekas-Singer J, Choyke PL, LeBlanc AK, Jensen-Jarolim E, Kobayashi H (2018). Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody. Oncotarget  9, 19026-19038.   https://doi.org/10.18632/oncotarget.24876|3. Naik S, Galyon GD, Jenks NJ, Steele MB, Miller AC, Allstadt SD, Suksanpaisan L, Peng KW, Federspiel MJ, Russell SJ, LeBlanc AK (2018). Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer. Mol Cancer Ther  17, 316-326.   https://doi.org/10.1158/1535-7163.MCT-17-0432",https://intramural.nih.gov/search/searchview.taf?ipid=104166
464,BC011697-03,"October 01, 2017 -  September 30, 2018",Effects of Antiretroviral Therapy on Transcriptional Activity of HIV Proviruses,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Michael Javier Bale|Valerie F Boltz|Cristina  Ceriani|William Richard McManus|Andrew Timothy Rajendra Musick|Wei  Shao; PhD|Show all 8,"John  Coffin (Tufts University)|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)|Jonathan  Li (Harvard University)|David M Margolis|John W Mellors",Stephen H Hughes; PhD (Retroviral Replication Laboratory),NULL,"1. Bui JK, Halvas EK, Fyne E, Sobolewski MD, Koontz D, Shao W, Luke B, Hong FF, Kearney MF, Mellors JW (2017). Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells. PLoS Pathog  13, e1006230.   https://doi.org/10.1371/journal.ppat.1006230",https://intramural.nih.gov/search/searchview.taf?ipid=104167
465,BC011698-03,"October 01, 2017 -  September 30, 2018",Impact of Interventions on Clonally Expanded Proviruses and Their RNA Expression,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Ann P Wiegand,"David M Margolis|John W Mellors|Steven  Deeks (San Francisco General Hospital, University of California, San Francisco)",Eric O Freed; PhD (HIV Drug Resistance Program),NULL,"1. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, et al. [7 more authors] (2017). HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med  14, e1002417.   https://doi.org/10.1371/journal.pmed.1002417",https://intramural.nih.gov/search/searchview.taf?ipid=104151
466,BC011699-03,"October 01, 2017 -  September 30, 2018",Ultrasensitive Single-Genome Sequencing to Study HIV Transmission and Evolution,Mary  Kearney,Frank  Maldarelli,"Host Virus Interaction Branch, NCI",Michael Javier Bale|Valerie F Boltz|Wei  Shao; PhD,John  Coffin (Tufts University)|Mark  Cotton (Stellenbosch University)|Michael  Hughes (U.S. Environmental Protection Agency)|Shahin  Lockman (Harvard University)|Sharon  Riddler (University of Pittsburgh)|Gert  van Zyl (Stellenbosch University)|Show all 9,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104168
467,BC011701-03,"October 01, 2017 -  September 30, 2018",Metabolic characterization of FH- and SDH-deficient RCC cell lines,Jeffrey Arnold Moscow,NULL,"Urologic Oncology Branch, NCI","Rony  Panarsky; PhD, BPHARM|William Marston Linehan; MD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104170
468,BC011704-03,"October 01, 2017 -  September 30, 2018",Discovery of genes required for expression or activity of fusion oncogenes,Natasha  Caplen|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Allison Margarethe Cross; PhD|Tamara L Jones|Carla Maya Neckles; PhD|Javed  Khan; MD,Philip L Lorenzi|Amanda  Hummon|Lee Jay Helman; MD (NCI),John Stephen Schneekloth (Chemical Biology Laboratory),Kwame A Donkor (OD) |Madhu A Lal (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104172
469,BC011707-03,"October 01, 2017 -  September 30, 2018",The effect of therapeutics on mutated IDH1 cell lines and mice tumor models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Alejandra  Cavazos Saldana,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104173
470,BC011708-03,"October 01, 2017 -  September 30, 2018",Targeted and untargeted metabolomics in IDH1 mutated xenografts in mice,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Victor  Ruiz Rodado,NULL,Kylie Janice Walters (Structural Biophysics Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104174
471,BC011709-03,"October 01, 2017 -  September 30, 2018","Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissue",Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Tyrone Maurice Dowdy|Victor  Ruiz Rodado|Deric Minwoo Park|Amber Jin Giles|Mark Richard Gilbert; MD|Jing  Wu; MD, PhD|Show all 7",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104175
472,BC011710-03,"October 01, 2017 -  September 30, 2018",In vivo and in vitro metabolic flux analysis in preclinical mouse models,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Tyrone Maurice Dowdy|Adrian  Lita,NULL,Murali  Krishna; PhD (Radiation Biology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104176
473,BC011711-03,"October 01, 2017 -  September 30, 2018",Develop RAMAN imaging to visualize metabolism in cell lines and tissue,Mioara  Larion; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Adrian  Lita|Deric Minwoo Park|Amber Jin Giles|Jing  Wu; MD, PhD",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104177
474,BC011713-03,"October 01, 2017 -  September 30, 2018",Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Kathleen  Kelly; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104178
475,BC011714-03,"October 01, 2017 -  September 30, 2018",Brain Tumor Immunotherapy,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orieta  Celiku|Amber Jin Giles|Nivedita Mohan Ratnam|Wei  Zhang|Marsha-Kay Norissa Deanna Hutchinson|Heather Marie Sonneman,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104179
476,BC011715-03,"October 01, 2017 -  September 30, 2018",T cell receptor proximal signaling,Jonathan D Ashwell; MD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Bei  Dong|Debjani  Dutta; PhD|June  Guha; PhD|Shizuka  Otsuka,NULL,Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology)|Ettore  Appella; MD (Chemical Immunology Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104180
477,BC011718-03,"October 01, 2017 -  September 30, 2018",Breast cancer aggressiveness in young patients,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI","Brunilde M Gril|Alex Man Lai Wu|Stanley  Lipkowitz; MD, PhD|Alexandra Dos Santos Zimmer",NULL,Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Li  Yang; PhD (Laboratory of Cancer Biology and Genetics)|Simone  Difilippantonio (Office Of The Director)|Craig David Shriver (Office Of The Clinical Director),Dorian  McGavern (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104183
478,BC011719-03,"October 01, 2017 -  September 30, 2018",Multiregion sequencing of localized prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Yen Thi Minh  Nguyen|Adam G Sowalsky,Hidewaki  Nakagawa (RIKEN Center for Integrative Medical Sciences)|Satoru  Miyano (University of Tokyo Institute of Medical Science)|Gladell  paner (University of Chicago),Margaret  Cam; PhD (Office of the Director)|Richard Phillip Finney (Cancer Informatics Branch)|David Lee Wheeler (Laboratory Of Biochemistry & Molecular Biology),Justin Britt Lack (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104184
479,BC011720-03,"October 01, 2017 -  September 30, 2018","Gag Trafficking, Assembly, and Release",Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",NULL,"Michael  Summers (University of Maryland, Baltimore County)|Asim  Debnath (Lindsley F. Kimball Research Institute of the New York Blood Center)|Katherine  Seley-Radtke (University of Maryland, Baltimore County)|James  Hurley (University of California, Berkeley)|Shan-Lu  Liu (University of Missouri)|Stefan  Sarafianos (Department of Molecular Microbiology & Immunology, University of Missouri School of Medicine)|Show all 7",Sherimay  Ablan (Retroviral Replication Laboratory)|Melissa Victoria Fernandez; PhD (Retroviral Replication Laboratory)|Ali Tufail Khan (Retroviral Replication Laboratory)|James Kiprotich Kirui (Retroviral Replication Laboratory)|Cheng Man  Lun (Retroviral Replication Laboratory)|Ahlam Amelia Majadly (Retroviral Replication Laboratory),Yihong  Ye (NIDDK) |Juan S Bonifacino; PhD (NICHD),"1. Lippincott-Schwartz J, Freed EO, van Engelenburg SB (2017). A Consensus View of ESCRT-Mediated Human Immunodeficiency Virus Type 1 Abscission. Annu Rev Virol  4, 309-325.   https://doi.org/10.1146/annurev-virology-101416-041840|2. Martins AN, Ke W, Jawahar V, Striplin M, Striplin C, Freed EO, Afonin KA (2017). Intracellular Reassociation of RNA-DNA Hybrids that Activates RNAi in HIV-Infected Cells. Methods Mol Biol  1632, 269-283.   https://doi.org/10.1007/978-1-4939-7138-1_18",https://intramural.nih.gov/search/searchview.taf?ipid=104185
480,BC011721-03,"October 01, 2017 -  September 30, 2018",Envelope Glycoprotein Incorporation,Eric O Freed; PhD|IRP Faculty Profile,NULL,"HIV Drug Resistance Program, NCI",NULL,"Michael  Summers (University of Maryland, Baltimore County)|Simon  Cocklin (Drexel University)|Eric  Barklis (University of Oregon)",Sherimay  Ablan (Retroviral Replication Laboratory)|Hannah Mary Carter (Retroviral Replication Laboratory)|Melissa Victoria Fernandez; PhD (Retroviral Replication Laboratory)|Cheng Man  Lun (Retroviral Replication Laboratory)|Mariia  Novikova; PhD (Retroviral Replication Laboratory)|Phuong Nhat Pham (Retroviral Replication Laboratory),NULL,"1. Fernandez MV, Freed EO (2017). ""Expand and Click"": A New Method for Labeling HIV-1 Envelope Glycoproteins. Cell Chem Biol  24, 548-550.   https://doi.org/10.1016/j.chembiol.2017.05.006",https://intramural.nih.gov/search/searchview.taf?ipid=104187
481,BC011722-03,"October 01, 2017 -  September 30, 2018",Genomic characterization and development of therapies for Rhabdomyosarcoma,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Haiyan  Lei|Carly Meyer Sayers,NULL,Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Bharathy N, Svalina MN, Settelmeyer TP, Cleary MM, Berlow NE, Airhart SD, Xiang S, Keck J, Hayden JB, Shern JF, Mansoor A, Lathara M, Srinivasa G, Langenau DM, Keller C (2017). Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma. Oncotarget  8, 62976-62983.   https://doi.org/10.18632/oncotarget.18520",https://intramural.nih.gov/search/searchview.taf?ipid=104186
482,BC011725-03,"October 01, 2017 -  September 30, 2018",Metabolic basis of chronic graft-versus-host disease,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Kathrynne Anelle Warrick,NULL,William Marston Linehan; MD (Urologic Oncology Branch)|Daniel  Crooks (Urologic Oncology Branch)|Murali  Krishna; PhD (Radiation Biology Branch)|James B Mitchell; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Leonard  Neckers; PhD (Urologic Oncology Branch),"Hellmut  Merkle; MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104189
483,BC011726-03,"October 01, 2017 -  September 30, 2018",Phenotypic variability within isogenic population of lymphocytes,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,Lia  Palomba (Memorial Sloan Kettering)|Paul  Franois (McGill University),NULL,NULL,"1. Chakravarty D, Pedraza AM, Cotari J, Liu AH, Punko D, Kokroo A, Huse JT, Altan-Bonnet G, Brennan CW (2017). EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines. Sci Rep  7, 9043.   https://doi.org/10.1038/s41598-017-08940-9|2. Oyler-Yaniv A, Oyler-Yaniv J, Whitlock BM, Liu Z, Germain RN, Huse M, Altan-Bonnet G, Krichevsky O (2017). A Tunable Diffusion-Consumption Mechanism of Cytokine Propagation Enables Plasticity in Cell-to-Cell Communication in the Immune System. Immunity  46, 609-620.   https://doi.org/10.1016/j.immuni.2017.03.011",https://intramural.nih.gov/search/searchview.taf?ipid=104190
484,BC011727-03,"October 01, 2017 -  September 30, 2018",In vivo cell kinetics and imaging of chronic graft-versus-host-disease,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Kathrynne Anelle Warrick,NULL,"Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Murali  Krishna; PhD (Radiation Biology Branch)|Keita  Saito (Office Of The Director)","Andrea Christine Bohrer (NIAID) |Hellmut  Merkle; MS, PHD (NINDS) |Michael  Eckhaus; DVM (OD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104191
485,BC011728-03,"October 01, 2017 -  September 30, 2018",Cell-cell communications create robust collective immunological responses,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,Laurent  Lauvau (Albert Einstein College of Medicine)|Paul  Franois (McGill University),NULL,Nihal  Altan-Bonnet; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104192
486,BC011730-03,"October 01, 2017 -  September 30, 2018",Studies on drug resistance in HIV-related Kaposis sarcoma,Michael Marc Gottesman; MD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Robert W Robey,NULL,Fatima Ghazanfar Ali-Rahmani (Multidrug Resistence Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104194
487,BC011732-03,"October 01, 2017 -  September 30, 2018",Discovery of combination therapy for KRAS mutant cancer,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Shinjen  Lin,NULL,NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104196
488,BC011733-03,"October 01, 2017 -  September 30, 2018",Mechanism of anchorage independent growth driven by the KRAS oncogene,Ji  Luo|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Xiang  Wang|Haibo  Zhang; PhD,NULL,NULL,Madhu A Lal (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104197
489,BC011734-03,"October 01, 2017 -  September 30, 2018",Genomic dissection of tumor heterogeneity and progression,John Frederick Shern|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Carly Meyer Sayers|Xiyuan  Zhang|Brigitte  Widemann; MD,NULL,"Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,"1. McBride MJ, Pulice JL, Beird HC, Ingram DR, D'Avino AR, Shern JF, Charville GW, Hornick JL, Nakayama RT, Garcia-Rivera EM, Araujo DM, Wang WL, Tsai JW, Yeagley M, Wagner AJ, Futreal PA, Khan J, Lazar AJ, Kadoch C (2018). The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell  33, 1128-1141.e7.   https://doi.org/10.1016/j.ccell.2018.05.002",https://intramural.nih.gov/search/searchview.taf?ipid=104198
490,BC011736-03,"October 01, 2017 -  September 30, 2018",Preclinical Development of Therapeutics in Murine Models of Lung Cancer,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI","Wendi Raye Custer Lawrence|Catherine I Drennan|Rajaa  Elmeskini|Theresa Mae Guerin|Nathan Michael Pate; DVM, DACVP|Stephanie L Henderson|Show all 7",NULL,Deborah B Householder (Basic Research Laboratory)|Bonita Anne Sears (Office Of The Director)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Hisataka  Kobayashi (Molecular Imaging Program),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104200
491,BC011737-03,"October 01, 2017 -  September 30, 2018",Therapeutic evaluation in ovarian and breast cancer GEMGDA models,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devon Ashley Atkinson|Wendi Raye Custer Lawrence|Catherine I Drennan|Melanie  Gordon|Theresa Mae Guerin|Alan Edward Kulaga|Show all 10,NULL,Deborah B Householder (Basic Research Laboratory)|Xiuyun  Lu (Basic Research Laboratory)|Bonita Anne Sears (Office Of The Director)|Yves  Pommier; PhD (Developmental Therapeutics Branch)|Robert  Shoemaker (Chemopreventive Agent Development Research Group)|Laura  Schmidt (Urologic Oncology Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104201
492,BC011738-03,"October 01, 2017 -  September 30, 2018",Preclinical GEM and GDA Models of Primary and Metastatic Melanoma,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI",Devon Ashley Atkinson|Wendi Raye Custer Lawrence|Catherine I Drennan|Rajaa  Elmeskini|Theresa Mae Guerin|Michelle Leann Gumprecht|Show all 10,NULL,Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Chi-Ping  Day (Laboratory of Cancer Biology and Genetics)|Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104202
493,BC011739-03,"October 01, 2017 -  September 30, 2018",Development and Preclinical Applications of Pancreatic Adenocarcinoma Models,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI","Wendi Raye Custer Lawrence|Catherine I Drennan|Theresa Mae Guerin|Jerome  Schlomer|Stephanie L Henderson|Ludmila  Szabova; MS, PhD|Show all 8","Guillermina Gigi  Lozano (MD Anderson)|Frank  McCormick (UCSF School of Medicine)|Leaf  Huang (University of North Carolina)|David  Frost (AbbVie)|Ruihong  Chen (K-Gen, Inc.)|Vincent  Bond (Morehouse School Of Medicine)",Debra J Gilbert (Basic Research Laboratory)|Theresa N O'Sullivan (Basic Research Laboratory)|Bonita Anne Sears (Office Of The Director)|Udo  Rudloff (Pediatric Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Christine Campo Alewine (Laboratory of Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104203
494,BC011740-03,"October 01, 2017 -  September 30, 2018",Inhibitors of Viral Membrane Fusion,Federico  Bernal|IRP Faculty Profile,NULL,"Laboratory of Protein Dynamics and Signaling, NCI",Merissa Lynnea Baxter,NULL,Eric  Batchelor; PhD (Laboratory of Pathology),Peter  Jahrling (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104204
495,BC011741-03,"October 01, 2017 -  September 30, 2018",Targeting Metabolic Pathways in Bladder Cancer,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mamatha  Garige|Leonard  Neckers; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104205
496,BC011743-03,"October 01, 2017 -  September 30, 2018",NIH Chronic GVHD Study Group,"Steven  Pavletic; MD, MS|IRP Faculty Profile",NULL,"Experimental Transplantation and Immunology Branch, NCI",Annie  Im|Filip  Pirsl,Paul  Martin|Daniel  Weisdorf (University of Minnesota)|J Doug  Rizzo (Medical College of Wisconsin)|Mary  Horawitz (Medical College of Wisconsin)|Georgia  Vogelsang (Johns Hopkins University)|Stephanie  Lee (University of Washington-Fred Hutchinson CRC)|Show all 12,"Daoud M Meerzaman (Cancer Informatics Branch)|Sandra  Mitchell (Outcomes Research Branch)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Liang  Cao (Cancer Genetics Branch)","Jacqueline W Mays; DDS, PhD (NIDCR) |Ann M Cohen-Berger; MD (CC) |Galen O Joe (CC) |Manuel B Datiles; MD (NEI) |Rachel Jessica Bishop; MD (NEI) |Theo  Heller; MD (NIDDK)","1. Im A, Hakim FT, Pavletic SZ (2017). Novel targets in the treatment of chronic graft-versus-host disease. Leukemia  31, 543-554.   https://doi.org/10.1038/leu.2016.367|2. Im A, Pavletic SZ (2017). Immunotherapy in hematologic malignancies: past, present, and future. J Hematol Oncol  10, 94.   https://doi.org/10.1186/s13045-017-0453-8",https://intramural.nih.gov/search/searchview.taf?ipid=104208
497,BC011744-02,"October 01, 2017 -  September 30, 2018",Oncogenic Kinase complexes,Ping  Zhang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Baohua  Cao; PhD|Juliana Andrea Martinez Fiesco; PhD|Sathish Narashimiha Yadav Kadapalakere,Sanford  Simon (Rockefeller University)|Susan S Taylor,Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104210
498,BC011745-02,"October 01, 2017 -  September 30, 2018",Development of biologic based therapies for rhabdomyosarcoma,Christine Marie Heske|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Choh L Yeung,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104209
499,BC011746-02,"October 01, 2017 -  September 30, 2018",Development Therapeutics Branch Clinical Trials,Yves  Pommier; PhD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",James Halpern Doroshow|Jane Beth Trepel|Anish  Thomas; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104245
500,BC011754-02,"October 01, 2017 -  September 30, 2018","Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1","Karlyne M Reilly; BS, PhD",Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI",Robert  Tuskan|John Frederick Shern,NULL,John A Beutler (Molecular Targets Laboratory)|Fathi  Elloumi (Developmental Therapeutics Branch)|Margaret  Cam; PhD (Office of the Director),Kapil  Bharti; PhD (NEI),"1. Reilly KM, Kim A, Blakely J, Ferner RE, Gutmann DH, Legius E, Miettinen MM, Randall RL, Ratner N, Jumbé NL, Bakker A, Viskochil D, Widemann BC, Stewart DR (2017). Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx124",https://intramural.nih.gov/search/searchview.taf?ipid=104213
501,BC011755-02,"October 01, 2017 -  September 30, 2018",The role of Foxo1 for intestinal epithelial cells during mucosal immune response,Chuan  Wu|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Zuojia  Chen; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104214
502,BC011756-02,"October 01, 2017 -  September 30, 2018",The Intersection between Cell-Intrinsic Innate Immunity and Metabolic Sensing,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Charles A Coomer|Kazi Mohammad Mostafizur Rahman|Guoli  Shi,Bruce  Torbett (The Scripps Research Institute)|Sergi  Padilla-Parra (University of Oxford),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104212
503,BC011757-02,"October 01, 2017 -  September 30, 2018","Biogenesis, Function and Turnover of Noncoding RNAs","Sandra Lynn Wolin; MD, PhD|IRP Faculty Profile",NULL,"Rna Biology Laboratory, NCI",Cedric  Belair; PhD|Marco Elio Boccitto; PhD|Xinguo  Chen; PhD|Kevin James Hughes|Yuanyuan  Leng|Hongmarn  Park; PhD|Show all 8,"S  Shuman (Sloan-Kettering Institute)|Martin  Kriegel (Yale School of Medicine)|Andrew  Goodman (Yale School of Medicine)|Sanford  Simon (Rockefeller University)|Eric  Meffre; MD (Dept of Immunobiology, Yale University)|Esther  Nolte-'t Hoen (Utrecht University)|Show all 7",Beverly  Mock; PhD (Office of the Director),Alexander  Burroughs (NLM) |Aravind L Iyer; PhD (NLM) |Eugene Victor Koonin; PhD (NLM) |Kira Semenovna Makarova; PhD (NLM) |Eric Paul Nawrocki; PhD (NLM),"1. Wang W, Chen X, Wolin S, Xiong Y (2018) Structural basis for transfer RNA mimicry by a bacterial Y RNA. Structure, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=104211
504,BC011758-02,"October 01, 2017 -  September 30, 2018",Computational Modeling Aggressive Brain Cancer,Orit  Lavi; PhD,Michael Marc Gottesman; MD,"Multidrug Resistence Section, NCI",NULL,Wojtek  Czaja (University Of Maryland)|Pierre  Jabin (University Of Maryland),Jeremiah Ogheneochuko Emidih (Laboratory of Cell Biology)|Sylvia Pamela Herrada (Laboratory of Cell Biology)|Vinodh  Rajapakse (Laboratory of Cell Biology)|Jack Harrington Saylor (Laboratory of Cell Biology)|Orieta  Celiku (Neuro-Oncology Branch),Nadia Madelaine Biassou (CC) |Joelle  Sarlls; PhD (NINDS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104216
505,BC011759-02,"October 01, 2017 -  September 30, 2018",Interrogating the molecular underpinnings of metastatic colonization,Jonathan Matthew Hernandez|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Imani Akili Alexander|Alok  Ranjan|Samantha Marilyn Ruff|Surajit  Sinha; PhD|Michael Martin Wach,Paulo  Fontes (University Of Pittsburgh)|Sidharth  Kerkar|Martin  Kuizenga (Organ Assist),NULL,Kamille Aisha West (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104215
506,BC011761-02,"October 01, 2017 -  September 30, 2018",Develop novel therapeutic strategy for brain tumor,Chun Zhang  Yang; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Yang  Liu|Di  Yu|Yiqiang  Zhou; MD,NULL,NULL,NULL,"1. Lu Y, Liu Y, Pang Y, Pacak K, Yang C (2018). Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy. Pharmacol Ther  188, 168-175.   https://doi.org/10.1016/j.pharmthera.2018.03.006|2. Lu Y, Liu Y, Yang C (2017). Evaluating In Vitro DNA Damage Using Comet Assay. J Vis Exp  .  https://doi.org/10.3791/56450|3. Pang Y, Gupta G, Yang C, Wang H, Huynh TT, Abdullaev Z, Pack SD, Percy MJ, Lappin TRJ, Zhuang Z, Pacak K (2018). A novel splicing site IRP1 somatic mutation in a patient with pheochromocytoma and JAK2V617F positive polycythemia vera: a case report. BMC Cancer  18, 286.   https://doi.org/10.1186/s12885-018-4127-x|4. Pang Y, Yang C, Schovanek J, Wang H, Bullova P, Caisova V, Gupta G, Wolf KI, Semenza GL, Zhuang Z, Pacak K (2017). Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway. Oncotarget  8, 22313-22324.   https://doi.org/10.18632/oncotarget.16224|5. Zhang C, Yang C, Feldman MJ, Wang H, Pang Y, Maggio DM, Zhu D, Nesvick CL, Dmitriev P, Bullova P, Chittiboina P, Brady RO, Pacak K, Zhuang Z (2017) Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha. Oncotarget, in press (e-pub ahead of print)  https://doi.org/10.18632/oncotarget.18125|6. Zhang C, Yang C, Feldman MJ, Wang H, Pang Y, Maggio DM, Zhu D, Nesvick CL, Dmitriev P, Bullova P, Chittiboina P, Brady RO, Pacak K, Zhuang Z (2017). Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha. Oncotarget  8, 56110-56125.   https://doi.org/10.18632/oncotarget.18125",https://intramural.nih.gov/search/searchview.taf?ipid=104218
507,BC011762-02,"October 01, 2017 -  September 30, 2018",Screening to identify protectors and mitigators of Radiation GI Syndrome,Deborah E Citrin|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Eunjoo Serena Chung|Seok Joo  Kwon; PhD|Bradley T Scroggins|Ayla Oksuz White,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104219
508,BC011763-02,"October 01, 2017 -  September 30, 2018",Signaling pathways regulating stem cell fate decisions,Ramiro  Iglesias-Bartolome; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",Yao  Yuan|Maria Del Pilar Pedro; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104223
509,BC011764-02,"October 01, 2017 -  September 30, 2018",G-protein-coupled receptor signaling in cancer development and treatment,Ramiro  Iglesias-Bartolome; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular and Molecular Biology, NCI",James Joseph Hoy|Natalia Fernanda Salinas Parra,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104224
510,BC011765-02,"October 01, 2017 -  September 30, 2018",Transcriptional regulation of inflammatory and autoimmune responses,Vanja  Lazarevic|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Yuanyuan  Gao; PhD,NULL,Yan  Wang (Immune Targeting Section),Dorian  McGavern (NINDS) |Yasmine  Belkaid; PhD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104225
511,BC011766-02,"October 01, 2017 -  September 30, 2018",Regulation of RNA biogenesis and function by RNA modifications,Pedro Jorge De Oliveira Rodrigues Batista; PhD|IRP Faculty Profile,NULL,"Laboratory of Cell Biology, NCI",Quinton Alexander Brail|Xu  Feng; PhD|Christina Marie Fitzsimmons; PhD|Alexandra Collins Schmiechen,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104222
512,BC011767-02,"October 01, 2017 -  September 30, 2018",Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1,Chengkai  Dai|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Zijian  Tang|Meng  Xu,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104220
513,BC011768-02,"October 01, 2017 -  September 30, 2018",Natural History and Specimen Banking for Patients with CNS Tumors,Terri Sue Armstrong; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Alvina A Acquaye|Elizabeth  Vera|Mark Richard Gilbert; MD|Tito Reyes Mendoza|Jing  Wu; MD, PhD",NULL,Kenneth Dean Aldape; MD (Laboratory of Pathology)|Mark  Raffeld; MD (Laboratory of Pathology)|Lindsay Shannon Rowe (Radiation Oncology Branch),Madeline Elizabeth Dahut (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104221
514,BC011771-02,"October 01, 2017 -  September 30, 2018",Development of therapy for aggressive variant prostate cancer,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Kathleen  Kelly; PhD,NULL,NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104226
515,BC011772-02,"October 01, 2017 -  September 30, 2018",The role of Galpha13 signaling in suppression of lymphoma,Jagan Reddy Muppidi|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI",Anne Robins Albright|Huifang  Li|Hang T Nguyen|Raud  Razzaghi|Louis  Staudt; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104227
516,BC011773-02,"October 01, 2017 -  September 30, 2018",Hypoxia signaling in cancer development,"Zhengping  Zhuang; MD, PhD|IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",Jing  Cui|Jared  Rosenblum|Qi  Song|Herui  Wang; PhD|Chun Zhang  Yang; PhD,NULL,NULL,"Timothy James Westlake (NINDS) |Karel  Pacak; MD, PhD (NICHD) |John D Heiss; MD (NINDS) |Emily Y Chew; MD (NEI)","1. Peng S, Shepard MJ, Wang J, Li T, Ning X, Cai L, Zhuang Z, Gong K (2017). Genotype-phenotype correlations in Chinese von Hippel-Lindau disease patients. Oncotarget  8, 38456-38465.   https://doi.org/10.18632/oncotarget.16594|2. Sizdahkhani S, Feldman MJ, Piazza MG, Ksendzovsky A, Edwards NA, Ray-Chaudhury A, Maric D, Merrill MJ, Pacak K, Zhuang Z, Chittiboina P (2017). Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target. Sci Rep  7, 40822.   https://doi.org/10.1038/srep40822|3. Zhang Q, Wang H, Mao C, Sun M, Dominah G, Chen L, Zhuang Z (2018). Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration. Mol Immunol  94, 27-35.   https://doi.org/10.1016/j.molimm.2017.12.011",https://intramural.nih.gov/search/searchview.taf?ipid=104229
517,BC011774-02,"October 01, 2017 -  September 30, 2018",Development and translation of novel therapies for pediatric sarcoma,Christine Marie Heske|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Anna Elizabeth Gibson|Choh L Yeung,NULL,Leonard  Neckers; PhD (Urologic Oncology Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),Craig Joseph Thomas (NCATS),"1. Heske CM, Davis MI, Baumgart JT, Wilson K, Gormally MV, Chen L, Zhang X, Ceribelli M, Duveau DY, Guha R, Ferrer M, Arnaldez FI, Ji J, Tran HL, Zhang Y, Mendoza A, Helman LJ, Thomas CJ (2017). Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma. Clin Cancer Res  23, 7301-7311.   https://doi.org/10.1158/1078-0432.CCR-17-1121",https://intramural.nih.gov/search/searchview.taf?ipid=104230
518,BC011775-02,"October 01, 2017 -  September 30, 2018",Immune cell control of ovarian cancer,Christina M Annunziata|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Daniel Saul Green|Jung-Min  Lee,NULL,NULL,Kathryn C Zoon; PhD (NIAID),"1. Fantini M, David JM, Saric O, Dubeykovskiy A, Cui Y, Mavroukakis SA, Bristol A, Annunziata CM, Tsang KY, Arlen PM (2017). Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas. Front Immunol  8, 1899.   https://doi.org/10.3389/fimmu.2017.01899|2. Green DS, Nunes AT, David-Ocampo V, Ekwede IB, Houston ND, Highfill SL, Khuu H, Stroncek DF, Steinberg SM, Zoon KC, Annunziata CM (2018). A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer. J Transl Med  16, 196.   https://doi.org/10.1186/s12967-018-1569-5",https://intramural.nih.gov/search/searchview.taf?ipid=104234
519,BC011777-02,"October 01, 2017 -  September 30, 2018",Stable Water Isotope Labeling for Imaging of Rapidly Proliferating Cells,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Kathrynne Anelle Warrick,NULL,Murali  Krishna; PhD (Radiation Biology Branch)|Keita  Saito (Office Of The Director),"Hellmut  Merkle; MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104231
520,BC011778-02,"October 01, 2017 -  September 30, 2018",Quantitative Single-Cell Assessment of Lentivirus Susceptibility Determinants,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Charles A Coomer|Saliha  Majdoul,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104232
521,BC011779-02,"October 01, 2017 -  September 30, 2018",Antiviral Mechanism of IFITM Proteins during HIV and Other Retrovirus Infections,Alex  Compton|IRP Faculty Profile,NULL,"Retroviral Replication Laboratory, NCI",Tirhas G Dempsey|Kazi Mohammad Mostafizur Rahman|Guoli  Shi|Alan  Rein; PhD,Chen  Liang (McGill University)|Olivier  Schwartz (Institut Pasteur)|Jacob  Yount (The Ohio State University)|Rajini  Mudhasani (Usamriid),NULL,NULL,"1. Shi G, Schwartz O, Compton AA (2017). More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins. Retrovirology  14, 53.   https://doi.org/10.1186/s12977-017-0377-y",https://intramural.nih.gov/search/searchview.taf?ipid=104233
522,BC011780-02,"October 01, 2017 -  September 30, 2018",Clinical development of mechanism-based lymphoma therapies,Louis  Staudt; MD|IRP Faculty Profile,NULL,"Lymphoid Malignancies Branch, NCI","Da Wei  Huang|Arthur L Shaffer|Wyndham H Wilson; MD, PhD|Mark Jason Roschewski",NULL,Elaine S Jaffe; MD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104235
523,BC011781-02,"October 01, 2017 -  September 30, 2018",Dynamics of hematopoietic differentiation,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Ratnadeep  Mukherjee; PhD,Frdric  Geissman (Memorial Sloan Kettering)|Pankaj  Mehta (Boston University),Jung-Hyun  Park (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104237
524,BC011782-02,"October 01, 2017 -  September 30, 2018",Mechanisms of pathogenesis in patient derived organoid models of prostate cancer,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Supreet  Agarwal|Aian Neil Seno Alilin|Michael Louis Beshiri; PhD|Keith Henry Jansson|Caitlin Marie Tice|Margaret Ellen White; BS|Show all 9,NULL,"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Peter L Choyke; MD (Molecular Imaging Program)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104236
525,BC011784-02,"October 01, 2017 -  September 30, 2018",Bioinformatics:  Characterizing Brain Tumor Data,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orieta  Celiku|Aiguo  Li|Xinyi  Li|Terri Sue Armstrong; PhD|Sadhana  Jackson|Mioara  Larion; PhD|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104238
526,BC011785-02,"October 01, 2017 -  September 30, 2018",Better understanding and handling of tautomerism,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Devendra Kumar  Dhaked|Hitesh Jayantilal Patel; PhD,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Steve  Heller (NIST),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104239
527,BC011786-02,"October 01, 2017 -  September 30, 2018",A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Rebecca Christine Dolan|Yvonne  Wall,Greg  Adams (Fox Chase Cancer Center)|Zenta  Tsuchihashi (Astrazeneca),"Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Jane Beth Trepel (Developmental Therapeutics Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104240
528,BC011787-02,"October 01, 2017 -  September 30, 2018",Predictive biomarker of BET bromodomain inhibitor in Small cell lung cancer,Haobin  Chen|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Lisa  Gesumaria|David  Schrump; MD,"Charles  Rudin (MSKCC)|John  Poirier (MSKCC)|Nenghui  Wang (Ningbo Wenda Pharma)|Trudy  Oliver (Huntsman Cancer Institute, University Of Utah)|Ulrike  Tontsch-grunt (Boehringer Ingelheim)",Dinah  Singer; PhD (Experimental Immunology Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104241
529,BC011789-02,"October 01, 2017 -  September 30, 2018",Phase 2 study of Lu-177-DOTATATE in inoperable paraganglioma  pheochromocytoa,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",NULL,NULL,Jaydira  del Rivero; MD (Pediatric Oncology Branch),"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104242
530,BC011790-02,"October 01, 2017 -  September 30, 2018",Metabolic imaging of the effects of brain radiotherapy,Deedee Kay Smart|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Hari Mony Nath,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104243
531,BC011793-01,"October 01, 2017 -  September 30, 2018",Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies,Anish  Thomas; MD|IRP Faculty Profile,NULL,"Developmental Therapeutics Branch, NCI",Samantha Krystle Nichols|Yang  Zhang|Jane Beth Trepel|Yves  Pommier; PhD,NULL,"Javed  Khan; MD (Cancer Genetics Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Christine Marie Heske (Pediatric Oncology Branch)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Fatima Hafiz Karzai; MD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107372
532,BC011798-01,"October 01, 2017 -  September 30, 2018",Identification of genomic regulatory elements in pancreas cells,Hatice Efsun Arda|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",Elizabeth Ridgely Duvall|Thucnhi  Truongvo|Li  Wang|John Alan Wildenthal,NULL,NULL,NULL,"1. Arda H, Tsai J, Rosli Y, Giresi P, Bottino R, Greenleaf W, Chang H, Kim S (2018) A chromatin basis for cell lineage and disease risk in the human pancreas. Cell Systems, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=107373
533,BC011800-01,"October 01, 2017 -  September 30, 2018",Engineering HCC-selective PET agent,"Freddy Enrique Escorcia; MD, PhD|IRP Faculty Profile",NULL,"Molecular Imaging Program, NCI",Rose Madeline Berman|Nicholas Tang Gutsche,Scott  Lowe (Cold Spring Harbor Laboratory)|Justin  Wilson (Cornell University),Mitchell  Ho (Laboratory of Molecular Biology)|Jane Beth Trepel (Developmental Therapeutics Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch),Rolf Eric Swenson; PhD (NHLBI),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107374
534,BC011801-01,"October 01, 2017 -  September 30, 2018",CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity,Chuan  Wu|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Zuojia  Chen; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107375
535,BC011802-01,"October 01, 2017 -  September 30, 2018",Discovery of genetic interactions in cancer,Eytan  Ruppin|IRP Faculty Profile,NULL,"Cancer Data Science Laboratory, NCI",Kuoyuan  Cheng|Joo Sang  Lee|Sanna  Madan|Nishanth Ulhas Nair,NULL,"Kenneth Dean Aldape; MD (Laboratory of Pathology)|Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Javed  Khan; MD (Cancer Genetics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,"1. Ruppin E (2018) Harnessing synthetic lethality to predict the response to cancer treatment. Nat Commun, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=107371
536,BC011803-01,"October 01, 2017 -  September 30, 2018",Cancer immunotherapy,Eytan  Ruppin|IRP Faculty Profile,NULL,"Cancer Data Science Laboratory, NCI",Joo Sang  Lee|Sushant Anant Patkar|Wells Ivens Robinson|Philippe Bijin Youkharibache; PhD,Keith  Flaherty (Harvard Medical School)|Meenhart  Herlyn (Wistar Insti),Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section),NULL,"1. Ruppin E (2018) Robust prediction of therapeutic response to immune checkpoint blockade therapy in metastatic melanoma"". Nature Med, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=107369
537,BC011804-01,"October 01, 2017 -  September 30, 2018",Dual Blockade of IGF1R and MEK synergistically inhibits RMS cell growth,Marielle Elizabeth Yohe|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Joshua Thomas Kowalczyk,NULL,Javed  Khan; MD (Cancer Genetics Branch),NULL,"1. Yohe M, Gryder B, Shern J, Chou H, Song Y, Sindiri S, Mendoza A, Patidar R, Zhang X, Guha R, Butcher D, Isanogle K, Robinson C, Luo X, Chen J, Walton A, Awasthi R, Edmondson E, Difilippantonio S, Wei J, Zhao K, Ferrer M, Thomas C, Khan J (2018). MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma. Science Translational Medicine  1, In Press.",https://intramural.nih.gov/search/searchview.taf?ipid=107370
538,BC011805-01,"October 01, 2017 -  September 30, 2018",Defining the Mechanism of Action of Rigosertib in Pediatric Cancers,Marielle Elizabeth Yohe|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Joshua Thomas Kowalczyk,NULL,Deborah K Morrison (Laboratory of Cell and Developmental Signaling),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107368
539,BC011806-01,"October 01, 2017 -  September 30, 2018",Thymus biology,Yousuke  Takahama; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",Kenta  Kondo|Yu  Tanaka,Graham  Anderson (University Of Birmingham)|Georg  Hollander (University of Oxford)|Shigeo  Murata (University Of Tokyo)|Izumi  Ohigashi (University Of Tokushima)|Keiji  Tanaka (Tokyo Metropolitan Institute Of Medical Science),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107367
540,BC011807-01,"October 01, 2017 -  September 30, 2018",Immunophenotyping by CyTOF and machine learning,Gregoire Yves Altan-Bonnet|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",NULL,Pankaj  Mehta (Boston University)|Hassane  Zarour (University Of Pittsburgh),NULL,Mariana Julieta Kaplan (NIAMS) |Michael J Lenardo; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107365
541,BC011808-01,"October 01, 2017 -  September 30, 2018",Role of ETS-Transcription Factors in Regulating Cell Fate,Sergio  Ruiz Macias; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107366
542,BC011809-01,"October 01, 2017 -  September 30, 2018",Identification of molecular pathways regulating quiescence in pluripotent cells,Sergio  Ruiz Macias; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107363
543,BC011810-01,"October 01, 2017 -  September 30, 2018",Canonical and non-canonical roles of Argonaute proteins in mammals,Joana  De Campos Alves Vidigal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,"1. Zheng J, Sadot E, De Campos Alves Vidigal J, Klimstra D, Balachandran V, Kingham P, Allen P, D'Angelica M, DeMatteo R, Jarnagin W, Ventura A (2018). Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. Plos One  00000, 00000.",https://intramural.nih.gov/search/searchview.taf?ipid=107364
544,BC011811-01,"October 01, 2017 -  September 30, 2018",CRISPR tools to dissect the coding and non-coding genome,Joana  De Campos Alves Vidigal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,Ralph  Garippa (Memorial Sloan Kettering Cancer Center)|Scott  Lowe (Cold Spring Harbor Laboratory),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107361
545,BC011812-01,"October 01, 2017 -  September 30, 2018",Dissecting the roles of Vault RNAs in mammals,Joana  De Campos Alves Vidigal|IRP Faculty Profile,NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107362
546,BC011813-01,"October 01, 2017 -  September 30, 2018",Molecular Determinants of Totipotency,Sergio  Ruiz Macias; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107359
547,BC011814-01,"October 01, 2017 -  September 30, 2018",RNA methylation as a modulator of cancer genome instability,Philipp  Oberdoerffer|IRP Faculty Profile,NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",William Walter Hannon|David  Sturgill|Andy Dong-Anh Tran; PhD,NULL,Pedro Jorge De Oliveira Rodrigues Batista; PhD (Laboratory of Cell Biology),NULL,"1. Sebastian R, Oberdoerffer P (2017). Transcription-associated events affecting genomic integrity. Philos Trans R Soc Lond B Biol Sci  372.   https://doi.org/10.1098/rstb.2016.0288",https://intramural.nih.gov/search/searchview.taf?ipid=107360
548,BC011815-01,"October 01, 2017 -  September 30, 2018",Investigate the mechanism of action of the novel telomere length regulator TZAP,Eros  Lazzerini Denchi|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107357
549,BC011816-01,"October 01, 2017 -  September 30, 2018",Determine how telomere dysfunction impacts neuronal function,Eros  Lazzerini Denchi|IRP Faculty Profile,NULL,"Laboratory Of Genome Integrity, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107358
550,BC011818-01,"October 01, 2017 -  September 30, 2018",Molecular characteristics of aggressive prostate cancer subtypes,David James Vanderweele|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Adam G Sowalsky,NULL,NULL,Justin Britt Lack (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107353
551,BC011819-01,"October 01, 2017 -  September 30, 2018",Mechanisms of multi-species bacterial interactions,Anupama  Khare|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107354
552,BC011821-01,"October 01, 2017 -  September 30, 2018",Genetic determinants of antibiotic persistence,Anupama  Khare|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,Ganesh  Sundar (Biochemical Genetics Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107356
553,BC011824-01,"October 01, 2017 -  September 30, 2018",Structural studies with regulatory RNAs,Stuart F J Le Grice; PhD|IRP Faculty Profile,NULL,"Basic Research Laboratory, NCI",Fardokht Assadi Abulwerdi|Samantha Beatrice Gacasan|Stefano  Ginocchio|Regan Michael Leblanc|Jennifer T Miller|Julie Marie Nyman|Show all 9,Theodore  Dayie (University of Maryland)|Ryan  Murelli (Brooklyn College)|Peter  Stockley (University of Leeds),Barry R O'Keefe (Molecular Targets Laboratory)|John Stephen Schneekloth (Chemical Biology Laboratory)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|John A Beutler (Molecular Targets Laboratory),NULL,"1. Abulwerdi F, Le Grice S (2017) Recent Advances in Targeting the HIV-1 TatTAR complex. Current Pharmaceutical Research, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=107351
554,BC011825-01,"October 01, 2017 -  September 30, 2018",Th227-mesothelin antibody conjugate in mesothelioma,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Peter L Choyke; MD,NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107352
555,BC011826-01,"October 01, 2017 -  September 30, 2018",Protection of Salivary Gland in PSMA-targeted radioligand therapy,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Peter L Choyke; MD,NULL,NULL,"Jay A Chiorini; PhD (NIDCR) |Blake Matthew Warner; DDS, PhD (NIDCR)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107349
556,BC011827-01,"October 01, 2017 -  September 30, 2018",Phase 12 study of Lu177-DOTATATE and olaparib in neuroendocrine tumors,Frank I-Kai Lin|IRP Faculty Profile,NULL,"Molecular Imaging Program, NCI",Jyoti  Roy|Maria Liza Lindenberg|Esther  Mena Gonzalez,NULL,Jaydira  del Rivero; MD (Pediatric Oncology Branch)|Dhaval T Patel (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107350
557,BC011828-01,"October 01, 2017 -  September 30, 2018",Mitochondrial metabolism in normal and transformed cells,Natalie  Porat-Shliom|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,"Daniel  Feliciano (Thoracic and GI Malignancies Branch)|Megan Lynn Stefkovich (Thoracic and GI Malignancies Branch)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107346
558,BC011830-01,"October 01, 2017 -  September 30, 2018",Control of cell cycle commitment by APCC-Cdh1,Steven David Cappell|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jenny Elana Frieder Nathans|Marwa Mounir Afifi; PhD,NULL,NULL,NULL,"1. Cappell SD, Mark KG, Garbett D, Pack LR, Rape M, Meyer T (2018). EMI1 switches from being a substrate to an inhibitor of APC/CCDH1 to start the cell cycle. Nature  558, 313-317.   https://doi.org/10.1038/s41586-018-0199-7",https://intramural.nih.gov/search/searchview.taf?ipid=107347
559,BC011831-01,"October 01, 2017 -  September 30, 2018",The Role of WHSC1L1 in Squamous Cell Carcinoma of the Head and Neck,Vassiliki  Saloura; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",NULL,NULL,Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression),"Carter  Van Waes; MD, PhD (NIDCD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107348
560,BC011832-01,"October 01, 2017 -  September 30, 2018",Study cell cycle regulation in dormant tumor cells,Steven David Cappell|IRP Faculty Profile,NULL,"Laboratory of Cancer Biology and Genetics, NCI",Jenny Elana Frieder Nathans|Marwa Mounir Afifi; PhD|Li  Yang; PhD,NULL,Rosandra N Kaplan (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107344
561,BC011833-01,"October 01, 2017 -  September 30, 2018",The DIPG All-In Initiative,Katherine Elizabeth Warren; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Cynthia M Lester mccully|Arman Bayazit Odabas,"Patricia  Baxter (Texas Children's Cancer Center)|Stewart  Goldman (Pediatric Oncology, Children's Memorial Hospital)|Sri  Gururangan (Duke University medical Center)|Cynthia  Hawkins (Hospital for Sick Children)|Gary  Kohanbash (Children's Hospital Of Pittsburgh)|Duane A Mitchell|Show all 11",Rafael  Cruz Garcia (Office Of The Director)|Simone  Difilippantonio (Office Of The Director)|Cody John Peer (Office Of The Clinical Director),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107345
562,BC011835-01,"October 01, 2017 -  September 30, 2018",Minimal Myc functional threshold for tumorigenesis,Susan  Mackem; MD|IRP Faculty Profile,NULL,"Cancer and Developmental Biology Laboratory, NCI",Xiaozhong  Bao,NULL,David  Levens; PhD (Laboratory of Pathology)|Svetlana Dmitriyevna Pack; PhD (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107342
563,BC011837-01,"October 01, 2017 -  September 30, 2018",Outcomes and Risk of Rare Tumors,Terri Sue Armstrong; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Alvina A Acquaye|Elizabeth  Vera|Mark Richard Gilbert; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107339
564,BC011838-01,"October 01, 2017 -  September 30, 2018",Mechanisms of resistance to treatment in aggressive prostate cancers,Adam G Sowalsky|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Nicole Vincele Carrabba|Scott Christopher Wilkinson|Huihui  Ye|Michael Louis Beshiri; PhD|Ross G Lake|Kathleen  Kelly; PhD|Show all 7,Steven  Balk (Beth Israel Deaconess Medical Center)|Glenn  Bubley (Beth Israel Deaconess Medical Center)|Mary-ellen  Taplin (Dana-farber Cancer Institute)|Huihui  Ye (Laboratory Of Genitourinary Cancer Pathogenesis),"Peter L Choyke; MD (Molecular Imaging Program)|Guinevere Joy Ng Chun (Office Of The Clinical Director)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|Stephanie Anne Harmon (Molecular Imaging Program)|Fatima Hafiz Karzai; MD (Genitourinary Malignancies Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107340
565,BC011839-01,"October 01, 2017 -  September 30, 2018",Developing an Effective BET bromodomain inhibitor Drug Combo to Target SCLC,Haobin  Chen|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Lisa  Gesumaria|David  Schrump; MD,Ulrike  Tontsch-grunt (Boehringer Ingelheim)|Nenghui  Wang (Ningbo Wenda Pharma),NULL,Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107341
566,BC011840-01,"October 01, 2017 -  September 30, 2018",Discovering novel therapies for glioma patients,"Jing  Wu; MD, PhD|IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",Yu-Ting  Su|Mark Richard Gilbert; MD|Terri Sue Armstrong; PhD,NULL,William D Figg; PharmD (Genitourinary Malignancies Branch),Doug B Kuhns; PhD (NIAID),"1. Ranjan S, Quezado M, Garren N, Boris L, Siegel C, Lopes Abath Neto O, Theeler BJ, Park DM, Nduom E, Zaghloul KA, Gilbert MR, Wu J (2018). Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases. BMC Cancer  18, 239.   https://doi.org/10.1186/s12885-018-4131-1|2. Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR (2018). MerTK as a therapeutic target in glioblastoma. Neuro Oncol  20, 92-102.   https://doi.org/10.1093/neuonc/nox111",https://intramural.nih.gov/search/searchview.taf?ipid=107337
567,BC011841-01,"October 01, 2017 -  September 30, 2018",Understanding IDH mutant gliomas,"Jing  Wu; MD, PhD|IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI",Terri Sue Armstrong; PhD|Mark Richard Gilbert; MD,NULL,Kenneth Dean Aldape; MD (Laboratory of Pathology)|Murali  Krishna; PhD (Radiation Biology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Javed  Khan; MD (Cancer Genetics Branch),Jun  Shen; PhD (NIMH),"1. Lu Y, Kwintkiewicz J, Liu Y, Tech K, Frady LN, Su YT, Bautista W, Moon SI, MacDonald J, Ewend MG, Gilbert MR, Yang C, Wu J (2017). Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair. Cancer Res  77, 1709-1718.   https://doi.org/10.1158/0008-5472.CAN-16-2773|2. Lukas RV, Wu J, Dey M, Buerki RA, Byrne RW, Dohrmann GJ (2018). A Survey of the Neuro-Oncology Landscape. J Clin Neurol  14, 8-15.   https://doi.org/10.3988/jcn.2018.14.1.8|3. Su Y, Phan F, Wu J (2018) Perspectives on IDH Mutation in Diffuse Gliomas. Trends in Cancer, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=107338
568,BC011843-01,"October 01, 2017 -  September 30, 2018",Identification and use of T-cell receptors recognizing common tumor mutations,"James Chung-Yin Yang; MD, PhD|IRP Faculty Profile",NULL,"Surgery Branch, NCI",Catherine Marie Ade|Kenichi  Hanada|Chihao  Zhao,NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107317
569,BC011846-01,"October 01, 2017 -  September 30, 2018",Single-cell DNA methylation analysis of human cancer,Kenneth Dean Aldape; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung,NULL,Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Eytan  Ruppin (Cancer Data Science Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107318
570,BC011847-01,"October 01, 2017 -  September 30, 2018",Development and validation of a predictor of meningioma recurrence,Kenneth Dean Aldape; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Russell William Bandle|Hye-Jung  Chung,NULL,Eytan  Ruppin (Cancer Data Science Laboratory),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107319
571,BC011848-01,"October 01, 2017 -  September 30, 2018",Preclinical Modelling and Therapeutic Development for Other Cancer Indications,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI","Nathan Michael Pate; DVM, DACVP|Stephanie L Henderson|Ludmila  Szabova; MS, PhD|Zoe W Ohler",NULL,Laura  Schmidt (Urologic Oncology Branch)|John Frederick Shern (Pediatric Oncology Branch)|Carol J Thiele (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107320
572,BC011852-01,"October 01, 2017 -  September 30, 2018",MyPART: My Pediatric and Adult Rare Tumor Network - Cures,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107797
573,BC011853-01,"October 01, 2017 -  September 30, 2018",CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors - Cures,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107799
574,BC011854-01,"October 01, 2017 -  September 30, 2018",NCI Program for Natural Products Discovery - Cures,Barry R O'Keefe,Joel Patrick Schneider; PhD,"Office of the Director, NCI",James Halpern Doroshow,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107796
575,BC011855-01,"October 01, 2017 -  September 30, 2018",Center for Cell-based Therapy - Cures,Nicholas Phillip Restifo; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107798
576,CP000101-14,"October 01, 2017 -  September 30, 2018",Human Studies of Diet and Nutrition,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  | |Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Terryl  Hartman (Penn State University)|David  Baer (BHNRC, USDA)|Joanne  Dorgan; PhD (NCI)|Jerry  Combs (USDA)|Meryl  Wastney (Metabolic Modeling Services)",Ruth  Pfeiffer; PhD (Biostatistics Branch)|Somdat  Mahabir (Analytic Epidemiology Research Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104289
577,CP000112-14,"October 01, 2017 -  September 30, 2018",Nutrition Intervention Trials,"Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Nan  Hu|Neal David Freedman|Gwen  Murphy,"You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|Wen-Qiang  Wei (Cancer Institute, Chinese Academy of Medical Sciences)",Alisa  Goldstein; PhD (Clinical Genetics Branch)|Kai  Yu (Biostatistics Branch)|Paula L Hyland (Genetic Epidemiology Branch),NULL,"1. Fan JH, Wang JB, Wang SM, Abnet CC, Qiao YL, Taylor PR (2018). Longitudinal change in blood pressure is associated with cardiovascular disease mortality in a Chinese cohort. Heart  104, 1764-1771.   https://doi.org/10.1136/heartjnl-2017-312850|2. Varga MG, Cai H, Waterboer T, Murphy G, Shimazu T, Taylor PR, Qiao YL, Park SK, Yoo KY, Jee SH, Cho ER, Kim J, Abnet CC, Tsugane S, Cai Q, Zheng W, Pawlita M, Shu XO, Epplein M (2018). Epstein-Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia. Dig Dis Sci  63, 2765-2772.   https://doi.org/10.1007/s10620-018-5154-9|3. Wang SM, Taylor PR, Fan JH, Pfeiffer RM, Gail MH, Liang H, Murphy GA, Dawsey SM, Qiao YL, Abnet CC (2018). Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial. J Natl Cancer Inst  110, 1229-1238.   https://doi.org/10.1093/jnci/djy043|4. Wang Z, Dai J, Hu N, Miao X, Abnet CC, Yang M, Freedman ND, Chen J, Burdette L, Zhu X, Chung CC, Ren C, Dawsey SM, Wang M, Ding T, Du J, Gao YT, Zhong R, Giffen C, Pan W, Koh WP, Dai N, Liao LM, Yan C, Qiao YL, et al. [21 more authors] (2017). Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. Gut  66, 581-587.   https://doi.org/10.1136/gutjnl-2015-310612",https://intramural.nih.gov/search/searchview.taf?ipid=104288
578,CP000176-14,"October 01, 2017 -  September 30, 2018",Biologic Specimen Bank for Early Lung Cancer Markers,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Nan  Hu,You-Lin  Qiao (Cancer Institute of the Chinese Academy of Science)|George M Weinstock|Jie  He (CICAMS)|Bert R Vogelstein,"Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Guoqin  Yu (Genetic Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104290
579,CP000185-14,"October 01, 2017 -  September 30, 2018",Upper Gastrointestinal Cancer Studies,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Michael Blaise Cook|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gwen  Murphy|Arash  Etemadi|Nan  Hu,"Paolo  Boffetta (International Agency for Research on Cancer)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|Renato  Fagundes|David  Fleischer (Mayo Clinic (Scottsdale))|Ning  Lu (Cancer Institute, Chinese Academy of Medical Sciences)|Reza  Malekzadeh (Digestive Disease Research Center, Tehran University of Medical Sciences)|Show all 11",NULL,NULL,"1. Abnet CC, Arnold M, Wei WQ (2018). Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology  154, 360-373.   https://doi.org/10.1053/j.gastro.2017.08.023|2. Agalliu I, Chen Z, Wang T, Hayes RB, Freedman ND, Gapstur SM, Burk RD (2018). Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. Cancer Epidemiol Biomarkers Prev  27, 1168-1175.   https://doi.org/10.1158/1055-9965.EPI-18-0287|3. Christensen CH, Rostron B, Cosgrove C, Altekruse SF, Hartman AM, Gibson JT, Apelberg B, Inoue-Choi M, Freedman ND (2018). Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population. JAMA Intern Med  178, 469-476.   https://doi.org/10.1001/jamainternmed.2017.8625|4. Codipilly DC, Qin Y, Dawsey SM, Kisiel J, Topazian M, Ahlquist D, Iyer PG (2018). Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc  88, 413-426.   https://doi.org/10.1016/j.gie.2018.04.2352|5. Etemadi A, Gandomkar A, Freedman ND, Moghadami M, Fattahi MR, Poustchi H, Islami F, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R (2017). The association between waterpipe smoking and gastroesophageal reflux disease. Int J Epidemiol  46, 1968-1977.   https://doi.org/10.1093/ije/dyx158|6. Hashemian M, Murphy G, Etemadi A, Poustchi H, Brockman JD, Kamangar F, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Brennan PJ, Boffetta P, Hekmatdoost A, Malekzadeh R, Abnet CC (2017). Toenail mineral concentration and risk of esophageal squamous cell carcinoma, results from the Golestan Cohort Study. Cancer Med  6, 3052-3059.   https://doi.org/10.1002/cam4.1247|7. Hashemian M, Murphy G, Etemadi A, Poustchi H, Sharafkhah M, Kamangar F, Pourshams A, Malekshah AF, Khoshnia M, Gharavi A, Hekmatdoost A, Brennan PJ, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R (2018). Nut consumption and the risk of oesophageal squamous cell carcinoma in the Golestan Cohort Study. Br J Cancer  119, 176-181.   https://doi.org/10.1038/s41416-018-0148-0|8. Khodamoradi Z, Gandomkar A, Poustchi H, Salehi A, Imanieh MH, Etemadi A, Malekzadeh R (2017). Prevalence and Correlates of Gastroesophageal Reflux Disease in Southern Iran: Pars Cohort Study. Middle East J Dig Dis  9, 129-138.   https://doi.org/10.15171/mejdd.2017.63|9. Li X, Kleeman S, Coburn SB, Fumagalli C, Perner J, Jammula S, Pfeiffer RM, Orzolek L, Hao H, Taylor PR, Miremadi A, Galeano-Dalmau N, Lao-Sirieix P, Tennyson M, MacRae S, Cook MB, Fitzgerald RC (2018). Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus. Gastroenterology  155, 771-783.e3.   https://doi.org/10.1053/j.gastro.2018.05.050|10. Lopes AB, Metzdorf M, Metzdorf L, Sousa MPR, Kavalco C, Etemadi A, Pritchett NR, Murphy G, Calafat AM, Abnet CC, Dawsey SM, Fagundes RB (2018). Urinary Concentrations of Polycyclic Aromatic Hydrocarbon Metabolites in Maté Drinkers in Rio Grande do Sul, Brazil. Cancer Epidemiol Biomarkers Prev  27, 331-337.   https://doi.org/10.1158/1055-9965.EPI-17-0773|11. Moossavi S, Mohamadnejad M, Pourshams A, Poustchi H, Islami F, Sharafkhah M, Mirminachi B, Nasseri-Moghaddam S, Semnani S, Shakeri R, Etemadi A, Merat S, Khoshnia M, Dawsey SM, Pharoah PD, Brennan P, Abnet CC, Boffetta P, Kamangar F, Malekzadeh R (2018). Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev  27, 268-273.   https://doi.org/10.1158/1055-9965.EPI-17-0592|12. Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, Freedman ND, Goldstein AM, Gopal S, Hashemian M, Hu N, Hyland PL, Kaimila B, Kamangar F, Malekzadeh R, Mathew CG, Menya D, Mulima G, Mwachiro MM, Mwasamwaja A, Pritchett N, et al. [14 more authors] (2017). International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol  28, 2086-2093.   https://doi.org/10.1093/annonc/mdx279|13. Nalini M, Oranuba E, Poustchi H, Sepanlou SG, Pourshams A, Khoshnia M, Gharavi A, Dawsey SM, Abnet CC, Boffetta P, Brennan P, Sotoudeh M, Nikmanesh A, Merat S, Etemadi A, Shakeri R, Sohrabpour AA, Nasseri-Moghaddam S, Kamangar F, Malekzadeh R (2018). Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran. BMJ Open  8, e021479.   https://doi.org/10.1136/bmjopen-2018-021479|14. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, Mohammadi Z, Mahmoudi Z, Shayanrad A, Roozafzai F, Sheikh M, Jalaeikhoo A, Somi MH, Mansour-Ghanaei F, Najafi F, Bahramali E, Mehrparvar A, Ansari-Moghaddam A, Enayati AA, Esmaeili Nadimi A, Rezaianzadeh A, Saki N, Alipour F, Kelishadi R, Rahimi-Movaghar A, et al. [3 more authors] (2018). Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. Am J Epidemiol  187, 647-655.   https://doi.org/10.1093/aje/kwx314|15. Pritchett NR, Burgert SL, Murphy GA, Brockman JD, White RE, Lando J, Chepkwony R, Topazian MD, Abnet CC, Dawsey SM, Mwachiro MM (2017). Cross sectional study of serum selenium concentration and esophageal squamous dysplasia in western Kenya. BMC Cancer  17, 835.   https://doi.org/10.1186/s12885-017-3837-9|16. Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Njoroge FW, Shaikh AJ, Prasad SV, Vinayak S, Gierach GL, Dawsey SM, Palakal M, Fan S, Mullooly M, Chauhan R, Okiro P, Gakinya S, Nzioka A, Kyobutungi C, Mohamed S, Haregu T, Mussajee M, Bonass B, Mariwa C, Sherman OA, et al. [12 more authors] (2018). Ethnicity and breast cancer characteristics in Kenya. Breast Cancer Res Treat  167, 425-437.   https://doi.org/10.1007/s10549-017-4511-2|17. VAN LOON K, MWACHIRO M, Abnet C, AKOKO L, ASSEFA M, BURGERT S, CHASIMPHA S, DZAMALALA C, FLEISCHER D, GOPAL S, IYER P, KAIMILA B, KAYAMBA V, KELLY P, LEON M, MATHEW C, MENYA D, MIDDLETON D, MLOMBE Y, MMBAGA B, MMBAGA E, MULIMA G, Murphy G, MUSHI B, MWANGA A, et al. [8 more authors] (2018). The African Esophageal Cancer Consortium (AfrECC): A Call to Action. Journal of Global Oncology  -, 1-9.",https://intramural.nih.gov/search/searchview.taf?ipid=104291
580,CP004410-42,"October 01, 2017 -  September 30, 2018",Family Studies,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Alisa  Goldstein; PhD|IRP Faculty Profile  | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI",June  Peters,Janis  Beach (Information Management Systems)|Donato  Calista (Bufalini Hospital)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Michael  Kelley (Duke University Medical Center)|Jeannette  Korczak (Karmanos Cancer Institute)|Yvonne  Reid (American Type Culture Collection)|Show all 11,Kenneth H Kraemer; MD (Laboratory of Cancer Biology and Genetics),"Jeffery P Struewing; MS, MD (NHGRI)","1. Goldstein AM, Xiao Y, Sampson J, Zhu B, Rotunno M, Bennett H, Wen Y, Jones K, Vogt A, Burdette L, Luo W, Zhu B, Yeager M, Hicks B, Han J, De Vivo I, Koutros S, Andreotti G, Beane-Freeman L, Purdue M, Freedman ND, Chanock SJ, Tucker MA, Yang XR (2017). Rare germline variants in known melanoma susceptibility genes in familial melanoma. Hum Mol Genet  26, 4886-4895.   https://doi.org/10.1093/hmg/ddx368|2. Helgadottir H, Olsson H, Tucker MA, Yang XR, Höiom V, Goldstein AM (2018). Phenocopies in melanoma-prone families with germ-line CDKN2A mutations. Genet Med  20, 1087-1090.   https://doi.org/10.1038/gim.2017.216|3. Zhou W, Goldin L, Wang M, McMaster ML, Jones K, Burdett L, Chanock SJ, Yeager M, Dean M, Caporaso NE (2018). Combined somatic mutation and copy number analysis in the survival of familial CLL. Br J Haematol  181, 604-613.   https://doi.org/10.1111/bjh.15239",https://intramural.nih.gov/search/searchview.taf?ipid=104263
581,CP005782-24,"October 01, 2017 -  September 30, 2018",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Liudmila  Prokunina-Olsson; PhD (Laboratory Translational Genomics)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch),Barbara  Rehermann; MD (NIDDK) |Raymond  Donnelly (OD),"1. Mahale P, Aka PV, Chen X, Liu P, Fram BJ, Wang AS, Simenel S, Tseng FC, Chen S, Edlin BR, Glenn JS, O'Brien TR (2018). Hepatitis D Viremia Among Injection Drug Users in San Francisco. J Infect Dis  217, 1902-1906.   https://doi.org/10.1093/infdis/jiy157|2. O'Brien TR, Kottilil S, Pfeiffer RM (2017). IFNL4 Genotype Is Associated With Virologic Relapse After 8-Week Treatment With Sofosbuvir, Velpatasvir, and Voxilaprevir. Gastroenterology  153, 1694-1695.   https://doi.org/10.1053/j.gastro.2017.06.069|3. Park H, O'Brien TR, Rehermann B (2018). The role of genetics in hepatic fibrosis among hepatitis C virus patients. Hepatology  67, 2043-2045.   https://doi.org/10.1002/hep.29659",https://intramural.nih.gov/search/searchview.taf?ipid=104262
582,CP005803-24,"October 01, 2017 -  September 30, 2018",Genetic Epidemiology,"Neil Edward Caporaso; MS, MD|IRP Faculty Profile  |Lynn Rachel Goldin; PhD| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Xiaohong Rose Yang; PhD|IRP Faculty Profile  | |Alisa  Goldstein; PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Human Genetics Program, NCI",Mary Louise McMaster; MD|Dilys  Parry; PhD,"Tim  Bishop (Institute for Cancer Research)|Florence  Demenais (Institut National de la Sante et de la Recherche Medicale)|Jorgen  Olsen (Danish Cancer Society)|Lene  Mellemkjaer (Danish Cancer Society)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Donato  Calista (Bufalini Hospital)","Mitchell Henry Gail; PhD, MD (Biostatistics Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104261
583,CP005804-24,"October 01, 2017 -  September 30, 2018",Pharmacogenetic Studies,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Genetic Epidemiology Branch, NCI",Lynn Rachel Goldin; PhD,Janis  Beach (Information Management Systems)|Maria  Landi (DCEG),Andrew Wells Bergen (Infection & Immunoepidemiology Branch)|Alisa  Goldstein; PhD (Clinical Genetics Branch)|Margaret Anne Tucker (Human Genetics Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104260
584,CP010119-23,"October 01, 2017 -  September 30, 2018",Studies of Occupational Cancer (Pesticides),"Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Stella  Koutros|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Gabriella  Andreotti|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD",Lisbeth  Lopez-Carrillo (Mexican National Institute of Public Health)|Andrew  Olshan (University of North Carolina)|Sandra  Petralia (Roche Laboratories)|Dennis  Weisenburger (University of Nebraska Medical Center)|Jane  Hoppin (North Carolina State University),NULL,NULL,"1. Alexander M, Koutros S, Bonner MR, Barry KH, Alavanja MCR, Andreotti G, Byun HM, Chen L, Beane Freeman LE, Hofmann JN, Kamel F, Moore LE, Baccarelli A, Rusiecki J (2017). Pesticide use and LINE-1 methylation among male private pesticide applicators in the Agricultural Health Study. Environ Epigenet  3, dvx005.   https://doi.org/10.1093/eep/dvx005|2. Andreotti G, Koutros S, Hofmann JN, Sandler DP, Lubin JH, Lynch CF, Lerro CC, De Roos AJ, Parks CG, Alavanja MC, Silverman DT, Beane Freeman LE (2018). Glyphosate Use and Cancer Incidence in the Agricultural Health Study. J Natl Cancer Inst  110, 509-516.   https://doi.org/10.1093/jnci/djx233|3. Engel LS, Werder E, Satagopan J, Blair A, Hoppin JA, Koutros S, Lerro CC, Sandler DP, Alavanja MC, Beane Freeman LE (2017). Insecticide Use and Breast Cancer Risk among Farmers' Wives in the Agricultural Health Study. Environ Health Perspect  125, 097002.   https://doi.org/10.1289/EHP1295|4. Hofmann JN, Shiels MS, Friesen MC, Kemp TJ, Chaturvedi AK, Lynch CF, Parks CG, Pinto LA, Hildesheim A, Alavanja MCR, Beane Freeman LE (2018). Industrial hog farming is associated with altered circulating immunological markers. Occup Environ Med  75, 212-217.   https://doi.org/10.1136/oemed-2017-104519|5. Lee MK, Carnes MU, Butz N, Azcarate-Peril MA, Richards M, Umbach DM, Thorne PS, Beane Freeman LE, Peddada SD, London SJ (2018). Exposures Related to House Dust Microbiota in a U.S. Farming Population. Environ Health Perspect  126, 067001.   https://doi.org/10.1289/EHP3145|6. Lerro CC, Andreotti G, Koutros S, Lee WJ, Hofmann JN, Sandler DP, Parks CG, Blair A, Lubin JH, Beane Freeman LE (2018). Alachlor Use and Cancer Incidence in the Agricultural Health Study: An Updated Analysis. J Natl Cancer Inst  110, 950-958.   https://doi.org/10.1093/jnci/djy005|7. Lerro CC, Beane Freeman LE, DellaValle CT, Kibriya MG, Aschebrook-Kilfoy B, Jasmine F, Koutros S, Parks CG, Sandler DP, Alavanja MCR, Hofmann JN, Ward MH (2018). Occupational pesticide exposure and subclinical hypothyroidism among male pesticide applicators. Occup Environ Med  75, 79-89.   https://doi.org/10.1136/oemed-2017-104431|8. Louis LM, Lerro CC, Friesen MC, Andreotti G, Koutros S, Sandler DP, Blair A, Robson MG, Beane Freeman LE (2017). A prospective study of cancer risk among Agricultural Health Study farm spouses associated with personal use of organochlorine insecticides. Environ Health  16, 95.   https://doi.org/10.1186/s12940-017-0298-1|9. Shrestha S, Kamel F, Umbach DM, Beane Freeman LE, Koutros S, Alavanja M, Sandler DP, Chen H (2017). Nonmotor symptoms and Parkinson disease in United States farmers and spouses. PLoS One  12, e0185510.   https://doi.org/10.1371/journal.pone.0185510|10. Shrestha S, Parks CG, Goldner WS, Kamel F, Umbach DM, Ward MH, Lerro CC, Koutros S, Hofmann JN, Beane Freeman LE, Sandler DP (2018). Incident thyroid disease in female spouses of private pesticide applicators. Environ Int  118, 282-292.   https://doi.org/10.1016/j.envint.2018.05.041|11. Stapleton EM, O'Shaughnessy PT, Locke SJ, Altmaier RW, Hofmann JN, Beane Freeman LE, Thorne PS, Jones RR, Friesen MC (2018). A task-based analysis of black carbon exposure in Iowa farmers during harvest. J Occup Environ Hyg  15, 293-304.   https://doi.org/10.1080/15459624.2017.1422870",https://intramural.nih.gov/search/searchview.taf?ipid=104255
585,CP010120-23,"October 01, 2017 -  September 30, 2018",Studies of Occupational Cancer,"Laura Elizabeth Beane Freeman|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Joanne S Colt|Bu Tian  Ji|Mary Helen Ward; MS, PhD|Aaron E Blair; PhD, MPH|Patricia S Stewart; PhD|Lee Elizabeth Moore; PhD, MD|Show all 10",Paolo  Boffetta (International Agency for Research on Cancer)|Leon  Burmeister (University of Iowa)|Larwence  Figgs (St. Louis University)|Daniel  Lackland (Medical University of South Carolina)|J.  Nichols (Medical University of South Carolina)|Dennis  Zaebst (National Institute for Occupational Safety and Health)|Show all 21,"Jay  Lubin; PhD (Biostatistics Branch)|Louise  Brinton; PhD (Office of the Director)|Montserrat  Garcia-Closas; MD, PhD (Office of the Director)","Dale  Sandler; PhD (NIEHS) |Freya  Kamel; PhD, MPH (NIEHS)","1. Bassig BA, Dai Y, Vermeulen R, Ren D, Hu W, Duan H, Niu Y, Xu J, Shiels MS, Kemp TJ, Pinto LA, Fu W, Meliefste K, Zhou B, Yang J, Ye M, Jia X, Meng T, Wong JYY, Bin P, Hosgood HD, Hildesheim A, Silverman DT, Rothman N, Zheng Y, et al. [1 more author] (2017). Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in China. Carcinogenesis  38, 1104-1111.   https://doi.org/10.1093/carcin/bgx081|2. Dai Y, Ren D, Bassig BA, Vermeulen R, Hu W, Niu Y, Duan H, Ye M, Meng T, Xu J, Bin P, Shen M, Yang J, Fu W, Meliefste K, Silverman D, Rothman N, Lan Q, Zheng Y (2018). Occupational exposure to diesel engine exhaust and serum cytokine levels. Environ Mol Mutagen  59, 144-150.   https://doi.org/10.1002/em.22142|3. Lerro CC, Jones RR, Langseth H, Grimsrud TK, Engel LS, Sjödin A, Choo-Wosoba H, Albert P, Ward MH (2018). A nested case-control study of polychlorinated biphenyls, organochlorine pesticides, and thyroid cancer in the Janus Serum Bank cohort. Environ Res  165, 125-132.   https://doi.org/10.1016/j.envres.2018.04.012|4. Silverman DT (2018). Diesel Exhaust and Lung Cancer-Aftermath of Becoming an IARC Group 1 Carcinogen. Am J Epidemiol  187, 1149-1152.   https://doi.org/10.1093/aje/kwy036",https://intramural.nih.gov/search/searchview.taf?ipid=104257
586,CP010121-23,"October 01, 2017 -  September 30, 2018",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Qing  Lan|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Mark  Purdue|Laura Elizabeth Beane Freeman","Stephen  Rappaport (School of Public Health, University of California)|Martyn  Smith (University of California at Berkeley)|Wei  Zheng (Vanderbilt University Medical Center)|John  Tessari (Colorado State University)|Xiao  Shu (Vanderbilt)|Robert  Branch (University of Pittsburgh)|Show all 13",NULL,NULL,"1. Grigoryan H, Edmands WMB, Lan Q, Carlsson H, Vermeulen R, Zhang L, Yin SN, Li GL, Smith MT, Rothman N, Rappaport SM (2018). Adductomic signatures of benzene exposure provide insights into cancer induction. Carcinogenesis  39, 661-668.   https://doi.org/10.1093/carcin/bgy042|2. Rothman N, Lan Q, Smith MT, Vermeulen R, Zhang L (2017). Response to letter to the editor of Carcinogenesis by Pira et al, 2017. Carcinogenesis  38, 1253-1255.   https://doi.org/10.1093/carcin/bgx111|3. Rothman N, Zhang L, Smith MT, Vermeulen R, Lan Q (2018). Formaldehyde, Hematotoxicity, and Chromosomal Changes-Response. Cancer Epidemiol Biomarkers Prev  27, 120-121.   https://doi.org/10.1158/1055-9965.EPI-17-0804|4. Wong JYY, Hu W, Downward GS, Seow WJ, Bassig BA, Ji BT, Wei F, Wu G, Li J, He J, Liu CS, Cheng WL, Huang Y, Yang K, Chen Y, Rothman N, Vermeulen RC, Lan Q (2017). Personal exposure to fine particulate matter and benzo[a]pyrene from indoor air pollution and leukocyte mitochondrial DNA copy number in rural China. Carcinogenesis  38, 893-899.   https://doi.org/10.1093/carcin/bgx068|5. Wong JYY, Margolis HG, Machiela M, Zhou W, Odden MC, Psaty BM, Robbins J, Jones RR, Rotter JI, Chanock SJ, Rothman N, Lan Q, Lee JS (2018). Outdoor air pollution and mosaic loss of chromosome Y in older men from the Cardiovascular Health Study. Environ Int  116, 239-247.   https://doi.org/10.1016/j.envint.2018.04.030",https://intramural.nih.gov/search/searchview.taf?ipid=104258
587,CP010122-23,"October 01, 2017 -  September 30, 2018",Occupational Exposure Assessment,Qing  Lan|IRP Faculty Profile  | |Melissa Charmaine Friesen|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Aaron E Blair; PhD, MPH|Mark  Purdue|Sarah J Locke|Debra  Silverman; ScD, ScM|Show all 9",NULL,NULL,NULL,"1. Su FC, Friesen MC, Stefaniak AB, Henneberger PK, LeBouf RF, Stanton ML, Liang X, Humann M, Virji MA (2018). Exposures to Volatile Organic Compounds among Healthcare Workers: Modeling the Effects of Cleaning Tasks and Product Use. Ann Work Expo Health  62, 852-870.   https://doi.org/10.1093/annweh/wxy055",https://intramural.nih.gov/search/searchview.taf?ipid=104256
588,CP010123-23,"October 01, 2017 -  September 30, 2018",Occupational and Environmental Determinants of Cancer among Women and Minorities,"Melissa Charmaine Friesen|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Qing  Lan|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile  | |Mary Helen Ward; MS, PhD|IRP Faculty Profile  | |Laura Elizabeth Beane Freeman|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Aaron E Blair; PhD, MPH|Bu Tian  Ji|Joanne S Colt",NULL,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Martha S Linet; PhD (Radiation Epidemiology Branch)",NULL,"1. Dai Y, Ren D, Bassig BA, Vermeulen R, Hu W, Niu Y, Duan H, Ye M, Meng T, Xu J, Bin P, Shen M, Yang J, Fu W, Meliefste K, Silverman D, Rothman N, Lan Q, Zheng Y (2018). Occupational exposure to diesel engine exhaust and serum cytokine levels. Environ Mol Mutagen  59, 144-150.   https://doi.org/10.1002/em.22142|2. Koutros S, Baris D, Waddell R, Beane Freeman LE, Colt JS, Schwenn M, Johnson A, Ward MH, Hosain GM, Moore LE, Stolzenberg-Solomon R, Rothman N, Karagas MR, Silverman DT (2018). Potential effect modifiers of the arsenic-bladder cancer risk relationship. Int J Cancer  143, 2640-2646.   https://doi.org/10.1002/ijc.31720",https://intramural.nih.gov/search/searchview.taf?ipid=104259
589,CP010124-23,"October 01, 2017 -  September 30, 2018",Human papillomavirus (HPV) infection and cervical and anal cancers,Mark  Schiffman; MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Julia  Gage,Robert  Burk (Albert Einstein College of Medicine)|Michael  Gold MD (Vanderbilt University)|Patti  Gravitt (Johns Hopkins University)|Martha  Hutchinson (Brown University)|David  Scott (Kaiser Permanente)|Joan  Walker MD (University of Oklahoma Health Sciences Center)|Show all 27,Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Joshua Neil Sampson (Biostatistics Branch)|Vikrant Vasant Sahasrabuddhe (Breast and Gynecologic Cancer Research Group)|Hannah  Yang (Office of the Director)|Clara  Bodelon (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Cuschieri K, Ronco G, Lorincz A, Smith L, Ogilvie G, Mirabello L, Carozzi F, Cubie H, Wentzensen N, Snijders P, Arbyn M, Monsonego J, Franceschi S (2018). Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs. Int J Cancer  143, 735-745.   https://doi.org/10.1002/ijc.31261|2. Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N (2017). Smoking and subsequent human papillomavirus infection: a mediation analysis. Ann Epidemiol  27, 724-730.e1.   https://doi.org/10.1016/j.annepidem.2017.10.004|3. Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, Mayeaux EJ, Waxman AG, Conageski C, Einstein MH, Huh WK (2017). ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. J Low Genit Tract Dis  21, 223-229.   https://doi.org/10.1097/LGT.0000000000000338|4. Litwin TR, Clarke MA, Dean M, Wentzensen N (2017). Somatic Host Cell Alterations in HPV Carcinogenesis. Viruses  9.   https://doi.org/10.3390/v9080206|5. Waxman AG, Conageski C, Silver MI, Tedeschi C, Stier EA, Apgar B, Huh WK, Wentzensen N, Massad LS, Khan MJ, Mayeaux EJ, Einstein MH, Schiffman MH, Guido RS (2017). ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing Standards. J Low Genit Tract Dis  21, 235-241.   https://doi.org/10.1097/LGT.0000000000000336",https://intramural.nih.gov/search/searchview.taf?ipid=104251
590,CP010125-23,"October 01, 2017 -  September 30, 2018",Cancer Risk and Environmental Exposures,"Mary Helen Ward; MS, PhD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Rena Rae Jones|Joanne S Colt|Debra  Silverman; ScD, ScM|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH|Lee Elizabeth Moore; PhD, MD|Show all 9","James  Cerhan (Mayo Clinic)|Charles  Lynch (University of Iowa)|R William  Field (University of Iowa)|Manolis  Kogevinas|John W Brock (CDC)|Alexander  Parker (Mayo Clinic, Rochestor, NM)|Show all 28",Jay  Lubin; PhD (Biostatistics Branch)|Maki  Inoue Choi (Hormonal and Reproductive Epidemiology Branch),Lawrence Stuart Engel; PhD (NIEHS),"1. Booth BJ, Jones RR, Turyk ME, Freels S, Patel DM, Stayner LT, Ward MH (2017). Livestock and poultry density and childhood cancer incidence in nine states in the USA. Environ Res  159, 444-451.   https://doi.org/10.1016/j.envres.2017.08.023|2. Koutros S, Baris D, Waddell R, Beane Freeman LE, Colt JS, Schwenn M, Johnson A, Ward MH, Hosain GM, Moore LE, Stolzenberg-Solomon R, Rothman N, Karagas MR, Silverman DT (2018). Potential effect modifiers of the arsenic-bladder cancer risk relationship. Int J Cancer  143, 2640-2646.   https://doi.org/10.1002/ijc.31720|3. Koutros S, Lenz P, Hewitt SM, Kida M, Jones M, Schned AR, Baris D, Pfeiffer R, Schwenn M, Johnson A, Karagas MR, Garcia-Closas M, Rothman N, Moore LE, Silverman DT (2018). RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic. J Natl Cancer Inst  110, 1273-1274.   https://doi.org/10.1093/jnci/djy045|4. Lim CC, Hayes RB, Ahn J, Shao Y, Silverman DT, Jones RR, Garcia C, Thurston GD (2018). Association between long-term exposure to ambient air pollution and diabetes mortality in the US. Environ Res  165, 330-336.   https://doi.org/10.1016/j.envres.2018.04.011|5. Quist AJL, Inoue-Choi M, Weyer PJ, Anderson KE, Cantor KP, Krasner S, Freeman LEB, Ward MH, Jones RR (2018). Ingested nitrate and nitrite, disinfection by-products, and pancreatic cancer risk in postmenopausal women. Int J Cancer  142, 251-261.   https://doi.org/10.1002/ijc.31055",https://intramural.nih.gov/search/searchview.taf?ipid=104264
591,CP010126-23,"October 01, 2017 -  September 30, 2018",Hormone-Related Cancers,"Louise  Brinton; PhD| | |Michael Blaise Cook|IRP Faculty Profile  | |Montserrat  Garcia-Closas; MD, PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Gretchen L Gierach|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI","Roni T Falk|Hannah  Yang|Stephen J Chanock; MD, PhD",David  Alberts (University of Arizona Cancer Center)|Douglas  Bauer (University of California at San Francisco)|Ralph  Coates (Centers for Disease Control and Prevention)|Joanne  Dorgan; PhD (NCI)|Kathleen  Egan (Harvard University)|R Loren  Erickson (Department of Defense)|Show all 11,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Barry Ira Graubard; PhD (Biostatistics Branch)|William Frederick Anderson (Biostatistics Branch)|Aaron E Blair; PhD, MPH (Occupational and Environmental Epidemiology Branch)","Jeffery P Struewing; MS, MD (NHGRI) |Matthew P. Longnecker; MD, ScD (NIEHS)","1. Callaghan RC, Allebeck P, Akre O, McGlynn KA, Sidorchuk A (2017). Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011. Cancer Epidemiol Biomarkers Prev  26, 1644-1652.   https://doi.org/10.1158/1055-9965.EPI-17-0428|2. Chollet-Hinton L, Puvanesarajah S, Sandhu R, Kirk EL, Midkiff BR, Ghosh K, Brandt KR, Scott CG, Gierach GL, Sherman ME, Vachon CM, Troester MA (2018). Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast. Mod Pathol  31, 1085-1096.   https://doi.org/10.1038/s41379-018-0033-7|3. Ehteshami Bejnordi B, Mullooly M, Pfeiffer RM, Fan S, Vacek PM, Weaver DL, Herschorn S, Brinton LA, van Ginneken B, Karssemeijer N, Beck AH, Gierach GL, van der Laak JAWM, Sherman ME (2018). Using deep convolutional neural networks to identify and classify tumor-associated stroma in diagnostic breast biopsies. Mod Pathol  31, 1502-1512.   https://doi.org/10.1038/s41379-018-0073-z|4. EHTESHAMIBEJNORDI B, LIN J, GLASS B, Mullooly M, Gierach G, SHERMAN M, KARSSEMEIJER N, VAN DER LAAK J, BECK A (2017). DEEP LEARNING-BASED ASSESSMENT OF TUMOR-ASSOCIATED STROMA FOR DIAGNOSING BREAST CANCER IN HISTOPATHOLOGY IMAGES. 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017) conference proceedings  none, 929-32.|5. Epidemiology Working Group Steering Committee, Ovarian Cancer Association Consortium Members of the EWG SC, in alphabetical order:, Doherty JA, Jensen A, Kelemen LE, Pearce CL, Poole E, Schildkraut JM, Terry KL, Tworoger SS, Webb PM, Wentzensen N (2017). Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx144|6. Fortner RT, Schock H, Jung S, Allen NE, Arslan AA, Brinton LA, Egleston BL, Falk RT, Gunter MJ, Helzlsouer KJ, Idahl A, Johnson TS, Kaaks R, Krogh V, Lundin E, Merritt MA, Navarro C, Onland-Moret NC, Palli D, Shu XO, Sluss PM, Staats PN, Trichopoulou A, Weiderpass E, Zeleniuch-Jacquotte A, et al. [2 more authors] (2017). Anti-Mullerian hormone and endometrial cancer: a multi-cohort study. Br J Cancer  117, 1412-1418.   https://doi.org/10.1038/bjc.2017.299|7. Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, Sandler DP, Schoemaker MJ, Sluss PM, Sund M, Swerdlow AJ, Visvanathan K, Liu M, Zeleniuch-Jacquotte A (2018). Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. Int J Cancer  142, 2215-2226.   https://doi.org/10.1002/ijc.31249|8. Ghazarian AA, Rusner C, Trabert B, Braunlin M, McGlynn KA, Stang A (2018). Testicular cancer among US men aged 50 years and older. Cancer Epidemiol  55, 68-72.   https://doi.org/10.1016/j.canep.2018.05.007|9. Ghazarian AA, Trabert B, Graubard BI, Longnecker MP, Klebanoff MA, McGlynn KA (2018). Placental Weight and Risk of Cryptorchidism and Hypospadias in the Collaborative Perinatal Project. Am J Epidemiol  187, 1354-1361.   https://doi.org/10.1093/aje/kwy005|10. Ghazarian AA, Trabert B, Robien K, Graubard BI, McGlynn KA (2018). Maternal use of personal care products during pregnancy and risk of testicular germ cell tumors in sons. Environ Res  164, 109-113.   https://doi.org/10.1016/j.envres.2018.02.017|11. Gurney JK, Stanley J, McGlynn K, Richiardi L, Shaw C, Edwards R, Merriman TR, Robson B, Koea J, McLeod M, Kennedy MA, Sarfati D (2018). Testicular Cancer in New Zealand (TCNZ) study: protocol for a national case-control study. BMJ Open  8, e025212.   https://doi.org/10.1136/bmjopen-2018-025212|12. Huang S, Signal V, Sarfati D, Shaw C, Stanley J, McGlynn K, Gurney J (2018). Physical activity and risk of testicular cancer: a systematic review. BMC Cancer  18, 189.   https://doi.org/10.1186/s12885-018-4093-3|13. Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, Kremeyer B, Luo L, von Holst S, Kontham V, Thutkawkorapin J, Margolin S, Du Q, Lundin J, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN, NBCS Collaborators, kConFab/AOCS Investigators, et al. [79 more authors] (2017). PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget  8, 102769-102782.   https://doi.org/10.18632/oncotarget.21800|14. Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, Lundin E, Onland-Moret NC, Rinaldi S, Schock H, Shu XO, Sluss PM, Staats PN, Sacerdote C, Travis RC, Tjønneland A, et al. [6 more authors] (2018). Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer  142, 262-270.   https://doi.org/10.1002/ijc.31058|15. McGlynn KA, Petrick JL, Gamborg M, Aarestrup J, Baker JL (2018). Childhood height and risk of testicular germ cell tumors in adulthood. Int J Cancer  143, 767-772.   https://doi.org/10.1002/ijc.31354|16. Morimoto LM, Zava D, McGlynn KA, Stanczyk FZ, Kang AY, Ma X, Wiemels JL, Metayer C (2018). Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT). Cancer Epidemiol Biomarkers Prev  27, 488-495.   https://doi.org/10.1158/1055-9965.EPI-17-0879|17. Murphy J, Pfeiffer RM, Lynn BCD, Caballero AI, Browne EP, Punska EC, Yang HP, Falk RT, Anderton DL, Gierach GL, Arcaro KF, Sherman ME (2018). Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology. Breast Cancer Res Treat  172, 209-219.   https://doi.org/10.1007/s10549-018-4907-7|18. Oh H, Arem H, Matthews CE, Wentzensen N, Reding KW, Brinton LA, Anderson GL, Coburn SB, Cauley JA, Chen C, Goodman D, Pfeiffer RM, Falk RT, Xu X, Trabert B (2017). Sitting, physical activity, and serum oestrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study. Br J Cancer  117, 1070-1078.   https://doi.org/10.1038/bjc.2017.268|19. Oh H, Pfeiffer RM, Falk RT, Horne HN, Xiang J, Pollak M, Brinton LA, Storniolo AMV, Sherman ME, Gierach GL, Figueroa JD (2018). Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank. Int J Cancer  143, 496-507.   https://doi.org/10.1002/ijc.31333|20. Playdon MC, Coburn SB, Moore SC, Brinton LA, Wentzensen N, Anderson G, Wallace R, Falk RT, Pfeiffer R, Xu X, Trabert B (2018). Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational Study. Br J Cancer  118, 448-457.   https://doi.org/10.1038/bjc.2017.419|21. Rudolph A, Song M, Brook MN, Milne RL, Mavaddat N, Michailidou K, Bolla MK, Wang Q, Dennis J, Wilcox AN, Hopper JL, Southey MC, Keeman R, Fasching PA, Beckmann MW, Gago-Dominguez M, Castelao JE, Guénel P, Truong T, Bojesen SE, Flyger H, Brenner H, Arndt V, Brauch H, Brüning T, et al. [26 more authors] (2018). Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium. Int J Epidemiol  47, 526-536.   https://doi.org/10.1093/ije/dyx242|22. Sak M, Duric N, Littrup P, Sherman M, Gierach G (2017). Ultrasound tomography imaging with waveform sound speed: Parenchymal changes in women undergoing tamoxifen therapy. Proc SPIE Int Soc Opt Eng  10139.   https://doi.org/10.1117/12.2254472|23. Sun X, Shan Y, Li Q, Chollet-Hinton L, Kirk EL, Gierach GL, Troester MA (2018). Intra-individual Gene Expression Variability of Histologically Normal Breast Tissue. Sci Rep  8, 9137.   https://doi.org/10.1038/s41598-018-27505-y",https://intramural.nih.gov/search/searchview.taf?ipid=104265
592,CP010127-23,"October 01, 2017 -  September 30, 2018",Etiologic Studies of Diet and Cancer,Eric Andrew Engels; PhD|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Lai GY, Wang JB, Weinstein SJ, Parisi D, Horst RL, McGlynn KA, Männistö S, Albanes D, Freedman ND (2018). Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study. Cancer Epidemiol Biomarkers Prev  27, 1075-1082.   https://doi.org/10.1158/1055-9965.EPI-17-0877",https://intramural.nih.gov/search/searchview.taf?ipid=104283
593,CP010128-23,"October 01, 2017 -  September 30, 2018",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD| | |Gretchen L Gierach|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile  |Vikrant Vasant Sahasrabuddhe| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Britton Lindsay Trabert|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI

Breast and Gynecologic Cancer Research Group, NCI",Roni T Falk,Lenore  Buckley (Virginia Commonwealth University)|Theodore  Colton (Boston University School of Public Health)|Olga  Dvorkina (SUNY Health Sciences Center)|Susanne  Kruger-Kjaer (Danish Cancer Registry)|Emmet  Lamb (Stanford University)|Lene  Mellemkjaer (Danish Cancer Society)|Show all 10,NULL,NULL,"1. Samimi G, Trabert B, Duggan MA, Robinson JL, Coa KI, Waibel E, Garcia E, Minasian LM, Sherman ME (2018). Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices. Gynecol Oncol  148, 515-520.   https://doi.org/10.1016/j.ygyno.2018.01.016|2. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL (2018). Ovarian cancer statistics, 2018. CA Cancer J Clin  68, 284-296.   https://doi.org/10.3322/caac.21456|3. Trabert B, Aarestrup J, Ulrich LG, Wentzensen N, Sørensen TIA, Baker JL (2018). Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register. Gynecol Oncol  148, 547-552.   https://doi.org/10.1016/j.ygyno.2017.12.031|4. Trabert B, Coburn SB, Mariani A, Yang HP, Rosenberg PS, Gierach GL, Wentzensen N, Cronin KA, Sherman ME (2018). Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries. J Natl Cancer Inst  110, 750-757.   https://doi.org/10.1093/jnci/djx263",https://intramural.nih.gov/search/searchview.taf?ipid=104266
594,CP010131-23,"October 01, 2017 -  September 30, 2018",Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents,"Amy  de Gonzalez|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Daryl  Freedman|Alina V Brenner|Show all 7,David  Abramson (New York Presbyterian Hospital)|Michael  Andersson (Danish Cancer Society)|Mary  Gospodarowicz (Princess Margaret Hospital)|Eric  Holowaty (Cancer Care Ontario)|Ann  Mertens (University of Minnesota)|Joseph  Neglia (University of Minnesota)|Show all 24,Steven L Simon (Epidemiology and Biostatistics Program)|Andre  Bouville (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Friedman DN, Chou JF, Francis JH, Sklar CA, Li Y, McCabe M, Robison LL, Kleinerman RA, Oeffinger KC, Abramson DH, Dunkel IJ, Ford JS (2018). Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma. JAMA Ophthalmol  136, 637-641.   https://doi.org/10.1001/jamaophthalmol.2018.1082|2. Mille MM, Hertel NE, Bergstrom PM, Lee C (2018). PIECEWISE POLYNOMIAL APPROXIMATIONS TO THE ICRP 116 EFFECTIVE DOSE COEFFICIENTS: PHOTONS AND NEUTRONS. Radiat Prot Dosimetry  178, 310-321.   https://doi.org/10.1093/rpd/ncx112",https://intramural.nih.gov/search/searchview.taf?ipid=104267
595,CP010132-23,"October 01, 2017 -  September 30, 2018",Studies of Populations Exposed to Environmental Sources of Radiation,"Amy  de Gonzalez|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Elizabeth  Cahoon|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Maureen Cusack Hatch; MD|Daryl  Freedman|Alice  Sigurdson; PhD,Boris  Gusev (Kazakh Institute for Radiation Medicine and Ecology)|Terry  Hartman (Pennsylvania State University)|Alex  Romanukha (National Institute for Standards and Technology)|N.  Shilnikova (Biophysics Institute-Branch 1)|Alexander  Sekerbaev (Kazakhstan Research Institute of Radiation Medicine and Ecology)|Mykola  Tronko (Research Institute of Endocrinology and Metabolism)|Show all 10,NULL,NULL,"1. Efanov AA, Brenner AV, Bogdanova TI, Kelly LM, Liu P, Little MP, Wald AI, Hatch M, Zurnadzy LY, Nikiforova MN, Drozdovitch V, Leeman-Neill R, Mabuchi K, Tronko MD, Chanock SJ, Nikiforov YE (2018). Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer. J Natl Cancer Inst  110, 371-378.   https://doi.org/10.1093/jnci/djx209|2. Hatch M, Cardis E (2017). Somatic health effects of Chernobyl: 30 years on. Eur J Epidemiol  32, 1047-1054.   https://doi.org/10.1007/s10654-017-0303-6",https://intramural.nih.gov/search/searchview.taf?ipid=104252
596,CP010133-23,"October 01, 2017 -  September 30, 2018",Studies of Populations Exposed to Occupational Sources of Radiation,"Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Kiyohiko  Mabuchi; MD, DPhil|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Michele M Doody; MS|Daryl  Freedman|Maureen Cusack Hatch; MD|Alice  Sigurdson; PhD|Alina V Brenner|Ethel S Gilbert,Bruce  Alexander (University of Minnesota)|Terry  Hartman (Pennsylvania State University)|Juozas  Kurtinaitis (Lithuanian Cancer Registry)|Dale  Preston (Hirosoft)|S.  Salomaa (Finnish Center for Radiation and Nuclear Safety)|N.  Shilnikova (Biophysics Institute-Branch 1)|Show all 16,NULL,NULL,"1. Bernier MO, Doody MM, Van Dyke ME, Villoing D, Alexander BH, Linet MS, Kitahara CM (2018). Work history and radioprotection practices in relation to cancer incidence and mortality in US radiologic technologists performing nuclear medicine procedures. Occup Environ Med  75, 533-561.   https://doi.org/10.1136/oemed-2017-104559|2. Bernier MO, Journy N, Villoing D, Doody MM, Alexander BH, Linet MS, Kitahara CM (2018). Cataract Risk in a Cohort of U.S. Radiologic Technologists Performing Nuclear Medicine Procedures. Radiology  286, 592-601.   https://doi.org/10.1148/radiol.2017170683|3. Chang LA, Miller DL, Lee C, Melo DR, Villoing D, Drozdovitch V, Thierry-Chef I, Winters SJ, Labrake M, Myers CF, Lim H, Kitahara CM, Linet MS, Simon SL (2017). Thyroid Radiation Dose to Patients from Diagnostic Radiology Procedures over Eight Decades: 1930-2010. Health Phys  113, 458-473.   https://doi.org/10.1097/HP.0000000000000723|4. Kitahara CM, Miller DL (2017). Reply to ""Occupational Radiation Exposure in Interventional Radiology and the Risks of Acquiring a Brain Tumor"". AJR Am J Roentgenol  209, W403.   https://doi.org/10.2214/AJR.17.18768|5. Kitahara CM, Preston DL, Neta G, Little MP, Doody MM, Simon SL, Sigurdson AJ, Alexander BH, Linet MS (2018). Occupational radiation exposure and thyroid cancer incidence in a cohort of U.S. radiologic technologists, 1983-2013. Int J Cancer  143, 2145-2149.   https://doi.org/10.1002/ijc.31270|6. Villoing D, Drozdovitch V, Simon SL, Kitahara CM, Linet MS, Melo DR (2017). Estimated Organ Doses to Patients from Diagnostic Nuclear Medicine Examinations over Five Decades: 1960-2010. Health Phys  113, 474-518.   https://doi.org/10.1097/HP.0000000000000721|7. Villoing D, Kitahara CM, Passmore C, Simon SL, Yoder RC (2018). Photon energy readings in OSL dosimeter filters: an application to retrospective dose estimation for nuclear medicine workers. J Radiol Prot  38, 1053-1063.   https://doi.org/10.1088/1361-6498/aacd64|8. Villoing D, Yoder RC, Passmore C, Bernier MO, Kitahara CM (2018). A U.S. Multicenter Study of Recorded Occupational Radiation Badge Doses in Nuclear Medicine. Radiology  287, 676-682.   https://doi.org/10.1148/radiol.2018171138",https://intramural.nih.gov/search/searchview.taf?ipid=104268
597,CP010135-23,"October 01, 2017 -  September 30, 2018",Studies of Non-Ionizing Radiation-Related Cancer,Cari Meinhold Kitahara|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",Alina V Brenner|Alice  Sigurdson; PhD|Rochelle E Curtis,Peter  Black (Brigham and Women's Hospital & Dana Farber Cancer Center)|W.  Bleyer (Children's Cancer Group)|Howard  Fine (NYU Langone Medical Center)|Jay  Loeffler (Massachusetts General Hospital)|Bruce  Alexander (University of Minnesota)|Ann  Mertens (University of Minnesota)|Show all 13,Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Preetha  Rajaraman (Center For Global Health)|Gila I Neta (Office of the Director)|Susan Shaw Devesa (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104269
598,CP010136-23,"October 01, 2017 -  September 30, 2018",Cancer Risk in Human Populations,"Sonja  Berndt|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Stella  Koutros|IRP Faculty Profile  | |Debra  Silverman; ScD, ScM|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Bu Tian  Ji|Joanne S Colt|Mary Helen Ward; MS, PhD|Kenneth  Cantor; PhD|Nathaniel C Rothman; MD|Aaron E Blair; PhD, MPH",NULL,Mark  Schiffman; MD (Clinical Genetics Branch),NULL,"1. Bock CH, Ruterbusch JJ, Holowatyj AN, Steck SE, Van Dyke AL, Ho WJ, Cote ML, Hofmann JN, Davis F, Graubard BI, Schwartz KL, Purdue MP (2018). Renal cell carcinoma risk associated with lower intake of micronutrients. Cancer Med  7, 4087-4097.   https://doi.org/10.1002/cam4.1639|2. Santo L, Teras LR, Giles GG, Weinstein SJ, Albanes D, Wang Y, Pfeiffer RM, Lan Q, Rothman N, Birmann BM, Colditz GA, Pollak MN, Purdue MP, Hofmann JN (2017). Circulating resistin levels and risk of multiple myeloma in three prospective cohorts. Br J Cancer  117, 1241-1245.   https://doi.org/10.1038/bjc.2017.282|3. Suarez-Sarmiento A, Yao X, Hofmann JN, Syed JS, Zhao WK, Purdue MP, Chow WH, Corley D, Shuch B (2017). Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system. Int J Urol  24, 765-770.   https://doi.org/10.1111/iju.13424",https://intramural.nih.gov/search/searchview.taf?ipid=104270
599,CP010142-20,"October 01, 2017 -  September 30, 2018",Genetic Modifiers of Cancer Risk,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Jennifer T Loud| | |Lisa  Mirabello|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI

Office of the Director, NCI",Anand  Pathak|Meredith  Yeager,Joseph  Constantino (National Surgical Adjuvant Breast & Bowel Project Statistical Center)|Larry  Wickerham (NSABP Group Headquarters)|Norman  Wolmark (National Surgical Adjuvant Breast and Bowel Project)|Phuong L Mai,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Koster R, Panagiotou OA, Wheeler WA, Karlins E, Gastier-Foster JM, Caminada de Toledo SR, Petrilli AS, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Lecanda F, Serra M, Hattinger C, Picci P, Scotlandi K, Thomas DM, Ballinger ML, Gorlick R, Barkauskas DA, Spector LG, Tucker M, Belynda DH, et al. [6 more authors] (2018). Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. Int J Cancer  142, 1594-1601.   https://doi.org/10.1002/ijc.31195",https://intramural.nih.gov/search/searchview.taf?ipid=104271
600,CP010144-20,"October 01, 2017 -  September 30, 2018",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Blanche P Alter|IRP Faculty Profile  | |Shahinaz M Gadalla|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Douglas Russell Stewart; BA, MD|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI","Mitchell Henry Gail; PhD, MD|Renee C Bremer|Hormuzdiar Aspandiar Katki; MS|Mary Louise McMaster; MD|Stephen J Chanock; MD, PhD",David  Alberts (University of Arizona Cancer Center)|Tim  Bishop (Institute for Cancer Research)|Robert  Brodsky (Johns Hopkins University School of Medicine)|Joseph  Califano (Johns Hopkins University School of Medicine)|Peter  Durie (Toronto Hospital for Sick Children)|M.  Elghetany (University of Texas)|Show all 50,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Margaret Anne Tucker (Human Genetics Program)|Gordon B Willis (Tobacco Control Research Branch)|Izumi  Horikawa (Laboratory of Human Carcinogenesis)",Pamela  Stratton; MD (NINDS),"1. Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, Achatz MI, Chojniak R, Balieiro da Costa A, Santiago KM, Garber J, O'Neill AF, Eeles RA, Evans DG, Bleiker E, Sonke GS, Ruijs M, Loo C, Schiffman J, Naumer A, Kohlmann W, Strong LC, Bojadzieva J, Malkin D, Rednam SP, et al. [11 more authors] (2017). Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. JAMA Oncol  3, 1634-1639.   https://doi.org/10.1001/jamaoncol.2017.1968|2. de Andrade KC, Mirabello L, Stewart DR, Karlins E, Koster R, Wang M, Gapstur SM, Gaudet MM, Freedman ND, Landi MT, Lemonnier N, Hainaut P, Savage SA, Achatz MI (2017). Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history. Hum Mutat  38, 1723-1730.   https://doi.org/10.1002/humu.23320|3. Khincha PP, Dagnall CL, Hicks B, Jones K, Aviv A, Kimura M, Katki H, Aubert G, Giri N, Alter BP, Savage SA, Gadalla SM (2017). Correlation of Leukocyte Telomere Length Measurement Methods in Patients with Dyskeratosis Congenita and in Their Unaffected Relatives. Int J Mol Sci  18.   https://doi.org/10.3390/ijms18081765|4. Kim J, Field A, Schultz KAP, Hill DA, Stewart DR (2017). The prevalence of DICER1 pathogenic variation in population databases. Int J Cancer  141, 2030-2036.   https://doi.org/10.1002/ijc.30907|5. Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, Wang Q, Aalfs CM, ABCTB Investigators, Adams M, Adlard J, Agata S, Ahmed S, Ahsan H, Aittomäki K, Al-Ejeh F, Allen J, EMBRACE, GEMO Study Collaborators, HEBON, kConFab/AOCS Investigators, NBSC Collaborators, et al. [445 more authors] (2017). Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet  49, 1767-1778.   https://doi.org/10.1038/ng.3785|6. Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, Kruse TA, Palmero EI, Park SK, Torres D, van Rensburg EJ, McGuffog L, Parsons MT, Leslie G, Aalfs CM, Abugattas J, EMBRACE, GEMO Study Collaborators, HEBON, et al. [217 more authors] (2018). Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. Hum Mutat  39, 593-620.   https://doi.org/10.1002/humu.23406|7. Wang Y, Pfeiffer RM, Alsaggaf R, Meeraus W, Gage JC, Anderson LA, Bremer RC, Nikolenko N, Lochmuller H, Greene MH, Gadalla SM (2018). Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. Int J Cancer  142, 1174-1181.   https://doi.org/10.1002/ijc.31143",https://intramural.nih.gov/search/searchview.taf?ipid=104272
601,CP010145-19,"October 01, 2017 -  September 30, 2018",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Mark H Greene; MD|IRP Faculty Profile  |Jennifer T Loud| |Mark E Sherman; MD| | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Sharon Ann Savage|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI

Breast and Gynecologic Cancer Research Group, NCI",June  Peters,David  Alberts (University of Arizona Cancer Center)|Steven  Skates (Massachusetts General Hospital)|Marion  Piedmonte (GOG Statistical and Data Center)|Martee  Hensley (Memorial Sloan-Kettering Cancer Center)|Austin  Miller (GOG Statistical and Data Center)|Karen  Lu (MD Anderson Cancer Center)|Show all 15,Margaret Anne Tucker (Human Genetics Program)|Lori M Minasian (Office of the Director)|Richard P Moser (Science Of Research & Technology Branch),Gustavo Javier Rodriguez (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104273
602,CP010150-19,"October 01, 2017 -  September 30, 2018","Infections, immunity, and inflammation in cancer",Eric Andrew Engels; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",Meredith Sarah Shiels|Jill Elizabeth Koshiol,NULL,Ruth  Pfeiffer; PhD (Biostatistics Branch)|Anil Kumar Chaturvedi (Clinical Genetics Branch)|Lindsay Mcomber Morton (Radiation Epidemiology Branch)|James Jerome Goedert; MD (Epidemiology and Biostatistics Program)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Joseph  Fraumeni; MD (Office of the Director),NULL,"1. Altekruse SF, Shiels MS, Modur SP, Land SR, Crothers KA, Kitahata MM, Thorne JE, Mathews WC, Fernández-Santos DM, Mayor AM, Gill JM, Horberg MA, Brooks JT, Moore RD, Silverberg MJ, Althoff KN, Engels EA (2018). Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS  32, 513-521.   https://doi.org/10.1097/QAD.0000000000001721|2. Colón-López V, Shiels MS, Machin M, Ortiz AP, Strickler H, Castle PE, Pfeiffer RM, Engels EA (2018). Anal Cancer Risk Among People With HIV Infection in the United States. J Clin Oncol  36, 68-75.   https://doi.org/10.1200/JCO.2017.74.9291|3. Engels EA, Yanik EL, Wheeler W, Gill MJ, Shiels MS, Dubrow R, Althoff KN, Silverberg MJ, Brooks JT, Kitahata MM, Goedert JJ, Grover S, Mayor AM, Moore RD, Park LS, Rachlis A, Sigel K, Sterling TR, Thorne JE, Pfeiffer RM, North American AIDS Cohort Collaboration on Research and           Design of the International Epidemiologic Databases to Evaluate AIDS, North American AIDS Cohort Collaboration on Research and Design           of the International Epidemiologic Databases to Evaluate AIDS (2017). Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America. Clin Infect Dis  65, 636-643.   https://doi.org/10.1093/cid/cix392|4. Gupta G, Kuppachi S, Kalil RS, Buck CB, Lynch CF, Engels EA (2018). Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States. Am J Transplant  18, 245-252.   https://doi.org/10.1111/ajt.14530|5. Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST, National Cancer Institute Keratinocyte Carcinoma Consortium (2017). Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol  177, 1202-1207.   https://doi.org/10.1111/bjd.15889|6. Madeleine MM, Patel NS, Plasmeijer EI, Engels EA, Bouwes Bavinck JN, Toland AE, Green AC, the Keratinocyte Carcinoma Consortium (KeraCon) Immunosuppression Working Group (2017). Epidemiology of keratinocyte carcinomas after organ transplantation. Br J Dermatol  177, 1208-1216.   https://doi.org/10.1111/bjd.15931|7. Mahale P, Engels EA, Coghill AE, Kahn AR, Shiels MS (2018). Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States. Clin Infect Dis  67, 50-57.   https://doi.org/10.1093/cid/ciy012|8. Mahale P, Shiels MS, Lynch CF, Engels EA (2018). Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients. Am J Transplant  18, 453-461.   https://doi.org/10.1111/ajt.14465|9. Shiels MS, Freedman ND, Thomas D, Berrington de Gonzalez A (2018). Trends in U.S. Drug Overdose Deaths in Non-Hispanic Black, Hispanic, and Non-Hispanic White Persons, 2000-2015. Ann Intern Med  168, 453-455.   https://doi.org/10.7326/M17-1812|10. Shiels MS, Islam JY, Rosenberg PS, Hall HI, Jacobson E, Engels EA (2018). Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030. Ann Intern Med  168, 866-873.   https://doi.org/10.7326/M17-2499|11. Shiels MS, Kirk GD, Drummond MB, Dhillon D, Hanash SM, Taguchi A, Engels EA (2018). HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D. J Infect Dis  217, 413-417.   https://doi.org/10.1093/infdis/jix510|12. Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, Stolzenberg-Solomon RZ, Abnet CC, Männistö S, Albanes D, Rabkin CS (2018). Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther  47, 494-503.   https://doi.org/10.1111/apt.14471|13. Yanik EL, Shiels MS, Smith JM, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA (2017). Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States. Cancer  123, 4663-4671.   https://doi.org/10.1002/cncr.30923",https://intramural.nih.gov/search/searchview.taf?ipid=104274
603,CP010152-19,"October 01, 2017 -  September 30, 2018",PLCO Trial Etiologic and Early Marker Study,"Sonja  Berndt|IRP Faculty Profile  | |Michael Blaise Cook|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Jonathan Nicholas Hofmann|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI",Wen-Yi  Huang|Amanda  Black,"Mona  Fouad (University of Alabama, Birmingham)|Paul  Kvale (Extramural PLCO)|David T Crawford|Lance  Yokochi (Pacific Health Research Institute)|Doug  Reding (Marshfield Clinic Research Foundation)|Timothy R. Church; PhD (Environ & Occup Health, University of Minnesota School of Public Health)|Show all 11",Christine Dorothy Berg (Office of the Director),NULL,"1. Bien SA, Auer PL, Harrison TA, Qu C, Connolly CM, Greenside PG, Chen S, Berndt SI, Bézieau S, Kang HM, Huyghe J, Brenner H, Casey G, Chan AT, Hopper JL, Banbury BL, Chang-Claude J, Chanock SJ, Haile RW, Hoffmeister M, Fuchsberger C, Jenkins MA, Leal SM, Lemire M, Newcomb PA, GECCO and CCFR, et al. [14 more authors] (2017). Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data. PLoS One  12, e0186518.   https://doi.org/10.1371/journal.pone.0186518|2. Chong DQ, Banbury BL, Phipps AI, Hua X, Kocarnik J, Peters U, Berndt SI, Huang WY, Potter JD, Slattery ML, White E, Campbell PT, Harrison T, Newcomb PA, Chan AT (2018). Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies. Cancer Med  7, 2192-2199.   https://doi.org/10.1002/cam4.1470|3. Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, John EM, Park JY, Xu J, Stevens VL, Berndt SI, Huff CD, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, PRACTICAL/ELLIPSE Consortium, et al. [63 more authors] (2017). Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djx084|4. Fan X, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Freedman ND, Alekseyenko AV, Wu J, Yang L, Pei Z, Hayes RB, Ahn J (2018). Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults. Microbiome  6, 59.   https://doi.org/10.1186/s40168-018-0448-x|5. Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, Li L, Lin Y, Le Marchand L, Potter JD, Qu C, Bien SA, Zubair N, Macinnis RJ, Buchanan DD, Hopper JL, Colorectal Transdisciplinary Study and Genetics and Epidemiology of Colorectal Cancer Consortium, et al. [14 more authors] (2018). Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology  154, 2152-2164.e19.   https://doi.org/10.1053/j.gastro.2018.02.021|6. Kunzmann AT, Coleman HG, Huang WY, Berndt SI (2018). The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study. PLoS Med  15, e1002585.   https://doi.org/10.1371/journal.pmed.1002585|7. Neumeyer S, Banbury BL, Arndt V, Berndt SI, Bezieau S, Bien SA, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Casey G, Chan AT, Chanock SJ, Dai JY, Gallinger S, Giovannucci EL, Giles GG, Grady WM, Hampe J, Hoffmeister M, Hopper JL, Hsu L, Jenkins MA, Joshi A, Larsson SC, et al. [26 more authors] (2018). Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer  118, 1639-1647.   https://doi.org/10.1038/s41416-018-0108-8|8. Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Qu C, Melas M, Van Den Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D, Alonso MH, Amos CI, Anton K, Aragaki AK, Arndt V, Barry EL, Berndt SI, Bezieau S, Bien S, Bloomer A, Boehm J, Boutron-Ruault MC, et al. [158 more authors] (2019). Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst  111, 146-157.   https://doi.org/10.1093/jnci/djy099|9. Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, Tyrer J, Muir K, Lophatananon A, Stevens VL, Gapstur SM, Carter BD, Tangen CM, Goodman PJ, Thompson IM, Batra J, Profile Study, Australian Prostate Cancer BioResource (APCB), IMPACT Study, Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Cancer of the Prostate in Sweden (CAPS), Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, et al. [162 more authors] (2018). Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet  50, 928-936.   https://doi.org/10.1038/s41588-018-0142-8|10. Su YR, Di C, Bien S, Huang L, Dong X, Abecasis G, Berndt S, Bezieau S, Brenner H, Caan B, Casey G, Chang-Claude J, Chanock S, Chen S, Connolly C, Curtis K, Figueiredo J, Gala M, Gallinger S, Harrison T, Hoffmeister M, Hopper J, Huyghe JR, Jenkins M, Joshi A, et al. [10 more authors] (2018). A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics. Am J Hum Genet  102, 904-919.   https://doi.org/10.1016/j.ajhg.2018.03.019|11. Trabert B, Poole EM, White E, Visvanathan K, Adami HO, Anderson GL, Brasky TM, Brinton LA, Fortner RT, Gaudet M, Hartge P, Hoffman-Bolton J, Jones M, Lacey JV, Larsson SC, Mackenzie GG, Schouten LJ, Sandler DP, O'Brien K, Patel AV, Peters U, Prizment A, Robien K, Setiawan VW, Swerdlow A, Ovarian Cancer Cohort Consortium (OC3), et al. [6 more authors] (2019). Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. J Natl Cancer Inst  111, 137-145.   https://doi.org/10.1093/jnci/djy100|12. Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, Woodhall SC, Pawlita M, Wentzensen N (2019). Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations. J Natl Cancer Inst  111, 129-136.   https://doi.org/10.1093/jnci/djy084",https://intramural.nih.gov/search/searchview.taf?ipid=104275
604,CP010158-18,"October 01, 2017 -  September 30, 2018",Studies of Rare Cancers,Michael Blaise Cook|IRP Faculty Profile  | |Katherine Ann McGlynn; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Yu-Tang  Gao (Shanghai Cancer Institute)|Evelyene  Lennette (Virolab, Inc.)|Lene  Mellemkjaer (Danish Cancer Society)|Jorgen  Olsen (Danish Cancer Society)|Asif  Rashid (MD Anderson Cancer Center)|Juergen  Reichardt (University of Southern California)|Show all 12",NULL,NULL,"1. Dultz G, Graubard BI, Martin P, Welker MW, Vermehren J, Zeuzem S, McGlynn KA, Welzel TM (2017). Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry. PLoS One  12, e0186898.   https://doi.org/10.1371/journal.pone.0186898|2. McGlynn KA, Petrick JL, Gamborg M, Aarestrup J, Baker JL (2018). Childhood height and risk of testicular germ cell tumors in adulthood. Int J Cancer  143, 767-772.   https://doi.org/10.1002/ijc.31354|3. Petrick JL, Campbell PT, Koshiol J, Thistle JE, Andreotti G, Beane-Freeman LE, Buring JE, Chan AT, Chong DQ, Doody MM, Gapstur SM, Gaziano JM, Giovannucci E, Graubard BI, Lee IM, Liao LM, Linet MS, Palmer JR, Poynter JN, Purdue MP, Robien K, Rosenberg L, Schairer C, Sesso HD, Sinha R, et al. [7 more authors] (2018). Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer  118, 1005-1012.   https://doi.org/10.1038/s41416-018-0007-z|4. Petrick JL, Yang B, Altekruse SF, Van Dyke AL, Koshiol J, Graubard BI, McGlynn KA (2017). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. PLoS One  12, e0186643.   https://doi.org/10.1371/journal.pone.0186643|5. Smith JW, Kroker-Lobos MF, Lazo M, Rivera-Andrade A, Egner PA, Wedemeyer H, Torres O, Freedman ND, McGlynn KA, Guallar E, Groopman JD, Ramirez-Zea M (2017). Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence. PLoS One  12, e0189255.   https://doi.org/10.1371/journal.pone.0189255|6. Valery PC, Laversanne M, Clark PJ, Petrick JL, McGlynn KA, Bray F (2018). Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology  67, 600-611.   https://doi.org/10.1002/hep.29498",https://intramural.nih.gov/search/searchview.taf?ipid=104276
605,CP010167-18,"October 01, 2017 -  September 30, 2018",General Studies of Epidemiology,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",Rebecca  Troisi,Chester  Douglass (Harvard School of Dentistry)|Patricia  Hartge; ScD (NCI),Sharon Ann Savage (Clinical Genetics Branch)|Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104277
606,CP010168-18,"October 01, 2017 -  September 30, 2018",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Ervin  Adam (Baylor College of Medicine)|Elizabeth  Hatch (Boston University)|Arthur  Herbst (University of Chicago)|Julie  Palmer (Boston University)|Stanley  Robboy; MD (Pathology and Obstetrics & Gynecology, Duke University Medical Center)|William  Strohsnitter (University of Massachusetts)|Show all 11",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104278
607,CP010169-17,"October 01, 2017 -  September 30, 2018","Nutrition, Metabolism, and Cancer","Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Regina Gale Ziegler; PhD, MPH|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Louise  Brinton; PhD|Mitchell Henry Gail; PhD, MD|Hormuzdiar Aspandiar Katki; MS","Lawrence  Kolonel (University of Hawaii)|Abraham  Nomura (School of Public Health, University of Hawaii)|Emanuel  Petricoin III (Food and Drug Administration)|Malcolm  Pike (University of Southern California)|Michael  Pollak (McGill University)|Frank  Stanczyk (University of Southern California)|Show all 11",Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Martha S Linet; PhD (Radiation Epidemiology Branch)|Katherine Ann McGlynn; PhD (Hormonal and Reproductive Epidemiology Branch)|Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch)|Stephanie Joan Weinstein (Hormonal and Reproductive Epidemiology Branch),NULL,"1. Kant AK, Graubard BI (2018). Complementary and compensatory dietary changes associated with consumption or omission of plain water by US adults. Appetite  128, 255-262.   https://doi.org/10.1016/j.appet.2018.06.020",https://intramural.nih.gov/search/searchview.taf?ipid=104281
608,CP010170-18,"October 01, 2017 -  September 30, 2018",Multidisciplinary Studies of Hematopoietic Malignancies,Martha S Linet; PhD|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Lindsay Mcomber Morton|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI","Joanne S Colt|Aaron E Blair; PhD, MPH|Mary Helen Ward; MS, PhD","Wendy  Cozen (Norris Comprehensive Cancer Center)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Richard  Severson (Barbara Karmanos Cancer Institute)|James  Cerhan (Mayo Clinic)|Anneclaire  De Roos (University of Washington, Seattle, WA)|Maryjean  Schenk (Barbara Karmanos Cancer Institute)",Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch),NULL,"1. Bernatsky S, Velásquez García HA, Spinelli JJ, Gaffney P, Smedby KE, Ramsey-Goldman R, Wang SS, Adami HO, Albanes D, Angelucci E, Ansell SM, Asmann YW, Becker N, Benavente Y, Berndt SI, Bertrand KA, Birmann BM, Boeing H, Boffetta P, Bracci PM, Brennan P, Brooks-Wilson AR, Cerhan JR, Chanock SJ, Clavel J, et al. [76 more authors] (2017). Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma. Lupus Sci Med  4, e000187.   https://doi.org/10.1136/lupus-2016-000187|2. Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami HO, Boffetta P, Brennan P, Maynadie M, McKay J, Cocco PL, Shanafelt TD, Call TG, Norman AD, Hanson C, Robinson D, et al. [23 more authors] (2018). Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood  131, 2541-2551.   https://doi.org/10.1182/blood-2017-11-814608",https://intramural.nih.gov/search/searchview.taf?ipid=104279
609,CP010176-18,"October 01, 2017 -  September 30, 2018",Epidemiology and Natural History of Cancer-Associated Viruses,"Eric Andrew Engels; PhD|IRP Faculty Profile  |James Jerome Goedert; MD| | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Thomas R O'Brien; BA, MPH, MD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Sam  Mbulaiteye|IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI",Charles  Rabkin,"M  Eyster (Pennsylvania State University)|Angelos  Hatzakis (University of Athens Medical School)|Michael  Lederman; MD (Case Western Reserve University)|Nino  Romano (University of Palermo)|Cloe  Thio (Dept of Medicine, Johns Hopkins University School of Medicine)|David  Thomas (Johns Hopkins University)|Show all 7","Anil Kumar Chaturvedi (Clinical Genetics Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Denise  Whitby (Office Of The Director)",NULL,"1. Legason ID, Pfeiffer RM, Udquim KI, Bergen AW, Gouveia MH, Kirimunda S, Otim I, Karlins E, Kerchan P, Nabalende H, Bayanjargal A, Emmanuel B, Kagwa P, Talisuna AO, Bhatia K, Yeager M, Biggar RJ, Ayers LW, Reynolds SJ, Goedert JJ, Ogwang MD, Fraumeni JF, Prokunina-Olsson L, Mbulaiteye SM (2017). Evaluating the Causal Link Between Malaria Infection and Endemic Burkitt Lymphoma in Northern Uganda: A Mendelian Randomization Study. EBioMedicine  25, 58-65.   https://doi.org/10.1016/j.ebiom.2017.09.037|2. Liao HM, Liu H, Lei H, Li B, Chin PJ, Tsai S, Bhatia K, Gutierrez M, Epelman S, Biggar RJ, Nkrumah F, Neequaye J, Ogwang MD, Reynolds SJ, Lo SC, Mbulaiteye SM (2018). Frequency of EBV LMP-1 Promoter and Coding Variations in Burkitt Lymphoma Samples in Africa and South America and Peripheral Blood in Uganda. Cancers (Basel)  10.   https://doi.org/10.3390/cancers10060177|3. Lombardo KA, Coffey DG, Morales AJ, Carlson CS, Towlerton AMH, Gerdts SE, Nkrumah FK, Neequaye J, Biggar RJ, Orem J, Casper C, Mbulaiteye SM, Bhatia KG, Warren EH (2017). High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis. Blood Adv  1, 535-544.   https://doi.org/10.1182/bloodadvances.2016000794|4. Lombardo KA, Coffey DG, Morales AJ, Carlson CS, Towlerton AMH, Gerdts SE, Nkrumah FK, Neequaye J, Biggar RJ, Orem J, Casper C, Mbulaiteye SM, Bhatia KG, Warren EH (2017). High-throughput sequencing reveals novel features of immunoglobulin gene rearrangements in Burkitt lymphoma. Blood Adv  1, 1261-1262.   https://doi.org/10.1182/bloodadvances.2017008060|5. Maziarz M, Nabalende H, Otim I, Legason ID, Kinyera T, Ogwang MD, Talisuna AO, Reynolds SJ, Kerchan P, Bhatia K, Biggar RJ, Goedert JJ, Pfeiffer RM, Mbulaiteye SM (2018). A cross-sectional study of asymptomatic Plasmodium falciparum infection burden and risk factors in general population children in 12 villages in northern Uganda. Malar J  17, 240.   https://doi.org/10.1186/s12936-018-2379-1|6. Ravell J, Otim I, Nabalende H, Legason ID, Reynolds SJ, Ogwang MD, Ndugwa CM, Marshall V, Whitby D, Goedert JJ, Engels EA, Bhatia K, Lenardo MJ, Mbulaiteye SM (2018). Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda. Cancer Epidemiol  52, 70-74.   https://doi.org/10.1016/j.canep.2017.12.004",https://intramural.nih.gov/search/searchview.taf?ipid=104280
610,CP010180-17,"October 01, 2017 -  September 30, 2018",Prostate Cancer Studies,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Chu  Chen (University of Washington)|Yu-Tang  Gao (Shanghai Cancer Institute)|Juergen  Reichardt (University of Southern California)|Frank  Stanczyk (University of Southern California)|Paul  Levine (George Washington U)|Streamson  Chua (Columbia University)|Show all 15,NULL,NULL,"1. Cook MB, Stanczyk FZ, Wood SN, Pfeiffer RM, Hafi M, Veneroso CC, Lynch B, Falk RT, Zhou CK, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhann IA, Levine PH, Hsing AW (2017). Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations. Cancer Epidemiol Biomarkers Prev  26, 1660-1666.   https://doi.org/10.1158/1055-9965.EPI-17-0215|2. Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB (2017). Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers. Prostate  77, 1573-1582.   https://doi.org/10.1002/pros.23433",https://intramural.nih.gov/search/searchview.taf?ipid=104294
611,CP010181-16,"October 01, 2017 -  September 30, 2018",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD|IRP Faculty Profile  | |Barry Ira Graubard; PhD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Philip Samuel Rosenberg; PhD|IRP Faculty Profile  | |Joshua Neil Sampson|IRP Faculty Profile  | |Jianxin  Shi|IRP Faculty Profile  | |Kai  Yu|IRP Faculty Profile  | |Paul Stuart Albert|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI",NULL,"Gang  Zheng (National Heart Lung and Blood Institute)|Efstathia  Bura (The George Washington University, Washington, DC)|Kari  Hemminki; PhD (Department of Biosciences, Karolinska Institute)|Raymond  Carroll (Texas A&M University)|Cathy  Kronin (DCCPS, NCI, Rockville, MD)|Zhaohai  Li|Show all 13","Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)|Sam  Mbulaiteye (Infection & Immunoepidemiology Branch)|Stephen J Chanock; MD, PhD (Office of the Director)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Edward L Korn (Biostatistics Branch)",NULL,"1. Albert PS (2019). Innovative modeling of naturalistic driving data: Inference and prediction. Stat Med  38, 175-183.   https://doi.org/10.1002/sim.7580|2. Anderson WF, Rabkin CS, Turner N, Fraumeni JF, Rosenberg PS, Camargo MC (2018). The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites. J Natl Cancer Inst  110, 608-615.   https://doi.org/10.1093/jnci/djx262|3. Breslow RA, Castle IP, Chen CM, Graubard BI (2017). Trends in Alcohol Consumption Among Older Americans: National Health Interview Surveys, 1997 to 2014. Alcohol Clin Exp Res  41, 976-986.   https://doi.org/10.1111/acer.13365|4. Cheung LC, Katki HA, Chaturvedi AK, Jemal A, Berg CD (2018). Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 2005-2015. Ann Intern Med  168, 229-232.   https://doi.org/10.7326/M17-2067|5. Gail MH (2017). The prediction impact curve is proportional to the proportion of cases followed (letter commenting: J Clin Epidemiol 2016;69:361-363). J Clin Epidemiol  85, 70.   https://doi.org/10.1016/j.jclinepi.2016.12.020|6. Gilman SE, Hornig M, Ghassabian A, Hahn J, Cherkerzian S, Albert PS, Buka SL, Goldstein JM (2017). Socioeconomic disadvantage, gestational immune activity, and neurodevelopment in early childhood. Proc Natl Acad Sci U S A  114, 6728-6733.   https://doi.org/10.1073/pnas.1617698114|7. Kant AK, Graubard BI (2018). A prospective study of frequency of eating restaurant prepared meals and subsequent 9-year risk of all-cause and cardiometabolic mortality in US adults. PLoS One  13, e0191584.   https://doi.org/10.1371/journal.pone.0191584|8. Kassahun-Yimer W, Albert PS, Lipsky LM, Nansel TR, Liu A (2019). A joint model for multivariate hierarchical semicontinuous data with replications. Stat Methods Med Res  28, 858-870.   https://doi.org/10.1177/0962280217738141|9. Katki HA, Greene MH, Achatz MI (2018). Testing Positive on a Multigene Panel Does Not Suffice to Determine Disease Risks. J Natl Cancer Inst  110, 797-798.   https://doi.org/10.1093/jnci/djy008|10. Katki HA, Kovalchik SA, Petito LC, Cheung LC, Jacobs E, Jemal A, Berg CD, Chaturvedi AK (2018). Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening. Ann Intern Med  169, 10-19.   https://doi.org/10.7326/M17-2701|11. Katki HA, Schiffman M (2018). A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations. Prev Med  110, 100-105.   https://doi.org/10.1016/j.ypmed.2018.02.013|12. Sakoda LC, Henderson LM, Caverly TJ, Wernli KJ, Katki HA (2017). Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions. Curr Epidemiol Rep  4, 307-320.   https://doi.org/10.1007/s40471-017-0126-8|13. Sampson JN, Boca SM, Moore SC, Heller R (2018). FWER and FDR control when testing multiple mediators. Bioinformatics  34, 2418-2424.   https://doi.org/10.1093/bioinformatics/bty064|14. Zhang C, Hediger ML, Albert PS, Grewal J, Sciscione A, Grobman WA, Wing DA, Newman RB, Wapner R, D'Alton ME, Skupski D, Nageotte MP, Ranzini AC, Owen J, Chien EK, Craigo S, Kim S, Grantz KL, Louis GMB (2018). Association of Maternal Obesity With Longitudinal Ultrasonographic Measures of Fetal Growth: Findings From the NICHD Fetal Growth Studies-Singletons. JAMA Pediatr  172, 24-31.   https://doi.org/10.1001/jamapediatrics.2017.3785",https://intramural.nih.gov/search/searchview.taf?ipid=104254
612,CP010182-16,"October 01, 2017 -  September 30, 2018",Epidemiologic Field Studies,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Wei-Cheng  You (Beijing Institute for Cancer Research)|Susan  Sturgeon (University of Massachusetts)|Paul  Levine (George Washington U)|Lian  Zhang|Amr  Soliman (M.D. Anderson Cancer Center)|Donghui  Li (M.D. Anderson Cancer Center)|Show all 7,"Joseph  Fraumeni; MD (Office of the Director)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104284
613,CP010183-16,"October 01, 2017 -  September 30, 2018",Descriptive Studies and Record Linkage,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Paul Stuart Albert|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI

Clinical Genetics Branch, NCI","Anil Kumar Chaturvedi|Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Philip Samuel Rosenberg; PhD",Susan Shaw Devesa (NCI)|Ismail  Jatoi (US Army)|Ahmedin  Jemal (American Cancer Society)|Niels  Kroman (Danish Breast Cancer Group)|Timothy R Rebbeck|Rebecca B Siegel|Show all 9,"Louise  Brinton; PhD (Office of the Director)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Nilanjan  Chatterjee (Epidemiology and Biostatistics Program)|Michael Blaise Cook (Hormonal and Reproductive Epidemiology Branch)|Rochelle E Curtis (Radiation Epidemiology Branch)|Eric Andrew Engels; PhD (Infection & Immunoepidemiology Branch)",Sean Fitzgerald Altekruse (NHLBI),"1. Davis Lynn BC, Rosenberg PS, Anderson WF, Gierach GL (2018). Black-White Breast Cancer Incidence Trends: Effects of Ethnicity. J Natl Cancer Inst  110, 1270-1272.   https://doi.org/10.1093/jnci/djy112|2. Kelly SP, Anderson WF, Rosenberg PS, Cook MB (2018). Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States. Eur Urol Focus  4, 121-127.   https://doi.org/10.1016/j.euf.2017.10.014|3. Mullooly M, Murphy J, Gierach GL, Walsh PM, Deady S, Barron TI, Sherman ME, Rosenberg PS, Anderson WF (2017). Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues. Eur J Cancer  86, 326-333.   https://doi.org/10.1016/j.ejca.2017.08.031",https://intramural.nih.gov/search/searchview.taf?ipid=104253
614,CP010184-16,"October 01, 2017 -  September 30, 2018",Consultation and Collaboration,Barry Ira Graubard; PhD|IRP Faculty Profile,NULL,"Biostatistics Branch, NCI","Mitchell Henry Gail; PhD, MD|Ruth  Pfeiffer; PhD|Hormuzdiar Aspandiar Katki; MS|Joshua Neil Sampson|Jianxin  Shi|Bin  Zhu",Eleuterio  Bravo-Otero (University of Puerto Rico)|David  Brenner (Columbia University)|Robert  Burk (Albert Einstein College of Medicine)|Julianne  Byrne (Washington Children's hospital)|David  Camann (Southwest Research Institute)|Scott  Davis (Fred Hutchinson Cancer Research Center)|Show all 78,"Regina Gale Ziegler; PhD, MPH (Epidemiology and Biostatistics Program)|Nilanjan  Chatterjee (Epidemiology and Biostatistics Program)|Michele M Doody; MS (Radiation Epidemiology Branch)|Roni T Falk (Hormonal and Reproductive Epidemiology Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Joanne S Colt (Occupational and Environmental Epidemiology Branch)",Harvey J Alter; MD (CC) |Joni L Rutter (OD) |Dale  Sandler; PhD (NIEHS) |Clarice  Weinberg; PhD (NIEHS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104286
615,CP010185-16,"October 01, 2017 -  September 30, 2018",Biodefense Project,Steven L Simon,"Robert  Hoover; MD, ScD","Epidemiology and Biostatistics Program, NCI",Andre  Bouville,"Harold  Beck (DOE Environmental Measurements Laboratory (retired))|Victor  Kryuchkov (Institute of Biophysics)|Sergey  Shinkarev (Moscow Institute of Biophysics)|Sergey  Sholom (URPI)|Eduardo  Yukihara (Oklahoma State University)|Nikolai  Talerko (Scientific Center of Radiation Medicine, Ukraine)",Alice  Sigurdson; PhD (Radiation Epidemiology Branch)|Vladimir  Drozdovitch (Radiation Epidemiology Branch)|Amy  de Gonzalez (Radiation Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104285
616,CP010187-14,"October 01, 2017 -  September 30, 2018",Cancer Genetic Markers of Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  | |Mark  Purdue|IRP Faculty Profile  | |Nathaniel C Rothman; MD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Human Genetics Program, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104292
617,CP010188-14,"October 01, 2017 -  September 30, 2018",Risk prediction methods,"Barry Ira Graubard; PhD|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  | |Mitchell Henry Gail; PhD, MD|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Epidemiology and Biostatistics Program, NCI",Nilanjan  Chatterjee,Garnet  Anderson (WHI Clinical Coordinating Center)|Heather  Feigelson (American Cancer Society)|David  Hunter (Harvard School of Public Health)|Mateo  Banegas (University of Washington)|Stephanie Ann Kovalchik|Ju-Hyun  Park,"Catherine G Schairer (Hormonal and Reproductive Epidemiology Branch)|Demetrius  Albanes; MD (Hormonal and Reproductive Epidemiology Branch)|Thomas R O'Brien; BA, MPH, MD (Infection & Immunoepidemiology Branch)",NULL,"1. Cheung LC, Pan Q, Hyun N, Schiffman M, Fetterman B, Castle PE, Lorey T, Katki HA (2017). Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records. Stat Med  36, 3583-3595.   https://doi.org/10.1002/sim.7380",https://intramural.nih.gov/search/searchview.taf?ipid=104287
618,CP010190-13,"October 01, 2017 -  September 30, 2018",Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,Shahinaz M Gadalla|IRP Faculty Profile  |Payal Premchand Khincha| | |Sharon Ann Savage|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Lisa  Mirabello|Lisa James McReynolds|Neelam K Giri; MD|Blanche P Alter,"Immaculata  DeVivo (Harvard Medical School)|Steven  Artandi (Stanford University)|Judy  Wong (University of British Columbia)|Alison  Bertuch; MD, PhD (Pediatrics, Baylor College of Medicine)|Davide  Ruggero (University of California San Francisco)|Catherine  Keegan (University of Michigan)|Show all 10",NULL,NULL,"1. Dagnall CL, Hicks B, Teshome K, Hutchinson AA, Gadalla SM, Khincha PP, Yeager M, Savage SA (2017). Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement. PLoS One  12, e0184098.   https://doi.org/10.1371/journal.pone.0184098|2. Gadalla SM, Aubert G, Wang T, Haagenson M, Spellman SR, Wang L, Katki HA, Savage SA, Lee SJ (2018). Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure. Blood  131, 2393-2398.   https://doi.org/10.1182/blood-2017-10-812735|3. Khandelwal P, Millard HR, Thiel E, Abdel-Azim H, Abraham AA, Auletta JJ, Boulad F, Brown VI, Camitta BM, Chan KW, Chaudhury S, Cowan MJ, Angel-Diaz M, Gadalla SM, Gale RP, Hale G, Kasow KA, Keating AK, Kitko CL, MacMillan ML, Olsson RF, Page KM, Seber A, Smith AR, Warwick AB, et al. [2 more authors] (2017). Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report. Biol Blood Marrow Transplant  23, 1342-1349.   https://doi.org/10.1016/j.bbmt.2017.04.018|4. Savage SA (2018). Beginning at the ends: telomeres and human disease. F1000Res  7.   https://doi.org/10.12688/f1000research.14068.1|5. Turcotte LM, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Ahmed I, Beitinjaneh A, Buchbinder D, Byrne M, Callander N, Chao N, Choi SW, DeFilipp Z, Gadalla SM, Gale RP, Gergis U, Hashmi S, Hematti P, Holmberg L, Inamoto Y, Kamble RT, et al. [20 more authors] (2018). Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. Bone Marrow Transplant  53, 932-937.   https://doi.org/10.1038/s41409-018-0100-1|6. Ungar RA, Giri N, Pao M, Khincha PP, Zhou W, Alter BP, Savage SA (2018). Complex phenotype of dyskeratosis congenita and mood dysregulation with novel homozygous RTEL1 and TPH1 variants. Am J Med Genet A  176, 1432-1437.   https://doi.org/10.1002/ajmg.a.38706|7. Wang Y, Zhou W, Alter BP, Wang T, Spellman SR, Haagenson M, Yeager M, Lee SJ, Chanock SJ, Savage SA, Gadalla SM (2018). Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia. Biol Blood Marrow Transplant  24, 2003-2008.   https://doi.org/10.1016/j.bbmt.2018.05.027|8. Ward SC, Savage SA, Giri N, Alter BP, Cowen EW (2017). Progressive reticulate skin pigmentation and anonychia in a patient with bone marrow failure. J Am Acad Dermatol  77, 1194-1198.   https://doi.org/10.1016/j.jaad.2017.07.018",https://intramural.nih.gov/search/searchview.taf?ipid=104295
619,CP010193-12,"October 01, 2017 -  September 30, 2018",Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan),"Laufey Thora Amundadottir|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Laboratory Translational Genomics, NCI",NULL,"Charles  Fuchs (Harvard)|Alan  Arslan (NYU)|Eric  Jacobs (American Cancer Society)|H  Bueno-de-Mesquita (Dept of Chronic Dis Epidemiology, Natl Inst for Pub Health and the Environ)|Wei  Zheng (Vanderbilt University Medical Center)|Andrea  LaCroix (Fred Hutchinson Cancer Research Center)|Show all 17",Geoffrey Scott Tobias (Office of the Director)|Kai  Yu (Biostatistics Branch)|Amy  Hutchinson (Office of the Director),NULL,"1. Antwi SO, Bamlet WR, Pedersen KS, Chaffee KG, Risch HA, Shivappa N, Steck SE, Anderson KE, Bracci PM, Polesel J, Serraino D, La Vecchia C, Bosetti C, Li D, Oberg AL, Arslan AA, Albanes D, Duell EJ, Huybrechts I, Amundadottir LT, Hoover R, Mannisto S, Chanock SJ, Zheng W, Shu XO, et al. [11 more authors] (2018). Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Carcinogenesis  39, 1056-1067.   https://doi.org/10.1093/carcin/bgy072|2. Huang J, Zagai U, Hallmans G, Nyrén O, Engstrand L, Stolzenberg-Solomon R, Duell EJ, Overvad K, Katzke VA, Kaaks R, Jenab M, Park JY, Murillo R, Trichopoulou A, Lagiou P, Bamia C, Bradbury KE, Riboli E, Aune D, Tsilidis KK, Capellá G, Agudo A, Krogh V, Palli D, Panico S, et al. [17 more authors] (2017). Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study. Int J Cancer  140, 1727-1735.   https://doi.org/10.1002/ijc.30590|3. Jeon CY, Li D, Cleary S, Stolzenberg-Solomon R, Bosetti C, La Vecchia C, Porta M, Toriola AT, Hung RJ, Kurtz RC, Olson SH (2018). The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis. Pancreas  47, 314-320.   https://doi.org/10.1097/MPA.0000000000000989|4. Telomeres Mendelian Randomization Collaboration, Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, Aviv A, Gaunt TR, Hemani G, Mangino M, Ellis HP, Kurian KM, Pooley KA, Eeles RA, Lee JE, Fang S, Chen WV, Law MH, Bowdler LM, Iles MM, Yang Q, et al. [173 more authors] (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol  3, 636-651.   https://doi.org/10.1001/jamaoncol.2016.5945",https://intramural.nih.gov/search/searchview.taf?ipid=104296
620,CP010195-12,"October 01, 2017 -  September 30, 2018","Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study",Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Philip  Taylor; MD, ScD|Michael Blaise Cook",David  Hunter (Harvard School of Public Health)|Brian  Henderson (University of Southern California)|Elio  Riboli (International Agency for Research on Cancer)|Peter  Kraft|Tim  Key (Oxford University)|Laurence N Kolonel|Show all 26,"Stephen J Chanock; MD, PhD (Office of the Director)|Nathaniel C Rothman; MD (Occupational and Environmental Epidemiology Branch)|Qing  Lan (Occupational and Environmental Epidemiology Branch)|Neil Edward Caporaso; MS, MD (Occupational and Environmental Epidemiology Branch)|Maria Teresa Pia Landi; MD, PhD (Genetic Epidemiology Branch)|Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)",NULL,"1. Carreras-Torres R, Johansson M, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Albanes D, Aldrich MC, Andrew A, Arnold SM, Bickeböller H, Bojesen SE, Brunnström H, Manjer J, Brüske I, Caporaso NE, Chen C, Christiani DC, Christian WJ, Doherty JA, Duell EJ, Field JK, Davies MPA, Marcus MW, et al. [39 more authors] (2017). Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLoS One  12, e0177875.   https://doi.org/10.1371/journal.pone.0177875|2. Dimitrakopoulou VI, Travis RC, Shui IM, Mondul A, Albanes D, Virtamo J, Agudo A, Boeing H, Bueno-de-Mesquita HB, Gunter MJ, Johansson M, Khaw KT, Overvad K, Palli D, Trichopoulou A, Giovannucci E, Hunter DJ, Lindström S, Willett W, Gaziano JM, Stampfer M, Berg C, Berndt SI, Black A, Hoover RN, et al. [3 more authors] (2017). Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. Am J Epidemiol  185, 452-464.   https://doi.org/10.1093/aje/kww143|3. Dimitrakopoulou VI, Tsilidis KK, Haycock PC, Dimou NL, Al-Dabhani K, Martin RM, Lewis SJ, Gunter MJ, Mondul A, Shui IM, Theodoratou E, Nimptsch K, Lindström S, Albanes D, Kühn T, Key TJ, Travis RC, Vimaleswaran KS, GECCO Consortium, PRACTICAL Consortium, GAME-ON Network (CORECT, DRIVE, ELLIPSE, FOCI-OCAC, TRICL-ILCCO), Kraft P, Pierce BL, Schildkraut JM (2017). Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ  359, j4761.   https://doi.org/10.1136/bmj.j4761|4. Fanidi A, Muller DC, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Thomsen CA, Pettinger M, Cai Q, Blot WJ, Wu J, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Han J, Stampfer MJ, Smith-Warner SA, Giovannucci E, Giles GG, Hodge AM, et al. [33 more authors] (2018). Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). J Natl Cancer Inst  110.   https://doi.org/10.1093/jnci/djx119|5. Huang J, Panagiotou OA, Anic GM, Mondul AM, Liao LM, Derkach A, Stolzenberg-Solomon R, Weinstein SJ, Albanes D (2017). Metabolomic Profiling of Serum Retinol in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Sci Rep  7, 10601.   https://doi.org/10.1038/s41598-017-09698-w|6. Huang J, Weinstein SJ, Kitahara CM, Karoly ED, Sampson JN, Albanes D (2017). A prospective study of serum metabolites and glioma risk. Oncotarget  8, 70366-70377.   https://doi.org/10.18632/oncotarget.19705|7. Huang J, Weinstein SJ, Moore SC, Derkach A, Hua X, Liao LM, Gu F, Mondul AM, Sampson JN, Albanes D (2018). Serum Metabolomic Profiling of All-Cause Mortality: A Prospective Analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study Cohort. Am J Epidemiol  187, 1721-1732.   https://doi.org/10.1093/aje/kwy017|8. Huang J, Weinstein SJ, Moore SC, Derkach A, Hua X, Mondul AM, Sampson JN, Albanes D (2019). Pre-diagnostic Serum Metabolomic Profiling of Prostate Cancer Survival. J Gerontol A Biol Sci Med Sci  74, 853-859.   https://doi.org/10.1093/gerona/gly128|9. Larose TL, Guida F, Fanidi A, Langhammer A, Kveem K, Stevens VL, Jacobs EJ, Smith-Warner SA, Giovannucci E, Albanes D, Weinstein SJ, Freedman ND, Prentice R, Pettinger M, Thomson CA, Cai Q, Wu J, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, Le Marchand L, Wilkens LR, Haiman CA, Zhang X, Stampfer MJ, et al. [28 more authors] (2018). Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). Int J Epidemiol  47, 1760-1771.   https://doi.org/10.1093/ije/dyy100|10. Li Y, Xiao X, Han Y, Gorlova O, Qian D, Leighl N, Johansen JS, Barnett M, Chen C, Goodman G, Cox A, Taylor F, Woll P, Wichmann HE, Manz J, Muley T, Risch A, Rosenberger A, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, et al. [51 more authors] (2018). Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis  39, 336-346.   https://doi.org/10.1093/carcin/bgx113|11. McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, Caporaso NE, Johansson M, Xiao X, Li Y, Byun J, Dunning A, Pooley KA, Qian DC, Ji X, Liu G, Timofeeva MN, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, SpiroMeta Consortium, et al. [115 more authors] (2017). Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet  49, 1126-1132.   https://doi.org/10.1038/ng.3892|12. Middha P, Weinstein SJ, Männistö S, Albanes D, Mondul AM (2019). β-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine. Nicotine Tob Res  21, 1045-1050.   https://doi.org/10.1093/ntr/nty115|13. Mondul AM, Weinstein SJ, Parisi D, Um CY, McCullough ML, Albanes D (2018). Vitamin D-Binding Protein and Risk of Renal Cell Carcinoma in the Cancer Prevention Study-II Cohort. Cancer Epidemiol Biomarkers Prev  27, 1203-1207.   https://doi.org/10.1158/1055-9965.EPI-18-0263|14. Theofylaktopoulou D, Midttun Ø, Ueland PM, Meyer K, Fanidi A, Zheng W, Shu XO, Xiang YB, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, Wu J, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough MM, Weinstein SJ, Albanes D, Ziegler R, Freedman ND, et al. [28 more authors] (2018). Impaired functional vitamin B6 status is associated with increased risk of lung cancer. Int J Cancer  142, 2425-2434.   https://doi.org/10.1002/ijc.31215|15. Wang T, Moon JY, Wu Y, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, Heijden EHFMV, Duell E, Rennert G, Goodman G, Liu G, Mckay JD, Yuan JM, Field JK, Manjer J, Grankvist K, Kiemeney LA, Marchand LL, Teare MD, Schabath MB, Johansson M, et al. [13 more authors] (2017). Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium. PLoS One  12, e0185660.   https://doi.org/10.1371/journal.pone.0185660|16. Weinstein SJ, Mondul AM, Yu K, Layne TM, Abnet CC, Freedman ND, Stolzenberg-Solomon RZ, Lim U, Gail MH, Albanes D (2018). Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival. Eur J Epidemiol  33, 1087-1099.   https://doi.org/10.1007/s10654-018-0428-2",https://intramural.nih.gov/search/searchview.taf?ipid=104297
621,CP010196-12,"October 01, 2017 -  September 30, 2018",Prospective Studies of Diet and Cancer in the AARP Cohort,Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Rachael Zoe Solomon|Neal David Freedman|Steven  Moore|Christian Cormac Abnet; PhD, MPH",NULL,Louise  Brinton; PhD (Office of the Director),NULL,"1. Arem H, Loftfield E, Saint-Maurice PF, Freedman ND, Matthews CE (2018). Physical activity across the lifespan and liver cancer incidence in the NIH-AARP Diet and Health Study cohort. Cancer Med  7, 1450-1457.   https://doi.org/10.1002/cam4.1343|2. Etemadi A, Abnet CC, Graubard BI, Beane-Freeman L, Freedman ND, Liao L, Dawsey SM, Sinha R (2018). Anatomical subsite can modify the association between meat and meat compounds and risk of colorectal adenocarcinoma: Findings from three large US cohorts. Int J Cancer  143, 2261-2270.   https://doi.org/10.1002/ijc.31612|3. Hashemian M, Murphy G, Etemadi A, Dawsey SM, Liao LM, Abnet CC (2017). Nut and peanut butter consumption and the risk of esophageal and gastric cancer subtypes. Am J Clin Nutr  106, 858-864.   https://doi.org/10.3945/ajcn.117.159467|4. Inoue-Choi M, Hartge P, Liao LM, Caporaso N, Freedman ND (2018). Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort. Int J Cancer  142, 271-280.   https://doi.org/10.1002/ijc.31059|5. Loftfield E, Freedman ND, Inoue-Choi M, Graubard BI, Sinha R (2017). A Prospective Investigation of Coffee Drinking and Bladder Cancer Incidence in the United States. Epidemiology  28, 685-693.   https://doi.org/10.1097/EDE.0000000000000676|6. Ordóñez-Mena JM, Walter V, Schöttker B, Jenab M, O'Doherty MG, Kee F, Bueno-de-Mesquita B, Peeters PHM, Stricker BH, Ruiter R, Hofman A, Söderberg S, Jousilahti P, Kuulasmaa K, Freedman ND, Wilsgaard T, Wolk A, Nilsson LM, Tjønneland A, Quirós JR, van Duijnhoven FJB, Siersema PD, Boffetta P, Trichopoulou A, Brenner H, Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) (2018). Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium. Ann Oncol  29, 472-483.   https://doi.org/10.1093/annonc/mdx761|7. Schmid D, Behrens G, Arem H, Hart C, Herr W, Jochem C, Matthews CE, Leitzmann MF (2018). Pre- and post-diagnosis physical activity, television viewing, and mortality among hematologic cancer survivors. PLoS One  13, e0192078.   https://doi.org/10.1371/journal.pone.0192078|8. Stolzenberg-Solomon RZ, Katki HA (2018). Is the Women's Health Initiative (WHI) Dietary Modification Associated With a Reduced Risk of Pancreatic Cancer? J Natl Cancer Inst  110.   https://doi.org/10.1093/jnci/djx139|9. Xiao Q, Keadle SK, Berrigan D, Matthews CE (2018). A prospective investigation of neighborhood socioeconomic deprivation and physical activity and sedentary behavior in older adults. Prev Med  111, 14-20.   https://doi.org/10.1016/j.ypmed.2018.02.011|10. Yang JJ, Yu D, Takata Y, Smith-Warner SA, Blot W, White E, Robien K, Park Y, Xiang YB, Sinha R, Lazovich D, Stampfer M, Tumino R, Aune D, Overvad K, Liao L, Zhang X, Gao YT, Johansson M, Willett W, Zheng W, Shu XO (2017). Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis. J Clin Oncol  35, 3055-3064.   https://doi.org/10.1200/JCO.2017.73.3329|11. Yu D, Zheng W, Johansson M, Lan Q, Park Y, White E, Matthews CE, Sawada N, Gao YT, Robien K, Sinha R, Langhammer A, Kaaks R, Giovannucci EL, Liao LM, Xiang YB, Lazovich D, Peters U, Zhang X, Bueno-de-Mesquita B, Willett WC, Tsugane S, Takata Y, Smith-Warner SA, Blot W, et al. [1 more author] (2018). Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis. J Natl Cancer Inst  110, 831-842.   https://doi.org/10.1093/jnci/djx286|12. Zheng J, Guinter MA, Merchant AT, Wirth MD, Zhang J, Stolzenberg-Solomon RZ, Steck SE (2017). Dietary patterns and risk of pancreatic cancer: a systematic review. Nutr Rev  75, 883-908.   https://doi.org/10.1093/nutrit/nux038",https://intramural.nih.gov/search/searchview.taf?ipid=104303
622,CP010197-12,"October 01, 2017 -  September 30, 2018","Physical Activity, Energy Balance, and Cancer",Charles E Matthews|IRP Faculty Profile  | |Rashmi P Sinha; PhD|IRP Faculty Profile  | |Rachael Zoe Solomon|IRP Faculty Profile  | |Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Steven  Moore,NULL,NULL,NULL,"1. Derkach A, Sampson J, Joseph J, Playdon MC, Stolzenberg-Solomon RZ (2017). Effects of dietary sodium on metabolites: the Dietary Approaches to Stop Hypertension (DASH)-Sodium Feeding Study. Am J Clin Nutr  106, 1131-1141.   https://doi.org/10.3945/ajcn.116.150136|2. McNeil J, Farris MS, Ruan Y, Merry H, Lynch BM, Matthews CE, Courneya KS, Friedenreich CM (2018). Effects of prescribed aerobic exercise volume on physical activity and sedentary time in postmenopausal women: a randomized controlled trial. Int J Behav Nutr Phys Act  15, 27.   https://doi.org/10.1186/s12966-018-0659-3|3. Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews CE, Ziegler RG (2018). A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst  110, 588-597.   https://doi.org/10.1093/jnci/djx244|4. Murphy RA, Moore S, Playdon M, Kritchevsky S, Newman AB, Satterfield S, Ayonayon H, Clish C, Gerszten R, Harris TB (2019). Metabolites Associated With Risk of Developing Mobility Disability in the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci  74, 73-80.   https://doi.org/10.1093/gerona/glx233|5. NOGUEIRA L, Solomon R, GAMBORG M, SRENSEN T, BAKER J (2017). Childhood body mass index and risk of adult pancreatic cancer. Current Developments in Nutrition  1, e001362.|6. Patel AV, Maliniak ML, Rees-Punia E, Matthews CE, Gapstur SM (2018). Prolonged Leisure Time Spent Sitting in Relation to Cause-Specific Mortality in a Large US Cohort. Am J Epidemiol  187, 2151-2158.   https://doi.org/10.1093/aje/kwy125|7. Playdon MC, Ziegler RG, Sampson JN, Stolzenberg-Solomon R, Thompson HJ, Irwin ML, Mayne ST, Hoover RN, Moore SC (2017). Nutritional metabolomics and breast cancer risk in a prospective study. Am J Clin Nutr  106, 637-649.   https://doi.org/10.3945/ajcn.116.150912|8. Saint-Maurice PF, Troiano RP, Berrigan D, Kraus WE, Matthews CE (2018). Volume of Light Versus Moderate-to-Vigorous Physical Activity: Similar Benefits for All-Cause Mortality? J Am Heart Assoc  7.   https://doi.org/10.1161/JAHA.118.008815|9. Saint-Maurice PF, Troiano RP, Matthews CE, Kraus WE (2018). Moderate-to-Vigorous Physical Activity and All-Cause Mortality: Do Bouts Matter? J Am Heart Assoc  7.   https://doi.org/10.1161/JAHA.117.007678",https://intramural.nih.gov/search/searchview.taf?ipid=104298
623,CP010198-12,"October 01, 2017 -  September 30, 2018",Lower Gastrointestinal Cancer Studies,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Gwen  Murphy,NULL,NULL,NULL,"1. Sinha R, Abu-Ali G, Vogtmann E, Fodor AA, Ren B, Amir A, Schwager E, Crabtree J, Ma S, Microbiome Quality Control Project Consortium, Abnet CC, Knight R, White O, Huttenhower C (2017). Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat Biotechnol  35, 1077-1086.   https://doi.org/10.1038/nbt.3981|2. Sinha R, Goedert JJ, Vogtmann E, Hua X, Porras C, Hayes R, Safaeian M, Yu G, Sampson J, Ahn J, Shi J (2018). Quantification of Human Microbiome Stability Over 6 Months: Implications for Epidemiologic Studies. Am J Epidemiol  187, 1282-1290.   https://doi.org/10.1093/aje/kwy064|3. Vogtmann E, Hua X, Zhou L, Wan Y, Suman S, Zhu B, Dagnall CL, Hutchinson A, Jones K, Hicks BD, Sinha R, Shi J, Abnet CC (2018). Temporal Variability of Oral Microbiota over 10 Months and the Implications for Future Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev  27, 594-600.   https://doi.org/10.1158/1055-9965.EPI-17-1004",https://intramural.nih.gov/search/searchview.taf?ipid=104299
624,CP010199-12,"October 01, 2017 -  September 30, 2018",Methods for Etiologic Studies of Diet and Cancer,Rashmi P Sinha; PhD|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",Charles E Matthews,NULL,Amy F Subar (Risk Factor Assessment Branch)|Victor  Kipnis (Biometry Research Group)|Frances E Thompson (Risk Factor Assessment Branch)|Douglas N Midthune (Biometry Research Group)|Richard P Troiano (Risk Factor Assessment Branch),NULL,"1. Bonn SE, Rimm EB, Matthews CE, Troiano RP, Bowles HR, Rood J, Barnett JB, Willett WC, Chomistek AK (2018). Associations of Sedentary Time with Energy Expenditure and Anthropometric Measures. Med Sci Sports Exerc  50, 2575-2583.   https://doi.org/10.1249/MSS.0000000000001729|2. Matthews CE, Keadle SK, Berrigan D, Staudenmayer J, F Saint-Maurice P, Troiano RP, Freedson PS (2018). Influence of Accelerometer Calibration Approach on Moderate-Vigorous Physical Activity Estimates for Adults. Med Sci Sports Exerc  50, 2285-2291.   https://doi.org/10.1249/MSS.0000000000001691|3. Matthews CE, Keadle SK, Saint-Maurice PF, Moore SC, Willis EA, Sampson JN, Berrigan D (2018). Use of Time and Energy on Exercise, Prolonged TV Viewing, and Work Days. Am J Prev Med  55, e61-e69.   https://doi.org/10.1016/j.amepre.2018.04.036|4. Matthews CE, Kozey Keadle S, Moore SC, Schoeller DS, Carroll RJ, Troiano RP, Sampson JN (2018). Measurement of Active and Sedentary Behavior in Context of Large Epidemiologic Studies. Med Sci Sports Exerc  50, 266-276.   https://doi.org/10.1249/MSS.0000000000001428",https://intramural.nih.gov/search/searchview.taf?ipid=104300
625,CP010200-11,"October 01, 2017 -  September 30, 2018",GEI - Genome-Wide Association Studies,"Stephen J Chanock; MD, PhD|IRP Faculty Profile  |Nilanjan  Chatterjee| | |Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile  | |Margaret Anne Tucker|IRP Faculty Profile  | |Neil Edward Caporaso; MS, MD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Genetic Epidemiology Branch, NCI

Human Genetics Program, NCI

Office of the Director, NCI",Mark  Purdue,NULL,NULL,NULL,"1. Jeon J, Du M, Schoen RE, Hoffmeister M, Newcomb PA, Berndt SI, Caan B, Campbell PT, Chan AT, Chang-Claude J, Giles GG, Gong J, Harrison TA, Huyghe JR, Jacobs EJ, Li L, Lin Y, Le Marchand L, Potter JD, Qu C, Bien SA, Zubair N, Macinnis RJ, Buchanan DD, Hopper JL, Colorectal Transdisciplinary Study and Genetics and Epidemiology of Colorectal Cancer Consortium, et al. [14 more authors] (2018). Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology  154, 2152-2164.e19.   https://doi.org/10.1053/j.gastro.2018.02.021",https://intramural.nih.gov/search/searchview.taf?ipid=104302
626,CP010201-09,"October 01, 2017 -  September 30, 2018",Laboratory of Translational Genomics,Michael  Dean; PhD|IRP Faculty Profile,NULL,"Laboratory Translational Genomics, NCI",Laufey Thora Amundadottir|Liudmila  Prokunina-Olsson; PhD|Kevin Michael Brown,NULL,NULL,NULL,"1. Cobo I, Martinelli P, Flández M, Bakiri L, Zhang M, Carrillo-de-Santa-Pau E, Jia J, Sánchez-Arévalo Lobo VJ, Megías D, Felipe I, Del Pozo N, Millán I, Thommesen L, Bruland T, Olson SH, Smith J, Schoonjans K, Bamlet WR, Petersen GM, Malats N, Amundadottir LT, Wagner EF, Real FX (2018). Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas. Nature  554, 533-537.   https://doi.org/10.1038/nature25751|2. Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, et al. [98 more authors] (2018). Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun  9, 556.   https://doi.org/10.1038/s41467-018-02942-5|3. Lou H, Gharzouzi E, Guerra SP, Domgue JF, Sawitzke J, Villagran G, Garland L, Boland JF, Wagner S, Rosas H, Troxler J, McMillen H, Kessing B, Alvirez E, Castillo M, Morales H, Argueta V, Rosingh A, van Aerde-van Nunen FJHB, Lopez G, Pinedo HM, Schiffman M, Dean M, Orozco R (2018). Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala. BMC Cancer  18, 562.   https://doi.org/10.1186/s12885-018-4438-y|4. Streicher SA, Klein AP, Olson SH, Amundadottir LT, DeWan AT, Zhao H, Risch HA (2017). Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews. Cancer Epidemiol Biomarkers Prev  26, 1540-1548.   https://doi.org/10.1158/1055-9965.EPI-17-0262",https://intramural.nih.gov/search/searchview.taf?ipid=104307
627,CP010202-10,"October 01, 2017 -  September 30, 2018","Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO",Rachael Zoe Solomon|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,Brietta M Oaks|K  Dodd (DCCPS/NCI),"Cari Meinhold Kitahara (Radiation Epidemiology Branch)|Debra  Silverman; ScD, ScM (Occupational and Environmental Epidemiology Branch)",NULL,"1. Zheng J, Merchant AT, Wirth MD, Zhang J, Antwi SO, Shoaibi A, Shivappa N, Stolzenberg-Solomon RZ, Hebert JR, Steck SE (2018). Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Int J Cancer  142, 2461-2470.   https://doi.org/10.1002/ijc.31271",https://intramural.nih.gov/search/searchview.taf?ipid=104250
628,CP010206-09,"October 01, 2017 -  September 30, 2018","Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment",Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Mark H Greene; MD|Nicolas Albert Hermann Wentzensen|Julia  Gage|Lisa  Mirabello,Robert  Burk (Albert Einstein College of Medicine)|Rodney D Long|Attila  Lorincz (Digene)|Walter  Kinney (Kaiser Permanente Northern California)|Tina  Raine-Bennett (Kaiser Permanente Northern California)|Cosette  Wheeler (University of New Mexico)|Show all 11,Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)|Allan  Hildesheim; PhD (Infection & Immunoepidemiology Branch)|Meredith  Yeager (Office of the Director)|Douglas  Lowy; MD (Office Of The Director),NULL,"1. Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M (2018). Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer. J Clin Oncol  36, 1184-1191.   https://doi.org/10.1200/JCO.2017.75.3442",https://intramural.nih.gov/search/searchview.taf?ipid=104308
629,CP010207-09,"October 01, 2017 -  September 30, 2018",PLCO EEMS and Extended Follow Up,"Neal David Freedman|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI",Amanda  Black,NULL,Philip  Prorok (Office of the Director)|Paul F Pinsky (Early Detection Research Group),NULL,"1. Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, Jacobs EJ, Gapstur SM, Hayes RB, Ahn J (2017). Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers. Cancer Res  77, 6777-6787.   https://doi.org/10.1158/0008-5472.CAN-17-1296",https://intramural.nih.gov/search/searchview.taf?ipid=104309
630,CP010209-09,"October 01, 2017 -  September 30, 2018",HPV and cancer at multiple anatomic sites,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104311
631,CP010210-09,"October 01, 2017 -  September 30, 2018","HPV, cervical neoplasia, and vaccination",Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Mahboobeh  Safaeian|Aimee Rebecca Kreimer,L  Pinto (SAIC-NCI)|Mary  Carrington (SAIC Frederick),"Douglas  Lowy; MD (Office Of The Director)|John  Schiller; PhD (Laboratory of Cellular Oncology)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Hormuzdiar Aspandiar Katki; MS (Biostatistics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104312
632,CP010211-09,"October 01, 2017 -  September 30, 2018",Viral and Host Factors Associated with NPC,Alisa  Goldstein; PhD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Clinical Genetics Branch, NCI",Kelly Jen-Yi Yu,Chen-Jen  Chen (Academia Sinica in Taiwan)|ChenPing  Wang (National Taiwan University),"Mary  Carrington; MS, PhD (Cancer Inflammation Program)|Ruth  Pfeiffer; PhD (Biostatistics Branch)|Kai  Yu (Biostatistics Branch)",NULL,"1. Liu Z, Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Yu KJ, Lou PJ, Wang CP, Mulvenna J, Middeldorp JM, Bethony J, Chen CJ, Doolan DL, Hildesheim A (2018). Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome. J Infect Dis  217, 1923-1931.   https://doi.org/10.1093/infdis/jiy122",https://intramural.nih.gov/search/searchview.taf?ipid=104313
633,CP010212-09,"October 01, 2017 -  September 30, 2018",Molecular mechanisms of infection-related cancer,Charles  Rabkin|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Cancer Genome Atlas Research Network, Thorsson V, et al. [2 more authors] (2018). Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell  33, 721-735.e8.   https://doi.org/10.1016/j.ccell.2018.03.010|2. Lunn RM, Jahnke GD, Rabkin CS (2017). Tumour virus epidemiology. Philos Trans R Soc Lond B Biol Sci  372.   https://doi.org/10.1098/rstb.2016.0266|3. Song M, Camargo MC, Weinstein SJ, Murphy G, Freedman ND, Koshiol J, Stolzenberg-Solomon RZ, Abnet CC, Männistö S, Albanes D, Rabkin CS (2018). Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males. Aliment Pharmacol Ther  47, 494-503.   https://doi.org/10.1111/apt.14471|4. Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Cancer Genome Atlas Research Network, et al. [32 more authors] (2018). The Immune Landscape of Cancer. Immunity  48, 812-830.e14.   https://doi.org/10.1016/j.immuni.2018.03.023|5. Wennerström ECM, Simonsen J, Camargo MC, Rabkin CS (2017). Acid-suppressing therapies and subsite-specific risk of stomach cancer. Br J Cancer  116, 1234-1238.   https://doi.org/10.1038/bjc.2017.84|6. Wong C, Gange SJ, Moore RD, Justice AC, Buchacz K, Abraham AG, Rebeiro PF, Koethe JR, Martin JN, Horberg MA, Boyd CM, Kitahata MM, Crane HM, Gebo KA, Gill MJ, Silverberg MJ, Palella FJ, Patel P, Samji H, Thorne J, Rabkin CS, Mayor A, Althoff KN, North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) (2018). Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States. Clin Infect Dis  66, 1230-1238.   https://doi.org/10.1093/cid/cix998",https://intramural.nih.gov/search/searchview.taf?ipid=104314
634,CP010213-09,"October 01, 2017 -  September 30, 2018",Studies of Head and Neck Cancers,Anil Kumar Chaturvedi|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104315
635,CP010214-09,"October 01, 2017 -  September 30, 2018",Microbes and Human Malignancies,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Jacques  Ravel; PhD (Microbial Genomics, The Institute for Genomic Research (TIGR))|Jeffrey  Gordon (WUSTL)|Wendy  Cozen (Norris Comprehensive Cancer Center)|Heather  Feigelson (American Cancer Society)|Dominique  Costagliola (INSERM, U943)|Nino  Romano (University of Palermo)|Show all 9",Roberto  Flores (Nutritional Science Research Group)|Rashmi P Sinha; PhD (Hormonal and Reproductive Epidemiology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104316
636,CP010215-09,"October 01, 2017 -  September 30, 2018",Human microbiome and cancer,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104317
637,CP010216-09,"October 01, 2017 -  September 30, 2018",Immune responses to HPV infection and HPV vaccination,Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104318
638,CP010217-08,"October 01, 2017 -  September 30, 2018",HPV Vaccine Trial,Hormuzdiar Aspandiar Katki; MS|IRP Faculty Profile  | |Aimee Rebecca Kreimer|IRP Faculty Profile  |Ligia  Pinto| |Mahboobeh  Safaeian| | |Mark  Schiffman; MD|IRP Faculty Profile  | |Allan  Hildesheim; PhD|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI

Biostatistics Branch, NCI

Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Anil Kumar Chaturvedi,Rolando  Herrero (IARC)|Douglas  Lowy; MD (NCI)|Ana-Cecilia  Rodriguez (Proyecto Epidemiologico Guanacaste)|John  Schiller; PhD (NCI)|Diane  Solomon; PhD (NCI)|Wim  Quint (Delft Diagnostic Laboratory),NULL,NULL,"1. Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR, Costa Rica HPV Vaccine Trial (CVT) Group (2018). Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial. J Natl Cancer Inst  110.   https://doi.org/10.1093/jnci/djx158",https://intramural.nih.gov/search/searchview.taf?ipid=104319
639,CP010218-08,"October 01, 2017 -  September 30, 2018",Etiology of Biliary Tract Cancer,Jill Elizabeth Koshiol|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,Gabriella  Andreotti (Occupational and Environmental Epidemiology Branch),NULL,"1. Koshiol J, Gao YT, Corbel A, Kemp TJ, Shen MC, Hildesheim A, Hsing AW, Rashid A, Wang B, Pfeiffer RM, Pinto LA (2018). Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions. Cancer Epidemiol  54, 25-30.   https://doi.org/10.1016/j.canep.2018.03.004|2. Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Roa JC, Wang B, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA, Koshiol J (2018). Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer. Sci Rep  8, 5671.   https://doi.org/10.1038/s41598-018-23848-8|3. Nelson SM, Gao YT, Nogueira LM, Shen MC, Wang B, Rashid A, Hsing AW, Koshiol J (2017). Diet and biliary tract cancer risk in Shanghai, China. PLoS One  12, e0173935.   https://doi.org/10.1371/journal.pone.0173935",https://intramural.nih.gov/search/searchview.taf?ipid=104320
640,CP010219-08,"October 01, 2017 -  September 30, 2018",Studies of other risk factors for radiosensitive tumors,Amy  de Gonzalez|IRP Faculty Profile  | |Martha S Linet; PhD|IRP Faculty Profile  | |Cari Meinhold Kitahara|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Kitahara CM (2017). New Evidence on the Association between Prediagnostic Thyroid-Stimulating Hormone Levels and Thyroid Cancer Risk. Cancer Epidemiol Biomarkers Prev  26, 1163-1164.   https://doi.org/10.1158/1055-9965.EPI-17-0329",https://intramural.nih.gov/search/searchview.taf?ipid=104321
641,CP010220-08,"October 01, 2017 -  September 30, 2018",Barretts Esophagus,"Christian Cormac Abnet; PhD, MPH|IRP Faculty Profile  | |Sanford Martin Dawsey; MD|IRP Faculty Profile  | |Neal David Freedman|IRP Faculty Profile  | |Ruth  Pfeiffer; PhD|IRP Faculty Profile  |Philip  Taylor; MD, ScD| | |Michael Blaise Cook|IRP Faculty Profile",NULL,"Biostatistics Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,"1. Cook MB, Wood S, Hyland PL, Caron P, Drahos J, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Guillemette C, Murray LJ, Anderson LA (2017). Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study. Andrology  5, 240-247.   https://doi.org/10.1111/andr.12314|2. Petrick JL, Falk RT, Hyland PL, Caron P, Pfeiffer RM, Wood SN, Dawsey SM, Abnet CC, Taylor PR, Guillemette C, Murray LJ, Anderson LA, Cook MB (2018). Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study. PLoS One  13, e0190325.   https://doi.org/10.1371/journal.pone.0190325|3. Petrick JL, Hyland PL, Caron P, Falk RT, Pfeiffer RM, Dawsey SM, Abnet CC, Taylor PR, Weinstein SJ, Albanes D, Freedman ND, Gapstur SM, Bradwin G, Guillemette C, Campbell PT, Cook MB (2019). Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men. J Natl Cancer Inst  111, 34-41.   https://doi.org/10.1093/jnci/djy082",https://intramural.nih.gov/search/searchview.taf?ipid=104322
642,CP010221-08,"October 01, 2017 -  September 30, 2018",Etiologic Studies of Prostate Cancer,Demetrius  Albanes; MD|IRP Faculty Profile,NULL,"Occupational and Environmental Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Office of the Director, NCI",Mark  Purdue|Meredith  Yeager|Zhaoming  Wang,"David  Hunter (Harvard School of Public Health)|Peter  Kraft|Brian  Henderson (University of Southern California)|Laurence N Kolonel|Susan  Gapstur (American Cancer Society)|Margie  Wright; PhD (Queensland Institute of Medical Research, Brisbane, Australia)|Show all 7","Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Joanne Lee Watters (Clinical & Translational Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104323
643,CP010222-08,"October 01, 2017 -  September 30, 2018",Studies of Populations Exposed to Diagnostic Medical Radiation,Cari Meinhold Kitahara|IRP Faculty Profile  | |Choonsik  Lee|IRP Faculty Profile  | |Mark Peter Little|IRP Faculty Profile  | |Amy  de Gonzalez|IRP Faculty Profile,NULL,"Radiation Epidemiology Branch, NCI","Rochelle E Curtis|Ruth Anne Kleinerman; MPH|Michele M Doody; MS|Alice  Sigurdson; PhD|Kiyohiko  Mabuchi; MD, DPhil|Martha S Linet; PhD|Show all 9",David  Abramson (New York Presbyterian Hospital)|Johanna  Seddon (Massachusetts Eye and Ear Infirmary)|Marilyn  Stovall (The University of Texas MD Anderson Cancer Center)|Neal Andrew Naito|Ritsu  Sakata; PhD|Eve  Roman (University of York)|Show all 14,Steven L Simon (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Preetha  Rajaraman (Center For Global Health)|Jay  Lubin; PhD (Biostatistics Branch),NULL,"1. Borrego D, Lowe EM, Kitahara CM, Lee C (2018). Assessment of PCXMC for patients with different body size in chest and abdominal x ray examinations: a Monte Carlo simulation study. Phys Med Biol  63, 065015.   https://doi.org/10.1088/1361-6560/aab13e|2. Lee C, Morton LM, de Gonzalez AB (2018). A NOVEL METHOD TO ESTIMATE LYMPHOCYTE DOSE AND APPLICATION TO PEDIATRIC AND YOUNG ADULT CT PATIENTS IN THE UNITED KINGDOM. Radiat Prot Dosimetry  178, 116-121.   https://doi.org/10.1093/rpd/ncx084|3. Meulepas JM, Ronckers CM, Smets AMJB, Nievelstein RAJ, Gradowska P, Lee C, Jahnen A, van Straten M, de Wit MY, Zonnenberg B, Klein WM, Merks JH, Visser O, van Leeuwen FE, Hauptmann M (2019). Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands. J Natl Cancer Inst  111, 256-263.   https://doi.org/10.1093/jnci/djy104",https://intramural.nih.gov/search/searchview.taf?ipid=104324
644,CP010224-07,"October 01, 2017 -  September 30, 2018",Esophageal cancer genetic project,Alisa  Goldstein; PhD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,"TI  Ding (DEPT OF THORACIC SURGERY, SCHI)|LiDong  Wang (Zhengzhou Medical University)|DongXin  Lin (CICAMS)|Wei  Zheng (Vanderbilt University)|XiaoOu  Shu (Vanderbilt University)|JianMin  Yuan (University of Pittsburgh)","Nan  Hu (Hormonal and Reproductive Epidemiology Branch)|Christian Cormac Abnet; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)|Sanford Martin Dawsey; MD (Hormonal and Reproductive Epidemiology Branch)|Neal David Freedman (Hormonal and Reproductive Epidemiology Branch)|Paula L Hyland (Genetic Epidemiology Branch)",NULL,"1. Sung H, Hu N, Yang HH, Giffen CA, Zhu B, Song L, Su H, Wang C, Parisi DM, Goldstein AM, Taylor PR, Hyland PL (2017). Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival. Carcinogenesis  38, 1119-1128.   https://doi.org/10.1093/carcin/bgx090",https://intramural.nih.gov/search/searchview.taf?ipid=104326
645,CP010225-07,"October 01, 2017 -  September 30, 2018",Barretts esophagus early detection project,Michael Blaise Cook|IRP Faculty Profile,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Nan  Hu|Sanford Martin Dawsey; MD|Christian Cormac Abnet; PhD, MPH",Ming  Zhou (SAIC)|Patrick  Young (WRNMMC),Paula L Hyland (Genetic Epidemiology Branch)|Ruth  Pfeiffer; PhD (Biostatistics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104327
646,CP010227-04,"October 01, 2017 -  September 30, 2018",Laboratory of Genetic Susceptibility,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,"Chris  Amos (Dartmouth University)|Smita  Bhatia (University of Alabama School of Medicine)|Paul  Brennan (International Agency for Research on Cancer, Lyon, France)|James  Cerhan (Mayo Clinic)|Fergus  Couch; PhD (Dept of Laboratory Medicine & Pathology, Mayo Clinic)|Olivier  Delattre (Institut Curie, Paris, France)|Show all 20","Leandro Machado Colli (Laboratory Of Genetic Susceptibility)|Lea  Jessop (Laboratory Of Genetic Susceptibility)|Roelof  Koster (Laboratory Of Genetic Susceptibility)|Mitchell John Machiela; PhD (Genetic Epidemiology Branch)|Timothy A Myers (Laboratory Of Genetic Susceptibility)|Mary  Carrington; MS, PhD (Cancer Inflammation Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104329
647,CP010228-03,"October 01, 2017 -  September 30, 2018",Human Papillomavirus (HPV) Genomics Project,Mark  Schiffman; MD|IRP Faculty Profile  | |Lisa  Mirabello|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Nicolas Albert Hermann Wentzensen|Yanzi  Xiao|Maisa  Pinheiro,NULL,Meredith  Yeager (Office of the Director)|Joseph  Boland (Office of the Director)|Kai  Yu (Biostatistics Branch)|Bin  Zhu (Biostatistics Branch),NULL,"1. Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, Cullen M, Boland JF, NCI HPV Workshop, Schiffman M, Burk RD (2018). The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. Viruses  10.   https://doi.org/10.3390/v10020080|2. Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, Steinberg M, Burdett L, Dean M, Roberson D, Mitchell J, Lorey T, Franceschi S, Castle PE, Walker J, Zuna R, et al. [7 more authors] (2017). HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell  170, 1164-1174.e6.   https://doi.org/10.1016/j.cell.2017.08.001",https://intramural.nih.gov/search/searchview.taf?ipid=104330
648,CP010229-01,"October 01, 2017 -  September 30, 2018",Clinical Epidemiology,Anil Kumar Chaturvedi|IRP Faculty Profile  | |Mark  Schiffman; MD|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",Maria  Demarco|Julia  Gage|Joseph Emilio Tota,NULL,Megan A Clarke-Corso (Cancer Prevention Fellowship Program)|Tamara Rae Litwin (Cancer Prevention Fellowship Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107116
649,CP010230-01,"October 01, 2017 -  September 30, 2018",Cervical Cancer Moonshot,Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Mark  Schiffman; MD|IRP Faculty Profile,NULL,"Clinical Genetics Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107117
650,CP101231-01,"October 01, 2017 -  September 30, 2018",Studies of Genetic and Environmental Epidemiology,"Maria Teresa Pia Landi; MD, PhD|IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107118
651,CP101232-01,"October 01, 2017 -  September 30, 2018",HPV Vaccine Moonshot - Cures,Aimee Rebecca Kreimer|IRP Faculty Profile,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107817
652,SC000550-38,"October 01, 2017 -  September 30, 2018",Lymphoma Disease Discovery and Definition,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Theresa M Davies Hill|Caoimhe Mary Egan; MD|Stefania  Pittaluga|Hao-Wei  Wang|Mark  Raffeld; MD,"Wing  Chan (Pathology, University of Nebraska)|Elias  Campo (University of Barcelona)|Steven  Swerdlow (University of Pittsburgh Med Center)|Reiner  Siebert (University of Kiel)|Falko  Fend|Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Show all 8","George W Wright (Computational & Systems Biology Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Louis  Staudt; MD (Center for Cancer Genomics)","Jeffrey  Cohen; MD (NIAID) |William A Gahl; MD, PhD (NHGRI)","1. Bouska A, Zhang W, Gong Q, Iqbal J, Scuto A, Vose J, Ludvigsen M, Fu K, Weisenburger DD, Greiner TC, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Wu CI, Staudt LM, D'Amore F, McKeithan TW, Chan WC (2017). Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia  31, 83-91.   https://doi.org/10.1038/leu.2016.175|2. Clot G, Jares P, Giné E, Navarro A, Royo C, Pinyol M, Martín-Garcia D, Demajo S, Espinet B, Salar A, Ferrer A, Muntañola A, Aymerich M, Rauert-Wunderlich H, Jaffe ES, Connors JM, Gascoyne RD, Delabie J, López-Guillermo A, Ott G, Wright GW, Staudt LM, Rosenwald A, Scott DW, Rimsza LM, et al. [2 more authors] (2018). A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. Blood  132, 413-422.   https://doi.org/10.1182/blood-2018-03-838136|3. Jaffe ES (2017). The Microscope as a Tool for Disease Discovery-A Personal Voyage. Annu Rev Pathol  12, 1-24.   https://doi.org/10.1146/annurev-pathol-052016-100351|4. Lai C, Roschewski M, Melani C, Pittaluga S, Shovlin M, Steinberg SM, Dunleavy K, Pack S, Jaffe ES, Wilson WH (2018). MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R. Leuk Lymphoma  59, 505-508.   https://doi.org/10.1080/10428194.2017.1339882|5. Marshall VA, Labo N, Hao XP, Holdridge B, Thompson M, Miley W, Brands C, Coalter V, Kiser R, Anver M, Golubeva Y, Warner A, Jaffe ES, Piatak M, Wong SW, Ohlen C, MacAllister R, Smedley J, Deleage C, Del Prete GQ, Lifson JD, Estes JD, Whitby D (2018). Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV. PLoS Pathog  14, e1007130.   https://doi.org/10.1371/journal.ppat.1007130|6. Perry AM, Bailey NG, Bonnett M, Jaffe ES, Chan WC (2019). Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract. Int J Surg Pathol  27, 102-107.   https://doi.org/10.1177/1066896918785985|7. Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, et al. [34 more authors] (2017). Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell  171, 481-494.e15.   https://doi.org/10.1016/j.cell.2017.09.027|8. Roswarski J, Roschewski M, Lucas A, Melani C, Pittaluga S, Jaffe ES, Steinberg SM, Waldmann TA, Wilson WH (2018). Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas. Leuk Lymphoma  59, 1466-1469.   https://doi.org/10.1080/10428194.2017.1387908|9. Schmidt J, Ramis-Zaldivar JE, Nadeu F, Gonzalez-Farre B, Navarro A, Egan C, Montes-Mojarro IA, Marafioti T, Cabeçadas J, van der Walt J, Dojcinov S, Rosenwald A, Ott G, Bonzheim I, Fend F, Campo E, Jaffe ES, Salaverria I, Quintanilla-Martinez L (2017). Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. Blood  130, 323-327.   https://doi.org/10.1182/blood-2017-03-776278",https://intramural.nih.gov/search/searchview.taf?ipid=104341
653,SC000892-35,"October 01, 2017 -  September 30, 2018",Molecular Biology of the Metastatic Phenotype,Patricia  Steeg; PhD|IRP Faculty Profile,NULL,"Womens Malignancies Branch, NCI",Hardik Hastibhai Amin|Imran  Khan; PhD,David  Lyden (Weill Cornell Medical School)|Fabio  Tucci (Epigen Biosciences),Simone  Difilippantonio (Office Of The Director)|Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104343
654,SC004002-49,"October 01, 2017 -  September 30, 2018",IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Olga Maria Anton Hurtado|Yuquan  Lin|Juergen R Mueller; PhD|Masao  Nakagawa|Yong  Zhang,Richard  Bamford; PhD|Georgy  Vamosi (University of Debrecen),"Mei  Zhang; MD, PhD (Office Of The Director)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104345
655,SC004020-41,"October 01, 2017 -  September 30, 2018","Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD|IRP Faculty Profile",NULL,"Vaccine Branch, NCI",Kurt Edward Berckmueller|Anja Constanze Bloom|Lee Chrisman England|Tianbo  Jiang|Laurel  Lagenaur; PhD|John Sangmin Lee|Show all 21,"David  Carbone (Vanderbilt University)|Guido  Forni (Clinical and Biological Sciences, University of Turin)|Steven  Ledbetter (Genzyme Corp.)|Scott  Lonning (Gene Therapy, Genzyme Corp.)|Dale  Godfrey (Immunolgy, University of Melbourne)|Wayne M. Yokoyama; MD (Rheumatology Division, Washington University)|Show all 40",Yichuan  Wang (Office Of The Director)|William Marston Linehan; MD (Urologic Oncology Branch)|Ira H Pastan; MD (Molecular Biology Section)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|David J Venzon; PhD (Biostatistics and Data Management Section)|Hisataka  Kobayashi (Molecular Imaging Program),"Brian  Kelsall; MD (NIAID) |David Harvey Margulies; MD, PhD (NIAID) |Warren  Strober; MD (NIAID) |Patricia  Earl; PhD (NIAID) |Warren J Leonard; MD (NHLBI) |Hee-Yong  Kim; PhD (NIAAA)","1. Billeskov R, Wang Y, Solaymani-Mohammadi S, Frey B, Kulkarni S, Andersen P, Agger EM, Sui Y, Berzofsky JA (2017). Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy. J Immunol  198, 3494-3506.   https://doi.org/10.4049/jimmunol.1600965|2. Castiello L, Sabatino M, Ren J, Terabe M, Khuu H, Wood LV, Berzofsky JA, Stroncek DF (2017). Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients. Clin Cancer Res  23, 3352-3364.   https://doi.org/10.1158/1078-0432.CCR-16-2199|3. Dzutsev A, Hogg A, Sui Y, Solaymani-Mohammadi S, Yu H, Frey B, Wang Y, Berzofsky JA (2017). Differential T cell homing to colon vs. small intestine is imprinted by local CD11c+ APCs that determine homing receptors. J Leukoc Biol  102, 1381-1388.   https://doi.org/10.1189/jlb.1A1116-463RR|4. Hogg A, Sui Y, Ben-Sasson SZ, Paul WE, Berzofsky JA (2017). Role of CD4 T cell helper subsets in immune response and deviation of CD8 T cells in mice. Eur J Immunol  47, 2059-2069.   https://doi.org/10.1002/eji.201747091|5. Speir M, Authier-Hall A, Brooks CR, Farrand KJ, Compton BJ, Anderson RJ, Heiser A, Osmond TL, Tang CW, Berzofsky JA, Terabe M, Painter GF, Hermans IF, Weinkove R (2017). Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins. Sci Rep  7, 14273.   https://doi.org/10.1038/s41598-017-14690-5",https://intramural.nih.gov/search/searchview.taf?ipid=104346
656,SC006321-39,"October 01, 2017 -  September 30, 2018",Modulation of Therapeutic Response,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",Rajani  Choudhuri|John Andrew Cook; PhD|Janet W Gamson|Sangeeta  Gohain|Askale Y Mathias|Chandrasek N. Nagineni; PhD|Show all 9,NULL,Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Leonard  Neckers; PhD (Urologic Oncology Branch),"Carter  Van Waes; MD, PhD (NIDCD) |Clint Tanner Allen (NIDCD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104347
657,SC006330-38,"October 01, 2017 -  September 30, 2018",Radiation Field Modeling and Computerized Treatment Planning,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Peter  Guion|Mary Kathleen Hawes|Holly  Ning|Ying  Zhuge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104336
658,SC006387-31,"October 01, 2017 -  September 30, 2018",Nitroxides as Protectors Against Oxidative Stress,James B Mitchell; PhD|IRP Faculty Profile,NULL,"Radiation Biology Branch, NCI",John Andrew Cook; PhD|Sangeeta  Gohain|Sarwat  Naz; PhD|Anastasia L Sowers|Murali  Krishna; PhD,NULL,Frank Jess Gonzalez; PhD (Laboratory of Metabolism),NULL,"1. Neil S, Huh J, Baronas V, Li X, McFarland HF, Cherukuri M, Mitchell JB, Quandt JA (2017). Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models. Brain Behav Immun  62, 332-343.   https://doi.org/10.1016/j.bbi.2017.02.018",https://intramural.nih.gov/search/searchview.taf?ipid=104349
659,SC006538-25,"October 01, 2017 -  September 30, 2018",Development of Angiogenesis Inhibitors,William D Figg; PharmD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI","Cindy Huong-Bich Chau|Emily Mae Harris|Suzana  Markolovic|Douglas K Price|James L Gulley; MD, PhD|William Laurence Dahut; MD|Show all 9","Neil  Vargesson; PhD (University of Aberdeen)|Christopher  Schofield (University of Oxford)|Brent R Copp; PhD (Chemistry, University of Auckland)|Michael  Gutschow (University of Bonn)",Phoebe Ao-Xue Huang (Office Of The Clinical Director)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|David J Venzon; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Ismail Baris Turkbey (Molecular Imaging Program),Nigel H Greig; PhD (NIA),"1. Beedie SL, Diamond AJ, Fraga LR, Figg WD, Vargesson N (2017). Vertebrate embryos as tools for anti-angiogenic drug screening and function. Reprod Toxicol  70, 49-59.   https://doi.org/10.1016/j.reprotox.2016.11.013|2. Harris EM, Strope JD, Beedie SL, Huang PA, Goey AKL, Cook KM, Schofield CJ, Chau CH, Cadelis MM, Copp BR, Gustafson KR, Figg WD (2018). Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models. Mar Drugs  16.   https://doi.org/10.3390/md16070241",https://intramural.nih.gov/search/searchview.taf?ipid=104350
660,SC006663-29,"October 01, 2017 -  September 30, 2018",Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer,David  Danforth,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,"Armando  Filie (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Mark H Greene; MD (Clinical Genetics Branch)|Maria  Merino; PhD (Laboratory of Pathology)|David Erwin Kleiner; MD, PhD (Laboratory of Pathology)|Sheila Ann Prindiville (Office Of The Director)",NULL,"1. Danforth D (2018). Risk assessment for sporadic breast cancer: The need for a molecular profile. Clinics in Surgery  3, 1-4.",https://intramural.nih.gov/search/searchview.taf?ipid=104351
661,SC006737-27,"October 01, 2017 -  September 30, 2018",Development of Novel Therapies for HIV Infection,Robert  Yarchoan; MD|IRP Faculty Profile,NULL,"HIV and AIDS Malignancy Branch, NCI",David A Davis; MD|Ramya Meenakshi Ramaswami|Prabha  Shrestha; PhD|Hiroaki  Mitsuya,NULL,"Kathryn Anne Lurain; MD, MPH (Office Of The Clinical Director)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)|Frank  Maldarelli (Host Virus Interaction Branch)|Stephen H Hughes; PhD (Retroviral Replication Laboratory)|Eric O Freed; PhD (HIV Drug Resistance Program)",Paul T Wingfield; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104352
662,SC006738-27,"October 01, 2017 -  September 30, 2018",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,NULL,"HIV and AIDS Malignancy Branch, NCI",Hiromi  Aoki|Manabu  Aoki; PhD|Haydar  Bulut; PhD|Debananda  Das; PhD|Yuki  Takamatsu; MD|Robert  Yarchoan; MD,Arun  Ghosh|Yasuhiro  Koh (Kumamoto University School of Medicine)|Masayuki  Amano (Kumamoto University School of Medicine)|Eiichi  Kodama (Kyoto University)|Hironori  Hayashi; MA|Nobuyo  Kuwata (National Center for Global Health & Medicine)|Show all 7,NULL,NULL,"1. Amano M, Miguel Salcedo-Gómez P, Yedidi RS, Delino NS, Nakata H, Venkateswara Rao K, Ghosh AK, Mitsuya H (2017). GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro. Sci Rep  7, 12235.   https://doi.org/10.1038/s41598-017-12052-9|2. Aoki M, Das D, Hayashi H, Aoki-Ogata H, Takamatsu Y, Ghosh AK, Mitsuya H (2018). Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance. MBio  9.   https://doi.org/10.1128/mBio.02425-17|3. Aoki M, Hayashi H, Rao KV, Das D, Higashi-Kuwata N, Bulut H, Aoki-Ogata H, Takamatsu Y, Yedidi RS, Davis DA, Hattori SI, Nishida N, Hasegawa K, Takamune N, Nyalapatla PR, Osswald HL, Jono H, Saito H, Yarchoan R, Misumi S, Ghosh AK, Mitsuya H (2017). A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potency. Elife  6.   https://doi.org/10.7554/eLife.28020|4. Delino NS, Aoki M, Hayashi H, Hattori SI, Chang SB, Takamatsu Y, Martyr CD, Das D, Ghosh AK, Mitsuya H (2018). GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants. Antimicrob Agents Chemother  62.   https://doi.org/10.1128/AAC.02060-17|5. Ghosh AK, Brindisi M, Nyalapatla PR, Takayama J, Ella-Menye JR, Yashchuk S, Agniswamy J, Wang YF, Aoki M, Amano M, Weber IT, Mitsuya H (2017). Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex. Bioorg Med Chem  25, 5114-5127.   https://doi.org/10.1016/j.bmc.2017.04.005|6. Ghosh AK, Fyvie WS, Brindisi M, Steffey M, Agniswamy J, Wang YF, Aoki M, Amano M, Weber IT, Mitsuya H (2017). Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2' Ligands of Darunavir. ChemMedChem  12, 1942-1952.   https://doi.org/10.1002/cmdc.201700614|7. Ghosh AK, R Nyalapatla P, Kovela S, Rao KV, Brindisi M, Osswald HL, Amano M, Aoki M, Agniswamy J, Wang YF, Weber IT, Mitsuya H (2018). Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis. J Med Chem  61, 4561-4577.   https://doi.org/10.1021/acs.jmedchem.8b00298|8. Ghosh AK, Rao KV, Nyalapatla PR, Kovela S, Brindisi M, Osswald HL, Sekhara Reddy B, Agniswamy J, Wang YF, Aoki M, Hattori SI, Weber IT, Mitsuya H (2018). Design of Highly Potent, Dual-Acting and Central-Nervous-System-Penetrating HIV-1 Protease Inhibitors with Excellent Potency against Multidrug-Resistant HIV-1 Variants. ChemMedChem  13, 803-815.   https://doi.org/10.1002/cmdc.201700824|9. Ghosh AK, Rao KV, Nyalapatla PR, Osswald HL, Martyr CD, Aoki M, Hayashi H, Agniswamy J, Wang YF, Bulut H, Das D, Weber IT, Mitsuya H (2017). Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants. J Med Chem  60, 4267-4278.   https://doi.org/10.1021/acs.jmedchem.7b00172|10. Ghosh AK, Sean Fyvie W, Brindisi M, Steffey M, Agniswamy J, Wang YF, Aoki M, Amano M, Weber IT, Mitsuya H (2017). Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligands. Bioorg Med Chem Lett  27, 4925-4931.   https://doi.org/10.1016/j.bmcl.2017.09.003|11. Yasutake Y, Hattori SI, Hayashi H, Matsuda K, Tamura N, Kohgo S, Maeda K, Mitsuya H (2018). HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir. Sci Rep  8, 1624.   https://doi.org/10.1038/s41598-018-19602-9",https://intramural.nih.gov/search/searchview.taf?ipid=104337
663,SC006741-26,"October 01, 2017 -  September 30, 2018",Lymphoma Studies,"Wyndham H Wilson; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Lydia L Yee|Christopher Joseph Melani|Saleema  Osman|Mark Jason Roschewski|Joseph Lee Roswarski,NULL,"Elaine S Jaffe; MD (Laboratory of Pathology)|Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)|Stefania  Pittaluga (Laboratory of Pathology)|Louis  Staudt; MD (Center for Cancer Genomics)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH (2018). Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. Lancet Haematol  5, e609-e617.   https://doi.org/10.1016/S2352-3026(18)30177-7",https://intramural.nih.gov/search/searchview.taf?ipid=104338
664,SC007263-26,"October 01, 2017 -  September 30, 2018",Activating Cell Death Pathways in Breast Cancer Cells,"Stanley  Lipkowitz; MD, PhD|IRP Faculty Profile",NULL,"Womens Malignancies Branch, NCI",Samuel Fredrick Gilbert; MPH|Yoshimi Endo Greer|Donna M Voeller|Patricia  Steeg; PhD|Christina M Annunziata|Alexandra Dos Santos Zimmer|Show all 7,David  Tice (MedImmune)|Doron  Levy (University Of Maryland),"Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Anand S Merchant (Cancer Diagnosis Program)|Margaret  Cam; PhD (Office of the Director)|William Marston Linehan; MD (Urologic Oncology Branch)|Yves  Pommier; PhD (Developmental Therapeutics Branch)",Markus  Hafner (NIAMS) |Madhu A Lal (NCATS) |Matthew David Hall (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104355
665,SC007281-25,"October 01, 2017 -  September 30, 2018",Nitric Oxide as a Modifier of Oxidative Stress,David Anderson Wink|IRP Faculty Profile,NULL,"Cancer Inflammation Program, NCI",Debashree  Basudhar|Gaurav  Bharadwaj|Yuk Sing Robert Cheng|Mayumi  Fujita; PhD|Luiz Gonzaga De Franca Lopes|Jae Hong  No; PhD|Show all 11,NULL,"Joseph  Saavedra (Office Of The Director)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Terry  Moody; PhD (Center For Cancer Training)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Stephen J Lockett; PhD (Office Of The Director)|Stefan  Ambs (Laboratory of Human Carcinogenesis)",NULL,"1. Cortese-Krott MM, Koning A, Kuhnle GGC, Nagy P, Bianco CL, Pasch A, Wink DA, Fukuto JM, Jackson AA, van Goor H, Olson KR, Feelisch M (2017). The Reactive Species Interactome: Evolutionary Emergence, Biological Significance, and Opportunities for Redox Metabolomics and Personalized Medicine. Antioxid Redox Signal  27, 684-712.   https://doi.org/10.1089/ars.2017.7083",https://intramural.nih.gov/search/searchview.taf?ipid=104356
666,SC009144-34,"October 01, 2017 -  September 30, 2018",Mechanisms of transcription factor integration at the c-myc promoter,David  Levens; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Brian  Lewis|Emil Francis Michelotti; PhD|Suzanne Laurie Sanford|Ying  Zheng,Juhong  Liu (FDA)|Leonie  Quinn (University of Melbourne),Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Louis  Staudt; MD (Center for Cancer Genomics),Keji  Zhao; PhD (NHLBI) |Teresa M Przytycka (NLM) |Rafael Cristian Casellas; PhD (NIAMS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104357
667,SC009172-30,"October 01, 2017 -  September 30, 2018",Cellular Interactions with Thrombospondin,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Joshua David Amason|Rajdeep  Banerjee|Sukhbir  Kaur|Thomas W Miller; PhD|Pulak Ranjan Nath|Ali Sam Razjooyan|Show all 10,Jeff  Isenberg (University of Pittsburgh)|Thomas  Miller (Paradigm Shift Therapeutics)|David  Soto-Pantoja (Wake Forest University School of Medicine)|Katherine  Cook (Georgetown University Medical Center)|Joanne  Murphy-ullrich (University Of Alabama At Birminghan),David Anderson Wink (Cancer Inflammation Program)|Nancy J Emenaker (Nutritional Science Research Group),Abdel G Elkahloun; PhD (NHGRI) |Chengyu  Liu; PhD (NHLBI) |Satya P Singh; PhD (NIAID) |Marc  Ferrer-Alegre (NCATS) |Ethan M Shevach; MD (NIAID) |Craig Joseph Thomas (NCATS),"1. FelizMosquea Y, Christensen A, Wilson A, Westwood B, Varagic Y, Melendez G, Schwartz A, Chen Q, MathewsGriner L, Guha R, Thomas C, Ferrer M, Merino M, Cook K, Roberts D, SotoPantoja D (2018) Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. Breast Cancer Res Treat, in press.|2. Kaur S, Elkahloun AG, Singh SP, Arakelyan A, Roberts DD (2018). A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells. J Cell Commun Signal  12, 157-170.   https://doi.org/10.1007/s12079-017-0428-0",https://intramural.nih.gov/search/searchview.taf?ipid=104333
668,SC009174-30,"October 01, 2017 -  September 30, 2018",Roles of Glycoconjugates and Redox Signaling in Tumor Biology,David D Roberts; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Sukhbir  Kaur|Thomas W Miller; PhD|John M Sipes,Jeff  Isenberg (University of Pittsburgh)|Lijuan  Zhang (Ocean University)|Thomas  Miller (Paradigm Shift Therapeutics)|David  Soto-Pantoja (Wake Forest University School of Medicine)|Katherine  Cook (Georgetown University Medical Center),David Anderson Wink (Cancer Inflammation Program),NULL,"1. Roberts DD (2017). Extracellular Matrix and Redox Signaling in Cellular Responses to Stress. Antioxid Redox Signal  27, 771-773.   https://doi.org/10.1089/ars.2017.7308|2. Roberts DD, Kaur S, Isenberg JS (2017). Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer. Antioxid Redox Signal  27, 874-911.   https://doi.org/10.1089/ars.2017.7140",https://intramural.nih.gov/search/searchview.taf?ipid=104332
669,SC009179-30,"October 01, 2017 -  September 30, 2018","The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis","William G Stetler-Stevenson; MD, PhD|IRP Faculty Profile",NULL,"Radiation Oncology Branch, NCI",Ananda  Chowdhury; PhD|Sandra  Jensen-Taubman|David  Peeney; PhD|Beiyang  Wei,NULL,"Maryalice  Stetler-Stevenson; MD, PhD (Laboratory of Pathology)",NULL,"1. SanchezPozo J, BakerWilliams A, Woodford M, Bullard R, Wei B, Mollapour M, Stetler-Stevenson W, Bratslavsky G, Bourboulia D (2018). Extracellular Phosphorylation of TIMP-2 by Secreted c-Src Tyrosine kinase Controls MMP-2 Activity. iScience  1, 87-96.|2. Yamada Y, Chowdhury A, Schneider JP, Stetler-Stevenson WG (2018). Macromolecule-Network Electrostatics Controlling Delivery of the Biotherapeutic Cell Modulator TIMP-2. Biomacromolecules  19, 1285-1293.   https://doi.org/10.1021/acs.biomac.8b00107",https://intramural.nih.gov/search/searchview.taf?ipid=104358
670,SC009389-25,"October 01, 2017 -  September 30, 2018",A Mitogen-induced G Protein-coupled Receptor,Kathleen  Kelly; PhD|IRP Faculty Profile,NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Aian Neil Seno Alilin|Adam G Sowalsky,NULL,Kent W Hunter; PhD (Laboratory of Cancer Biology and Genetics),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104359
671,SC010074-23,"October 01, 2017 -  September 30, 2018",HSP90 Chaperone Proteins  Chaperone Interactors in Cellular Signal Transduction,Leonard  Neckers; PhD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Joseph Andrew Baiocco|Kristin  Eckfeld|Li  Dai|Paolo  Pergami-Peries|Marianne  Poruchynsky|Genesis Mayliz Rivera-Marquez|Show all 8,"Brian  Blagg (Chemistry, University of Kansas)|Laurence  Pearl (University of Sussex)|Matthias  Mayer (University of Heidelberg)|Marc  Cox (University of Texas at El Paso)|Gabriela X Chiosis|Timothy  Haystead (Duke University)|Show all 16",Christine Marie Heske (Pediatric Oncology Branch)|Jane Beth Trepel (Developmental Therapeutics Branch),Joe K Jackson (OD) |Daniel C Masison; PhD (NIDDK) |Yihong  Ye (NIDDK),"1. Shao H, Li X, Moses MA, Gilbert LA, Kalyanaraman C, Young ZT, Chernova M, Journey SN, Weissman JS, Hann B, Jacobson MP, Neckers L, Gestwicki JE (2018). Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein-Protein Interactions with Heat Shock Protein 70 (Hsp70). J Med Chem  61, 6163-6177.   https://doi.org/10.1021/acs.jmedchem.8b00583|2. Xu W, Neckers L (2017). A USE1ful Biomarker and Molecular Target in Lung Cancer? J Natl Cancer Inst  109.   https://doi.org/10.1093/jnci/djw227|3. Zuehlke AD, Moses MA, Neckers L (2018). Heat shock protein 90: its inhibition and function. Philos Trans R Soc Lond B Biol Sci  373.   https://doi.org/10.1098/rstb.2016.0527|4. Zuehlke AD, Neckers L (2017). Out with the old: Hsp90 finds amino acid residue more useful than co-chaperone protein. Microb Cell  4, 273-274.   https://doi.org/10.15698/mic2017.08.586",https://intramural.nih.gov/search/searchview.taf?ipid=104361
672,SC010093-22,"October 01, 2017 -  September 30, 2018",Epigenetic Therapy for Thoracic Malignancies,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Mary R Zhang|Julie A Hong,"Nasser  Altorki (Thoracic Surgery, Cornell University Medical Center)|Xinmin  Li (Functional Genomics, University of Chicago)|Sacha  Ghnatic (Ludwig Cancer Inst)",William D Figg; PharmD (Genitourinary Malignancies Branch),NULL,"1. Bu X, Kato J, Hong JA, Merino MJ, Schrump DS, Lund FE, Moss J (2018). CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells. Carcinogenesis  39, 242-251.   https://doi.org/10.1093/carcin/bgx137|2. Inaguma S, Lasota J, Wang Z, Czapiewski P, Langfort R, Rys J, Szpor J, Waloszczyk P, Okoń K, Biernat W, Ikeda H, Schrump DS, Hassan R, Miettinen M (2018). Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma. Hum Pathol  71, 1-7.   https://doi.org/10.1016/j.humpath.2017.04.032|3. McLoughlin KC, Kaufman AS, Schrump DS (2017). Targeting the epigenome in malignant pleural mesothelioma. Transl Lung Cancer Res  6, 350-365.   https://doi.org/10.21037/tlcr.2017.06.06|4. Schrump DS (2017). Circulating tumor DNA: Solid data from liquid biopsies. J Thorac Cardiovasc Surg  154, 1132-1133.   https://doi.org/10.1016/j.jtcvs.2017.05.059",https://intramural.nih.gov/search/searchview.taf?ipid=104340
673,SC010098-16,"October 01, 2017 -  September 30, 2018",The Evaluation of Novel Therapeutics for Genitourinary Malignancies,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Genitourinary Malignancies Branch, NCI",Anna C Couvillon; NP|Fatima Hafiz Karzai; MD|Ravi  Madan,Phil  Kantoff (DFCI)|Joseph  KIm (Yale),"Philip M Arlen; MD (Office Of The Clinical Director)|William Marston Linehan; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter A Pinto; MD (Urologic Oncology Branch)",NULL,"1. Fakhrejahani F, Madan RA, Dahut WL (2017). Management Options for Biochemically Recurrent Prostate Cancer. Curr Treat Options Oncol  18, 26.   https://doi.org/10.1007/s11864-017-0462-4",https://intramural.nih.gov/search/searchview.taf?ipid=104378
674,SC010354-19,"October 01, 2017 -  September 30, 2018",Research and Development of Effective Therapies for Patients with Rare Tumors,Brigitte  Widemann; MD|IRP Faculty Profile,NULL,"Pediatric Oncology Branch, NCI",Eva  Dombi|Ira Lignugaris Kraft|Robert F Murphy|Julia Wanda Cohen|Andrea Michelle Gross; MD|Katherine Elizabeth Warren; MD|Show all 11,"John  Perentesis (Pediatric Oncology, Cincinnati Children's Hospital)|AeRang  Kim (Children's National Medical Center)|Srivandana  Akshintala|Lee Jay Helman; MD (NCI)","Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Abby  Sandler (Office Of The Director)|William Marston Linehan; MD (Urologic Oncology Branch)|Alice Pinting Chen (Office of the Director)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)","Karel  Pacak; MD, PhD (NICHD)","1. Huang V, Bergner AL, Halpin C, Merker VL, Sheridan MR, Widemann BC, Blakeley JO, Plotkin SR (2018). Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2. Otol Neurotol  39, 632-638.   https://doi.org/10.1097/MAO.0000000000001781|2. Reilly K, Kim A, Blakeley J, Ferner R, Gutmann D, Legius E, Miettinen M, Randall L, Ratner N, Jumbe S, Bakker A, Viskochil D, Widemann B, Stewart D (2017) Neurofibromatosis Type-1 associated MPNST State of the Science: Outlining a Research Agenda for the Future. JNCI, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=104363
675,SC010355-19,"October 01, 2017 -  September 30, 2018",Angiogenesis and Tumor Growth,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Michael Joseph Diprima|Taekyu  Ha|Brittney Sophia Harrington|Hidetaka  Ohnuki|Lisa Beth Ritchey|Yuyi  Wang,Maria  Cid (Univ. of Barcelona Medical School)|Amparo  Acher-Palmer (University of Frankfurt)|Shushang  Wang (Univ. Texas Southwestern Med Center)|Elena  Pasquale (Burnham Inst),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Ira  Daar; PhD (Cancer and Developmental Biology Laboratory),Manfred  Boehm; MD (NHLBI) |Yosuke  Mukoyama; PhD (NHLBI),"1. Sánchez-Martín D, Otsuka A, Kabashima K, Ha T, Wang D, Qian X, Lowy DR, Tosato G (2018). Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression. J Natl Cancer Inst  110, 390-399.   https://doi.org/10.1093/jnci/djx219",https://intramural.nih.gov/search/searchview.taf?ipid=104364
676,SC010356-19,"October 01, 2017 -  September 30, 2018",A Role for KSHV in the Pathogenesis of Malignancies,Giovanna  Tosato; PhD|IRP Faculty Profile,NULL,"Laboratory of Cellular Oncology, NCI",Michael Joseph Diprima|Jing-Xin  Feng|Hidetaka  Ohnuki,Frederick  Wang (Harvard Univ)|Stefan  Rose-John (Univ. of Kiel),Elaine S Jaffe; MD (Laboratory of Pathology)|David A Davis; MD (HIV and AIDS Malignancy Branch)|Stefania  Pittaluga (Laboratory of Pathology)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch),Manfred  Boehm; MD (NHLBI),"1. Agerbaek MØ, Pereira MA, Clausen TM, Pehrson C, Oo HZ, Spliid C, Rich JR, Fung V, Nkrumah F, Neequaye J, Biggar RJ, Reynolds SJ, Tosato G, Pullarkat ST, Ayers LW, Theander TG, Daugaard M, Bhatia K, Nielsen MA, Mbulaiteye SM, Salanti A (2017). Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration. Int J Cancer  140, 1597-1608.   https://doi.org/10.1002/ijc.30575",https://intramural.nih.gov/search/searchview.taf?ipid=104365
677,SC010357-19,"October 01, 2017 -  September 30, 2018",Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses,"Zhi Ming  Zheng; MD, PhD|IRP Faculty Profile",NULL,"Rna Biology Laboratory, NCI",Beatriz  Alvarado Hernandez; PhD|Deanna R Gotte|Mina Katariina Griffioen|Pengfei  Jiang|Haibin  Liu|Vladimir  Majerciak|Show all 9,"Craig  Meyers (Microbiology and Immunology, Penn State University College of Medicine)|Louise T Chow|Xing  Xie (Zhejiang University)|Thomas  Tuschl (Rockefeller University)|Chuxia  Deng; PhD (NIDDK)|Paul  Lambert (University of Wisconsin School of Medicine)|Show all 9",Michael John Kruhlak; PhD (Laboratory of Cancer Biology and Genetics)|Xinhua  Ji; PhD (Biomolecular Structure Section),Jun  Zhu; PhD (NHLBI),"1. Cladel NM, Budgeon LR, Cooper TK, Balogh KK, Christensen ND, Myers R, Majerciak V, Gotte D, Zheng ZM, Hu J (2017) Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy. J Gen Virol, in press (e-pub ahead of print)  https://doi.org/10.1099/jgv.0.000926|2. Wang X, Liu H, Ge H, Ajiro M, Sharma NR, Meyers C, Morozov P, Tuschl T, Klar A, Court D, Zheng ZM (2017). Viral DNA Replication Orientation and hnRNPs Regulate Transcription of the Human Papillomavirus 18 Late Promoter. MBio  8.   https://doi.org/10.1128/mBio.00713-17|3. Xue XY, Majerciak V, Uberoi A, Kim BH, Gotte D, Chen X, Cam M, Lambert PF, Zheng ZM (2017). The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues. PLoS Pathog  13, e1006715.   https://doi.org/10.1371/journal.ppat.1006715",https://intramural.nih.gov/search/searchview.taf?ipid=104366
678,SC010366-18,"October 01, 2017 -  September 30, 2018",Identification of Genes for Predicting Prognosis in Pediatric Cancers,Javed  Khan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Leslie Ann Brents|Berkley Eric Gryder|Jeetendra  Kumar|Nityashree  Shivaprasad|Young K Song|Jun S Wei|Show all 7,"John  Maris (Pharmacology, Children's Hospital of Philadelphia)|Daniel  Catchpoole (The Children's Hospital at Westmead)|Robert  Seeger (Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)|Stephen  Skapek (The University of Chicago)|Douglas  Hawkins (Pediatric Oncology, Children's Hosp. of Seattle)|Janet  Shipley (The Institute of Cancer Research)|Show all 7","Carol J Thiele (Pediatric Oncology Branch)|Douglas Russell Stewart; BA, MD (Clinical Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104367
679,SC010372-18,"October 01, 2017 -  September 30, 2018",Molecular Profiling of Patients Undergoing Radiotherapy,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Jason E Savage|Mary T Sproull,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104368
680,SC010373-18,"October 01, 2017 -  September 30, 2018",The Synergy Between Radiotherapy and Molecularly Targeted Agents,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Tatsuya  Kawai|Tamalee  Scott|Jennifer Amy Lee|Mary T Sproull|Hong Shik  Yun; PhD,NULL,NULL,NULL,"1. Hao S, Song H, Zhang W, Seldomridge A, Jung J, Giles AJ, Hutchinson MK, Cao X, Colwell N, Lita A, Larion M, Maric D, Abu-Asab M, Quezado M, Kramp T, Camphausen K, Zhuang Z, Gilbert MR, Park DM (2018). Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma. Neuro Oncol  20, 799-809.   https://doi.org/10.1093/neuonc/nox241|2. Ho WS, Sizdahkhani S, Hao S, Song H, Seldomridge A, Tandle A, Maric D, Kramp T, Lu R, Heiss JD, Camphausen K, Gilbert MR, Zhuang Z, Park DM (2018). LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Lett  415, 217-226.   https://doi.org/10.1016/j.canlet.2017.11.035|3. Rath BH, Waung I, Camphausen K, Tofilon PJ (2018). Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity. Mol Cancer Ther  17, 1070-1078.   https://doi.org/10.1158/1535-7163.MCT-17-1053|4. Timme CR, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ (2018). The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and as Orthotopic Xenografts. Mol Cancer Ther  17, 1207-1216.   https://doi.org/10.1158/1535-7163.MCT-17-1267|5. Wahba A, Rath BH, O'Neill JW, Camphausen K, Tofilon PJ (2018). The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo. Mol Cancer Ther  17, 1717-1726.   https://doi.org/10.1158/1535-7163.MCT-17-1303",https://intramural.nih.gov/search/searchview.taf?ipid=104369
681,SC010375-18,"October 01, 2017 -  September 30, 2018",TAF7: A Check-point Regulator in Transcription Initiation,Dinah  Singer; PhD|IRP Faculty Profile,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,Dan  Cheng (Molecular Regulation Section)|Anne G M Gegonne Bosselut (Molecular Regulation Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104370
682,SC010376-18,"October 01, 2017 -  September 30, 2018","TNF Signaling, Cell Death and Cancer",Zhenggang  Liu; PhD|IRP Faculty Profile,NULL,"Laboratory of Immune Cell Biology, NCI",Jin Young  Baik|Swati Suresh Choksi|Delong  Jiao; PhD|Chamila Charthuranga Kadigamuwa|Hyung Joon  Kwon; PhD|Hongwei  Zhao,"Xuemin  Zhang|Brian  Rowan (School of Medicine, Tulane University)|Jennifer  Yu (Cleveland Clinic)",NULL,Richard James Youle; PhD (NINDS) |Chengyu  Liu; PhD (NHLBI),"1. Jiao D, Cai Z, Choksi S, Ma D, Choe M, Kwon HJ, Baik JY, Rowan BG, Liu C, Liu ZG (2018). Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res  28, 868-870.   https://doi.org/10.1038/s41422-018-0058-y|2. Xu Q, Choksi S, Liu Z (2018). Switching from TNF-induced inflammation to death signaling. Mol Cell Oncol  5, e1392402.   https://doi.org/10.1080/23723556.2017.1392402",https://intramural.nih.gov/search/searchview.taf?ipid=104371
683,SC010378-18,"October 01, 2017 -  September 30, 2018",Activation of Proto-Oncogenes by Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Yang-Jo  Chung|Subhadip  Kundu|Toshihiro  Matsukawa|Vijay  Negi|Mianmian  Yin|Zhenhua  Zhang|Show all 7,Trang  Hoang (U. Montreal)|Crystal L. Mackall; MD (NCI)|Laura  Schuettpelz (Washington University),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104372
684,SC010379-18,"October 01, 2017 -  September 30, 2018",Mechanisms of Chromosomal Translocation,Peter D Aplan; MD|IRP Faculty Profile,NULL,"Cancer Genetics Branch, NCI",Mianmian  Yin|Zhenhua  Zhang,NULL,Andre A Nussenzweig; PhD (Laboratory Of Genome Integrity),NULL,"1. Qiu Z, Zhang Z, Roschke A, Varga T, Aplan PD (2017). Generation of Gross Chromosomal Rearrangements by a Single Engineered DNA Double Strand Break. Sci Rep  7, 43156.   https://doi.org/10.1038/srep43156",https://intramural.nih.gov/search/searchview.taf?ipid=104373
685,SC010384-18,"October 01, 2017 -  September 30, 2018",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,Dennis D Hickstein|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Thomas R Bauer,David  Russell (University of Washington)|Punam  Malik,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104374
686,BC010906-11,"October 01, 2017 -  September 30, 2018",Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy,"Thomas Alexander Waldmann; MD, PhD|IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",Nancy  Beltran|Bonita R Bryant|Kevin Charles Conlon|Sigrid Priscilla Dubois|Liyanage P Perera; PhD|Michael N Petrus,"Nicole  Urquhart (Dept of, University of the West Indies)|Joseph  Murray (Department of Gastroenterology, Mayo Clinic)|Jeffrey  Miller (University of Minnesota)",Jason L Yovandich (Biological Resources Branch),NULL,"1. Perera LP, Zhang M, Nakagawa M, Petrus MN, Maeda M, Kadin ME, Waldmann TA, Perera PY (2017). Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. Am J Hematol  92, 892-901.   https://doi.org/10.1002/ajh.24794",https://intramural.nih.gov/search/searchview.taf?ipid=103859
687,BC009255-44,"October 01, 2017 -  September 30, 2018",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Anthony J Adams|Assiatu Jalloh Crossman|Lawrence G Granger|Donald G Plugge,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103584
688,BC010469-16,"October 01, 2017 -  September 30, 2018",Molecular Targets Program,Barry R O'Keefe,Joel Patrick Schneider; PhD,"Molecular Targets Laboratory, NCI",NULL,"Peter  Seeberger (Chemistry, MIT/)|David  Craik (Institute for Molecular Bioscience, Univ. of Queensland)|Patrick  Cummings (Masters Program development, Johns Hopkins University)|Ihsan  Calis (Natural product diversity librarires, Hacteppe University)|Johnny  Easmon (HDAC Inhibitors, University of Innsbruck)|Yutaka  Takebe (National Institute of Infectious Diseases)|Show all 9",Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|William Marston Linehan; MD (Urologic Oncology Branch)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)|Alexander  Wlodawer; PhD (Macromolecular Crystallography Laboratory)|Robert Andrew Byrd (Structural Biophysics Laboratory)|Stephen J Lockett; PhD (Office Of The Director),Michael P Bray (NIAID),"1. Jia L, Lin H, Oppenheim J, Howard OMZ, Li J, Fan H, Zhao Z, Farrar W, Zhang Y, Colburn N, Young MR, Li W, Newman D, O'Keefe BR, Beutler J, Liu J, Hao X, Yang X, Ji T, White JD (2017). US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer. J Natl Cancer Inst Monogr  2017.   https://doi.org/10.1093/jncimonographs/lgx007",https://intramural.nih.gov/search/searchview.taf?ipid=103698
689,BC010517-16,"October 01, 2017 -  September 30, 2018",Large Databases of Small Molecules - Drug Development Tool and Public Resource,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Hitesh Jayantilal Patel; PhD,Wolf-Dietrich  Ihlenfeldt (Xemistry GmbH)|Ann  Richard (EPA)|Stephen  Boyer|Lawrence  Callahan (FDA)|Eugene  Demchuk (CDC)|Antony  Williams|Show all 9,NULL,"Evan  Bolton; PhD (NLM) |Igor V Filippov (NLM) |Christopher P Austin; AB, MD (NCATS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103701
690,BC010548-16,"October 01, 2017 -  September 30, 2018",Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Julie Katherine Barnes|Oliver Morgan Hall|Cody John Peer|Keith Thomas Schmidt|Jonathan Dale Strope,NULL,"Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)",NULL,"1. Peer CJ, Hall OM, Sissung TM, Piekarz R, Balasubramaniam S, Bates SE, Figg WD (2018). A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat. Cancer Chemother Pharmacol  82, 565-570.   https://doi.org/10.1007/s00280-018-3631-7",https://intramural.nih.gov/search/searchview.taf?ipid=103779
691,BC010639-15,"October 01, 2017 -  September 30, 2018",In Silico Screening for Cancer Targets,Marc C Nicklaus|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Megan L Peach|John Stephen Schneekloth|Jordan Leslie Meier; PhD|Jeffrey  Gildersleeve,"Iwona Elzbieta Weidlich|Julieta  Comin (University of Buenos Aires)|Kevin  Gardner; MD, PhD (NCI)",Donald P Bottaro; PhD (Urologic Oncology Branch)|Kyung  Lee; PhD (Chemistry Section)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|David D Roberts; PhD (Laboratory of Pathology)|Sergey G Tarasov (Structural Biophysics Laboratory)|Terry  Moody; PhD (Center For Cancer Training),"Paul P. Liu; MD, PhD (NHGRI)","1. Zlotkowski K, Hewitt WM, Yan P, Bokesch HR, Peach ML, Nicklaus MC, O'Keefe BR, McMahon JB, Gustafson KR, Schneekloth JS (2017). Macrophilone A: Structure Elucidation, Total Synthesis, and Functional Evaluation of a Biologically Active Iminoquinone from the Marine Hydroid Macrorhynchia philippina. Org Lett  19, 1726-1729.   https://doi.org/10.1021/acs.orglett.7b00496",https://intramural.nih.gov/search/searchview.taf?ipid=103711
692,BC010685-14,"October 01, 2017 -  September 30, 2018",Postmortem Pathology,"David Erwin Kleiner; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI","Willie J Young|Stephen M Hewitt; MD, PhD",NULL,Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)|Mark Richard Gilbert; MD (Neuro-Oncology Branch),"Theo  Heller; MD (NIDDK) |Steven M Holland; MD (NIAID) |Kenneth  Olivier; MD, MPH (NHLBI)","1. Suffredini DA, Lee JM, Peer CJ, Pratt D, Kleiner DE, Elinoff JM, Solomon MA (2018). Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab. BMC Pulm Med  18, 112.   https://doi.org/10.1186/s12890-018-0681-x",https://intramural.nih.gov/search/searchview.taf?ipid=103724
693,BC010687-14,"October 01, 2017 -  September 30, 2018",Histology Core Laboratory,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",NULL,NULL,Tashanda Renee Ashford (Laboratory of Pathology)|Neil J Hardegen (Laboratory of Pathology)|Terrica Shuntay Johnson (Laboratory of Pathology)|Mohammad Javed Mahboob (Laboratory of Pathology)|Michael Kanwolo Newford (Laboratory of Pathology)|Kylie Marie Rapso (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103726
694,BC010858-12,"October 01, 2017 -  September 30, 2018",CCR Confocal Microscopy Core,Langston  Lim,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,Sarwat  Naz; PhD (Radiation Biology Branch)|Weiye  Wang (Laboratory of Cellular and Molecular Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103784
695,BC010903-11,"October 01, 2017 -  September 30, 2018",Transgenic Core Facility,Deborah A Swing,Lino  Tessarollo,"Mouse Cancer Genetics Program, NCI",Robert H Koogle|Holly Marie Morris,NULL,NULL,NULL,"1. Xiong Y, Neifert S, Karuppagounder SS, Liu Q, Stankowski JN, Lee BD, Ko HS, Lee Y, Grima JC, Mao X, Jiang H, Kang SU, Swing DA, Iacovitti L, Tessarollo L, Dawson TM, Dawson VL (2018). Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proc Natl Acad Sci U S A  115, 1635-1640.   https://doi.org/10.1073/pnas.1712648115|2. Xiong Y, Neifert S, Karuppagounder SS, Stankowski JN, Lee BD, Grima JC, Chen G, Ko HS, Lee Y, Swing D, Tessarollo L, Dawson TM, Dawson VL (2017). Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology. eNeuro  4.   https://doi.org/10.1523/ENEURO.0004-17.2017",https://intramural.nih.gov/search/searchview.taf?ipid=103852
696,BC010905-11,"October 01, 2017 -  September 30, 2018",Surgery Branch Cell Prep Core,John R Wunderlich,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",NULL,NULL,"Nicholas Phillip Restifo; MD (Surgery Branch)|Paul  Robbins (Surgery Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Richard  Sherry; MD (Surgery Branch)|Donald E White (Surgery Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103865
697,BC010915-11,"October 01, 2017 -  September 30, 2018",EIB Microscopy Core Facility,Michael John Kruhlak; PhD,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Paul A Roche; PhD|Dinah  Singer; PhD|Vanja  Lazarevic|Jung-Hyun  Park|Richard J Hodes; MD,NULL,"Zhi Ming  Zheng; MD, PhD (Rna Biology Laboratory)|Louis  Staudt; MD (Lymphoid Malignancies Branch)|Martin W Brechbiel; PhD (Radiation Oncology Branch)|Philip Jeffrey Tofilon (Radiation Oncology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Ronald E Gress; MD (Experimental Transplantation and Immunology Branch)","Elissa P Lei; BS, PhD (NIDDK) |Richard D Leapman; PhD (NIBIB) |Rafael Cristian Casellas; PhD (NIAMS) |Myung Hee  Park; PhD (NIDCR) |David Barry Sacks (CC) |Keisuke  Nagao (NIAMS)","1. Klebanoff CA, Crompton JG, Leonardi AJ, Yamamoto TN, Chandran SS, Eil RL, Sukumar M, Vodnala SK, Hu J, Ji Y, Clever D, Black MA, Gurusamy D, Kruhlak MJ, Jin P, Stroncek DF, Gattinoni L, Feldman SA, Restifo NP (2017). Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight  2.   https://doi.org/10.1172/jci.insight.95103|2. Kwong B, Rua R, Gao Y, Flickinger J, Wang Y, Kruhlak MJ, Zhu J, Vivier E, McGavern DB, Lazarevic V (2017). T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation. Nat Immunol  18, 1117-1127.   https://doi.org/10.1038/ni.3816|3. Sharma NR, Majerciak V, Kruhlak MJ, Zheng ZM (2017). KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation. PLoS Pathog  13, e1006677.   https://doi.org/10.1371/journal.ppat.1006677|4. Vizcardo R, Klemen ND, Islam SMR, Gurusamy D, Tamaoki N, Yamada D, Koseki H, Kidder BL, Yu Z, Jia L, Henning AN, Good ML, Bosch-Marce M, Maeda T, Liu C, Abdullaev Z, Pack S, Palmer DC, Stroncek DF, Ito F, Flomerfelt FA, Kruhlak MJ, Restifo NP (2018). Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System. Cell Rep  22, 3175-3190.   https://doi.org/10.1016/j.celrep.2018.02.087",https://intramural.nih.gov/search/searchview.taf?ipid=103877
698,BC010934-11,"October 01, 2017 -  September 30, 2018",Immune reconstitution following autologous and allogeneic stem cell transplant,Jeremy J Rose,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,Libsework Muluneh Belete (Experimental Transplantation and Immunology Branch)|Nicole A Crofton (Experimental Transplantation and Immunology Branch)|Divya Lakshmi Deverakonda (Experimental Transplantation and Immunology Branch)|Shayla M Duncan (Experimental Transplantation and Immunology Branch)|Jae Ho  Kim (Experimental Transplantation and Immunology Branch)|Adam  Tyrlik (Experimental Transplantation and Immunology Branch),"David F Stroncek; MD (CC) |Edward W Cowen (NIAMS) |Jacqueline W Mays; DDS, PhD (NIDCR) |John F Tisdale; MD (NHLBI) |Matthew M Hsieh (NHLBI) |Dominique C Pichard (NIAMS)","1. Poe JC, Jia W, Su H, Anand S, Rose JJ, Tata PV, Suthers AN, Jones CD, Kuan PF, Vincent BG, Serody JS, Horwitz ME, Ho VT, Pavletic SZ, Hakim FT, Owzar K, Zhang D, Blazar BR, Siebel CW, Chao NJ, Maillard I, Sarantopoulos S (2017). An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD. Blood  130, 2131-2145.   https://doi.org/10.1182/blood-2017-05-782466",https://intramural.nih.gov/search/searchview.taf?ipid=103819
699,BC010936-11,"October 01, 2017 -  September 30, 2018",CCR Vaccine Branch FACS Core,Katherine M McKinnon,"Jay Arthur Berzofsky; MD, PhD","Vaccine Branch, NCI",Sophia Nadine Brown|Marjorie  Robert-Guroff; PhD|Genoveffa  Franchini; MD|Masaki  Terabe|Monica  Vaccari|Yongjun  Sui|Show all 12,Kent  Weinhold (DUMC)|Cliburn  Chan (Duke University)|Marcin  Moniuszko|Jason  Warfal (FDA),Thomas A Misteli; PhD (Laboratory of Receptor Biology and Gene Expression)|Gordon Lee Hager; PhD (Laboratory of Receptor Biology and Gene Expression)|Lyuba  Varticovski (Laboratory of Receptor Biology and Gene Expression)|Charles  Vinson; PhD (Nucleic Acids Section)|Cynthia  Masison (Office of the Director)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics),Lois Jean Patterson (NIAID) |Myong-Hee  Sung (NIA),"1. Sui Y, Frey B, Wang Y, Billeskov R, Kulkarni S, McKinnon K, Rourke T, Fritts L, Miller CJ, Berzofsky JA (2017). Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques. PLoS Pathog  13, e1006395.   https://doi.org/10.1371/journal.ppat.1006395",https://intramural.nih.gov/search/searchview.taf?ipid=103890
700,BC010937-11,"October 01, 2017 -  September 30, 2018",Novel Targets for Vaccine Therapy,Claudia Mercedes Palena|IRP Faculty Profile,NULL,"Laboratory of Tumor Immunology and Biology, NCI",Heidi A Hempel|Lucas Alan Horn|Hanne Thor Lind|Jeffrey Charles Riskin|Kristen Koenig McCampbell|Jeffrey  Schlom; PhD|Show all 7,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)",NULL,"1. David JM, Dominguez C, McCampbell KK, Gulley JL, Schlom J, Palena C (2017). A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells. Oncoimmunology  6, e1349589.   https://doi.org/10.1080/2162402X.2017.1349589|2. David JM, Dominguez C, Palena C (2017). Pharmacological and immunological targeting of tumor mesenchymalization. Pharmacol Ther  170, 212-225.   https://doi.org/10.1016/j.pharmthera.2016.11.011|3. Dominguez C, David JM, Palena C (2017). Epithelial-mesenchymal transition and inflammation at the site of the primary tumor. Semin Cancer Biol  47, 177-184.   https://doi.org/10.1016/j.semcancer.2017.08.002|4. Dominguez C, McCampbell KK, David JM, Palena C (2017). Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer. JCI Insight  2.   https://doi.org/10.1172/jci.insight.94296|5. Hamilton DH, David JM, Dominguez C, Palena C (2017). Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition. Cells Tissues Organs  203, 128-138.   https://doi.org/10.1159/000446495|6. Heery CR, Palena C, McMahon S, Donahue RN, Lepone LM, Grenga I, Dirmeier U, Cordes L, Marté J, Dahut W, Singh H, Madan RA, Fernando RI, Hamilton DH, Schlom J, Gulley JL (2017). Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury. Clin Cancer Res  23, 6833-6845.   https://doi.org/10.1158/1078-0432.CCR-17-1087|7. Shah SR, David JM, Tippens ND, Mohyeldin A, Martinez-Gutierrez JC, Ganaha S, Schiapparelli P, Hamilton DH, Palena C, Levchenko A, Quiñones-Hinojosa A (2017). Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer. Cell Rep  21, 495-507.   https://doi.org/10.1016/j.celrep.2017.09.057|8. Tsang KY, Fantini M, Fernando RI, Palena C, David JM, Hodge JW, Gabitzsch ES, Jones FR, Schlom J (2017). Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7. Vaccine  35, 2605-2611.   https://doi.org/10.1016/j.vaccine.2017.03.025",https://intramural.nih.gov/search/searchview.taf?ipid=103901
701,BC010947-11,"October 01, 2017 -  September 30, 2018",Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility,Ross G Lake,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,Zhenggang  Liu; PhD (Laboratory of Immune Cell Biology)|Adam G Sowalsky (Laboratory Of Genitourinary Cancer Pathogenesis)|Kandice Danielle Tanner; PhD (Laboratory of Cell Biology)|Philip Jeffrey Tofilon (Radiation Oncology Branch)|David James Vanderweele (Laboratory Of Genitourinary Cancer Pathogenesis)|Smitha  Antony (Office of the Director),NULL,"1. Jansson K, Tucker J, Stahl L, Simmons J, Fuller C, Beshiri M, Agarwal S, Fang L, Hynes P, Alilin A, Lake R, Abbey Y, Cawley J, Tice C, McNight C, KlumpThomas C, Zhang X, Guha R, Hoover S, Simpson R, Nguyen H, Corey E, Thomas C, Proia D, Kelly K (2018) High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. Molecular Cancer Therapeutics, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103862
702,BC010948-11,"October 01, 2017 -  September 30, 2018",DNA Sequencing and FACS Core Facilities,Paul  Robbins,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Shahram S Farid|Jared Joseph Gartner|Victoria Kate Hill|Li  Jia|Almin Iqbalali Lalani|Yili  Li|Show all 9,Benoit  Van den Eynde (Ludwig Institute for Cancer Research)|Yardena  Samuel (Weizmann Institute of Science)|Cyrille  Cohen|David  Haussler (Howard Hughes Medical Institute),NULL,NULL,"1. Assadipour Y, Zacharakis N, Crystal JS, Prickett TD, Gartner JJ, Somerville RPT, Xu H, Black MA, Jia L, Chinnasamy H, Kriley I, Lu L, Wunderlich JR, Zheng Z, Lu YC, Robbins PF, Rosenberg SA, Goff SL, Feldman SA (2017). Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer. Clin Cancer Res  23, 4347-4353.   https://doi.org/10.1158/1078-0432.CCR-16-1423|2. Deniger DC, Pasetto A, Robbins PF, Gartner JJ, Prickett TD, Paria BC, Malekzadeh P, Jia L, Yossef R, Langhan MM, Wunderlich JR, Danforth DN, Somerville RPT, Rosenberg SA (2018). T-cell Responses to TP53 ""Hotspot"" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers. Clin Cancer Res  24, 5562-5573.   https://doi.org/10.1158/1078-0432.CCR-18-0573|3. Lu YC, Parker LL, Lu T, Zheng Z, Toomey MA, White DE, Yao X, Li YF, Robbins PF, Feldman SA, van der Bruggen P, Klebanoff CA, Goff SL, Sherry RM, Kammula US, Yang JC, Rosenberg SA (2017). Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3. J Clin Oncol  35, 3322-3329.   https://doi.org/10.1200/JCO.2017.74.5463|4. Lu YC, Zheng Z, Robbins PF, Tran E, Prickett TD, Gartner JJ, Li YF, Ray S, Franco Z, Bliskovsky V, Fitzgerald PC, Rosenberg SA (2018). An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors. Mol Ther  26, 379-389.   https://doi.org/10.1016/j.ymthe.2017.10.018|5. Parkhurst M, Gros A, Pasetto A, Prickett T, Crystal JS, Robbins P, Rosenberg SA (2017). Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression. Clin Cancer Res  23, 2491-2505.   https://doi.org/10.1158/1078-0432.CCR-16-2680|6. Robbins PF (2017). Tumor-Infiltrating Lymphocyte Therapy and Neoantigens. Cancer J  23, 138-143.   https://doi.org/10.1097/PPO.0000000000000267|7. Rosenberg SA, Tran E, Robbins PF (2017). T-Cell Transfer Therapy Targeting Mutant KRAS. N Engl J Med  376, e11.   https://doi.org/10.1056/NEJMc1616637|8. Stevanović S, Pasetto A, Helman SR, Gartner JJ, Prickett TD, Howie B, Robins HS, Robbins PF, Klebanoff CA, Rosenberg SA, Hinrichs CS (2017). Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science  356, 200-205.   https://doi.org/10.1126/science.aak9510|9. Tran E, Robbins PF, Rosenberg SA (2017). 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations. Nat Immunol  18, 255-262.   https://doi.org/10.1038/ni.3682|10. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu YC, Zheng Z, Pasetto A, Langhan M, Shelton T, Prickett T, Gartner J, Jia L, Trebska-McGowan K, Somerville RP, Robbins PF, Rosenberg SA, Goff SL, Feldman SA (2018). Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med  24, 724-730.   https://doi.org/10.1038/s41591-018-0040-8",https://intramural.nih.gov/search/searchview.taf?ipid=103823
703,BC010953-11,"October 01, 2017 -  September 30, 2018",Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Hibret Amare Adissu|Jennifer B Dwyer|Belen Guadalupa Hernandez|John  Hickerson|Shelley B Hoover|Jing  Huang|Show all 11,brandon  gallas (Food and Drug Administration)|Charles Harrison Castle Halsey (LABORATORY CANCER BIOLOGY & GENETICS)|Kevin D Woolard,"Bih-Rong  Wei (Office Of The Director)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Natasha  Caplen (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103836
704,BC010965-11,"October 01, 2017 -  September 30, 2018",CCR Biophysics Resource Core,Sergey G Tarasov,Kylie Janice Walters,"Structural Biophysics Laboratory, NCI",Robert Andrew Byrd,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Stuart F J Le Grice; PhD (Basic Research Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section)|Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling),NULL,"1. Stagno JR, Liu Y, Bhandari YR, Conrad CE, Panja S, Swain M, Fan L, Nelson G, Li C, Wendel DR, White TA, Coe JD, Wiedorn MO, Knoska J, Oberthuer D, Tuckey RA, Yu P, Dyba M, Tarasov SG, Weierstall U, Grant TD, Schwieters CD, Zhang J, Ferré-D'Amaré AR, Fromme P, et al. [13 more authors] (2017). Structures of riboswitch RNA reaction states by mix-and-inject XFEL serial crystallography. Nature  541, 242-246.   https://doi.org/10.1038/nature20599|2. Tripathi BK, Grant T, Qian X, Zhou M, Mertins P, Wang D, Papageorge AG, Tarasov SG, Hunter KW, Carr SA, Lowy DR (2017). Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1. J Cell Biol  216, 4255-4270.   https://doi.org/10.1083/jcb.201703105",https://intramural.nih.gov/search/searchview.taf?ipid=103853
705,BC010978-11,"October 01, 2017 -  September 30, 2018",Confocal Core for the Laboratory of Cellular and Molecular Biology,Valarie  Barr; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI","Itoro O Akpan|Paul A Randazzo; MD, PhD|Ying  Zhang|Ramiro  Iglesias-Bartolome; PhD",Wolfgang  Losert (University of Maryland)|Stephen  Bunnell (Tufts University School of Medicine)|Eilon  Sherman|Robert  Rottapel (University of Toronto),"Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Stanley  Lipkowitz; MD, PhD (Womens Malignancies Branch)|Prabhakar R Gudla; PhD (Laboratory of Receptor Biology and Gene Expression)","Paul E Love; MD, PhD (NICHD) |Keir Cajal Neuman; BA, PhD (NHLBI)","1. Barr VA, Yi J, Samelson LE (2017). Super-resolution Analysis of TCR-Dependent Signaling: Single-Molecule Localization Microscopy. Methods Mol Biol  1584, 183-206.   https://doi.org/10.1007/978-1-4939-6881-7_13|2. Dutta D, Barr VA, Akpan I, Mittelstadt PR, Singha LI, Samelson LE, Ashwell JD (2017). Recruitment of calcineurin to the TCR positively regulates T cell activation. Nat Immunol  18, 196-204.   https://doi.org/10.1038/ni.3640|3. Yi J, Manna A, Barr VA, Hong J, Neuman KC, Samelson LE (2017). Highly Multiplexed, Super-resolution Imaging of T Cells Using madSTORM. J Vis Exp  .  https://doi.org/10.3791/55997",https://intramural.nih.gov/search/searchview.taf?ipid=103796
706,BC010981-11,"October 01, 2017 -  September 30, 2018",Biomarker Investigations for Clinical Trials,Liang  Cao,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",Zhigang  Kang|Yunkai  Yu|Javed  Khan; MD,NULL,"James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Tim Friedrich Greten (Thoracic & Oncologic Surgery Branch)|Jung-Min  Lee (Womens Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)",NULL,"1. Lee JM, Cimino-Mathews A, Peer CJ, Zimmer A, Lipkowitz S, Annunziata CM, Cao L, Harrell MI, Swisher EM, Houston N, Botesteanu DA, Taube JM, Thompson E, Ogurtsova A, Xu H, Nguyen J, Ho TW, Figg WD, Kohn EC (2017). Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study. J Clin Oncol  35, 2193-2202.   https://doi.org/10.1200/JCO.2016.72.1340|2. Meaney CL, Zingone A, Brown D, Yu Y, Cao L, Ryan BM (2017). Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma. Oncotarget  8, 40946-40957.   https://doi.org/10.18632/oncotarget.16784",https://intramural.nih.gov/search/searchview.taf?ipid=103804
707,BC010989-11,"October 01, 2017 -  September 30, 2018",Clinical production of viral vectors for cancer gene therapy,Rachel  Beyer,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI","Mary Alexandra Black|Harshini  Chinnasamy|Hui  Xu|John Russell Fisher|James Chung-Yin Yang; MD, PhD|Nicholas Phillip Restifo; MD",Dirk  Jager (University Medical Center Heidelberg)|Gary T Lee|Marc  Better (KITE Pharma),Ira H Pastan; MD (Molecular Biology Section)|James N Kochenderfer (Experimental Transplantation and Immunology Branch),Joseph  Shiloach; PhD (NIDDK) |Harry Lewis Malech; MD (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103812
708,BC010991-11,"October 01, 2017 -  September 30, 2018",Radiation Oncology Branch - Microarray Facility,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",Shaoli  Das; PhD|Xiang  Deng|Uma  Shankavaram; PhD,NULL,NULL,NULL,"1. Celiku O, Tandle A, Chung JY, Hewitt SM, Camphausen K, Shankavaram U (2017). Computational analysis of the mesenchymal signature landscape in gliomas. BMC Med Genomics  10, 13.   https://doi.org/10.1186/s12920-017-0252-7|2. Sproull M, Kramp T, Tandle A, Shankavaram U, Camphausen K (2017). Multivariate Analysis of Radiation Responsive Proteins to Predict Radiation Exposure in Total-Body Irradiation and Partial-Body Irradiation Models. Radiat Res  187, 251-258.   https://doi.org/10.1667/RR14558.1|3. Wahba A, Ryan MC, Shankavaram UT, Camphausen K, Tofilon PJ (2018). Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA. Oncotarget  9, 691-705.   https://doi.org/10.18632/oncotarget.21672",https://intramural.nih.gov/search/searchview.taf?ipid=103802
709,BC011016-11,"October 01, 2017 -  September 30, 2018",Protein Production,Joseph Edward Tropea,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",NULL,"Jozsef  Tozser|Robert  Ulrich (Molecular Immunology, USAMRIID)|Vaclav  Veverka (Institute of Organic Chemistry and Biochemistry of the ASCR, v.v.i.)",Xinhua  Ji; PhD (Biomolecular Structure Section)|David S Waugh; PhD (Protein Engineering Section)|Donald L Court; PhD (Rna Biology Laboratory)|Zbigniew  Dauter (Synchrotron Radiation Research Section)|John Stephen Schneekloth (Chemical Biology Laboratory)|Ding Jun Jin (Rna Biology Laboratory),NULL,"1. Zlotkowski K, Hewitt WM, Sinniah RS, Tropea JE, Needle D, Lountos GT, Barchi JJ, Waugh DS, Schneekloth JS (2017). A Small-Molecule Microarray Approach for the Identification of E2 Enzyme Inhibitors in Ubiquitin-Like Conjugation Pathways. SLAS Discov  22, 760-766.   https://doi.org/10.1177/2472555216683937",https://intramural.nih.gov/search/searchview.taf?ipid=103854
710,BC011021-10,"October 01, 2017 -  September 30, 2018",Basic Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103574
711,BC011029-11,"October 01, 2017 -  September 30, 2018",Preclinical development and clinical monitoring of adoptive immune therapy,Jeremy J Rose,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",Libsework Muluneh Belete|Nicole A Crofton|Divya Lakshmi Deverakonda|Shayla M Duncan|Vicki  Fellowes|Jae Ho  Kim|Show all 13,NULL,Mark Jason Roschewski (Lymphoid Malignancies Branch),David F Stroncek; MD (CC),"1. Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, Kochenderfer JN (2018). T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma. J Clin Oncol  36, 2267-2280.   https://doi.org/10.1200/JCO.2018.77.8084",https://intramural.nih.gov/search/searchview.taf?ipid=103820
712,BC011030-11,"October 01, 2017 -  September 30, 2018",The Antigen Targeting Core,Maria  Parkhurst,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Nicholas Phillip Restifo; MD|Steven A Feldman|Paul  Robbins,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103902
713,BC011040-11,"October 01, 2017 -  September 30, 2018",Molecular Profiling of Clinical Specimens,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",NULL,NULL,David  Petersen (Cancer Genetics Branch)|Jennifer  Walling (Cancer Genetics Branch)|Yonghong  Wang (Cancer Genetics Branch)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103810
714,BC011041-11,"October 01, 2017 -  September 30, 2018",Technical Development of Molecular Profiling Technologies,Daniel C Edelman,"Paul S Meltzer; MD, PhD","Cancer Genetics Branch, NCI",NULL,NULL,David  Petersen (Cancer Genetics Branch)|Jennifer  Walling (Cancer Genetics Branch)|Yonghong  Wang (Cancer Genetics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103811
715,BC011044-11,"October 01, 2017 -  September 30, 2018",Tissue Processing-Sequencing Facility,Cathy  Vocke; PhD,William Marston Linehan; MD,"Urologic Oncology Branch, NCI",Julian  Custer|Robert A Worrell|Youfeng  Yang,William  Kaelin (Dana-Farber Cancer Institute)|Paul T Spellman|James  Brugarolas (University of Texas Southwestern Medical Center)|Maria  Czyzyk-Krzeska (University of Cincinnati)|Arul Moli Chinnaiyan|Teresa  Fan (University of Louisville)|Show all 8,"Catherine  Wells (Office Of The Director)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Maria  Merino; PhD (Laboratory of Pathology)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)","Karel  Pacak; MD, PhD (NICHD) |Richard  Childs; MD (NHLBI) |Joel  Moss; MD, PhD (NHLBI) |Jeffrey Burnett Kopp; MD (NIDDK) |Ann C.M. Smith; MA, DSc (hon) (NHGRI) |Leslie Glenn Biesecker; MD (NHGRI)","1. Hasumi H, Hasumi Y, Baba M, Nishi H, Furuya M, Vocke CD, Lang M, Irie N, Esumi C, Merino MJ, Kawahara T, Isono Y, Makiyama K, Warner AC, Haines DC, Wei MH, Zbar B, Hagenau H, Feigenbaum L, Kondo K, Nakaigawa N, Yao M, Metwalli AR, Marston Linehan W, Schmidt LS (2017). H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation. Hum Mol Genet  26, 354-366.   https://doi.org/10.1093/hmg/ddw392|2. Schmidt LS, Linehan WM (2018). FLCN: The causative gene for Birt-Hogg-Dubé syndrome. Gene  640, 28-42.   https://doi.org/10.1016/j.gene.2017.09.044",https://intramural.nih.gov/search/searchview.taf?ipid=103857
716,BC011047-11,"October 01, 2017 -  September 30, 2018",Animal Model and Genotyping Core Support Facility,Wendy Dianne Du Bois De Vroylande,Glenn  Merlino; PhD,"Laboratory of Cancer Biology and Genetics, NCI",NULL,NULL,Marta  Custer (Office Of The Director)|Maudeline  Etienne (Office Of The Director)|Anthony W Vieira (Laboratory of Cancer Biology and Genetics)|Tina M Wellington (Laboratory of Cancer Biology and Genetics)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|James B Mitchell; PhD (Radiation Biology Branch),"Susan  Walters (OD) |Pamela Lee Schwartzberg; MD, PhD (NHGRI) |Rafael Cristian Casellas; PhD (NIAMS) |Herbert Carpenter Morse; MD (NIAID) |Neal S Young; MD (NHLBI)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103807
717,BC011052-11,"October 01, 2017 -  September 30, 2018",Cytopathology Core,Armando  Filie|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Tangi Y Howard|Dana K Erickson|May Ester Owens|Mark J Roth|Mark  Raffeld; MD|Stephen M Hewitt; MD, PhD|Show all 7",NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Christina M Annunziata (Womens Malignancies Branch),Joanna  Klubo-Gwiezdzinska (NIDDK),"1. Kaler M, Barochia AV, Weir NA, Cuento RA, Stylianou M, Roth MJ, Filie AC, Vaughey EC, Nathan SD, Levine SJ (2017). A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma. J Allergy Clin Immunol  140, 1716-1718.   https://doi.org/10.1016/j.jaci.2017.05.033",https://intramural.nih.gov/search/searchview.taf?ipid=103813
718,BC011075-11,"October 01, 2017 -  September 30, 2018",Molecular Modeling of the Human P-glycoprotein Transporter Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir,NULL,Suresh V Ambudkar; PhD (Transport Biochemistry Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103808
719,BC011077-11,"October 01, 2017 -  September 30, 2018",Molecular Modeling of Interactions Regulating the Activity of the p53 Protein,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section)|Hanqiao  Feng (Laboratory Of Biochemistry & Molecular Biology)|Yawen  Bai; PhD (Laboratory Of Biochemistry & Molecular Biology),Daniel  Appella; PhD (NIDDK),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103809
720,BC011079-11,"October 01, 2017 -  September 30, 2018",Molecular Diagnostics Core Laboratory,Mark  Raffeld; MD,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Winnifred Theresa Navarro|Snehalkumar Bhikhubhai Patel|Thu A Pham|Trinh  Pham|Liqiang  Xi; MD|Elaine S Jaffe; MD|Show all 8,"Leticia  Quintanilla-Martinez (Pathology, Technical University of Munich)|Giuseppe  Giaccone; MD","Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Udo  Rudloff (Pediatric Oncology Branch)|Thomas Alexander Waldmann; MD, PhD (Lymphoid Malignancies Branch)","Steven M Holland; MD (NIAID) |Amy D Klion; MD (NIAID) |Adrian U Wiestner; MD, PhD (NHLBI) |Irina  Maric; MD (CC) |William A Gahl; MD, PhD (NHGRI)","1. Ahn IE, Underbayev C, Albitar A, Herman SE, Tian X, Maric I, Arthur DC, Wake L, Pittaluga S, Yuan CM, Stetler-Stevenson M, Soto S, Valdez J, Nierman P, Lotter J, Xi L, Raffeld M, Farooqui M, Albitar M, Wiestner A (2017). Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. Blood  129, 1469-1479.   https://doi.org/10.1182/blood-2016-06-719294|2. Chandran SS, Somerville RPT, Yang JC, Sherry RM, Klebanoff CA, Goff SL, Wunderlich JR, Danforth DN, Zlott D, Paria BC, Sabesan AC, Srivastava AK, Xi L, Pham TH, Raffeld M, White DE, Toomey MA, Rosenberg SA, Kammula US (2017). Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study. Lancet Oncol  18, 792-802.   https://doi.org/10.1016/S1470-2045(17)30251-6|3. Ma CA, Xi L, Cauff B, DeZure A, Freeman AF, Hambleton S, Kleiner G, Leahy TR, O'Sullivan M, Makiya M, O'Regan G, Pittaluga S, Niemela J, Stoddard J, Rosenzweig SD, Raffeld M, Klion AD, Milner JD (2017). Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea. Blood  129, 650-653.   https://doi.org/10.1182/blood-2016-09-737817|4. McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, et al. [31 more authors] (2017). The Genetic Basis of Hepatosplenic T-cell Lymphoma. Cancer Discov  7, 369-379.   https://doi.org/10.1158/2159-8290.CD-16-0330|5. Pratt D, Pittaluga S, Palisoc M, Fetsch P, Xi L, Raffeld M, Gilbert MR, Quezado M (2017). Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma. J Neuropathol Exp Neurol  76, 697-708.   https://doi.org/10.1093/jnen/nlx051|6. Wang H, Raffeld M (2018) Molecular assessment of clonality in lymphoid neoplasms. Seminars in Hematology, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103907
721,BC011093-11,"October 01, 2017 -  September 30, 2018",Flow Cytometric Detection of Malignant Cells in Body Fluids,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Bradley Austin Lezak|Catharine S Mccoy|Dalia Abdel-Raouf Salem|Linda Shonk Weaver,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Daniel H Fowler (Experimental Transplantation and Immunology Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch)|Ramya Meenakshi Ramaswami (HIV and AIDS Malignancy Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103851
722,BC011104-11,"October 01, 2017 -  September 30, 2018",Flow Cytometric Evaluation of Biomarkers,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Bradley Austin Lezak|Catharine S Mccoy|Dalia Abdel-Raouf Salem|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Cherian S, Stetler-Stevenson M (2018). Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies. Curr Protoc Cytom  86, e44.   https://doi.org/10.1002/cpcy.44",https://intramural.nih.gov/search/searchview.taf?ipid=103850
723,BC011138-11,"October 01, 2017 -  September 30, 2018",ETIB FACS Core Facility,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,NULL,"1. Buxbaum NP, Farthing DE, Maglakelidze N, Lizak M, Merkle H, Carpenter AC, Oliver BU, Kapoor V, Castro E, Swan GA, Dos Santos LM, Bouladoux NJ, Bare CV, Flomerfelt FA, Eckhaus MA, Telford WG, Belkaid Y, Bosselut RJ, Gress RE (2017). In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host disease. JCI Insight  2.   https://doi.org/10.1172/jci.insight.92851|2. Porter JR, Telford WG, Batchelor E (2017). Single-cell Gene Expression Profiling Using FACS and qPCR with Internal Standards. J Vis Exp  .  https://doi.org/10.3791/55219",https://intramural.nih.gov/search/searchview.taf?ipid=103905
724,BC011139-11,"October 01, 2017 -  September 30, 2018",Application of novel laser technology for flow cytometric analysis,William G Telford,Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Vladislav  Verkhusha; PhD (Albert Einstein College of Medicine, Jack and Pearl Resnick Campus)|Awtar  Krishan (University of Miami School of Medicine)|Fetah  Benabid (University of Limoges)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103906
725,BC011236-10,"October 01, 2017 -  September 30, 2018",CCR-Frederick Flow Cytometry Core,Kimberly D Klarmann,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",Jeffrey Alan Carrell|Roberta M Matthai,NULL,NULL,NULL,"1. Singh S, Singh S, Gadomski S, Sun L, Pfannenstein A, Magidson V, Chen X, Kozlov S, Tessarollo L, Klarmann K, Keller J (2018) Id1 Ablation Protects Hematopoietic Stem Cells from Stress-Induced Exhaustion and Aging. Cell Stem Cell, in press.",https://intramural.nih.gov/search/searchview.taf?ipid=103931
726,BC011237-10,"October 01, 2017 -  September 30, 2018",CIP Microbiome and Genetics Core,Colm  Ohuigin,Giorgio  Trinchieri,"Cancer Inflammation Program, NCI",NULL,Effie  Petersdorf (Fred Hutchinson)|Robert  Lanford (Texas Biomedical Research Institute),Sonia Vikas Ahluwalia (Cancer Inflammation Program)|Tatyana Y Fuksenko (Cancer Inflammation Program)|Ying  Qi (Cancer Inflammation Program)|Shurjo  Sen; PhD (Cancer Inflammation Program)|Vishal Vijayan Thovarai (Cancer Inflammation Program)|Wuxing  Yuan (Cancer Inflammation Program),NULL,"1. Ramsuran V, Hernández-Sanchez PG, O'hUigin C, Sharma G, Spence N, Augusto DG, Gao X, García-Sepúlveda CA, Kaur G, Mehra NK, Carrington M (2017). Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes. J Immunol  198, 2320-2329.   https://doi.org/10.4049/jimmunol.1601679",https://intramural.nih.gov/search/searchview.taf?ipid=103932
727,BC011265-09,"October 01, 2017 -  September 30, 2018",Gene Targeting Facility,Lino  Tessarollo|IRP Faculty Profile,NULL,"Mouse Cancer Genetics Program, NCI",Jodi L Becker|Susan W Reid|Bradley D St Croix,NULL,"Mary Ellen  Palko (Neural Development Section)|Francesco  Tomassoni Ardori; PhD (Neural Development Section)|Teizo  Yoshimura; PhD (Cancer Inflammation Program)|Jairaj K Acharya; MBBS, PhD (Cancer and Developmental Biology Laboratory)|David  Levens; PhD (Laboratory of Pathology)",NULL,"1. Casoni F, Croci L, Bosone C, D'Ambrosio R, Badaloni A, Gaudesi D, Barili V, Sarna JR, Tessarollo L, Cremona O, Hawkes R, Warming S, Consalez GG (2017). Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA-damage response in Purkinje neuron progenitors. Development  144, 3686-3697.   https://doi.org/10.1242/dev.155077|2. Kieffer-Kwon KR, Nimura K, Rao SSP, Xu J, Jung S, Pekowska A, Dose M, Stevens E, Mathe E, Dong P, Huang SC, Ricci MA, Baranello L, Zheng Y, Tomassoni Ardori F, Resch W, Stavreva D, Nelson S, McAndrew M, Casellas A, Finn E, Gregory C, St Hilaire BG, Johnson SM, Dubois W, et al. [13 more authors] (2017). Myc Regulates Chromatin Decompaction and Nuclear Architecture during B Cell Activation. Mol Cell  67, 566-578.e10.   https://doi.org/10.1016/j.molcel.2017.07.013|3. Seaman S, Zhu Z, Saha S, Zhang XM, Yang MY, Hilton MB, Morris K, Szot C, Morris H, Swing DA, Tessarollo L, Smith SW, Degrado S, Borkin D, Jain N, Scheiermann J, Feng Y, Wang Y, Li J, Welsch D, DeCrescenzo G, Chaudhary A, Zudaire E, Klarmann KD, Keller JR, et al. [2 more authors] (2017). Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature. Cancer Cell  31, 501-515.e8.   https://doi.org/10.1016/j.ccell.2017.03.005|4. Tsai YC, Kotiya A, Kiris E, Yang M, Bavari S, Tessarollo L, Oyler GA, Weissman AM (2017). Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication. Proc Natl Acad Sci U S A  114, E5158-E5166.   https://doi.org/10.1073/pnas.1621076114|5. Tu Z, Bayazit MB, Liu H, Zhang J, Busayavalasa K, Risal S, Shao J, Satyanarayana A, Coppola V, Tessarollo L, Singh M, Zheng C, Han C, Chen Z, Kaldis P, Gustafsson JÅ, Liu K (2017). Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation. Proc Natl Acad Sci U S A  114, 592-597.   https://doi.org/10.1073/pnas.1618465114|6. Windpassinger C, Piard J, Bonnard C, Alfadhel M, Lim S, Bisteau X, Blouin S, Ali NB, Ng AYJ, Lu H, Tohari S, Talib SZA, van Hul N, Caldez MJ, Van Maldergem L, Yigit G, Kayserili H, Youssef SA, Coppola V, de Bruin A, Tessarollo L, Choi H, Rupp V, Roetzer K, Roschger P, et al. [12 more authors] (2017). CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays. Am J Hum Genet  101, 391-403.   https://doi.org/10.1016/j.ajhg.2017.08.003",https://intramural.nih.gov/search/searchview.taf?ipid=103951
728,BC011309-09,"October 01, 2017 -  September 30, 2018",DNA Extraction Service,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Paul A Roche; PhD (Experimental Immunology Branch)|Richard J Hodes; MD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch)|Chuan  Wu (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103968
729,BC011310-09,"October 01, 2017 -  September 30, 2018",Hollow Fiber Production of Monoclonal Antibodies,Jeffrey A Hammer; MS,Alfred  Singer; MD,"Molecular Regulation Section, NCI",NULL,NULL,Dinah  Singer; PhD (Experimental Immunology Branch)|Jung-Hyun  Park (Experimental Immunology Branch)|Vanja  Lazarevic (Experimental Immunology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103969
730,BC011331-09,"October 01, 2017 -  September 30, 2018",CCR Sequencing Facility,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Bao D Quoe  Tran|Vicky  Chen; PhD|Xiongfong  Chen|Oksana  German|Sujatha B Gowda|Parimal  Kumar|Show all 15,NULL,NULL,NULL,"1. Reinhold WC, Varma S, Sunshine M, Rajapakse V, Luna A, Kohn KW, Stevenson H, Wang Y, Heyn H, Nogales V, Moran S, Goldstein DJ, Doroshow JH, Meltzer PS, Esteller M, Pommier Y (2017). The NCI-60 Methylome and Its Integration into CellMiner. Cancer Res  77, 601-612.   https://doi.org/10.1158/0008-5472.CAN-16-0655",https://intramural.nih.gov/search/searchview.taf?ipid=103980
731,BC011380-08,"October 01, 2017 -  September 30, 2018",HIV NCp7 inhibitors and Multivalent Inhibition of Membrane Receptors,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Ettore  Appella; MD (Chemical Immunology Section),Daniel  Appella; PhD (NIDDK),"1. Saha M, Scerba MT, Shank NI, Hartman TL, Buchholz CA, Buckheit RW, Durell SR, Appella DH (2017). Probing Mercaptobenzamides as HIV Inactivators via Nucleocapsid Protein 7. ChemMedChem  12, 714-721.   https://doi.org/10.1002/cmdc.201700141",https://intramural.nih.gov/search/searchview.taf?ipid=103997
732,BC011428-07,"October 01, 2017 -  September 30, 2018","CCR, LGI, Flow Cytometry Core",Ferenc  Livak,Andre A Nussenzweig; PhD,"Laboratory Of Genome Integrity, NCI",Subhadra  Banerjee|Caiyi  Li|Shafiuddin  Siddiqui|Karen Marie Wolcott,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104050
733,BC011430-07,"October 01, 2017 -  September 30, 2018",CPTR - Mass Spectrometry Unit,Lisa Marie Jenkins,Suresh V Ambudkar; PhD,"Pigment Cell Biology Section, NCI",NULL,NULL,"Paul A Randazzo; MD, PhD (Laboratory of Cellular and Molecular Biology)|Michael Marc Gottesman; MD (Laboratory of Cell Biology)|Ettore  Appella; MD (Chemical Immunology Section)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Jonathan D Ashwell; MD (Laboratory of Immune Cell Biology)|Jennifer Clare Jones; MD, PhD (Vaccine Branch)","Juan S Bonifacino; PhD (NICHD) |Lisa Lynn Cunningham (NIDCD) |Paul P. Liu; MD, PhD (NHGRI) |Maria Irene Morasso; PhD (NIAMS) |Peter Jonathan Walter; PhD (NIDDK)","1. Chaudhary R, Gryder B, Woods WS, Subramanian M, Jones MF, Li XL, Jenkins LM, Shabalina SA, Mo M, Dasso M, Yang Y, Wakefield LM, Zhu Y, Frier SM, Moriarity BS, Prasanth KV, Perez-Pinera P, Lal A (2017). Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3. Elife  6.   https://doi.org/10.7554/eLife.23244|2. Mazur SJ, Gallagher ES, Debnath S, Durell SR, Anderson KW, Miller Jenkins LM, Appella E, Hudgens JW (2017). Conformational Changes in Active and Inactive States of Human PP2Cα Characterized by Hydrogen/Deuterium Exchange-Mass Spectrometry. Biochemistry  56, 2676-2689.   https://doi.org/10.1021/acs.biochem.6b01220",https://intramural.nih.gov/search/searchview.taf?ipid=104034
734,BC011434-07,"October 01, 2017 -  September 30, 2018","Nano-scale proteomic analysis: development, implementation, and applications",Jinqiu  Chen,Thomas A Misteli; PhD,"Office of the Director, NCI",Noemi  Kedei|Xiaoling  Luo,NULL,"Lalage  Wakefield; PhD (Laboratory of Cancer Biology and Genetics)|Peter  Blumberg; PhD (Laboratory of Cancer Biology and Genetics)|Karlyne M Reilly; BS, PhD (Pediatric Oncology Branch)|Beverly  Mock; PhD (Laboratory of Cancer Biology and Genetics)|Javed  Khan; MD (Cancer Genetics Branch)|Stuart H Yuspa; MD (Laboratory of Cancer Biology and Genetics)","Robert Simon Adelstein; MD (NHLBI) |Perry Justin Blackshear; MD, DPhil (NIEHS) |Mark Robert Cookson; PhD (NIA)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104037
735,BC011475-06,"October 01, 2017 -  September 30, 2018",Genomics and Bioinformatics Group web site development and maintenance,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,Yanghsin  Wang (Developmental Therapeutics Branch)|Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104062
736,BC011497-06,"October 01, 2017 -  September 30, 2018",RNA sequencing (RNA-Seq) of the NCI-60,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,"Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|Yanghsin  Wang (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104060
737,BC011509-06,"October 01, 2017 -  September 30, 2018",Comparison of molecular factors to drug activities,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,"Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|David Jay Goldstein (Office of the Director)",NULL,"1. Jiang X, Hu C, Ferchen K, Nie J, Cui X, Chen CH, Cheng L, Zuo Z, Seibel W, He C, Tang Y, Skibbe JR, Wunderlich M, Reinhold WC, Dong L, Shen C, Arnovitz S, Ulrich B, Lu J, Weng H, Su R, Huang H, Wang Y, Li C, Qin X, et al. [9 more authors] (2018). Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia. Nat Commun  9, 670.   https://doi.org/10.1038/s41467-018-02947-0|2. Yan P, Ritt DA, Zlotkowski K, Bokesch HR, Reinhold WC, Schneekloth JS, Morrison DK, Gustafson KR (2018). Macrophilones from the Marine Hydroid Macrorhynchia philippina Can Inhibit ERK Cascade Signaling. J Nat Prod  81, 1666-1672.   https://doi.org/10.1021/acs.jnatprod.8b00343",https://intramural.nih.gov/search/searchview.taf?ipid=104061
738,BC011515-06,"October 01, 2017 -  September 30, 2018",Chemical Synthesis Core,Joel Patrick Schneider; PhD|IRP Faculty Profile,NULL,"Chemical Biology Laboratory, NCI",Gary T Pauly,NULL,Patricia  Steeg; PhD (Womens Malignancies Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104070
739,BC011531-06,"October 01, 2017 -  September 30, 2018",High Throughput Screening of Agents in Bladder Cancer Cell Lines,Piyush Kumar Agarwal; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Reema Sunil Railkar,NULL,Andrea Borghese Apolo (Genitourinary Malignancies Branch),Craig Joseph Thomas (NCATS) |Marc  Ferrer-Alegre (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104077
740,BC011532-06,"October 01, 2017 -  September 30, 2018",CCR Collaborative Bioinformatics Resource,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Margaret  Cam; PhD|Parthav A Jailwala|Alexei Viktorovich Lobanov|George  Nelson|Abdalla Amr Abdelmaksoud|Vishal Nitinchandra Koparde; PhD|Show all 12,NULL,"Justin Britt Lack (Office Of The Director)|Frank Jess Gonzalez; PhD (Laboratory of Metabolism)|Cheryl Ann Winkler (Basic Research Laboratory)|Remy J Bosselut; MD, PhD (Laboratory of Immune Cell Biology)|Dennis D Hickstein (Experimental Transplantation and Immunology Branch)|Carol J Thiele (Pediatric Oncology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104087
741,BC011535-05,"October 01, 2017 -  September 30, 2018",SAXS Core,Yun Xing M Wang|IRP Faculty Profile,NULL,"Structural Biophysics Laboratory, NCI",Lixin  Fan; PhD,NULL,Alan  Rein; PhD (Retroviral Replication Laboratory)|Xinhua  Ji; PhD (Biomolecular Structure Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104119
742,BC011567-05,"October 01, 2017 -  September 30, 2018",HiTIF Microscopy Core Facility,Gianluca  Pegoraro,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",Adrian Alejandro Carcamo|Prabhakar R Gudla; PhD|Thomas A Misteli; PhD|Daniel Robert Larson; PhD|Philipp  Oberdoerffer,NULL,"Laurent L Ozbun (Hormone Action and Oncogenesis Section)|Munira A Basrai; PhD (Cancer Genetics Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)","Mary C Dasso; BA, PhD (NICHD) |Madhu A Lal (NCATS) |Iain  Fraser (NIAID) |Kapil  Bharti; PhD (NEI) |Luis Miguel Franco (NIAID) |Elissa P Lei; BS, PhD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104101
743,BC011569-05,"October 01, 2017 -  September 30, 2018",Cell Production Core Facility,Robert P Somerville,"Steven Aaron Rosenberg; MD, PhD","Surgery Branch, NCI",Carol Marie Bryant|John Russell Fisher|Zulmarie  Franco; MSc|Mary B Ganges|Michelle  Pelletier|Tangying  Lu|Show all 10,NULL,James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Christian S Hinrichs (Experimental Transplantation and Immunology Branch),NULL,"1. Kochenderfer JN, Somerville RPT, Lu T, Shi V, Bot A, Rossi J, Xue A, Goff SL, Yang JC, Sherry RM, Klebanoff CA, Kammula US, Sherman M, Perez A, Yuan CM, Feldman T, Friedberg JW, Roschewski MJ, Feldman SA, McIntyre L, Toomey MA, Rosenberg SA (2017). Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. J Clin Oncol  35, 1803-1813.   https://doi.org/10.1200/JCO.2016.71.3024",https://intramural.nih.gov/search/searchview.taf?ipid=104099
744,BC011571-05,"October 01, 2017 -  September 30, 2018",Transcription factor mobility,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,Gunjan Deepakkumar Mehta; PhD (Laboratory of Receptor Biology and Gene Expression),NULL,"1. Kannan R, Song JK, Karpova T, Clarke A, Shivalkar M, Wang B, Kotlyanskaya L, Kuzina I, Gu Q, Giniger E (2017). The Abl pathway bifurcates to balance Enabled and Rac signaling in axon patterning in Drosophila. Development  144, 487-498.   https://doi.org/10.1242/dev.143776|2. Presman DM, Ball DA, Paakinaho V, Grimm JB, Lavis LD, Karpova TS, Hager GL (2017). Quantifying transcription factor binding dynamics at the single-molecule level in live cells. Methods  123, 76-88.   https://doi.org/10.1016/j.ymeth.2017.03.014",https://intramural.nih.gov/search/searchview.taf?ipid=104095
745,BC011574-05,"October 01, 2017 -  September 30, 2018",LRBGE Optical Microscopy Core,Tatiana  Karpova,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,John S Choy|Jeffrey  Rothstein (Johns Hopkins University School of Medicine),"David Allan Ball (Laboratory of Receptor Biology and Gene Expression)|Munira A Basrai; PhD (Cancer Genetics Branch)|Genoveffa  Franchini; MD (Vaccine Branch)|Vladimir L Larionov; PhD, DSc (Developmental Therapeutics Branch)|Kyung  Lee; PhD (Chemistry Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)","Marta Liliana Catalfamo; PhD (NIAID) |Edward  Giniger; BS, MS, PHD (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104098
746,BC011596-05,"October 01, 2017 -  September 30, 2018",CCR Dedicated Cores at the ATRF,Janelle  Cortner,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104089
747,BC011622-04,"October 01, 2017 -  September 30, 2018",Development of novel molecular or phenotypic databases,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,"Manel  Esteller (Cancer Epigenetics Laboratory, Spanish National Cancer Center)|Mathew  Garnett (Wellcome Trust Sanger Institute)|Ruedi  Aebersold (Institute for Systems Biology)","Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|Yanghsin  Wang (Developmental Therapeutics Branch)|James Halpern Doroshow (Developmental Therapeutics Branch)|Paul S Meltzer; MD, PhD (Cancer Genetics Branch)|Kirk R Gustafson; PhD (Molecular Targets Laboratory)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104137
748,BC011623-04,"October 01, 2017 -  September 30, 2018",CCR Genomics Core,Elizabeth A Conner,Javed  Khan; MD,"Cancer Genetics Branch, NCI",NULL,NULL,Valery  Bliskovsky; PhD (Cancer Genetics Branch)|Steven W Shema (Cancer Genetics Branch)|Qin  Wei (Cancer Genetics Branch)|Sankar  Adhya; PhD (Developmental Genetics Section)|Christopher  Buck (Laboratory of Cellular Oncology)|Yong-Chen  Lu; PhD (Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104136
749,BC011638-04,"October 01, 2017 -  September 30, 2018",Experimental Pathology Laboratory (EPL),"Stephen M Hewitt; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI","Jeffrey C Hanson|Kristofferson R Ylaya|Elaine S Jaffe; MD|David  Levens; PhD|David Erwin Kleiner; MD, PhD|Armando  Filie",NULL,NULL,NULL,"1. Hewitt SM (2017). Formulation and pH of the Buffered Ethanol Fixative BE70. J Histochem Cytochem  65, 251-252.   https://doi.org/10.1369/0022155416687279",https://intramural.nih.gov/search/searchview.taf?ipid=104132
750,BC011641-04,"October 01, 2017 -  September 30, 2018",Pre-clinical Translational Research Facility,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI","Dionne  Davis|Jinkyu  Jung|Hua  Song|Yu-Ting  Su|Funita Pindria Phan; PhD|Jing  Wu; MD, PhD|Show all 11",NULL,James W Hodge; PhD (Laboratory of Tumor Immunology and Biology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104141
751,BC011724-03,"October 01, 2017 -  September 30, 2018",Effects of Cytosine Modifications on Transcription Factor Binding,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,Charles  Vinson; PhD (Nucleic Acids Section),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104188
752,BC011731-03,"October 01, 2017 -  September 30, 2018",Tissue Procurement  Processing Facility and Biorepository,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",NULL,NULL,Neil J Hardegen (Laboratory of Pathology)|Mohammad Javed Mahboob (Laboratory of Pathology)|Sarah Paige Young (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104195
753,BC011820-01,"October 01, 2017 -  September 30, 2018",DNA methylation data development and for small cell lung cancer,William Curtis Reinhold,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,Fathi  Elloumi (Developmental Therapeutics Branch)|Sudhir  Varma (Developmental Therapeutics Branch)|Yanghsin  Wang (Developmental Therapeutics Branch)|Beverly Ann Teicher (Molecular Pharmocology Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107355
754,BC011842-01,"October 01, 2017 -  September 30, 2018",Molecular Mechanisms of Cancer Development,Svetlana Dmitriyevna Pack; PhD,Frederic Glenn Barr,"Laboratory of Pathology, NCI","Ziedulla  Abdullaev|Shannon I Skarshaug|Valerie M Zgonc|Armando  Filie|Elaine S Jaffe; MD|David Erwin Kleiner; MD, PhD|Show all 10","Phyu Phyu Aung; MD, PhD|Klaus  Gerwert (Ruhr-Universität Bochum)",Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Susan  Mackem; MD (Cancer and Developmental Biology Laboratory)|Hoyoung  Maeng; MD (Vaccine Branch)|Christopher Joseph Melani (Lymphoid Malignancies Branch),"Isaac Franklin Brownell; MD, PhD (NIAMS) |Alexander M Gorbach; PhD (NIBIB)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107316
755,BC011849-01,"October 01, 2017 -  September 30, 2018",Structural studies of biomolecules related to cancer and HIV-AIDS,Hiroshi  Matsuo; PhD,Joel Patrick Schneider; PhD,"Basic Research Laboratory, NCI",Tapan  Kanai|Atanu  Maiti; PhD,NULL,Marzeena  Dyba (Structural Biophysics Laboratory)|Vinay K Pathak; PhD (Retroviral Replication Laboratory)|Sergey G Tarasov (Structural Biophysics Laboratory),NULL,"1. Kouno T, Silvas TV, Hilbert BJ, Shandilya SMD, Bohn MF, Kelch BA, Royer WE, Somasundaran M, Kurt Yilmaz N, Matsuo H, Schiffer CA (2017). Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity. Nat Commun  8, 15024.   https://doi.org/10.1038/ncomms15024|2. Pan Y, Sun Z, Maiti A, Kanai T, Matsuo H, Li M, Harris RS, Shlyakhtenko LS, Lyubchenko YL (2017). Nanoscale Characterization of Interaction of APOBEC3G with RNA. Biochemistry  56, 1473-1481.   https://doi.org/10.1021/acs.biochem.6b01189",https://intramural.nih.gov/search/searchview.taf?ipid=107336
756,CO020007-10,"October 01, 2017 -  September 30, 2018",NCI-Frederick Support and Technical Services,Norman Edward Sharpless; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",NULL,NULL,Kristin L Komschlies McConville; PhD  (NCI Frederick Office Scientific Operations),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104249
757,CP010178-17,"October 01, 2017 -  September 30, 2018",Cancer Genomics Research Laboratory,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Meredith  Yeager|Michael  Beerman|Laura Ann Burdett|Salma  Chowdhury; MS|Casey  Dagnall|Belynda D Hicks|Show all 11,NULL,Xiang  Deng (Radiation Oncology Branch)|Calvin  Ott (Office Of The Director)|Liqun  Qi (Biorepositories & Biospecimen Research Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104282
758,CP010192-11,"October 01, 2017 -  September 30, 2018","Biorepository Processing, Storage, and Research","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104301
759,CP010203-10,"October 01, 2017 -  September 30, 2018",Applied Molecular Pathology Laboratory,"Montserrat  Garcia-Closas; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Karen E Berliner,NULL,"Mark E Sherman; MD (Breast and Gynecologic Cancer Research Group)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104304
760,CP010223-07,"October 01, 2017 -  September 30, 2018",Endogenous Hormone Measurement Production Assay Infrastructure at the FNLCR,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI

Office of the Director, NCI","Regina Gale Ziegler; PhD, MPH",Timothy  Veenstra (SAIC)|Xia  Xu (SAIC frederick),NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104325
761,CP010226-05,"October 01, 2017 -  September 30, 2018",Cohort and Biobank Development,"Amy  de Gonzalez|IRP Faculty Profile  | |Nicolas Albert Hermann Wentzensen|IRP Faculty Profile  | |Robert  Hoover; MD, ScD|IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI

Radiation Epidemiology Branch, NCI

Hormonal and Reproductive Epidemiology Branch, NCI

Epidemiology and Biostatistics Program, NCI

Clinical Genetics Branch, NCI

Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104328
762,SC006536-25,"October 01, 2017 -  September 30, 2018",Biospecimen Processing  Biorepository,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Julie Katherine Barnes|Paula A Carter|Aaron David Frederick|Alesia J Holly|Veronica  Krevinko|Brenna Marie Noone|Show all 9,NULL,"Brigitte  Widemann; MD (Pediatric Oncology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|James L Gulley; MD, PhD (Genitourinary Malignancies Branch)|William Laurence Dahut; MD (Genitourinary Malignancies Branch)|Ismail Baris Turkbey (Molecular Imaging Program)",Heidi H Kong (NIAMS),"1. Jackson S, Weingart J, Nduom EK, Harfi TT, George RT, McAreavey D, Ye X, Anders NM, Peer C, Figg WD, Gilbert M, Rudek MA, Grossman SA (2018). The effect of an adenosine A2A agonist on intra-tumoral concentrations of temozolomide in patients with recurrent glioblastoma. Fluids Barriers CNS  15, 2.   https://doi.org/10.1186/s12987-017-0088-8|2. Lee JM, Hays JL, Chiou VL, Annunziata CM, Swisher EM, Harrell MI, Yu M, Gordon N, Sissung TM, Ji J, Figg WD, Minasian L, Lipkowitz S, Wood BJ, Doroshow J, Kohn EC (2017). Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer. Oncotarget  8, 79175-79187.   https://doi.org/10.18632/oncotarget.16577|3. Lee JM, Peer CJ, Yu M, Amable L, Gordon N, Annunziata CM, Houston N, Goey AK, Sissung TM, Parker B, Minasian L, Chiou VL, Murphy RF, Widemann BC, Figg WD, Kohn EC (2017). Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer. Clin Cancer Res  23, 1397-1406.   https://doi.org/10.1158/1078-0432.CCR-16-1546",https://intramural.nih.gov/search/searchview.taf?ipid=104376
763,SC006537-25,"October 01, 2017 -  September 30, 2018",Using Clinical Pharmacology Principles to Develop New Anticancer Therapies,William D Figg; PharmD|IRP Faculty Profile,NULL,"Office Of The Clinical Director, NCI",Julie Katherine Barnes|Oliver Morgan Hall|Cody John Peer|Keith Thomas Schmidt|Tristan  Sissung|Jonathan Dale Strope|Show all 7,C  Landgren (Memorial Sloan Kettering Cancer Center)|Richard  Horenstein (University of Maryland),Seth M Steinberg; PhD (Biostatistics and Data Management Section)|Peter L Choyke; MD (Molecular Imaging Program)|Howard  Parnes (Prostate and Urologic Cancer Research Group)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Richard Lawrence Piekarz (Investigational Drug Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),Heidi H Kong (NIAMS),"1. Chau C, Figg W (2018) Antimitotic Drugs, in Cancer Chemotherapy, Immunotherapy and Biotherapy; Principles and Practices 6th Edition, in press.|2. Dao K, Chtioui H, Lu Y, Peer CJ, Figg WD, Pruijm M, Buclin T, Kissling S (2017). Pharmacokinetics of Pomalidomide in a Patient Receiving Hemodialysis Using a High-Cutoff Filter. Am J Kidney Dis  69, 553-554.   https://doi.org/10.1053/j.ajkd.2016.10.026|3. Dao K, Lu Y, Peer CJ, Figg WD, Stadelmann R, Burnier M, Buclin T, Kissling S (2017). Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure. Cancer Chemother Pharmacol  79, 215-218.   https://doi.org/10.1007/s00280-016-3219-z|4. Ferraz Nogueira Filho MA, Peer CJ, Nguyen J, McCalla A, Helman L, Figg WD (2017). A simple and rapid UHPLC-MS/MS method for the quantitation of the dual aurora kinase A/B inhibitor SCH-1473759 in murine plasma. J Pharm Biomed Anal  132, 223-226.   https://doi.org/10.1016/j.jpba.2016.10.003|5. Gril B, Paranjape AN, Woditschka S, Hua E, Dolan EL, Hanson J, Wu X, Kloc W, Izycka-Swieszewska E, Duchnowska R, Pęksa R, Biernat W, Jassem J, Nayyar N, Brastianos PK, Hall OM, Peer CJ, Figg WD, Pauly GT, Robinson C, Difilippantonio S, Bialecki E, Metellus P, Schneider JP, Steeg PS (2018). Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases. Nat Commun  9, 2705.   https://doi.org/10.1038/s41467-018-05030-w|6. Grohar PJ, Glod J, Peer CJ, Sissung TM, Arnaldez FI, Long L, Figg WD, Whitcomb P, Helman LJ, Widemann BC (2017). A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript. Cancer Chemother Pharmacol  80, 645-652.   https://doi.org/10.1007/s00280-017-3382-x|7. Li M, Thapa P, Rajaputra P, Bio M, Peer CJ, Figg WD, You Y, Woo S (2017). Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system. J Pharmacokinet Pharmacodyn  44, 521-536.   https://doi.org/10.1007/s10928-017-9543-z|8. Manasanch EE, de Larrea CF, Zingone A, Steinberg SM, Kwok M, Tageja N, Bhutani M, Kazandjian D, Roschewski M, Wu P, Carter G, Zuchlinski D, Mulquin M, Lamping L, Costello R, Burton D, Gil LA, Figg WD, Maric I, Calvo KR, Yuan C, Stetler-Stevenson M, Korde N, Landgren O (2017). Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone. Leuk Lymphoma  58, 639-645.   https://doi.org/10.1080/10428194.2016.1214953|9. Marzi L, Agama K, Murai J, Difilippantonio S, James A, Peer CJ, Figg WD, Beck D, Elsayed MSA, Cushman M, Pommier Y (2018). Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors. Mol Cancer Ther  17, 1694-1704.   https://doi.org/10.1158/1535-7163.MCT-18-0028|10. Peer CJ, Chau CH, Figg WD (2017). Jumping the Barrier: Modeling Drug Penetration across the Blood-Brain Barrier. Clin Cancer Res  23, 7437-7439.   https://doi.org/10.1158/1078-0432.CCR-17-2741|11. Peer CJ, Lee JM, Roth J, Rodgers L, Nguyen J, Annunziata CM, Minasian L, Kohn EC, Figg WD (2017). Population pharmacokinetic analyses of the effect of carboplatin pretreatment on olaparib in recurrent or refractory women's cancers. Cancer Chemother Pharmacol  80, 165-175.   https://doi.org/10.1007/s00280-017-3346-1|12. Rodgers L, Peer CJ, Figg WD (2017). Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects. Cancer Biol Ther  18, 470-472.   https://doi.org/10.1080/15384047.2017.1323600|13. Szmulewitz RZ, Peer CJ, Ibraheem A, Martinez E, Kozloff MF, Carthon B, Harvey RD, Fishkin P, Yong WP, Chiong E, Nabhan C, Karrison T, Figg WD, Stadler WM, Ratain MJ (2018). Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol  36, 1389-1395.   https://doi.org/10.1200/JCO.2017.76.4381|14. Wang J, Yeung BZ, Cui M, Peer CJ, Lu Z, Figg WD, Guillaume Wientjes M, Woo S, Au JL (2017). Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology. J Control Release  268, 147-158.   https://doi.org/10.1016/j.jconrel.2017.10.020",https://intramural.nih.gov/search/searchview.taf?ipid=104377
764,SC006743-25,"October 01, 2017 -  September 30, 2018",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Min Jung Lee|Sunmin T Lee|Ayzhan J Murphy|Akira  Yuno|Jonathan Michael Baker|Anish  Thomas; MD,NULL,"Leonard  Neckers; PhD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Peter A Pinto; MD (Urologic Oncology Branch)|Jay Arthur Berzofsky; MD, PhD (Vaccine Branch)|Lauren V Wood; MD (Vaccine Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)",NULL,"1. Balasubramaniam S, Redon CE, Peer CJ, Bryla C, Lee MJ, Trepel JB, Tomita Y, Rajan A, Giaccone G, Bonner WM, Figg WD, Fojo T, Piekarz RL, Bates SE (2018). Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung. Anticancer Drugs  29, 457-465.   https://doi.org/10.1097/CAD.0000000000000596|2. Berzofsky JA, Terabe M, Trepel JB, Pastan I, Stroncek DF, Morris JC, Wood LV (2018). Cancer vaccine strategies: translation from mice to human clinical trials. Cancer Immunol Immunother  67, 1863-1869.   https://doi.org/10.1007/s00262-017-2084-x|3. Brzezniak C, Oronsky B, Trepel J, Summers TA, Cabrales P, Lee MJ, Day R, Jha S, Caroen S, Zeman K, Ferry L, Harmer C, Oronsky N, Lybeck M, Lybeck HE, Brown JF, Reid TR, Carter CA (2017). RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor. Case Rep Oncol  10, 276-280.   https://doi.org/10.1159/000464101|4. Davarpanah NN, Yuno A, Trepel JB, Apolo AB (2017) Immunotherapy: a new treatment paradigm in bladder cancer. Curr Opin Oncol, in press (e-pub ahead of print)  https://doi.org/10.1097/CCO.0000000000000366|5. Kijima T, Prince TL, Tigue ML, Yim KH, Schwartz H, Beebe K, Lee S, Budzynski MA, Williams H, Trepel JB, Sistonen L, Calderwood S, Neckers L (2018). HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation. Sci Rep  8, 6976.   https://doi.org/10.1038/s41598-018-25404-w|6. Moses MA, Kim YS, Rivera-Marquez GM, Oshima N, Watson MJ, Beebe KE, Wells C, Lee S, Zuehlke AD, Shao H, Bingman WE, Kumar V, Malhotra SV, Weigel NL, Gestwicki JE, Trepel JB, Neckers LM (2018). Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer. Cancer Res  78, 4022-4035.   https://doi.org/10.1158/0008-5472.CAN-17-3728|7. Neckers L, Blagg B, Haystead T, Trepel JB, Whitesell L, Picard D (2018). Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development. Cell Stress Chaperones  23, 467-482.   https://doi.org/10.1007/s12192-018-0877-2|8. Ogawa M, Tomita Y, Nakamura Y, Lee MJ, Lee S, Tomita S, Nagaya T, Sato K, Yamauchi T, Iwai H, Kumar A, Haystead T, Shroff H, Choyke PL, Trepel JB, Kobayashi H (2017). Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget  8, 10425-10436.   https://doi.org/10.18632/oncotarget.14425|9. Oronsky B, Paulmurugan R, Foygel K, Scicinski J, Knox SJ, Peehl D, Zhao H, Ning S, Cabrales P, Summers TA, Reid TR, Fitch WL, Kim MM, Trepel JB, Lee MJ, Kesari S, Abrouk ND, Day RM, Oronsky A, Ray CM, Carter CA (2017). RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials. Expert Opin Investig Drugs  26, 109-119.   https://doi.org/10.1080/13543784.2017.1268600|10. Oronsky B, Ray CM, Spira AI, Trepel JB, Carter CA, Cottrill HM (2017). A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer. Med Oncol  34, 103.   https://doi.org/10.1007/s12032-017-0960-z|11. Shatzer A, Ali MA, Chavez M, Dowdell K, Lee MJ, Tomita Y, El-Hariry I, Trepel JB, Proia DA, Cohen JI (2017). Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood. Leuk Lymphoma  58, 923-931.   https://doi.org/10.1080/10428194.2016.1213823|12. Thomas A, Redon CE, Sciuto L, Padiernos E, Ji J, Lee MJ, Yuno A, Lee S, Zhang Y, Tran L, Yutzy W, Rajan A, Guha U, Chen H, Hassan R, Alewine CC, Szabo E, Bates SE, Kinders RJ, Steinberg SM, Doroshow JH, Aladjem MI, Trepel JB, Pommier Y (2018). Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors. J Clin Oncol  36, 1594-1602.   https://doi.org/10.1200/JCO.2017.76.6915|13. Thomas A, Tanaka M, Trepel J, Reinhold WC, Rajapakse VN, Pommier Y (2017). Temozolomide in the Era of Precision Medicine. Cancer Res  77, 823-826.   https://doi.org/10.1158/0008-5472.CAN-16-2983",https://intramural.nih.gov/search/searchview.taf?ipid=104375
765,SC009372-27,"October 01, 2017 -  September 30, 2018",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD",Frederic Glenn Barr,"Laboratory of Pathology, NCI",Gregory A Jasper|Bradley Austin Lezak|Catharine S Mccoy|Dalia Abdel-Raouf Salem|Linda Shonk Weaver|Constance M Yuan,NULL,"Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)|Ira H Pastan; MD (Molecular Biology Section)|Thomas S Uldrick (HIV and AIDS Malignancy Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|James N Kochenderfer (Experimental Transplantation and Immunology Branch)|Nirali Niranjan Shah (Pediatric Oncology Branch)","Adrian U Wiestner; MD, PhD (NHLBI)","1. Herndon TM, Chen SS, Saba NS, Valdez J, Emson C, Gatmaitan M, Tian X, Hughes TE, Sun C, Arthur DC, Stetler-Stevenson M, Yuan CM, Niemann CU, Marti GE, Aue G, Soto S, Farooqui MZH, Herman SEM, Chiorazzi N, Wiestner A (2017). Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia  31, 1340-1347.   https://doi.org/10.1038/leu.2017.11|2. Salem DA, Korde N, Venzon DJ, Liewehr DJ, Maric I, Calvo KR, Braylan R, Tembhare PR, Yuan CM, Landgren CO, Stetler-Stevenson M (2018). Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma. Leuk Lymphoma  59, 178-186.   https://doi.org/10.1080/10428194.2017.1321746",https://intramural.nih.gov/search/searchview.taf?ipid=104339
766,BC010686-14,"October 01, 2017 -  September 30, 2018",Clinical Operations for Laboratory of Pathology,Joseph  Chinquee,Frederic Glenn Barr,"Laboratory of Pathology, NCI",NULL,NULL,Tashanda Renee Ashford (Laboratory of Pathology)|Neil J Hardegen (Laboratory of Pathology)|Terrica Shuntay Johnson (Laboratory of Pathology)|Mohammad Javed Mahboob (Laboratory of Pathology)|Michael Kanwolo Newford (Laboratory of Pathology)|Kayla A O'Donnell (Laboratory of Pathology),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103725
767,BC010882-11,"October 01, 2017 -  September 30, 2018",Center for Cancer Research Clinical Trials Support,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,Deborah Anne Grady (Office Of The Clinical Director)|Lisa R King (Office Of The Clinical Director)|Susan G Mcmullen (Office Of The Clinical Director)|Elizabeth A Ness (Office Of The Clinical Director)|Martha B Shaw (Office Of The Clinical Director)|Allison P Wise (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103848
768,BC010963-11,"October 01, 2017 -  September 30, 2018",ETIB Clinical Research Core,Ronald E Gress; MD|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI",Daniele N Avila|Judy Liliana Baruffaldi|Megan Irene Kenyon|Jennifer Amy Mann|Lauren R Skeffington|Jennifer Sproul Wilder|Show all 7,"Andrew  Pecora (Cancer Center, Hackensack University)|Robert  Korngold (Cancer Center, Hackensack University)|Scott  Rowley (Hackensack University)",NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103816
769,BC010987-11,"October 01, 2017 -  September 30, 2018",Center for Cancer Research Patient Travel,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103849
770,BC010990-11,"October 01, 2017 -  September 30, 2018",Radiation Oncology Branch - Radiation Clinic,Kevin A Camphausen; MD|IRP Faculty Profile,NULL,"Radiation Oncology Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103803
771,BC011022-10,"October 01, 2017 -  September 30, 2018",Clinical Research Support for the CCR,Thomas A Misteli; PhD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103575
772,BC011089-11,"October 01, 2017 -  September 30, 2018",Clinical Nursing and Data Management Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Jonathan Barrett Bloom|Sharon Denise Gibbons|Gustavo Emilio Pene La Grave; MD|Thomas  Sanford|Abhinav  Sidana|Siobhan Ivy Telfer|Show all 8,NULL,Kristin K Shouck (Office Of The Clinical Director)|Maria  Merino; PhD (Laboratory of Pathology)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director),"Emily Y Chew; MD (NEI) |Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103881
773,BC011092-11,"October 01, 2017 -  September 30, 2018",Urologic Oncology Branch Consult Core,William Marston Linehan; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",Mark Wayne Ball|Jonathan Barrett Bloom|Gustavo Emilio Pene La Grave; MD|Thomas  Sanford|Abhinav  Sidana|Siobhan Ivy Telfer|Show all 7,NULL,Maria  Merino; PhD (Laboratory of Pathology),"Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103882
774,BC011242-10,"October 01, 2017 -  September 30, 2018",Center for Interventional Oncology,Bradford J Wood; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,Mark  Dewhirst (Duke)|Russel  Taylor (Johns Hopkins University)|Emad  Boctor (Johns Hopkins University)|Umar  Mahmood (Harvard / Massachusetts General Hospital)|Luigi  Solbiati (Busto Arsizio)|Thierry  de Bare (Institut de Cancrologie Gustave Roussy)|Show all 21,"Peter A Pinto; MD (Urologic Oncology Branch)|William Marston Linehan; MD (Urologic Oncology Branch)|Deborah E Citrin (Radiation Oncology Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Peter L Choyke; MD (Molecular Imaging Program)|Steven Aaron Rosenberg; MD, PhD (Surgery Branch)","Elliot Brian Levy (CC) |Karel  Pacak; MD, PhD (NICHD) |Karun  Sharma (CC) |Andrew J Mannes; MD (CC) |Sheng  Xu (CC) |Theo  Heller; MD (NIDDK)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103948
775,BC011291-09,"October 01, 2017 -  September 30, 2018",General Surgical Pathology,Markku Martti Miettinen|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Anna  Felisiak-Golabek|Jerzy P Lasota,"John  Fetsch (Joint Pathology Center)|Shingo  Inaguma; MD, PhD (Laboratory Of Pathology)",Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Claudia Mercedes Palena (Laboratory of Tumor Immunology and Biology)|Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|David  Schrump; MD (Thoracic & Oncologic Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103959
776,BC011317-09,"October 01, 2017 -  September 30, 2018",Dermatology Consultation Service,Edward W Cowen|IRP Faculty Profile,NULL,"Dermatology Branch, NCI",NULL,NULL,NULL,"Olanda M Hathaway (NIAMS) |Dominique C Pichard (NIAMS) |Raphaela  Goldbach-Mansky; MD, MHS (NIAID)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103973
777,BC011517-06,"October 01, 2017 -  September 30, 2018",Pediatric Oncology Branch Behavioral Science Core,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI",Haven  Battles; PhD|Stacia Martin Peron; PhD|Marie Claire Roderick|Kanesha  Simmons|Kari Lyn Struemph|Julia Barbara Tager|Show all 13,NULL,"Marina  Noronha F Dearruda Colli (Laboratory Of Genetic Susceptibility)|Fernanda  Arnaldez (Developmental Therapeutics Branch)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)","Courtney Dayle Fitzhugh (NHLBI) |John F Tisdale; MD (NHLBI) |Margaret Frances Bevans; RN, PhD (OD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104068
778,BC011534-05,"October 01, 2017 -  September 30, 2018",EOB Clinical Core,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Mustapha Ahmed el Lakis|Douglas Shane Wiseman; MD|Patience Chantel Green,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104120
779,BC011540-05,"October 01, 2017 -  September 30, 2018",Thoracic and Gastrointestinal Malignancies Branch Clinical Core,Raffit  Hassan|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Gideon Michael Blumenthal|Emerson Baes Padiernos|Arun  Rajan|Susan C Sansone,NULL,Maria Gracia Lualhati Agra (Office Of The Clinical Director)|Ira H Pastan; MD (Molecular Biology Section)|Jeffrey  Schlom; PhD (Laboratory of Tumor Immunology and Biology)|Peter L Choyke; MD (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104118
780,BC011541-05,"October 01, 2017 -  September 30, 2018",Surgical Consultative Services in the Thoracic and Oncologic Surgery Branch,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Jeremy Lee Davis; MD|Claudia Lissette Espinoza|Paul J Nolen|Yvonne  Shutack|Robert Taylor Ripley; MD|Show all 8,NULL,Udo  Rudloff (Pediatric Oncology Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104117
781,BC011543-05,"October 01, 2017 -  September 30, 2018",Medical Oncology Service Clinical Core,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",George L Carter|Janet A Edds|Daniel Hicks Johnson|Atena Sadat Kamali; MD|Vikas  Kapoor; MD|Jeannette Christine Nashed|Show all 8,NULL,Heaven Damitrius Russell (Genitourinary Malignancies Branch)|Ravi  Madan (Genitourinary Malignancies Branch)|Christina M Annunziata (Womens Malignancies Branch)|Mark Jason Roschewski (Lymphoid Malignancies Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|Jennifer Ann Kanakry (Experimental Transplantation and Immunology Branch),Diane  Aker (CC) |Ekene  Monyei (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104115
782,BC011642-04,"October 01, 2017 -  September 30, 2018",Brain Tumor Clinical and Clinical Research Program,Mark Richard Gilbert; MD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Orwa  Aboud|Tracy D Ani|Ramya  Parthasarathy|Katherine Elizabeth Blackburn|Lisa Marie Boris|Kiera M Caffee|Show all 17,NULL,Ewa Maria Grajkowska (Office Of The Clinical Director)|Kevin A Camphausen; MD (Radiation Oncology Branch)|Kenneth Dean Aldape; MD (Laboratory of Pathology),"Kristen Elizabeth Lem (NICHD) |John Anthony Butman; MD, PhD (CC) |John D Heiss; MD (NINDS) |Kareem Amir Zaghloul; MD, PhD (NINDS) |Edjah K Nduom (NINDS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104138
783,BC011683-03,"October 01, 2017 -  September 30, 2018",Medical Oncology HIV-AIDS Clinical Research,"James L Gulley; MD, PhD|IRP Faculty Profile",NULL,"Office Of The Clinical Director, NCI",NULL,NULL,Mark Jason Roschewski (Lymphoid Malignancies Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch),Diane  Aker (CC) |Ekene  Monyei (CC) |Deborah A Kolakowski (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104156
784,BC011716-03,"October 01, 2017 -  September 30, 2018",CCR Research Nursing,"Caryn  Steakley; BA, BSN, MSW",William Laurence Dahut; MD,"Office Of The Clinical Director, NCI",NULL,NULL,Deborah E Allen (Office Of The Clinical Director)|Melissa Maria Amaya (Office Of The Clinical Director)|Sonia Elisa Bellfield (Office Of The Clinical Director)|Arlene Wendy Berman (Office Of The Clinical Director)|Donna B Bernstein (Office Of The Clinical Director)|Bazetta A Blacklock-Schuver (Office Of The Clinical Director),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104181
785,BC011729-03,"October 01, 2017 -  September 30, 2018",Chronic graft-versus-host disease in children and young adults,Nataliya Prokopenko Buxbaum|IRP Faculty Profile,NULL,"Experimental Transplantation and Immunology Branch, NCI","Steven  Pavletic; MD, MS",NULL,NULL,"Jacqueline W Mays; DDS, PhD (NIDCR) |Maya Beth Lodish (NICHD) |Ninet  Sinaii (CC)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104193
786,BC011792-02,"October 01, 2017 -  September 30, 2018",Development of FISH Molecular Diagnostics to support Clinical Trials at NCI,Svetlana Dmitriyevna Pack; PhD,Frederic Glenn Barr,"Laboratory of Pathology, NCI",Ziedulla  Abdullaev|Shannon I Skarshaug|Valerie M Zgonc|Elaine S Jaffe; MD|Stefania  Pittaluga|Markku Martti Miettinen|Show all 10,"Klaus  Gerwert (Ruhr-Universität Bochum)|Phyu Phyu Aung; MD, PhD","Lauren V Wood; MD (Vaccine Branch)|Udayan  Guha (Thoracic & Oncologic Surgery Branch)|Arun  Rajan (Thoracic & Oncologic Surgery Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch)|Nicholas Phillip Restifo; MD (Surgery Branch)|Wyndham H Wilson; MD, PhD (Lymphoid Malignancies Branch)","Alexander M Gorbach; PhD (NIBIB) |Constantine Argyrios Stratakis; MD, DSc (NICHD) |Isaac Franklin Brownell; MD, PhD (NIAMS)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104244
787,BC011856-01,"October 01, 2017 -  September 30, 2018",Rare Tumor Patient Engagement Network - Cures,William Laurence Dahut; MD|IRP Faculty Profile,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107800
788,SC006329-38,"October 01, 2017 -  September 30, 2018",Clinical Radiation Physics Service,Robert W Miller,Kevin A Camphausen; MD,"Radiation Oncology Branch, NCI",Barbara Chin Arora|Jason Yulin Cheng; PhD|Peter  Guion|Mary Kathleen Hawes|Holly  Ning|Ying  Zhuge|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104335
789,SC007202-35,"October 01, 2017 -  September 30, 2018",Biostatistics and Data Management Section,Seth M Steinberg; PhD|IRP Faculty Profile,NULL,"Biostatistics and Data Management Section, NCI",David J Liewehr|David J Venzon; PhD,NULL,"Steven Aaron Rosenberg; MD, PhD (Surgery Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Steven  Pavletic; MD, MS (Experimental Transplantation and Immunology Branch)|Robert  Yarchoan; MD (HIV and AIDS Malignancy Branch)|James Chung-Yin Yang; MD, PhD (Surgery Branch)|Marjorie  Robert-Guroff; PhD (Vaccine Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104331
790,BC010843-12,"October 01, 2017 -  September 30, 2018",Medical Oncology Fellowship Program,Marijo  Bilusic,"James L Gulley; MD, PhD","Genitourinary Malignancies Branch, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103754
791,BC011023-11,"October 01, 2017 -  September 30, 2018",Clinical Fellowship Training Program,Peter A Pinto; MD|IRP Faculty Profile,NULL,"Urologic Oncology Branch, NCI",NULL,NULL,Sherif  Mehralivand (Molecular Imaging Program)|Peter L Choyke; MD (Molecular Imaging Program)|Bradford J Wood; MD (Office of the Director)|Maria  Merino; PhD (Laboratory of Pathology)|Ismail Baris Turkbey (Molecular Imaging Program),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103903
792,BC011241-10,"October 01, 2017 -  September 30, 2018",Hematopathology Fellowship,Elaine S Jaffe; MD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Jayalakshmi Panicker Balakrishna|Theresa M Davies Hill|Nancy Ellen Diener|Princess Yah Dorley|Caoimhe Mary Egan; MD|Pallavi Kanwar  Galera|Show all 14,Donald  Karcher (George Washington University Medical Center)|Michael  Borowitz (Johns Hopkins Medical School),NULL,Irina  Maric; MD (CC) |Katherine Rainsford Calvo (CC) |Raul Cipriano Braylan; MD (CC),"1. Balakrishna JP, Jaffe ES (2017). Crystal-storing histiocytosis associated with thymic extranodal marginal zone lymphoma. Blood  130, 1683.   https://doi.org/10.1182/blood-2017-07-794230|2. Egan C, Jaffe ES (2018). Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes. Semin Diagn Pathol  35, 20-33.   https://doi.org/10.1053/j.semdp.2017.11.002|3. Li Y, Gupta G, Molofsky A, Xie Y, Shihabi N, McCormick J, Jaffe ES (2018). B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients. Am J Surg Pathol  42, 269-276.   https://doi.org/10.1097/PAS.0000000000000982|4. Nicolae A, Ganapathi KA, Pham TH, Xi L, Torres-Cabala CA, Nanaji NM, Zha HD, Fan Z, Irwin S, Pittaluga S, Raffeld M, Jaffe ES (2017). EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol  41, 67-74.   https://doi.org/10.1097/PAS.0000000000000735|5. Okonkwo L, Jaffe ES (2017). Intravascular large cell lymphoma of NK/T-cell type, EBV positive. Blood  130, 837.   https://doi.org/10.1182/blood-2017-05-785857|6. Pilichowska M, Pittaluga S, Ferry JA, Hemminger J, Chang H, Kanakry JA, Sehn LH, Feldman T, Abramson JS, Kritharis A, Hernandez-Ilizaliturri FJ, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA, Jagadeesh D, Woda B, Gupta GK, Gascoyne RD, Jaffe ES, Evens AM (2017). Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. Blood Adv  1, 2600-2609.   https://doi.org/10.1182/bloodadvances.2017009472",https://intramural.nih.gov/search/searchview.taf?ipid=103928
793,BC011384-08,"October 01, 2017 -  September 30, 2018",Anatomic Pathology Residency Program,Frederic Glenn Barr|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI","Tanupriya  Agrawal|Selena Tomeka Brantley|Kelly Maureen Brenan-Rothschild|Hong  Jiang|Sun A  Kim|Osorio  Lopes Abath Neto; MD, PhD|Show all 11",NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104001
794,BC011516-06,"October 01, 2017 -  September 30, 2018",Pediatric Oncology Branch Clinical Care and Education,John Walter Glod,Brigitte  Widemann; MD,"Pediatric Oncology Branch, NCI",Lingling  Chen|Andrea Joan Cuviello|Sherri L Depollar|Joanne A Derdak|Wei-Ming  Kao|Yiouli Panayiota Ktena; MD|Show all 22,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104067
795,BC011542-05,"October 01, 2017 -  September 30, 2018",TOSB Surgical Oncology Fellowship Program,David  Schrump; MD|IRP Faculty Profile,NULL,"Thoracic & Oncologic Surgery Branch, NCI",Colleen Donahue Bond|Jeremy Lee Davis; MD|Stacey Lynn Doran; MD|Justin Alan Drake|Claudia Lissette Espinoza|Mohammad Shamsuddin Jafferji; MD|Show all 10,NULL,Amy  Copeland (Surgery Branch)|Meghan Lyn Good; MD (Surgery Branch)|Gabriel David Ivey (Surgery Branch)|Christine Mari Kariya; MD (Surgery Branch)|Winifred Margaret Lo; MD (Surgery Branch)|Parisa None Malekzadeh; MD (Surgery Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104116
796,BC011653-04,"October 01, 2017 -  September 30, 2018",Clinical Support,Christine Campo Alewine|IRP Faculty Profile,NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,Raffit  Hassan (Thoracic & Oncologic Surgery Branch)|Anish  Thomas; MD (Developmental Therapeutics Branch),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104142
797,BC011656-04,"October 01, 2017 -  September 30, 2018",EOB Clinical and Research Fellowship Training Program,Electron  Kebebew; MD|IRP Faculty Profile,NULL,"Endocrine Oncology Branch, NCI",Mustapha Ahmed el Lakis|Patience Chantel Green|Amit  Tirosh|Douglas Shane Wiseman; MD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104127
798,SC000853-65,"October 01, 2017 -  September 30, 2018",Translational Surgical Pathology,Maria  Merino; PhD|IRP Faculty Profile,NULL,"Laboratory of Pathology, NCI",Mark  Raffeld; MD,NULL,"Peter L Choyke; MD (Molecular Imaging Program)|Peter A Pinto; MD (Urologic Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|Ramaprasad  Srinivasan; MD, PhD (Urologic Oncology Branch)|Piyush Kumar Agarwal; MD (Urologic Oncology Branch)|Andrea Borghese Apolo (Genitourinary Malignancies Branch)","Karel  Pacak; MD, PhD (NICHD)",NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104342
799,BC010856-12,"October 01, 2017 -  September 30, 2018",Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research,Mary C Custer,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103783
800,BC010931-11,"October 01, 2017 -  September 30, 2018",Comparative Biomedical Scientist Training Program,"Robert Mark Simpson; DVM, PhD|IRP Faculty Profile",NULL,"Laboratory of Cancer Biology and Genetics, NCI",Hibret Amare Adissu|Jennifer B Dwyer|Amy Lynn Flis|Raisa Allie Glabman|John  Hickerson|Shelley B Hoover|Show all 9,"Siba  Samal; PhD (Virginia-Maryland Regional College of Vet Med, University of Maryland)|Matti  Kiupel; PhD|Margaret  Miller (Purdue)|John M Cullen; VMD, PhD","Bih-Rong  Wei (Office Of The Director)|Jonathan S Wiest; PhD (Center For Cancer Training)|Natasha  Caplen (Cancer Genetics Branch)|Scott K Durum; PhD (Cancer Inflammation Program)|Curtis  Harris; MD (Laboratory of Human Carcinogenesis)|Stephen M Hewitt; MD, PhD (Laboratory of Pathology)",Amy Claire McCalla-Martin (NIEHS) |Michael Anthony Richardson; DVM (NIAID),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103835
801,BC011689-03,"October 01, 2017 -  September 30, 2018",Comparative Oncology Trials Consortium,Amy Kathleen Leblanc; DVM,Peter L Choyke; MD,"Pediatric Oncology Branch, NCI",NULL,"Lisa  Barber (Veterinary Medicine, Tufts University)|Antonella  Borgatti (University of Minnesota)|E  Ehrhart (Colorado State University)|Timothy  Fan (Veterinary Clinical Medicine, University of Illinois)|Carolyn  Henry (Veterinary Medicine, University of Missouri)|Michael  Kent (UC Davis)|Show all 32",James Halpern Doroshow (Developmental Therapeutics Branch),NULL,"1. Koehler JW, Miller AD, Miller CR, Porter B, Aldape K, Beck J, Brat D, Cornax I, Corps K, Frank C, Giannini C, Horbinski C, Huse JT, O'Sullivan MG, Rissi DR, Mark Simpson R, Woolard K, Shih JH, Mazcko C, Gilbert MR, LeBlanc AK (2018). A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma. J Neuropathol Exp Neurol  77, 1039-1054.   https://doi.org/10.1093/jnen/nly085|2. Nagaya T, Okuyama S, Ogata F, Maruoka Y, Knapp DW, Karagiannis SN, Fazekas-Singer J, Choyke PL, LeBlanc AK, Jensen-Jarolim E, Kobayashi H (2018). Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody. Oncotarget  9, 19026-19038.   https://doi.org/10.18632/oncotarget.24876",https://intramural.nih.gov/search/searchview.taf?ipid=104161
802,BC011735-03,"October 01, 2017 -  September 30, 2018",Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure,Shyam K Sharan|IRP Faculty Profile,NULL,"Office of the Director, NCI","Catherine I Drennan|Theresa Mae Guerin|Jerome  Schlomer|Stephanie L Henderson|Ludmila  Szabova; MS, PhD|Zoe W Ohler|Show all 7","Guillermina Gigi  Lozano (MD Anderson)|Michael  Oberst (MedImmune, Inc.)",N Keith Collins (Basic Research Laboratory)|Debra J Gilbert (Basic Research Laboratory)|Theresa N O'Sullivan (Basic Research Laboratory)|Bonita Anne Sears (Office Of The Director)|Glenn  Merlino; PhD (Laboratory of Cancer Biology and Genetics)|Udo  Rudloff (Pediatric Oncology Branch),Craig Joseph Thomas (NCATS),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104199
803,BC011836-01,"October 01, 2017 -  September 30, 2018",NOB-018  Mouse Model of CNS Radiation-Induced Hypersomnia,Terri Sue Armstrong; PhD|IRP Faculty Profile,NULL,"Neuro-Oncology Branch, NCI",Caitlin Renee Figiel|Dorela Doris Shuboni-Mulligan; PhD|Mark Richard Gilbert; MD,NULL,Deedee Kay Smart (Radiation Oncology Branch),NULL,"1. Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM (2017). Sleep-wake disturbance in patients with brain tumors. Neuro Oncol  19, 323-335.   https://doi.org/10.1093/neuonc/now119",https://intramural.nih.gov/search/searchview.taf?ipid=107343
804,BC011235-10,"October 01, 2017 -  September 30, 2018",Support of NCI CCR Clinical Research and Bioinformatics,Jason Edward Levine,Thomas A Misteli; PhD,"Office of the Director, NCI",Ravi Sankar Srinivas Dinavahi|Ming  Ji|Christian Jose Mambrin|Richard J Moon|Rohit  Paul|Jeffrey David Saxe|Show all 7,NULL,Mark Richard Gilbert; MD (Neuro-Oncology Branch)|Brigitte  Widemann; MD (Pediatric Oncology Branch)|William D Figg; PharmD (Genitourinary Malignancies Branch)|Pamela  Wolters (Pediatric Oncology Branch)|Stacia Martin Peron; PhD (Pediatric Oncology Branch),Heidi H Kong (NIAMS) |Jon W McKeeby (CC),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103938
805,BC011445-07,"October 01, 2017 -  September 30, 2018",Mathematical Modeling of cell colony growth and DNA Replication.,Stewart  Durell,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",Yinon  Shafrir|Kandice Danielle Tanner; PhD,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104028
806,BC011703-03,"October 01, 2017 -  September 30, 2018","Integrated analyses of genetics, epigenetics, and gene expression",Maxwell P Lee; PhD,Stuart H Yuspa; MD,"Laboratory of Cancer Biology and Genetics, NCI",Huaitian  Liu|Howard H Yang|Lalage  Wakefield; PhD|Kent W Hunter; PhD|Jeffrey E Green; MD|Glenn  Merlino; PhD|Show all 11,Kathleen  Arcaro (University of Massachusetts)|Hai  Hu (Windber Research Institute)|Sulma Ibrahim Mohammed,"Dinah  Singer; PhD (Experimental Immunology Branch)|Xin Wei Wang; PhD (Molecular Genetics and Carcinogenesis Section)|Karl Thomas Ried; MD (Cancer Genetics Branch)|Kevin  Gardner; MD, PhD (Cancer Genetics Branch)|Masaki  Terabe (Vaccine Branch)|Philip  Taylor; MD, ScD (Hormonal and Reproductive Epidemiology Branch)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104171
807,CP010205-10,"October 01, 2017 -  September 30, 2018",Scientific Computing,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Alyssa Marie Voss|Geoffrey Scott Tobias,NULL,"Robert  Hoover; MD, ScD (Epidemiology and Biostatistics Program)|Margaret Anne Tucker (Human Genetics Program)|Amanda  Black (Epidemiology and Biostatistics Program)",NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104306
808,BC011234-10,"October 01, 2017 -  September 30, 2018",CCR New Space Activation,Darren W Henderson,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103923
809,CO020002-10,"October 01, 2017 -  September 30, 2018",Space and Facilities Management,Norman Edward Sharpless; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,Jean P Khoshbin (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104247
810,CO030001-01,"October 01, 2017 -  September 30, 2018",TIL Rosenberuge Modular Processing Facility,Norman Edward Sharpless; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",NULL,NULL,NULL,Jean P Khoshbin (OD),NULL,https://intramural.nih.gov/search/searchview.taf?ipid=107756
811,BC011133-10,"October 01, 2017 -  September 30, 2018",CCR Office of Training and Education,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103576
812,BC011285-09,"October 01, 2017 -  September 30, 2018",CCR Education and Outreach,Melissa A Bronez,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103956
813,BC011365-06,"October 01, 2017 -  September 30, 2018","Cancer, Genetics, and Signaling Training Program",Janelle  Cortner,Thomas A Misteli; PhD,"Office of the Director, NCI",NULL,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103573
814,CP010204-10,"October 01, 2017 -  September 30, 2018","Communications, Education and Outreach","Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Alyssa Marie Voss|Catherine B McClave|Wendy  Schneider-Levinson|Jennifer K Loukissas|Victoria Anne McCallum|Jackie Ann Lavigne,NULL,Kristin O Kiser (Office of Education),NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104305
815,CP010208-09,"October 01, 2017 -  September 30, 2018",Special Studies Institutional Review Board Support,"Stephen J Chanock; MD, PhD|IRP Faculty Profile",NULL,"Office of the Director, NCI",Catherine G Schairer|Catherine B McClave,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104310
816,BC010857-12,"October 01, 2017 -  September 30, 2018",Science and Technology Resources,David Jay Goldstein,Thomas A Misteli; PhD,"Office of the Director, NCI",Ramalakshmi  Darbha|Peter C Fitzgerald|J  Foley|Scott Andrew Hannon|Mariam Q Malik|Carl E Mcintosh|Show all 8,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=103785
817,CO020001-10,"October 01, 2017 -  September 30, 2018",Technology Transfer Center,Norman Edward Sharpless; MD|IRP Faculty Profile,NULL,"Office Of The Director, NCI",Karen M Maurey,NULL,NULL,NULL,NULL,https://intramural.nih.gov/search/searchview.taf?ipid=104246
